archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,2.856e-06,1.1243,0.97428,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,4.9361e-06,0.98647,0.79322,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,9.9185e-12,0.92884,0.94652,1,1
1,GO BLEB ASSEMBLY,2.801e-10,0.9284,0.98896,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,8.4415e-08,0.90638,0.75609,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.7068e-11,0.8856,0.79702,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,1.1858e-08,0.83755,0.79246,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,6.6581e-11,0.83357,0.74354,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.0922e-10,0.80349,0.75889,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,4.8076e-11,0.7972,0.76677,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.277e-11,0.79054,0.75634,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.1595e-09,0.79012,0.77427,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.2926e-08,0.75827,0.72909,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.4499e-11,0.75129,0.6794,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,2.5223e-10,0.73633,0.7145,1,1
1,GO ETHANOL OXIDATION,7.8124e-06,0.73098,0.54156,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,5.5016e-10,0.7199,0.69532,1,1
1,GO RESPONSE TO INTERFERON BETA,2.6362e-08,0.71686,0.69726,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.3554e-11,0.71593,0.67206,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,6.0979e-10,0.71282,0.75608,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,2.3933e-10,0.7124,0.76507,1,1
1,GO HEMIDESMOSOME ASSEMBLY,8.0712e-08,0.71097,0.76376,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,5.5016e-10,0.70906,0.73217,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.5277e-10,0.70605,0.72521,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.3948e-05,0.70119,0.60342,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,3.9872e-06,0.70084,0.56158,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,9.9064e-10,0.68676,0.66061,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,5.8262e-07,0.68406,0.60295,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.9047e-09,0.68135,0.57772,1,1
1,GO MEMBRANE RAFT ORGANIZATION,1.2604e-07,0.67951,0.63292,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,7.6792e-10,0.67233,0.66851,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.1535e-07,0.66924,0.50886,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.0554e-07,0.66713,0.50481,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.1789e-06,0.66496,0.6042,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.1533e-09,0.66384,0.62549,1,1
1,GO NEUTROPHIL HOMEOSTASIS,4.249e-10,0.65718,0.63597,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.0422e-09,0.65394,0.63155,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,4.4807e-06,0.64269,0.57987,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.9872e-09,0.64248,0.56085,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.8396e-06,0.63919,0.56106,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.4341e-06,0.63632,0.52158,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,5.5016e-10,0.63353,0.57246,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.9941e-08,0.62293,0.59571,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,1.8793e-06,0.61717,0.54779,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,2.457e-10,0.60549,0.61224,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4112e-09,0.60432,0.57006,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,4.2444e-07,0.60182,0.50975,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,1.8142e-08,0.58574,0.47449,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.0554e-07,0.58549,0.55198,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,1.2954e-05,0.58314,0.50912,1,1
1,GO RESPONSE TO TYPE I INTERFERON,6.337e-06,0.58203,0.45423,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.2604e-07,0.58122,0.5931,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,2.5934e-07,0.5809,0.50342,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,9.7991e-09,0.58061,0.51738,1,1
1,GO TOLERANCE INDUCTION,2.7804e-05,0.5746,0.41721,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,2.1543e-10,0.56918,0.59072,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.7154e-07,0.56423,0.48292,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.1543e-10,0.56256,0.60623,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.7041e-11,0.56236,0.52319,1,1
1,GO MYOBLAST MIGRATION,6.6578e-05,0.56145,0.45772,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,6.0205e-08,0.56129,0.49066,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,8.9487e-10,0.55924,0.578,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,8.4877e-09,0.55893,0.48123,1,1
1,GO EPIBOLY,9.4499e-11,0.5477,0.56708,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.5688e-10,0.54749,0.5273,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,1.0554e-07,0.54646,0.46816,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.3629e-10,0.54427,0.537,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,3.0156e-07,0.54187,0.5259,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.9465e-08,0.54179,0.58582,1,1
1,GO HIPPO SIGNALING,2.9805e-09,0.54153,0.52534,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,8.9047e-09,0.5395,0.6324,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,3.4296e-07,0.53617,0.50405,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,1.3693e-05,0.53341,0.46007,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,4.0868e-08,0.52967,0.5597,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,4.3082e-09,0.52801,0.47601,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.8419e-06,0.52669,0.57568,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.4407e-08,0.52633,0.45299,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,3.7356e-07,0.52613,0.48739,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,3.6361e-10,0.52591,0.5904,1,1
1,GO CYTOLYSIS,4.7963e-08,0.52496,0.47542,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.1041e-08,0.52475,0.48805,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.9064e-09,0.52436,0.54583,1,1
1,GO NOTOCHORD DEVELOPMENT,5.77e-09,0.52239,0.56239,1,1
1,GO LEUKOCYTE AGGREGATION,2.0776e-06,0.52181,0.44563,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.6823e-09,0.51951,0.52496,1,1
1,GO MUCUS SECRETION,2.3661e-05,0.51648,0.5133,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,2.6914e-06,0.51648,0.50755,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.8396e-06,0.51553,0.41731,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.3784e-07,0.51531,0.4782,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.8246e-05,0.51463,0.4033,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.4471e-09,0.51204,0.46311,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,6.5125e-09,0.50743,0.47096,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,3.2894e-09,0.50618,0.53193,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,1.5052e-06,0.50585,0.46309,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.0205e-08,0.50268,0.39924,1,1
1,GO BIOLOGICAL PHASE,3.8983e-07,0.50166,0.54228,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.8001e-06,0.499,0.47665,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.8142e-08,0.49804,0.48238,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.6981e-08,0.49287,0.38531,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.6362e-08,0.48884,0.40807,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7668e-07,0.48881,0.41926,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.357e-07,0.48853,0.44796,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,7.969e-07,0.48742,0.59806,1,1
1,GO ZYMOGEN INHIBITION,1.0161e-09,0.48734,0.56697,1,1
1,GO SKIN MORPHOGENESIS,7.969e-07,0.48626,0.55986,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,9.6538e-08,0.48611,0.53894,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,8.4415e-08,0.48427,0.45735,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.892e-08,0.48377,0.44342,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.5037e-07,0.48205,0.41337,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.9859e-05,0.48088,0.41518,1,1
1,GO TYPE 2 IMMUNE RESPONSE,1.2733e-08,0.48071,0.44338,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,3.0905e-06,0.48011,0.44753,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.3468e-07,0.47973,0.49047,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.2321e-08,0.47781,0.39349,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.8318e-07,0.47469,0.41514,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,5.77e-09,0.47371,0.47198,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,4.7963e-08,0.47251,0.54825,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.8885e-07,0.46824,0.38873,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,1.069e-09,0.46822,0.43268,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.0554e-07,0.46703,0.51122,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,1.0958e-05,0.46547,0.36077,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,3.1729e-08,0.46497,0.56619,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.2775e-07,0.46401,0.48315,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.3617e-10,0.46334,0.40072,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,4.7963e-08,0.46312,0.47575,1,1
1,GO FIBRINOLYSIS,1.1041e-08,0.46246,0.54346,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.0398e-08,0.46237,0.40999,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,3.9822e-07,0.46216,0.54807,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.4471e-09,0.46173,0.46374,1,1
1,GO MITRAL VALVE DEVELOPMENT,2.6352e-05,0.4585,0.3946,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.6907e-08,0.45777,0.39479,1,1
1,GO ENDODERM FORMATION,1.069e-09,0.45754,0.5072,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00014129,0.45503,0.38151,1,1
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,1.2482e-05,0.45103,0.43627,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,1.2281e-06,0.45039,0.45812,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.8753e-10,0.44953,0.46081,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,4.4285e-07,0.44847,0.42793,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.4854e-10,0.44821,0.51857,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00022927,0.4478,0.53707,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,2.8262e-08,0.4467,0.45753,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,1.3999e-08,0.44667,0.42079,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,7.6446e-07,0.4458,0.40092,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.8885e-07,0.44518,0.37002,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,3.0295e-08,0.44314,0.42043,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,5.02e-08,0.44211,0.41836,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,3.6361e-10,0.44192,0.47095,1,1
1,GO ETHANOL METABOLIC PROCESS,1.6158e-05,0.441,0.39886,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,8.4415e-08,0.44098,0.42094,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.6567e-07,0.44049,0.48278,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00053704,0.44015,0.37235,1,1
1,GO ENDODERM DEVELOPMENT,1.6001e-09,0.43778,0.4431,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.9498e-07,0.43745,0.39203,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,1.2143e-08,0.43744,0.39068,1,1
1,GO INTERLEUKIN 1 PRODUCTION,3.1004e-08,0.43708,0.3981,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,3.2162e-07,0.43608,0.44267,1,1
1,GO T CELL MEDIATED IMMUNITY,1.4076e-07,0.43523,0.35796,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,6.545e-05,0.43489,0.33639,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.4452e-09,0.43483,0.39312,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,2.7078e-07,0.43464,0.45396,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.6435e-08,0.43458,0.39343,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,2.6362e-08,0.43415,0.44603,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.2046e-07,0.43399,0.3562,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,5.2445e-07,0.43343,0.51662,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.00012804,0.4329,0.40502,1,1
1,GO RETINAL METABOLIC PROCESS,2.2416e-05,0.43236,0.4052,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.1361e-07,0.43202,0.39471,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,3.055e-09,0.4319,0.42376,1,1
1,GO HEME METABOLIC PROCESS,1.2682e-10,0.43181,0.42722,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00010497,0.43133,0.34961,1,1
1,GO RESPONSE TO INTERLEUKIN 18,2.2824e-05,0.43099,0.52782,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.5427e-10,0.43049,0.45948,1,1
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0024609,0.42956,0.32104,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,2.0478e-05,0.42847,0.39343,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,7.6657e-06,0.42801,0.45122,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.9309e-10,0.42796,0.44508,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0001803,0.42662,0.39363,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.2792e-06,0.42638,0.44281,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,5.332e-06,0.42633,0.3928,1,1
1,GO VASCULOGENESIS,1.6542e-10,0.42595,0.44826,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,1.5293e-05,0.425,0.41944,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,9.9064e-10,0.424,0.45776,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.3769e-07,0.42367,0.51581,1,1
1,GO PINOCYTOSIS,1.9064e-09,0.42361,0.40308,1,1
1,GO TROPHOBLAST CELL MIGRATION,2.1807e-07,0.42335,0.45307,1,1
1,GO INTERLEUKIN 13 PRODUCTION,4.4807e-06,0.42306,0.42546,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.4701e-07,0.42291,0.43402,1,1
1,GO DEFENSE RESPONSE TO VIRUS,6.1583e-08,0.42288,0.34062,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,7.4873e-07,0.42275,0.44796,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,4.4148e-09,0.42244,0.38161,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.0776e-06,0.42224,0.41012,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,1.6321e-06,0.4222,0.42294,1,1
1,GO REGULATION OF PINOCYTOSIS,1.9989e-07,0.42219,0.34549,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.8673e-09,0.41983,0.40609,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,5.5127e-05,0.41952,0.34547,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.0983e-10,0.4192,0.46618,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,4.4807e-06,0.41723,0.34833,1,1
1,GO APOPTOTIC CELL CLEARANCE,3.055e-09,0.41648,0.42984,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.6457e-05,0.41524,0.37932,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.6386e-06,0.414,0.43738,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,5.8262e-07,0.41307,0.43366,1,1
1,GO DETECTION OF BIOTIC STIMULUS,5.7051e-07,0.41282,0.41344,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.6457e-05,0.4116,0.45179,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,3.0395e-05,0.41118,0.43162,1,1
1,GO ENTRY INTO HOST,4.8673e-09,0.41098,0.39274,1,1
1,GO CD40 SIGNALING PATHWAY,8.5043e-10,0.4104,0.43287,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.9989e-07,0.41004,0.39293,1,1
1,GO ZYMOGEN ACTIVATION,1.3325e-06,0.40991,0.4108,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,5.7051e-07,0.40872,0.34745,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,1.0322e-07,0.40867,0.37242,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.3784e-07,0.40805,0.39896,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.4148e-09,0.40791,0.39241,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,6.0759e-07,0.40788,0.34741,1,1
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00084997,0.40574,0.32746,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.4163e-06,0.405,0.37361,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00040235,0.40403,0.37507,1,1
1,GO PIGMENT ACCUMULATION,6.1583e-08,0.40386,0.41354,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.484e-09,0.40345,0.3686,1,1
1,GO INTERLEUKIN 8 PRODUCTION,3.3228e-08,0.40339,0.39248,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.9175e-06,0.40301,0.41439,1,1
1,GO SERTOLI CELL DEVELOPMENT,1.3056e-06,0.40271,0.39021,1,1
1,GO CYSTEINE METABOLIC PROCESS,5.9056e-05,0.40207,0.35742,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,3.628e-05,0.40201,0.30737,1,1
1,GO INTERLEUKIN 17 PRODUCTION,5.2445e-07,0.40168,0.33738,1,1
1,GO RESPONSE TO INTERLEUKIN 12,9.5677e-09,0.40076,0.35025,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.2886e-07,0.39981,0.36499,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.9822e-07,0.39803,0.3496,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.6418e-07,0.39763,0.43896,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,7.3772e-08,0.39729,0.42644,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.9175e-06,0.39727,0.40763,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.3056e-06,0.39691,0.34224,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,1.7693e-06,0.39587,0.39203,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,1.3948e-05,0.39504,0.34358,1,1
1,GO PROTEIN ACTIVATION CASCADE,2.2926e-08,0.39495,0.39128,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.6657e-06,0.39322,0.34869,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.2094e-09,0.39302,0.41407,1,1
1,GO LYMPH VESSEL DEVELOPMENT,3.6924e-05,0.3912,0.34701,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,2.3853e-09,0.39081,0.40272,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.0437e-10,0.39072,0.37739,1,1
1,GO FOCAL ADHESION ASSEMBLY,1.8723e-07,0.38946,0.37398,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.3948e-05,0.38945,0.29847,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,4.7488e-06,0.38934,0.39595,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,5.5127e-05,0.38921,0.33109,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,2.4972e-05,0.38893,0.40834,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,2.4837e-07,0.38859,0.44647,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,6.5837e-06,0.38779,0.47233,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.5868e-06,0.38756,0.36628,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,3.7605e-06,0.38747,0.37041,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,8.8389e-07,0.3868,0.40726,1,1
1,GO VIRAL GENOME REPLICATION,2.0398e-08,0.38565,0.34109,1,1
1,GO T CELL APOPTOTIC PROCESS,5.6317e-09,0.38494,0.32733,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,1.0361e-05,0.38479,0.37019,1,1
1,GO T CELL EXTRAVASATION,7.6657e-06,0.38475,0.39897,1,1
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.013546,0.38351,0.30298,1,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00024045,0.3835,0.31893,1,1
1,GO PLASMINOGEN ACTIVATION,2.6914e-06,0.3821,0.4033,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.7309e-08,0.38158,0.35259,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,1.9393e-05,0.3814,0.41109,1,1
1,GO POSITIVE REGULATION OF COAGULATION,3.2784e-06,0.3813,0.31885,1,1
1,GO GERMINAL CENTER FORMATION,2.4972e-05,0.38118,0.3459,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.0279e-08,0.38112,0.34749,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,7.5451e-08,0.38011,0.3869,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,8.6328e-08,0.38003,0.40488,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.0557e-05,0.38002,0.35774,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.5934e-07,0.37983,0.32047,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,6.2169e-06,0.3795,0.38403,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,7.0337e-07,0.37776,0.35178,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,8.7237e-10,0.37738,0.3841,1,1
1,GO OSTEOBLAST DEVELOPMENT,1.2886e-07,0.37728,0.35615,1,1
1,GO MONOCYTE CHEMOTAXIS,7.8124e-06,0.37681,0.30168,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.5865e-05,0.37641,0.32666,1,1
1,GO MUSCLE CELL FATE COMMITMENT,1.0169e-05,0.37613,0.33581,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00027716,0.37567,0.28865,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,1.3599e-06,0.3756,0.35333,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.0791e-07,0.3752,0.38223,1,1
1,GO RESPONSE TO SALT STRESS,1.1034e-07,0.3751,0.32162,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,1.0169e-05,0.37505,0.37218,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,1.3878e-06,0.37426,0.29532,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.1196e-06,0.37408,0.36676,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,6.0991e-06,0.37405,0.34689,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.734e-06,0.37401,0.32194,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.5027e-08,0.37384,0.41571,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,1.7154e-07,0.37303,0.33766,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,6.545e-05,0.37159,0.30855,1,1
1,GO PROSTATE GLAND GROWTH,0.003607,0.37126,0.37319,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,9.0235e-07,0.36937,0.42933,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,3.3214e-05,0.36904,0.26595,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,1.5865e-05,0.36894,0.40601,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.475e-06,0.36886,0.3104,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0005618,0.36846,0.33091,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.5713e-07,0.36709,0.40365,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,9.4407e-08,0.36686,0.5116,1,1
1,GO I KAPPAB PHOSPHORYLATION,1.7534e-07,0.3667,0.29844,1,1
1,GO PEPTIDE CROSS LINKING,2.6828e-05,0.3664,0.3333,1,1
1,GO LYMPHANGIOGENESIS,1.3351e-08,0.3663,0.39784,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,5.6085e-05,0.36594,0.33368,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,5.6317e-09,0.36509,0.37688,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7909e-10,0.36487,0.34659,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,9.9064e-10,0.36418,0.35363,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.9014e-08,0.36409,0.3228,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.3024e-10,0.36376,0.34362,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,6.2046e-07,0.36369,0.37098,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,7.0017e-09,0.36345,0.37433,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,6.0759e-07,0.36333,0.28882,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.9624e-10,0.36285,0.4323,1,1
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00064263,0.36224,0.30329,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.734e-06,0.36146,0.41836,1,1
1,GO AMYLOID BETA CLEARANCE,1.2604e-07,0.36038,0.3326,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,3.094e-05,0.35995,0.32912,1,1
1,GO AMINE CATABOLIC PROCESS,0.00011033,0.35983,0.30073,1,1
1,GO GAP JUNCTION ASSEMBLY,3.4773e-06,0.35963,0.35803,1,1
1,GO FIBROBLAST MIGRATION,8.8282e-08,0.35954,0.33296,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.2321e-08,0.35904,0.3847,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,1.1794e-07,0.35902,0.35096,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.7078e-07,0.35746,0.34143,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,7.105e-06,0.35688,0.31509,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.8053e-06,0.35681,0.33133,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.8416e-06,0.35669,0.36001,1,1
1,GO RESPONSE TO HYDROPEROXIDE,0.0021215,0.35633,0.25698,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,4.1815e-08,0.35632,0.3835,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,9.5999e-07,0.35622,0.39304,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00027284,0.35605,0.29362,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,5.02e-08,0.35604,0.44475,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,6.5906e-08,0.35577,0.32571,1,1
1,GO DNA DEAMINATION,1.1806e-05,0.35571,0.44625,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.8124e-06,0.35564,0.42122,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,9.0235e-07,0.35479,0.34072,1,1
1,GO REGULATION OF TRANSPOSITION,0.00027716,0.35415,0.3202,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,1.1307e-08,0.35401,0.35394,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0007901,0.35386,0.29156,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.3769e-07,0.35275,0.37133,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.9047e-09,0.35228,0.34614,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.1041e-08,0.35186,0.40261,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,2.1624e-06,0.35146,0.34029,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00076726,0.35129,0.3127,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,3.4773e-06,0.35112,0.31432,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,7.2414e-06,0.35083,0.36389,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,2.2139e-09,0.35042,0.33004,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,3.7605e-06,0.34928,0.3894,1,1
1,GO MATURATION OF LSU RRNA,1.3693e-05,0.34921,0.30677,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0056255,0.34916,0.23316,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.7963e-08,0.34889,0.32383,1,1
1,GO HYPOTONIC RESPONSE,1.1588e-05,0.34864,0.30489,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.00019541,0.34783,0.51576,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.6328e-08,0.34738,0.36425,1,1
1,GO MYOBLAST PROLIFERATION,0.0012177,0.34666,0.2391,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.892e-08,0.3461,0.30993,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.00038422,0.34606,0.27084,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,3.8924e-05,0.34536,0.35322,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2792e-06,0.34526,0.40333,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.342e-06,0.3446,0.28913,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,1.1375e-05,0.34399,0.33606,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,5.7582e-06,0.34399,0.32614,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,6.2046e-07,0.34393,0.35071,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,7.4873e-07,0.34287,0.26623,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,5.8262e-07,0.34284,0.29966,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0024609,0.34279,0.30478,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.1196e-06,0.34248,0.29088,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,5.8698e-06,0.34218,0.30331,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.6782e-07,0.34167,0.37421,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.9102e-06,0.34147,0.46416,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,9.5677e-09,0.34147,0.36564,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.8363e-05,0.34134,0.25798,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.00076726,0.34133,0.32469,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.7668e-07,0.34132,0.35769,1,1
1,GO TYPE I INTERFERON PRODUCTION,7.5451e-08,0.34072,0.29351,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,2.5756e-08,0.34046,0.31999,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.00091404,0.34044,0.25894,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,4.9694e-05,0.33984,0.35453,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0013069,0.33933,0.25249,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,3.9035e-08,0.33895,0.36502,1,1
1,GO RESPONSE TO ANGIOTENSIN,7.1726e-09,0.33871,0.36164,1,1
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0071051,0.33869,0.27238,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,3.3228e-08,0.33868,0.33538,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,7.6283e-05,0.33866,0.34688,1,1
1,GO EMBRYO IMPLANTATION,2.402e-08,0.33849,0.33859,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.3359e-07,0.33822,0.38429,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.9228e-07,0.33767,0.37023,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,7.9617e-06,0.33765,0.3689,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.5794e-07,0.33722,0.33188,1,1
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00012186,0.33715,0.32366,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,7.105e-06,0.33713,0.4017,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,1.3693e-05,0.33637,0.3252,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.0759e-07,0.33613,0.28161,1,1
1,GO INTERACTION WITH SYMBIONT,5.1101e-09,0.33605,0.29323,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,1.9175e-06,0.33601,0.44049,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.6202e-07,0.336,0.35177,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,1.6761e-05,0.3358,0.37855,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,4.4807e-06,0.33494,0.31122,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.4873e-07,0.33491,0.2933,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,1.0756e-05,0.33463,0.29597,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,3.3629e-10,0.33376,0.38007,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,4.7999e-05,0.33352,0.33816,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,2.0364e-06,0.33333,0.30255,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.1307e-08,0.33306,0.33653,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.0056255,0.33293,0.19648,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0023957,0.33212,0.2386,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,8.4262e-06,0.33207,0.3472,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.0905e-06,0.33186,0.35833,1,1
1,GO RESPONSE TO VIRUS,4.0868e-08,0.33168,0.2963,1,1
1,GO RESPONSE TO X RAY,6.5125e-09,0.33161,0.41991,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.9749e-05,0.3312,0.29977,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,3.9102e-06,0.33119,0.32069,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.8149e-08,0.33108,0.3665,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.9069e-08,0.33077,0.44707,1,1
1,GO REGULATION OF GASTRULATION,1.7687e-09,0.33034,0.33834,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.7693e-06,0.33014,0.29667,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.8389e-07,0.32999,0.31722,1,1
1,GO INTERFERON BETA PRODUCTION,6.8885e-07,0.32986,0.28502,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,6.3359e-07,0.32964,0.31893,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00053704,0.32961,0.23585,1,1
1,GO CELLULAR RESPONSE TO X RAY,2.206e-06,0.329,0.37803,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,5.6085e-05,0.32817,0.32069,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,4.4285e-07,0.32772,0.40023,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,5.4967e-09,0.3277,0.27517,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,3.5038e-07,0.32757,0.26573,1,1
1,GO CYTOKINE METABOLIC PROCESS,6.1583e-08,0.32679,0.31334,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00029052,0.32658,0.38166,1,1
1,GO PLATELET AGGREGATION,5.9498e-07,0.32614,0.3217,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,8.9166e-06,0.3258,0.28024,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,4.9228e-07,0.32413,0.36089,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0048405,0.32385,0.33914,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00019541,0.32374,0.25965,1,1
1,GO REGULATION OF CELL KILLING,0.00027716,0.32364,0.22399,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.2733e-08,0.32334,0.30798,1,1
1,GO VIRAL TRANSLATION,7.892e-08,0.32324,0.336,1,1
1,GO CERAMIDE CATABOLIC PROCESS,2.1621e-05,0.32312,0.30704,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,1.6654e-06,0.32285,0.28832,1,1
1,GO NIK NF KAPPAB SIGNALING,1.0964e-09,0.32253,0.31294,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.8419e-06,0.32244,0.47973,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,3.5794e-07,0.3224,0.33274,1,1
1,GO KERATINOCYTE PROLIFERATION,0.00084997,0.32155,0.29593,1,1
1,GO ARTERY DEVELOPMENT,0.00018323,0.3213,0.265,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,4.2784e-08,0.32098,0.38148,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,5.2344e-05,0.32089,0.47005,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,5.3647e-09,0.32051,0.34311,1,1
1,GO HAIR FOLLICLE MATURATION,7.3803e-06,0.31973,0.33037,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.00086244,0.31972,0.29557,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,1.2482e-05,0.31904,0.30744,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.471e-07,0.31903,0.31599,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,8.7316e-05,0.31897,0.27095,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00037835,0.31892,0.30254,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,4.2042e-09,0.31792,0.31787,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,2.0478e-05,0.31774,0.27687,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.6877e-06,0.31771,0.25341,1,1
1,GO SERTOLI CELL DIFFERENTIATION,1.3693e-05,0.31691,0.30072,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,2.2824e-05,0.3169,0.38276,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.4334e-08,0.31646,0.30874,1,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00015838,0.31635,0.25396,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.5239e-09,0.31612,0.30524,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,5.4982e-08,0.31606,0.3321,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,8.6328e-08,0.31592,0.3294,1,1
1,GO PROSTANOID METABOLIC PROCESS,5.7051e-07,0.31581,0.37457,1,1
1,GO MONONUCLEAR CELL MIGRATION,4.719e-07,0.31559,0.30476,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.2775e-07,0.31544,0.25908,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,1.2534e-06,0.3154,0.2939,1,1
1,GO HYALURONAN METABOLIC PROCESS,6.2993e-08,0.31512,0.31723,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,3.7282e-08,0.31503,0.38753,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,7.2129e-08,0.31485,0.34725,1,1
1,GO PODOSOME ASSEMBLY,9.2321e-08,0.31454,0.40043,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0016806,0.31429,0.26723,1,1
1,GO B CELL MEDIATED IMMUNITY,6.0759e-07,0.31412,0.31155,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.5753e-08,0.31392,0.42081,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,3.0295e-08,0.31391,0.32164,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.2253e-05,0.31368,0.35349,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,3.2057e-05,0.31344,0.28415,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,1.7071e-05,0.31297,0.37179,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00014839,0.31263,0.28914,1,1
1,GO LIPOPROTEIN LOCALIZATION,1.2253e-05,0.31254,0.30885,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,5.3256e-05,0.31246,0.27628,1,1
1,GO GENITALIA MORPHOGENESIS,0.00013016,0.31228,0.30364,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,5.0278e-07,0.3122,0.31693,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0013633,0.31216,0.24842,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00017741,0.3116,0.37958,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0001179,0.31159,0.22963,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.9558e-07,0.31141,0.30912,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0001803,0.31114,0.23371,1,1
1,GO MACROPHAGE CHEMOTAXIS,1.5713e-07,0.31061,0.29438,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.4296e-07,0.31042,0.3064,1,1
1,GO VIRAL LIFE CYCLE,1.5217e-09,0.31023,0.29814,1,1
1,GO VIRAL RNA GENOME REPLICATION,7.3772e-08,0.31014,0.31331,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,4.1751e-05,0.3101,0.32712,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,9.086e-06,0.31006,0.36841,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,4.2271e-06,0.30996,0.26682,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,7.105e-06,0.30986,0.27755,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0012527,0.30984,0.35623,1,1
1,GO NEUROBLAST DIVISION,0.0016575,0.30938,0.29829,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.5233e-07,0.30924,0.29815,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,6.545e-05,0.30912,0.34403,1,1
1,GO RESPONSE TO ESTROGEN,2.5756e-08,0.30881,0.29989,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.001568,0.30873,0.28705,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,4.5233e-07,0.30865,0.33389,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,5.4184e-05,0.30852,0.29449,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0037985,0.30848,0.26725,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00044103,0.30795,0.27936,1,1
1,GO ENAMEL MINERALIZATION,0.00057029,0.30791,0.33936,1,1
1,GO T CELL CHEMOTAXIS,3.5794e-07,0.30787,0.29269,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00010852,0.30782,0.27042,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.0089251,0.30757,0.25568,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,1.8053e-06,0.30756,0.35382,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00032916,0.30747,0.40884,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.6062e-07,0.30688,0.33365,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.0361e-05,0.30679,0.28291,1,1
1,GO MACROPHAGE MIGRATION,2.4586e-08,0.30664,0.30974,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,2.2015e-05,0.30648,0.25809,1,1
1,GO PROTEIN DEGLYCOSYLATION,1.4163e-06,0.30601,0.31456,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.2397e-08,0.30586,0.258,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,8.8796e-05,0.30521,0.21734,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00048316,0.30518,0.23116,1,1
1,GO TRACHEA DEVELOPMENT,0.00024819,0.30518,0.28895,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.7706e-05,0.30517,0.25345,1,1
1,GO TRANSPOSITION,0.00082553,0.30517,0.25998,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,1.0424e-06,0.30449,0.35071,1,1
1,GO LIVER REGENERATION,2.188e-08,0.30441,0.30745,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,2.971e-06,0.3044,0.32903,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.8416e-06,0.30433,0.27591,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0062877,0.30429,0.23385,1,1
1,GO CHONDROCYTE PROLIFERATION,0.00026858,0.30409,0.37047,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.3355e-07,0.30344,0.28464,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,1.2792e-06,0.30335,0.31713,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.4409e-05,0.30312,0.32874,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.3999e-08,0.30304,0.29332,1,1
1,GO RIG I SIGNALING PATHWAY,1.4677e-08,0.30297,0.32562,1,1
1,GO FOREGUT MORPHOGENESIS,2.9514e-07,0.30271,0.36577,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,6.1583e-08,0.30241,0.32158,1,1
1,GO ERBB2 SIGNALING PATHWAY,4.719e-07,0.30234,0.28318,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0001803,0.30233,0.24922,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.5424e-05,0.30222,0.27096,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,7.7166e-08,0.3022,0.28541,1,1
1,GO REGULATION OF STEROL TRANSPORT,4.2444e-07,0.30211,0.30746,1,1
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0071051,0.30184,0.24068,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,1.0756e-05,0.30183,0.29795,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.8911e-05,0.30179,0.27851,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.8814e-05,0.30158,0.26584,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.8124e-06,0.30146,0.25965,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,4.9228e-07,0.30128,0.31646,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,4.4807e-06,0.30119,0.26254,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0024609,0.30074,0.23133,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,4.8839e-05,0.30072,0.27482,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.2958e-06,0.30069,0.26388,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,9.9844e-05,0.30063,0.32951,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.0776e-06,0.30053,0.27092,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.1004e-08,0.30051,0.31763,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.7051e-07,0.30005,0.33225,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,4.0868e-08,0.30003,0.2847,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,3.5794e-07,0.29985,0.23478,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,3.6435e-08,0.29902,0.32531,1,1
1,GO PROTEIN OXIDATION,0.0039481,0.29895,0.29336,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,3.4098e-06,0.29847,0.32262,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,7.3739e-05,0.29777,0.33233,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,4.31e-06,0.29749,0.37087,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.3693e-05,0.29736,0.30653,1,1
1,GO EPITHELIAL CELL CELL ADHESION,0.0078263,0.29719,0.31198,1,1
1,GO SALIVARY GLAND DEVELOPMENT,5.4356e-06,0.29699,0.38554,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,1.6907e-08,0.29678,0.2651,1,1
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0010558,0.29669,0.24665,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,7.105e-06,0.29668,0.31927,1,1
1,GO COLLAGEN CATABOLIC PROCESS,4.2444e-07,0.29667,0.33437,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.2859e-07,0.29593,0.27117,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.8305e-05,0.29543,0.26258,1,1
1,GO CHEMOKINE PRODUCTION,3.3214e-05,0.29537,0.24756,1,1
1,GO MEMBRANE INVAGINATION,3.0156e-07,0.29528,0.28863,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.5576e-05,0.29526,0.28935,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.5293e-05,0.29525,0.28109,1,1
1,GO LAMELLIPODIUM ORGANIZATION,2.4371e-06,0.29513,0.2499,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,1.7693e-06,0.29504,0.31404,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.7356e-07,0.2947,0.29355,1,1
1,GO ASYMMETRIC CELL DIVISION,6.0991e-06,0.29383,0.28186,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.0657e-06,0.29374,0.38108,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2534e-06,0.2935,0.34486,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,1.1588e-05,0.29348,0.23258,1,1
1,GO BONE GROWTH,1.7385e-05,0.29335,0.33707,1,1
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0012886,0.29333,0.25097,1,1
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0078263,0.29313,0.21164,1,1
1,GO INTERFERON ALPHA PRODUCTION,3.6924e-05,0.29281,0.2541,1,1
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00015838,0.29273,0.23966,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00022208,0.29236,0.30734,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.5753e-08,0.29213,0.29804,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.8246e-05,0.29201,0.25353,1,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0088198,0.29163,0.21515,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.1316e-06,0.29163,0.29159,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,3.152e-06,0.29136,0.25869,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.3784e-07,0.29129,0.27351,1,1
1,GO REGULATION OF BONE DEVELOPMENT,6.0991e-06,0.291,0.27413,1,1
1,GO T CELL MIGRATION,1.4454e-06,0.29099,0.28407,1,1
1,GO VAGINA DEVELOPMENT,1.4163e-06,0.29093,0.36112,1,1
1,GO RESPONSE TO INTERLEUKIN 15,8.7316e-05,0.2909,0.27035,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.3468e-07,0.29081,0.29072,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,6.6578e-05,0.29057,0.27657,1,1
1,GO CELL SUBSTRATE ADHESION,2.538e-07,0.29055,0.32066,1,1
1,GO RECEPTOR CATABOLIC PROCESS,9.6538e-08,0.29042,0.33763,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,1.6761e-05,0.29041,0.22036,1,1
1,GO OSTEOCLAST DEVELOPMENT,1.5052e-06,0.28982,0.33484,1,1
1,GO INNATE IMMUNE RESPONSE,9.5999e-07,0.28968,0.25719,1,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.00022927,0.28953,0.29321,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,1.3948e-05,0.2892,0.2836,1,1
1,GO MUSCLE FILAMENT SLIDING,2.7452e-06,0.28919,0.25109,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0016575,0.28872,0.30504,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.8305e-05,0.28849,0.25467,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.8135e-09,0.28847,0.29409,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.7668e-07,0.28838,0.30434,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1086e-06,0.28833,0.31411,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00024045,0.28808,0.25259,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,6.0079e-05,0.28771,0.29228,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,3.094e-05,0.28768,0.27263,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,1.4741e-05,0.28732,0.30941,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.3056e-06,0.28718,0.30079,1,1
1,GO AORTIC VALVE DEVELOPMENT,3.4409e-05,0.28709,0.34016,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,1.4472e-05,0.2869,0.25364,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.011e-05,0.28684,0.3155,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.9136e-07,0.28665,0.2885,1,1
1,GO T CELL PROLIFERATION,2.3661e-05,0.28603,0.22132,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,3.2631e-05,0.28576,0.34325,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.1588e-05,0.28566,0.26981,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.0323e-06,0.28554,0.2376,1,1
1,GO DENDRITIC CELL MIGRATION,0.0011021,0.28536,0.251,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,2.1375e-08,0.28503,0.34944,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0429e-07,0.28502,0.28209,1,1
1,GO INTERACTION WITH HOST,9.5677e-09,0.28498,0.29341,1,1
1,GO PROSTATE GLAND DEVELOPMENT,6.5837e-06,0.28485,0.37328,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,6.337e-06,0.28457,0.29161,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3325e-06,0.28428,0.29051,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,1.2032e-06,0.28408,0.30503,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,5.7582e-06,0.28407,0.32895,1,1
1,GO T CELL CYTOKINE PRODUCTION,6.7105e-06,0.28407,0.25481,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00031907,0.28382,0.229,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.8369e-09,0.2837,0.32628,1,1
1,GO REGULATION OF PROTEIN MATURATION,3.4553e-09,0.28356,0.29796,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,8.5858e-05,0.28323,0.29216,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00072342,0.28322,0.20645,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.00043435,0.28319,0.25448,1,1
1,GO PROSTATIC BUD FORMATION,0.0068504,0.28316,0.26879,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.1456e-06,0.283,0.31458,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.2032e-06,0.28291,0.35753,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.1034e-07,0.28234,0.29338,1,1
1,GO MATURATION OF SSU RRNA,4.2487e-05,0.28233,0.27133,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,1.5713e-07,0.28219,0.30396,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.0212e-06,0.28192,0.31401,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.2886e-07,0.28158,0.382,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0002117,0.28148,0.26687,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.188e-08,0.2809,0.29499,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,1.0554e-07,0.28076,0.29882,1,1
1,GO CELL MATRIX ADHESION,1.3599e-06,0.28061,0.29692,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,1.5052e-06,0.28059,0.27491,1,1
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0012886,0.28041,0.23295,1,1
1,GO RESPONSE TO DSRNA,1.1086e-06,0.28032,0.26155,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.7385e-05,0.28023,0.26766,1,1
1,GO MACROPHAGE PROLIFERATION,0.00055343,0.28019,0.31497,1,1
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,5.1304e-06,0.27977,0.34341,1,1
1,GO AMYLOID FIBRIL FORMATION,0.0049019,0.27949,0.24492,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.4677e-08,0.27914,0.31863,1,1
1,GO ARGININE METABOLIC PROCESS,6.8396e-06,0.27914,0.30603,1,1
1,GO RESPONSE TO INTERLEUKIN 1,7.3476e-09,0.27885,0.26802,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,4.9694e-05,0.27885,0.25328,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.4163e-06,0.27883,0.26194,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,5.0323e-06,0.27876,0.34918,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.1338e-07,0.27811,0.2559,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,4.2487e-05,0.27806,0.3399,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.5424e-05,0.27778,0.25382,1,1
1,GO AORTA DEVELOPMENT,0.0020367,0.27752,0.23706,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,4.4771e-05,0.27716,0.24934,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.7312e-05,0.27705,0.23316,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0019023,0.277,0.22859,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,0.0046604,0.27684,0.18333,1,1
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00014129,0.27656,0.35666,1,1
1,GO REGULATION OF MYOBLAST FUSION,2.8305e-05,0.2763,0.3297,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,9.086e-06,0.27626,0.27923,1,1
1,GO NADPH REGENERATION,3.9102e-06,0.27615,0.28322,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.1624e-06,0.2761,0.31772,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013899,0.27596,0.21791,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,6.4699e-07,0.27595,0.24343,1,1
1,GO RESPONSE TO MANGANESE ION,2.5934e-07,0.27587,0.26803,1,1
1,GO PORE COMPLEX ASSEMBLY,2.3891e-06,0.27583,0.24782,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,6.9711e-06,0.27577,0.27458,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,5.2538e-08,0.27566,0.27001,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.0364e-06,0.27561,0.24416,1,1
1,GO MUSCLE CELL MIGRATION,0.00016361,0.27538,0.24389,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1234e-05,0.27533,0.24906,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,3.628e-05,0.2751,0.32107,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,5.4701e-07,0.27493,0.29879,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,2.7804e-05,0.2749,0.32751,1,1
1,GO MATURATION OF 5 8S RRNA,7.5001e-05,0.27474,0.23161,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,2.538e-07,0.27451,0.2923,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,5.3562e-07,0.27442,0.25606,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0011021,0.27435,0.23269,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,1.1282e-07,0.27418,0.25605,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,9.2585e-06,0.2741,0.25927,1,1
1,GO PIGMENT GRANULE ORGANIZATION,4.8198e-07,0.27368,0.30411,1,1
1,GO FIBROBLAST ACTIVATION,5.2344e-05,0.27363,0.28652,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.0098086,0.27359,0.21431,1,1
1,GO SPROUTING ANGIOGENESIS,5.5864e-07,0.27344,0.30446,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00084997,0.27343,0.21922,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,2.4586e-08,0.27337,0.30971,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0002443,0.27336,0.22702,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00019857,0.27308,0.24462,1,1
1,GO SEQUESTERING OF METAL ION,5.2344e-05,0.27299,0.25847,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5386e-08,0.27299,0.27027,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.155e-06,0.27298,0.24867,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.5022e-05,0.27297,0.28591,1,1
1,GO MYOBLAST FUSION,1.4207e-05,0.27296,0.30822,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,1.1789e-06,0.27292,0.3489,1,1
1,GO RESPONSE TO CYTOKINE,1.7534e-07,0.27289,0.24421,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0015249,0.2722,0.28716,1,1
1,GO VIRAL GENE EXPRESSION,2.206e-06,0.27208,0.23967,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.6579e-07,0.27205,0.2365,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,2.1624e-06,0.27179,0.26094,1,1
1,GO POSITIVE REGULATION OF WOUND HEALING,0.002631,0.27165,0.21242,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.0557e-05,0.27139,0.25989,1,1
1,GO PROTEASOME ASSEMBLY,0.00013016,0.27124,0.19133,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.003607,0.27122,0.2715,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.8814e-05,0.27101,0.2722,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.001776,0.27095,0.23218,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.0079e-05,0.27089,0.21275,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0015463,0.27085,0.2087,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,3.094e-05,0.27043,0.23305,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,7.0072e-05,0.27041,0.25215,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.3039e-08,0.27024,0.30277,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1.6457e-05,0.27001,0.24008,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,5.6317e-09,0.26995,0.29979,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.1086e-06,0.26977,0.31235,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.4163e-06,0.26977,0.2758,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0019819,0.26968,0.22869,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,1.0756e-05,0.26894,0.25766,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00014839,0.26879,0.23931,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00046165,0.26859,0.31442,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,2.7668e-07,0.26781,0.27537,1,1
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.016027,0.26777,0.19001,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,2.2015e-05,0.26774,0.28675,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00021857,0.26766,0.27517,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0011836,0.26758,0.30172,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,4.6578e-06,0.26736,0.27673,1,1
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.8363e-05,0.26728,0.24559,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,3.0302e-06,0.26703,0.27332,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.5674e-06,0.26673,0.31817,1,1
1,GO GASTRULATION,3.8149e-08,0.26654,0.29567,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.8318e-07,0.26645,0.2908,1,1
1,GO CELL REDOX HOMEOSTASIS,2.0364e-06,0.26588,0.21997,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.7166e-08,0.26579,0.25509,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5386e-08,0.26546,0.26812,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0010865,0.26511,0.26392,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,3.7282e-08,0.26498,0.29879,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,4.0314e-05,0.26482,0.2794,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.152e-06,0.2645,0.24293,1,1
1,GO ARTERY MORPHOGENESIS,0.0070192,0.26449,0.21296,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,1.439e-07,0.26448,0.23893,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.8032e-05,0.26414,0.23106,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.0678e-07,0.26386,0.26408,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.856e-06,0.26382,0.23797,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.023668,0.26377,0.20909,1,1
1,GO TISSUE REGENERATION,2.4371e-06,0.26368,0.24885,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,2.6386e-06,0.26334,0.24241,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0005056,0.26313,0.26342,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,5.3256e-05,0.26293,0.25029,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,4.4807e-06,0.26292,0.26334,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,7.5217e-06,0.26287,0.27975,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.6321e-06,0.26277,0.25075,1,1
1,GO NATURAL KILLER CELL ACTIVATION,1.5994e-06,0.26265,0.25556,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.0094e-07,0.26244,0.26695,1,1
1,GO TERPENOID METABOLIC PROCESS,0.00015083,0.2623,0.19624,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.2169e-06,0.26201,0.22855,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,3.4409e-05,0.26192,0.25099,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,8.4262e-06,0.26187,0.26848,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,1.2253e-05,0.26183,0.23203,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,8.9166e-06,0.2612,0.28971,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00086244,0.26107,0.20304,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1.5293e-05,0.26086,0.2837,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,4.0657e-06,0.26084,0.25188,1,1
1,GO STEM CELL DIVISION,0.00019229,0.26028,0.26082,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.734e-06,0.26022,0.25616,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.2027e-05,0.26016,0.26045,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.6828e-05,0.26006,0.2526,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,6.545e-05,0.25981,0.20252,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,1.1307e-08,0.2598,0.27602,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9989e-07,0.25963,0.27827,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,7.105e-06,0.2596,0.26932,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00011218,0.25952,0.26495,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.8246e-05,0.25921,0.26722,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0005789,0.25921,0.16695,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00015583,0.25912,0.21155,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.9035e-08,0.25905,0.27772,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00036686,0.25903,0.20736,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.7534e-07,0.25899,0.26753,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,1.0361e-05,0.25897,0.30477,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,7.2414e-06,0.25889,0.24675,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.6446e-07,0.25879,0.2395,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,4.8839e-05,0.25866,0.2215,1,1
1,GO ALPHA BETA T CELL ACTIVATION,8.4424e-05,0.25855,0.22756,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.6062e-07,0.25849,0.2709,1,1
1,GO BLOOD VESSEL REMODELING,0.00011406,0.25793,0.27557,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.010645,0.25769,0.27476,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0011021,0.25735,0.29866,1,1
1,GO GLOMERULUS DEVELOPMENT,0.00022565,0.25714,0.30959,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,1.9749e-05,0.25701,0.25691,1,1
1,GO GLYCEROL ETHER METABOLIC PROCESS,1.8701e-05,0.25695,0.25759,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0013255,0.25675,0.19126,1,1
1,GO RESPONSE TO IONIZING RADIATION,2.5934e-07,0.25674,0.23746,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.8271e-07,0.25667,0.29266,1,1
1,GO RRNA MODIFICATION,1.6457e-05,0.25659,0.2147,1,1
1,GO TRNA METHYLATION,3.628e-05,0.25658,0.21897,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0021798,0.25651,0.22148,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00081356,0.2565,0.18378,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.00013016,0.25604,0.21057,1,1
1,GO NCRNA PROCESSING,6.337e-06,0.25589,0.21706,1,1
1,GO ISOPRENOID METABOLIC PROCESS,4.6359e-05,0.25546,0.18731,1,1
1,GO VESICLE CARGO LOADING,7.5451e-08,0.25535,0.29169,1,1
1,GO NECROTIC CELL DEATH,0.00013016,0.25505,0.21423,1,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00096848,0.25492,0.20204,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.6202e-07,0.25479,0.28064,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,8.3066e-07,0.25429,0.25543,1,1
1,GO KERATINOCYTE MIGRATION,1.5576e-05,0.25338,0.23026,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011813,0.25321,0.15074,1,1
1,GO T CELL ACTIVATION,9.6129e-06,0.25315,0.21727,1,1
1,GO IMMUNE EFFECTOR PROCESS,4.719e-07,0.25288,0.2497,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.152e-06,0.25268,0.21353,1,1
1,GO RETINOL METABOLIC PROCESS,1.3693e-05,0.25254,0.24589,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00033432,0.25155,0.35322,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.00057029,0.25151,0.22134,1,1
1,GO WOUND HEALING,1.9563e-06,0.2515,0.25549,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.1041e-08,0.25146,0.28228,1,1
1,GO TRABECULA FORMATION,0.00073415,0.25128,0.29467,1,1
1,GO CHOLESTEROL EFFLUX,5.6085e-05,0.25114,0.22106,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.064e-06,0.25058,0.27017,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,7.6657e-06,0.25054,0.23702,1,1
1,GO MYOBLAST DIFFERENTIATION,1.0554e-07,0.25039,0.28899,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.6782e-07,0.25038,0.29258,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,4.2444e-07,0.25031,0.27808,1,1
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.004964,0.25029,0.26,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0042636,0.24999,0.19491,1,1
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00029052,0.24983,0.26654,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.6994e-06,0.24974,0.31473,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.4773e-06,0.24962,0.27077,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.6446e-07,0.2491,0.25533,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,1.9175e-06,0.24898,0.28244,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.5277e-10,0.24897,0.26149,1,1
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.032278,0.24894,0.24127,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.1274e-05,0.24887,0.19516,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2253e-05,0.24861,0.29437,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,6.4699e-07,0.24857,0.24927,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,2.4091e-05,0.24849,0.22665,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,1.6158e-05,0.24837,0.23636,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.7804e-05,0.24802,0.24483,1,1
1,GO REGULATION OF T CELL ACTIVATION,4.4771e-05,0.24791,0.19949,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.1338e-07,0.24763,0.26488,1,1
1,GO PLATELET DEGRANULATION,6.9711e-06,0.24754,0.29308,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,2.7452e-06,0.24746,0.25244,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.00013673,0.24709,0.24666,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0028872,0.24671,0.25777,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0013633,0.24668,0.2095,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00076726,0.24665,0.22489,1,1
1,GO PHAGOCYTOSIS,1.2058e-07,0.24665,0.2771,1,1
1,GO MICROVILLUS ASSEMBLY,0.032607,0.24645,0.14422,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00010497,0.2464,0.26484,1,1
1,GO PIGMENT METABOLIC PROCESS,9.6538e-08,0.24636,0.23959,1,1
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0013443,0.24633,0.19993,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,3.2057e-05,0.24632,0.29341,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.9822e-07,0.24613,0.25232,1,1
1,GO REGULATION OF LIPASE ACTIVITY,1.9558e-07,0.24581,0.24956,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0059116,0.24571,0.18231,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.00026024,0.24556,0.22131,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,1.6457e-05,0.24503,0.26521,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,8.1623e-05,0.24489,0.20309,1,1
1,GO FIBROBLAST PROLIFERATION,5.7582e-06,0.24487,0.26309,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00013232,0.24486,0.29008,1,1
1,GO PROTEIN DEMANNOSYLATION,0.00024819,0.24465,0.22741,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0018006,0.24454,0.21662,1,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0066851,0.24449,0.23022,1,1
1,GO P38MAPK CASCADE,1.2253e-05,0.24448,0.24774,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.2534e-06,0.24447,0.24416,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,4.4771e-05,0.24427,0.26304,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,1.0361e-05,0.24413,0.24886,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,5.9834e-06,0.24412,0.25093,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.5994e-06,0.24395,0.28247,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.8363e-05,0.24349,0.23009,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,2.1624e-06,0.24339,0.30258,1,1
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.015674,0.24335,0.19084,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.0322e-07,0.24332,0.27132,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,2.2824e-05,0.2429,0.19684,1,1
1,GO REPLACEMENT OSSIFICATION,0.00026024,0.24287,0.28533,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0011668,0.24269,0.23037,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.6881e-08,0.24266,0.26314,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0022095,0.24257,0.19147,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.6129e-06,0.24257,0.22836,1,1
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.036048,0.24252,0.15415,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00042777,0.2425,0.29776,1,1
1,GO ACTIN FILAMENT SEVERING,0.0049019,0.24245,0.26441,1,1
1,GO REPLICATIVE SENESCENCE,0.018091,0.24235,0.16175,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.019523,0.242,0.22115,1,1
1,GO CYTOKINE PRODUCTION,6.7461e-07,0.24193,0.23605,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,1.8032e-05,0.24184,0.29005,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,4.7999e-05,0.24178,0.23374,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0022396,0.24175,0.21755,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.0756e-05,0.24144,0.24104,1,1
1,GO CERAMIDE TRANSPORT,1.8701e-05,0.2414,0.29687,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00061456,0.24101,0.26037,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00048316,0.24051,0.19833,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,6.7724e-05,0.23999,0.27385,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,8.8389e-07,0.23978,0.22126,1,1
1,GO CELLULAR RESPONSE TO VIRUS,2.1196e-06,0.23971,0.24665,1,1
1,GO COPPER ION HOMEOSTASIS,8.8389e-07,0.23968,0.29805,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00071283,0.23957,0.3265,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012527,0.23957,0.22205,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.206e-06,0.23945,0.31539,1,1
1,GO NUCLEAR PORE ORGANIZATION,1.5293e-05,0.23937,0.24447,1,1
1,GO RNA 5 END PROCESSING,5.1446e-05,0.23925,0.23412,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00020835,0.23916,0.21287,1,1
1,GO REGULATION OF WOUND HEALING,5.5127e-05,0.23914,0.243,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,5.4982e-08,0.23905,0.24789,1,1
1,GO PRIMARY MIRNA PROCESSING,5.5412e-06,0.23882,0.30187,1,1
1,GO ERK1 AND ERK2 CASCADE,1.5994e-06,0.23835,0.22301,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00027284,0.23827,0.25046,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.6578e-06,0.23809,0.23384,1,1
1,GO VASCULATURE DEVELOPMENT,8.6579e-07,0.23795,0.26037,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.4371e-06,0.23784,0.21876,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00020835,0.23763,0.19268,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.5372e-07,0.23758,0.26346,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.4741e-05,0.23758,0.23722,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.4356e-06,0.23758,0.24057,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,4.2487e-05,0.23747,0.2631,1,1
1,GO LEUKOCYTE PROLIFERATION,7.2497e-05,0.23733,0.20122,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,2.1621e-05,0.23662,0.24939,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,8.4262e-06,0.23643,0.22335,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,4.3946e-06,0.23594,0.34121,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00052901,0.23586,0.23309,1,1
1,GO ERBB SIGNALING PATHWAY,7.3803e-06,0.23574,0.21137,1,1
1,GO COAGULATION,1.0756e-05,0.23554,0.21833,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.795e-06,0.23535,0.1936,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.0011341,0.23529,0.21308,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.2146e-06,0.23513,0.23408,1,1
1,GO ERYTHROCYTE DEVELOPMENT,0.00026438,0.23505,0.19011,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,1.0424e-06,0.23501,0.26321,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,8.5867e-06,0.23494,0.21967,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.0776e-06,0.2349,0.25797,1,1
1,GO RESPONSE TO RETINOIC ACID,7.3803e-06,0.23481,0.23571,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4341e-05,0.23475,0.23216,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0001179,0.23457,0.20596,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0017517,0.23447,0.18357,1,1
1,GO STEROL TRANSPORT,3.628e-05,0.23447,0.21297,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.8793e-06,0.23438,0.25419,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00029976,0.23406,0.20615,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,9.404e-07,0.234,0.23411,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00064263,0.23399,0.22796,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,1.1588e-05,0.23374,0.29968,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0005056,0.23369,0.18968,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,8.8796e-05,0.23347,0.21457,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.0395e-05,0.23325,0.27586,1,1
1,GO RESPONSE TO BACTERIUM,1.9175e-06,0.23309,0.2215,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00045468,0.23278,0.25829,1,1
1,GO BILE ACID AND BILE SALT TRANSPORT,0.010041,0.23276,0.16134,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,8.8796e-05,0.23273,0.25732,1,1
1,GO ASTROCYTE DEVELOPMENT,5.9056e-05,0.23243,0.23756,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.0361e-05,0.23237,0.2322,1,1
1,GO MACROPHAGE DIFFERENTIATION,1.2954e-05,0.23218,0.26283,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.0429e-07,0.23206,0.26316,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,8.5858e-05,0.23202,0.2862,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0010865,0.23197,0.21842,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,2.913e-06,0.23179,0.20875,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.3948e-05,0.23178,0.27887,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.0060595,0.23173,0.18156,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.5867e-06,0.23173,0.22101,1,1
1,GO REGULATION OF CELL AGING,1.5052e-06,0.23161,0.20409,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.00022927,0.23132,0.20326,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,2.0364e-06,0.23125,0.30571,1,1
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.037139,0.23117,0.11855,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,5.332e-06,0.23084,0.26218,1,1
1,GO HISTONE H4 DEACETYLATION,0.00043435,0.23076,0.22034,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.5864e-07,0.2307,0.2708,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00019541,0.2305,0.20974,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,6.4592e-06,0.23041,0.2504,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00016361,0.23029,0.21438,1,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.00046872,0.23024,0.22796,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.00012186,0.22987,0.2627,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.3214e-05,0.22981,0.21594,1,1
1,GO COPPER ION TRANSPORT,1.3693e-05,0.22972,0.24284,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0023637,0.22964,0.19683,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.1789e-06,0.22933,0.29844,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.000662,0.22919,0.22349,1,1
1,GO RNA DECAPPING,1.2954e-05,0.22904,0.19371,1,1
1,GO LAMELLIPODIUM ASSEMBLY,1.7706e-05,0.22899,0.21724,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.001776,0.22899,0.16825,1,1
1,GO STEROID ESTERIFICATION,0.0050269,0.22885,0.18188,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.1165e-05,0.2287,0.1984,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.4334e-08,0.22855,0.25383,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,4.9694e-05,0.22851,0.24969,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00024819,0.22804,0.20697,1,1
1,GO AUTOPHAGY OF NUCLEUS,8.4262e-06,0.22798,0.23094,1,1
1,GO STRESS FIBER ASSEMBLY,7.105e-06,0.22789,0.25555,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.0035146,0.22788,0.20112,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.2792e-06,0.22787,0.23484,1,1
1,GO GLIAL CELL ACTIVATION,0.00012388,0.2275,0.21699,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.2397e-08,0.22739,0.25013,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,0.00014129,0.22701,0.18961,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0078263,0.22649,0.23699,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.5412e-06,0.22645,0.22942,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,3.7605e-06,0.22638,0.23379,1,1
1,GO RESPONSE TO TUMOR CELL,0.0022396,0.22623,0.22565,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,1.1806e-05,0.22605,0.2256,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.1375e-05,0.226,0.25088,1,1
1,GO GLAND MORPHOGENESIS,2.5884e-05,0.22597,0.30936,1,1
1,GO TISSUE MIGRATION,4.0657e-06,0.22593,0.26782,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,8.1623e-05,0.22591,0.18492,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.010895,0.22591,0.18289,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,6.2175e-05,0.22579,0.22988,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,5.8049e-05,0.22561,0.19482,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.5994e-06,0.22559,0.2344,1,1
1,GO TONGUE MORPHOGENESIS,0.01995,0.22549,0.19201,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.8911e-05,0.22543,0.18902,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,8.9166e-06,0.22538,0.21998,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.2027e-05,0.22533,0.20154,1,1
1,GO SYNCYTIUM FORMATION,1.064e-06,0.22526,0.29907,1,1
1,GO GTP METABOLIC PROCESS,1.1316e-06,0.22518,0.27265,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0048405,0.22507,0.19433,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,1.4472e-05,0.22505,0.23515,1,1
1,GO FOAM CELL DIFFERENTIATION,0.000286,0.22484,0.23608,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00054518,0.22474,0.23314,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00042777,0.22465,0.22707,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.00029052,0.22448,0.23554,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,7.6657e-06,0.2244,0.2249,1,1
1,GO SYMBIOTIC PROCESS,5.7923e-10,0.22435,0.22139,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,6.5837e-06,0.22429,0.32116,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.0429e-07,0.22422,0.2065,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.2146e-06,0.22385,0.27304,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0011668,0.2237,0.22534,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,7.3739e-05,0.22353,0.17355,1,1
1,GO INTERFERON GAMMA PRODUCTION,4.3236e-05,0.22342,0.2166,1,1
1,GO MESODERM MORPHOGENESIS,9.2118e-07,0.22341,0.23881,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00032916,0.22338,0.29634,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.3174e-07,0.2233,0.24521,1,1
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00017176,0.22312,0.2128,1,1
1,GO MULTI ORGANISM LOCALIZATION,9.2321e-08,0.22304,0.22955,1,1
1,GO RRNA METHYLATION,5.0563e-05,0.22296,0.20984,1,1
1,GO FATTY ACID BETA OXIDATION,1.1375e-05,0.22292,0.19556,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.004156,0.22278,0.23408,1,1
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0040509,0.22271,0.18174,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,1.0004e-06,0.22264,0.26329,1,1
1,GO SELECTIVE AUTOPHAGY,7.1726e-09,0.22243,0.24244,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,4.6359e-05,0.22226,0.27742,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,8.0256e-05,0.22197,0.22173,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,2.0478e-05,0.22188,0.19128,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.7909e-10,0.22185,0.24243,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,5.3256e-05,0.22164,0.21394,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00042777,0.22147,0.17899,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0070192,0.22102,0.19526,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,6.3249e-05,0.22082,0.16991,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,1.4207e-05,0.22057,0.23816,1,1
1,GO REGULATION OF CELL SHAPE,6.3249e-05,0.22056,0.2161,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0016806,0.22043,0.1942,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00065224,0.22036,0.24658,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,1.6994e-06,0.22005,0.2512,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,2.2416e-05,0.21988,0.23965,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,3.6162e-06,0.21952,0.24735,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.6914e-06,0.21931,0.23418,1,1
1,GO PROTEIN HYDROXYLATION,0.0014624,0.21929,0.2502,1,1
1,GO PROTEIN TARGETING TO VACUOLE,7.0072e-05,0.21925,0.19844,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.00022565,0.21919,0.2482,1,1
1,GO ENDOTHELIAL CELL MIGRATION,5.6487e-06,0.2185,0.27569,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,1.9175e-06,0.21845,0.2355,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.024947,0.21812,0.15863,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00015083,0.21797,0.25289,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,4.2487e-05,0.21797,0.26421,1,1
1,GO RESPONSE TO WOUNDING,1.2027e-05,0.21791,0.21656,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,2.0853e-05,0.21777,0.18322,1,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.003654,0.21772,0.17354,1,1
1,GO CHONDROCYTE DIFFERENTIATION,2.4091e-05,0.21744,0.24789,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00044103,0.21741,0.21909,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00063314,0.21736,0.20325,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.8416e-06,0.21729,0.25098,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0005618,0.21715,0.20327,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,2.6914e-06,0.21712,0.23043,1,1
1,GO HISTONE H2B UBIQUITINATION,9.3381e-05,0.21708,0.18685,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0027747,0.21694,0.19886,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.6162e-06,0.21689,0.22198,1,1
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0030839,0.21681,0.19158,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.0853e-05,0.21668,0.21187,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,2.206e-06,0.21661,0.20628,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00052901,0.21658,0.21144,1,1
1,GO REGULATION OF IMMUNE RESPONSE,2.6386e-06,0.21655,0.20861,1,1
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.057179,0.21655,0.15774,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.7452e-06,0.2163,0.17793,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.5865e-05,0.21624,0.20235,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,2.0853e-05,0.21621,0.21352,1,1
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.014658,0.21611,0.1608,1,1
1,GO RESPONSE TO INTERLEUKIN 7,9.03e-05,0.21602,0.20166,1,1
1,GO NCRNA METABOLIC PROCESS,1.6761e-05,0.21597,0.1879,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,1.1794e-07,0.21585,0.23221,1,1
1,GO SNRNA PROCESSING,0.00022565,0.2158,0.29614,1,1
1,GO BARBED END ACTIN FILAMENT CAPPING,0.0028492,0.21579,0.24185,1,1
1,GO ERYTHROCYTE MATURATION,0.0019819,0.21576,0.23519,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.001118,0.21565,0.21192,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0002443,0.21565,0.24232,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,2.5884e-05,0.21549,0.27305,1,1
1,GO BLASTODERM SEGMENTATION,0.027118,0.21544,0.17631,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00091404,0.21533,0.21282,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,2.6352e-05,0.21528,0.17957,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,5.9834e-06,0.21507,0.30575,1,1
1,GO ASTROCYTE ACTIVATION,0.00029511,0.21507,0.18939,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,4.7488e-06,0.21473,0.25362,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,2.8305e-05,0.2147,0.23895,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.064e-06,0.21466,0.23994,1,1
1,GO SECRETION BY TISSUE,0.0018508,0.21457,0.18597,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,1.7071e-05,0.21457,0.25158,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,5.0563e-05,0.21455,0.23007,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00073415,0.21423,0.20061,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00026858,0.21402,0.23503,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,1.3878e-06,0.21397,0.21038,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00023667,0.21353,0.19735,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.2416e-05,0.21332,0.1967,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00042128,0.21325,0.19604,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,2.4972e-05,0.21304,0.22916,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0013443,0.213,0.30268,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00010852,0.2125,0.18117,1,1
1,GO ERAD PATHWAY,1.2792e-06,0.21243,0.19707,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,1.536e-06,0.21234,0.24085,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,8.2686e-06,0.21207,0.22548,1,1
1,GO REGULATION OF CELL CELL ADHESION,0.00045468,0.21204,0.17727,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,4.1456e-06,0.21192,0.21185,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,4.0314e-05,0.21173,0.2654,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00054518,0.21164,0.24166,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00015331,0.21161,0.23687,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00020504,0.21134,0.28859,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00015331,0.21133,0.21176,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00012594,0.21096,0.24798,1,1
1,GO OSTEOCLAST DIFFERENTIATION,1.3693e-05,0.2109,0.20295,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.9136e-07,0.21088,0.22823,1,1
1,GO REGULATION OF MRNA BINDING,4.1026e-05,0.2108,0.23888,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00019541,0.21076,0.16226,1,1
1,GO TOOTH MINERALIZATION,0.0030436,0.21067,0.23655,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00029052,0.21061,0.20607,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00010852,0.21035,0.19773,1,1
1,GO DEFENSE RESPONSE,9.795e-06,0.21025,0.19567,1,1
1,GO AUTOPHAGOSOME MATURATION,1.7922e-07,0.21016,0.22437,1,1
1,GO ANIMAL ORGAN REGENERATION,8.6579e-07,0.2101,0.24392,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00054518,0.20996,0.21185,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0042095,0.20984,0.19517,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00059648,0.20977,0.21401,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,2.856e-06,0.20972,0.23911,1,1
1,GO REGULATION OF HEMOPOIESIS,7.969e-07,0.20947,0.212,1,1
1,GO RIBOSOME BIOGENESIS,1.9044e-05,0.20934,0.22581,1,1
1,GO NEURAL TUBE PATTERNING,0.00070238,0.20931,0.19964,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.971e-06,0.20927,0.1876,1,1
1,GO TRANSLATIONAL INITIATION,0.000286,0.20908,0.19398,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.2129e-08,0.20908,0.20375,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,2.9859e-05,0.20894,0.21045,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,2.0853e-05,0.2089,0.20207,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,4.9228e-07,0.20881,0.20293,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00024819,0.2088,0.21674,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,5.1446e-05,0.20867,0.22075,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.6761e-05,0.20865,0.23131,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,5.9834e-06,0.20863,0.18362,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,1.8363e-05,0.20854,0.30327,1,1
1,GO PLACENTA DEVELOPMENT,0.00030928,0.20845,0.16843,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00046165,0.20841,0.1895,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,8.2686e-06,0.2083,0.23421,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.9859e-05,0.20791,0.20846,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0030038,0.20787,0.18544,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0061347,0.20783,0.14051,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,9.03e-05,0.20783,0.19854,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,0.00022927,0.20768,0.19228,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.000286,0.20751,0.20018,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,2.1234e-05,0.20747,0.24147,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.7999e-05,0.20734,0.20623,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,3.5038e-07,0.20727,0.22914,1,1
1,GO LIPID OXIDATION,2.2416e-05,0.20686,0.18324,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,7.9617e-06,0.20677,0.20607,1,1
1,GO L SERINE METABOLIC PROCESS,0.058787,0.20658,0.112,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.3239e-05,0.20631,0.22954,1,1
1,GO TOXIN TRANSPORT,6.4341e-05,0.20594,0.18356,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00013016,0.20588,0.2003,1,1
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00037835,0.20585,0.22801,1,1
1,GO RRNA METABOLIC PROCESS,3.2631e-05,0.20585,0.21271,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0038478,0.20585,0.15059,1,1
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,6.8888e-05,0.20585,0.21706,1,1
1,GO CELLULAR RESPONSE TO LIPID,1.2482e-05,0.20579,0.17897,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.1196e-06,0.20579,0.23549,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00025215,0.20525,0.23592,1,1
1,GO REGULATION OF CELL ADHESION,0.00015838,0.20524,0.19345,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0050269,0.20521,0.24207,1,1
1,GO HISTONE H3 K4 TRIMETHYLATION,0.01128,0.205,0.1647,1,1
1,GO REGENERATION,1.475e-06,0.20487,0.20411,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.0323e-06,0.20476,0.19566,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0056255,0.20475,0.15785,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.031631,0.20461,0.13559,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,4.7488e-06,0.20439,0.21227,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.4771e-05,0.2043,0.30602,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0020929,0.20423,0.19169,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00099681,0.2042,0.21377,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.8396e-06,0.20413,0.22661,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.6994e-06,0.20412,0.19518,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.033608,0.20412,0.20112,1,1
1,GO CYTOPLASMIC TRANSLATION,0.0030436,0.20391,0.17065,1,1
1,GO PLATELET ACTIVATION,0.00053704,0.20386,0.19088,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0025617,0.20384,0.19702,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.3878e-06,0.20377,0.22206,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0081133,0.20363,0.22129,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.0156e-07,0.20339,0.19534,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,6.7724e-05,0.20332,0.17951,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0023321,0.20319,0.23203,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,3.628e-05,0.2026,0.1932,1,1
1,GO RESPONSE TO CORTICOSTEROID,4.8839e-05,0.20254,0.19422,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0002117,0.2025,0.21271,1,1
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.03902,0.20245,0.12202,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00027284,0.20228,0.1881,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00020178,0.20206,0.21056,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,5.02e-08,0.2019,0.20179,1,1
1,GO PEPTIDE CATABOLIC PROCESS,1.9563e-06,0.20181,0.25868,1,1
1,GO RESPONSE TO GAMMA RADIATION,3.9102e-06,0.20178,0.22379,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2954e-05,0.20153,0.21668,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0050269,0.2015,0.30302,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.0010113,0.20145,0.18735,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,1.0756e-05,0.20115,0.28729,1,1
1,GO LIPID STORAGE,2.5424e-05,0.2008,0.20105,1,1
1,GO CELL CELL RECOGNITION,1.7721e-08,0.20073,0.21122,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00061456,0.20046,0.27248,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.003607,0.20033,0.21423,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00027716,0.19999,0.22593,1,1
1,GO REGULATION OF GENE SILENCING,7.4873e-07,0.19993,0.18508,1,1
1,GO MANGANESE ION TRANSPORT,0.00041488,0.19982,0.18373,1,1
1,GO MALE GENITALIA DEVELOPMENT,0.023668,0.19975,0.15698,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0032078,0.19938,0.18444,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.00094089,0.19934,0.20747,1,1
1,GO RECEPTOR RECYCLING,0.00017457,0.19932,0.16857,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,3.6877e-06,0.19927,0.19466,1,1
1,GO IRON ION HOMEOSTASIS,9.404e-07,0.19925,0.21417,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,4.7488e-06,0.19922,0.22552,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,1.5293e-05,0.19889,0.18265,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,4.1026e-05,0.19808,0.21792,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,1.1086e-06,0.198,0.20073,1,1
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0011341,0.19772,0.16504,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,9.404e-07,0.1976,0.2091,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.007921,0.19742,0.17352,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,9.6538e-08,0.1973,0.22847,1,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.024173,0.19723,0.22605,1,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0056255,0.1969,0.18843,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.3803e-06,0.19673,0.20293,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00033955,0.19624,0.1864,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00010152,0.1959,0.23197,1,1
1,GO TRNA MODIFICATION,0.00033955,0.19547,0.16327,1,1
1,GO LATERAL VENTRICLE DEVELOPMENT,0.00094089,0.19537,0.26126,1,1
1,GO GLYCINE METABOLIC PROCESS,0.017506,0.19533,0.14564,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0018508,0.19528,0.21582,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.0424e-06,0.19515,0.24086,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,8.4424e-05,0.1951,0.25219,1,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0025277,0.19498,0.16576,1,1
1,GO RESPONSE TO VITAMIN A,0.0022396,0.19482,0.1669,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0043184,0.19476,0.13359,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00027284,0.1947,0.21949,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,9.795e-06,0.19467,0.23845,1,1
1,GO DNA LIGATION,0.0002117,0.19464,0.19099,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00043435,0.19461,0.22836,1,1
1,GO MUSCLE CELL PROLIFERATION,1.6321e-06,0.1945,0.2445,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.155e-06,0.19445,0.19181,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.001235,0.19426,0.1671,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,9.086e-06,0.19426,0.1945,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0030436,0.19413,0.19834,1,1
1,GO REGULATION OF CELL ACTIVATION,1.4472e-05,0.19409,0.19867,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,1.2716e-05,0.19397,0.23209,1,1
1,GO TRNA CATABOLIC PROCESS,0.026561,0.19384,0.20644,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.00044781,0.1938,0.28151,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,9.4959e-05,0.19374,0.22106,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0054192,0.1935,0.30167,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00037835,0.19345,0.24384,1,1
1,GO RNA METHYLATION,3.5022e-05,0.19327,0.18766,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,9.086e-06,0.19326,0.19719,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0005789,0.193,0.16548,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,2.4528e-05,0.1924,0.18238,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00083767,0.19227,0.19505,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001235,0.19216,0.21058,1,1
1,GO TUMOR NECROSIS FACTOR SECRETION,0.00090088,0.19196,0.16275,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00032408,0.19177,0.19989,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00012594,0.19175,0.22535,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0054192,0.19158,0.14823,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0022095,0.19144,0.198,1,1
1,GO B CELL HOMEOSTASIS,0.027401,0.19141,0.13915,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00071283,0.1913,0.17868,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00071283,0.19075,0.1966,1,1
1,GO REGULATION OF T CELL MIGRATION,0.00092737,0.19075,0.1855,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.9056e-05,0.19017,0.1972,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,1.7071e-05,0.18951,0.18072,1,1
1,GO RNA DESTABILIZATION,5.4184e-05,0.18943,0.19898,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,2.2958e-06,0.18936,0.20722,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.0657e-06,0.18926,0.23903,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,9.9844e-05,0.18924,0.17073,1,1
1,GO NUCLEOSIDE SALVAGE,0.0068504,0.18906,0.17368,1,1
1,GO MYELOID CELL HOMEOSTASIS,1.996e-06,0.18897,0.203,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,8.1623e-05,0.18886,0.24157,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,2.4528e-05,0.18885,0.1526,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.734e-06,0.18878,0.17478,1,1
1,GO REGULATION OF DEFENSE RESPONSE,1.1375e-05,0.18854,0.18604,1,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0044298,0.18816,0.14725,1,1
1,GO COPII COATED VESICLE CARGO LOADING,8.5867e-06,0.18813,0.21018,1,1
1,GO RESPONSE TO ANTIBIOTIC,1.2253e-05,0.18788,0.19062,1,1
1,GO LEUKOCYTE DIFFERENTIATION,3.628e-05,0.18781,0.18548,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00054518,0.18763,0.23117,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,4.3946e-06,0.1876,0.23081,1,1
1,GO CELL ACTIVATION,3.3435e-06,0.1876,0.20043,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010152,0.18758,0.16526,1,1
1,GO PROTEIN KINASE B SIGNALING,5.6085e-05,0.18749,0.17523,1,1
1,GO HISTONE PHOSPHORYLATION,0.00013451,0.18734,0.16093,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,1.6654e-06,0.1872,0.2126,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,3.8924e-05,0.18713,0.25363,1,1
1,GO PROTEIN KINASE A SIGNALING,9.4959e-05,0.18692,0.17192,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,6.4592e-06,0.18658,0.1852,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00035024,0.18657,0.18044,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,8.3066e-07,0.18651,0.19021,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,2.2416e-05,0.18638,0.23135,1,1
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0042095,0.18624,0.1695,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00064263,0.18617,0.18751,1,1
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.013243,0.18607,0.2179,1,1
1,GO PLASMA MEMBRANE TUBULATION,8.0256e-05,0.18606,0.22449,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00010323,0.18584,0.17716,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.001568,0.18581,0.17826,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,7.8911e-05,0.18542,0.15138,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021505,0.18542,0.22858,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0011668,0.18539,0.17561,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,1.2027e-05,0.1853,0.1965,1,1
1,GO TRNA 5 END PROCESSING,0.00032916,0.18483,0.19525,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,2.5884e-05,0.18478,0.21652,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00098255,0.18466,0.13224,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0011341,0.18462,0.30242,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,3.9613e-05,0.18459,0.19546,1,1
1,GO CYTOKINETIC PROCESS,8.1138e-06,0.18421,0.21053,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0050904,0.18415,0.144,1,1
1,GO RNA INTERFERENCE,0.014823,0.18411,0.11606,1,1
1,GO NCRNA 3 END PROCESSING,0.00019541,0.18405,0.22222,1,1
1,GO RRNA TRANSCRIPTION,0.00017457,0.18378,0.18861,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0017277,0.18376,0.24339,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00016901,0.1837,0.1974,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,1.9749e-05,0.18349,0.17189,1,1
1,GO LYMPHOCYTE ACTIVATION,8.9166e-06,0.18335,0.19392,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9613e-05,0.18332,0.18768,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,7.1274e-05,0.18316,0.18874,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0011021,0.18313,0.19227,1,1
1,GO REGULATION OF PROTEOLYSIS,4.4807e-06,0.18304,0.17136,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0072795,0.18302,0.16968,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00098255,0.18267,0.20813,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0094686,0.18266,0.18885,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,3.4296e-07,0.18244,0.18084,1,1
1,GO RESPONSE TO UV C,0.00037257,0.18225,0.24394,1,1
1,GO RNA MODIFICATION,1.9393e-05,0.18224,0.17978,1,1
1,GO LYMPHOCYTE MIGRATION,1.7071e-05,0.18224,0.21074,1,1
1,GO REGULATION OF HEART GROWTH,0.00022565,0.18215,0.18762,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,6.7461e-07,0.18209,0.18362,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.8723e-07,0.18187,0.19112,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00039622,0.18182,0.16785,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0094686,0.18161,0.15019,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0025277,0.18128,0.19335,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.4454e-06,0.18105,0.25445,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.2859e-07,0.18103,0.22856,1,1
1,GO BONE DEVELOPMENT,2.4091e-05,0.18069,0.22902,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0011021,0.18067,0.20832,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,5.1304e-06,0.1806,0.20718,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00011033,0.18059,0.21796,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.00046165,0.18051,0.21993,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.6158e-05,0.18046,0.15244,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0015249,0.18037,0.18561,1,1
1,GO CARTILAGE DEVELOPMENT,5.8049e-05,0.18031,0.21951,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,2.2416e-05,0.1801,0.21918,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.6202e-07,0.1801,0.17013,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00044103,0.17993,0.18192,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00073415,0.17993,0.17728,1,1
1,GO PLASMA MEMBRANE FUSION,0.020828,0.17987,0.18348,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,2.0853e-05,0.17936,0.17363,1,1
1,GO RESPONSE TO ISCHEMIA,0.000286,0.17909,0.17382,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.001118,0.17893,0.18281,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,1.3442e-05,0.17891,0.18665,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0020929,0.17871,0.16598,1,1
1,GO RESPONSE TO TESTOSTERONE,1.7071e-05,0.17854,0.2144,1,1
1,GO REGULATION OF TELOMERASE ACTIVITY,0.001704,0.17837,0.14677,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,9.3381e-05,0.17831,0.21231,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00067188,0.17827,0.1914,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0068504,0.1782,0.20632,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0051547,0.178,0.086591,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.0478e-05,0.178,0.14124,1,1
1,GO ODONTOGENESIS,0.0023321,0.1779,0.19143,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.000286,0.17765,0.17026,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00028155,0.17755,0.18802,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,5.0323e-06,0.17751,0.21063,1,1
1,GO TONGUE DEVELOPMENT,0.0069343,0.177,0.18848,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.00040235,0.17674,0.19787,1,1
1,GO ETHER METABOLIC PROCESS,0.00023294,0.17668,0.2339,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00015083,0.17644,0.23257,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00031907,0.17631,0.1539,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00046165,0.17628,0.24329,1,1
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.011678,0.17619,0.2338,1,1
1,GO VIRION ASSEMBLY,4.5558e-05,0.17611,0.14678,1,1
1,GO NCRNA CATABOLIC PROCESS,0.004156,0.17606,0.14144,1,1
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0090315,0.17592,0.22331,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,2.8814e-05,0.17581,0.18475,1,1
1,GO REGULATION OF CELL FATE COMMITMENT,0.017125,0.17567,0.18188,1,1
1,GO TRNA METABOLIC PROCESS,0.00024045,0.17564,0.14492,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0047798,0.17533,0.16449,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00033432,0.17512,0.25166,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00076726,0.17487,0.1983,1,1
1,GO LIPID IMPORT INTO CELL,0.0044864,0.17481,0.16252,1,1
1,GO GLIAL CELL MIGRATION,0.010041,0.17464,0.15085,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.0019023,0.17424,0.19102,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00071283,0.17399,0.19966,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0065235,0.17398,0.17793,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,7.3739e-05,0.17357,0.17007,1,1
1,GO MYELOID CELL DIFFERENTIATION,3.4773e-06,0.17338,0.19457,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.041383,0.17338,0.14358,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00075607,0.1733,0.21022,1,1
1,GO DECIDUALIZATION,0.0053519,0.17316,0.20965,1,1
1,GO VIRAL RELEASE FROM HOST CELL,2.0776e-06,0.17302,0.20019,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00033432,0.17282,0.22512,1,1
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0057669,0.17255,0.20926,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00159,0.17234,0.1749,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0050269,0.17229,0.12873,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.001776,0.17218,0.29458,1,1
1,GO RNA CATABOLIC PROCESS,2.8886e-07,0.17216,0.17522,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,7.7586e-05,0.1721,0.19618,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0037016,0.17198,0.18797,1,1
1,GO MYELOID CELL DEVELOPMENT,0.0038977,0.17195,0.15407,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.3948e-05,0.17184,0.18844,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,3.6877e-06,0.17159,0.20574,1,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0072795,0.17156,0.17686,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00012388,0.17147,0.17409,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.3435e-06,0.17141,0.20089,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,3.3214e-05,0.17131,0.18936,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.0557e-05,0.17119,0.21474,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,6.8888e-05,0.17115,0.17518,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,6.1119e-05,0.17114,0.16248,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.00021511,0.17113,0.15473,1,1
1,GO MITOTIC RECOMBINATION,0.011151,0.17108,0.13472,1,1
1,GO AMELOGENESIS,0.018091,0.17078,0.18666,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00016361,0.17076,0.14733,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.037509,0.17054,0.10188,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00084997,0.17038,0.152,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.2416e-05,0.17027,0.16572,1,1
1,GO NEURAL TUBE FORMATION,0.00045468,0.16976,0.17992,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0071918,0.16974,0.15503,1,1
1,GO MESODERM DEVELOPMENT,1.3693e-05,0.16957,0.1727,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,6.545e-05,0.1693,0.15845,1,1
1,GO SNRNA METABOLIC PROCESS,0.00021511,0.16899,0.23393,1,1
1,GO TRACHEA MORPHOGENESIS,0.0013443,0.16894,0.21406,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0035146,0.16875,0.18882,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.017894,0.16868,0.17697,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00026024,0.16839,0.17164,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00021511,0.16831,0.17051,1,1
1,GO ACTIVATED T CELL PROLIFERATION,0.0088198,0.16822,0.14573,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.00081356,0.1681,0.20718,1,1
1,GO ACUTE PHASE RESPONSE,0.013856,0.16775,0.13505,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0018006,0.16758,0.20214,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.00012804,0.16753,0.16389,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0068504,0.16752,0.19246,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,3.7605e-06,0.16751,0.1901,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.001118,0.16744,0.18078,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00082553,0.16733,0.21864,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.00053704,0.16721,0.14878,1,1
1,GO RESPONSE TO CHEMOKINE,6.7724e-05,0.16718,0.17583,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.0015463,0.16713,0.13279,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,2.6914e-06,0.16712,0.1572,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00036124,0.16703,0.17855,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.00026024,0.16692,0.22495,1,1
1,GO FACE DEVELOPMENT,0.00031907,0.16682,0.2304,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0031247,0.16666,0.16995,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.010645,0.16659,0.19316,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0014022,0.16649,0.14808,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0022701,0.16639,0.21389,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00025617,0.16621,0.18039,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00017176,0.16617,0.14255,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.00017176,0.16599,0.18931,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.033271,0.16589,0.11575,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0010113,0.16586,0.15928,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.6994e-06,0.16584,0.19498,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,1.5576e-05,0.16569,0.15422,1,1
1,GO RESPONSE TO UV B,0.040187,0.16565,0.17398,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.00040235,0.16562,0.15593,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.00034485,0.1656,0.12664,1,1
1,GO AMINO ACID ACTIVATION,0.0024609,0.16547,0.15055,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,1.3442e-05,0.16508,0.18051,1,1
1,GO CELL AGING,4.0657e-06,0.16481,0.1712,1,1
1,GO REGULATION OF RNA BINDING,5.9056e-05,0.16479,0.18173,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.9749e-05,0.16473,0.20445,1,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00090088,0.16469,0.17659,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0037016,0.16468,0.14422,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045468,0.16447,0.20825,1,1
1,GO REGULATION OF LIPID STORAGE,4.3997e-05,0.16445,0.19932,1,1
1,GO GENITALIA DEVELOPMENT,0.0010865,0.16437,0.15579,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00052901,0.16432,0.15564,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00020178,0.1643,0.20464,1,1
1,GO MRNA TRANSCRIPTION,5.6487e-06,0.16426,0.26372,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,7.5001e-05,0.16406,0.1588,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00055343,0.16367,0.18637,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,2.9332e-05,0.16358,0.19068,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.00013673,0.16349,0.15868,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00032408,0.16345,0.19764,1,1
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.028556,0.16345,0.1619,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.0012177,0.16335,0.14983,1,1
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.023919,0.16325,0.20206,1,1
1,GO CELLULAR RESPONSE TO KETONE,0.010645,0.16294,0.11622,1,1
1,GO TUBE MORPHOGENESIS,3.6924e-05,0.16287,0.20079,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,2.9859e-05,0.16268,0.18317,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.00048316,0.16265,0.18323,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,6.2175e-05,0.16263,0.15829,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00059648,0.1626,0.17579,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,7.105e-06,0.16251,0.17435,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,5.4184e-05,0.16218,0.16302,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00029052,0.16203,0.18365,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0028118,0.16194,0.16902,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.3803e-06,0.16193,0.17083,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00042128,0.16164,0.18422,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00063314,0.16159,0.15629,1,1
1,GO VESICLE TARGETING,9.6562e-05,0.16143,0.1546,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00036686,0.1614,0.11391,1,1
1,GO RESPONSE TO PROGESTERONE,0.0061347,0.16139,0.17037,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4472e-05,0.16133,0.19862,1,1
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.00060545,0.16115,0.17104,1,1
1,GO REGULATION OF ORGAN GROWTH,1.6994e-06,0.16113,0.22366,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,3.628e-05,0.16106,0.14855,1,1
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.024173,0.16076,0.16833,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.018091,0.16059,0.14893,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0072795,0.16037,0.12118,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00036686,0.16015,0.15776,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.0010113,0.16005,0.098366,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0084096,0.15997,0.1665,1,1
1,GO LIPID MODIFICATION,0.00047589,0.15995,0.12967,1,1
1,GO MITOTIC CYTOKINESIS,0.00036686,0.1599,0.14456,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.00039018,0.1596,0.18229,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,1.8419e-06,0.15954,0.15779,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.017506,0.15949,0.30944,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00017457,0.15946,0.16644,1,1
1,GO RESPONSE TO OSMOTIC STRESS,7.0072e-05,0.1594,0.16504,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0037985,0.15931,0.1509,1,1
1,GO TRANSCYTOSIS,0.0068504,0.15928,0.14989,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,8.7502e-06,0.15914,0.16803,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,7.8124e-06,0.1584,0.19219,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,4.3236e-05,0.15839,0.12264,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.8839e-05,0.15804,0.13891,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0015463,0.15796,0.1523,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0047798,0.15795,0.16079,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0013826,0.15793,0.14721,1,1
1,GO NEPHRON DEVELOPMENT,0.0071051,0.15788,0.16812,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,5.9834e-06,0.15785,0.16935,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00025215,0.1578,0.22049,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.045155,0.1577,0.11154,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.8885e-07,0.15766,0.17238,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,7.0522e-08,0.15743,0.1576,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0005618,0.15739,0.17016,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0034692,0.15718,0.13298,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.9228e-07,0.15717,0.16013,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00053704,0.15711,0.15364,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0095807,0.15701,0.11707,1,1
1,GO RNA LOCALIZATION,4.9694e-05,0.15692,0.15549,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0033799,0.15657,0.16101,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,5.9056e-05,0.15645,0.1719,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0065235,0.15624,0.13028,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.019104,0.15612,0.12383,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0056255,0.15585,0.12678,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00039622,0.15564,0.17985,1,1
1,GO RESPONSE TO LIPID,0.00023294,0.1553,0.14673,1,1
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0042095,0.15508,0.15279,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00054518,0.15497,0.16117,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,7.6283e-05,0.15485,0.17644,1,1
1,GO NADP METABOLIC PROCESS,0.0026663,0.15468,0.16253,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,3.3214e-05,0.15455,0.16525,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00049053,0.15444,0.15467,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00022208,0.1544,0.13924,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,8.1623e-05,0.15411,0.16511,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,1.0169e-05,0.15406,0.16877,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,1.2716e-05,0.15404,0.15487,1,1
1,GO SPERM EGG RECOGNITION,8.5858e-05,0.154,0.14323,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.001568,0.15391,0.11513,1,1
1,GO LYMPHOCYTE DIFFERENTIATION,0.00013899,0.15381,0.17706,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.0021798,0.15374,0.16934,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0007786,0.15352,0.1246,1,1
1,GO LEFT RIGHT PATTERN FORMATION,0.0038478,0.15345,0.19214,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0005133,0.15337,0.16691,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00012594,0.15336,0.19556,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,8.0256e-05,0.15302,0.17148,1,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.026838,0.153,0.16626,1,1
1,GO B CELL DIFFERENTIATION,0.0017277,0.15296,0.16086,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,9.9803e-06,0.15272,0.16298,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,7.3739e-05,0.15263,0.13596,1,1
1,GO TRNA TRANSPORT,0.00061456,0.15257,0.14308,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0020929,0.15243,0.17963,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,3.4409e-05,0.15237,0.1773,1,1
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0051547,0.15236,0.145,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.048746,0.15181,0.12461,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.024173,0.15176,0.11015,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0045438,0.15171,0.13452,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.00054518,0.15166,0.13196,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.010522,0.15165,0.13906,1,1
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0037016,0.15152,0.13572,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,6.7724e-05,0.15152,0.19108,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,7.8124e-06,0.15144,0.23026,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00081356,0.1514,0.13573,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.017894,0.15135,0.19537,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,1.0361e-05,0.15109,0.14618,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.00041488,0.15094,0.13111,1,1
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.0069343,0.15093,0.17055,1,1
1,GO PROTEIN PROCESSING,0.00012186,0.15078,0.15782,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0070192,0.15074,0.18328,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,3.3214e-05,0.15064,0.2027,1,1
1,GO DRUG METABOLIC PROCESS,0.0085105,0.15054,0.13741,1,1
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0038977,0.15035,0.1136,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00010323,0.15023,0.16915,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00041488,0.1502,0.16282,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.003607,0.15014,0.15576,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.001442,0.15009,0.13077,1,1
1,GO STEM CELL DIFFERENTIATION,1.9044e-05,0.15,0.17004,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0056958,0.14999,0.13582,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.002631,0.14992,0.14565,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00063314,0.14967,0.16826,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.010041,0.14921,0.11475,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00027284,0.14891,0.1314,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,9.6562e-05,0.14889,0.15159,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0025617,0.14875,0.1041,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00019857,0.14868,0.15108,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0039481,0.14846,0.12248,1,1
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.038258,0.14841,0.13746,1,1
1,GO FATTY ACID METABOLIC PROCESS,0.00013016,0.14825,0.13859,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.1274e-05,0.14823,0.1692,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00094089,0.14823,0.19591,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0022095,0.14818,0.10569,1,1
1,GO RNA SURVEILLANCE,0.0029256,0.14793,0.13471,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,2.9332e-05,0.14786,0.15795,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.6914e-06,0.1478,0.16869,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,4.2487e-05,0.14771,0.16536,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.001955,0.14766,0.19517,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00047589,0.14748,0.18504,1,1
1,GO HISTONE DEACETYLATION,0.00055343,0.14725,0.12317,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.013546,0.1472,0.17686,1,1
1,GO MAINTENANCE OF CELL NUMBER,0.0031247,0.14683,0.15473,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0052854,0.14679,0.21648,1,1
1,GO TISSUE MORPHOGENESIS,0.00025617,0.14679,0.15248,1,1
1,GO REGULATION OF URINE VOLUME,3.1494e-05,0.14664,0.21377,1,1
1,GO MRNA TRANSPORT,3.094e-05,0.14645,0.15149,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,7.7586e-05,0.14642,0.13986,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0021505,0.14624,0.17522,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00098255,0.14609,0.12911,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0088198,0.14602,0.15653,1,1
1,GO MIRNA METABOLIC PROCESS,0.0017277,0.14592,0.14937,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.010522,0.14571,0.13219,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0041031,0.14566,0.14919,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.017506,0.1456,0.14629,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.009139,0.14558,0.12455,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0027747,0.14554,0.17311,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00054518,0.14543,0.13874,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0025277,0.14535,0.12965,1,1
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.014494,0.14534,0.12445,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,9.404e-07,0.14509,0.17366,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00031907,0.14505,0.15006,1,1
1,GO PIGMENT CELL DIFFERENTIATION,0.022686,0.14495,0.11934,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,5.8698e-06,0.14489,0.14323,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00081356,0.14485,0.18807,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0011836,0.14475,0.14649,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00075607,0.14437,0.13613,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0018256,0.14432,0.18427,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.001955,0.14404,0.11916,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.3381e-05,0.14401,0.14322,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.1375e-05,0.14396,0.15607,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00032408,0.14385,0.1506,1,1
1,GO OSTEOBLAST DIFFERENTIATION,3.6924e-05,0.14382,0.21442,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0005618,0.14374,0.13657,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0076401,0.14356,0.19251,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.00058763,0.14352,0.13228,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0062877,0.14351,0.15581,1,1
1,GO RESPONSE TO UV,0.00011406,0.14344,0.15108,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,8.3013e-05,0.14336,0.18179,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.8053e-06,0.14331,0.17936,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00036124,0.14318,0.13655,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00044103,0.14309,0.16505,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.012653,0.14308,0.18266,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00030449,0.14305,0.18235,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,4.3946e-06,0.14271,0.14531,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0022396,0.14262,0.12674,1,1
1,GO PROTEIN SUMOYLATION,0.0007786,0.14254,0.11739,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0077327,0.1424,0.11978,1,1
1,GO BLASTOCYST FORMATION,4.7172e-05,0.14225,0.15766,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.5037e-07,0.14223,0.1434,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.7724e-05,0.14218,0.16692,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,5.0323e-06,0.14217,0.13586,1,1
1,GO PEPTIDE METABOLIC PROCESS,6.0759e-07,0.14212,0.14885,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0018256,0.14211,0.16546,1,1
1,GO NUCLEAR EXPORT,1.2253e-05,0.14206,0.14987,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,2.2824e-05,0.14174,0.19425,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00083767,0.14171,0.10888,1,1
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.045155,0.14166,0.07878,1,1
1,GO PROTEIN IMPORT,1.5576e-05,0.14111,0.14717,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0010865,0.1411,0.15508,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.038637,0.14102,0.15856,1,1
1,GO KERATINOCYTE DIFFERENTIATION,0.054582,0.14101,0.15233,1,1
1,GO MITOPHAGY,0.00026438,0.14097,0.16888,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0012886,0.1407,0.17403,1,1
1,GO PIGMENTATION,0.051595,0.14062,0.084782,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.0048405,0.14062,0.18364,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,7.0072e-05,0.14025,0.14467,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0017277,0.13983,0.17743,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,8.8389e-07,0.13976,0.12761,1,1
1,GO REGULATION OF RESPONSE TO STRESS,1.2716e-05,0.13946,0.14424,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0018508,0.13923,0.18001,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00049053,0.13906,0.14898,1,1
1,GO CELLULAR RESPONSE TO ATP,0.00159,0.13903,0.11468,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,2.9332e-05,0.13902,0.15438,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00094089,0.13881,0.14704,1,1
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.045155,0.13867,0.12867,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00010497,0.13867,0.1591,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00037835,0.13851,0.15363,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.8053e-06,0.13833,0.16779,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0005211,0.13832,0.16987,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0096941,0.13815,0.13815,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.8793e-06,0.13804,0.15537,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00041488,0.13795,0.14729,1,1
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0058389,0.13788,0.13244,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.0018508,0.13781,0.15118,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.1165e-05,0.13773,0.13121,1,1
1,GO RNA PROCESSING,0.00016629,0.13758,0.13135,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00022208,0.1375,0.11999,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.033948,0.13747,0.079112,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00021857,0.13745,0.13235,1,1
1,GO RNA POLYADENYLATION,0.0023321,0.13744,0.12232,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00015083,0.13716,0.14843,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,7.3739e-05,0.13714,0.15396,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00022565,0.13702,0.16271,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.049681,0.13702,0.14499,1,1
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0029256,0.13693,0.15744,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.2585e-06,0.13691,0.16166,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00024045,0.13689,0.12915,1,1
1,GO AGING,4.6359e-05,0.13685,0.13408,1,1
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.032938,0.13672,0.19291,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.00069207,0.13666,0.1422,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.0021798,0.13654,0.1515,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0012886,0.13636,0.13527,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0057669,0.13631,0.18306,1,1
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.011151,0.1363,0.13853,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.8814e-05,0.13624,0.13231,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0065235,0.13624,0.11881,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,1.0557e-05,0.13622,0.15664,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,7.5001e-05,0.13617,0.14493,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.022686,0.13615,0.12897,1,1
1,GO CELLULAR RESPONSE TO UV,0.00013016,0.1361,0.15586,1,1
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.022686,0.13605,0.15142,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,5.1304e-06,0.13566,0.15799,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00015583,0.13559,0.14637,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0041031,0.13549,0.16947,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,6.2175e-05,0.13524,0.12477,1,1
1,GO MALE SEX DIFFERENTIATION,0.019104,0.13521,0.11006,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,3.5646e-05,0.13507,0.11462,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0065235,0.13497,0.11229,1,1
1,GO NUCLEUS LOCALIZATION,0.015329,0.13487,0.14681,1,1
1,GO ENDOCRINE PROCESS,0.0016806,0.13473,0.15419,1,1
1,GO OSSIFICATION,0.0011836,0.1346,0.15579,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0043737,0.13437,0.1539,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,9.9844e-05,0.13431,0.16354,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0049019,0.13427,0.12999,1,1
1,GO LIPID HOMEOSTASIS,0.0011341,0.13421,0.13604,1,1
1,GO REGULATION OF CELL DEATH,0.00024819,0.13408,0.12152,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00035024,0.13403,0.1772,1,1
1,GO RESPONSE TO INTERLEUKIN 4,2.7804e-05,0.13401,0.19028,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00075607,0.13397,0.1512,1,1
1,GO BIOLOGICAL ADHESION,0.0060595,0.13382,0.13137,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0016806,0.1336,0.13325,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,2.538e-07,0.13338,0.13847,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0078263,0.13315,0.12226,1,1
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.020605,0.13301,0.10501,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00024045,0.13287,0.13567,1,1
1,GO RESPONSE TO STEROL,0.012798,0.13278,0.14341,1,1
1,GO CARNITINE SHUTTLE,0.010279,0.13273,0.14762,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00013899,0.1326,0.13478,1,1
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00055343,0.13252,0.16456,1,1
1,GO BODY FLUID SECRETION,2.2824e-05,0.13243,0.17543,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00064263,0.13237,0.16656,1,1
1,GO TISSUE HOMEOSTASIS,0.0072795,0.13234,0.1091,1,1
1,GO REGULATION OF VASCULOGENESIS,0.047827,0.13221,0.18577,1,1
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.0046018,0.13217,0.13755,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00064263,0.1321,0.21498,1,1
1,GO GOLGI VESICLE TRANSPORT,2.913e-06,0.13196,0.14858,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00039622,0.13192,0.13067,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0012527,0.13184,0.16039,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.001955,0.13177,0.11769,1,1
1,GO PROTEIN MATURATION,9.6562e-05,0.13167,0.12561,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00030449,0.13159,0.12163,1,1
1,GO JNK CASCADE,0.0087156,0.13145,0.10322,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.0059852,0.13139,0.1529,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0078263,0.13129,0.1503,1,1
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0033799,0.13114,0.13543,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.043866,0.131,0.13725,1,1
1,GO MEMBRANE DISASSEMBLY,0.05063,0.131,0.12459,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.0020367,0.13068,0.096667,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.0056958,0.13059,0.12204,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.035336,0.13046,0.12386,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.0067673,0.13033,0.15255,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00063314,0.13029,0.14412,1,1
1,GO DE NOVO PROTEIN FOLDING,0.024947,0.13007,0.10309,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.028264,0.12999,0.095204,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0095807,0.12986,0.13294,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0018256,0.12982,0.11849,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0023321,0.12979,0.10843,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.4472e-05,0.12964,0.15347,1,1
1,GO IMPORT INTO NUCLEUS,0.00010323,0.12961,0.13142,1,1
1,GO EPITHELIAL TUBE FORMATION,0.0059116,0.12946,0.1398,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00010673,0.12936,0.15334,1,1
1,GO RESPONSE TO NUTRIENT,0.003607,0.12934,0.13751,1,1
1,GO RNA 3 END PROCESSING,5.7059e-05,0.1293,0.13935,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.02945,0.12929,0.10806,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,9.1829e-05,0.12877,0.15271,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00018323,0.12875,0.15835,1,1
1,GO OVULATION,0.028556,0.1287,0.14707,1,1
1,GO RESPONSE TO HEAT,0.00027284,0.12838,0.13678,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00015083,0.12824,0.15954,1,1
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.016938,0.12812,0.11569,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00033432,0.12792,0.15768,1,1
1,GO CHOLESTEROL STORAGE,0.011022,0.12771,0.21105,1,1
1,GO GOLGI VESICLE BUDDING,0.00026858,0.12758,0.13517,1,1
1,GO FAT CELL DIFFERENTIATION,0.006444,0.1274,0.12696,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00046872,0.12739,0.11353,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.01849,0.12731,0.13405,1,1
1,GO ANION HOMEOSTASIS,0.0052854,0.12701,0.13515,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00081356,0.12682,0.16183,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.025743,0.12678,0.14824,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0022396,0.12673,0.14418,1,1
1,GO PROTEIN STABILIZATION,0.00023294,0.12625,0.12726,1,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.027686,0.12624,0.083955,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.039406,0.12624,0.13414,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.013243,0.12617,0.15856,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,1.8363e-05,0.12614,0.12999,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00026024,0.1261,0.1042,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,6.6578e-05,0.12605,0.15161,1,1
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0010408,0.12602,0.12988,1,1
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011022,0.12599,0.16669,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.036048,0.12597,0.10436,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00033955,0.12574,0.1447,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,1.1588e-05,0.12563,0.17722,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.032278,0.1256,0.070263,1,1
1,GO RESPONSE TO KETONE,0.004156,0.12555,0.12043,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.00034485,0.12549,0.15998,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0030038,0.12533,0.10194,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00044103,0.12508,0.12814,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.015329,0.12498,0.098829,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0002117,0.12483,0.17585,1,1
1,GO NUCLEAR TRANSPORT,4.8839e-05,0.12449,0.12226,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.021973,0.12442,0.11218,1,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0092477,0.12437,0.13781,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00042128,0.12427,0.18955,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00091404,0.12421,0.13792,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0049019,0.12407,0.15598,1,1
1,GO CARNITINE METABOLIC PROCESS,0.0050269,0.12403,0.19178,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.0016347,0.12382,0.11239,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.042197,0.12381,0.13452,1,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.063836,0.12374,0.071487,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.8924e-05,0.12372,0.13326,1,1
1,GO SPINDLE LOCALIZATION,0.0056255,0.12365,0.11164,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.00010152,0.12325,0.15461,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00076726,0.12297,0.13488,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00086244,0.12292,0.1334,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.037882,0.12282,0.14104,1,1
1,GO CELLULAR RESPONSE TO RADIATION,2.4972e-05,0.12279,0.15755,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00059648,0.12275,0.13899,1,1
1,GO COPII COATED VESICLE BUDDING,0.00041488,0.12259,0.13138,1,1
1,GO REGULATION OF JUN KINASE ACTIVITY,0.028852,0.12251,0.11071,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00087508,0.12222,0.12172,1,1
1,GO CELLULAR RESPONSE TO ALCOHOL,0.012653,0.12219,0.13468,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00027716,0.12215,0.15036,1,1
1,GO TUBE DEVELOPMENT,0.00043435,0.12215,0.16275,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.0029645,0.12178,0.12187,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00053704,0.12157,0.13432,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,1.8053e-06,0.12129,0.13752,1,1
1,GO REGULATION OF MAPK CASCADE,0.0005211,0.12114,0.1367,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.023173,0.12087,0.12619,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00090088,0.12082,0.11853,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.056652,0.12075,0.13166,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,8.4262e-06,0.12047,0.11476,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.3256e-05,0.12041,0.16204,1,1
1,GO PROTEOLYSIS,3.628e-05,0.12023,0.12113,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00064263,0.11999,0.12245,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0030436,0.11998,0.148,1,1
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.021053,0.11978,0.09314,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0046018,0.11977,0.11724,1,1
1,GO PROTEIN AUTOPHOSPHORYLATION,0.0054192,0.11971,0.12303,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0005056,0.11971,0.12681,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.0010408,0.11941,0.17488,1,1
1,GO LIPID CATABOLIC PROCESS,0.00076726,0.11933,0.11673,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0022095,0.11928,0.12578,1,1
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0024281,0.11905,0.14641,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0066851,0.11903,0.14855,1,1
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.014172,0.11897,0.1717,1,1
1,GO MRNA 3 END PROCESSING,0.003166,0.11879,0.10091,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00016629,0.11877,0.12676,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0010408,0.11861,0.10658,1,1
1,GO HISTONE DEUBIQUITINATION,0.040981,0.1185,0.099968,1,1
1,GO TUBE FORMATION,0.004964,0.11849,0.14005,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,3.3806e-05,0.11848,0.11769,1,1
1,GO POSITIVE REGULATION OF JNK CASCADE,0.013243,0.11811,0.1127,1,1
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0037498,0.118,0.1504,1,1
1,GO REGULATION OF CATABOLIC PROCESS,6.8396e-06,0.11785,0.12641,1,1
1,GO BONE CELL DEVELOPMENT,0.037139,0.11767,0.14966,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,6.2175e-05,0.11766,0.13921,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.2716e-05,0.1176,0.14905,1,1
1,GO ACETYL COA METABOLIC PROCESS,0.011949,0.11743,0.13796,1,1
1,GO PROTEIN CATABOLIC PROCESS,3.094e-05,0.11732,0.11741,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0059116,0.11644,0.078404,1,1
1,GO CELLULAR LIPID METABOLIC PROCESS,0.0013633,0.11631,0.11193,1,1
1,GO MRNA METABOLIC PROCESS,0.00013016,0.11624,0.11475,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0011836,0.11621,0.10719,1,1
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.019735,0.11618,0.12511,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00033432,0.11611,0.1124,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,2.1196e-06,0.11596,0.13498,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.8363e-05,0.11562,0.12276,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00010497,0.11542,0.1124,1,1
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.027686,0.11537,0.11386,1,1
1,GO VACUOLAR TRANSPORT,0.00040235,0.11496,0.13052,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1.7385e-05,0.11491,0.1431,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.060432,0.11475,0.088284,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00011596,0.1146,0.11884,1,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0035146,0.11431,0.12442,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,3.152e-06,0.11416,0.13241,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0018256,0.11411,0.14904,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0010558,0.11383,0.10935,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.016568,0.11365,0.093355,1,1
1,GO TELOMERE ORGANIZATION,0.00033432,0.11362,0.10403,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0070192,0.11338,0.1072,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00018323,0.11337,0.12977,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.0053519,0.11335,0.12296,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00014839,0.11324,0.13816,1,1
1,GO ACTIVATION OF GTPASE ACTIVITY,0.028556,0.113,0.099754,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.020828,0.11242,0.092821,1,1
1,GO APOPTOTIC PROCESS,0.00063314,0.11242,0.10713,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.015501,0.11232,0.11811,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0046604,0.11209,0.11976,1,1
1,GO P BODY ASSEMBLY,0.051111,0.11198,0.083746,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00034485,0.11189,0.12894,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.001422,0.11185,0.11609,1,1
1,GO PEROXISOMAL TRANSPORT,0.0013826,0.11175,0.1333,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.017125,0.11154,0.12189,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00013232,0.11153,0.13955,1,1
1,GO ORGANELLE INHERITANCE,0.024687,0.11146,0.08464,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00061456,0.11145,0.13583,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0012005,0.1114,0.11274,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021798,0.11132,0.16173,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.01251,0.11092,0.087594,1,1
1,GO RESPONSE TO PEPTIDE,0.0045438,0.11083,0.09874,1,1
1,GO REGULATION OF PROTEIN STABILITY,0.00010673,0.11077,0.1206,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00037835,0.11034,0.11666,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023294,0.11028,0.11579,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0010259,0.11015,0.11296,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0054872,0.11013,0.15183,1,1
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0090315,0.10984,0.095816,1,1
1,GO VACUOLE ORGANIZATION,0.00019857,0.10974,0.137,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0033799,0.10971,0.14114,1,1
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.03006,0.10958,0.15302,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.013243,0.10934,0.1398,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0057669,0.1092,0.12253,1,1
1,GO ORGAN GROWTH,0.00073415,0.1091,0.17979,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.018693,0.10907,0.12921,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.024173,0.10901,0.11961,1,1
1,GO RESPONSE TO DRUG,0.0065235,0.10863,0.1087,1,1
1,GO CYTOKINESIS,0.040582,0.10848,0.066553,1,1
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.039795,0.10845,0.088332,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.027401,0.10844,0.17379,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.0022095,0.10841,0.12457,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0089251,0.10823,0.070021,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0038977,0.10813,0.11255,1,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.063258,0.10811,0.065262,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.038637,0.10803,0.12858,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0034692,0.10788,0.12565,1,1
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0010558,0.10761,0.11946,1,1
1,GO ER NUCLEUS SIGNALING PATHWAY,0.03902,0.10756,0.098167,1,1
1,GO REGULATION OF DNA REPAIR,0.01499,0.10733,0.062626,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.016752,0.10728,0.089655,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0019819,0.10726,0.13337,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.015501,0.10687,0.09594,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0011021,0.10686,0.10959,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00021857,0.10675,0.13584,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,5.4184e-05,0.10674,0.13349,1,1
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.066192,0.10668,0.089591,1,1
1,GO GOLGI RIBBON FORMATION,0.016938,0.10666,0.14577,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0033799,0.1063,0.079115,1,1
1,GO DNA BIOSYNTHETIC PROCESS,0.00011218,0.10617,0.10479,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0013069,0.10613,0.081145,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0014624,0.10609,0.11095,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0030839,0.10598,0.10998,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0017277,0.10564,0.11069,1,1
1,GO RRNA 3 END PROCESSING,0.013546,0.10551,0.095376,1,1
1,GO PEROXISOME ORGANIZATION,0.00080175,0.10541,0.13085,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0012005,0.10528,0.118,1,1
1,GO LIPID METABOLIC PROCESS,0.0018764,0.10508,0.10525,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.2344e-05,0.1048,0.117,1,1
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.006444,0.10478,0.084787,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00015583,0.10464,0.11521,1,1
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0040509,0.10463,0.12855,1,1
1,GO GLYCEROLIPID METABOLIC PROCESS,0.0017277,0.10442,0.10768,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.010895,0.10438,0.13001,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,4.4771e-05,0.10434,0.10221,1,1
1,GO PROTEIN NEDDYLATION,0.0073682,0.10426,0.10596,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.011151,0.10423,0.11948,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,8.7316e-05,0.10409,0.14122,1,1
1,GO REGULATION OF MITOPHAGY,0.02945,0.10403,0.12511,1,1
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0052854,0.10403,0.10065,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.013093,0.10389,0.13755,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00029052,0.10369,0.10366,1,1
1,GO B CELL APOPTOTIC PROCESS,0.027401,0.10342,0.13704,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.043025,0.1034,0.1482,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.0032501,0.10325,0.10921,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00039622,0.103,0.11413,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00024819,0.10297,0.10688,1,1
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.052083,0.1029,0.082585,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00094089,0.10271,0.12289,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.001118,0.10258,0.11032,1,1
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.026561,0.1024,0.089794,1,1
1,GO MAINTENANCE OF LOCATION,7.6283e-05,0.10223,0.13907,1,1
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0021798,0.10182,0.14245,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0035605,0.10128,0.12923,1,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.02521,0.10085,0.15909,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0014624,0.10073,0.1117,1,1
1,GO PROTEIN AUTOUBIQUITINATION,0.03068,0.10073,0.07377,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0019285,0.10031,0.11832,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0054872,0.1003,0.12475,1,1
1,GO GENE SILENCING,0.00014362,0.1002,0.11932,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0050904,0.10001,0.1179,1,1
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.029754,0.099967,0.097536,1,1
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00071283,0.099874,0.11277,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0010558,0.099346,0.12713,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00014129,0.099253,0.12408,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.016027,0.0991,0.13033,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.01016,0.098837,0.09715,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.010279,0.098761,0.10807,1,1
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.007921,0.098694,0.11443,1,1
1,GO SNORNA METABOLIC PROCESS,0.065005,0.098575,0.082896,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0016806,0.097933,0.10154,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.025743,0.097918,0.061505,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00022208,0.097867,0.10021,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.014494,0.097862,0.10516,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.052083,0.097594,0.089322,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0034243,0.096948,0.1174,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0013826,0.096932,0.13303,1,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0096941,0.096879,0.10427,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00074504,0.096793,0.11292,1,1
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.0022095,0.096729,0.1088,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0023321,0.096455,0.10636,1,1
1,GO POSTREPLICATION REPAIR,0.011151,0.096348,0.067343,1,1
1,GO ANIMAL ORGAN FORMATION,0.041789,0.096345,0.12719,1,1
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00032408,0.096239,0.10793,1,1
1,GO BLASTOCYST GROWTH,0.0023321,0.095902,0.17729,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.017315,0.095704,0.15309,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.0028492,0.095562,0.15392,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0058389,0.095494,0.083719,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.02945,0.094979,0.13745,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.019104,0.094658,0.1457,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00096848,0.09456,0.1064,1,1
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.053071,0.094497,0.11764,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,9.4959e-05,0.094471,0.11885,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.002702,0.094465,0.099784,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0050904,0.094387,0.093239,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00013899,0.094161,0.11893,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.011151,0.093901,0.064703,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.039406,0.093661,0.075272,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0042636,0.093475,0.093245,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.007921,0.093405,0.090301,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0094686,0.092919,0.092402,1,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.025743,0.092888,0.08553,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0016347,0.092877,0.12147,1,1
1,GO HYPEROSMOTIC RESPONSE,0.021053,0.092858,0.11775,1,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.01849,0.092836,0.12249,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0039992,0.092816,0.090748,1,1
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.012367,0.092697,0.095319,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0055559,0.092631,0.11486,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00025617,0.092596,0.11265,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0033799,0.092377,0.10999,1,1
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.01849,0.092291,0.1101,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.055609,0.092031,0.10477,1,1
1,GO CELL DIVISION,0.012945,0.091883,0.070017,1,1
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0019023,0.091683,0.1051,1,1
1,GO RESPONSE TO ESTRADIOL,0.037139,0.091546,0.090637,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.015329,0.091496,0.1456,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00067188,0.091277,0.11662,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.0066851,0.09114,0.087864,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.0041031,0.090903,0.12198,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0054872,0.090818,0.096284,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.023419,0.090725,0.12782,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0012705,0.090702,0.10167,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0063654,0.090288,0.089575,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0092477,0.090158,0.097509,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0056255,0.09007,0.11778,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00044103,0.08984,0.10097,1,1
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.01829,0.08972,0.12214,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.019104,0.089653,0.091385,1,1
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00072342,0.089552,0.11409,1,1
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.054074,0.089458,0.083377,1,1
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0019819,0.08936,0.10732,1,1
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0010113,0.088848,0.1814,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.027686,0.088475,0.084829,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.03006,0.088406,0.063289,1,1
1,GO DNA METHYLATION,0.058787,0.088239,0.067356,1,1
1,GO TRANSLESION SYNTHESIS,0.024687,0.088171,0.068033,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.027686,0.088032,0.08792,1,1
1,GO OXIDATION REDUCTION PROCESS,0.0010113,0.087933,0.097057,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.01995,0.0878,0.076876,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.027401,0.087753,0.10931,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.030994,0.087524,0.09437,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00038422,0.087395,0.093145,1,1
1,GO DNA DEALKYLATION,0.0067673,0.087279,0.14869,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,6.0079e-05,0.0872,0.10859,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014823,0.087124,0.10708,1,1
1,GO ENDOSOMAL TRANSPORT,0.0024281,0.087106,0.10037,1,1
1,GO REGULATION OF GTPASE ACTIVITY,0.043025,0.086766,0.0929,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0075485,0.086715,0.06339,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0050904,0.086463,0.085439,1,1
1,GO DNA MODIFICATION,0.013546,0.086338,0.079898,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.049681,0.086176,0.052409,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00045468,0.085702,0.091036,1,1
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.028556,0.085426,0.1139,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0021798,0.085395,0.091794,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.016205,0.085056,0.081349,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0137,0.084734,0.087893,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.02128,0.08456,0.097898,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0090315,0.084511,0.084601,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0033361,0.084487,0.14764,1,1
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.02945,0.084445,0.1096,1,1
1,GO CELL VOLUME HOMEOSTASIS,0.016568,0.083892,0.10567,1,1
1,GO ALCOHOL METABOLIC PROCESS,0.0029256,0.083482,0.10878,1,1
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0098086,0.083325,0.091642,1,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.011949,0.083098,0.11532,1,1
1,GO MACROAUTOPHAGY,7.8911e-05,0.083091,0.11752,1,1
1,GO ENDOSOME ORGANIZATION,0.00082553,0.082691,0.12734,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.014494,0.082633,0.13792,1,1
1,GO DNA RECOMBINATION,0.0093576,0.081906,0.073155,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0042636,0.081489,0.084872,1,1
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0011341,0.081089,0.088728,1,1
1,GO DNA GEOMETRIC CHANGE,0.006444,0.080748,0.088867,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0050269,0.080721,0.12295,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.023419,0.080678,0.077344,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0050904,0.080612,0.10023,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.002702,0.080472,0.076853,1,1
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.032938,0.080108,0.10637,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0022701,0.07971,0.10983,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0053519,0.079611,0.078995,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0093576,0.079128,0.064825,1,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.067397,0.079049,0.077625,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.046031,0.07903,0.045849,1,1
1,GO NUCLEUS ORGANIZATION,0.022209,0.078935,0.075293,1,1
1,GO HISTONE H3 ACETYLATION,0.049212,0.078469,0.07273,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.0035146,0.07842,0.067514,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.011151,0.078254,0.11613,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.016027,0.077496,0.075777,1,1
1,GO PROTEIN DESTABILIZATION,0.026286,0.077435,0.095827,1,1
1,GO ACTIVATION OF MAPK ACTIVITY,0.042609,0.077207,0.079668,1,1
1,GO DNA METABOLIC PROCESS,0.0015463,0.076487,0.065252,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0038977,0.076463,0.10908,1,1
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0046018,0.07633,0.11366,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0074579,0.076105,0.091112,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.025743,0.076027,0.10362,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00029976,0.076005,0.083687,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0070192,0.075789,0.11185,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0038977,0.075632,0.10785,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.0066851,0.075438,0.070419,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.014823,0.075021,0.061143,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.01128,0.074794,0.087605,1,1
1,GO MITOTIC CELL CYCLE,0.0038478,0.07466,0.071628,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.0043737,0.073222,0.077305,1,1
1,GO CYTOSKELETON ORGANIZATION,0.065596,0.073181,0.071629,1,1
1,GO HORMONE METABOLIC PROCESS,0.05357,0.072779,0.076599,1,1
1,GO PROTEIN TARGETING,0.00035024,0.072632,0.10925,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00021857,0.072618,0.097676,1,1
1,GO PROTEIN TETRAMERIZATION,0.0096941,0.072189,0.088877,1,1
1,GO CELLULAR SENESCENCE,0.0013633,0.071635,0.12545,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.030994,0.071151,0.079785,1,1
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.023419,0.070839,0.084987,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0068504,0.070687,0.089731,1,1
1,GO SULFATE TRANSPORT,0.034984,0.070464,0.085551,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.027118,0.069976,0.058579,1,1
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.02128,0.069633,0.085313,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.015501,0.069236,0.079379,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00038422,0.069216,0.10513,1,1
1,GO BASE EXCISION REPAIR,0.046474,0.069147,0.055625,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.024173,0.06912,0.09894,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.003166,0.068539,0.074014,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0087156,0.067565,0.087651,1,1
1,GO HEART GROWTH,0.0070192,0.067255,0.13762,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.036772,0.065758,0.069993,1,1
1,GO MACROMOLECULE DEACYLATION,0.012227,0.06552,0.082805,1,1
1,GO RESPONSE TO RADIATION,0.0083098,0.065269,0.077421,1,1
1,GO SNRNA TRANSCRIPTION,0.038258,0.065267,0.06388,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.058787,0.065234,0.053333,1,1
1,GO REGULATION OF CELL CYCLE,0.023668,0.06458,0.053273,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0032078,0.063801,0.066937,1,1
1,GO CELL CYCLE PROCESS,0.009139,0.06367,0.057682,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.049212,0.063374,0.061362,1,1
1,GO CELL CYCLE CHECKPOINT,0.058787,0.062751,0.046375,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.057179,0.062403,0.12847,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00069207,0.06211,0.082409,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0068504,0.060733,0.082264,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.014172,0.06008,0.10794,1,1
1,GO DNA METHYLATION OR DEMETHYLATION,0.048285,0.059916,0.072859,1,1
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.011022,0.059374,0.080455,1,1
1,GO REGULATION OF AUTOPHAGY,0.0011836,0.058796,0.10262,1,1
1,GO NCRNA TRANSCRIPTION,0.038637,0.058281,0.068098,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.028852,0.055106,0.080035,1,1
1,GO DNA REPAIR,0.01128,0.054104,0.049078,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.024947,0.054004,0.079811,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.012227,0.05372,0.080726,1,1
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.017315,0.053146,0.078079,1,1
1,GO CELL CYCLE,0.016027,0.051178,0.05248,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.042197,0.050243,0.060606,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0074579,0.045053,0.096948,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.012653,0.040782,0.071231,1,1
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00021857,0.38426,0.32557,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,5.5127e-05,0.33221,0.31296,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0056255,0.3305,0.25215,1,0
1,GO RESPONSE TO PROTOZOAN,4.1751e-05,0.32919,0.29766,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,3.9613e-05,0.32596,0.32521,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0032928,0.32225,0.28494,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00036686,0.32081,0.28344,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.004964,0.31153,0.28494,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00049053,0.30379,0.25778,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00071283,0.30283,0.27417,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.357e-07,0.28873,0.36191,1,0
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,3.3214e-05,0.28731,0.28872,1,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0005133,0.28589,0.36253,1,0
1,GO REGULATION OF RECEPTOR BINDING,0.012798,0.28498,0.21339,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00037257,0.28067,0.25167,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.0563e-05,0.26966,0.23604,1,0
1,GO DETECTION OF OTHER ORGANISM,0.0020367,0.26883,0.29454,1,0
1,GO GRANULOCYTE CHEMOTAXIS,4.7172e-05,0.26644,0.21062,1,0
1,GO COMPLEMENT ACTIVATION,7.3803e-06,0.26375,0.30499,1,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00055343,0.26057,0.29484,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.015674,0.25905,0.22712,1,0
1,GO GRANULOCYTE MIGRATION,5.0323e-06,0.25564,0.22767,1,0
1,GO PHAGOCYTOSIS RECOGNITION,6.9711e-06,0.25366,0.35609,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00024819,0.25139,0.21345,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,1.0958e-05,0.25137,0.22065,1,0
1,GO RESPONSE TO HYPEROXIA,5.1446e-05,0.25044,0.27417,1,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.023668,0.25028,0.27858,1,0
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.003607,0.24981,0.23331,1,0
1,GO REGULATION OF COAGULATION,4.4807e-06,0.24571,0.31597,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0032078,0.23956,0.18105,1,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0010558,0.23806,0.23778,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00013673,0.2374,0.20937,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.001955,0.23647,0.1943,1,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.021973,0.23525,0.22135,1,0
1,GO REGULATION OF PLATELET ACTIVATION,0.0022095,0.23501,0.25543,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.4472e-05,0.23427,0.25526,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0010113,0.23417,0.27409,1,0
1,GO NEUTROPHIL MIGRATION,0.0003557,0.23404,0.17774,1,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.001422,0.23242,0.31418,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.00058763,0.23114,0.20695,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0005618,0.22847,0.2726,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,5.8698e-06,0.22681,0.24866,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0020367,0.22541,0.21729,1,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0092477,0.22435,0.2077,1,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0049019,0.2241,0.22621,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0057669,0.22309,0.2276,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0071918,0.21903,0.2179,1,0
1,GO LUNG MORPHOGENESIS,8.4424e-05,0.21738,0.28788,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.0039481,0.21691,0.20821,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00029511,0.21661,0.24925,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00159,0.21547,0.1822,1,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00060545,0.21411,0.22204,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.054074,0.21327,0.17205,1,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,2.3891e-06,0.21274,0.24013,1,0
1,GO NEGATIVE T CELL SELECTION,0.0026663,0.21254,0.16903,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0025617,0.21127,0.21628,1,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0033799,0.20789,0.28173,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.8032e-05,0.20583,0.20863,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00059648,0.20522,0.24573,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.00068191,0.20521,0.16783,1,0
1,GO NEUTROPHIL CHEMOTAXIS,0.0052854,0.20481,0.14652,1,0
1,GO CELL CHEMOTAXIS,0.0002443,0.20294,0.18405,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,4.0657e-06,0.20208,0.2411,1,0
1,GO CYCLOOXYGENASE PATHWAY,0.016027,0.20184,0.26667,1,0
1,GO HOMOTYPIC CELL CELL ADHESION,0.00033955,0.2018,0.23946,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0029256,0.19839,0.20538,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00067188,0.19638,0.23768,1,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.0075485,0.19524,0.20839,1,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.036772,0.19447,0.21715,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0005618,0.19384,0.18624,1,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0095807,0.19243,0.18852,1,0
1,GO RESPONSE TO THYROID HORMONE,0.0034692,0.19166,0.20559,1,0
1,GO CELL KILLING,0.0013633,0.19147,0.16212,1,0
1,GO URETER DEVELOPMENT,0.0030038,0.18977,0.18822,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,5.8049e-05,0.18937,0.19815,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.002631,0.18904,0.26478,1,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0072795,0.18801,0.2257,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.008211,0.18755,0.15298,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00015331,0.18682,0.23489,1,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.020166,0.1855,0.25137,1,0
1,GO RESPONSE TO VITAMIN,0.0039481,0.18538,0.16831,1,0
1,GO LEUKOCYTE CHEMOTAXIS,0.0038478,0.18378,0.14841,1,0
1,GO LEUKOCYTE HOMEOSTASIS,4.9694e-05,0.18281,0.18504,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00013899,0.18273,0.21158,1,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.013856,0.18048,0.15787,1,0
1,GO INFLAMMATORY RESPONSE,3.6924e-05,0.17848,0.19269,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.010279,0.17807,0.15227,1,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00159,0.17724,0.25853,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0065235,0.17441,0.15,1,0
1,GO T CELL DIFFERENTIATION,0.00026024,0.17244,0.17774,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.00015583,0.17121,0.1741,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.6578e-05,0.17098,0.17633,1,0
1,GO TISSUE REMODELING,0.00067188,0.16977,0.20108,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0020929,0.16878,0.21732,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0003557,0.16851,0.21162,1,0
1,GO CELLULAR EXTRAVASATION,0.00024045,0.16735,0.19274,1,0
1,GO INTERLEUKIN 4 PRODUCTION,0.0012527,0.16732,0.17196,1,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.016386,0.16606,0.2703,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.004156,0.16485,0.16672,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00087508,0.16479,0.1934,1,0
1,GO HEART VALVE DEVELOPMENT,0.003654,0.16426,0.21319,1,0
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0030839,0.16348,0.24612,1,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.060988,0.16272,0.14732,1,0
1,GO LEUKOCYTE MIGRATION,0.0005618,0.16183,0.17177,1,0
1,GO TRANSITION METAL ION HOMEOSTASIS,4.8839e-05,0.1607,0.16914,1,0
1,GO DETOXIFICATION,0.00096848,0.16063,0.15524,1,0
1,GO SUPEROXIDE ANION GENERATION,0.01829,0.16039,0.15797,1,0
1,GO DENDRITIC SPINE MAINTENANCE,0.011151,0.16037,0.18639,1,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00080175,0.16025,0.19832,1,0
1,GO REGULATION OF HAIR CYCLE,0.003166,0.15929,0.194,1,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.017315,0.15897,0.26305,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.00088789,0.15872,0.16672,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00059648,0.15846,0.22158,1,0
1,GO MIDGUT DEVELOPMENT,0.0074579,0.15841,0.23568,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.041789,0.15841,0.14775,1,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.016027,0.15719,0.16011,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0029645,0.15697,0.17719,1,0
1,GO POSITIVE CHEMOTAXIS,0.0033361,0.15658,0.18858,1,0
1,GO INTERLEUKIN 12 PRODUCTION,0.009139,0.15574,0.14886,1,0
1,GO LYMPHOCYTE COSTIMULATION,0.0011503,0.15553,0.16549,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0034692,0.15501,0.16961,1,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0010865,0.15442,0.17784,1,0
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,5.2344e-05,0.1535,0.19707,1,0
1,GO CELLULAR PIGMENTATION,3.0395e-05,0.15239,0.19342,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0018508,0.15233,0.17566,1,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.046474,0.15228,0.10109,1,0
1,GO EOSINOPHIL MIGRATION,0.032938,0.15213,0.17569,1,0
1,GO GLIAL CELL APOPTOTIC PROCESS,0.01016,0.15173,0.20246,1,0
1,GO SKIN DEVELOPMENT,0.049212,0.15089,0.13735,1,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.02174,0.14858,0.12917,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00098255,0.14781,0.18045,1,0
1,GO RESPONSE TO GROWTH HORMONE,0.0038478,0.14779,0.20496,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.001704,0.14725,0.16713,1,0
1,GO UV PROTECTION,0.047827,0.14492,0.16179,1,0
1,GO MYOTUBE DIFFERENTIATION,0.015501,0.14283,0.1179,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.037882,0.14178,0.18471,1,0
1,GO REGULATION OF ANOIKIS,0.059331,0.14062,0.14291,1,0
1,GO ASTROCYTE DIFFERENTIATION,0.0063654,0.14052,0.14798,1,0
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.00059648,0.14041,0.23677,1,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.0070192,0.14029,0.1523,1,0
1,GO LIVER MORPHOGENESIS,0.047372,0.14014,0.12827,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0013443,0.13995,0.18838,1,0
1,GO STEROL HOMEOSTASIS,0.0015463,0.13848,0.17606,1,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.0061347,0.13773,0.18467,1,0
1,GO AMYLOID BETA FORMATION,0.0029645,0.13679,0.1732,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.059879,0.1356,0.11452,1,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00046165,0.13523,0.12347,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.015501,0.1349,0.17903,1,0
1,GO CELL CELL ADHESION,0.049681,0.13411,0.096158,1,0
1,GO FATTY ACID TRANSPORT,0.0057669,0.13385,0.11154,1,0
1,GO REGULATION OF BODY FLUID LEVELS,0.00074504,0.13382,0.15192,1,0
1,GO REGULATION OF TISSUE REMODELING,0.057711,0.13351,0.10515,1,0
1,GO NUCLEOTIDE SALVAGE,0.060432,0.13317,0.18139,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00072342,0.1316,0.14567,1,0
1,GO RUFFLE ORGANIZATION,0.00090088,0.13147,0.13796,1,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.041789,0.13132,0.13604,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.024687,0.13131,0.16653,1,0
1,GO INTERLEUKIN 6 PRODUCTION,0.032278,0.13126,0.12194,1,0
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0096941,0.1308,0.13636,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,4.7999e-05,0.13065,0.15074,1,0
1,GO CYTOKINE SECRETION,0.055609,0.13065,0.093611,1,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0051547,0.12995,0.2039,1,0
1,GO BONE REMODELING,0.0068504,0.12922,0.1481,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0071918,0.12914,0.14784,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00023667,0.12878,0.14273,1,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.054074,0.12818,0.13586,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.001955,0.12801,0.16184,1,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.049681,0.12707,0.086502,1,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.057179,0.12671,0.10899,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0005618,0.12614,0.16509,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.025475,0.12561,0.12501,1,0
1,GO REGULATION OF CHEMOTAXIS,0.0014022,0.12555,0.1441,1,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.014823,0.12533,0.13223,1,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.059879,0.12506,0.15246,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0013443,0.12496,0.14292,1,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0040509,0.12471,0.11461,1,0
1,GO REGULATION OF BONE MINERALIZATION,0.036409,0.1234,0.13967,1,0
1,GO EPITHELIAL CELL PROLIFERATION,0.0023957,0.12338,0.15154,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0012005,0.12327,0.13716,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.03429,0.12228,0.17818,1,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.028852,0.12173,0.12169,1,0
1,GO LYSOSOMAL TRANSPORT,0.00046165,0.1207,0.14974,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0033361,0.12052,0.12664,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.01016,0.12019,0.13211,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.034636,0.11999,0.13302,1,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.052083,0.11995,0.15217,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0027747,0.11968,0.13806,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.03429,0.11931,0.14188,1,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.03429,0.11861,0.15633,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0048405,0.11853,0.16569,1,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.060988,0.1183,0.1038,1,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.045591,0.1176,0.090307,1,0
1,GO EPITHELIUM DEVELOPMENT,0.032278,0.11693,0.098033,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00061456,0.1168,0.17237,1,0
1,GO MAMMARY GLAND DEVELOPMENT,0.015501,0.11619,0.12858,1,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.014658,0.11581,0.20613,1,0
1,GO HEPARIN METABOLIC PROCESS,0.0066851,0.11572,0.26662,1,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.023419,0.11496,0.13652,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.063836,0.11486,0.13382,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,8.4424e-05,0.11441,0.14498,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0039481,0.11427,0.1131,1,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.016752,0.11421,0.12699,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0051547,0.11365,0.11884,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00059648,0.11344,0.1496,1,0
1,GO RESPONSE TO GONADOTROPIN,0.028556,0.11325,0.13821,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.002631,0.11258,0.17274,1,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.032278,0.11251,0.13327,1,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0034692,0.11093,0.16249,1,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0058389,0.11037,0.17062,1,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.017315,0.1101,0.14502,1,0
1,GO ICOSANOID METABOLIC PROCESS,0.018898,0.10963,0.14299,1,0
1,GO MOLTING CYCLE,0.062684,0.10943,0.12069,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0065235,0.10936,0.14138,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,0.0066851,0.10907,0.096115,1,0
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0043737,0.1087,0.125,1,0
1,GO B CELL ACTIVATION,0.00029511,0.10804,0.16309,1,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0074579,0.10749,0.13152,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0041031,0.10699,0.10617,1,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.028556,0.10695,0.11789,1,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0031247,0.10616,0.14963,1,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.035691,0.10571,0.17955,1,0
1,GO CELL MOTILITY,0.0070192,0.10525,0.11446,1,0
1,GO VACUOLAR ACIDIFICATION,0.01995,0.10518,0.10099,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.0047198,0.10489,0.10036,1,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.023919,0.10461,0.17964,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.044292,0.10286,0.14133,1,0
1,GO ADHESION OF SYMBIONT TO HOST,0.067397,0.10248,0.14718,1,0
1,GO INTEGRIN ACTIVATION,0.0092477,0.10217,0.15933,1,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.014494,0.10215,0.13031,1,0
1,GO MUSCLE ADAPTATION,0.0092477,0.10112,0.12472,1,0
1,GO RESPONSE TO PEPTIDE HORMONE,0.0049019,0.10025,0.096155,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.013093,0.099889,0.092611,1,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.016938,0.099321,0.092794,1,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.022686,0.099002,0.10444,1,0
1,GO RESPONSE TO MINERALOCORTICOID,0.0059852,0.098698,0.14054,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0024941,0.098587,0.11823,1,0
1,GO REGULATION OF LIPID TRANSPORT,0.00080175,0.098478,0.14749,1,0
1,GO GOLGI ORGANIZATION,0.0037498,0.097789,0.10906,1,0
1,GO REGULATION OF OSSIFICATION,0.0062108,0.097724,0.15184,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.030368,0.097617,0.14095,1,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.054074,0.096488,0.11241,1,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0057669,0.096367,0.14249,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0022701,0.095613,0.13172,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.010645,0.095342,0.16365,1,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.046474,0.095015,0.1045,1,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.046474,0.094519,0.09457,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.023919,0.094272,0.1102,1,0
1,GO NEUROINFLAMMATORY RESPONSE,0.020385,0.094125,0.12535,1,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.012798,0.0936,0.11383,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.016205,0.093176,0.089325,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.039406,0.093158,0.075288,1,0
1,GO RESPONSE TO PH,0.040582,0.091391,0.12156,1,0
1,GO RESPONSE TO HORMONE,0.0043737,0.090951,0.10355,1,0
1,GO NEGATIVE CHEMOTAXIS,0.063836,0.086197,0.1466,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0062877,0.086172,0.13451,1,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.016386,0.085896,0.096012,1,0
1,GO XENOBIOTIC TRANSPORT,0.0090315,0.085599,0.14046,1,0
1,GO HEART MORPHOGENESIS,0.0089251,0.085573,0.13546,1,0
1,GO LIPID LOCALIZATION,0.0061347,0.084157,0.10932,1,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.023419,0.084125,0.12249,1,0
1,GO BONE RESORPTION,0.023668,0.082459,0.1172,1,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.037882,0.081446,0.098632,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.037882,0.080737,0.09653,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0056255,0.080256,0.16771,1,0
1,GO RUFFLE ASSEMBLY,0.042197,0.080213,0.095225,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.013243,0.079962,0.086849,1,0
1,GO EXOCYTOSIS,0.0093576,0.079431,0.10478,1,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0084096,0.077284,0.15859,1,0
1,GO MACROPHAGE ACTIVATION,0.032278,0.076275,0.11423,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.029754,0.075509,0.16749,1,0
1,GO REGULATION OF ENDOCYTOSIS,0.040187,0.075337,0.086275,1,0
1,GO ORGANELLE DISASSEMBLY,0.0035605,0.07511,0.08635,1,0
1,GO RESPONSE TO ATP,0.025475,0.074169,0.075498,1,0
1,GO ENDOCYTIC RECYCLING,0.040187,0.074074,0.10047,1,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.03006,0.074053,0.12554,1,0
1,GO B CELL PROLIFERATION,0.048746,0.074005,0.10727,1,0
1,GO RESPONSE TO INSULIN,0.063258,0.073002,0.072952,1,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.05357,0.072951,0.069465,1,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.036772,0.072347,0.13223,1,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.063258,0.072194,0.089373,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036409,0.071228,0.077111,1,0
1,GO HORMONE BIOSYNTHETIC PROCESS,0.015329,0.070953,0.11787,1,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.060432,0.07014,0.09201,1,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.053071,0.069451,0.11617,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.028264,0.06906,0.09063,1,0
1,GO THIOESTER METABOLIC PROCESS,0.0072795,0.068835,0.12943,1,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.046921,0.066531,0.13958,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.043444,0.066412,0.094104,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0051547,0.065658,0.11868,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.011544,0.065628,0.078344,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.043025,0.065226,0.07089,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023919,0.064403,0.0796,1,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.047827,0.064159,0.089274,1,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.022446,0.062375,0.095021,1,0
1,GO POSITIVE REGULATION OF SIGNALING,0.066192,0.061743,0.064278,1,0
1,GO TRANSITION METAL ION TRANSPORT,0.024947,0.061264,0.067366,1,0
1,GO PIGMENT GRANULE LOCALIZATION,0.066192,0.060779,0.10402,1,0
1,GO ENDOCYTOSIS,0.011151,0.059936,0.096579,1,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.047372,0.059704,0.090738,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.025743,0.059645,0.13011,1,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.039406,0.059465,0.088557,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.024687,0.058572,0.11435,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.035336,0.058458,0.07775,1,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.030368,0.057978,0.086977,1,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.022928,0.057853,0.080198,1,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.027973,0.057468,0.11271,1,0
1,GO VITAMIN METABOLIC PROCESS,0.058247,0.057019,0.077561,1,0
1,GO STEROL METABOLIC PROCESS,0.040981,0.056633,0.08697,1,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.05063,0.056555,0.066107,1,0
1,GO STEROID METABOLIC PROCESS,0.040187,0.054404,0.077232,1,0
1,GO CELLULAR RESPONSE TO IRON ION,0.030994,0.052515,0.18776,1,0
1,GO NEGATIVE REGULATION OF BINDING,0.024687,0.052264,0.084054,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.01829,0.051518,0.075173,1,0
1,GO CYTOSOLIC TRANSPORT,0.054074,0.050724,0.074294,1,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.019312,0.050546,0.098529,1,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.045155,0.050127,0.072617,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.046921,0.049328,0.13182,1,0
1,GO OSTEOBLAST PROLIFERATION,0.053071,0.048928,0.1659,1,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.038258,0.048833,0.061089,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.041383,0.047666,0.073764,1,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.058247,0.047658,0.1042,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.048285,0.043669,0.075488,1,0
1,GO NEGATIVE REGULATION OF GROWTH,0.060432,0.036901,0.080463,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.042197,0.027654,0.067065,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.048285,0.027528,0.052278,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.055609,-0.038645,-0.053574,1,0
1,GO REGULATION OF TRANSPORT,0.054074,-0.045443,-0.03419,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.036048,-0.054588,-0.096306,1,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.066792,-0.055686,-0.039532,1,0
1,GO RHYTHMIC PROCESS,0.047372,-0.056088,-0.045211,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.046031,-0.056893,-0.04419,1,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.063258,-0.057458,-0.078668,1,0
1,GO CARDIAC MUSCLE CONTRACTION,0.040582,-0.057807,-0.077728,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.042609,-0.05933,-0.050029,1,0
1,GO SENSORY PERCEPTION,0.0058389,-0.060614,-0.076861,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.037509,-0.064311,-0.08246,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.023419,-0.066735,-0.042913,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.065005,-0.067484,-0.067157,1,0
1,GO ENERGY HOMEOSTASIS,0.010645,-0.070797,-0.13841,1,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.049681,-0.07118,-0.051996,1,0
1,GO CALCIUM ION IMPORT,0.023419,-0.071272,-0.073716,1,0
1,GO TRANSFERRIN TRANSPORT,0.063258,-0.074746,-0.065663,1,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.023173,-0.075106,-0.057736,1,0
1,GO MICROTUBULE BASED MOVEMENT,0.059331,-0.075999,-0.065396,1,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.051595,-0.076676,-0.05582,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.024947,-0.077502,-0.10245,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.01829,-0.079703,-0.057964,1,0
1,GO RESPONSE TO CALCIUM ION,0.038258,-0.080974,-0.062906,1,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.062684,-0.081177,-0.05394,1,0
1,GO DETECTION OF STIMULUS,0.028852,-0.081301,-0.052704,1,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.05063,-0.081973,-0.10371,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.0066851,-0.083033,-0.070736,1,0
1,GO ORGANIC ACID TRANSPORT,0.02945,-0.084658,-0.050133,1,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.058787,-0.084754,-0.084577,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0062108,-0.084898,-0.081874,1,0
1,GO RESPONSE TO MONOSACCHARIDE,0.02174,-0.085358,-0.049839,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.0062877,-0.085381,-0.071565,1,0
1,GO CIRCADIAN RHYTHM,0.0011021,-0.085443,-0.08616,1,0
1,GO TRANSPORT ALONG MICROTUBULE,0.058247,-0.08704,-0.0593,1,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.061549,-0.088568,-0.10336,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.019312,-0.088849,-0.056852,1,0
1,GO ORGANELLE MEMBRANE FUSION,0.02945,-0.08994,-0.057583,1,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.028556,-0.089956,-0.074089,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.045155,-0.090362,-0.055868,1,0
1,GO REGULATION OF APPETITE,0.00046165,-0.090439,-0.12646,1,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.026013,-0.092162,-0.083984,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.051111,-0.092577,-0.064786,1,0
1,GO STRIATED MUSCLE CONTRACTION,0.0078263,-0.093118,-0.095667,1,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.040187,-0.094054,-0.096667,1,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0047198,-0.094392,-0.09765,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0059116,-0.095265,-0.082473,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.041383,-0.09563,-0.11755,1,0
1,GO NEURON PROJECTION GUIDANCE,0.02521,-0.096803,-0.093716,1,0
1,GO ORGANELLE FUSION,0.015674,-0.098298,-0.052414,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0035146,-0.099046,-0.086451,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.021509,-0.099448,-0.088563,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.0020646,-0.099644,-0.08333,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.021053,-0.10012,-0.090105,1,0
1,GO ION TRANSPORT,0.0020646,-0.10027,-0.072615,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.017894,-0.10034,-0.1144,1,0
1,GO CHLORIDE TRANSPORT,0.006444,-0.101,-0.082622,1,0
1,GO REGULATION OF HORMONE LEVELS,0.00046165,-0.10167,-0.10698,1,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.048746,-0.1017,-0.070301,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.037139,-0.10258,-0.065334,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00081356,-0.10266,-0.086153,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.053071,-0.10294,-0.12194,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.023919,-0.10523,-0.13266,1,0
1,GO MULTICELLULAR ORGANISM AGING,0.01829,-0.10634,-0.090042,1,0
1,GO RESPONSE TO AMINE,0.0098086,-0.10642,-0.11338,1,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.011411,-0.10663,-0.095559,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.0025961,-0.1069,-0.12506,1,0
1,GO REGULATION OF ANION TRANSPORT,0.0046018,-0.10782,-0.090669,1,0
1,GO LIPID TRANSLOCATION,0.049681,-0.10787,-0.095164,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.021973,-0.10822,-0.066439,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.055093,-0.10927,-0.050388,1,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0087156,-0.10968,-0.14116,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.017506,-0.11004,-0.089935,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.010645,-0.11012,-0.080205,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.00092737,-0.11025,-0.090672,1,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.016027,-0.11075,-0.1085,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.009139,-0.11076,-0.095103,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.054074,-0.11096,-0.081463,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.022686,-0.11102,-0.10328,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.014823,-0.11139,-0.12013,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0023321,-0.11211,-0.094128,1,0
1,GO HEART PROCESS,0.00074504,-0.11237,-0.11399,1,0
1,GO REGULATION OF ICOSANOID SECRETION,0.026286,-0.11393,-0.10524,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.041789,-0.11418,-0.12567,1,0
1,GO AXO DENDRITIC TRANSPORT,0.0037985,-0.11421,-0.11676,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0032928,-0.11459,-0.07903,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0020646,-0.11507,-0.10993,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.042197,-0.11607,-0.10924,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.0024609,-0.11663,-0.084981,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00072342,-0.11739,-0.13501,1,0
1,GO HEAD DEVELOPMENT,0.0005618,-0.11789,-0.10984,1,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.011022,-0.1196,-0.11135,1,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0018006,-0.11972,-0.1105,1,0
1,GO MATING,0.0024609,-0.12105,-0.11402,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.0014624,-0.12177,-0.18476,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.008211,-0.12193,-0.15927,1,0
1,GO CELL MATURATION,0.0005056,-0.12197,-0.10433,1,0
1,GO EATING BEHAVIOR,0.0046018,-0.12198,-0.10858,1,0
1,GO METAL ION TRANSPORT,0.0014022,-0.1226,-0.080362,1,0
1,GO REGULATION OF BEHAVIOR,0.0020929,-0.12291,-0.12434,1,0
1,GO MEMBRANE REPOLARIZATION,0.0071051,-0.12403,-0.12621,1,0
1,GO CELL CELL SIGNALING,0.00015583,-0.12471,-0.099314,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.014823,-0.12493,-0.084949,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.00029052,-0.12541,-0.14527,1,0
1,GO PROTEIN AUTOPROCESSING,0.047827,-0.12544,-0.080857,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.014013,-0.12573,-0.10784,1,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0023957,-0.12673,-0.1341,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,0.00015838,-0.12711,-0.12513,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.057711,-0.12725,-0.069834,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.019735,-0.12735,-0.085621,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00098255,-0.12857,-0.093863,1,0
1,GO REGULATION OF SYSTEM PROCESS,0.00029052,-0.1293,-0.11033,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.0005618,-0.12933,-0.091277,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.022686,-0.12986,-0.10337,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00022208,-0.12986,-0.11387,1,0
1,GO DENDRITE SELF AVOIDANCE,0.043866,-0.13016,-0.12288,1,0
1,GO NEURON PROJECTION EXTENSION,0.0025617,-0.13135,-0.11931,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.060988,-0.13298,-0.14377,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.0062877,-0.13466,-0.12519,1,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0024609,-0.13471,-0.12884,1,0
1,GO IMPORT INTO CELL,0.001442,-0.13499,-0.11051,1,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.057179,-0.13501,-0.078416,1,0
1,GO REGULATION OF BLOOD CIRCULATION,0.00029052,-0.13517,-0.1217,1,0
1,GO PEPTIDE SECRETION,0.00026024,-0.1355,-0.10421,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0013255,-0.13569,-0.14456,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0027381,-0.13581,-0.10533,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.013546,-0.1364,-0.10112,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0001179,-0.13781,-0.15802,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.0032501,-0.13789,-0.13167,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00083767,-0.13846,-0.12766,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.020166,-0.1386,-0.09896,1,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.020828,-0.13928,-0.14456,1,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.00060545,-0.13958,-0.16171,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.020605,-0.14084,-0.13012,1,0
1,GO CATION TRANSPORT,0.00011406,-0.14104,-0.10383,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.0012177,-0.14114,-0.14253,1,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0018256,-0.14135,-0.15821,1,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.017125,-0.14364,-0.094928,1,0
1,GO ORGANIC CATION TRANSPORT,0.00043435,-0.14376,-0.16061,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0021798,-0.14392,-0.14282,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0007786,-0.14402,-0.14616,1,0
1,GO RESPONSE TO ALKALOID,6.7105e-06,-0.14419,-0.14914,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.026286,-0.14503,-0.11717,1,0
1,GO CELL PART MORPHOGENESIS,0.00049802,-0.14587,-0.12558,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0067673,-0.14635,-0.12866,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00012388,-0.14653,-0.18148,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00073415,-0.14709,-0.19631,1,0
1,GO HEAT GENERATION,0.026561,-0.1471,-0.12651,1,0
1,GO SODIUM ION HOMEOSTASIS,0.019312,-0.14813,-0.12314,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,9.03e-05,-0.14892,-0.10994,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.01849,-0.14929,-0.15077,1,0
1,GO REGULATION OF AXONOGENESIS,0.0053519,-0.14969,-0.11469,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.060432,-0.15008,-0.086041,1,0
1,GO AXONAL TRANSPORT,0.00159,-0.15093,-0.13827,1,0
1,GO AXONAL FASCICULATION,0.0043184,-0.15162,-0.23857,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0034243,-0.15163,-0.11146,1,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.040981,-0.15269,-0.07586,1,0
1,GO REGULATION OF SECRETION,1.3196e-05,-0.15277,-0.12481,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.018898,-0.15285,-0.096488,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.046921,-0.15296,-0.16671,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.024428,-0.15302,-0.11944,1,0
1,GO TELENCEPHALON DEVELOPMENT,0.00022927,-0.15361,-0.13159,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.026286,-0.15421,-0.14424,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.022209,-0.15429,-0.15463,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,1.5293e-05,-0.15489,-0.16419,1,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0047798,-0.1555,-0.10108,1,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.027401,-0.1558,-0.13499,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.00033955,-0.15586,-0.11219,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00059648,-0.15596,-0.21674,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0010259,-0.15673,-0.14987,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0013826,-0.15716,-0.15448,1,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.014658,-0.15723,-0.11748,1,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0049019,-0.15821,-0.20296,1,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.001704,-0.15835,-0.11858,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.040981,-0.15839,-0.21349,1,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.0015038,-0.15858,-0.10902,1,0
1,GO ACID SECRETION,0.00049053,-0.15879,-0.12789,1,0
1,GO NERVOUS SYSTEM PROCESS,8.5867e-06,-0.15941,-0.14246,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,4.1751e-05,-0.15967,-0.1166,1,0
1,GO ACROSOME ASSEMBLY,0.0063654,-0.16023,-0.15273,1,0
1,GO FEAR RESPONSE,0.00038422,-0.16242,-0.14214,1,0
1,GO COLLATERAL SPROUTING,0.028264,-0.16248,-0.12854,1,0
1,GO RESPONSE TO FOOD,7.6657e-06,-0.16325,-0.17429,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.001422,-0.16352,-0.12195,1,0
1,GO REGULATION OF ION TRANSPORT,5.4184e-05,-0.16387,-0.12479,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00076726,-0.16416,-0.14652,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0095807,-0.16444,-0.15542,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0020367,-0.16483,-0.15302,1,0
1,GO SODIUM ION TRANSPORT,0.00020178,-0.16511,-0.12616,1,0
1,GO RESPONSE TO POTASSIUM ION,0.027973,-0.1653,-0.17066,1,0
1,GO POSTSYNAPSE ORGANIZATION,0.00024819,-0.16598,-0.17133,1,0
1,GO REGULATION OF HEART RATE,0.0003557,-0.16601,-0.15875,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00011218,-0.16737,-0.14368,1,0
1,GO SECRETORY GRANULE ORGANIZATION,0.0020646,-0.16791,-0.13118,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00026024,-0.1699,-0.11787,1,0
1,GO REGULATION OF RESPONSE TO FOOD,0.00022565,-0.17052,-0.18162,1,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0040509,-0.17074,-0.14561,1,0
1,GO REGULATION OF CILIUM MOVEMENT,0.001118,-0.17095,-0.14863,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,8.3013e-05,-0.1713,-0.17681,1,0
1,GO POTASSIUM ION HOMEOSTASIS,0.0063654,-0.17175,-0.13621,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0013255,-0.1719,-0.14481,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.0056255,-0.1724,-0.16078,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0043184,-0.1734,-0.17398,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.014823,-0.17401,-0.12312,1,0
1,GO PHAGOSOME ACIDIFICATION,0.01128,-0.17454,-0.10562,1,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.038637,-0.17499,-0.172,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0024609,-0.17515,-0.11414,1,0
1,GO MEMORY,1.6158e-05,-0.17626,-0.17497,1,0
1,GO RESPONSE TO AMPHETAMINE,0.00016901,-0.17632,-0.20494,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0062108,-0.17734,-0.16339,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,0.00068191,-0.17767,-0.13733,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00038422,-0.17801,-0.1601,1,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.037509,-0.17801,-0.084551,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,9.4959e-05,-0.17849,-0.19382,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,3.2146e-06,-0.17955,-0.16784,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0069343,-0.17974,-0.17358,1,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0047198,-0.17991,-0.18878,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00064263,-0.18019,-0.17532,1,0
1,GO SKELETAL MUSCLE ADAPTATION,0.015329,-0.18212,-0.12749,1,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.026286,-0.18263,-0.16007,1,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.001776,-0.18325,-0.16424,1,0
1,GO MEMBRANE FISSION,0.0020367,-0.1848,-0.17433,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0028492,-0.18541,-0.15562,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0018256,-0.18695,-0.19147,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00020178,-0.18726,-0.14178,1,0
1,GO MAINTENANCE OF CELL POLARITY,0.00098255,-0.1877,-0.16552,1,0
1,GO PALLIUM DEVELOPMENT,0.00016629,-0.1886,-0.15091,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,5.5412e-06,-0.18934,-0.16344,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00083767,-0.19122,-0.14863,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00022927,-0.19145,-0.19027,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0013069,-0.19206,-0.23119,1,0
1,GO DEVELOPMENTAL MATURATION,3.4773e-06,-0.19294,-0.16007,1,0
1,GO SPINAL CORD DEVELOPMENT,0.00067188,-0.19299,-0.16528,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00084997,-0.19384,-0.20191,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.043866,-0.19626,-0.11796,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,4.9694e-05,-0.19668,-0.22622,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.018091,-0.1973,-0.14189,1,0
1,GO COGNITION,1.2253e-05,-0.19861,-0.16314,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.3948e-05,-0.19869,-0.17368,1,0
1,GO FOREBRAIN DEVELOPMENT,7.1274e-05,-0.19876,-0.15175,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00088789,-0.19911,-0.18325,1,0
1,GO GLYCINE TRANSPORT,0.059879,-0.19934,-0.12754,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,4.4285e-07,-0.19977,-0.24992,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00019541,-0.2001,-0.20903,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,8.4424e-05,-0.20029,-0.23571,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,0.00030449,-0.20034,-0.15512,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0030038,-0.20077,-0.17297,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,2.5868e-06,-0.20124,-0.19766,1,0
1,GO RESPONSE TO LEUCINE,0.0034243,-0.20169,-0.22616,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,1.7922e-07,-0.20233,-0.18606,1,0
1,GO RESPONSE TO MAGNESIUM ION,0.022928,-0.20246,-0.1658,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00046165,-0.20354,-0.18209,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,1.0756e-05,-0.20361,-0.18663,1,0
1,GO AXONEME ASSEMBLY,0.0015038,-0.20538,-0.1922,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00038422,-0.20543,-0.19719,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0012005,-0.2057,-0.20963,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00017741,-0.20579,-0.24511,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,1.4207e-05,-0.20581,-0.17045,1,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00015083,-0.20636,-0.19341,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00159,-0.20748,-0.22911,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00065224,-0.20789,-0.20067,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0028872,-0.20827,-0.19573,1,0
1,GO ACTION POTENTIAL,1.0861e-06,-0.20914,-0.23293,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00030928,-0.20987,-0.20996,1,0
1,GO BEHAVIOR,7.6446e-07,-0.21024,-0.18567,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0013443,-0.21089,-0.24739,1,0
1,GO ACROSOME REACTION,0.00028155,-0.21127,-0.16907,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00036124,-0.21207,-0.24681,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.004156,-0.2136,-0.18678,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00053704,-0.21391,-0.15242,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,2.6386e-06,-0.21396,-0.1829,1,0
1,GO INCLUSION BODY ASSEMBLY,0.019523,-0.2147,-0.15951,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,3.6877e-06,-0.21644,-0.22081,1,0
1,GO WALKING BEHAVIOR,0.00036124,-0.21645,-0.19596,1,0
1,GO RESPONSE TO NICOTINE,6.337e-06,-0.2168,-0.23247,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00014362,-0.21777,-0.19451,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0023957,-0.21849,-0.2827,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,3.1494e-05,-0.21953,-0.2018,1,0
1,GO SECONDARY PALATE DEVELOPMENT,0.0060595,-0.21985,-0.15058,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0010865,-0.21986,-0.21107,1,0
1,GO REGULATION OF MICROTUBULE BINDING,1.3442e-05,-0.22072,-0.24092,1,0
1,GO HORMONE TRANSPORT,7.3772e-08,-0.22222,-0.21098,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,1.0169e-05,-0.22247,-0.19421,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,8.3013e-05,-0.22399,-0.29283,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.051595,-0.225,-0.12336,1,0
1,GO REGULATION OF HORMONE SECRETION,2.8886e-07,-0.22536,-0.20038,1,0
1,GO MRNA SPLICE SITE SELECTION,9.6562e-05,-0.22712,-0.22331,1,0
1,GO CRANIAL NERVE DEVELOPMENT,0.00040857,-0.2272,-0.18864,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,8.7316e-05,-0.22825,-0.18176,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0005056,-0.22849,-0.24538,1,0
1,GO CARDIAC CONDUCTION,3.7605e-06,-0.22892,-0.20842,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.015501,-0.22903,-0.14441,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0023009,-0.22951,-0.21945,1,0
1,GO FEEDING BEHAVIOR,5.2538e-08,-0.22972,-0.22065,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00015583,-0.23048,-0.26266,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00060545,-0.23067,-0.28493,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.8052e-07,-0.23101,-0.19396,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.0055559,-0.23187,-0.23628,1,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.047827,-0.23206,-0.1435,1,0
1,GO TELENCEPHALON REGIONALIZATION,0.0051547,-0.23238,-0.24467,1,0
1,GO DENDRITE DEVELOPMENT,4.3236e-05,-0.23323,-0.18253,1,0
1,GO RESPONSE TO CATECHOLAMINE,4.5233e-07,-0.23373,-0.20318,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.016205,-0.23415,-0.2193,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,1.3948e-05,-0.23442,-0.15263,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.042197,-0.2351,-0.18848,1,0
1,GO MITOCHONDRION DISTRIBUTION,2.6352e-05,-0.23522,-0.23742,1,0
1,GO RESPONSE TO DOPAMINE,4.9069e-08,-0.23675,-0.22282,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,0.00090088,-0.23681,-0.20409,1,0
1,GO RELAXATION OF MUSCLE,0.011949,-0.23732,-0.15501,1,0
1,GO REGULATION OF INSULIN SECRETION,1.471e-07,-0.23782,-0.224,1,0
1,GO DENDRITE MORPHOGENESIS,0.00011218,-0.23782,-0.19287,1,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.0099244,-0.23786,-0.22869,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0011341,-0.23855,-0.24732,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00022208,-0.23958,-0.27723,1,0
1,GO TOXIN METABOLIC PROCESS,0.0099244,-0.24081,-0.177,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.00010323,-0.24265,-0.19829,1,0
1,GO DIVALENT METAL ION EXPORT,0.0069343,-0.24352,-0.18612,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00042128,-0.24367,-0.22804,1,0
1,GO REGULATION OF NEURON MATURATION,0.031311,-0.24462,-0.21049,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,1.064e-06,-0.24716,-0.30481,1,0
1,GO SENSORY PERCEPTION OF PAIN,4.5233e-07,-0.24736,-0.21591,1,0
1,GO PROTEIN PALMITOYLATION,1.2027e-05,-0.24739,-0.20517,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,3.357e-07,-0.24825,-0.26594,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,7.3803e-06,-0.2483,-0.22475,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,7.6657e-06,-0.24865,-0.31087,1,0
1,GO SYNAPSE ORGANIZATION,4.9361e-06,-0.24957,-0.22251,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,1.3468e-07,-0.24957,-0.26253,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.045155,-0.25095,-0.13213,1,0
1,GO SIGNAL RELEASE,2.7e-09,-0.25189,-0.22861,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00041488,-0.25208,-0.1855,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,1.7534e-07,-0.25299,-0.22732,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,5.9498e-07,-0.2536,-0.21519,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,4.1751e-05,-0.25368,-0.26175,1,0
1,GO HINDBRAIN DEVELOPMENT,1.3056e-06,-0.25376,-0.21589,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.8363e-05,-0.25516,-0.24457,1,0
1,GO RESPONSE TO FORSKOLIN,0.0076401,-0.25634,-0.21652,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.004964,-0.25698,-0.18124,1,0
1,GO ASSOCIATIVE LEARNING,7.4873e-07,-0.25764,-0.21046,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,1.1806e-05,-0.2588,-0.23824,1,0
1,GO DENDRITIC TRANSPORT,0.00062378,-0.25906,-0.22504,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,8.7502e-06,-0.26002,-0.25691,1,0
1,GO NEURAL RETINA DEVELOPMENT,2.4091e-05,-0.26028,-0.27034,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.3435e-06,-0.26041,-0.25066,1,0
1,GO METENCEPHALON DEVELOPMENT,1.8723e-07,-0.26046,-0.27167,1,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0011341,-0.2609,-0.24015,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0033799,-0.26318,-0.20116,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.2032e-06,-0.26398,-0.24062,1,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0055559,-0.26507,-0.2147,1,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00032408,-0.26537,-0.22501,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,6.0205e-08,-0.26771,-0.26686,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,1.3039e-08,-0.26773,-0.24807,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,7.969e-07,-0.26821,-0.24639,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00073415,-0.26961,-0.21819,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0012005,-0.27145,-0.25084,1,0
1,GO PRESYNAPSE ORGANIZATION,6.8888e-05,-0.27231,-0.24032,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,1.2281e-06,-0.27292,-0.31284,1,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.0003557,-0.27329,-0.29388,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.7172e-05,-0.27566,-0.27137,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.012087,-0.27635,-0.16521,1,0
1,GO LEARNING,4.4285e-07,-0.27785,-0.25012,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,4.0868e-08,-0.27823,-0.26788,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0055559,-0.27924,-0.16267,1,0
1,GO N GLYCAN PROCESSING,0.021509,-0.28155,-0.15647,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,2.0853e-05,-0.28237,-0.26471,1,0
1,GO MEMBRANE DEPOLARIZATION,2.5934e-07,-0.28289,-0.27356,1,0
1,GO INSULIN SECRETION,9.5677e-09,-0.28437,-0.25308,1,0
1,GO PEPTIDE HORMONE SECRETION,1.069e-09,-0.28564,-0.27722,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,7.6446e-07,-0.28688,-0.31149,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.9859e-05,-0.28716,-0.26021,1,0
1,GO REGULATION OF EXOCYTOSIS,7.2964e-10,-0.28809,-0.26997,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.7676e-09,-0.28842,-0.26908,1,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0020646,-0.28866,-0.25158,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0002443,-0.28981,-0.3142,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.7668e-07,-0.29036,-0.28945,1,0
1,GO ADRENAL GLAND DEVELOPMENT,9.6129e-06,-0.29118,-0.27562,1,0
1,GO SIALYLATION,0.004156,-0.29147,-0.22132,1,0
1,GO EPITHELIAL CELL MATURATION,3.1494e-05,-0.29389,-0.29628,1,0
1,GO NEURON MIGRATION,1.996e-06,-0.2942,-0.27498,1,0
1,GO REGULATION OF HEAT GENERATION,0.0022396,-0.29467,-0.22562,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.0036e-08,-0.29556,-0.29859,1,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00041488,-0.29574,-0.28753,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,9.1829e-05,-0.29595,-0.27479,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,2.5884e-05,-0.29693,-0.31759,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,6.8396e-06,-0.29714,-0.24814,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,6.7105e-06,-0.2989,-0.28886,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00017741,-0.2992,-0.28911,1,0
1,GO SECRETORY GRANULE LOCALIZATION,1.536e-06,-0.30191,-0.4221,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,4.6578e-06,-0.30499,-0.29886,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00033432,-0.30564,-0.25288,1,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.0043184,-0.30683,-0.23828,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,6.0205e-08,-0.30712,-0.27704,1,0
1,GO SYNAPTIC VESICLE TRANSPORT,3.6567e-07,-0.30743,-0.28776,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,1.439e-07,-0.30766,-0.28587,1,0
1,GO RESPONSE TO L GLUTAMATE,0.0012886,-0.30822,-0.2691,1,0
1,GO POTASSIUM ION TRANSPORT,7.1726e-09,-0.30894,-0.27659,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,7.6792e-10,-0.31249,-0.29414,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,1.155e-06,-0.31264,-0.29016,1,0
1,GO SYNAPTIC SIGNALING,1.069e-09,-0.31284,-0.3027,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.4371e-06,-0.31285,-0.32483,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,5.4982e-08,-0.31303,-0.33093,1,0
1,GO RESPONSE TO DIETARY EXCESS,9.9803e-06,-0.31443,-0.30171,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,2.7668e-07,-0.31598,-0.31732,1,0
1,GO LOCOMOTORY BEHAVIOR,1.2434e-08,-0.31863,-0.29154,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00018923,-0.31867,-0.32755,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,4.4807e-06,-0.32018,-0.27517,1,0
1,GO NEUROTRANSMITTER UPTAKE,2.4371e-06,-0.32078,-0.26858,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,1.3325e-06,-0.32196,-0.34025,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,6.545e-05,-0.32396,-0.23269,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.0013255,-0.3242,-0.33521,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,6.6066e-07,-0.32425,-0.30567,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,2.9514e-07,-0.32745,-0.36695,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00054518,-0.3301,-0.24743,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,1.6761e-05,-0.33087,-0.28474,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.4837e-07,-0.33113,-0.3287,1,0
1,GO NEURON RECOGNITION,2.6914e-06,-0.33125,-0.35072,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0005133,-0.33208,-0.27483,1,0
1,GO SYNAPSE ASSEMBLY,1.2886e-07,-0.33279,-0.32224,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,2.0546e-09,-0.33283,-0.31854,1,0
1,GO MAST CELL MIGRATION,4.9694e-05,-0.33309,-0.35547,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,7.2414e-06,-0.33505,-0.36194,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00010852,-0.3364,-0.25132,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00010852,-0.33744,-0.32858,1,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0069343,-0.33784,-0.22294,1,0
1,GO RESPONSE TO COCAINE,6.5125e-09,-0.33859,-0.32096,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,1.9393e-05,-0.33928,-0.44399,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,1.1535e-07,-0.34173,-0.33048,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,4.6356e-09,-0.3425,-0.33226,1,0
1,GO NERVE DEVELOPMENT,4.7488e-06,-0.34331,-0.27278,1,0
1,GO NEURON MATURATION,3.6435e-08,-0.34335,-0.33307,1,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00043435,-0.34375,-0.38006,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,9.6129e-06,-0.34591,-0.29179,1,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,1.4741e-05,-0.34626,-0.24449,1,0
1,GO NEUROTRANSMITTER REUPTAKE,1.1165e-05,-0.34665,-0.28609,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,3.0156e-07,-0.34733,-0.32689,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.0811e-07,-0.34746,-0.32275,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,4.1025e-09,-0.34853,-0.31997,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.4773e-06,-0.34867,-0.31241,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.5293e-05,-0.35088,-0.32565,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,1.3693e-05,-0.35096,-0.35939,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00014839,-0.35129,-0.25604,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.8032e-05,-0.35132,-0.33358,1,0
1,GO NOREPINEPHRINE SECRETION,3.6435e-08,-0.35472,-0.34693,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,4.2487e-05,-0.35551,-0.36178,1,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,1.536e-06,-0.35605,-0.37439,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.6158e-05,-0.35805,-0.30313,1,0
1,GO RESPONSE TO ACETYLCHOLINE,5.7051e-07,-0.36164,-0.32899,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.2604e-07,-0.36164,-0.31765,1,0
1,GO FOREBRAIN REGIONALIZATION,2.538e-07,-0.36374,-0.37703,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,1.0422e-09,-0.36416,-0.3305,1,0
1,GO LUNG CELL DIFFERENTIATION,0.0099244,-0.36568,-0.21019,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,5.1304e-06,-0.36849,-0.25963,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,5.2303e-06,-0.36897,-0.28297,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,7.3476e-09,-0.36925,-0.34147,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,6.0991e-06,-0.36996,-0.30235,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.0422e-09,-0.3709,-0.37672,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,7.892e-08,-0.37508,-0.39347,1,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,6.545e-05,-0.37633,-0.33226,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.032278,-0.37822,-0.17856,1,0
1,GO EXOCYTIC PROCESS,2.8753e-10,-0.38021,-0.35752,1,0
1,GO GROOMING BEHAVIOR,5.9116e-09,-0.38268,-0.38648,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,7.105e-06,-0.38646,-0.35138,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.2146e-06,-0.38751,-0.39668,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,3.2894e-09,-0.39012,-0.35279,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.1706e-10,-0.39076,-0.36437,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,3.357e-07,-0.39115,-0.37853,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,1.0279e-08,-0.39213,-0.38281,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,2.004e-09,-0.39316,-0.39591,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00020835,-0.39723,-0.4142,1,0
1,GO CEREBELLAR CORTEX FORMATION,3.1004e-08,-0.39724,-0.34892,1,0
1,GO SEROTONIN TRANSPORT,2.3784e-07,-0.40069,-0.40395,1,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,5.5412e-06,-0.40363,-0.37515,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.5893e-10,-0.40543,-0.3838,1,0
1,GO SUCKLING BEHAVIOR,7.333e-07,-0.4071,-0.38425,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,3.8246e-05,-0.40825,-0.34201,1,0
1,GO ADULT BEHAVIOR,3.7319e-10,-0.41405,-0.38246,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,9.4341e-06,-0.41412,-0.35541,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00015583,-0.41601,-0.35412,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,5.3562e-07,-0.41813,-0.41189,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,7.1726e-09,-0.42455,-0.42146,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,4.7172e-05,-0.42744,-0.34853,1,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,6.8885e-07,-0.43043,-0.45264,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,6.586e-10,-0.43391,-0.4308,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,3.3697e-11,-0.43581,-0.44836,1,0
1,GO CGMP METABOLIC PROCESS,4.0657e-06,-0.43783,-0.39941,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,1.6823e-09,-0.43846,-0.43288,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.0922e-10,-0.43991,-0.42245,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,4.1403e-10,-0.44188,-0.38143,1,0
1,GO REGULATION OF SYNAPSE MATURATION,1.734e-06,-0.44198,-0.48188,1,0
1,GO POSTSYNAPSE ASSEMBLY,1.5293e-05,-0.44333,-0.38155,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,1.3693e-05,-0.44521,-0.33935,1,0
1,GO RESPONSE TO LITHIUM ION,5.2445e-07,-0.44553,-0.38918,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,2.0983e-10,-0.44581,-0.44175,1,0
1,GO REGULATION OF VESICLE FUSION,1.0036e-08,-0.44882,-0.43698,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.3853e-09,-0.44956,-0.42157,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,1.1588e-05,-0.4534,-0.39375,1,0
1,GO NOREPINEPHRINE TRANSPORT,1.471e-07,-0.45398,-0.33159,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.1004e-08,-0.45503,-0.46411,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,3.3435e-06,-0.45611,-0.40021,1,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,4.8198e-07,-0.45704,-0.39452,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,2.0437e-10,-0.45866,-0.44713,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,5.9116e-09,-0.45938,-0.414,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,9.404e-07,-0.46223,-0.45048,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,7.0522e-08,-0.46508,-0.42,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.5372e-07,-0.46631,-0.50197,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,5.4356e-06,-0.4672,-0.40481,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,7.1726e-09,-0.46895,-0.52273,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.1282e-07,-0.47242,-0.45543,1,0
1,GO DOPAMINE METABOLIC PROCESS,9.7068e-11,-0.47343,-0.4838,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,9.5677e-09,-0.47703,-0.44477,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.4302e-11,-0.47832,-0.46719,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,3.1098e-10,-0.47851,-0.4602,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00044781,-0.48087,-0.38253,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00023667,-0.48325,-0.39893,1,0
1,GO CATECHOLAMINE UPTAKE,1.9926e-08,-0.48494,-0.41531,1,0
1,GO OPTIC NERVE DEVELOPMENT,2.856e-06,-0.4908,-0.40383,1,0
1,GO DETECTION OF CALCIUM ION,7.0017e-09,-0.49102,-0.47529,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,7.2129e-08,-0.49273,-0.42512,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00010852,-0.50483,-0.38264,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,2.4837e-07,-0.50885,-0.43218,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,6.6717e-09,-0.51105,-0.48755,1,0
1,GO SEROTONIN SECRETION,1.6062e-07,-0.51446,-0.4455,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,4.6881e-08,-0.51507,-0.41264,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.8118e-09,-0.51525,-0.52581,1,0
1,GO NEUROTRANSMITTER TRANSPORT,1.9402e-11,-0.51758,-0.50441,1,0
1,GO GLIAL CELL FATE COMMITMENT,1.3693e-05,-0.52506,-0.47309,1,0
1,GO REFLEX,9.404e-07,-0.5321,-0.46856,1,0
1,GO THALAMUS DEVELOPMENT,2.2397e-08,-0.53362,-0.46891,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,9.6431e-12,-0.53547,-0.52659,1,0
1,GO NEURONAL ACTION POTENTIAL,6.757e-10,-0.53574,-0.54167,1,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,1.0861e-06,-0.53986,-0.43877,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,3.3629e-10,-0.54523,-0.49514,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,3.1004e-08,-0.54944,-0.612,1,0
1,GO STARTLE RESPONSE,2.9805e-09,-0.55653,-0.49897,1,0
1,GO DENSE CORE GRANULE TRANSPORT,1.6823e-09,-0.55685,-0.71125,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.1034e-07,-0.56447,-0.54976,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.5688e-10,-0.56496,-0.50552,1,0
1,GO NEUROTRANSMITTER SECRETION,7.479e-12,-0.5661,-0.56025,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,2.2707e-10,-0.56955,-0.55107,1,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,4.9361e-06,-0.56965,-0.51264,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,4.6359e-05,-0.57166,-0.45111,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.1085e-11,-0.58492,-0.57157,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,2.6981e-08,-0.59153,-0.5346,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,2.8753e-10,-0.59325,-0.56709,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,2.4893e-11,-0.5979,-0.59692,1,0
1,GO SYNAPSE MATURATION,9.4157e-10,-0.60087,-0.65777,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,8.1414e-12,-0.60639,-0.59649,1,0
1,GO VOCALIZATION BEHAVIOR,1.2328e-07,-0.6234,-0.58591,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,3.5606e-08,-0.63041,-0.56996,1,0
1,GO INNERVATION,6.0205e-08,-0.63762,-0.56584,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,1.0202e-11,-0.64003,-0.75272,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,7.8286e-11,-0.64404,-0.61532,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,6.205e-09,-0.64955,-0.61668,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.8824e-12,-0.64961,-0.65412,1,0
1,GO AMINE TRANSPORT,6.1321e-12,-0.65494,-0.58914,1,0
1,GO GROWTH HORMONE SECRETION,3.3629e-10,-0.65595,-0.60357,1,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,1.1533e-09,-0.65657,-0.5849,1,0
1,GO PREPULSE INHIBITION,1.7442e-10,-0.66027,-0.67899,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.725e-09,-0.66561,-0.62027,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,7.8778e-10,-0.67023,-0.65997,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,2.7041e-11,-0.67088,-0.6356,1,0
1,GO DENDRITE EXTENSION,3.1896e-11,-0.67167,-0.596,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,3.5427e-10,-0.6943,-0.63936,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,2.3554e-11,-0.69516,-0.69464,1,0
1,GO MONOAMINE TRANSPORT,1.0792e-11,-0.70112,-0.61884,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,2.6306e-11,-0.7018,-0.69796,1,0
1,GO REGULATION OF DENDRITE EXTENSION,1.3505e-11,-0.72425,-0.69693,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,5.2253e-10,-0.74468,-0.70281,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.5526e-11,-0.7506,-0.72041,1,0
1,GO PROTEIN LOCALIZATION TO AXON,5.4967e-09,-0.75106,-0.73134,1,0
1,GO NEURON CELL CELL ADHESION,5.9116e-09,-0.75141,-0.71442,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,3.1729e-08,-0.7875,-0.70008,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,3.1757e-12,-0.79555,-0.8348,1,0
1,GO DOPAMINE TRANSPORT,1.1099e-11,-0.8142,-0.75009,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,3.7195e-09,-0.82108,-0.74717,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,7.1726e-09,-0.83676,-0.77242,1,0
1,GO CATECHOLAMINE SECRETION,4.6112e-12,-0.84655,-0.77158,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,7.0279e-11,-0.87798,-0.82116,1,0
1,GO MECHANOSENSORY BEHAVIOR,7.2129e-08,-0.88598,-0.77414,1,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,1.5968e-11,-0.92161,-0.89144,1,0
1,GO REGULATION OF DOPAMINE SECRETION,6.8695e-12,-0.97786,-0.91264,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.4282e-11,-0.98832,-0.92268,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,8.6145e-12,-1.0256,-0.98354,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,2.9979e-12,-1.1886,-1.1368,1,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,6.6581e-11,-1.3622,-1.2023,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,1.5838e-12,-1.4131,-1.3967,1,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.13763,0.25586,0.21604,0,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.082591,0.22953,0.22313,0,1
1,GO IMP METABOLIC PROCESS,0.075009,0.21653,0.14396,0,1
1,GO AORTA MORPHOGENESIS,0.10912,0.20781,0.15332,0,1
1,GO COCHLEA MORPHOGENESIS,0.15921,0.20181,0.082955,0,1
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.20554,0.19076,0.12416,0,1
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.11275,0.17026,0.14761,0,1
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.31021,0.16962,0.072909,0,1
1,GO PSEUDOPODIUM ORGANIZATION,0.15447,0.16944,0.14521,0,1
1,GO BRONCHUS DEVELOPMENT,0.23128,0.16181,0.10895,0,1
1,GO CHROMATIN DISASSEMBLY,0.11183,0.15892,0.071014,0,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.081168,0.15762,0.16087,0,1
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.10558,0.15513,0.10233,0,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.06986,0.14827,0.10609,0,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.10214,0.14761,0.098612,0,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.15565,0.14273,0.098624,0,1
1,GO HISTONE MONOUBIQUITINATION,0.085497,0.14078,0.072455,0,1
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.24416,0.1399,0.11968,0,1
1,GO DRUG CATABOLIC PROCESS,0.086981,0.13892,0.1036,0,1
1,GO RESPONSE TO FATTY ACID,0.13338,0.13849,0.077683,0,1
1,GO NUCLEAR MIGRATION,0.10558,0.13846,0.11426,0,1
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.11553,0.13321,0.16592,0,1
1,GO SARCOMERE ORGANIZATION,0.23766,0.13247,0.0667,0,1
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.12126,0.13161,0.09254,0,1
1,GO LINOLEIC ACID METABOLIC PROCESS,0.14983,0.13147,0.12198,0,1
1,GO DEVELOPMENTAL PIGMENTATION,0.093126,0.12963,0.070527,0,1
1,GO NODAL SIGNALING PATHWAY,0.077698,0.1288,0.075803,0,1
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.068619,0.12724,0.098893,0,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.36098,0.127,0.04894,0,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.50516,0.12604,0.031955,0,1
1,GO ER OVERLOAD RESPONSE,0.1793,0.12596,0.086344,0,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.21738,0.12454,0.052552,0,1
1,GO PEPTIDYL ARGININE METHYLATION,0.16285,0.12032,0.056341,0,1
1,GO GOLGI LOCALIZATION,0.18062,0.11995,0.08559,0,1
1,GO PROTEIN NITROSYLATION,0.10912,0.11858,0.094281,0,1
1,GO CELL AGGREGATION,0.32993,0.11849,0.10498,0,1
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.35463,0.11812,0.059745,0,1
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.17029,0.1163,0.10492,0,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.14197,0.11462,0.11225,0,1
1,GO MITOTIC CELL CYCLE ARREST,0.11647,0.11316,0.08231,0,1
1,GO RESPONSE TO VITAMIN D,0.23445,0.1128,0.06748,0,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.084763,0.10989,0.065555,0,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.14755,0.10953,0.061918,0,1
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.084763,0.10501,0.12135,0,1
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.1914,0.10355,0.086608,0,1
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.11275,0.10301,0.052759,0,1
1,GO REGULATION OF GONAD DEVELOPMENT,0.41899,0.10283,0.038348,0,1
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.15565,0.10276,0.10478,0,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.17411,0.10189,0.067719,0,1
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.20265,0.10182,0.11801,0,1
1,GO TRICARBOXYLIC ACID CYCLE,0.25078,0.10169,0.045159,0,1
1,GO HISTONE UBIQUITINATION,0.081877,0.10073,0.05993,0,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.16285,0.099654,0.07531,0,1
1,GO QUINONE METABOLIC PROCESS,0.21889,0.09831,0.048467,0,1
1,GO CENTRIOLE ASSEMBLY,0.11553,0.097493,0.053517,0,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.069238,0.09635,0.099148,0,1
1,GO HISTONE H3 K14 ACETYLATION,0.079765,0.096258,0.069463,0,1
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.61402,0.096233,0.025062,0,1
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.21288,0.094859,0.057467,0,1
1,GO RRNA CATABOLIC PROCESS,0.3871,0.094819,0.044558,0,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.11002,0.094502,0.046812,0,1
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.18062,0.093231,0.090171,0,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.095518,0.092475,0.06863,0,1
1,GO KINETOCHORE ASSEMBLY,0.1387,0.092152,0.052867,0,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.22814,0.091673,0.070322,0,1
1,GO RENAL TUBULE DEVELOPMENT,0.084763,0.091672,0.12809,0,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.093918,0.091378,0.081191,0,1
1,GO MESONEPHROS DEVELOPMENT,0.33194,0.090682,0.05999,0,1
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.47712,0.089776,0.037723,0,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.073694,0.089465,0.11684,0,1
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.10129,0.088279,0.075051,0,1
1,GO BICARBONATE TRANSPORT,0.16042,0.086602,0.062134,0,1
1,GO EXTRACELLULAR TRANSPORT,0.31604,0.085894,0.051649,0,1
1,GO HORMONE CATABOLIC PROCESS,0.41899,0.085576,0.056844,0,1
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.28945,0.084286,0.046809,0,1
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.28395,0.084043,0.035038,0,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.20122,0.083722,0.053875,0,1
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.090011,0.083159,0.076181,0,1
1,GO SPLEEN DEVELOPMENT,0.12224,0.081374,0.078684,0,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.16163,0.081089,0.040404,0,1
1,GO PROTEIN DENEDDYLATION,0.20992,0.081082,0.052734,0,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.090011,0.081002,0.029639,0,1
1,GO ATP BIOSYNTHETIC PROCESS,0.079765,0.080275,0.088341,0,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.10214,0.079973,0.071682,0,1
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.40286,0.079783,0.038278,0,1
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.10471,0.079649,0.073136,0,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.10558,0.077143,0.030431,0,1
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.081877,0.076285,0.074758,0,1
1,GO REGULATION OF HELICASE ACTIVITY,0.25753,0.07578,0.057167,0,1
1,GO BONE MATURATION,0.1387,0.073383,0.08375,0,1
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.17669,0.073334,0.053992,0,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.77519,0.073207,-0.031023,0,1
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.6055,0.073145,0.017693,0,1
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.22348,0.073121,0.0442,0,1
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.18194,0.071623,0.030375,0,1
1,GO MITOTIC NUCLEAR DIVISION,0.10912,0.071413,0.027768,0,1
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.079071,0.070145,0.10042,0,1
1,GO FEMALE GAMETE GENERATION,0.16904,0.069808,0.039084,0,1
1,GO MRNA PROCESSING,0.076344,0.069417,0.051645,0,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.10646,0.069307,0.072572,0,1
1,GO LIPID PHOSPHORYLATION,0.23128,0.069263,0.053303,0,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.072397,0.069212,0.078721,0,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.095518,0.068847,0.042475,0,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.070488,0.068247,0.063967,0,1
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.32393,0.067266,0.045893,0,1
1,GO GMP METABOLIC PROCESS,0.45482,0.067001,0.043007,0,1
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.12126,0.066724,0.08398,0,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.095518,0.06667,0.056051,0,1
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.75356,0.066629,0.0076709,0,1
1,GO HISTONE H3 K9 ACETYLATION,0.071756,0.06504,0.099743,0,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.32592,0.064592,0.022081,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.13979,0.062805,0.068795,0,1
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.2714,0.060198,0.099427,0,1
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.52082,0.060163,0.035019,0,1
1,GO CHROMOSOME SEGREGATION,0.11092,0.059797,0.021047,0,1
1,GO RNA SPLICING,0.10646,0.059767,0.044841,0,1
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.22195,0.058812,0.056008,0,1
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.45727,0.058151,0.032822,0,1
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.20699,0.057788,0.054457,0,1
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15447,0.057658,0.037271,0,1
1,GO REGULATION OF SENSORY PERCEPTION,0.25924,0.057552,0.042026,0,1
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.43789,0.056844,0.044484,0,1
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.37608,0.056494,0.077942,0,1
1,GO CHROMOSOME SEPARATION,0.084034,0.056376,0.041952,0,1
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.32195,0.054574,-0.014562,0,1
1,GO METHYLATION,0.10823,0.054093,0.050736,0,1
1,GO REGULATION OF DNA REPLICATION,0.075674,0.052917,0.048237,0,1
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.28213,0.052295,0.028583,0,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.093126,0.050885,0.03962,0,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25246,0.050497,0.0036849,0,1
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.21288,0.048308,0.073202,0,1
1,GO DNA CATABOLIC PROCESS,0.20122,0.045972,0.032972,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.28578,0.044814,0.050313,0,1
1,GO COVALENT CHROMATIN MODIFICATION,0.58585,0.038752,0.021613,0,1
1,GO PEPTIDYL LYSINE MODIFICATION,0.44994,0.035118,0.021419,0,1
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.39606,0.035013,0.033357,0,1
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.36098,0.034897,0.058697,0,1
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.50776,0.034773,0.037315,0,1
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.52082,0.032178,0.035609,0,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,2.2824e-05,0.41042,0.30641,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0020646,0.30262,0.3653,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0055559,0.28201,0.35017,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.1829e-05,0.28172,0.27478,0,0
1,GO OXYGEN TRANSPORT,0.079765,0.26757,0.14017,0,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00011406,0.26602,0.23011,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.00049802,0.26298,0.28423,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0024281,0.26025,0.26676,0,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00068191,0.25556,0.23893,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.011813,0.24012,0.35234,0,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.0047198,0.24011,0.25394,0,0
1,GO PENTOSE METABOLIC PROCESS,0.00016629,0.23546,0.26223,0,0
1,GO CELLULAR COPPER ION HOMEOSTASIS,5.4356e-06,0.23276,0.31995,0,0
1,GO PSEUDOURIDINE SYNTHESIS,0.00020835,0.23229,0.22001,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,6.545e-05,0.22799,0.31037,0,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0012705,0.22037,0.19586,0,0
1,GO RIBOSOME ASSEMBLY,0.00029052,0.21951,0.21285,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0043737,0.21558,0.2504,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.063836,0.21141,0.23694,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0095807,0.21085,0.25759,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0043184,0.20795,0.21312,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.08331,0.20688,0.19097,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10471,0.20335,0.14331,0,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00010323,0.20304,0.25961,0,0
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.015329,0.20286,0.27908,0,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0010259,0.19975,0.15714,0,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,1.7706e-05,0.19847,0.19352,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.038637,0.1964,0.13686,0,0
1,GO GAS TRANSPORT,0.0078263,0.18879,0.2048,0,0
1,GO RESPIRATORY BURST,0.02915,0.18874,0.13012,0,0
1,GO AXIS ELONGATION,0.001118,0.18874,0.28315,0,0
1,GO METANEPHROS DEVELOPMENT,0.0001862,0.18793,0.20219,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.048285,0.18729,0.2609,0,0
1,GO PULMONARY VALVE MORPHOGENESIS,0.0063654,0.18521,0.33042,0,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14197,0.18479,0.065044,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.040187,0.18383,0.21987,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.087731,0.18326,0.1059,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.073694,0.18209,0.16644,0,0
1,GO PLATELET MORPHOGENESIS,6.8888e-05,0.17871,0.25289,0,0
1,GO TRNA PROCESSING,0.0001803,0.17809,0.15026,0,0
1,GO REGULATION OF GTP BINDING,0.0024609,0.1755,0.21756,0,0
1,GO SOMATIC STEM CELL DIVISION,0.25924,0.17541,0.14521,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.076344,0.17539,0.19546,0,0
1,GO BONE MORPHOGENESIS,4.5558e-05,0.16978,0.24705,0,0
1,GO HINDLIMB MORPHOGENESIS,0.022446,0.16874,0.15788,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.10385,0.1679,0.12768,0,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.079071,0.16712,0.14769,0,0
1,GO NEURAL CREST FORMATION,0.22814,0.16693,0.11138,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.028264,0.16328,0.13196,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.15802,0.16183,0.093095,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.021973,0.16127,0.13657,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.11092,0.15969,0.11175,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.29315,0.15961,0.073575,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.001704,0.1562,0.15915,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0032928,0.15607,0.14645,0,0
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0012705,0.15558,0.16519,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.1252,0.15511,0.22404,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.31021,0.15382,0.094436,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.14642,0.15298,0.26561,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.084763,0.1527,0.15652,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.03068,0.15202,0.15518,0,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.011022,0.15136,0.24417,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.039406,0.15093,0.1337,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.093918,0.14981,0.13697,0,0
1,GO BODY MORPHOGENESIS,0.0065235,0.14925,0.17654,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0030839,0.14901,0.14659,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.016205,0.14866,0.12649,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0016347,0.1477,0.17191,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.21288,0.14749,0.10221,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.093126,0.14667,0.11869,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.081168,0.1454,0.10129,0,0
1,GO HEAD MORPHOGENESIS,0.0061347,0.14537,0.20153,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0028872,0.14337,0.16051,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.20265,0.14292,0.16292,0,0
1,GO TRABECULA MORPHOGENESIS,0.0025617,0.1424,0.21227,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.29689,0.13952,0.069649,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0085105,0.13942,0.14024,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.13444,0.13912,0.15719,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.078382,0.13855,0.14111,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.02915,0.13783,0.20854,0,0
1,GO POSITIVE REGULATION OF URINE VOLUME,0.0022701,0.13674,0.22567,0,0
1,GO RESPONSE TO PARATHYROID HORMONE,0.045155,0.13665,0.13517,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.027973,0.13545,0.24194,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.001568,0.13286,0.18653,0,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0028492,0.13278,0.20059,0,0
1,GO FLUID TRANSPORT,0.0055559,0.13182,0.14791,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.10734,0.13148,0.11358,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00091404,0.13133,0.19852,0,0
1,GO REGULATION OF ODONTOGENESIS,0.15683,0.13096,0.094426,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0024281,0.13033,0.14023,0,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0046604,0.12975,0.19718,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.20992,0.12972,0.07847,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.02128,0.1293,0.19899,0,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00074504,0.12929,0.18035,0,0
1,GO NEPHRON TUBULE FORMATION,0.071119,0.12866,0.16148,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.11553,0.12805,0.10187,0,0
1,GO MESENCHYME MORPHOGENESIS,0.014172,0.12636,0.19629,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.0030038,0.12534,0.12526,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.55558,0.12461,0.019662,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.1453,0.12398,0.083566,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.095518,0.12362,0.076691,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.013546,0.12349,0.15755,0,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0062108,0.12289,0.17841,0,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.001955,0.12287,0.19923,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.11742,0.12271,0.12634,0,0
1,GO MESENCHYME DEVELOPMENT,0.00071283,0.12165,0.17521,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.21738,0.12152,0.073601,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.09714,0.12139,0.12641,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.11837,0.12105,0.093146,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.38933,0.1208,0.098675,0,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.048746,0.11928,0.2311,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0078263,0.11924,0.12057,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.054582,0.11918,0.078542,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.090782,0.11913,0.13438,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.19278,0.11895,0.1521,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.41434,0.11845,0.078945,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.095518,0.11844,0.10416,0,0
1,GO SNORNA 3 END PROCESSING,0.049681,0.11805,0.098301,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.10646,0.1178,0.092314,0,0
1,GO FATTY ACID HOMEOSTASIS,0.078382,0.11745,0.09722,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.14755,0.11694,0.072598,0,0
1,GO PRO B CELL DIFFERENTIATION,0.12322,0.11668,0.15177,0,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.032938,0.11603,0.18516,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.03068,0.11516,0.12737,0,0
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.023173,0.11478,0.154,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.0083098,0.11461,0.17524,0,0
1,GO LIPID DIGESTION,0.48215,0.11337,0.040936,0,0
1,GO PANCREATIC JUICE SECRETION,0.16654,0.11314,0.098607,0,0
1,GO EPIDERMIS DEVELOPMENT,0.072397,0.113,0.12179,0,0
1,GO RESPONSE TO CADMIUM ION,0.18062,0.1129,0.095703,0,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00049802,0.11288,0.20752,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.58585,0.11275,0.052595,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.20554,0.11245,0.086712,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.088486,0.11161,0.079022,0,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0059116,0.11138,0.13025,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0093576,0.11032,0.11554,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.50776,0.10993,0.064837,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.31215,0.10972,0.096697,0,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.054582,0.10965,0.15267,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18062,0.10961,0.091746,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.007921,0.10954,0.1373,0,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.015329,0.10942,0.15961,0,0
1,GO PROTEIN REFOLDING,0.30637,0.10925,0.052393,0,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.077698,0.10837,0.14049,0,0
1,GO HISTAMINE SECRETION,0.55558,0.10829,0.043182,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.10045,0.10815,0.13212,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.077018,0.10724,0.10152,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.039795,0.10674,0.117,0,0
1,GO MRNA CLEAVAGE,0.00070238,0.10635,0.11204,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.11275,0.10561,0.11443,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0071051,0.10507,0.15507,0,0
1,GO AMP METABOLIC PROCESS,0.011544,0.10485,0.18829,0,0
1,GO VIRAL BUDDING,0.0095807,0.10485,0.10785,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.27853,0.10463,0.039566,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.01499,0.10456,0.12075,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.033271,0.10448,0.16097,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.031953,0.10296,0.17778,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.084034,0.10248,0.092599,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.13549,0.10187,0.084633,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.081877,0.10096,0.11998,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.038637,0.10073,0.14717,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.001704,0.10047,0.10379,0,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.0039992,0.10026,0.16673,0,0
1,GO FOLIC ACID METABOLIC PROCESS,0.037509,0.09987,0.11408,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.35886,0.099518,0.074122,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.12126,0.099516,0.092036,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.13338,0.098785,0.15079,0,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0013255,0.098684,0.10587,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.36098,0.098313,0.08172,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.085497,0.098207,0.11353,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.10045,0.097773,0.09478,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.016752,0.097609,0.12952,0,0
1,GO HISTONE H2A UBIQUITINATION,0.26095,0.096854,0.046077,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.068619,0.096669,0.10085,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.072397,0.096553,0.054329,0,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.089246,0.096301,0.088365,0,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.053071,0.096235,0.11722,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.54208,0.095426,0.066634,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0026663,0.095359,0.11485,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.10734,0.095318,0.24455,0,0
1,GO GONADOTROPIN SECRETION,0.059879,0.095136,0.11244,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.073043,0.094684,0.12118,0,0
1,GO TRANSLATIONAL TERMINATION,0.0022701,0.094428,0.13932,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.21288,0.094354,0.10186,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.12126,0.094343,0.074581,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.13656,0.093781,0.084319,0,0
1,GO ALDITOL METABOLIC PROCESS,0.034984,0.093747,0.11681,0,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.043866,0.093494,0.056747,0,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.074349,0.09279,0.092478,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.72603,0.092561,0.040114,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.3739,0.09256,0.040018,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.97899,0.092346,0.022384,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.086237,0.091962,0.062672,0,0
1,GO CELLULAR RESPONSE TO DRUG,0.0065235,0.091915,0.10911,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.51296,0.091762,0.031932,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.10734,0.091523,0.10205,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.25583,0.091514,0.090528,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.016752,0.091414,0.10594,0,0
1,GO SULFATION,0.044722,0.090728,0.14141,0,0
1,GO RENAL FILTRATION,0.062684,0.090684,0.20496,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.044292,0.090655,0.13471,0,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.001568,0.090578,0.11977,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.060988,0.090148,0.11081,0,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0054872,0.090044,0.11113,0,0
1,GO LIMB BUD FORMATION,0.44028,0.089938,0.17894,0,0
1,GO REGULATION OF CYTOKINESIS,0.2913,0.089906,0.020921,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.017699,0.089638,0.11158,0,0
1,GO CONVERGENT EXTENSION,0.16778,0.089535,0.087203,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0096941,0.089478,0.087092,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.23445,0.089306,0.052282,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.086237,0.089171,0.11255,0,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.021053,0.088926,0.14624,0,0
1,GO ENDOTHELIUM DEVELOPMENT,0.23128,0.088763,0.086095,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.31215,0.088081,0.054619,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.40743,0.087378,0.05443,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.43312,0.087324,0.052915,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.023419,0.086832,0.10899,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.82842,0.086581,0.0061413,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.010769,0.086271,0.090626,0,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.017506,0.086237,0.08788,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.23445,0.086075,0.077419,0,0
1,GO SPINDLE ORGANIZATION,0.18327,0.085585,0.033928,0,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0034243,0.085347,0.14291,0,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.016205,0.08528,0.10065,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.38267,0.085221,0.059778,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.077018,0.084996,0.096806,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.31604,0.084853,0.10815,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.24745,0.084712,0.08413,0,0
1,GO HEART DEVELOPMENT,0.0027381,0.084525,0.13249,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.1914,0.084516,0.061305,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.33599,0.084499,0.057672,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.22348,0.084101,0.090934,0,0
1,GO MIDBODY ABSCISSION,0.043444,0.084049,0.11742,0,0
1,GO POLYAMINE METABOLIC PROCESS,0.010645,0.083921,0.12403,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.09714,0.083661,0.090131,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.10912,0.08362,0.071073,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.03068,0.083471,0.13752,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.044722,0.083348,0.14375,0,0
1,GO CELL JUNCTION DISASSEMBLY,0.037882,0.083064,0.14263,0,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0063654,0.082492,0.093513,0,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.086237,0.082468,0.099445,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.85694,0.081491,-0.0079064,0,0
1,GO SECONDARY METABOLIC PROCESS,0.20122,0.081272,0.054141,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.10045,0.080999,0.079386,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.22658,0.080983,0.094555,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.024687,0.080887,0.096075,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.22503,0.080837,0.12569,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.021053,0.080395,0.12475,0,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.24252,0.080321,0.064341,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.30066,0.080192,0.0774,0,0
1,GO NEPHRON MORPHOGENESIS,0.25924,0.080098,0.063119,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.22971,0.079817,0.069422,0,0
1,GO CRISTAE FORMATION,0.13027,0.079418,0.10021,0,0
1,GO REGULATION OF BINDING,0.0042636,0.079344,0.097237,0,0
1,GO VIRAL LATENCY,0.2114,0.07925,0.041344,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.075009,0.078796,0.067504,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.34627,0.078667,0.046108,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.062684,0.078448,0.10882,0,0
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.1533,0.078331,0.099941,0,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.06986,0.07812,0.15602,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.20554,0.078092,0.057631,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.47712,0.07807,0.034671,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.22658,0.078062,0.058186,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.21437,0.078054,0.17175,0,0
1,GO HEART VALVE FORMATION,0.40058,0.077969,0.069309,0,0
1,GO REGULATION OF DNA METHYLATION,0.1146,0.077937,0.10364,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.094715,0.077822,0.060421,0,0
1,GO GLIAL CELL PROLIFERATION,0.28761,0.077783,0.067524,0,0
1,GO L GLUTAMATE IMPORT,0.10823,0.077765,0.10334,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.073694,0.077312,0.082828,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.20554,0.077103,0.08103,0,0
1,GO ARACHIDONIC ACID SECRETION,0.24089,0.076982,0.047896,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.14308,0.076736,0.075706,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.19417,0.076713,0.076475,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12721,0.076569,0.076861,0,0
1,GO REGULATION OF ATPASE ACTIVITY,0.013546,0.07643,0.073099,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.318,0.076343,0.072351,0,0
1,GO REGULATION OF MYELINATION,0.043866,0.076319,0.11623,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.081877,0.075926,0.10633,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0041031,0.075826,0.11087,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.25246,0.075521,0.06382,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.27495,0.074954,0.054441,0,0
1,GO RNA CAPPING,0.003166,0.074896,0.08651,0,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.11837,0.074618,0.1102,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0005789,0.074605,0.10616,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.30829,0.074469,0.050301,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.2644,0.074459,0.053929,0,0
1,GO RESPONSE TO INTERLEUKIN 6,0.27853,0.074014,0.061421,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.12224,0.073896,0.084417,0,0
1,GO MRNA MODIFICATION,0.1793,0.073873,0.093617,0,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.09714,0.073829,0.063521,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.31409,0.073806,0.075428,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.52609,0.073663,0.032046,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.19557,0.073054,0.035317,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.18866,0.072942,0.10699,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.34008,0.072883,0.036488,0,0
1,GO REGULATION OF SPINDLE ORGANIZATION,0.10646,0.072784,0.049293,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.16654,0.072741,0.068187,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.10299,0.072728,0.064348,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.38488,0.072713,0.037954,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.57476,0.072613,0.038994,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.10214,0.072549,0.066061,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.15565,0.072527,0.069382,0,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.23927,0.072025,0.013033,0,0
1,GO RESPONSE TO WATER,0.54746,0.071959,0.051353,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.19417,0.071785,0.071698,0,0
1,GO GLIAL CELL DEVELOPMENT,0.36956,0.071784,0.048921,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.19557,0.071494,0.051463,0,0
1,GO ANOIKIS,0.19417,0.07137,0.085987,0,0
1,GO PEPTIDYL THREONINE MODIFICATION,0.075009,0.071338,0.069036,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.031311,0.071333,0.11175,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.19003,0.071301,0.13816,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,0.26095,0.071262,0.065338,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.060432,0.071258,0.086685,0,0
1,GO REGULATION OF CENTROSOME DUPLICATION,0.046921,0.071231,0.071079,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.18327,0.071191,0.10501,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.17411,0.071151,0.059071,0,0
1,GO TRANSLATIONAL ELONGATION,0.012087,0.071011,0.10569,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.086981,0.070892,0.069658,0,0
1,GO O GLYCAN PROCESSING,0.16778,0.07086,0.083259,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.10912,0.070738,0.068791,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.36956,0.070575,0.053565,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.13979,0.070297,0.095674,0,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.16042,0.069913,0.079725,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.085497,0.069843,0.06241,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.90167,0.069769,-0.027331,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.24416,0.06954,0.065839,0,0
1,GO AEROBIC RESPIRATION,0.076344,0.069404,0.052361,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.45482,0.069118,0.075407,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.42838,0.068982,0.059283,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.032938,0.068492,0.13334,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.14755,0.068418,0.15896,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.40286,0.068281,0.049417,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.43075,0.06821,0.063702,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.057711,0.06815,0.073234,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.92738,0.068086,-0.049719,0,0
1,GO MEIOTIC SPINDLE ORGANIZATION,0.12822,0.067758,0.045539,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.22348,0.067506,0.053491,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.14419,0.067441,0.10932,0,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0052854,0.067303,0.07715,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.10471,0.067098,0.074362,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.72907,0.066942,0.0024639,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.040981,0.066757,0.092901,0,0
1,GO POSITIVE REGULATION OF BINDING,0.036409,0.066714,0.079483,0,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.11837,0.06671,0.06857,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.5583,0.066606,0.02368,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.14642,0.066537,0.080882,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.088486,0.066227,0.067913,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.08331,0.066222,0.077651,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.14088,0.066186,0.10449,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.71391,0.066143,0.007316,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.1793,0.066133,0.047593,0,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.18866,0.066033,0.05848,0,0
1,GO CORNIFICATION,0.572,0.065929,0.059232,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.093126,0.065905,0.12956,0,0
1,GO PIRNA METABOLIC PROCESS,0.90167,0.065781,-0.0094009,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.091558,0.06539,0.070054,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.23766,0.065373,0.058497,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.012087,0.065267,0.07851,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.073694,0.064915,0.1609,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.4451,0.064883,0.038421,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.12322,0.064819,0.10158,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.22042,0.064716,0.083549,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.41434,0.064285,0.057619,0,0
1,GO HISTONE H3 DEACETYLATION,0.15683,0.064187,0.066172,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.59986,0.064128,0.045098,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.092339,0.064084,0.063566,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.38933,0.063834,0.079483,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.053071,0.063589,0.085581,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.19003,0.06355,0.074927,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.33599,0.063541,0.051113,0,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.21288,0.063194,0.0080389,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.11183,0.063056,0.077681,0,0
1,GO VESICLE ORGANIZATION,0.13234,0.062791,0.060226,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.055093,0.062771,0.076242,0,0
1,GO SPECIFICATION OF SYMMETRY,0.075009,0.062613,0.069899,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.84107,0.062427,0.033136,0,0
1,GO ENDOCARDIAL CUSHION FORMATION,0.24745,0.06228,0.12388,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.028852,0.062135,0.09517,0,0
1,GO HISTAMINE TRANSPORT,0.87606,0.061956,0.0050835,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.74128,0.06132,0.041957,0,0
1,GO PROTEIN FOLDING,0.010645,0.060521,0.11701,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.066792,0.06048,0.07688,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.3871,0.060272,0.045292,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12822,0.060254,0.063339,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.95961,0.060148,-0.01707,0,0
1,GO AMINE METABOLIC PROCESS,0.092339,0.05997,0.054944,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.18194,0.059818,0.035919,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.1313,0.059736,0.090621,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.29315,0.05963,0.079007,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.30255,0.059542,0.057291,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.28761,0.059519,0.072003,0,0
1,GO RNA STABILIZATION,0.19979,0.059504,0.044628,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.47712,0.059416,0.069727,0,0
1,GO RENAL ABSORPTION,0.22195,0.059225,0.15188,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.34008,0.059126,0.039341,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.31215,0.058992,0.095345,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.318,0.058924,0.057168,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.24416,0.058923,0.031867,0,0
1,GO V D J RECOMBINATION,0.52874,0.058895,0.063035,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.19278,0.058727,0.061262,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.23927,0.058495,0.065312,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.027401,0.058297,0.045747,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.20122,0.058208,0.054742,0,0
1,GO CENTROSOME SEPARATION,0.38267,0.058065,0.014336,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.52609,0.058014,0.078091,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.6312,0.058003,0.027895,0,0
1,GO LACTATION,0.02945,0.057727,0.1183,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.23766,0.057708,0.055217,0,0
1,GO TAXIS,0.20122,0.057604,0.061465,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.038258,0.057583,0.091804,0,0
1,GO INTRACELLULAR TRANSPORT,0.006444,0.057533,0.067533,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.030994,0.05753,0.068006,0,0
1,GO SPINDLE ASSEMBLY,0.085497,0.057517,0.036624,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.4451,0.057413,0.05118,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.54477,0.057272,0.046648,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.26095,0.057171,0.065843,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.016938,0.057094,0.14894,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.20845,0.056694,0.073709,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.33194,0.056551,0.040763,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.38488,0.056442,0.054628,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.30446,0.056391,0.14386,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.30255,0.056235,0.0044391,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.20554,0.05623,0.011864,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.27495,0.055749,0.072559,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.23128,0.05572,0.045335,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.52609,0.055546,0.035162,0,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.20699,0.05489,0.092083,0,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.14308,0.054478,0.047886,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.25583,0.054338,0.070041,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.16163,0.054057,0.052916,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.1313,0.053973,0.067712,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.23128,0.053782,0.09873,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.24745,0.053617,0.043901,0,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.077018,0.053439,0.080677,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.19417,0.053265,0.08982,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.42602,0.05324,0.039638,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.75356,0.053128,0.0017155,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.10734,0.05307,0.059093,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.41434,0.053061,0.028445,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.46713,0.053004,0.029667,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.36741,0.052758,0.045397,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.61117,0.052677,0.049803,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.086981,0.052659,0.096746,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.25414,0.052536,0.083111,0,0
1,GO ORGAN INDUCTION,0.41203,0.052335,0.072028,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.29315,0.052304,0.098316,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.054582,0.052293,0.046782,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.572,0.052192,0.051155,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.09796,0.052062,0.057158,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.26964,0.052021,0.059231,0,0
1,GO RESPONSE TO IRON ION,0.78763,0.051932,0.01592,0,0
1,GO MICROVILLUS ORGANIZATION,0.85059,0.051879,0.0044809,0,0
1,GO G2 DNA DAMAGE CHECKPOINT,0.09714,0.051729,0.065273,0,0
1,GO RESPONSE TO AMYLOID BETA,0.46713,0.051639,0.057499,0,0
1,GO REGULATION OF NUCLEAR DIVISION,0.086237,0.05159,0.034951,0,0
1,GO BIOMINERALIZATION,0.20122,0.05158,0.085489,0,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.075009,0.051489,0.055859,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.3871,0.051486,0.048041,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.41666,0.051382,0.036272,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.26789,0.0511,0.084388,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.25414,0.051081,0.044628,0,0
1,GO MEMBRANE ORGANIZATION,0.068006,0.051,0.06074,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.30637,0.050828,0.12319,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14197,0.050806,0.078732,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.14197,0.050778,0.07646,0,0
1,GO CELL CYCLE ARREST,0.18461,0.050673,0.043449,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.12224,0.050661,0.084288,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.1453,0.050577,0.06527,0,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.026286,0.050486,0.059198,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.30255,0.050458,0.087155,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.35674,0.050411,0.089078,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.08331,0.05031,0.080694,0,0
1,GO METAPHASE PLATE CONGRESSION,0.1873,0.04988,0.021203,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.36098,0.049743,0.076098,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.19003,0.049742,0.057882,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.099614,0.049636,0.086937,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.27853,0.049574,0.10489,0,0
1,GO ORGANELLE FISSION,0.32195,0.049552,0.011353,0,0
1,GO GLAND DEVELOPMENT,0.28395,0.049531,0.059207,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.069238,0.04936,0.066374,0,0
1,GO VITAMIN TRANSPORT,0.84424,0.049296,0.020879,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.62545,0.049238,0.054884,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.47712,0.048947,0.033831,0,0
1,GO OVULATION CYCLE,0.1653,0.048475,0.074292,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.44269,0.04839,0.049497,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.2114,0.048372,0.057256,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.5314,0.04807,-0.023988,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.33599,0.048003,0.06623,0,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.10734,0.047999,0.056483,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.26964,0.047811,0.07801,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.1453,0.047795,0.067209,0,0
1,GO EMBRYO DEVELOPMENT,0.023419,0.047756,0.092952,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.3739,0.047654,0.036965,0,0
1,GO MUSCLE HYPERTROPHY,0.09714,0.047642,0.087505,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.45238,0.047631,0.039374,0,0
1,GO RESPONSE TO ALCOHOL,0.17411,0.047546,0.062948,0,0
1,GO APPENDAGE DEVELOPMENT,0.10045,0.047469,0.10374,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.071756,0.04745,0.083982,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.93704,0.047415,-0.018418,0,0
1,GO LIPID EXPORT FROM CELL,0.53672,0.047229,0.034475,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.12721,0.04709,0.14823,0,0
1,GO BONE MINERALIZATION,0.75356,0.046884,0.048121,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.17669,0.046875,0.06376,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.57476,0.046818,0.041512,0,0
1,GO CHROMOSOME LOCALIZATION,0.36526,0.046766,0.014395,0,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.26964,0.04648,0.050947,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.20992,0.046463,0.082983,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.31604,0.046441,0.074198,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.67206,0.046401,0.033636,0,0
1,GO CENTROSOME DUPLICATION,0.39381,0.046325,0.024782,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.31215,0.04617,0.0696,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.51035,0.045897,0.060063,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.5,0.045808,0.043759,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.19979,0.045767,0.061598,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.25924,0.045697,0.082553,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.2714,0.045638,0.051809,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.37173,0.045591,0.049079,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.80012,0.045576,0.031098,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.40286,0.045398,0.049203,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.49743,0.045386,0.077276,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.33599,0.045345,0.0010135,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.26267,0.045259,0.064266,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.32792,0.045132,0.056154,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.35674,0.044982,0.047187,0,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.20409,0.044941,0.051987,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.056652,0.044926,0.083147,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.26789,0.044885,0.078199,0,0
1,GO RESPONSE TO INACTIVITY,0.797,0.044854,0.021838,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.10214,0.044686,0.064086,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.56103,0.044501,0.031073,0,0
1,GO REGULATION OF CELL DIVISION,0.12924,0.044497,0.061306,0,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.60268,0.044469,0.029472,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.85694,0.044373,-0.023333,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.44994,0.044343,0.059461,0,0
1,GO SCHWANN CELL DEVELOPMENT,0.178,0.044292,0.085603,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.11553,0.044279,0.060894,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.6515,0.044243,0.029296,0,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.10214,0.044128,0.045795,0,0
1,GO MRNA METHYLATION,0.39832,0.044047,0.063923,0,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.069238,0.044009,0.066201,0,0
1,GO DNA CONFORMATION CHANGE,0.073694,0.043945,0.037649,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.37827,0.043574,0.03692,0,0
1,GO STEM CELL PROLIFERATION,0.41666,0.043569,0.044398,0,0
1,GO KIDNEY MORPHOGENESIS,0.6515,0.043367,0.026884,0,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.61402,0.043361,-0.031806,0,0
1,GO CHROMATIN REMODELING,0.66028,0.043307,-0.0033679,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.16407,0.043235,0.059328,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.1653,0.043203,0.086791,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.39832,0.043121,0.057707,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.94348,0.043119,-0.0087274,0,0
1,GO REPLICATION FORK PROCESSING,0.36956,0.043095,0.047776,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.3442,0.043035,0.058553,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.079765,0.043028,0.16582,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.075009,0.043026,0.12287,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.86649,0.04288,-0.046653,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.89846,0.04285,0.012305,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.086237,0.042709,0.072669,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.5583,0.042602,0.055573,0,0
1,GO REGULATION OF AXON GUIDANCE,0.2714,0.042443,0.075508,0,0
1,GO ECTODERM DEVELOPMENT,0.094715,0.042375,0.084824,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.50776,0.042068,0.041742,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.47963,0.04199,0.055941,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.15802,0.041972,0.050931,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.23927,0.041855,0.081417,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.36956,0.041786,0.028164,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.23927,0.041781,0.092265,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.39381,0.04176,0.056349,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.29502,0.041412,0.037242,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.13234,0.041365,0.060274,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.71693,0.041363,0.028792,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.22503,0.041106,0.027131,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.65734,0.040953,0.034552,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.31997,0.040767,0.027427,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.016205,0.040732,0.11254,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.56376,0.040722,0.011642,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.62832,0.040547,0.041718,0,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.14197,0.04047,0.059743,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.094715,0.040442,0.057693,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.14308,0.04036,0.060352,0,0
1,GO COENZYME A METABOLIC PROCESS,0.54746,0.040242,0.03683,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.20265,0.040082,0.057005,0,0
1,GO REGULATION OF CENTROSOME CYCLE,0.14755,0.039859,0.038465,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.26267,0.03983,0.097896,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.95316,0.039788,-0.013112,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.22348,0.039744,0.064739,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.15921,0.03957,0.057808,0,0
1,GO POLYOL METABOLIC PROCESS,0.12421,0.039507,0.063894,0,0
1,GO ESTROUS CYCLE,0.46218,0.039452,0.057208,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.13549,0.039419,0.13433,0,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.081168,0.039088,0.048444,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.27317,0.039072,0.0064264,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.42133,0.039069,0.032195,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.86331,0.039028,0.0079611,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.49487,0.03899,0.013221,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.61402,0.038958,0.010094,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.30637,0.038909,0.072088,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.72603,0.038712,0.039586,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.318,0.038644,0.052754,0,0
1,GO NAD METABOLIC PROCESS,0.96284,0.038545,0.0068672,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.38488,0.038508,0.035806,0,0
1,GO ACTIN NUCLEATION,0.13234,0.038441,0.053308,0,0
1,GO MISMATCH REPAIR,0.25246,0.038407,0.022004,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.38933,0.038362,0.069604,0,0
1,GO GLYCOSYLATION,0.36311,0.038156,0.027345,0,0
1,GO EYE MORPHOGENESIS,0.51557,0.038151,0.043092,0,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.31021,0.03796,0.017765,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.12322,0.03789,0.080856,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.58585,0.037779,-0.0022703,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.5665,0.037612,0.039855,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.58029,0.037498,0.044527,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.44269,0.03736,0.02882,0,0
1,GO ORGANELLE ASSEMBLY,0.13444,0.037238,0.044038,0,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.74435,0.03709,-0.0028757,0,0
1,GO REGULATION OF BONE REMODELING,0.45238,0.036987,0.044101,0,0
1,GO LYSINE METABOLIC PROCESS,0.87287,0.036881,0.052434,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.99515,0.036855,-0.024867,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.87287,0.036818,-0.0061669,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.21587,0.036796,0.059383,0,0
1,GO OVULATION CYCLE PROCESS,0.51035,0.036771,0.034354,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.20554,0.036731,0.11401,0,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.090782,0.036729,0.060287,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.17283,0.036726,0.062262,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.80953,0.036539,0.023441,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.4451,0.036448,0.053855,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.2913,0.036373,0.046936,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.29689,0.036354,0.071156,0,0
1,GO CELLULAR RESPIRATION,0.12421,0.036038,0.043933,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.87606,0.03599,0.018304,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.069238,0.035981,0.12752,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.6515,0.035918,0.02508,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.28945,0.035789,0.049777,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.25753,0.035764,0.010967,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.22195,0.035624,0.057057,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.16163,0.035525,0.086322,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.90488,0.035123,0.0044822,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.15683,0.035123,0.080723,0,0
1,GO HOMEOSTATIC PROCESS,0.17156,0.035119,0.045556,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.20845,0.035064,0.095287,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.73212,0.034991,-0.016234,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.22658,0.034955,0.065374,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.040187,0.034758,0.072905,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.42602,0.03473,0.042527,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.1653,0.034606,0.055822,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.15565,0.034451,0.034339,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.15447,0.034402,0.065676,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.086981,0.034281,0.051039,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.45972,0.034239,0.061073,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.48722,0.034192,0.07742,0,0
1,GO MIDBRAIN DEVELOPMENT,0.18062,0.034111,0.07566,0,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.10558,0.033938,0.089254,0,0
1,GO PROTEIN POLYMERIZATION,0.092339,0.033618,0.058714,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.58029,0.033602,0.031549,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.59705,0.033523,0.032588,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.23927,0.033452,0.0836,0,0
1,GO RESPONSE TO BMP,0.11837,0.033424,0.097102,0,0
1,GO APPENDAGE MORPHOGENESIS,0.17283,0.033412,0.090064,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.72299,0.033199,0.03041,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.63986,0.032966,0.025305,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.30255,0.032828,0.058787,0,0
1,GO STRESS GRANULE ASSEMBLY,0.81896,0.032804,0.0099996,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.14419,0.0328,0.049657,0,0
1,GO ATP METABOLIC PROCESS,0.45482,0.032757,0.024878,0,0
1,GO RETINA HOMEOSTASIS,0.29502,0.03269,0.05346,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.40286,0.032326,0.052334,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.25414,0.032158,0.049149,0,0
1,GO REPRODUCTION,0.44752,0.032153,0.031791,0,0
1,GO RESPONSE TO COPPER ION,0.68392,0.03215,0.022983,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.88565,0.032119,0.0083827,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.81581,0.032105,0.019001,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.39606,0.032011,0.055158,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.54746,0.031847,0.036281,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.59705,0.03184,0.023286,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.83474,0.031683,0.0041851,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.68689,0.031584,0.029924,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55558,0.031493,0.028828,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.22195,0.031461,0.03286,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.54477,0.031367,0.04687,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.36741,0.031144,0.022558,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.2458,0.031126,0.055878,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.97253,0.031028,0.0054849,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.45972,0.03098,0.044018,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.42602,0.030951,0.044133,0,0
1,GO REGULATION OF DNA BINDING,0.80326,0.030848,0.01324,0,0
1,GO REGULATION OF CELL SIZE,0.50516,0.030841,0.029718,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.46962,0.030746,0.029357,0,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.28761,0.030645,0.024895,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.15921,0.030522,0.067527,0,0
1,GO IRON ION TRANSPORT,0.14197,0.030427,0.056923,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.72299,0.030328,0.005423,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.2714,0.030207,0.092863,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.36311,0.030036,0.053167,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.32792,0.029846,-0.072269,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.31409,0.029772,0.054344,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.69885,0.029627,0.027868,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.59424,0.029561,0.0066791,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.51296,0.029552,-0.068713,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.80326,0.029496,0.0241,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.17156,0.029471,0.10396,0,0
1,GO SISTER CHROMATID SEGREGATION,0.33599,0.029417,0.0011349,0,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.30637,0.029368,0.079155,0,0
1,GO RENAL SODIUM EXCRETION,0.96284,0.029309,0.0057464,0,0
1,GO HISTONE H3 K27 METHYLATION,0.53406,0.029163,0.020182,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.1533,0.029096,0.053939,0,0
1,GO CHROMOSOME CONDENSATION,0.36526,0.029038,0.01389,0,0
1,GO CHROMATIN ORGANIZATION,0.75048,0.028922,0.0084914,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.69286,0.028837,0.046742,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.24745,0.028674,0.066832,0,0
1,GO DNA REPLICATION INITIATION,0.56376,0.028523,-0.031091,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.51296,0.028481,0.053427,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15565,0.028463,0.034668,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.40973,0.028422,0.033866,0,0
1,GO CELL PROJECTION ASSEMBLY,0.34213,0.028366,0.049322,0,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.21288,0.028343,0.044114,0,0
1,GO METHIONINE METABOLIC PROCESS,0.68392,0.028342,0.0050814,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.34213,0.028162,0.036712,0,0
1,GO MITOCHONDRION ORGANIZATION,0.13027,0.028021,0.04118,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.68094,0.027968,0.021665,0,0
1,GO AMINO ACID IMPORT,0.73822,0.027818,0.01518,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.13027,0.027812,0.053784,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.54477,0.027611,0.041423,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.08331,0.027519,0.1149,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.29315,0.027202,0.043325,0,0
1,GO NADH METABOLIC PROCESS,0.95961,0.027153,0.0035852,0,0
1,GO GASTRIC ACID SECRETION,0.68094,0.027005,0.040157,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.26789,0.026979,0.047684,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.040981,0.026972,0.12239,0,0
1,GO MICROTUBULE ANCHORING,0.49743,0.026899,0.050632,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.15214,0.026736,0.068666,0,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.45482,0.026729,0.054594,0,0
1,GO HISTONE EXCHANGE,0.74435,0.026624,-0.017946,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.34008,0.026475,0.041314,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.1754,0.026447,0.05422,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.16042,0.026296,0.092866,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.90167,0.02628,0.023,0,0
1,GO SPHINGOID METABOLIC PROCESS,0.39381,0.026253,0.046762,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.797,0.026101,-0.051285,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.36956,0.026094,0.039464,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.44994,0.02581,0.070543,0,0
1,GO RESPONSE TO ACID CHEMICAL,0.11183,0.025723,0.079036,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.50258,0.025477,0.035306,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.30446,0.025467,0.060326,0,0
1,GO REGULATION OF GROWTH,0.38267,0.025453,0.040179,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.25583,0.025412,0.062609,0,0
1,GO RECOMBINATIONAL REPAIR,0.44752,0.025407,0.01759,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.1873,0.025216,0.12239,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.68392,0.025058,-0.010473,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.58585,0.024929,0.035216,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.40743,0.024727,0.04726,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.49487,0.024721,0.045284,0,0
1,GO RESPONSE TO ACIDIC PH,0.27673,0.024647,0.081564,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.42133,0.024628,0.057903,0,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.54208,0.024624,0.018054,0,0
1,GO ADAPTIVE THERMOGENESIS,0.75356,0.024596,0.028365,0,0
1,GO SECRETION,0.28761,0.024567,0.044568,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.5,0.024477,0.034988,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.75356,0.024376,0.02055,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.42602,0.024284,0.090332,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.38047,0.024269,0.060193,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.27673,0.023941,0.060724,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.65734,0.023721,-0.0077242,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.59705,0.023596,0.036997,0,0
1,GO DNA DEMETHYLATION,0.22814,0.023568,0.08643,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.53406,0.023404,0.043541,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.95639,0.023392,0.012318,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.53406,0.023265,0.049881,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.31997,0.023159,0.16671,0,0
1,GO LOCOMOTOR RHYTHM,0.72299,0.023157,0.023473,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.35463,0.022978,0.038036,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.36098,0.02295,0.04076,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.28578,0.02291,0.063095,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.79075,0.022829,0.0096347,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.6055,0.022603,0.027219,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.35674,0.022518,0.059951,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.88245,0.022461,0.017537,0,0
1,GO CHROMOSOME ORGANIZATION,0.17669,0.022289,0.026436,0,0
1,GO GROWTH,0.21437,0.022166,0.057047,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.39832,0.022143,0.076113,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.51296,0.022131,-0.079157,0,0
1,GO NEURON PROJECTION REGENERATION,0.67501,0.02212,0.03924,0,0
1,GO RECEPTOR INTERNALIZATION,0.5,0.022111,0.041197,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.80953,0.022092,0.024181,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.71089,0.022062,0.025227,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.3739,0.021957,0.039114,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.9306,0.021937,0.0091934,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.64567,0.021883,0.045991,0,0
1,GO LIPID DROPLET ORGANIZATION,0.33803,0.021837,0.048458,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.6055,0.021716,0.027352,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.55558,0.021563,-0.050357,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.95316,0.021523,-0.027036,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.39381,0.021412,0.032075,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.64276,0.021404,0.025693,0,0
1,GO HISTONE H2A ACETYLATION,0.74741,0.021326,0.0018664,0,0
1,GO DNA REPLICATION CHECKPOINT,0.66616,0.021192,-0.024374,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.39156,0.021111,0.036964,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.36098,0.021096,0.088244,0,0
1,GO REGULATION OF MRNA PROCESSING,0.68988,0.020622,0.0075085,0,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.85376,0.020444,0.023894,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.84741,0.01986,0.014055,0,0
1,GO LACTATE METABOLIC PROCESS,0.45972,0.019837,0.045596,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.80326,0.019658,0.021847,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.33599,0.019315,0.095172,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.45238,0.019281,0.030589,0,0
1,GO RENAL SYSTEM PROCESS,0.98869,0.019231,0.027866,0,0
1,GO BLASTOCYST DEVELOPMENT,0.2644,0.019219,0.031904,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.57752,0.019208,0.015892,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.38933,0.019195,0.053145,0,0
1,GO PHOTOPERIODISM,0.67206,0.019032,0.01593,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.88245,0.019024,0.02598,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.21288,0.018997,0.066692,0,0
1,GO REGULATION OF RNA SPLICING,0.68094,0.018956,0.0062577,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.41434,0.018929,0.019507,0,0
1,GO DEVELOPMENTAL GROWTH,0.81581,0.018746,0.026901,0,0
1,GO DNA REPLICATION,0.15683,0.018723,0.028275,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.70486,0.018638,-0.050431,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.6055,0.018578,0.031304,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.99515,0.018563,-0.014226,0,0
1,GO SEX DIFFERENTIATION,0.57476,0.01853,0.028446,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.27495,0.018373,0.053143,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.90167,0.018284,0.01568,0,0
1,GO REGULATION OF TUBE SIZE,0.59986,0.01809,0.037843,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.318,0.018076,0.063613,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.66616,0.017923,0.02475,0,0
1,GO RESPONSE TO ACTIVITY,0.22971,0.017852,0.050142,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.24416,0.017651,0.016885,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.36098,0.017524,0.07203,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.30066,0.017204,0.057436,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.82211,0.017137,-0.0094926,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.98546,0.017046,0.0051391,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.31021,0.016873,0.031481,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.36741,0.016767,0.046235,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.64567,0.01672,-0.038422,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.27317,0.016388,0.086436,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.54746,0.016337,0.02206,0,0
1,GO REGULATION OF EXCRETION,0.95961,0.016257,-0.0039953,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.39832,0.015943,0.0095498,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,0.75356,0.015942,-0.0086564,0,0
1,GO CARBOHYDRATE TRANSPORT,0.85694,0.015933,0.013197,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.8379,0.01591,-0.0047297,0,0
1,GO RESPONSE TO ETHANOL,0.77519,0.015575,0.0056468,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.98869,0.015529,0.0061168,0,0
1,GO MANNOSYLATION,0.78763,0.015376,0.015325,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.16407,0.015286,0.10554,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.85059,0.015225,0.0033293,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.67501,0.015051,0.028701,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.76281,0.014965,0.026724,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.48976,0.014959,0.020065,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.84424,0.014852,-0.0096613,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.99515,0.014645,0.0075133,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.48468,0.014524,0.0091794,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.74435,0.014421,0.020543,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.30255,0.01436,0.09944,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.96607,0.014184,-0.020465,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.45238,0.01399,0.041716,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.97253,0.013899,0.016844,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.67501,0.013719,0.023389,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29877,0.01361,0.068857,0,0
1,GO CELLULAR HOMEOSTASIS,0.66616,0.013597,0.025361,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.54208,0.013499,0.043019,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.90488,0.013406,0.0048812,0,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.3871,0.013396,0.00036887,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.23445,0.013046,0.045594,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.89205,0.013024,-0.032058,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.74435,0.013008,0.023622,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.95316,0.012945,0.0054235,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.38488,0.012762,0.038681,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.73212,0.012629,0.03255,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.44028,0.012554,0.078426,0,0
1,GO CELLULAR RESPONSE TO PH,0.88245,0.012128,0.012402,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.85059,0.012059,-0.065898,0,0
1,GO ION HOMEOSTASIS,0.83474,0.012032,0.021262,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.88245,0.011969,0.014233,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.75356,0.011872,-0.01854,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.43312,0.011778,0.066256,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.23927,0.011757,0.11499,0,0
1,GO THYMUS DEVELOPMENT,0.68392,0.011751,0.031817,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.47712,0.011653,-0.029309,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.56376,0.011625,0.076406,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.60834,0.011597,0.024329,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.45482,0.011575,0.04672,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.96607,0.011439,-0.011559,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.98222,0.011167,0.017866,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.7814,0.011086,0.026262,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.92416,0.01088,0.0058657,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.90488,0.010771,0.00091443,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.38488,0.010762,0.086406,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.56925,0.010711,0.050876,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.20554,0.01068,0.098661,0,0
1,GO SEGMENTATION,0.66321,0.01053,0.035096,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.72907,0.010529,-0.0056347,0,0
1,GO CELL GROWTH,0.94348,0.010416,0.022483,0,0
1,GO MYELIN ASSEMBLY,0.41899,0.0099512,0.074038,0,0
1,GO EXIT FROM MITOSIS,0.99192,0.0099438,-0.0082646,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.74128,0.0098768,0.027016,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.39606,0.0097221,0.089603,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.50516,0.0095775,0.032741,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.61402,0.0094581,0.065248,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.70486,0.0094001,0.035253,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.47211,0.0091053,-0.032463,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.6691,0.0090521,-0.025292,0,0
1,GO RESPONSE TO CAMP,0.45238,0.0089979,0.05304,0,0
1,GO WATER TRANSPORT,0.84741,0.0089815,0.020365,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.39381,0.0089586,0.046712,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.66321,0.0088947,0.0030137,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.44994,0.0088494,0.073918,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.98222,0.0088415,-0.0064898,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.93382,0.0087768,-0.019922,0,0
1,GO HEART TRABECULA FORMATION,0.6312,0.0086791,0.066618,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.44752,0.0085647,0.038193,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.59986,0.0085398,0.045871,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.84424,0.0084682,0.012872,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.81267,0.0083979,0.0045425,0,0
1,GO TELOMERE CAPPING,0.75048,0.0083914,0.016248,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.82211,0.0083264,0.031905,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.72907,0.0082931,0.019027,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.76899,0.008185,-0.024674,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.2644,0.0075992,0.1333,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.85376,0.007391,0.027959,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.99515,0.0070818,0.0027536,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.46466,0.0070098,0.044956,0,0
1,GO KINETOCHORE ORGANIZATION,0.65442,0.0069549,-0.026491,0,0
1,GO RESPONSE TO LEAD ION,0.572,0.006901,0.044519,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.64276,0.0068994,0.040293,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.93382,0.0068229,0.026765,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.71693,0.0067992,0.022145,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.46962,0.0067911,0.044347,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.74128,0.0066941,0.018673,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.63408,0.0065293,-0.022957,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.72907,0.0060781,-0.030202,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.86968,0.006063,-0.0018344,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.79387,0.0059818,0.028903,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.13549,0.0058408,0.094962,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.71996,0.0056437,0.012916,0,0
1,GO DNA PACKAGING,0.91772,0.0054882,-0.022548,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.74435,0.0054252,0.0056478,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.47963,0.0053575,0.070158,0,0
1,GO MUSCLE SYSTEM PROCESS,0.5665,0.0053499,0.036172,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.85694,0.0053251,0.0080545,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.83158,0.005274,0.010639,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.9113,0.005242,0.010421,0,0
1,GO OXIDATIVE DEMETHYLATION,0.67206,0.005011,-0.021911,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.30446,0.0047907,0.068044,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.95316,0.0047469,0.01483,0,0
1,GO TOR SIGNALING,0.87606,0.0047095,0.020745,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.69885,0.0046452,0.032139,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.43312,0.0045363,0.044286,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.22814,0.0044298,0.052385,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.41203,0.0043959,-0.04611,0,0
1,GO GLUCOSE IMPORT,0.55558,0.0042578,0.035291,0,0
1,GO NEURON REMODELING,0.58307,0.0042239,-0.035444,0,0
1,GO FERTILIZATION,0.4451,0.0042153,-0.020301,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.50776,0.0041764,0.030055,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.25246,0.0040673,0.057743,0,0
1,GO PLASMA MEMBRANE ORGANIZATION,0.36526,0.004012,0.06776,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.98869,0.0039918,0.019807,0,0
1,GO G0 TO G1 TRANSITION,0.9306,0.0039789,-0.0040286,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.9113,0.0036595,0.012042,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.5665,0.0035384,0.044926,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.92416,0.0032568,-0.031117,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.3442,0.0027242,-0.042919,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.97899,0.002528,-0.026239,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.23128,0.0025077,-0.082939,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.98869,0.0023437,0.010808,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.90167,0.0020988,0.016445,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.52345,0.0019333,0.050062,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.94348,0.0019,0.004801,0,0
1,GO MULTI ORGANISM PROCESS,0.61117,0.0018923,0.024142,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.61402,0.001888,0.041356,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.91772,0.0018309,-0.0017254,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.76281,0.0018045,-0.026569,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.95639,0.001802,0.002538,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.38488,0.0017885,0.05267,0,0
1,GO T CELL LINEAGE COMMITMENT,0.52345,0.001764,0.049741,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.22195,0.0016644,-0.017319,0,0
1,GO SENSORY PERCEPTION OF TASTE,0.42838,0.0015903,0.0074483,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.67798,0.0015402,0.036176,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.40743,0.0013608,0.040498,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.64567,0.00097438,-0.0064657,0,0
1,GO OOGENESIS,0.48976,0.00081246,-0.031793,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.85376,0.00069435,0.0045026,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.44994,0.0003318,0.048007,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.64858,0.00017171,0.035748,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.85059,8.1573e-05,0.01619,0,0
1,GO CELL JUNCTION ASSEMBLY,0.89205,-1.5011e-05,0.011466,0,0
1,GO T CELL HOMEOSTASIS,0.63697,-0.00018594,-0.004059,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.98869,-0.00019891,0.063988,0,0
1,GO INOSITOL METABOLIC PROCESS,0.94671,-0.00024661,-9.9805e-05,0,0
1,GO THYROID GLAND DEVELOPMENT,0.97899,-0.00040771,-0.0067304,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.37173,-0.00043461,-0.014281,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.51035,-0.00056539,-0.0024993,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.62545,-0.00091012,0.026071,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.40514,-0.0009707,0.083916,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.62545,-0.0011431,0.024622,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.86649,-0.0013367,-0.012375,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.77519,-0.0013738,0.011378,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.82842,-0.0014259,0.0036883,0,0
1,GO RESPONSE TO SALT,0.77829,-0.0014331,-0.023378,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.54208,-0.0014436,0.0014817,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.79075,-0.0017163,0.021733,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.82211,-0.0019111,0.018347,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.89846,-0.0019651,0.033841,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.61117,-0.001995,-0.022111,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.76899,-0.0020552,-0.041691,0,0
1,GO ATP TRANSPORT,0.96284,-0.0020796,0.0036301,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.85059,-0.0022446,-0.0093518,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.86968,-0.0023367,0.01661,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.45972,-0.0024972,-0.050679,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.53672,-0.0025582,0.046777,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.52609,-0.0026327,0.064755,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.94026,-0.0026331,0.013228,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.55287,-0.0028385,0.049737,0,0
1,GO METAL ION HOMEOSTASIS,0.59986,-0.0031616,0.028104,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.90488,-0.003216,-0.0017301,0,0
1,GO NUCLEOSOME ORGANIZATION,0.87926,-0.0032268,-0.019283,0,0
1,GO GLIOGENESIS,0.95639,-0.0032271,0.013138,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.3871,-0.0032833,0.12184,0,0
1,GO STEROID CATABOLIC PROCESS,0.99192,-0.0033268,0.010546,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.76899,-0.0033854,-0.017075,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.77209,-0.0034354,0.00036863,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.48468,-0.0038473,0.050829,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.83158,-0.0038574,-0.023372,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.54208,-0.0039198,-0.031512,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.90488,-0.0045274,0.014811,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.42602,-0.0050295,-0.036516,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.12421,-0.0050785,-0.057964,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.5665,-0.0052702,-0.010522,0,0
1,GO MEMBRANE BIOGENESIS,0.44028,-0.0053985,0.069192,0,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.50258,-0.0056082,0.077286,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.71089,-0.0058929,0.018133,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.90488,-0.005932,-0.012536,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.50258,-0.0060529,0.051093,0,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.51035,-0.0061151,-0.056383,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.7659,-0.0061586,-0.0015536,0,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.66616,-0.0063332,0.031371,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.96607,-0.0063473,0.018509,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.6312,-0.0065344,0.026319,0,0
1,GO PROTEIN TRIMERIZATION,0.67501,-0.0066151,0.029915,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.68094,-0.0067638,0.001034,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.80953,-0.0068078,-0.010608,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.4451,-0.0068222,-0.021258,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.97253,-0.0068578,0.011111,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.70486,-0.0069961,-0.019459,0,0
1,GO CELL CYCLE DNA REPLICATION,0.797,-0.0071154,-0.051091,0,0
1,GO ENSHEATHMENT OF NEURONS,0.60834,-0.0072089,0.043539,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.97899,-0.0072672,-0.0029021,0,0
1,GO RESPONSE TO ZINC ION,0.90488,-0.0073632,0.0091935,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.87606,-0.0077909,0.017109,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.52345,-0.0078393,-0.017921,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.95316,-0.0079161,0.012385,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.60834,-0.0079323,0.036629,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.90809,-0.0082329,-0.0082325,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.6515,-0.0082404,-0.1341,0,0
1,GO REGULATION OF TOR SIGNALING,0.52345,-0.0082726,-0.0016006,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.46218,-0.0083926,0.077364,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.95639,-0.0084057,0.0088381,0,0
1,GO REGULATION OF PH,0.98222,-0.0084478,0.0078487,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.73212,-0.0084741,0.02254,0,0
1,GO MICROTUBULE NUCLEATION,0.81896,-0.0085707,-0.0020574,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.37827,-0.008764,-0.0089927,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.72603,-0.0089118,-0.020745,0,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.90167,-0.0090628,-0.0080795,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.80953,-0.0093005,0.020322,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.54477,-0.009328,-0.0484,0,0
1,GO ZINC ION HOMEOSTASIS,0.80639,-0.0094515,0.046154,0,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.26614,-0.0097418,-0.049466,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.81896,-0.0098264,-0.010449,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.61687,-0.0098387,-0.056578,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.52082,-0.0098562,-0.0163,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.20122,-0.0098637,-0.048602,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.60268,-0.0099132,-0.034016,0,0
1,GO DEPHOSPHORYLATION,0.72603,-0.0099834,0.0050818,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.37827,-0.0099996,0.056511,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.19278,-0.010031,0.10801,0,0
1,GO PROTEIN MANNOSYLATION,0.38488,-0.010062,-0.031583,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.6515,-0.010093,0.028385,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.29502,-0.010201,-0.075944,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.76899,-0.010337,0.027339,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.47211,-0.010385,-0.026912,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.60268,-0.010578,0.016909,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.68392,-0.010606,-0.0047029,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.76899,-0.010751,-0.0055268,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.86968,-0.010965,0.033509,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.82526,-0.010997,0.013259,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.97253,-0.011348,0.014506,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.55558,-0.011353,-0.022176,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.42133,-0.011684,-0.019662,0,0
1,GO RESPONSE TO STARVATION,0.32792,-0.011812,-0.009991,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.71391,-0.011957,0.0017447,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.55287,-0.01215,-0.034777,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.53406,-0.012231,-0.012725,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.46218,-0.012395,-0.0054419,0,0
1,GO SEXUAL REPRODUCTION,0.38267,-0.012427,-0.015544,0,0
1,GO MEIOTIC CELL CYCLE,0.5394,-0.012539,-0.038749,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.29877,-0.013009,-0.045605,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.23927,-0.013142,0.21433,0,0
1,GO MYOFIBRIL ASSEMBLY,0.39832,-0.01322,0.06498,0,0
1,GO SINGLE FERTILIZATION,0.31409,-0.013315,-0.026673,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.59986,-0.013426,-0.023387,0,0
1,GO PROTEIN ACETYLATION,0.32592,-0.01357,-0.022167,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.93382,-0.013775,0.020231,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.40973,-0.013949,-0.021699,0,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.45972,-0.01416,-0.014385,0,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.39606,-0.014207,0.11367,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.52874,-0.014428,-0.005722,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.63408,-0.014493,-0.046555,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.39381,-0.01452,-0.043397,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.70486,-0.014691,0.028145,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.44752,-0.014771,-0.040256,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.75048,-0.01515,0.035639,0,0
1,GO CAMP METABOLIC PROCESS,0.63408,-0.015308,0.075486,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.60268,-0.015406,-0.013235,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.6055,-0.015592,-0.059202,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.88245,-0.015819,0.010693,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.6055,-0.016024,0.039422,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.66028,-0.016125,-0.012683,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.87606,-0.016178,0.028073,0,0
1,GO DIOL METABOLIC PROCESS,0.74128,-0.01618,-0.024847,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.88885,-0.016385,0.021948,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.88565,-0.016493,0.023576,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.63986,-0.016541,0.0082708,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.77209,-0.016605,-0.0085331,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.41434,-0.016795,-0.045949,0,0
1,GO MUSCLE CONTRACTION,0.88245,-0.016835,0.013142,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.51296,-0.0169,-0.0097619,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.58307,-0.017106,0.038332,0,0
1,GO NUCLEOTIDE TRANSPORT,0.39832,-0.017196,-0.032669,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.56103,-0.017496,-0.0065198,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.68094,-0.017555,-0.015625,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.92738,-0.017607,0.012028,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.68689,-0.017675,0.029105,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.92094,-0.017752,0.01615,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.97899,-0.017845,0.026909,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.33599,-0.01796,-0.062478,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.95316,-0.01799,-0.0018037,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.65442,-0.018092,0.046512,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.62258,-0.01837,0.0036675,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.797,-0.018494,-0.0005452,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.61687,-0.018583,-0.027202,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.26964,-0.018689,-0.066674,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.32792,-0.01883,-0.0086837,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.76899,-0.018848,-0.016098,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.98546,-0.01897,0.01059,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.50776,-0.019076,-0.0042692,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.46713,-0.019206,-0.017479,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.73517,-0.01924,-0.00020837,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.95316,-0.019276,-0.0027188,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.95961,-0.019288,0.0081591,0,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.95316,-0.019314,-0.019916,0,0
1,GO CHEMICAL HOMEOSTASIS,0.70486,-0.019331,0.0029845,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.66028,-0.019365,0.023263,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.47712,-0.019456,-0.012493,0,0
1,GO DOSAGE COMPENSATION,0.75356,-0.019558,-0.0025747,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.74128,-0.019612,-0.0061907,0,0
1,GO DNA STRAND ELONGATION,0.66616,-0.019792,-0.071393,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.45238,-0.019893,-0.035444,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.44752,-0.019935,-0.015375,0,0
1,GO ALANINE TRANSPORT,0.37608,-0.019954,-0.044258,0,0
1,GO PROTEIN ACYLATION,0.073043,-0.020116,-0.040525,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.61972,-0.02033,-0.047237,0,0
1,GO MITOCHONDRIAL FISSION,0.35674,-0.02037,-0.030453,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.66616,-0.0205,0.051894,0,0
1,GO NOTCH SIGNALING PATHWAY,0.46466,-0.0205,-0.01522,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.3871,-0.020634,-0.043058,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.70185,-0.020699,-0.018948,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.22042,-0.020758,-0.029831,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.9306,-0.020914,0.0051131,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.1387,-0.020988,-0.092286,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.71391,-0.021114,-0.007615,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.96607,-0.021214,0.008765,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.55558,-0.021372,-0.040296,0,0
1,GO MAGNESIUM ION TRANSPORT,0.42367,-0.021571,-0.043884,0,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.63697,-0.021571,-0.00065463,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.80639,-0.021578,0.030386,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.27495,-0.021923,-0.031707,0,0
1,GO FUCOSE METABOLIC PROCESS,0.70486,-0.022334,-0.015269,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.36098,-0.022454,-0.033053,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.74128,-0.022671,0.0085905,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.3871,-0.022763,-0.043846,0,0
1,GO L AMINO ACID TRANSPORT,0.18327,-0.023025,-0.017331,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.6515,-0.023053,-0.012839,0,0
1,GO MICROTUBULE BASED PROCESS,0.22814,-0.023084,-0.036448,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.61972,-0.023367,-0.028494,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.61972,-0.023443,-0.0047094,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.87606,-0.023469,0.035045,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.75664,-0.023808,0.029391,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.22503,-0.024105,-0.022982,0,0
1,GO SISTER CHROMATID COHESION,0.87926,-0.02416,-0.031403,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.51819,-0.024191,0.070876,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.72907,-0.0244,0.0026871,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.59705,-0.024412,0.030547,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.23927,-0.024442,-0.1356,0,0
1,GO PARTURITION,0.61687,-0.02454,-0.03133,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.75048,-0.024596,0.0059569,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.61402,-0.024751,0.060086,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.35253,-0.024899,-0.02138,0,0
1,GO GAMETE GENERATION,0.52874,-0.025089,-0.012686,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.46466,-0.025106,-0.021545,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.68988,-0.025116,-0.033752,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.68988,-0.025168,-0.0040376,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.76899,-0.025188,0.024976,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.14197,-0.025215,-0.073273,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.25414,-0.025413,-0.085569,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.90167,-0.025525,0.041103,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.96607,-0.025621,0.018415,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.83474,-0.025718,0.0083262,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.68988,-0.025725,-0.0043773,0,0
1,GO PROSTAGLANDIN SECRETION,0.38933,-0.025772,0.050885,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.44269,-0.025805,0.083355,0,0
1,GO CHROMATIN SILENCING,0.68392,-0.025895,-0.016649,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.78763,-0.025955,0.035701,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.48722,-0.026114,0.043935,0,0
1,GO PHOSPHATE ION TRANSPORT,0.5,-0.026235,-0.0094794,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.96607,-0.026254,0.018442,0,0
1,GO MALE GAMETE GENERATION,0.38933,-0.026293,-0.020786,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.84107,-0.026395,0.0024836,0,0
1,GO MICROTUBULE SEVERING,0.32393,-0.026427,-0.040588,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.18595,-0.026432,-0.045328,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.38267,-0.026461,-0.036599,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.51819,-0.026594,-0.051675,0,0
1,GO RESPONSE TO LEPTIN,0.96284,-0.026748,0.023086,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.12822,-0.027141,-0.044191,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.85376,-0.027247,0.010745,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.59986,-0.027452,-0.019791,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.68392,-0.027561,-0.0080995,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.68988,-0.027732,0.097644,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.5,-0.027861,-0.012489,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.59424,-0.028144,0.037321,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.25246,-0.028149,-0.049907,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.21738,-0.028239,-0.057051,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.54477,-0.028431,-0.019545,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.78763,-0.028534,0.014993,0,0
1,GO ANIMAL ORGAN MATURATION,0.60834,-0.028581,0.040801,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.52609,-0.028643,-0.0054538,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.47461,-0.028911,-0.06178,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.50776,-0.028993,-0.0034604,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.29502,-0.029283,-0.038299,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.86968,-0.029392,0.01615,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.52345,-0.029551,-0.017994,0,0
1,GO MEMBRANE FUSION,0.318,-0.029553,-0.02118,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.63697,-0.029569,0.063288,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.36311,-0.029681,-0.03556,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.43312,-0.02973,-0.053929,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.1793,-0.030061,-0.065126,0,0
1,GO LYSOSOME LOCALIZATION,0.68988,-0.030492,-0.0017096,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.76899,-0.030766,-0.01446,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.19979,-0.030866,-0.028499,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.42367,-0.030913,-0.012455,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.67798,-0.031095,-0.010781,0,0
1,GO NEURON DEATH,0.12822,-0.031473,-0.027651,0,0
1,GO ORGANELLE LOCALIZATION,0.13338,-0.031585,-0.022389,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.94026,-0.031784,0.017394,0,0
1,GO REGULATION OF CELLULAR PH,0.98546,-0.031844,0.0084916,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.76899,-0.031851,-0.0035315,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.95316,-0.032125,0.0071054,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.16654,-0.032143,-0.14656,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.90488,-0.032168,0.029755,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.89205,-0.032185,0.025176,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.34627,-0.032252,-0.016195,0,0
1,GO AXON EXTENSION,0.54477,-0.032604,-0.016042,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.44269,-0.032624,-0.020433,0,0
1,GO CELL RECOGNITION,0.23445,-0.032748,-0.029726,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.12721,-0.032909,-0.032881,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.58029,-0.032962,-0.030265,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.92738,-0.033127,0.042844,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.70486,-0.033207,0.0032845,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.11183,-0.033266,-0.083016,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.39606,-0.03337,-0.043098,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.77829,-0.033395,0.018022,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.19979,-0.033835,-0.059931,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.59705,-0.033917,-0.036826,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.60268,-0.033951,0.012249,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.55287,-0.033991,-0.0083141,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.83474,-0.034043,-0.0083497,0,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.035336,-0.034063,-0.081437,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.97899,-0.034229,0.023388,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.24416,-0.034244,-0.044714,0,0
1,GO KERATINIZATION,0.94026,-0.034646,0.0017839,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.51557,-0.034738,-0.0087073,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.45238,-0.034837,-0.021943,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.66321,-0.034838,-0.0031526,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.31215,-0.035055,-0.026287,0,0
1,GO MITOCHONDRIAL FUSION,0.63408,-0.035329,-0.00085878,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.61402,-0.035469,-0.0037015,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.82211,-0.035781,0.0087775,0,0
1,GO INORGANIC ANION TRANSPORT,0.31409,-0.035962,-0.015752,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.54477,-0.036215,-0.013275,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.74128,-0.036268,0.060683,0,0
1,GO LYMPH NODE DEVELOPMENT,0.42367,-0.036471,-0.010643,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.72603,-0.03674,0.0046904,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.32792,-0.037072,-0.027145,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.53406,-0.037256,-0.050826,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.8379,-0.037445,0.0050667,0,0
1,GO HISTONE METHYLATION,0.39606,-0.037586,-0.029364,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.48215,-0.037609,0.00064383,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.23605,-0.037674,-0.038854,0,0
1,GO RESPONSE TO COLD,0.24252,-0.037699,-0.048718,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.087731,-0.037704,-0.065329,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.41434,-0.037841,-0.03866,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15802,-0.038255,-0.12245,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.33803,-0.038525,-0.0197,0,0
1,GO VASODILATION,0.2913,-0.038683,-0.074775,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.55558,-0.038871,-0.0035728,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.81896,-0.038908,0.01008,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.56925,-0.039168,-0.029892,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.18866,-0.039203,-0.02787,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.60834,-0.039282,0.001138,0,0
1,GO NUCLEOSOME ASSEMBLY,0.51035,-0.039563,-0.05832,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.58585,-0.039605,-0.014806,0,0
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.24252,-0.039808,0.12297,0,0
1,GO FILOPODIUM ASSEMBLY,0.5665,-0.040094,-0.015595,0,0
1,GO RESPONSE TO ETHER,0.67798,-0.040119,-0.03727,0,0
1,GO PEPTIDYL LYSINE METHYLATION,0.48468,-0.040164,-0.031007,0,0
1,GO SOMITOGENESIS,0.40973,-0.040176,-0.013876,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.87606,-0.040371,0.012532,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.74741,-0.040625,-0.042087,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.14088,-0.040697,-0.075158,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.33803,-0.04094,-0.023282,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.13979,-0.041001,-0.02996,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.18461,-0.041383,-0.034258,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.58029,-0.041632,-0.052608,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.23927,-0.041709,-0.042186,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.42133,-0.041892,-0.026869,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.63697,-0.042117,-0.024546,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.3871,-0.042152,-0.05741,0,0
1,GO VESICLE LOCALIZATION,0.36741,-0.042168,-0.0069757,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.58864,-0.042287,-0.01683,0,0
1,GO HISTONE H3 K9 METHYLATION,0.32993,-0.042411,-0.0294,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.66028,-0.042818,-0.011724,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.18194,-0.043099,-0.060687,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.21889,-0.043107,-0.04383,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.45972,-0.043123,-0.061958,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.15921,-0.043214,-0.036241,0,0
1,GO SOMITE DEVELOPMENT,0.16904,-0.043216,-0.043399,0,0
1,GO HISTONE H3 K4 METHYLATION,0.40058,-0.043358,-0.064195,0,0
1,GO PROTEIN DEMETHYLATION,0.35253,-0.043539,-0.037048,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.65442,-0.043912,-0.0023018,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.52345,-0.043971,-0.023216,0,0
1,GO POLYOL CATABOLIC PROCESS,0.26789,-0.044008,-0.052369,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.20122,-0.044255,-0.017698,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.1653,-0.044473,-0.057698,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.25924,-0.044584,-0.043743,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.27317,-0.044618,-0.034016,0,0
1,GO REGULATION OF GLIOGENESIS,0.2114,-0.044711,-0.043501,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.40058,-0.044925,-0.017816,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.56376,-0.045314,-0.019583,0,0
1,GO CELL MORPHOGENESIS,0.28033,-0.045316,-0.018163,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.7659,-0.045332,0.0016605,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.40973,-0.045442,-0.051529,0,0
1,GO OOCYTE MATURATION,0.54477,-0.045564,-0.042593,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51819,-0.046231,-0.02291,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.57476,-0.046711,-0.0098975,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.46962,-0.046784,-0.047796,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.3871,-0.046801,-0.035335,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.32195,-0.047454,-0.035429,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.2114,-0.048149,-0.038069,0,0
1,GO THYMIC T CELL SELECTION,0.59986,-0.04825,0.0014711,0,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.1453,-0.048314,-0.077563,0,0
1,GO EAR MORPHOGENESIS,0.70486,-0.048571,-0.014763,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.40058,-0.048784,-0.019509,0,0
1,GO REGULATION OF FERTILIZATION,0.22042,-0.049062,-0.056472,0,0
1,GO GERM CELL DEVELOPMENT,0.11553,-0.049145,-0.048991,0,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.9113,-0.049185,0.014353,0,0
1,GO PENILE ERECTION,0.50258,-0.049191,-0.047044,0,0
1,GO RESPONSE TO CAFFEINE,0.56376,-0.04941,-0.010879,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.40286,-0.049555,-0.056348,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.26095,-0.049778,-0.04034,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.1793,-0.04988,-0.084612,0,0
1,GO MYELIN MAINTENANCE,0.69885,-0.049922,-0.016816,0,0
1,GO HISTONE H4 ACETYLATION,0.099614,-0.050111,-0.051349,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.94671,-0.050251,0.038553,0,0
1,GO ZINC ION TRANSPORT,0.92416,-0.050336,0.031348,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.92094,-0.050369,0.021939,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.13234,-0.050435,-0.089757,0,0
1,GO RESPONSE TO FUNGUS,0.22042,-0.050638,-0.064933,0,0
1,GO RESPONSE TO REDOX STATE,0.9693,-0.050647,0.013064,0,0
1,GO PROTEIN METHYLATION,0.27495,-0.050691,-0.037125,0,0
1,GO MAST CELL ACTIVATION,0.61972,-0.05101,-0.025676,0,0
1,GO DEMETHYLATION,0.89846,-0.051617,0.013186,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.086981,-0.05163,-0.06736,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.69885,-0.051694,-0.020023,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.55287,-0.051926,-0.035338,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.52609,-0.052124,0.00045782,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.45238,-0.052159,-0.014696,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.23445,-0.052292,-0.12244,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.91772,-0.052394,0.016858,0,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.15802,-0.05253,-0.057642,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.15214,-0.052683,-0.072417,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.089246,-0.05276,-0.060603,0,0
1,GO BILE ACID METABOLIC PROCESS,0.78451,-0.052919,-0.010819,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.67798,-0.052929,-0.011568,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.69885,-0.053066,-0.019142,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.13234,-0.05315,-0.035887,0,0
1,GO DIGESTION,0.21738,-0.053185,-0.061364,0,0
1,GO T CELL SELECTION,0.75048,-0.053368,0.015446,0,0
1,GO SPERM CAPACITATION,0.23927,-0.053587,-0.055532,0,0
1,GO GDP METABOLIC PROCESS,0.41203,-0.05368,-0.060766,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.090011,-0.053858,-0.054009,0,0
1,GO EXCRETION,0.28033,-0.053892,-0.028991,0,0
1,GO CELL FATE COMMITMENT,0.029754,-0.054109,-0.085668,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.64567,-0.054481,-0.029031,0,0
1,GO PHAGOSOME MATURATION,0.99838,-0.054562,0.018354,0,0
1,GO FORELIMB MORPHOGENESIS,0.75664,-0.054575,-0.013516,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.089246,-0.05466,-0.079026,0,0
1,GO MITOTIC DNA REPLICATION,0.58307,-0.055045,-0.058032,0,0
1,GO METANEPHROS MORPHOGENESIS,0.14308,-0.05544,-0.085547,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.19838,-0.055446,-0.034905,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.47963,-0.055753,-0.0095942,0,0
1,GO HISTONE H3 K36 METHYLATION,0.72603,-0.0559,-0.020476,0,0
1,GO AXIS SPECIFICATION,0.35043,-0.0559,-0.036754,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.66321,-0.055976,-0.023985,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.94993,-0.056126,0.007634,0,0
1,GO ANION TRANSPORT,0.21437,-0.056228,-0.021041,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.45727,-0.056905,-0.038936,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.17411,-0.057455,-0.069871,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.20992,-0.057488,-0.055613,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.048285,-0.057524,-0.050904,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.318,-0.057533,-0.037995,0,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.18866,-0.058188,-0.13327,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.082591,-0.058223,-0.0524,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.57476,-0.058657,-0.0032438,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.22503,-0.058865,-0.04838,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.77519,-0.05918,0.014307,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.52345,-0.059314,-0.01592,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.064418,-0.059724,-0.075069,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.34008,-0.059812,-0.01799,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.12224,-0.059829,-0.092,0,0
1,GO STEROID HORMONE SECRETION,0.76899,-0.05998,-0.020144,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.14642,-0.060091,-0.033612,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.15921,-0.060341,-0.041796,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.27673,-0.060421,0.037188,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.21288,-0.060482,-0.047915,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.16042,-0.060585,-0.1574,0,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.1252,-0.060616,-0.049231,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.77209,-0.060943,0.04569,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.37173,-0.060979,-0.033016,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.25753,-0.061031,-0.07751,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.14755,-0.061048,-0.041869,0,0
1,GO PHOTOTRANSDUCTION,0.27495,-0.061561,0.033823,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.16285,-0.061576,-0.043569,0,0
1,GO DIET INDUCED THERMOGENESIS,0.34213,-0.062048,-0.052113,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.61402,-0.062303,-0.014096,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.4355,-0.062318,-0.043206,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.49231,-0.062659,-0.024181,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.56925,-0.062746,-0.063382,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.98869,-0.063008,0.0086907,0,0
1,GO OOCYTE DIFFERENTIATION,0.052575,-0.063461,-0.077785,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.1262,-0.063802,-0.06994,0,0
1,GO BRAIN MORPHOGENESIS,0.1793,-0.06381,-0.069457,0,0
1,GO RESPONSE TO AXON INJURY,0.53406,-0.064599,-0.013824,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.5,-0.064606,-0.056174,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.23605,-0.064727,-0.048958,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.077698,-0.064815,-0.045844,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.14983,-0.064841,-0.024288,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.19557,-0.065099,-0.057941,0,0
1,GO ORGANIC ANION TRANSPORT,0.24911,-0.065789,-0.020567,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.16778,-0.065851,-0.045207,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.70787,-0.065906,0.036982,0,0
1,GO CILIUM ORGANIZATION,0.2644,-0.066163,-0.034624,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.28213,-0.066488,-0.052444,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.797,-0.067214,-0.013815,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.26964,-0.067442,-0.066717,0,0
1,GO SPERM MOTILITY,0.10823,-0.067632,-0.059927,0,0
1,GO VASCULAR WOUND HEALING,0.38047,-0.067751,-0.06135,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.068619,-0.067791,-0.057739,0,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.073694,-0.067943,-0.074452,0,0
1,GO RESPONSE TO METAL ION,0.087731,-0.068106,-0.036364,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.24089,-0.068581,-0.023147,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.1453,-0.068586,-0.038267,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.062684,-0.068619,-0.10625,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.29877,-0.069017,-0.026424,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.085497,-0.069113,-0.038438,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.51557,-0.069396,-0.083151,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.58585,-0.070204,0.0040575,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.36526,-0.070314,-0.042254,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.046921,-0.070498,-0.12527,0,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.68988,-0.070771,-0.010439,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.87926,-0.070787,-0.0066546,0,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.32592,-0.070927,-0.094787,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.17156,-0.070946,-0.043318,0,0
1,GO CELL PROJECTION ORGANIZATION,0.026286,-0.071021,-0.049807,0,0
1,GO NEURON APOPTOTIC PROCESS,0.020828,-0.071201,-0.061366,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.49231,-0.07163,-0.025326,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.19697,-0.071667,-0.057536,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.13656,-0.072108,-0.10213,0,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.079071,-0.072669,-0.12217,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.78763,-0.072862,0.0070348,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.34008,-0.074063,-0.043348,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.86649,-0.074242,0.030818,0,0
1,GO MEMBRANE DOCKING,0.011544,-0.074471,-0.070086,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.27673,-0.07506,-0.036898,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.57476,-0.075158,-0.012118,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.3871,-0.075601,-0.022761,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.09714,-0.075769,-0.062008,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.24089,-0.075903,-0.063094,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.54746,-0.076491,-0.041949,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.24089,-0.076544,-0.079953,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.46466,-0.076584,-0.053877,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.081877,-0.076631,0.015657,0,0
1,GO PH REDUCTION,0.13656,-0.076763,-0.045021,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.14419,-0.076961,-0.071576,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0096941,-0.077442,-0.078445,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.090782,-0.07785,-0.10701,0,0
1,GO UTERUS DEVELOPMENT,0.23605,-0.078588,-0.066488,0,0
1,GO FEVER GENERATION,0.45727,-0.078723,-0.044034,0,0
1,GO NEUROBLAST PROLIFERATION,0.10129,-0.078851,-0.086901,0,0
1,GO RESPONSE TO EPINEPHRINE,0.572,-0.078941,-0.046561,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.39832,-0.079199,-0.037707,0,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.19697,-0.079277,-0.068778,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.23286,-0.079421,-0.041867,0,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.09796,-0.07944,-0.063116,0,0
1,GO POSITIVE T CELL SELECTION,0.71693,-0.07958,0.0034273,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.087731,-0.079883,-0.095021,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.11367,-0.079953,-0.060199,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.33396,-0.080096,-0.05459,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.29689,-0.080114,-0.051051,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.049681,-0.080213,-0.099824,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.26095,-0.080565,-0.063732,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.49487,-0.080658,0.066973,0,0
1,GO AUTOPHAGIC CELL DEATH,0.26964,-0.080673,-0.037707,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.079071,-0.080971,-0.037954,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.37608,-0.081007,-0.058899,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.91772,-0.081711,0.03268,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.12721,-0.082412,-0.097766,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.44752,-0.083021,-0.030171,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.46962,-0.083289,-0.10171,0,0
1,GO EAR DEVELOPMENT,0.081168,-0.083327,-0.073667,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.22348,-0.083578,-0.039117,0,0
1,GO TORC1 SIGNALING,0.19979,-0.08431,-0.029806,0,0
1,GO CGMP MEDIATED SIGNALING,0.14869,-0.084529,-0.068416,0,0
1,GO SHORT TERM MEMORY,0.76281,-0.084581,0.033174,0,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.08331,-0.084584,-0.12685,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.21437,-0.085416,-0.048713,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.27853,-0.085649,-0.039429,0,0
1,GO CELL JUNCTION ORGANIZATION,0.075674,-0.085957,-0.049449,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.48722,-0.086187,-0.022387,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.024687,-0.086365,-0.061575,0,0
1,GO REGULATION OF NEURON MIGRATION,0.094715,-0.086815,-0.1003,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.0035605,-0.086871,-0.11281,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.30637,-0.087671,-0.067009,0,0
1,GO EXPLORATION BEHAVIOR,0.12721,-0.088697,-0.11796,0,0
1,GO RESPONSE TO GLUCAGON,0.058247,-0.089435,-0.072249,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.086237,-0.08984,-0.081028,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.18866,-0.090091,-0.053021,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.46466,-0.090192,-0.050227,0,0
1,GO CYTOPLASM ORGANIZATION,0.69586,-0.090432,0.098225,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.10558,-0.09199,-0.13507,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.4451,-0.092083,-0.030562,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.96284,-0.092414,0.015024,0,0
1,GO HISTONE H4 K16 ACETYLATION,0.11367,-0.092475,-0.069442,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.086981,-0.0926,-0.071813,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.40514,-0.09302,-0.045148,0,0
1,GO CILIUM MOVEMENT,0.14983,-0.093119,-0.061097,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.19003,-0.093139,-0.059663,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.74435,-0.093684,-0.020116,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.7814,-0.093684,0.012672,0,0
1,GO INTESTINAL ABSORPTION,0.46218,-0.094049,-0.040706,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.68094,-0.094108,0.0010009,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.081877,-0.094472,-0.054807,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.38933,-0.094514,-0.018282,0,0
1,GO INNER EAR MORPHOGENESIS,0.42133,-0.09469,-0.038166,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.031311,-0.094856,-0.070114,0,0
1,GO FUCOSYLATION,0.11275,-0.095306,-0.060277,0,0
1,GO DIGESTIVE SYSTEM PROCESS,0.30066,-0.095313,-0.044904,0,0
1,GO DEVELOPMENTAL INDUCTION,0.15447,-0.095567,-0.061198,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.25078,-0.095629,-0.07588,0,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.10471,-0.09568,-0.11758,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.047372,-0.095955,-0.11063,0,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0024281,-0.096283,-0.1171,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.3739,-0.096296,-0.034822,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.17411,-0.096908,-0.048618,0,0
1,GO PROTEIN KINASE C SIGNALING,0.1252,-0.097122,-0.079825,0,0
1,GO REGULATION OF CELL MATURATION,0.32195,-0.097549,-0.04982,0,0
1,GO REGIONALIZATION,0.17156,-0.09761,-0.051249,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.99515,-0.097734,0.011423,0,0
1,GO RESPONSE TO PAIN,0.17283,-0.098281,-0.07726,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.08331,-0.098429,-0.075865,0,0
1,GO WATER HOMEOSTASIS,0.1914,-0.099008,-0.057296,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.22814,-0.099244,-0.080805,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.12924,-0.099425,-0.072238,0,0
1,GO DEVELOPMENTAL CELL GROWTH,0.0026663,-0.099806,-0.10258,0,0
1,GO SPERMATID DIFFERENTIATION,0.12822,-0.10014,-0.051214,0,0
1,GO ACTIN CROSSLINK FORMATION,0.13549,-0.1002,-0.11629,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.042609,-0.1003,-0.10878,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0074579,-0.10103,-0.083852,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.59705,-0.10122,0.014044,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10214,-0.10224,-0.073393,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.10734,-0.10261,-0.089923,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.42133,-0.10267,-0.048813,0,0
1,GO DETECTION OF LIGHT STIMULUS,0.0056255,-0.10341,-0.02654,0,0
1,GO MICROTUBULE POLYMERIZATION,0.0021798,-0.10397,-0.12856,0,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.11275,-0.10415,-0.04196,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.1313,-0.10441,-0.072001,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.33599,-0.10463,-0.040457,0,0
1,GO LONG TERM MEMORY,0.051111,-0.10483,-0.084959,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.31021,-0.10484,-0.055668,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.086981,-0.10508,-0.042268,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.27495,-0.1051,-0.038446,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.093126,-0.10598,-0.084272,0,0
1,GO CARTILAGE MORPHOGENESIS,0.37608,-0.10602,-0.027404,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.077018,-0.10617,-0.11504,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.24252,-0.10636,-0.043125,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.25414,-0.10661,-0.053794,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.10558,-0.10698,-0.070878,0,0
1,GO REGULATION OF OOGENESIS,0.018693,-0.10741,-0.084952,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.15921,-0.10778,-0.097177,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.36956,-0.10778,-0.035316,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.069238,-0.10826,-0.078949,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0080166,-0.10831,-0.08082,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.10385,-0.10911,-0.14806,0,0
1,GO GLUTAMATE METABOLIC PROCESS,0.070488,-0.10939,-0.066096,0,0
1,GO HAIR CELL DIFFERENTIATION,0.31604,-0.10976,-0.049255,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.28395,-0.1098,-0.052457,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.35043,-0.10984,-0.077383,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.11275,-0.11035,-0.060729,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.47211,-0.11045,-0.017114,0,0
1,GO REGULATION OF ACROSOME REACTION,0.068006,-0.11078,-0.1224,0,0
1,GO NEUROGENESIS,0.0019285,-0.11142,-0.093462,0,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.037139,-0.11174,-0.067724,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.073694,-0.11185,-0.078417,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.55016,-0.11204,-0.006347,0,0
1,GO ADULT HEART DEVELOPMENT,0.18461,-0.11248,-0.062119,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.26964,-0.11254,-0.058806,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.40973,-0.11284,-0.035724,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.095518,-0.11293,-0.065876,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.19838,-0.11326,-0.07713,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.51296,-0.11515,-0.02306,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.021973,-0.11553,-0.11987,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.036772,-0.11583,-0.074272,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.17156,-0.11587,-0.056253,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.077698,-0.11673,-0.075694,0,0
1,GO GENETIC IMPRINTING,0.28033,-0.11716,-0.02537,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.21587,-0.11792,-0.079691,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0012005,-0.11909,-0.13637,0,0
1,GO RECEPTOR CLUSTERING,0.023173,-0.1191,-0.11937,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.048285,-0.11947,-0.092302,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.23927,-0.11958,-0.05066,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.035691,-0.11967,-0.10318,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.073043,-0.12003,-0.16353,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.015501,-0.12014,-0.20845,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.024428,-0.12125,-0.092462,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.24911,-0.1215,-0.03843,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0069343,-0.12153,-0.091437,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.0014624,-0.12249,-0.10795,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.11647,-0.12253,-0.089078,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.086237,-0.12365,-0.094571,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.077018,-0.12381,-0.080709,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.58307,-0.12382,-0.048724,0,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.090011,-0.12408,-0.097612,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0052854,-0.12417,-0.13782,0,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0018764,-0.12442,-0.13406,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.40286,-0.12457,-0.01089,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.098784,-0.12545,-0.058559,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.39156,-0.12551,-0.070167,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.28395,-0.12648,-0.1512,0,0
1,GO RESPONSE TO INTERLEUKIN 2,0.48976,-0.12662,-0.024665,0,0
1,GO INTRACILIARY TRANSPORT,0.076344,-0.12697,-0.10254,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.035691,-0.1271,-0.14176,0,0
1,GO RENAL WATER HOMEOSTASIS,0.22814,-0.12811,-0.034149,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.2913,-0.12881,-0.018777,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.096327,-0.12895,-0.072731,0,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.03902,-0.1293,-0.10606,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.28213,-0.1299,-0.047243,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.19557,-0.13028,-0.099624,0,0
1,GO SEX DETERMINATION,0.024428,-0.13046,-0.13698,0,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.09796,-0.13163,-0.08752,0,0
1,GO CARDIAC CHAMBER FORMATION,0.12924,-0.13255,-0.11521,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.54746,-0.13413,-0.089621,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.025743,-0.1345,-0.1201,0,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.00094089,-0.13632,-0.12027,0,0
1,GO DETECTION OF VISIBLE LIGHT,0.0015249,-0.13654,-0.047869,0,0
1,GO PROTEIN DEPOLYMERIZATION,0.00013451,-0.1374,-0.12549,0,0
1,GO FOREBRAIN CELL MIGRATION,0.0026663,-0.13744,-0.1444,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.15447,-0.13951,-0.098771,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.1754,-0.13954,-0.098001,0,0
1,GO HISTONE H4 K5 ACETYLATION,0.027401,-0.14011,-0.12802,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.040582,-0.1402,-0.076079,0,0
1,GO AXON DEVELOPMENT,0.0045438,-0.14048,-0.10879,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.016386,-0.14093,-0.10534,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.39381,-0.14134,-0.031467,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.087731,-0.14137,-0.088273,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.095518,-0.1417,-0.095348,0,0
1,GO NEURON DIFFERENTIATION,0.00024045,-0.14251,-0.12366,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.1252,-0.14279,-0.087129,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.22971,-0.14296,-0.056259,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.075009,-0.143,-0.12897,0,0
1,GO LIPOXYGENASE PATHWAY,0.26789,-0.14325,-0.10167,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010279,-0.14378,-0.10952,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.9306,-0.14463,-0.062466,0,0
1,GO SPERM AXONEME ASSEMBLY,0.081168,-0.14575,-0.10236,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.14983,-0.14614,-0.075809,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0022701,-0.14629,-0.15466,0,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.0010865,-0.14668,-0.15946,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00075607,-0.14925,-0.1221,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.080464,-0.14986,-0.09527,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.029754,-0.14986,-0.08778,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.95961,-0.14998,0.037027,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.012945,-0.15076,-0.1429,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.0044864,-0.15136,-0.15484,0,0
1,GO VISUAL BEHAVIOR,0.00030449,-0.15264,-0.12499,0,0
1,GO HEART FORMATION,0.050154,-0.15318,-0.12195,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.10471,-0.15346,-0.065502,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.7172e-05,-0.15424,-0.19853,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.31215,-0.15504,-0.086305,0,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0026663,-0.15601,-0.12512,0,0
1,GO NEURON DEVELOPMENT,0.00015083,-0.15648,-0.13035,0,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0001862,-0.15746,-0.14639,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0047198,-0.15827,-0.1225,0,0
1,GO RHYTHMIC BEHAVIOR,0.0023637,-0.15944,-0.1323,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.020166,-0.15977,-0.11191,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00096848,-0.16001,-0.16234,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0083098,-0.16167,-0.11689,0,0
1,GO COCHLEA DEVELOPMENT,0.0025277,-0.16169,-0.15925,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0020092,-0.16173,-0.15725,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.11183,-0.1627,-0.10896,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.011544,-0.1643,-0.12488,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.0023637,-0.16469,-0.15456,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.39832,-0.16511,-0.086489,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0029645,-0.16568,-0.17442,0,0
1,GO MALE SEX DETERMINATION,0.030994,-0.16623,-0.16613,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.027973,-0.16635,-0.13737,0,0
1,GO COPULATION,0.1313,-0.16656,-0.079651,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.1252,-0.16701,-0.11774,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00030449,-0.16722,-0.13831,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.019312,-0.16825,-0.103,0,0
1,GO CELL JUNCTION MAINTENANCE,0.01016,-0.1684,-0.13702,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.00024819,-0.16877,-0.1823,0,0
1,GO MATING BEHAVIOR,0.00048316,-0.16898,-0.1653,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,3.5646e-05,-0.17141,-0.19474,0,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.0030839,-0.17156,-0.14722,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.00065224,-0.17176,-0.15342,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.00159,-0.17472,-0.13932,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0016575,-0.17513,-0.17698,0,0
1,GO SLEEP,0.00017457,-0.17607,-0.17672,0,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.089246,-0.17745,-0.11797,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00013016,-0.17758,-0.2085,0,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,6.1119e-05,-0.1776,-0.16397,0,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.000662,-0.17793,-0.176,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,9.9844e-05,-0.1781,-0.17174,0,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.093126,-0.17876,-0.11193,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.61402,-0.18139,-0.035996,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.00036124,-0.18205,-0.16819,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0062877,-0.1827,-0.13263,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.016027,-0.18386,-0.14041,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.35674,-0.1845,-0.058663,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.048285,-0.18527,-0.084996,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.021053,-0.18812,-0.13157,0,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00047589,-0.18825,-0.16807,0,0
1,GO REPRODUCTIVE BEHAVIOR,1.3196e-05,-0.18833,-0.20141,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.30446,-0.18874,-0.13868,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0042095,-0.18981,-0.18574,0,0
1,GO MALE MEIOSIS I,0.0027381,-0.19332,-0.2238,0,0
1,GO TUBULIN DEACETYLATION,0.0001862,-0.19352,-0.22317,0,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.03068,-0.19403,-0.12762,0,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,2.4091e-05,-0.19407,-0.1731,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.0032078,-0.1942,-0.18766,0,0
1,GO CELL FATE DETERMINATION,0.00099681,-0.19445,-0.18085,0,0
1,GO MITOCHONDRION LOCALIZATION,1.1806e-05,-0.19506,-0.20729,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.00012186,-0.19706,-0.16397,0,0
1,GO PROTEIN POLYGLUTAMYLATION,1.0169e-05,-0.19739,-0.25556,0,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,3.8347e-06,-0.19748,-0.20573,0,0
1,GO FAT CELL PROLIFERATION,0.0012005,-0.199,-0.21764,0,0
1,GO CELL FATE SPECIFICATION,0.00010152,-0.2025,-0.22882,0,0
1,GO STRIATUM DEVELOPMENT,0.00012594,-0.20449,-0.22472,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00018323,-0.20554,-0.18126,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0025961,-0.20629,-0.16169,0,0
1,GO PANCREAS DEVELOPMENT,0.001776,-0.21179,-0.1506,0,0
1,GO NEUROMUSCULAR PROCESS,2.2015e-05,-0.21457,-0.18718,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0047798,-0.21788,-0.1826,0,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0027747,-0.21874,-0.21324,0,0
1,GO PARENTAL BEHAVIOR,0.0032501,-0.22091,-0.2114,0,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00030449,-0.22779,-0.20728,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.10214,-0.22954,-0.12446,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,2.8814e-05,-0.23726,-0.22664,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,3.4409e-05,-0.23739,-0.19298,0,0
1,GO CELL MIGRATION IN HINDBRAIN,0.00064263,-0.24346,-0.21512,0,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00015083,-0.24961,-0.27166,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.029754,-0.2498,-0.25031,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.15802,-0.25176,-0.08099,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.11183,-0.25521,-0.13661,0,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,4.7999e-05,-0.25575,-0.23539,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00094089,-0.26187,-0.26428,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.0067673,-0.26188,-0.17802,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00021511,-0.2638,-0.24324,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.0005133,-0.2647,-0.23897,0,0
1,GO AMINO ACID TRANSPORT,4.5233e-07,-0.26515,-0.20918,0,0
1,GO SEGMENT SPECIFICATION,0.0033361,-0.27425,-0.22509,0,0
1,GO VESICLE DOCKING,3.1479e-07,-0.27465,-0.21116,0,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.8262e-07,-0.27567,-0.21687,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,9.3381e-05,-0.27614,-0.2457,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,9.2585e-06,-0.27722,-0.26746,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00015838,-0.28053,-0.2991,0,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.003607,-0.28926,-0.18961,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,2.7614e-08,-0.29541,-0.26105,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0069343,-0.29885,-0.20758,0,0
1,GO SYNAPTIC VESICLE RECYCLING,2.5756e-08,-0.30211,-0.30085,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0029645,-0.30935,-0.26648,0,0
1,GO HEART INDUCTION,0.063836,-0.31207,-0.14925,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,3.8924e-05,-0.31249,-0.27547,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00040235,-0.31297,-0.2482,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,5.3747e-08,-0.32387,-0.33385,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,1.0557e-05,-0.33113,-0.39931,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,8.7502e-06,-0.33117,-0.28042,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,5.3647e-09,-0.33712,-0.30824,0,0
1,GO DIENCEPHALON DEVELOPMENT,1.9926e-08,-0.33967,-0.3432,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,6.895e-08,-0.34872,-0.3407,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.7687e-09,-0.3545,-0.32673,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,1.4454e-06,-0.35541,-0.34697,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,1.1316e-06,-0.37345,-0.36103,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,2.4861e-06,-0.37381,-0.39541,0,0
1,GO HEART FIELD SPECIFICATION,0.00159,-0.38567,-0.30106,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,6.8396e-06,-0.39167,-0.443,0,0
1,GO RETINA LAYER FORMATION,2.8305e-05,-0.39476,-0.41888,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,4.719e-07,-0.40515,-0.41997,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.00022208,-0.41995,-0.41577,0,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0018006,-0.42021,-0.23607,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,5.1356e-08,-0.42545,-0.39726,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,5.3562e-07,-0.42619,-0.42609,0,0
1,GO SPINAL CORD PATTERNING,4.0678e-07,-0.4329,-0.42389,0,0
1,GO RESPONSE TO INSECTICIDE,2.9602e-08,-0.43565,-0.44038,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,1.7687e-09,-0.45012,-0.3887,0,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,1.734e-06,-0.46662,-0.48272,0,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,3.1004e-08,-0.46746,-0.52085,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00084997,-0.47188,-0.3173,0,0
1,GO SUBPALLIUM DEVELOPMENT,2.3274e-07,-0.48627,-0.42243,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.6356e-09,-0.48768,-0.49446,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.001235,-0.49334,-0.41168,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,6.0759e-07,-0.49351,-0.39446,0,0
1,GO PITUITARY GLAND DEVELOPMENT,4.1815e-08,-0.51188,-0.42547,0,0
1,GO NEURON FATE COMMITMENT,1.2131e-09,-0.52344,-0.53187,0,0
1,GO GLUTAMATE SECRETION,2.9371e-11,-0.53019,-0.50348,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,5.7923e-10,-0.55504,-0.57718,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,1.1282e-07,-0.55902,-0.5656,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,1.1099e-11,-0.58038,-0.57638,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,1.9465e-08,-0.59297,-0.55948,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,2.3312e-10,-0.60432,-0.5991,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,3.3629e-10,-0.60844,-0.56621,0,0
1,GO NEURON FATE SPECIFICATION,9.9705e-11,-0.67322,-0.74249,0,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.105e-06,-0.67642,-0.49369,0,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.5604e-09,-0.67719,-0.63584,0,0
1,GO SYNAPTIC VESICLE PRIMING,7.6937e-12,-0.68056,-0.70533,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,7.8286e-11,-0.70931,-0.67487,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,5.9748e-11,-0.72189,-0.71318,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.2733e-08,-0.73211,-0.65499,0,0
1,GO GANGLION DEVELOPMENT,2.1543e-10,-0.78679,-0.73354,0,0
1,GO SYNAPTIC VESICLE MATURATION,4.6356e-09,-0.79173,-0.71884,0,0
1,GO SYNAPTIC VESICLE DOCKING,1.887e-11,-0.80229,-0.79597,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,8.8611e-12,-0.80399,-0.72919,0,0
1,GO NOSE DEVELOPMENT,1.0094e-07,-0.85321,-0.63287,0,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,3.1098e-10,-0.88551,-0.7237,0,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,2.3467e-08,-0.92513,-0.93047,0,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,5.0237e-12,-0.95116,-0.91864,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,2.801e-10,-0.98916,-0.93334,0,0
2,GO REGULATION OF SYNAPSE MATURATION,4.8673e-09,0.81286,0.67492,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,4.9872e-09,0.78886,0.76211,1,1
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.1338e-07,0.73535,0.66684,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,8.6328e-08,0.72875,0.73446,1,1
2,GO VOCALIZATION BEHAVIOR,9.1205e-09,0.69355,0.64198,1,1
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.4334e-08,0.69093,0.72033,1,1
2,GO SYNAPSE MATURATION,2.5066e-09,0.68262,0.66544,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,6.6717e-09,0.65483,0.57057,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,3.6293e-09,0.64,0.59056,1,1
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,2.5695e-09,0.63395,0.63837,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.9624e-10,0.6296,0.6666,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,7.7166e-08,0.62521,0.5898,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,7.2202e-11,0.62002,0.58658,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,1.1858e-08,0.61903,0.56753,1,1
2,GO DENTATE GYRUS DEVELOPMENT,1.2434e-08,0.61884,0.62972,1,1
2,GO COMMISSURAL NEURON AXON GUIDANCE,6.5906e-08,0.60862,0.57494,1,1
2,GO PREPULSE INHIBITION,4.8673e-09,0.60138,0.58596,1,1
2,GO CARDIAC VENTRICLE FORMATION,5.4967e-09,0.59794,0.62947,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,4.2784e-08,0.58862,0.64706,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,1.9558e-07,0.58276,0.53059,1,1
2,GO SYNAPTIC VESICLE CLUSTERING,2.6981e-08,0.57544,0.64,1,1
2,GO POSTSYNAPSE ASSEMBLY,4.7125e-10,0.57073,0.63371,1,1
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,1.5052e-06,0.56609,0.52069,1,1
2,GO NEURONAL ION CHANNEL CLUSTERING,1.7154e-07,0.56517,0.54101,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,3.7282e-08,0.55813,0.53926,1,1
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,8.5043e-10,0.52913,0.56079,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,6.205e-09,0.52345,0.49204,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,1.4207e-05,0.52111,0.50096,1,1
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,1.0161e-09,0.52072,0.5207,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,3.7282e-08,0.51068,0.44145,1,1
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,3.4296e-07,0.50948,0.45222,1,1
2,GO DENSE CORE GRANULE TRANSPORT,3.3806e-05,0.5082,0.39499,1,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.4837e-07,0.50639,0.54124,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.5066e-09,0.50322,0.49463,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,6.8406e-11,0.50285,0.49938,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,2.7668e-07,0.50152,0.53963,1,1
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.9465e-08,0.49671,0.52841,1,1
2,GO NEURON CELL CELL ADHESION,1.5994e-06,0.49425,0.5453,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,4.1815e-08,0.49261,0.51025,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.7e-09,0.48518,0.49626,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.0964e-09,0.48279,0.49406,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,1.0212e-06,0.47974,0.40351,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,1.6129e-08,0.47898,0.48102,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.3761e-09,0.47572,0.47099,1,1
2,GO MECHANOSENSORY BEHAVIOR,5.7059e-05,0.47435,0.49693,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,1.3671e-08,0.47222,0.45396,1,1
2,GO RESPONSE TO L GLUTAMATE,5.3647e-09,0.47184,0.4665,1,1
2,GO REGULATION OF NEURON MIGRATION,1.3419e-09,0.47019,0.46024,1,1
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,9.3415e-09,0.468,0.53794,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,5.5078e-11,0.4679,0.44827,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,8.2543e-08,0.46393,0.48786,1,1
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.00018323,0.46374,0.39038,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,7.105e-06,0.46332,0.60158,1,1
2,GO CARDIAC CHAMBER FORMATION,4.5822e-08,0.45978,0.52134,1,1
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,2.3268e-09,0.45616,0.47461,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.4471e-09,0.45492,0.5079,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,3.6435e-08,0.45417,0.39535,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.9514e-07,0.45324,0.49831,1,1
2,GO PROTEIN LOCALIZATION TO AXON,2.3274e-07,0.452,0.54591,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,2.0881e-08,0.44414,0.45686,1,1
2,GO MICROTUBULE DEPOLYMERIZATION,3.5038e-07,0.44254,0.35527,1,1
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.0781e-08,0.44142,0.47198,1,1
2,GO CEREBELLAR CORTEX MORPHOGENESIS,8.4871e-11,0.43752,0.41296,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,1.3325e-06,0.43336,0.43215,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,5.77e-09,0.43311,0.41063,1,1
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,1.0422e-09,0.43005,0.41536,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.00013673,0.42777,0.36233,1,1
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,3.0296e-10,0.42602,0.43175,1,1
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,1.3948e-05,0.42527,0.40789,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,2.011e-05,0.42429,0.39335,1,1
2,GO LIMB BUD FORMATION,2.1621e-05,0.4242,0.40416,1,1
2,GO DIVALENT METAL ION EXPORT,3.247e-08,0.42376,0.45403,1,1
2,GO SECRETORY GRANULE LOCALIZATION,2.6914e-06,0.42317,0.39676,1,1
2,GO CEREBELLAR CORTEX FORMATION,7.3476e-09,0.42142,0.39372,1,1
2,GO BEHAVIORAL RESPONSE TO COCAINE,1.6761e-05,0.41956,0.40387,1,1
2,GO GENITALIA MORPHOGENESIS,0.0031247,0.41767,0.32122,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.00011218,0.41601,0.36857,1,1
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,9.8716e-08,0.4156,0.4144,1,1
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,3.8118e-09,0.41456,0.41426,1,1
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.4454e-06,0.41133,0.42015,1,1
2,GO DENDRITIC SPINE MORPHOGENESIS,5.5016e-10,0.4112,0.42211,1,1
2,GO NEURON RECOGNITION,1.0322e-07,0.40987,0.38471,1,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,3.6435e-08,0.40664,0.4063,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.247e-08,0.4063,0.41733,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,1.6158e-05,0.40525,0.36411,1,1
2,GO AXONAL FASCICULATION,8.6579e-07,0.40253,0.39835,1,1
2,GO REGULATION OF NEUROBLAST PROLIFERATION,8.2903e-10,0.40221,0.42886,1,1
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,7.0337e-07,0.39938,0.4378,1,1
2,GO CEREBELLAR CORTEX DEVELOPMENT,1.5529e-11,0.39826,0.40086,1,1
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,1.6158e-05,0.39369,0.32373,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.4452e-09,0.39367,0.40673,1,1
2,GO RESPONSE TO ACETYLCHOLINE,4.0868e-08,0.3935,0.41697,1,1
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,5.9116e-09,0.3926,0.39908,1,1
2,GO CORONARY VASCULATURE MORPHOGENESIS,2.4861e-06,0.38981,0.3797,1,1
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,7.6283e-05,0.38853,0.47405,1,1
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,8.8282e-08,0.38713,0.40844,1,1
2,GO HEART VALVE FORMATION,2.7452e-06,0.38702,0.4594,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,7.3772e-08,0.38612,0.35667,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,2.2775e-07,0.38428,0.46886,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00046872,0.3836,0.29871,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,5.9116e-09,0.38196,0.45039,1,1
2,GO REGULATION OF COLLATERAL SPROUTING,4.9361e-06,0.3817,0.3406,1,1
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,9.6129e-06,0.38154,0.375,1,1
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,5.6487e-06,0.38029,0.32718,1,1
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,9.5999e-07,0.37953,0.38867,1,1
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,9.404e-07,0.37932,0.34754,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.2303e-06,0.37813,0.33393,1,1
2,GO LONG TERM SYNAPTIC DEPRESSION,6.7461e-07,0.37773,0.33468,1,1
2,GO FOREBRAIN NEURON DEVELOPMENT,1.1806e-05,0.37507,0.35225,1,1
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.00090088,0.37491,0.33683,1,1
2,GO FOREBRAIN REGIONALIZATION,1.0212e-06,0.37279,0.3911,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,9.9064e-10,0.37086,0.40107,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,2.6362e-08,0.37022,0.37588,1,1
2,GO VITAMIN CATABOLIC PROCESS,0.0010865,0.36936,0.39368,1,1
2,GO SUCKLING BEHAVIOR,6.5837e-06,0.36921,0.39389,1,1
2,GO THALAMUS DEVELOPMENT,5.1304e-06,0.36888,0.35313,1,1
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,6.2993e-08,0.36853,0.39243,1,1
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.1806e-05,0.367,0.28766,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9064e-09,0.36676,0.38589,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,2.0879e-07,0.36506,0.39596,1,1
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.6158e-05,0.36462,0.33638,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.9323e-10,0.36455,0.39554,1,1
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.7501e-09,0.36318,0.38855,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,1.2534e-06,0.36281,0.36987,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,3.4409e-05,0.36207,0.29601,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.8118e-09,0.36147,0.40567,1,1
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.9624e-10,0.36029,0.37394,1,1
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.1533e-09,0.35974,0.39636,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,6.7411e-08,0.35935,0.34099,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0048405,0.35684,0.23203,1,1
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,8.7502e-06,0.35671,0.3589,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,5.6487e-06,0.35659,0.34723,1,1
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.00011033,0.35628,0.29241,1,1
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.2032e-06,0.35582,0.40193,1,1
2,GO POSTSYNAPSE ORGANIZATION,9.4157e-10,0.35578,0.36566,1,1
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.4076e-07,0.35495,0.43052,1,1
2,GO NEURON PROJECTION ORGANIZATION,8.4877e-09,0.35465,0.35907,1,1
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00015583,0.35373,0.30443,1,1
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,4.6359e-05,0.35306,0.35331,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,4.9872e-09,0.35258,0.35201,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,1.536e-06,0.35075,0.28216,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.1789e-06,0.35052,0.35647,1,1
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,4.7488e-06,0.35036,0.32973,1,1
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.011949,0.34965,0.26588,1,1
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0088198,0.34961,0.24453,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.4471e-09,0.34818,0.38153,1,1
2,GO NEGATIVE REGULATION OF AXONOGENESIS,6.4434e-08,0.34796,0.34212,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,3.6877e-06,0.34786,0.31535,1,1
2,GO DENDRITIC TRANSPORT,2.6981e-08,0.34704,0.40162,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.4148e-09,0.34395,0.36801,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,2.5756e-08,0.34257,0.3404,1,1
2,GO DENDRITIC SPINE DEVELOPMENT,2.004e-09,0.34127,0.34432,1,1
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.0554e-07,0.34072,0.33531,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,4.3774e-08,0.33911,0.32244,1,1
2,GO AXONAL TRANSPORT OF MITOCHONDRION,7.333e-07,0.33899,0.38619,1,1
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0099244,0.33882,0.28051,1,1
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.5027e-08,0.33879,0.3756,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.5052e-06,0.33799,0.37165,1,1
2,GO PROTEIN LOCALIZATION TO SYNAPSE,1.3999e-08,0.33662,0.3696,1,1
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.2886e-07,0.33506,0.34939,1,1
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,3.628e-05,0.33256,0.27417,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0010408,0.33204,0.29489,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,3.5646e-05,0.3314,0.27277,1,1
2,GO DORSAL SPINAL CORD DEVELOPMENT,1.2792e-06,0.33005,0.38278,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,7.3772e-08,0.32975,0.36664,1,1
2,GO RENAL VESICLE DEVELOPMENT,2.913e-06,0.32946,0.32831,1,1
2,GO METENCEPHALON DEVELOPMENT,2.8753e-10,0.3293,0.34602,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,3.2784e-06,0.32808,0.37934,1,1
2,GO CGMP METABOLIC PROCESS,1.5865e-05,0.32762,0.39287,1,1
2,GO NEURON PROJECTION GUIDANCE,3.9064e-09,0.32745,0.33684,1,1
2,GO PRESYNAPSE ORGANIZATION,8.0712e-08,0.3271,0.33718,1,1
2,GO NEUROTRANSMITTER REUPTAKE,8.5867e-06,0.32636,0.29535,1,1
2,GO SEROTONIN TRANSPORT,6.8396e-06,0.3253,0.31641,1,1
2,GO REGULATION OF DENDRITE MORPHOGENESIS,2.801e-10,0.32467,0.35628,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0045438,0.32411,0.27844,1,1
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,7.9617e-06,0.32368,0.44715,1,1
2,GO RESPONSE TO AUDITORY STIMULUS,0.00012388,0.32314,0.36371,1,1
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,3.1494e-05,0.31919,0.34208,1,1
2,GO STARTLE RESPONSE,7.6657e-06,0.31884,0.33897,1,1
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,1.5713e-07,0.31621,0.32028,1,1
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,2.3891e-06,0.31421,0.31332,1,1
2,GO NEGATIVE REGULATION OF AXON EXTENSION,3.4296e-07,0.31331,0.32059,1,1
2,GO REGULATION OF AXONOGENESIS,6.3569e-09,0.31293,0.33318,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.0279e-08,0.31275,0.31906,1,1
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,1.6907e-08,0.31267,0.33116,1,1
2,GO PROSTATE GLAND MORPHOGENESIS,0.0065235,0.31254,0.2371,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.01251,0.31239,0.21002,1,1
2,GO MICROTUBULE ANCHORING AT CENTROSOME,2.1196e-06,0.31236,0.30278,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,2.0881e-08,0.31234,0.30958,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,3.1004e-08,0.31222,0.3032,1,1
2,GO NEURON MIGRATION,1.9546e-09,0.31187,0.36842,1,1
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,3.247e-08,0.31171,0.3437,1,1
2,GO DENDRITE MORPHOGENESIS,2.7e-09,0.31132,0.33723,1,1
2,GO HINDBRAIN MORPHOGENESIS,1.7721e-08,0.31101,0.28079,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,5.5016e-10,0.30994,0.33793,1,1
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,8.5043e-10,0.30946,0.34218,1,1
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,3.1479e-07,0.30931,0.30635,1,1
2,GO EXPLORATION BEHAVIOR,4.3997e-05,0.30853,0.27585,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,8.3013e-05,0.30734,0.43289,1,1
2,GO MRNA SPLICE SITE SELECTION,1.5037e-07,0.30598,0.3011,1,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0039992,0.30592,0.25202,1,1
2,GO LEARNING,1.1828e-09,0.3058,0.33138,1,1
2,GO ADULT HEART DEVELOPMENT,5.6085e-05,0.30568,0.29438,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,2.0478e-05,0.30529,0.2959,1,1
2,GO MAST CELL MIGRATION,0.0039992,0.30415,0.29914,1,1
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00018923,0.30161,0.32124,1,1
2,GO ACTIN CROSSLINK FORMATION,4.31e-06,0.30096,0.33937,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,4.0868e-08,0.30046,0.27254,1,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,2.5424e-05,0.30029,0.25907,1,1
2,GO RESPONSE TO POTASSIUM ION,4.9694e-05,0.29963,0.30157,1,1
2,GO SOMATIC STEM CELL DIVISION,0.0090315,0.29885,0.25838,1,1
2,GO NEURAL RETINA DEVELOPMENT,1.5674e-06,0.29815,0.27869,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,1.1789e-06,0.29808,0.28225,1,1
2,GO SIALYLATION,1.3056e-06,0.29686,0.43189,1,1
2,GO SYNAPSE ORGANIZATION,5.4967e-09,0.29553,0.30888,1,1
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,5.4982e-08,0.2942,0.32694,1,1
2,GO NEUROTRANSMITTER SECRETION,4.6881e-08,0.29397,0.32806,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.057179,0.29245,0.16339,1,1
2,GO BRAIN MORPHOGENESIS,4.9361e-06,0.29208,0.26753,1,1
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,1.2281e-06,0.29203,0.3095,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,9.3415e-09,0.29088,0.30122,1,1
2,GO NEUROBLAST PROLIFERATION,1.5994e-06,0.29085,0.28061,1,1
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.064e-06,0.29064,0.27665,1,1
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,9.3381e-05,0.29053,0.32408,1,1
2,GO COLLATERAL SPROUTING,6.0991e-06,0.29046,0.29438,1,1
2,GO CARTILAGE MORPHOGENESIS,0.01849,0.28956,0.21828,1,1
2,GO COCHLEA MORPHOGENESIS,0.00083767,0.28911,0.24679,1,1
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.7282e-08,0.28872,0.30909,1,1
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.0861e-06,0.28871,0.26963,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,4.8416e-06,0.28866,0.26764,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,2.4837e-07,0.28755,0.34036,1,1
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.7195e-09,0.28727,0.30039,1,1
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,3.7195e-09,0.28699,0.30607,1,1
2,GO POSITIVE REGULATION OF AXONOGENESIS,2.1375e-08,0.28611,0.31638,1,1
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0057669,0.28572,0.18072,1,1
2,GO CATECHOLAMINE UPTAKE,1.8701e-05,0.28461,0.31066,1,1
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,2.8001e-06,0.28427,0.2693,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,2.3312e-10,0.28419,0.31848,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,2.342e-06,0.28412,0.29047,1,1
2,GO ACROSOME ASSEMBLY,7.1274e-05,0.28394,0.25579,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.014658,0.28389,0.19929,1,1
2,GO NEURON MATURATION,6.6066e-07,0.28381,0.28097,1,1
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0048405,0.28314,0.27314,1,1
2,GO SYNAPTIC VESICLE EXOCYTOSIS,1.6418e-07,0.28254,0.31674,1,1
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,7.1274e-05,0.28242,0.27207,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00062378,0.28176,0.29757,1,1
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,2.6352e-05,0.28136,0.27911,1,1
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00026858,0.28127,0.24364,1,1
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.00073415,0.28094,0.24167,1,1
2,GO MIDGUT DEVELOPMENT,0.0007901,0.2809,0.26012,1,1
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00026024,0.28088,0.22861,1,1
2,GO REGULATION OF EXTENT OF CELL GROWTH,1.2143e-08,0.28082,0.32102,1,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0057669,0.27903,0.29799,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,1.1245e-09,0.27898,0.3079,1,1
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,9.5999e-07,0.27824,0.24483,1,1
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,1.9926e-08,0.27804,0.31303,1,1
2,GO NEGATIVE CHEMOTAXIS,7.5001e-05,0.27781,0.28975,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.2146e-06,0.27742,0.32532,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,9.1205e-09,0.27725,0.32071,1,1
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0040509,0.27669,0.21936,1,1
2,GO FORELIMB MORPHOGENESIS,0.0012886,0.27555,0.2287,1,1
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0054872,0.27524,0.2071,1,1
2,GO NEURAL TUBE PATTERNING,4.1026e-05,0.27499,0.2195,1,1
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0037985,0.27477,0.29005,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,3.094e-05,0.27462,0.25806,1,1
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0088198,0.27374,0.18001,1,1
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,8.1623e-05,0.27357,0.27325,1,1
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.00072342,0.2732,0.25658,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,8.5867e-06,0.27292,0.26842,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.00015331,0.27195,0.26647,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.0010558,0.27186,0.25223,1,1
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,3.5646e-05,0.27117,0.24597,1,1
2,GO REGULATION OF VESICLE FUSION,0.020605,0.27105,0.17657,1,1
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.030368,0.27026,0.18452,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,2.8001e-06,0.2686,0.22881,1,1
2,GO ADULT BEHAVIOR,2.3467e-08,0.26851,0.30092,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,6.0205e-08,0.2683,0.29703,1,1
2,GO NEUROTRANSMITTER TRANSPORT,9.8716e-08,0.26758,0.30443,1,1
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,1.9558e-07,0.26747,0.2528,1,1
2,GO NOREPINEPHRINE TRANSPORT,1.2027e-05,0.26712,0.27525,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,3.8149e-08,0.26696,0.26685,1,1
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,4.3236e-05,0.26667,0.26018,1,1
2,GO SYNAPSE ASSEMBLY,8.4415e-08,0.26657,0.30341,1,1
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00060545,0.26619,0.21747,1,1
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.0044298,0.26573,0.36637,1,1
2,GO DENDRITE SELF AVOIDANCE,0.00042128,0.2653,0.25371,1,1
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.021509,0.26505,0.23728,1,1
2,GO CELL PART MORPHOGENESIS,6.3569e-09,0.26452,0.28314,1,1
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,1.0036e-08,0.26412,0.29359,1,1
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.0018508,0.26405,0.21592,1,1
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,5.5127e-05,0.26287,0.26922,1,1
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00022927,0.26278,0.2751,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0003557,0.26278,0.22058,1,1
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00014599,0.26226,0.20751,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,8.1623e-05,0.26182,0.27524,1,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0066039,0.26126,0.2513,1,1
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,7.0072e-05,0.26029,0.25305,1,1
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,9.0235e-07,0.25991,0.27156,1,1
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00086244,0.25975,0.28463,1,1
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0032078,0.25957,0.18785,1,1
2,GO HINDBRAIN DEVELOPMENT,1.6418e-07,0.25713,0.2518,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.2416e-05,0.25694,0.33578,1,1
2,GO PHOTORECEPTOR CELL MAINTENANCE,8.3013e-05,0.25611,0.18589,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,2.7078e-07,0.25549,0.26749,1,1
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.1552e-07,0.25476,0.25139,1,1
2,GO POSITIVE REGULATION OF AXON EXTENSION,2.4861e-06,0.25416,0.26782,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0020367,0.25399,0.25834,1,1
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,5.5127e-05,0.25248,0.27318,1,1
2,GO URETER DEVELOPMENT,0.0044298,0.25232,0.30714,1,1
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,1.5576e-05,0.25189,0.26194,1,1
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0054192,0.25133,0.21285,1,1
2,GO DENDRITE DEVELOPMENT,4.3082e-09,0.25091,0.29308,1,1
2,GO RESPONSE TO NICOTINE,2.206e-06,0.25011,0.27404,1,1
2,GO WALKING BEHAVIOR,1.5994e-06,0.24941,0.28348,1,1
2,GO REGULATION OF STEM CELL PROLIFERATION,3.0395e-05,0.2494,0.21842,1,1
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.00023294,0.24884,0.27335,1,1
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.001422,0.24878,0.21755,1,1
2,GO REGULATION OF BEHAVIOR,2.1624e-06,0.24763,0.23195,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,2.2505e-06,0.24724,0.3137,1,1
2,GO PROTEIN LOCALIZATION TO CILIUM,0.00015838,0.24704,0.21439,1,1
2,GO DOPAMINE TRANSPORT,7.6283e-05,0.24677,0.32857,1,1
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.002702,0.24668,0.25568,1,1
2,GO INNER DYNEIN ARM ASSEMBLY,0.026561,0.24577,0.24996,1,1
2,GO METANEPHROS MORPHOGENESIS,9.4959e-05,0.24502,0.23014,1,1
2,GO NEURAL CREST FORMATION,0.027973,0.24472,0.16018,1,1
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0053519,0.2443,0.19235,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00014362,0.24332,0.20712,1,1
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.6761e-05,0.24326,0.28218,1,1
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2716e-05,0.24312,0.23339,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.001483,0.24294,0.21481,1,1
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,4.31e-06,0.24252,0.25035,1,1
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0012527,0.24235,0.23715,1,1
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.03006,0.24173,0.17166,1,1
2,GO MEMBRANE HYPERPOLARIZATION,0.00024819,0.24156,0.27113,1,1
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0015038,0.24128,0.20164,1,1
2,GO REGULATION OF DOPAMINE SECRETION,5.1446e-05,0.24121,0.39083,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,8.4262e-06,0.24055,0.28361,1,1
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,5.4356e-06,0.24014,0.22305,1,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0022396,0.24009,0.25566,1,1
2,GO OVULATION CYCLE PROCESS,1.5293e-05,0.23992,0.21319,1,1
2,GO LIMBIC SYSTEM DEVELOPMENT,9.7991e-09,0.23961,0.25729,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,6.545e-05,0.23943,0.26717,1,1
2,GO REGULATION OF FILOPODIUM ASSEMBLY,4.6359e-05,0.23936,0.23085,1,1
2,GO STRESS GRANULE ASSEMBLY,0.00014129,0.23926,0.20058,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.002702,0.23903,0.22718,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.012227,0.23896,0.17051,1,1
2,GO INTRACILIARY TRANSPORT,0.001235,0.23878,0.19903,1,1
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,3.4296e-07,0.23857,0.26804,1,1
2,GO HISTONE H3 K27 METHYLATION,6.3249e-05,0.23824,0.21807,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,1.2792e-06,0.23813,0.25718,1,1
2,GO MYELIN MAINTENANCE,0.010645,0.23811,0.22143,1,1
2,GO EPITHELIAL CELL MATURATION,0.003607,0.23811,0.19051,1,1
2,GO AXONAL TRANSPORT,8.3066e-07,0.23794,0.24494,1,1
2,GO SPINAL CORD DEVELOPMENT,6.6066e-07,0.23786,0.28031,1,1
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.0075485,0.23774,0.24158,1,1
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,1.6457e-05,0.23728,0.24584,1,1
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,2.4305e-07,0.2371,0.28248,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00062378,0.23688,0.22518,1,1
2,GO NEURON PROJECTION EXTENSION,8.4415e-08,0.23618,0.26616,1,1
2,GO SYNAPTIC SIGNALING,8.4877e-09,0.23604,0.27932,1,1
2,GO CHEMOSENSORY BEHAVIOR,1.9749e-05,0.23594,0.20309,1,1
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.010769,0.23561,0.23421,1,1
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0023637,0.2356,0.1972,1,1
2,GO ANTEROGRADE AXONAL TRANSPORT,1.4454e-06,0.23467,0.23869,1,1
2,GO NEUROTRANSMITTER UPTAKE,1.3442e-05,0.23397,0.24119,1,1
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0059116,0.23392,0.19836,1,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,7.5001e-05,0.23332,0.38237,1,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,5.8698e-06,0.23244,0.22533,1,1
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00069207,0.2316,0.17945,1,1
2,GO TONGUE DEVELOPMENT,0.041383,0.22957,0.15785,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0012886,0.22923,0.2127,1,1
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.2538e-08,0.22856,0.25468,1,1
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,1.8701e-05,0.22856,0.33324,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,9.819e-05,0.22848,0.19364,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013069,0.22844,0.22938,1,1
2,GO OVULATION CYCLE,9.4341e-06,0.22827,0.21173,1,1
2,GO REGULATION OF TUBULIN DEACETYLATION,5.9056e-05,0.22819,0.27237,1,1
2,GO IRON COORDINATION ENTITY TRANSPORT,3.5022e-05,0.22805,0.22666,1,1
2,GO CENTRIOLE CENTRIOLE COHESION,4.9694e-05,0.22804,0.26905,1,1
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.1494e-05,0.22711,0.26203,1,1
2,GO REGULATION OF RECEPTOR INTERNALIZATION,2.5934e-07,0.22695,0.24058,1,1
2,GO RESPONSE TO COCAINE,1.5052e-06,0.22674,0.25309,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.1552e-07,0.22647,0.26284,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING,2.4837e-07,0.22633,0.22834,1,1
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.020385,0.22584,0.17534,1,1
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,9.4407e-08,0.22469,0.23895,1,1
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0014624,0.22402,0.22545,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,4.3997e-05,0.224,0.28789,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.027118,0.22324,0.26021,1,1
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.00063314,0.22297,0.22603,1,1
2,GO ASSOCIATIVE LEARNING,1.5713e-07,0.22243,0.24098,1,1
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.020385,0.22236,0.17387,1,1
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00013899,0.22135,0.22047,1,1
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,1.2058e-07,0.22118,0.24076,1,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00024045,0.2209,0.20992,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.015501,0.22064,0.17474,1,1
2,GO NUCLEAR MIGRATION,0.0005056,0.22025,0.23224,1,1
2,GO POST ANAL TAIL MORPHOGENESIS,0.00044781,0.22002,0.22309,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0023957,0.21976,0.26011,1,1
2,GO NEURAL CREST CELL MIGRATION,7.3739e-05,0.21925,0.25727,1,1
2,GO TELENCEPHALON DEVELOPMENT,2.4586e-08,0.2188,0.25311,1,1
2,GO ATRIAL SEPTUM DEVELOPMENT,0.024687,0.21722,0.17295,1,1
2,GO AXON EXTENSION,5.4982e-08,0.21718,0.28354,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0047198,0.2162,0.23945,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0013069,0.21607,0.27825,1,1
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.062114,0.21544,0.33605,1,1
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.039795,0.21478,0.16776,1,1
2,GO NEPHRIC DUCT MORPHOGENESIS,0.010279,0.21438,0.19392,1,1
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,2.7312e-05,0.21307,0.21738,1,1
2,GO FOREBRAIN DEVELOPMENT,1.471e-07,0.21286,0.23363,1,1
2,GO MITOCHONDRION DISTRIBUTION,1.8053e-06,0.21274,0.25038,1,1
2,GO NUCLEUS LOCALIZATION,0.00023294,0.21253,0.22678,1,1
2,GO LOCOMOTORY BEHAVIOR,6.4699e-07,0.21139,0.26088,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.00052901,0.21121,0.30392,1,1
2,GO SPERMATID NUCLEUS DIFFERENTIATION,1.0557e-05,0.21116,0.22133,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00047589,0.21106,0.30558,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,3.628e-05,0.21067,0.28357,1,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.012945,0.21043,0.1599,1,1
2,GO COGNITION,5.1356e-08,0.21035,0.23272,1,1
2,GO EMBRYONIC EYE MORPHOGENESIS,0.00029511,0.21008,0.20654,1,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,2.3784e-07,0.20983,0.2177,1,1
2,GO REGULATION OF CAMP MEDIATED SIGNALING,5.7582e-06,0.20961,0.22845,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0022095,0.20948,0.18331,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0042636,0.2091,0.20794,1,1
2,GO HISTONE H3 K9 METHYLATION,0.0063654,0.20871,0.17243,1,1
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,4.1751e-05,0.20855,0.2636,1,1
2,GO PALLIUM DEVELOPMENT,5.4982e-08,0.2081,0.23569,1,1
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,4.9228e-07,0.20792,0.20749,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,9.03e-05,0.20777,0.23275,1,1
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,6.3359e-07,0.20754,0.23281,1,1
2,GO SEROTONIN SECRETION,0.00084997,0.20729,0.25821,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,3.9613e-05,0.20657,0.17041,1,1
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,3.0156e-07,0.20629,0.21412,1,1
2,GO SMOOTH MUSCLE CONTRACTION,7.8911e-05,0.20618,0.16371,1,1
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,8.3013e-05,0.20597,0.21529,1,1
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0037498,0.20592,0.17448,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.034984,0.20568,0.14064,1,1
2,GO PRESYNAPTIC ENDOCYTOSIS,1.475e-06,0.20563,0.24693,1,1
2,GO SMOOTHENED SIGNALING PATHWAY,0.00015083,0.20514,0.17669,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,0.0080166,0.20507,0.20756,1,1
2,GO CATECHOLAMINE SECRETION,2.011e-05,0.20469,0.32568,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0049019,0.2041,0.18108,1,1
2,GO FEEDING BEHAVIOR,1.2253e-05,0.20401,0.1959,1,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0005618,0.20399,0.19909,1,1
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0023637,0.20367,0.23061,1,1
2,GO REGULATION OF HEAT GENERATION,0.0011503,0.2031,0.22156,1,1
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0028492,0.20275,0.18719,1,1
2,GO REGULATION OF HEART MORPHOGENESIS,0.060988,0.20226,0.12087,1,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.00022927,0.20185,0.19922,1,1
2,GO CGMP MEDIATED SIGNALING,0.022686,0.20172,0.14254,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00019541,0.20162,0.24434,1,1
2,GO REGULATION OF MEMBRANE POTENTIAL,4.8416e-06,0.20136,0.20935,1,1
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,9.03e-05,0.20118,0.25891,1,1
2,GO BEHAVIOR,3.1729e-08,0.20111,0.2317,1,1
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,2.4861e-06,0.20106,0.19769,1,1
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,9.2118e-07,0.20104,0.23566,1,1
2,GO AXO DENDRITIC TRANSPORT,1.475e-06,0.20087,0.21972,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0011836,0.20011,0.20919,1,1
2,GO GROWTH HORMONE SECRETION,0.00018323,0.19999,0.34525,1,1
2,GO TRANSPORT ALONG MICROTUBULE,2.5868e-06,0.19966,0.191,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0066039,0.19943,0.18462,1,1
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0031247,0.19903,0.18359,1,1
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0050269,0.19889,0.17377,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00025215,0.19877,0.20685,1,1
2,GO MOTILE CILIUM ASSEMBLY,0.060432,0.19849,0.12607,1,1
2,GO REGULATION OF RESPONSE TO FOOD,5.8049e-05,0.1984,0.2163,1,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00019541,0.1977,0.17125,1,1
2,GO RECEPTOR INTERNALIZATION,4.1456e-06,0.19674,0.1918,1,1
2,GO RESPIRATORY SYSTEM PROCESS,0.00031414,0.19653,0.20426,1,1
2,GO FILOPODIUM ASSEMBLY,0.0001179,0.19608,0.19559,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.00091404,0.19601,0.20317,1,1
2,GO PROSTATE GLAND GROWTH,0.0063654,0.19589,0.22314,1,1
2,GO PROTEIN DEMETHYLATION,0.00086244,0.19579,0.17779,1,1
2,GO HEAD DEVELOPMENT,5.1351e-07,0.19564,0.19839,1,1
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,3.8347e-06,0.19528,0.22459,1,1
2,GO GLIAL CELL MIGRATION,0.0093576,0.19512,0.14182,1,1
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.057179,0.19488,0.12176,1,1
2,GO MEMORY,2.1196e-06,0.19468,0.20771,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,8.7502e-06,0.19381,0.19205,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.044292,0.1937,0.12098,1,1
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0005211,0.19368,0.19521,1,1
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,7.2497e-05,0.1927,0.1674,1,1
2,GO CHROMATIN SILENCING AT TELOMERE,0.00013451,0.1923,0.17503,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.029754,0.19223,0.14632,1,1
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.00024045,0.19191,0.20115,1,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00010497,0.1919,0.18382,1,1
2,GO GANGLIOSIDE METABOLIC PROCESS,0.0002117,0.19046,0.21618,1,1
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.2253e-05,0.19024,0.186,1,1
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,3.5646e-05,0.19009,0.19516,1,1
2,GO UTERUS DEVELOPMENT,0.0034692,0.18966,0.20837,1,1
2,GO RESPONSE TO LEUCINE,0.0047798,0.18876,0.19335,1,1
2,GO INCLUSION BODY ASSEMBLY,0.0012705,0.18875,0.22925,1,1
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,2.5934e-07,0.18874,0.2004,1,1
2,GO VENTRICULAR SYSTEM DEVELOPMENT,1.0557e-05,0.18852,0.21633,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0012005,0.1883,0.17721,1,1
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,7.5001e-05,0.1878,0.18375,1,1
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0015463,0.18774,0.18808,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.059331,0.1877,0.11323,1,1
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0021798,0.18769,0.20627,1,1
2,GO NEUROPEPTIDE SIGNALING PATHWAY,4.8839e-05,0.18753,0.2159,1,1
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0020092,0.18733,0.17464,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0042095,0.18708,0.16232,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.0011341,0.18676,0.16243,1,1
2,GO ACIDIC AMINO ACID TRANSPORT,1.2954e-05,0.18675,0.20384,1,1
2,GO MESENCHYMAL CELL PROLIFERATION,0.011151,0.18654,0.18107,1,1
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0016347,0.18617,0.20976,1,1
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.0090315,0.18614,0.19481,1,1
2,GO AXONEME ASSEMBLY,0.0030839,0.18598,0.18311,1,1
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00022208,0.18596,0.23235,1,1
2,GO CLATHRIN COAT ASSEMBLY,0.014013,0.18595,0.13921,1,1
2,GO CELLULAR RESPONSE TO X RAY,0.0058389,0.18583,0.12502,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00091404,0.18516,0.16907,1,1
2,GO REGULATION OF FEEDING BEHAVIOR,5.5127e-05,0.18501,0.24115,1,1
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,5.6085e-05,0.1848,0.2704,1,1
2,GO MONOAMINE TRANSPORT,2.4091e-05,0.18403,0.27455,1,1
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.006444,0.18388,0.1699,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00099681,0.18355,0.18244,1,1
2,GO SPERM AXONEME ASSEMBLY,0.003654,0.18354,0.17118,1,1
2,GO UV PROTECTION,0.0067673,0.1827,0.17625,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0002117,0.18264,0.17025,1,1
2,GO RESPONSE TO DOPAMINE,2.1624e-06,0.18245,0.20782,1,1
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00042777,0.18242,0.21911,1,1
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.016568,0.18172,0.15937,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.2482e-05,0.1815,0.18448,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.8701e-05,0.18147,0.19487,1,1
2,GO CORONARY VASCULATURE DEVELOPMENT,0.00055343,0.18095,0.1939,1,1
2,GO REGULATION OF MICROTUBULE BINDING,0.0012527,0.18044,0.22168,1,1
2,GO SECRETORY GRANULE ORGANIZATION,0.0054192,0.18032,0.13673,1,1
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,5.3256e-05,0.17994,0.18284,1,1
2,GO SOMITE DEVELOPMENT,8.4424e-05,0.17968,0.17021,1,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.035336,0.17887,0.10754,1,1
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00042777,0.17838,0.19534,1,1
2,GO NOREPINEPHRINE SECRETION,0.0015463,0.17835,0.21532,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.00013899,0.17834,0.17982,1,1
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0013255,0.17822,0.13632,1,1
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0010259,0.17822,0.15295,1,1
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00028155,0.17796,0.16285,1,1
2,GO ADHERENS JUNCTION ASSEMBLY,0.056652,0.17759,0.12155,1,1
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.00052901,0.17744,0.16652,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,4.6202e-07,0.17743,0.20274,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,8.8796e-05,0.17735,0.184,1,1
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,1.1165e-05,0.1772,0.17386,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.045155,0.17705,0.16072,1,1
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.054582,0.17635,0.15904,1,1
2,GO MICROTUBULE BASED TRANSPORT,1.0958e-05,0.17623,0.18797,1,1
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.015159,0.17619,0.12515,1,1
2,GO APPENDAGE MORPHOGENESIS,0.0072795,0.17608,0.14375,1,1
2,GO POTASSIUM ION TRANSPORT,9.086e-06,0.17603,0.20118,1,1
2,GO MICROTUBULE ANCHORING,2.1234e-05,0.17591,0.20215,1,1
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00053704,0.17525,0.19969,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0044864,0.17517,0.19793,1,1
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.023419,0.17494,0.1249,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.001442,0.17493,0.17569,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0051547,0.17458,0.16844,1,1
2,GO CARDIAC ATRIUM DEVELOPMENT,0.023919,0.17454,0.14655,1,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0020646,0.17376,0.19956,1,1
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.0038977,0.17275,0.20134,1,1
2,GO HISTONE H3 K9 MODIFICATION,0.013394,0.17238,0.14691,1,1
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.042609,0.17215,0.15582,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.058787,0.17168,0.15152,1,1
2,GO MICROTUBULE BASED MOVEMENT,7.8124e-06,0.1716,0.17656,1,1
2,GO REGULATION OF CILIUM MOVEMENT,0.00072342,0.17146,0.1613,1,1
2,GO OUTER DYNEIN ARM ASSEMBLY,0.030368,0.17142,0.16055,1,1
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00019229,0.17142,0.16542,1,1
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0014624,0.17121,0.16668,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.045591,0.17117,0.11991,1,1
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.012087,0.17093,0.15507,1,1
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.0010865,0.17092,0.19266,1,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.025743,0.17082,0.13204,1,1
2,GO ORGANIC CATION TRANSPORT,0.00020178,0.17054,0.18719,1,1
2,GO DENDRITIC SPINE MAINTENANCE,0.0069343,0.1705,0.193,1,1
2,GO GLIAL CELL DIFFERENTIATION,2.9332e-05,0.17047,0.18086,1,1
2,GO SYNAPTIC VESICLE TRANSPORT,0.00059648,0.17005,0.18819,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,7.8911e-05,0.1699,0.17873,1,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.043866,0.16966,0.14323,1,1
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0037498,0.16942,0.16529,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.019104,0.16941,0.14365,1,1
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.00035024,0.1691,0.17609,1,1
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.8698e-06,0.16888,0.18323,1,1
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.036048,0.16785,0.11901,1,1
2,GO REGULATION OF SENSORY PERCEPTION,0.0002117,0.16733,0.17877,1,1
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0043737,0.16666,0.15516,1,1
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00023294,0.16646,0.17978,1,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.00092737,0.16611,0.1847,1,1
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,7.1274e-05,0.16608,0.17717,1,1
2,GO REGULATION OF TRANSPORTER ACTIVITY,1.5014e-05,0.16601,0.1801,1,1
2,GO STEM CELL DIVISION,0.013243,0.16538,0.13955,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,8.1138e-06,0.16532,0.21257,1,1
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0046018,0.16443,0.16704,1,1
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00091404,0.16439,0.14733,1,1
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.00044781,0.16325,0.21721,1,1
2,GO TOOTH MINERALIZATION,0.01585,0.16254,0.16608,1,1
2,GO PROTEIN PALMITOYLATION,0.00018923,0.16227,0.18944,1,1
2,GO MEMBRANE REPOLARIZATION,0.011949,0.1622,0.14866,1,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.026561,0.16213,0.11023,1,1
2,GO EXTRACELLULAR TRANSPORT,0.036048,0.16194,0.12605,1,1
2,GO SEGMENTATION,0.00023294,0.16186,0.15905,1,1
2,GO FEAR RESPONSE,0.0001179,0.16168,0.17923,1,1
2,GO TRANSMISSION OF NERVE IMPULSE,0.0011503,0.16161,0.21947,1,1
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0074579,0.16154,0.1206,1,1
2,GO MEMBRANE BIOGENESIS,0.00046872,0.16153,0.21706,1,1
2,GO REGULATION OF CELL SIZE,1.155e-06,0.16108,0.20791,1,1
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.011411,0.16092,0.17959,1,1
2,GO PEPTIDE HORMONE SECRETION,0.00017741,0.16092,0.16276,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.00017176,0.16058,0.1987,1,1
2,GO MATING,7.2414e-06,0.16046,0.18124,1,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.0059116,0.16042,0.15968,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.033948,0.16022,0.14663,1,1
2,GO TRACHEA DEVELOPMENT,0.03068,0.15907,0.14305,1,1
2,GO SINGLE STRAND BREAK REPAIR,0.017894,0.15906,0.12117,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00071283,0.1589,0.25597,1,1
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,1.9749e-05,0.15863,0.20029,1,1
2,GO HISTONE H3 K9 TRIMETHYLATION,0.00012186,0.15859,0.1788,1,1
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,1.9749e-05,0.15831,0.1642,1,1
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,5.8049e-05,0.15805,0.17881,1,1
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0033361,0.15803,0.15184,1,1
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.00064263,0.15797,0.17865,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00049053,0.15791,0.22282,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0043737,0.15751,0.12347,1,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,1.9563e-06,0.15745,0.1728,1,1
2,GO L GLUTAMATE IMPORT,0.023919,0.15704,0.12132,1,1
2,GO ECTODERM DEVELOPMENT,0.016386,0.15688,0.11901,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0086125,0.15671,0.13546,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0028118,0.15655,0.13653,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.000662,0.15622,0.15033,1,1
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0011836,0.15609,0.18143,1,1
2,GO PLASMA MEMBRANE TUBULATION,0.054074,0.15598,0.1045,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0014624,0.15572,0.17044,1,1
2,GO SCHWANN CELL DEVELOPMENT,0.001776,0.15422,0.16627,1,1
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00073415,0.1542,0.18101,1,1
2,GO CELL RECOGNITION,8.5858e-05,0.15377,0.16039,1,1
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,4.0657e-06,0.15336,0.18463,1,1
2,GO PATTERN SPECIFICATION PROCESS,0.0001803,0.15326,0.15504,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.031311,0.15323,0.15448,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.011151,0.15309,0.15729,1,1
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0012177,0.15305,0.23712,1,1
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.03429,0.153,0.15565,1,1
2,GO CELLULAR RESPONSE TO STEROL,8.4424e-05,0.15298,0.23435,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.05063,0.15287,0.11046,1,1
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,2.4528e-05,0.15276,0.15576,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.0027747,0.15224,0.22087,1,1
2,GO POSITIVE REGULATION OF DNA REPAIR,0.0011668,0.15204,0.1392,1,1
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0024609,0.15185,0.16758,1,1
2,GO NEPHRIC DUCT DEVELOPMENT,0.046474,0.15126,0.13412,1,1
2,GO RESPONSE TO FOOD,0.0078263,0.151,0.12427,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.011151,0.15078,0.19145,1,1
2,GO MUSCLE ORGAN MORPHOGENESIS,0.0076401,0.15055,0.1222,1,1
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.012227,0.15054,0.17248,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02945,0.15029,0.11949,1,1
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00012388,0.15021,0.1633,1,1
2,GO AMINE TRANSPORT,0.0015463,0.14985,0.21427,1,1
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0017517,0.14966,0.11865,1,1
2,GO FUCOSYLATION,0.021509,0.14948,0.12236,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.024947,0.14907,0.11036,1,1
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0022396,0.14903,0.1499,1,1
2,GO MALE GAMETE GENERATION,0.00023667,0.14902,0.13033,1,1
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.03429,0.14815,0.11277,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.01829,0.14731,0.12656,1,1
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.0033361,0.14719,0.13967,1,1
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00036686,0.14663,0.18339,1,1
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.00088789,0.14643,0.15167,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0020092,0.14642,0.16206,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0028118,0.14638,0.13789,1,1
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.017894,0.14561,0.1243,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0049019,0.14557,0.16048,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.00015838,0.14539,0.12278,1,1
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.0042636,0.14533,0.16393,1,1
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.013093,0.14531,0.16725,1,1
2,GO GLIAL CELL DEVELOPMENT,0.00027716,0.14528,0.16895,1,1
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0084096,0.14499,0.19097,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0086125,0.14496,0.14138,1,1
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.03068,0.14487,0.14024,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.021973,0.1436,0.21992,1,1
2,GO REGULATION OF DNA BINDING,0.00015838,0.14352,0.13856,1,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.2416e-05,0.14322,0.16302,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0035146,0.14293,0.11931,1,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.063258,0.1429,0.11915,1,1
2,GO GERM CELL DEVELOPMENT,0.00036686,0.14284,0.13692,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.014494,0.14282,0.14496,1,1
2,GO REGULATION OF VASCULAR PERMEABILITY,0.043866,0.14262,0.10995,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.020605,0.14248,0.13978,1,1
2,GO INSULIN SECRETION,0.00076726,0.14227,0.15158,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.015674,0.14208,0.11247,1,1
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00072342,0.14136,0.14398,1,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.015674,0.14136,0.13138,1,1
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00013899,0.14127,0.15931,1,1
2,GO REGULATION OF APPETITE,0.0039481,0.14127,0.11083,1,1
2,GO DEVELOPMENTAL GROWTH,1.3693e-05,0.14075,0.16092,1,1
2,GO REGULATION OF EXOCYTOSIS,0.00013016,0.1405,0.16524,1,1
2,GO SPERM MOTILITY,0.00015083,0.14006,0.15416,1,1
2,GO FATTY ACID HOMEOSTASIS,0.010645,0.14001,0.17057,1,1
2,GO REGULATION OF MICROTUBULE BASED PROCESS,1.1588e-05,0.13973,0.1671,1,1
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0034692,0.13969,0.13194,1,1
2,GO MULTICELLULAR ORGANISM GROWTH,3.8246e-05,0.13938,0.16198,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.0037498,0.13934,0.14519,1,1
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,6.5837e-06,0.13932,0.16302,1,1
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0013069,0.13919,0.12498,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.024687,0.13916,0.12791,1,1
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00046872,0.1391,0.17343,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,4.9361e-06,0.139,0.19901,1,1
2,GO HEART MORPHOGENESIS,0.0028492,0.13866,0.1363,1,1
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.9749e-05,0.13849,0.16755,1,1
2,GO FEVER GENERATION,0.047827,0.13848,0.1115,1,1
2,GO REGULATION OF HORMONE SECRETION,0.0024609,0.13838,0.12284,1,1
2,GO ODONTOGENESIS,0.0078263,0.13799,0.14482,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,4.0657e-06,0.13771,0.16376,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.057711,0.13728,0.10586,1,1
2,GO HISTONE METHYLATION,0.00081356,0.13685,0.15139,1,1
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00017741,0.13649,0.16155,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0060595,0.13645,0.1386,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.038637,0.1362,0.102,1,1
2,GO FUCOSE METABOLIC PROCESS,0.033608,0.13612,0.10995,1,1
2,GO REGULATION OF HISTONE METHYLATION,0.00030449,0.1359,0.15701,1,1
2,GO REGULATION OF INSULIN SECRETION,0.0001803,0.13587,0.16217,1,1
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0012705,0.13575,0.14812,1,1
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0023957,0.13563,0.15481,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0056255,0.13556,0.12843,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00037257,0.13533,0.13926,1,1
2,GO P BODY ASSEMBLY,0.010522,0.1349,0.1154,1,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.011813,0.13478,0.11596,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.0038977,0.1342,0.1438,1,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.014823,0.13413,0.12076,1,1
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.054074,0.1339,0.11206,1,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.03902,0.13361,0.087525,1,1
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00012804,0.13347,0.13337,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0086125,0.13346,0.155,1,1
2,GO REGULATION OF HEART GROWTH,0.033948,0.13303,0.094882,1,1
2,GO CHROMATIN SILENCING,0.00010673,0.13303,0.15462,1,1
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0057669,0.13268,0.12072,1,1
2,GO VASCULOGENESIS,0.066192,0.13208,0.1197,1,1
2,GO CELLULAR RESPONSE TO ATP,0.0034243,0.13184,0.1348,1,1
2,GO ENSHEATHMENT OF NEURONS,0.0010865,0.13176,0.1396,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.041383,0.13069,0.11477,1,1
2,GO HEAT GENERATION,0.0042636,0.13039,0.15425,1,1
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0074579,0.13039,0.12743,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.028556,0.13015,0.12498,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.011949,0.12981,0.11805,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.054582,0.12978,0.16303,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.00060545,0.12972,0.13486,1,1
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.030994,0.12961,0.15448,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.046031,0.12951,0.089425,1,1
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00015083,0.12951,0.15091,1,1
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.031311,0.12942,0.089666,1,1
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0018256,0.12912,0.15928,1,1
2,GO APPENDAGE DEVELOPMENT,0.0086125,0.12896,0.12613,1,1
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0021505,0.12875,0.18184,1,1
2,GO MUSCLE FIBER DEVELOPMENT,0.0020092,0.12867,0.16639,1,1
2,GO NON MOTILE CILIUM ASSEMBLY,0.042609,0.12867,0.11083,1,1
2,GO GAMETE GENERATION,0.00038422,0.12866,0.12856,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0038478,0.12854,0.10556,1,1
2,GO POSITIVE REGULATION OF DNA BINDING,0.0033361,0.12854,0.12492,1,1
2,GO HEART VALVE DEVELOPMENT,0.013394,0.12787,0.14071,1,1
2,GO SPECIFICATION OF SYMMETRY,0.001568,0.12754,0.11405,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0044864,0.12729,0.12625,1,1
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.02915,0.12708,0.086553,1,1
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0041031,0.12697,0.12995,1,1
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03068,0.12692,0.12254,1,1
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.018693,0.12655,0.12695,1,1
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0010408,0.12639,0.13714,1,1
2,GO TUBE FORMATION,0.057179,0.12544,0.093773,1,1
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.016027,0.12461,0.14307,1,1
2,GO MYOBLAST PROLIFERATION,0.0053519,0.12454,0.1348,1,1
2,GO POSITIVE REGULATION OF CELL DIVISION,0.0069343,0.12433,0.12869,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0018508,0.1242,0.15746,1,1
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.047372,0.12417,0.10588,1,1
2,GO REGULATION OF CENTRIOLE REPLICATION,0.058247,0.1237,0.13815,1,1
2,GO AXIS SPECIFICATION,0.0078263,0.12355,0.12093,1,1
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.026561,0.12265,0.12108,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001776,0.12258,0.16957,1,1
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00096848,0.12253,0.11934,1,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.023419,0.12247,0.098849,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.052575,0.12238,0.099288,1,1
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.046474,0.1223,0.11561,1,1
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.030368,0.12213,0.087178,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.010279,0.12206,0.14153,1,1
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.00082553,0.12178,0.13777,1,1
2,GO REGULATION OF SODIUM ION TRANSPORT,0.001568,0.12146,0.15421,1,1
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.028264,0.12113,0.12937,1,1
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.022686,0.12103,0.086767,1,1
2,GO GROOMING BEHAVIOR,0.0078263,0.12069,0.15595,1,1
2,GO CARDIAC SEPTUM DEVELOPMENT,0.0098086,0.12067,0.14567,1,1
2,GO REGULATION OF PHOSPHATASE ACTIVITY,5.4184e-05,0.12037,0.14844,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00159,0.12029,0.1051,1,1
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.025475,0.1201,0.12117,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0044298,0.12002,0.097012,1,1
2,GO REGULATION OF GLIOGENESIS,0.0032078,0.11952,0.12598,1,1
2,GO COVALENT CHROMATIN MODIFICATION,0.0003557,0.1195,0.12862,1,1
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0023957,0.11918,0.1245,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0088198,0.1189,0.13326,1,1
2,GO REGULATION OF CHROMATIN BINDING,0.010645,0.11854,0.17199,1,1
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.5359e-06,0.11852,0.1651,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.021509,0.11815,0.13379,1,1
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.00046872,0.11788,0.12016,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.038258,0.11783,0.13163,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.020605,0.11773,0.090821,1,1
2,GO NAD METABOLIC PROCESS,0.018898,0.11749,0.14367,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.00010497,0.11744,0.14468,1,1
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.00032916,0.11616,0.12075,1,1
2,GO SEXUAL REPRODUCTION,0.00022565,0.11541,0.12164,1,1
2,GO ACTION POTENTIAL,0.002702,0.11526,0.1546,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0044298,0.11489,0.12507,1,1
2,GO REGULATION OF RNA SPLICING,0.00098255,0.11472,0.12225,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.002631,0.11466,0.11609,1,1
2,GO RESPONSE TO AMYLOID BETA,0.027973,0.11433,0.11742,1,1
2,GO RRNA CATABOLIC PROCESS,0.034984,0.11417,0.10446,1,1
2,GO CILIUM MOVEMENT,0.001235,0.11317,0.14931,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.034636,0.11289,0.113,1,1
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0007786,0.11245,0.11624,1,1
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.001955,0.11241,0.13223,1,1
2,GO RHYTHMIC PROCESS,0.00025215,0.11241,0.13347,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.0021505,0.11229,0.1399,1,1
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0005789,0.11143,0.11365,1,1
2,GO SPERMATID DIFFERENTIATION,0.00074504,0.11112,0.12446,1,1
2,GO MICROTUBULE BASED PROCESS,1.2253e-05,0.11085,0.1602,1,1
2,GO CELL CYCLE ARREST,0.001776,0.11076,0.11364,1,1
2,GO RECEPTOR METABOLIC PROCESS,0.00088789,0.11053,0.12734,1,1
2,GO HORMONE TRANSPORT,0.0066851,0.11009,0.1126,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0023957,0.10984,0.11149,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0035146,0.10958,0.10454,1,1
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.065005,0.10949,0.069522,1,1
2,GO POSITIVE REGULATION OF MYELINATION,0.02128,0.10949,0.09861,1,1
2,GO GROWTH,0.0013826,0.10945,0.10837,1,1
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.062114,0.10933,0.089575,1,1
2,GO MISMATCH REPAIR,0.01585,0.10916,0.11244,1,1
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0028492,0.10915,0.13483,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,0.022928,0.10901,0.086221,1,1
2,GO FEMALE GAMETE GENERATION,0.003607,0.1087,0.10605,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0062108,0.1085,0.091894,1,1
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.027401,0.10844,0.093441,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.045155,0.10834,0.091753,1,1
2,GO EATING BEHAVIOR,0.021509,0.10812,0.11121,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0098086,0.10713,0.13036,1,1
2,GO PEPTIDYL LYSINE METHYLATION,0.0032501,0.10701,0.13771,1,1
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.044292,0.10661,0.17825,1,1
2,GO ONE CARBON METABOLIC PROCESS,0.02945,0.1064,0.11264,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.054582,0.10551,0.10458,1,1
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0016347,0.10544,0.1495,1,1
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00030928,0.1053,0.15688,1,1
2,GO LENS FIBER CELL DIFFERENTIATION,0.040981,0.10422,0.12157,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.049212,0.10363,0.11354,1,1
2,GO CALCINEURIN MEDIATED SIGNALING,0.0059852,0.10311,0.1531,1,1
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.00036686,0.10289,0.14528,1,1
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.018693,0.10278,0.10721,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0098086,0.1026,0.13358,1,1
2,GO REGULATION OF DEPHOSPHORYLATION,0.00021857,0.10254,0.13033,1,1
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.050154,0.10222,0.1159,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.011813,0.10215,0.12096,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.053071,0.1016,0.10454,1,1
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.01829,0.10104,0.10047,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.021509,0.10084,0.078576,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.027973,0.10081,0.11872,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00068191,0.10017,0.12241,1,1
2,GO CHROMATIN ORGANIZATION,0.0037498,0.099545,0.11798,1,1
2,GO MULTI ORGANISM PROCESS,0.0020646,0.099511,0.098288,1,1
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0043737,0.099262,0.11228,1,1
2,GO REGULATION OF PROTEIN DEACETYLATION,0.013546,0.098979,0.11058,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.002631,0.098826,0.1166,1,1
2,GO RESPONSE TO AMINO ACID STARVATION,0.01585,0.098609,0.10865,1,1
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00022927,0.098524,0.095863,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.037139,0.0983,0.079254,1,1
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0027747,0.098275,0.13585,1,1
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.001422,0.098178,0.10486,1,1
2,GO SODIUM ION TRANSPORT,0.0017517,0.097594,0.12211,1,1
2,GO ESTABLISHMENT OF CELL POLARITY,0.0062877,0.097567,0.11711,1,1
2,GO NEURON DEATH,0.0018256,0.097471,0.10884,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.012945,0.096085,0.12201,1,1
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.025475,0.095833,0.096977,1,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.046921,0.095562,0.080052,1,1
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.016752,0.095468,0.11827,1,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.0039992,0.095103,0.10704,1,1
2,GO ORGAN GROWTH,0.012653,0.095023,0.093087,1,1
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00099681,0.094868,0.10846,1,1
2,GO REGULATION OF ORGAN GROWTH,0.041789,0.094508,0.084831,1,1
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.02174,0.093824,0.13079,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.025743,0.093814,0.092004,1,1
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.020166,0.093781,0.089707,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.046031,0.093728,0.091872,1,1
2,GO NEGATIVE REGULATION OF BINDING,0.001071,0.093453,0.11803,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.011544,0.093186,0.11617,1,1
2,GO REGULATION OF CIRCADIAN RHYTHM,0.0020646,0.09289,0.13527,1,1
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.0023637,0.092364,0.11849,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.013856,0.09182,0.10743,1,1
2,GO LIPID PHOSPHORYLATION,0.012367,0.091808,0.11156,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.018693,0.091599,0.10272,1,1
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.001118,0.091394,0.11321,1,1
2,GO RESPONSE TO ACID CHEMICAL,0.026286,0.090973,0.0874,1,1
2,GO SKELETAL MUSCLE CONTRACTION,0.0047198,0.090753,0.14997,1,1
2,GO RESPONSE TO ATP,0.0137,0.089887,0.098347,1,1
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.038258,0.08977,0.10801,1,1
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.01995,0.089679,0.12365,1,1
2,GO CALCIUM MEDIATED SIGNALING,0.024687,0.089137,0.06938,1,1
2,GO REGULATION OF HISTONE MODIFICATION,0.0039481,0.088452,0.1042,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0011668,0.087882,0.13975,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.052083,0.087481,0.13115,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.046921,0.087134,0.091885,1,1
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.040187,0.08711,0.075598,1,1
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.011813,0.087046,0.10109,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.062114,0.086732,0.080563,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.052575,0.086638,0.096607,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.020385,0.086427,0.082119,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.044292,0.086231,0.077498,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.026286,0.082822,0.079018,1,1
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0034243,0.082673,0.11189,1,1
2,GO REPRODUCTION,0.013546,0.081644,0.085827,1,1
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.004964,0.08154,0.10981,1,1
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.058247,0.080373,0.096754,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00029511,0.079479,0.14305,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.048285,0.07919,0.078179,1,1
2,GO PROTEIN METHYLATION,0.0085105,0.078036,0.12223,1,1
2,GO PROTEIN AUTOUBIQUITINATION,0.017506,0.077327,0.09534,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.014494,0.076738,0.092012,1,1
2,GO DEVELOPMENTAL INDUCTION,0.045155,0.076593,0.125,1,1
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.019312,0.075753,0.084063,1,1
2,GO REGULATION OF GROWTH,0.0054192,0.075626,0.095314,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.019735,0.075177,0.10057,1,1
2,GO REGULATION OF PROTEIN TARGETING,0.0032928,0.073257,0.10381,1,1
2,GO STEM CELL DIFFERENTIATION,0.041789,0.073211,0.068264,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.018898,0.072385,0.08209,1,1
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.01849,0.07133,0.10284,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.019523,0.071157,0.082242,1,1
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.064418,0.070807,0.076038,1,1
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.02945,0.070614,0.088527,1,1
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.05357,0.070325,0.068175,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.01128,0.070191,0.093262,1,1
2,GO FERTILIZATION,0.0050269,0.069748,0.096603,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE,0.045591,0.06963,0.059412,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0044864,0.069375,0.1093,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.054074,0.069157,0.10161,1,1
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.017699,0.068947,0.082577,1,1
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.052575,0.068821,0.089538,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.017699,0.067289,0.080663,1,1
2,GO SINGLE FERTILIZATION,0.046474,0.067285,0.077886,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,0.044722,0.066907,0.071117,1,1
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.028264,0.066678,0.096608,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.013856,0.065557,0.084402,1,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.032938,0.064306,0.070181,1,1
2,GO NADH METABOLIC PROCESS,0.029754,0.063689,0.13495,1,1
2,GO MACROMOLECULE DEACYLATION,0.0039992,0.063644,0.11171,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.018693,0.063433,0.07859,1,1
2,GO GENE SILENCING,0.042197,0.063312,0.071891,1,1
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.045591,0.060887,0.11163,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.047827,0.05934,0.069099,1,1
2,GO NEGATIVE REGULATION OF SECRETION,0.032607,0.058128,0.072329,1,1
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.026286,0.0572,0.088052,1,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.043444,0.048146,0.080277,1,1
2,GO REGULATION OF CELL CYCLE,0.017125,0.047587,0.08528,1,1
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.065596,0.045623,0.10033,1,1
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.019735,0.044818,0.069782,1,1
2,GO CELL CYCLE PROCESS,0.017125,0.042848,0.089562,1,1
2,GO INNERVATION,6.2169e-06,0.36564,0.46147,1,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0049019,0.27544,0.24088,1,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.065596,0.24514,0.14751,1,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0032501,0.23253,0.2863,1,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0035605,0.2302,0.19129,1,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.006444,0.22198,0.19398,1,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,9.9844e-05,0.22059,0.27633,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.019523,0.20586,0.28598,1,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0010408,0.20073,0.19223,1,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00047589,0.19708,0.20025,1,0
2,GO HEPARIN METABOLIC PROCESS,0.044292,0.19119,0.12236,1,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.00092737,0.19115,0.18655,1,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,7.0072e-05,0.1877,0.20857,1,0
2,GO PERICARDIUM DEVELOPMENT,0.040981,0.1862,0.12828,1,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.047372,0.18332,0.14516,1,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.00039622,0.18157,0.18701,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,5.9498e-07,0.18084,0.20332,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.001483,0.17759,0.24866,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.00030449,0.17666,0.1926,1,0
2,GO NERVE DEVELOPMENT,0.00082553,0.17572,0.24499,1,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.00092737,0.17351,0.17466,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,8.4262e-06,0.17344,0.24436,1,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0024609,0.17259,0.22656,1,0
2,GO CARDIAC CONDUCTION,6.2175e-05,0.17242,0.21166,1,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0087156,0.16906,0.14514,1,0
2,GO CELL JUNCTION ORGANIZATION,2.6352e-05,0.16712,0.1799,1,0
2,GO ENERGY HOMEOSTASIS,0.0050269,0.16638,0.17021,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0030038,0.16546,0.26161,1,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.019104,0.16289,0.20428,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0056255,0.15884,0.14779,1,0
2,GO HIPPO SIGNALING,0.043444,0.15823,0.13365,1,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.0050269,0.15419,0.17027,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,5.6487e-06,0.15231,0.18499,1,0
2,GO FEMALE SEX DIFFERENTIATION,9.3381e-05,0.15157,0.17483,1,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.054582,0.15104,0.11758,1,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00030449,0.14992,0.15723,1,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.029754,0.14932,0.24723,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,7.3739e-05,0.14856,0.18013,1,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.054582,0.14761,0.10902,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.023173,0.14737,0.16882,1,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.046474,0.14668,0.20459,1,0
2,GO RESPONSE TO STEROL,0.00053704,0.14629,0.194,1,0
2,GO IMPORT INTO CELL,0.00035024,0.14433,0.15575,1,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.065005,0.14288,0.12754,1,0
2,GO RESPONSE TO CATECHOLAMINE,0.00012594,0.14021,0.17415,1,0
2,GO ARGININE METABOLIC PROCESS,0.062684,0.13965,0.11193,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0095807,0.13964,0.24773,1,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.043444,0.13954,0.12901,1,0
2,GO CRANIAL NERVE DEVELOPMENT,0.03429,0.13923,0.16781,1,0
2,GO POTASSIUM ION HOMEOSTASIS,0.00072342,0.13858,0.20787,1,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.062114,0.13845,0.23078,1,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.001776,0.13539,0.16379,1,0
2,GO CELL CELL SIGNALING,3.2784e-06,0.13537,0.15548,1,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.011678,0.13524,0.18092,1,0
2,GO GLIOGENESIS,0.00014362,0.13391,0.15909,1,0
2,GO REGULATION OF SYSTEM PROCESS,1.7706e-05,0.1339,0.16581,1,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.006444,0.13347,0.20821,1,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.048746,0.13344,0.15894,1,0
2,GO MEMBRANE DEPOLARIZATION,0.024687,0.13245,0.12818,1,0
2,GO GLIAL CELL PROLIFERATION,0.044722,0.13226,0.10637,1,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0073682,0.13206,0.18399,1,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0074579,0.13082,0.13554,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0016575,0.13045,0.20058,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0047798,0.1304,0.21263,1,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.03068,0.13037,0.1174,1,0
2,GO NERVOUS SYSTEM PROCESS,9.086e-06,0.13022,0.14941,1,0
2,GO DEVELOPMENTAL MATURATION,3.3214e-05,0.12924,0.15638,1,0
2,GO SENSORY PERCEPTION OF PAIN,7.5001e-05,0.12822,0.16224,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.536e-06,0.12791,0.14988,1,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00072342,0.1279,0.20106,1,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.0031247,0.12771,0.13879,1,0
2,GO SOMITOGENESIS,0.0012177,0.12612,0.1292,1,0
2,GO DENDRITE EXTENSION,0.00069207,0.12363,0.21774,1,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.001235,0.12222,0.16609,1,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.013243,0.12219,0.16577,1,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.00081356,0.12186,0.11924,1,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0033361,0.12133,0.13023,1,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0011021,0.11972,0.1631,1,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.02174,0.11925,0.11401,1,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0027747,0.1186,0.11778,1,0
2,GO BLASTODERM SEGMENTATION,0.055609,0.11705,0.14866,1,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.01995,0.11615,0.10605,1,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.01251,0.11591,0.13726,1,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0010259,0.11495,0.14761,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.01499,0.11482,0.17618,1,0
2,GO CELL JUNCTION ASSEMBLY,0.012945,0.11467,0.11898,1,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.018091,0.11446,0.11232,1,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,6.1119e-05,0.11434,0.15588,1,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00024819,0.11408,0.14006,1,0
2,GO RESPONSE TO BMP,0.019735,0.11289,0.11676,1,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.057179,0.11286,0.11434,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.043025,0.11242,0.16299,1,0
2,GO SECONDARY PALATE DEVELOPMENT,0.024947,0.11199,0.15292,1,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.046031,0.11137,0.12803,1,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.0025277,0.11062,0.14594,1,0
2,GO HEART PROCESS,0.0030436,0.11062,0.12892,1,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.060432,0.11022,0.12436,1,0
2,GO BONE GROWTH,0.014013,0.11022,0.16878,1,0
2,GO OPTIC NERVE DEVELOPMENT,0.02945,0.11019,0.20926,1,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.038637,0.11017,0.10241,1,0
2,GO REGULATION OF ENDOCYTOSIS,0.0052854,0.1098,0.11152,1,0
2,GO RNA INTERFERENCE,0.060432,0.10862,0.091085,1,0
2,GO MITRAL VALVE DEVELOPMENT,0.024173,0.10719,0.15111,1,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.00019857,0.10651,0.12829,1,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00024045,0.10649,0.19107,1,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.031631,0.10607,0.11767,1,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.060988,0.1052,0.10728,1,0
2,GO BONE DEVELOPMENT,0.038258,0.10414,0.092175,1,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.022209,0.10379,0.15963,1,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.055093,0.10373,0.078117,1,0
2,GO SIGNAL RELEASE,0.00062378,0.10354,0.13459,1,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.036048,0.10352,0.1125,1,0
2,GO REGULATION OF ION TRANSPORT,0.00060545,0.10292,0.1265,1,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.066792,0.10262,0.11444,1,0
2,GO REGULATION OF BLOOD CIRCULATION,0.004156,0.10247,0.12409,1,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0099244,0.10191,0.16246,1,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0023009,0.10161,0.15549,1,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0047798,0.10147,0.11126,1,0
2,GO CHLORIDE TRANSPORT,0.0076401,0.10064,0.096964,1,0
2,GO LIPID DROPLET ORGANIZATION,0.060432,0.10032,0.076992,1,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.0070192,0.099978,0.10669,1,0
2,GO ANION HOMEOSTASIS,0.023419,0.099973,0.11775,1,0
2,GO RECEPTOR RECYCLING,0.036048,0.09993,0.091991,1,0
2,GO ACROSOME REACTION,0.022928,0.099318,0.14772,1,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.026286,0.099016,0.12278,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.031631,0.098418,0.1097,1,0
2,GO REGULATION OF DENDRITE EXTENSION,0.023668,0.098064,0.21891,1,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.015501,0.09753,0.15989,1,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.0052854,0.097412,0.11099,1,0
2,GO RESPONSE TO CARBOHYDRATE,0.020166,0.096784,0.084566,1,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.040981,0.096685,0.14526,1,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.011813,0.096273,0.12388,1,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.01585,0.096143,0.091491,1,0
2,GO EAR DEVELOPMENT,0.019312,0.095867,0.12937,1,0
2,GO ANIMAL ORGAN MATURATION,0.018898,0.095653,0.13144,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.039406,0.094137,0.16791,1,0
2,GO METAL ION TRANSPORT,0.0018508,0.092906,0.10565,1,0
2,GO REGULATION OF SECRETION,0.014823,0.092699,0.089578,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0010865,0.092435,0.10351,1,0
2,GO REGULATION OF METAL ION TRANSPORT,0.0024281,0.092316,0.10858,1,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.014494,0.092009,0.14419,1,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.056128,0.092,0.10034,1,0
2,GO ASTROCYTE DEVELOPMENT,0.017315,0.09186,0.13655,1,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0083098,0.09127,0.1004,1,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.0071918,0.09124,0.099014,1,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.022686,0.090894,0.17376,1,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.0104,0.090688,0.10174,1,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00037257,0.090349,0.13002,1,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.01849,0.089541,0.097351,1,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.027973,0.089329,0.10308,1,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0055559,0.089221,0.14181,1,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.0084096,0.088942,0.13321,1,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.01995,0.088899,0.17958,1,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.0032928,0.08871,0.10142,1,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.061549,0.088501,0.12159,1,0
2,GO CHLORIDE ION HOMEOSTASIS,0.014494,0.088368,0.20341,1,0
2,GO SENSORY PERCEPTION OF SMELL,0.032938,0.087915,0.072299,1,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.02174,0.087631,0.12159,1,0
2,GO RESPONSE TO CALCIUM ION,0.058787,0.087522,0.0812,1,0
2,GO REGULATION OF GLUCOSE IMPORT,0.042197,0.087472,0.10158,1,0
2,GO STRIATED MUSCLE ADAPTATION,0.051111,0.086986,0.10239,1,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.048285,0.086604,0.062451,1,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.017125,0.086566,0.14957,1,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0027381,0.08572,0.10554,1,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.008211,0.085696,0.10053,1,0
2,GO RESPONSE TO ALKALOID,0.0056255,0.085224,0.10373,1,0
2,GO CELL GROWTH,0.0019819,0.084978,0.10691,1,0
2,GO CELL CELL SIGNALING BY WNT,0.0028872,0.084704,0.11247,1,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.061549,0.084466,0.089794,1,0
2,GO CATION TRANSPORT,0.0029256,0.084364,0.1037,1,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.043444,0.08431,0.11651,1,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.02174,0.084191,0.084338,1,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.00092737,0.084174,0.11724,1,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.028852,0.084031,0.08509,1,0
2,GO CYTOSKELETON ORGANIZATION,0.0021505,0.082962,0.10874,1,0
2,GO EXCRETION,0.011022,0.082696,0.11395,1,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.046031,0.082564,0.077423,1,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.012227,0.082522,0.088773,1,0
2,GO DEPHOSPHORYLATION,0.0054192,0.08251,0.093093,1,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.051595,0.081399,0.079473,1,0
2,GO REGULATION OF TRANSPORT,0.0059852,0.081262,0.090001,1,0
2,GO STRIATED MUSCLE CONTRACTION,0.035336,0.081122,0.094995,1,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0023009,0.08093,0.11622,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.055609,0.080658,0.083605,1,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.055093,0.08004,0.086634,1,0
2,GO PROTEIN KINASE A SIGNALING,0.065596,0.079903,0.095683,1,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.044292,0.079676,0.076462,1,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.064418,0.079283,0.079844,1,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.037882,0.079102,0.092696,1,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0049019,0.07893,0.11528,1,0
2,GO KIDNEY MORPHOGENESIS,0.055609,0.078582,0.099112,1,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.053071,0.078466,0.094056,1,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.013394,0.078199,0.12341,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.012653,0.078015,0.12141,1,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.049681,0.077946,0.08019,1,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0044864,0.077335,0.096677,1,0
2,GO RESPONSE TO MONOSACCHARIDE,0.01128,0.077285,0.092885,1,0
2,GO REGULATION OF DNA REPAIR,0.001704,0.077236,0.12541,1,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.02915,0.076578,0.096348,1,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.0071918,0.076564,0.10775,1,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.0083098,0.076098,0.14681,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.051111,0.075983,0.080481,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.035336,0.075975,0.090214,1,0
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.054582,0.075658,0.068405,1,0
2,GO REGULATION OF GTPASE ACTIVITY,0.0075485,0.075575,0.10482,1,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.067397,0.075509,0.10592,1,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.014332,0.075224,0.13336,1,0
2,GO EMBRYONIC MORPHOGENESIS,0.02915,0.075136,0.094933,1,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.024947,0.074542,0.080538,1,0
2,GO ION TRANSPORT,0.01585,0.073617,0.079988,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.035336,0.073578,0.094995,1,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.012087,0.073016,0.093922,1,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.040187,0.07245,0.087738,1,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.056128,0.072396,0.14348,1,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.023173,0.072146,0.13062,1,0
2,GO TRANSMEMBRANE TRANSPORT,0.027401,0.071926,0.0698,1,0
2,GO CIRCULATORY SYSTEM PROCESS,0.019735,0.071581,0.086125,1,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.02915,0.071576,0.092821,1,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0065235,0.071202,0.11345,1,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.062684,0.070985,0.091446,1,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.052575,0.070951,0.078218,1,0
2,GO CELL MATURATION,0.016386,0.070511,0.09321,1,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.056652,0.070305,0.10018,1,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.041383,0.069721,0.08003,1,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.023668,0.069586,0.085055,1,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.020166,0.069465,0.13937,1,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027118,0.069254,0.093839,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.048746,0.068976,0.094365,1,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.047372,0.068725,0.073474,1,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.028556,0.068561,0.083436,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.050154,0.068513,0.10286,1,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.051111,0.06832,0.088256,1,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.062114,0.068217,0.071455,1,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.002631,0.068049,0.095437,1,0
2,GO MUSCLE CONTRACTION,0.023419,0.067531,0.08412,1,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.033948,0.067452,0.12502,1,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.060432,0.067406,0.074166,1,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.048746,0.06711,0.074367,1,0
2,GO SENSORY PERCEPTION,0.0078263,0.067083,0.087019,1,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.023419,0.067063,0.088135,1,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.018091,0.066806,0.10176,1,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.063258,0.06659,0.068256,1,0
2,GO EXOCYTIC PROCESS,0.067397,0.066165,0.10623,1,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0070192,0.065618,0.10601,1,0
2,GO CIRCADIAN RHYTHM,0.007921,0.063486,0.10361,1,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0095807,0.063196,0.086377,1,0
2,GO RESPONSE TO VITAMIN A,0.066792,0.062875,0.14072,1,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.015501,0.062657,0.09203,1,0
2,GO HEART GROWTH,0.058787,0.062511,0.084948,1,0
2,GO FOREGUT MORPHOGENESIS,0.062684,0.062379,0.11542,1,0
2,GO RESPONSE TO GROWTH FACTOR,0.062114,0.061463,0.073648,1,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.026013,0.060188,0.10926,1,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.049212,0.060134,0.11194,1,0
2,GO LYSOSOMAL TRANSPORT,0.049681,0.059332,0.087238,1,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.014013,0.059327,0.092623,1,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.015501,0.058608,0.092272,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.049681,0.058405,0.062355,1,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.0062108,0.058344,0.091167,1,0
2,GO HYPOTONIC RESPONSE,0.043444,0.056837,0.16036,1,0
2,GO MUSCLE SYSTEM PROCESS,0.047372,0.056412,0.075026,1,0
2,GO HISTONE DEACETYLATION,0.027118,0.055437,0.10964,1,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.020166,0.055207,0.093577,1,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.058787,0.054927,0.072214,1,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.022686,0.054035,0.10247,1,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0104,0.053872,0.086813,1,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.020605,0.053037,0.091791,1,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.065005,0.051979,0.10823,1,0
2,GO PEPTIDYL SERINE MODIFICATION,0.020605,0.05018,0.086935,1,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.046921,0.049605,0.076899,1,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.037882,0.049307,0.097765,1,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.03068,0.047533,0.10561,1,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.058247,0.045482,0.098572,1,0
2,GO MRNA METABOLIC PROCESS,0.043444,0.045362,0.063173,1,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037882,0.041603,0.08816,1,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.053071,0.041334,0.065452,1,0
2,GO HISTONE H3 ACETYLATION,0.028556,0.040726,0.08911,1,0
2,GO RNA POLYADENYLATION,0.066792,0.039872,0.087741,1,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.052083,0.039331,0.076026,1,0
2,GO CELL CYCLE,0.029754,0.036955,0.08196,1,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.056652,0.035505,0.074829,1,0
2,GO MRNA 3 END PROCESSING,0.040582,0.034605,0.090076,1,0
2,GO CELL DIVISION,0.055609,0.03448,0.084881,1,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.05357,0.031274,0.073093,1,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.046031,0.030592,0.13865,1,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.047827,0.015801,0.068767,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.041789,-0.029757,-0.0974,1,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.060988,-0.038951,-0.093755,1,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.054582,-0.040141,-0.10679,1,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.061549,-0.042026,-0.085033,1,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.031631,-0.044977,-0.099036,1,0
2,GO GRANULOCYTE MIGRATION,0.031631,-0.045813,-0.095196,1,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.030994,-0.048299,-0.062039,1,0
2,GO ESTROGEN METABOLIC PROCESS,0.041383,-0.049408,-0.082212,1,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.065005,-0.049702,-0.19765,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.048285,-0.050844,-0.098536,1,0
2,GO RESPONSE TO GAMMA RADIATION,0.028556,-0.05183,-0.075226,1,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.040187,-0.052563,-0.093033,1,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.062684,-0.053755,-0.077504,1,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.037139,-0.053758,-0.052556,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.058787,-0.054123,-0.076411,1,0
2,GO RESPONSE TO INTERLEUKIN 1,0.066792,-0.054414,-0.069457,1,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.033271,-0.05716,-0.090719,1,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.065005,-0.057277,-0.098011,1,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.022686,-0.058489,-0.098403,1,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.035691,-0.059138,-0.10473,1,0
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.066792,-0.059269,-0.064701,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.050154,-0.059394,-0.069353,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.056652,-0.059676,-0.15363,1,0
2,GO REGULATION OF PH,0.042197,-0.059862,-0.047895,1,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.057711,-0.060042,-0.10304,1,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.062684,-0.060977,-0.067755,1,0
2,GO NEGATIVE T CELL SELECTION,0.05357,-0.061261,-0.1099,1,0
2,GO SPERM EGG RECOGNITION,0.012367,-0.061775,-0.076813,1,0
2,GO VITAMIN METABOLIC PROCESS,0.055093,-0.06236,-0.061605,1,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.027973,-0.062537,-0.098627,1,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.028264,-0.063124,-0.064172,1,0
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.047827,-0.063149,-0.12151,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.045155,-0.063269,-0.11015,1,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.047372,-0.063349,-0.078254,1,0
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.058247,-0.063383,-0.090795,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.062114,-0.063921,-0.094323,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.040981,-0.064081,-0.081398,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.028852,-0.064288,-0.092165,1,0
2,GO INTERACTION WITH HOST,0.065596,-0.065324,-0.078155,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.049681,-0.065388,-0.066388,1,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.032607,-0.065596,-0.091872,1,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.020385,-0.066647,-0.088148,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.067397,-0.066692,-0.084949,1,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.061549,-0.066921,-0.085986,1,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.03006,-0.067491,-0.10944,1,0
2,GO VESICLE TARGETING,0.051111,-0.067508,-0.059597,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.058787,-0.06909,-0.089047,1,0
2,GO PROTEIN PROCESSING,0.057711,-0.06909,-0.055525,1,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.065005,-0.069157,-0.046385,1,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.053071,-0.069168,-0.09009,1,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.03902,-0.069215,-0.092063,1,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.015159,-0.07042,-0.07883,1,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.043444,-0.070744,-0.077339,1,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.016568,-0.070874,-0.083609,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020605,-0.07137,-0.045905,1,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.056652,-0.072149,-0.093615,1,0
2,GO RNA 5 END PROCESSING,0.023419,-0.072391,-0.11092,1,0
2,GO RESPONSE TO BACTERIUM,0.040187,-0.072543,-0.079369,1,0
2,GO IMMUNOGLOBULIN SECRETION,0.046031,-0.072686,-0.11632,1,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.010645,-0.072704,-0.08059,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.03902,-0.073282,-0.099315,1,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.011813,-0.073833,-0.092981,1,0
2,GO RIG I SIGNALING PATHWAY,0.059879,-0.074174,-0.08905,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.02915,-0.074286,-0.07528,1,0
2,GO RUFFLE ASSEMBLY,0.046921,-0.074571,-0.055896,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.027686,-0.075026,-0.11035,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027686,-0.07509,-0.066784,1,0
2,GO REGULATION OF CELLULAR PH,0.015674,-0.075192,-0.061579,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.057711,-0.075429,-0.11522,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.041383,-0.07561,-0.070028,1,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.038258,-0.076357,-0.11985,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.062114,-0.077379,-0.081955,1,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.066792,-0.07795,-0.099074,1,0
2,GO COPII COATED VESICLE BUDDING,0.062114,-0.077961,-0.057685,1,0
2,GO GRANULOCYTE CHEMOTAXIS,0.044722,-0.07798,-0.088853,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020385,-0.078241,-0.050977,1,0
2,GO AMINE METABOLIC PROCESS,0.021973,-0.078756,-0.069745,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.028264,-0.078897,-0.096039,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.05357,-0.078916,-0.056809,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.037509,-0.079079,-0.10096,1,0
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.023668,-0.07942,-0.11051,1,0
2,GO GOLGI VESICLE BUDDING,0.045155,-0.079545,-0.061914,1,0
2,GO SENSORY PERCEPTION OF TASTE,0.024173,-0.079589,-0.10194,1,0
2,GO INNATE IMMUNE RESPONSE,0.05357,-0.079733,-0.08767,1,0
2,GO VIRAL RELEASE FROM HOST CELL,0.056128,-0.079804,-0.068118,1,0
2,GO T CELL LINEAGE COMMITMENT,0.048746,-0.079944,-0.070359,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.063836,-0.081051,-0.10218,1,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.032278,-0.081891,-0.08032,1,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.021509,-0.082009,-0.1471,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.055093,-0.082125,-0.055871,1,0
2,GO CELL CELL RECOGNITION,0.021973,-0.082315,-0.064088,1,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.036048,-0.082433,-0.13546,1,0
2,GO T CELL MEDIATED IMMUNITY,0.023668,-0.082638,-0.15029,1,0
2,GO RESPONSE TO INTERFERON GAMMA,0.059331,-0.08279,-0.14045,1,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.054582,-0.083548,-0.10163,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.048285,-0.083751,-0.10103,1,0
2,GO INTERLEUKIN 6 PRODUCTION,0.066792,-0.084175,-0.071275,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.052575,-0.084544,-0.097863,1,0
2,GO AMINO ACID ACTIVATION,0.024947,-0.084788,-0.11123,1,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.065596,-0.084846,-0.071773,1,0
2,GO BONE RESORPTION,0.036409,-0.084985,-0.087573,1,0
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.028852,-0.085749,-0.096803,1,0
2,GO PINOCYTOSIS,0.033948,-0.085973,-0.10407,1,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.013856,-0.086017,-0.066161,1,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.0022396,-0.086229,-0.13455,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.026286,-0.08625,-0.069287,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,0.05063,-0.08669,-0.087707,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.021053,-0.086697,-0.12057,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.040981,-0.086719,-0.070491,1,0
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.054582,-0.086816,-0.075082,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.030994,-0.087175,-0.091583,1,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.017315,-0.087747,-0.1263,1,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0137,-0.087831,-0.10323,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.025475,-0.089415,-0.1423,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.03902,-0.08953,-0.14323,1,0
2,GO TRNA 5 END PROCESSING,0.024428,-0.089766,-0.10445,1,0
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.023919,-0.090267,-0.10036,1,0
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0041031,-0.090647,-0.17415,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.021973,-0.090888,-0.10374,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.043444,-0.090923,-0.084373,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.052575,-0.091849,-0.10112,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.030368,-0.093521,-0.13376,1,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.053071,-0.09366,-0.084351,1,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.019735,-0.093736,-0.12023,1,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0086125,-0.09399,-0.07733,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.011544,-0.094897,-0.10893,1,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.064418,-0.094973,-0.070334,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.014823,-0.096095,-0.15105,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.051111,-0.096135,-0.10888,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.030994,-0.096334,-0.071854,1,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.048285,-0.096398,-0.068049,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.011411,-0.096463,-0.089032,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.016568,-0.096528,-0.076983,1,0
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.036772,-0.096711,-0.083415,1,0
2,GO PROSTANOID METABOLIC PROCESS,0.022686,-0.09683,-0.17887,1,0
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.031311,-0.097065,-0.0921,1,0
2,GO DRUG METABOLIC PROCESS,0.0075485,-0.097448,-0.11594,1,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00081356,-0.097466,-0.17408,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.014823,-0.098069,-0.11305,1,0
2,GO SULFUR COMPOUND TRANSPORT,0.062684,-0.098077,-0.051827,1,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.029754,-0.098345,-0.10888,1,0
2,GO PHAGOSOME MATURATION,0.020828,-0.098448,-0.085831,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.016027,-0.098574,-0.12878,1,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.063836,-0.098694,-0.15789,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.051595,-0.099159,-0.10639,1,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.026838,-0.099503,-0.097039,1,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0137,-0.099754,-0.091552,1,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.0059116,-0.099792,-0.12797,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.059331,-0.099853,-0.059183,1,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.049681,-0.10002,-0.093111,1,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.036772,-0.10004,-0.1012,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.015329,-0.10017,-0.11547,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.055609,-0.10034,-0.095252,1,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.047827,-0.10099,-0.079003,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.012653,-0.1011,-0.09143,1,0
2,GO CHEMOKINE PRODUCTION,0.048746,-0.10168,-0.095664,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.016568,-0.10171,-0.11416,1,0
2,GO WATER HOMEOSTASIS,0.051111,-0.10172,-0.09053,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.065005,-0.10188,-0.17378,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.018091,-0.10209,-0.11635,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.049681,-0.10274,-0.061553,1,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.055609,-0.10276,-0.075462,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.043025,-0.10278,-0.084761,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.019104,-0.10283,-0.084416,1,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.037882,-0.10311,-0.11338,1,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.040582,-0.10324,-0.14403,1,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0094686,-0.10407,-0.14246,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.03068,-0.10441,-0.079284,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.032607,-0.10444,-0.10043,1,0
2,GO CYTOKINETIC PROCESS,0.0065235,-0.10455,-0.1002,1,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.048285,-0.10469,-0.10967,1,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.049212,-0.10497,-0.08224,1,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.016752,-0.10519,-0.078141,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.037509,-0.10573,-0.08587,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.032938,-0.10599,-0.13741,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.022928,-0.10645,-0.1007,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013394,-0.10648,-0.15556,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0087156,-0.10707,-0.1204,1,0
2,GO NECROTIC CELL DEATH,0.02174,-0.10744,-0.10624,1,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.014013,-0.10781,-0.098063,1,0
2,GO VIRION ASSEMBLY,0.0055559,-0.10796,-0.084624,1,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.027686,-0.10821,-0.12373,1,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.015501,-0.10868,-0.1278,1,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0086125,-0.10932,-0.10858,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.043025,-0.11016,-0.084707,1,0
2,GO VACUOLAR ACIDIFICATION,0.0025961,-0.11059,-0.11945,1,0
2,GO ICOSANOID METABOLIC PROCESS,0.0099244,-0.11071,-0.1336,1,0
2,GO MOVEMENT IN HOST ENVIRONMENT,0.020385,-0.11263,-0.1207,1,0
2,GO RESPONSE TO PROTOZOAN,0.031311,-0.11296,-0.13834,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.023919,-0.11298,-0.14506,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.013546,-0.11372,-0.099356,1,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0087156,-0.11372,-0.09052,1,0
2,GO ENTRY INTO HOST,0.023919,-0.11438,-0.13443,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.042197,-0.11451,-0.13124,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0054192,-0.11464,-0.1184,1,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.01499,-0.11476,-0.10391,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.011544,-0.11481,-0.11903,1,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.037509,-0.1155,-0.10163,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.012087,-0.11565,-0.095285,1,0
2,GO INTERLEUKIN 12 PRODUCTION,0.0104,-0.1159,-0.13205,1,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.013243,-0.11624,-0.14026,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.048746,-0.11636,-0.11834,1,0
2,GO KERATINOCYTE DIFFERENTIATION,0.0052854,-0.11651,-0.17911,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0053519,-0.11654,-0.14099,1,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0014624,-0.1172,-0.13621,1,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.05063,-0.11754,-0.053415,1,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.02174,-0.11825,-0.10308,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009139,-0.11864,-0.13836,1,0
2,GO NUCLEOTIDE TRANSPORT,0.050154,-0.11875,-0.059725,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0052854,-0.11919,-0.14464,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.024173,-0.11937,-0.11246,1,0
2,GO B CELL MEDIATED IMMUNITY,0.05063,-0.11962,-0.10836,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.01995,-0.11966,-0.12378,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.022209,-0.12011,-0.1216,1,0
2,GO CELL REDOX HOMEOSTASIS,0.0059852,-0.12045,-0.118,1,0
2,GO PH REDUCTION,0.001442,-0.12073,-0.10048,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.024947,-0.12077,-0.10375,1,0
2,GO PIGMENT METABOLIC PROCESS,0.010279,-0.12096,-0.088557,1,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.020385,-0.12128,-0.12214,1,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0021505,-0.12138,-0.13646,1,0
2,GO AUTOPHAGOSOME MATURATION,0.0076401,-0.12146,-0.10048,1,0
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.044722,-0.12147,-0.13478,1,0
2,GO NADP METABOLIC PROCESS,0.043025,-0.12159,-0.085733,1,0
2,GO LIPID DIGESTION,0.018693,-0.12163,-0.23102,1,0
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.027118,-0.12222,-0.188,1,0
2,GO REGULATION OF ANOIKIS,0.023173,-0.12232,-0.15445,1,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.024947,-0.12234,-0.1365,1,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.011813,-0.12248,-0.10996,1,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0013443,-0.12264,-0.10933,1,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.033948,-0.12329,-0.089848,1,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.010041,-0.12336,-0.15724,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.03006,-0.12342,-0.083455,1,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.033608,-0.12345,-0.09293,1,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0027747,-0.12354,-0.17252,1,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0028492,-0.12359,-0.1322,1,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0094686,-0.12391,-0.11125,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0065235,-0.12415,-0.16544,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0092477,-0.1243,-0.15035,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.055609,-0.1246,-0.13235,1,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.028852,-0.12463,-0.11658,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.060432,-0.12475,-0.068106,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.022209,-0.12508,-0.10992,1,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00034485,-0.12529,-0.16488,1,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0056255,-0.12554,-0.1434,1,0
2,GO CELLULAR DEFENSE RESPONSE,0.0033361,-0.12562,-0.15645,1,0
2,GO REGULATION OF CELL KILLING,0.011544,-0.1258,-0.14758,1,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0029256,-0.1258,-0.132,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0078263,-0.12764,-0.11602,1,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.029754,-0.12769,-0.10321,1,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.028852,-0.12815,-0.15464,1,0
2,GO INTERLEUKIN 10 PRODUCTION,0.0093576,-0.12837,-0.14426,1,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.020605,-0.12887,-0.13583,1,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.040981,-0.12899,-0.10639,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.018693,-0.12916,-0.12643,1,0
2,GO MONONUCLEAR CELL MIGRATION,0.012653,-0.13031,-0.12588,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0037016,-0.13067,-0.10531,1,0
2,GO RUFFLE ORGANIZATION,0.0051547,-0.13115,-0.084746,1,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.023173,-0.13122,-0.10769,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.029754,-0.13178,-0.12353,1,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.036048,-0.13208,-0.068042,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.003654,-0.1322,-0.11842,1,0
2,GO PHAGOSOME ACIDIFICATION,0.0032501,-0.13251,-0.12951,1,0
2,GO INTERLEUKIN 5 PRODUCTION,0.059879,-0.13325,-0.15044,1,0
2,GO TRNA 5 LEADER REMOVAL,0.0024609,-0.13327,-0.13957,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.031311,-0.13359,-0.14779,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0049019,-0.13393,-0.11707,1,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.0034692,-0.13508,-0.1436,1,0
2,GO INTERLEUKIN 8 PRODUCTION,0.0044864,-0.13548,-0.15634,1,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.031953,-0.13592,-0.097124,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.004964,-0.13598,-0.13776,1,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0010865,-0.13617,-0.18683,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0030038,-0.13618,-0.12086,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.057179,-0.13694,-0.085707,1,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.057179,-0.13727,-0.12736,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.067397,-0.13748,-0.13093,1,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.018898,-0.138,-0.12935,1,0
2,GO RESPONSE TO ACIDIC PH,0.05357,-0.1391,-0.1106,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0063654,-0.13918,-0.18093,1,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.035691,-0.13928,-0.1175,1,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0059116,-0.13942,-0.12527,1,0
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0035146,-0.13951,-0.14783,1,0
2,GO HEPATOCYTE DIFFERENTIATION,0.0046018,-0.13968,-0.1706,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.031953,-0.13986,-0.17973,1,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.031311,-0.14055,-0.13619,1,0
2,GO PEPTIDE CROSS LINKING,0.001235,-0.14078,-0.22078,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.010522,-0.14098,-0.13897,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.010041,-0.14099,-0.12874,1,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0052197,-0.14121,-0.12962,1,0
2,GO COPPER ION TRANSPORT,0.0016122,-0.14172,-0.15816,1,0
2,GO REGULATION OF BONE DEVELOPMENT,0.0086125,-0.14193,-0.11097,1,0
2,GO POSITIVE REGULATION OF WOUND HEALING,0.027973,-0.14223,-0.14395,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0095807,-0.14233,-0.10265,1,0
2,GO ETHER METABOLIC PROCESS,0.020385,-0.14274,-0.13244,1,0
2,GO BILE ACID AND BILE SALT TRANSPORT,0.01251,-0.14286,-0.19889,1,0
2,GO PROTEASOME ASSEMBLY,0.00087508,-0.14294,-0.14916,1,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.0088198,-0.14303,-0.13899,1,0
2,GO NUCLEOTIDE SALVAGE,0.05063,-0.14303,-0.11383,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0026663,-0.14322,-0.12414,1,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.03006,-0.14323,-0.12979,1,0
2,GO TRANSCYTOSIS,0.011813,-0.14384,-0.11243,1,0
2,GO CELL KILLING,0.0035146,-0.14389,-0.13786,1,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0035146,-0.14408,-0.19991,1,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0010113,-0.14474,-0.12306,1,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0081133,-0.14475,-0.14886,1,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.0011668,-0.14551,-0.13856,1,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.032278,-0.14577,-0.11064,1,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.028852,-0.14622,-0.084991,1,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.064418,-0.14629,-0.086797,1,0
2,GO INTEGRIN ACTIVATION,0.034636,-0.14646,-0.10337,1,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.023668,-0.1466,-0.12987,1,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.059879,-0.14675,-0.12522,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0092477,-0.14678,-0.14661,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0027381,-0.14701,-0.12473,1,0
2,GO REGULATION OF COAGULATION,0.022209,-0.14759,-0.13767,1,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.028556,-0.148,-0.11275,1,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.03006,-0.14964,-0.12376,1,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.056652,-0.15014,-0.11704,1,0
2,GO RESPONSE TO DSRNA,0.0038478,-0.15039,-0.11762,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0038977,-0.15122,-0.1687,1,0
2,GO APICAL JUNCTION ASSEMBLY,0.035691,-0.1514,-0.11507,1,0
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00053704,-0.15145,-0.14216,1,0
2,GO CD40 SIGNALING PATHWAY,0.0035146,-0.15153,-0.16408,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.044292,-0.15167,-0.13957,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.0025961,-0.15209,-0.12689,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.022928,-0.15242,-0.11712,1,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0020646,-0.15259,-0.15045,1,0
2,GO POSITIVE REGULATION OF CELL KILLING,0.02174,-0.1527,-0.14725,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.011544,-0.15359,-0.14443,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0074579,-0.15424,-0.15351,1,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0065235,-0.15494,-0.19281,1,0
2,GO HEME METABOLIC PROCESS,0.0056958,-0.15513,-0.14363,1,0
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0023957,-0.15517,-0.15799,1,0
2,GO B CELL PROLIFERATION,0.0028118,-0.15518,-0.13521,1,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.001235,-0.15603,-0.15649,1,0
2,GO ETHER BIOSYNTHETIC PROCESS,0.017125,-0.15626,-0.1974,1,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0034243,-0.15703,-0.1934,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0099244,-0.15738,-0.15881,1,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0040509,-0.15764,-0.1209,1,0
2,GO GLUTATHIONE METABOLIC PROCESS,0.0095807,-0.15863,-0.13266,1,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.052575,-0.15866,-0.13355,1,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.00047589,-0.15884,-0.15563,1,0
2,GO INTERLEUKIN 13 PRODUCTION,0.016938,-0.159,-0.19536,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.035691,-0.16012,-0.17,1,0
2,GO NEUTROPHIL HOMEOSTASIS,0.023173,-0.1611,-0.16363,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0011668,-0.1611,-0.16645,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0028118,-0.16116,-0.1724,1,0
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0099244,-0.16128,-0.1557,1,0
2,GO PLASMA MEMBRANE FUSION,0.015159,-0.16201,-0.191,1,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0025277,-0.16247,-0.25177,1,0
2,GO GAP JUNCTION ASSEMBLY,0.037139,-0.16384,-0.13806,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0034243,-0.16428,-0.15117,1,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0054872,-0.16435,-0.14808,1,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.02915,-0.16481,-0.18729,1,0
2,GO O GLYCAN PROCESSING,0.0027747,-0.16673,-0.16396,1,0
2,GO GALACTOSE METABOLIC PROCESS,0.016027,-0.16717,-0.15256,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.00029511,-0.16763,-0.19833,1,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0034243,-0.16765,-0.15984,1,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0025617,-0.16774,-0.24686,1,0
2,GO POSITIVE REGULATION OF COAGULATION,0.024428,-0.16795,-0.12604,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.010895,-0.16829,-0.18479,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.042197,-0.16906,-0.1334,1,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00069207,-0.16922,-0.25872,1,0
2,GO PIGMENT ACCUMULATION,0.030994,-0.17131,-0.14211,1,0
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0043184,-0.17192,-0.24218,1,0
2,GO MONOCYTE CHEMOTAXIS,0.00040857,-0.17214,-0.20153,1,0
2,GO VITAMIN D METABOLIC PROCESS,0.0031247,-0.17241,-0.20389,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.061549,-0.17281,-0.1572,1,0
2,GO TYPE I INTERFERON PRODUCTION,0.033271,-0.1743,-0.088618,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.016568,-0.17446,-0.25683,1,0
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0054872,-0.17551,-0.1441,1,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.026561,-0.17705,-0.17896,1,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010852,-0.17714,-0.18571,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.012653,-0.17721,-0.15813,1,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0037498,-0.1776,-0.20256,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.002702,-0.1784,-0.12525,1,0
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0028872,-0.17877,-0.16707,1,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0020367,-0.17903,-0.20096,1,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0028118,-0.17941,-0.19056,1,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.012367,-0.1795,-0.19118,1,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,7.7586e-05,-0.17973,-0.15838,1,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0013633,-0.18007,-0.16687,1,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.019104,-0.18253,-0.16931,1,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.060432,-0.18472,-0.11586,1,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0028492,-0.18524,-0.24648,1,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.0024941,-0.18552,-0.11772,1,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.014823,-0.18601,-0.12308,1,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.027973,-0.18612,-0.18474,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.017506,-0.18627,-0.12703,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00092737,-0.18734,-0.23447,1,0
2,GO MICROVILLUS ORGANIZATION,0.021509,-0.18735,-0.14969,1,0
2,GO PLATELET AGGREGATION,0.017506,-0.18821,-0.12113,1,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0030436,-0.18826,-0.14409,1,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0016122,-0.19,-0.25638,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.057711,-0.19015,-0.14815,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00090088,-0.19015,-0.18821,1,0
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.015674,-0.19049,-0.15567,1,0
2,GO RESPONSE TO LITHIUM ION,0.0068504,-0.19071,-0.15478,1,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0031247,-0.19315,-0.22718,1,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0054192,-0.19338,-0.12401,1,0
2,GO B CELL APOPTOTIC PROCESS,0.00075607,-0.19398,-0.19615,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0020092,-0.19418,-0.18854,1,0
2,GO DETECTION OF OTHER ORGANISM,0.034636,-0.19434,-0.17709,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0081133,-0.1959,-0.16784,1,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0020092,-0.19601,-0.13858,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.047827,-0.19647,-0.14022,1,0
2,GO CERAMIDE CATABOLIC PROCESS,0.032938,-0.19658,-0.13692,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00014362,-0.1976,-0.16257,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.015674,-0.19763,-0.2496,1,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0023957,-0.19803,-0.18931,1,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.031953,-0.19917,-0.15776,1,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00047589,-0.20319,-0.21432,1,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0056958,-0.20427,-0.18506,1,0
2,GO ETHANOL METABOLIC PROCESS,0.0024281,-0.20436,-0.2222,1,0
2,GO OLIGOPEPTIDE TRANSPORT,0.002702,-0.20606,-0.19418,1,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.064418,-0.20687,-0.15981,1,0
2,GO EOSINOPHIL MIGRATION,0.063258,-0.20758,-0.14453,1,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.031631,-0.20816,-0.18599,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.034984,-0.20831,-0.13849,1,0
2,GO BLOOD VESSEL REMODELING,0.0038977,-0.21125,-0.14778,1,0
2,GO REGULATION OF B CELL PROLIFERATION,0.00032408,-0.21163,-0.17837,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0005211,-0.21283,-0.1979,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.000662,-0.21346,-0.24128,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0027747,-0.21355,-0.21831,1,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.00034485,-0.21395,-0.18647,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0084096,-0.21448,-0.28391,1,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00013899,-0.2162,-0.18293,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030928,-0.21726,-0.19969,1,0
2,GO GERMINAL CENTER FORMATION,0.0030038,-0.21764,-0.24275,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.010645,-0.21769,-0.21632,1,0
2,GO ZYMOGEN ACTIVATION,0.0068504,-0.21782,-0.18804,1,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.010895,-0.21882,-0.16366,1,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.0063654,-0.2189,-0.20316,1,0
2,GO HISTAMINE TRANSPORT,0.0067673,-0.2198,-0.23393,1,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.022928,-0.22111,-0.21146,1,0
2,GO RESPONSE TO TYPE I INTERFERON,0.0096941,-0.22224,-0.24861,1,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.011949,-0.22272,-0.16889,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.0012527,-0.22274,-0.17425,1,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.018091,-0.22279,-0.16731,1,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.010645,-0.22369,-0.17745,1,0
2,GO ACTIN FILAMENT SEVERING,0.0069343,-0.2238,-0.19164,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.049681,-0.22458,-0.19302,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.00062378,-0.22478,-0.20349,1,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.003654,-0.22505,-0.20882,1,0
2,GO MEMBRANE RAFT ORGANIZATION,0.018091,-0.2267,-0.21295,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.01016,-0.2284,-0.14073,1,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.0035146,-0.22849,-0.22212,1,0
2,GO RESPONSE TO INTERLEUKIN 18,0.01128,-0.22932,-0.25578,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00041488,-0.22942,-0.22036,1,0
2,GO REGULATION OF MYOBLAST FUSION,0.00080175,-0.23069,-0.20111,1,0
2,GO BARBED END ACTIN FILAMENT CAPPING,0.0028872,-0.23096,-0.18779,1,0
2,GO ETHANOL OXIDATION,0.0016806,-0.23103,-0.31378,1,0
2,GO T CELL MEDIATED CYTOTOXICITY,0.0029645,-0.23233,-0.28288,1,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.016938,-0.23263,-0.175,1,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.0032501,-0.23568,-0.25956,1,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.758e-05,-0.2357,-0.31136,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00037835,-0.23611,-0.31167,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0071051,-0.23922,-0.19982,1,0
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00063314,-0.24101,-0.21783,1,0
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0023957,-0.24313,-0.2468,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0015463,-0.24344,-0.23428,1,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0032928,-0.24377,-0.2832,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.035691,-0.24551,-0.18256,1,0
2,GO INTESTINAL ABSORPTION,0.00071283,-0.24745,-0.24709,1,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00082553,-0.24939,-0.19761,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00094089,-0.2667,-0.22615,1,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.010041,-0.26816,-0.17647,1,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.047827,-0.26836,-0.20328,1,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,3.1494e-05,-0.26945,-0.23283,1,0
2,GO KERATINIZATION,0.00055343,-0.27053,-0.26034,1,0
2,GO LIPOXYGENASE PATHWAY,0.016568,-0.27344,-0.22254,1,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0010113,-0.27375,-0.27335,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.0059852,-0.27439,-0.3184,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0020367,-0.27614,-0.40857,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.003166,-0.28663,-0.22727,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.001442,-0.28719,-0.25486,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00046165,-0.28783,-0.29673,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0022396,-0.28882,-0.30106,1,0
2,GO TOLERANCE INDUCTION,0.0137,-0.29317,-0.23482,1,0
2,GO SIGNAL PEPTIDE PROCESSING,5.5412e-06,-0.29919,-0.27538,1,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.066192,-0.30017,-0.24492,1,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0010558,-0.30359,-0.31738,1,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00013232,-0.30992,-0.32945,1,0
2,GO CORNIFICATION,0.00064263,-0.31098,-0.29551,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0025961,-0.31151,-0.27,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00054518,-0.31737,-0.22386,1,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0030839,-0.32451,-0.28864,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0023321,-0.33301,-0.39443,1,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.00034485,-0.3336,-0.36501,1,0
2,GO HISTAMINE SECRETION,0.00041488,-0.34027,-0.33447,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00010323,-0.34609,-0.33244,1,0
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0012527,-0.36715,-0.28022,1,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0029645,-0.39084,-0.3516,1,0
2,GO RESPONSE TO INTERFERON BETA,3.628e-05,-0.39483,-0.41633,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0019819,-0.40386,-0.349,1,0
2,GO FRUCTOSE METABOLIC PROCESS,0.0044864,-0.4338,-0.25844,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.01499,-0.44569,-0.42267,1,0
2,GO MUCUS SECRETION,3.1494e-05,-0.45556,-0.50547,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.01849,-0.50136,-0.48114,1,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.22348,0.26526,0.083426,0,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.071119,0.25083,0.1318,0,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.077018,0.24445,0.15111,0,1
2,GO TONGUE MORPHOGENESIS,0.15098,0.24175,0.085706,0,1
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.079765,0.23008,0.14964,0,1
2,GO ELASTIC FIBER ASSEMBLY,0.10471,0.19786,0.13993,0,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.15683,0.18849,0.1244,0,1
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.2114,0.18841,0.11166,0,1
2,GO MALE SEX DETERMINATION,0.11837,0.18668,0.13526,0,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.47211,0.17787,0.047551,0,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.10045,0.16211,0.11226,0,1
2,GO PROSTATIC BUD FORMATION,0.11933,0.16153,0.16166,0,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.16778,0.15764,0.078986,0,1
2,GO AXIS ELONGATION,0.1873,0.15475,0.085787,0,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.11647,0.15425,0.1191,0,1
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.32393,0.15365,0.04077,0,1
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.081168,0.15218,0.10328,0,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.19003,0.15108,0.08653,0,1
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.093126,0.15084,0.089316,0,1
2,GO NAD BIOSYNTHETIC PROCESS,0.075674,0.1478,0.11196,0,1
2,GO SKIN EPIDERMIS DEVELOPMENT,0.14642,0.1473,0.070085,0,1
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.069238,0.14729,0.091463,0,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.093918,0.14688,0.11897,0,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.40286,0.14266,0.070782,0,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.15683,0.14192,0.096461,0,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.56103,0.1409,0.027379,0,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.15098,0.13867,0.12755,0,1
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.11647,0.13732,0.090863,0,1
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.084034,0.13518,0.098374,0,1
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16285,0.13459,0.10507,0,1
2,GO CENTROMERE COMPLEX ASSEMBLY,0.22042,0.13102,0.093922,0,1
2,GO NEURAL TUBE DEVELOPMENT,0.081877,0.12901,0.093613,0,1
2,GO MAGNESIUM ION HOMEOSTASIS,0.30637,0.12838,0.072348,0,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.084034,0.12752,0.17706,0,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.076344,0.126,0.15164,0,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.33194,0.12574,0.016783,0,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.44994,0.12572,0.082152,0,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.40973,0.12391,0.033897,0,1
2,GO MITOTIC SISTER CHROMATID COHESION,0.091558,0.12381,0.10937,0,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.1313,0.1237,0.061944,0,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.074349,0.12239,0.083928,0,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.20122,0.12232,0.078378,0,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.086237,0.12188,0.10031,0,1
2,GO GENITALIA DEVELOPMENT,0.073043,0.12179,0.082881,0,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.088486,0.12051,0.11968,0,1
2,GO CHONDROCYTE DEVELOPMENT,0.079071,0.12022,0.11767,0,1
2,GO EPITHELIAL TUBE FORMATION,0.178,0.11977,0.073895,0,1
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.10385,0.11818,0.10578,0,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.10385,0.11808,0.06921,0,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.17029,0.11654,0.083538,0,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.29877,0.11614,0.063907,0,1
2,GO ANIMAL ORGAN FORMATION,0.077018,0.11592,0.10262,0,1
2,GO DEFINITIVE HEMOPOIESIS,0.1754,0.11354,0.10072,0,1
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.17156,0.11128,0.067521,0,1
2,GO INTRACELLULAR MRNA LOCALIZATION,0.078382,0.10992,0.10837,0,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.10823,0.10861,0.065493,0,1
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.19557,0.10847,0.066343,0,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.070488,0.10816,0.10712,0,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.45972,0.10787,0.017086,0,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.14983,0.10785,0.05795,0,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.11275,0.10779,0.096433,0,1
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.13027,0.10696,0.090595,0,1
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.071756,0.10645,0.10352,0,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.20845,0.10564,0.068833,0,1
2,GO MAINTENANCE OF CELL NUMBER,0.14308,0.10467,0.06746,0,1
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.46713,0.10382,0.036311,0,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.06986,0.10314,0.13357,0,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.1313,0.10286,0.11089,0,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.15447,0.1008,0.067762,0,1
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.10912,0.10066,0.065011,0,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.10734,0.10007,0.096335,0,1
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.4355,0.098335,0.035692,0,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.31021,0.097559,0.066438,0,1
2,GO REGULATION OF RNA BINDING,0.14197,0.096807,0.058665,0,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.073694,0.095601,0.088824,0,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.089246,0.094386,0.063616,0,1
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.10471,0.094148,0.062695,0,1
2,GO RNA DESTABILIZATION,0.51557,0.093998,0.047188,0,1
2,GO CHROMATIN REMODELING AT CENTROMERE,0.24416,0.093755,0.092969,0,1
2,GO GOLGI RIBBON FORMATION,0.11183,0.092622,0.092492,0,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.15565,0.092538,0.082571,0,1
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.096327,0.091797,0.079152,0,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.06986,0.091537,0.088577,0,1
2,GO MALE SEX DIFFERENTIATION,0.085497,0.091261,0.077996,0,1
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.092339,0.090685,0.10319,0,1
2,GO OVULATION,0.19278,0.090639,0.065986,0,1
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.098784,0.090395,0.084047,0,1
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.33803,0.089893,0.066518,0,1
2,GO SISTER CHROMATID COHESION,0.084034,0.089686,0.098141,0,1
2,GO CELLULAR RESPONSE TO FATTY ACID,0.17669,0.086793,0.068372,0,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.27317,0.086566,0.03512,0,1
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.080464,0.086414,0.12667,0,1
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.17156,0.086236,0.069294,0,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.19557,0.086023,0.065071,0,1
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.086237,0.084661,0.072292,0,1
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.11002,0.084643,0.068271,0,1
2,GO BONE MINERALIZATION,0.13338,0.084228,0.077189,0,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.44994,0.084024,0.0357,0,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14642,0.083994,0.07778,0,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.24089,0.083696,0.061756,0,1
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.28033,0.083124,0.059073,0,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.10129,0.082476,0.096014,0,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.18194,0.082133,0.068867,0,1
2,GO THYMUS DEVELOPMENT,0.070488,0.081975,0.090091,0,1
2,GO LIPOPROTEIN METABOLIC PROCESS,0.095518,0.081284,0.059989,0,1
2,GO FIBROBLAST MIGRATION,0.2458,0.080675,0.056364,0,1
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.13234,0.080328,0.078221,0,1
2,GO PROSTATE GLAND DEVELOPMENT,0.21889,0.079798,0.072516,0,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.075009,0.079186,0.099066,0,1
2,GO ASYMMETRIC CELL DIVISION,0.085497,0.079171,0.13087,0,1
2,GO TRANSEPITHELIAL TRANSPORT,0.1653,0.078862,0.058488,0,1
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.079765,0.0777,0.087961,0,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.13763,0.077279,0.063204,0,1
2,GO LIVER REGENERATION,0.35253,0.077135,0.025226,0,1
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.1262,0.076597,0.072111,0,1
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.17029,0.076482,0.071245,0,1
2,GO MESODERM DEVELOPMENT,0.1146,0.07641,0.06791,0,1
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.32592,0.076167,0.056474,0,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.56925,0.075235,0.038254,0,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.073043,0.0749,0.08201,0,1
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.11275,0.074108,0.068491,0,1
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26964,0.073704,0.04557,0,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.41899,0.07364,0.03601,0,1
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.32993,0.07268,0.06559,0,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.24911,0.071562,0.060343,0,1
2,GO MRNA MODIFICATION,0.28213,0.071119,0.048282,0,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.1252,0.069849,0.06625,0,1
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.13549,0.068363,0.062645,0,1
2,GO LYMPH VESSEL DEVELOPMENT,0.26964,0.06711,0.070899,0,1
2,GO ACTIVATION OF MAPK ACTIVITY,0.095518,0.066792,0.067307,0,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.086237,0.066773,0.084937,0,1
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.178,0.066311,0.056937,0,1
2,GO TOXIN TRANSPORT,0.28761,0.066189,0.057511,0,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.19417,0.065689,0.074046,0,1
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.29689,0.062799,0.051918,0,1
2,GO ENDOCYTOSIS,0.072397,0.062686,0.073608,0,1
2,GO RESPONSE TO NITRIC OXIDE,0.33194,0.06113,0.032388,0,1
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.068006,0.060894,0.07681,0,1
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.35253,0.060517,0.042752,0,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.13444,0.060301,0.11369,0,1
2,GO RESPONSE TO PROSTAGLANDIN,0.11275,0.059847,0.084522,0,1
2,GO PYRUVATE METABOLIC PROCESS,0.10385,0.059752,0.07521,0,1
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.19557,0.059656,0.065737,0,1
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.18866,0.059253,0.050358,0,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.64567,0.058283,0.02579,0,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.084763,0.058049,0.070884,0,1
2,GO HISTONE EXCHANGE,0.1873,0.057857,0.091291,0,1
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.6312,0.05736,0.012794,0,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.1914,0.056906,0.045372,0,1
2,GO CELLULAR RESPONSE TO PEPTIDE,0.18595,0.055253,0.059103,0,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.89205,0.054488,0.01351,0,1
2,GO LEFT RIGHT PATTERN FORMATION,0.49743,0.053089,0.056052,0,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.13549,0.052033,0.074052,0,1
2,GO INORGANIC ANION TRANSPORT,0.090011,0.051475,0.053435,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.1754,0.050698,0.050431,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.18461,0.048046,0.070663,0,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.48468,0.045283,0.030638,0,1
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.21738,0.044603,0.051191,0,1
2,GO PROTEIN NITROSYLATION,0.85059,0.042075,0.012959,0,1
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.47712,0.033057,0.035954,0,1
2,GO MITOTIC CELL CYCLE,0.12721,0.030624,0.064968,0,1
2,GO DNA CATABOLIC PROCESS,0.21587,0.026697,0.047399,0,1
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1.3693e-05,0.40332,0.43244,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,1.8363e-05,0.3868,0.36911,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,6.6066e-07,0.38602,0.3639,0,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,9.9803e-06,0.36969,0.48445,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,1.5674e-06,0.33775,0.41619,0,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,6.2169e-06,0.31448,0.35051,0,0
2,GO RECEPTOR CLUSTERING,2.5756e-08,0.30886,0.36676,0,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0024281,0.30206,0.32969,0,0
2,GO SPINAL CORD PATTERNING,0.00040235,0.29722,0.32039,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,1.8032e-05,0.29237,0.3088,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.0137,0.29235,0.21004,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0059852,0.29213,0.22832,0,0
2,GO AXON DEVELOPMENT,4.3082e-09,0.28374,0.3086,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00095459,0.28162,0.32732,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,4.0657e-06,0.27987,0.25998,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00011596,0.2713,0.22798,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.046031,0.26855,0.19955,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,4.7172e-05,0.26767,0.30603,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00021857,0.26284,0.28289,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,1.4472e-05,0.2599,0.32498,0,0
2,GO FOREBRAIN CELL MIGRATION,8.2543e-08,0.25953,0.30089,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,1.0004e-06,0.25745,0.30896,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,1.9989e-07,0.25475,0.27764,0,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,3.3713e-09,0.25335,0.30585,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0033799,0.25147,0.3613,0,0
2,GO LONG TERM MEMORY,5.3256e-05,0.24644,0.23394,0,0
2,GO SYNAPTIC VESICLE MATURATION,0.00067188,0.24582,0.31565,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,4.7999e-05,0.24526,0.29212,0,0
2,GO NEURON PROJECTION ARBORIZATION,9.1829e-05,0.24336,0.27663,0,0
2,GO PROTEIN POLYGLUTAMYLATION,4.1751e-05,0.24216,0.24094,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,2.1375e-08,0.24003,0.26391,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,7.2129e-08,0.2393,0.24839,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,1.2434e-08,0.23902,0.26024,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.0019285,0.23489,0.22394,0,0
2,GO MITOCHONDRION LOCALIZATION,1.064e-06,0.23338,0.2222,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,2.4528e-05,0.23218,0.25456,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0010113,0.22599,0.22719,0,0
2,GO GLUTAMATE SECRETION,0.0019819,0.22078,0.2029,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,2.8925e-08,0.22045,0.25259,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,2.0429e-07,0.21843,0.2472,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00016629,0.21743,0.33469,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,2.5756e-08,0.21505,0.24997,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.013394,0.21479,0.22344,0,0
2,GO NEURON DEVELOPMENT,1.3351e-08,0.2139,0.2442,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,4.2487e-05,0.2137,0.16957,0,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.00012388,0.21342,0.38817,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,1.7693e-06,0.21324,0.26699,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,3.6924e-05,0.21274,0.23802,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.018693,0.21171,0.19327,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.017506,0.20996,0.23781,0,0
2,GO MICROTUBULE SEVERING,0.00046165,0.20974,0.1991,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0038478,0.20671,0.20011,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.023173,0.20649,0.2406,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,4.6881e-08,0.20625,0.2287,0,0
2,GO TUBULIN DEACETYLATION,6.3249e-05,0.20489,0.24464,0,0
2,GO NEURON REMODELING,0.0090315,0.20438,0.17494,0,0
2,GO REGULATION OF LYASE ACTIVITY,6.8885e-07,0.20248,0.25611,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00022927,0.202,0.21301,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.1034e-07,0.20165,0.22018,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,3.1479e-07,0.2015,0.21775,0,0
2,GO MICROTUBULE POLYMERIZATION,1.1806e-05,0.20135,0.21923,0,0
2,GO DEVELOPMENTAL CELL GROWTH,2.8886e-07,0.20078,0.2344,0,0
2,GO HINDLIMB MORPHOGENESIS,0.0035146,0.20034,0.18904,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.178,0.19743,0.11002,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,4.0657e-06,0.19737,0.21515,0,0
2,GO NEURON DIFFERENTIATION,1.9465e-08,0.19533,0.23694,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,3.2859e-07,0.19379,0.21203,0,0
2,GO NEURON FATE SPECIFICATION,0.026838,0.1937,0.2021,0,0
2,GO REGULATION OF AXON GUIDANCE,4.7999e-05,0.19361,0.23548,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,9.3381e-05,0.19349,0.30453,0,0
2,GO MOTOR NEURON AXON GUIDANCE,9.03e-05,0.19273,0.21292,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.00021857,0.19253,0.23442,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00064263,0.19246,0.22275,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,3.3806e-05,0.19213,0.2153,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,2.4091e-05,0.19205,0.19156,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00086244,0.19133,0.27997,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,3.3435e-06,0.19119,0.21408,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.0062877,0.19048,0.24779,0,0
2,GO SYNAPTIC VESICLE RECYCLING,6.9711e-06,0.18967,0.22419,0,0
2,GO GANGLION DEVELOPMENT,0.090782,0.18928,0.16678,0,0
2,GO STRIATUM DEVELOPMENT,0.0062877,0.18917,0.18505,0,0
2,GO NEUROGENESIS,5.4982e-08,0.18891,0.21509,0,0
2,GO PENILE ERECTION,0.046921,0.18819,0.12201,0,0
2,GO REGULATION OF CELL DEVELOPMENT,4.9228e-07,0.18665,0.196,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,2.7804e-05,0.18622,0.24956,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,1.6418e-07,0.18544,0.21316,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,2.1234e-05,0.18507,0.18509,0,0
2,GO MATING BEHAVIOR,6.545e-05,0.18467,0.22479,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.0005133,0.18451,0.18744,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,8.1361e-07,0.18423,0.18775,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00067188,0.18261,0.22745,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0022095,0.18016,0.222,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00159,0.1799,0.19728,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.00011986,0.17941,0.21074,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.032278,0.1792,0.16344,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.068619,0.17906,0.13884,0,0
2,GO THYROID GLAND DEVELOPMENT,0.024173,0.17886,0.15901,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0056958,0.17836,0.2072,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.33599,0.17778,0.11249,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.035691,0.17775,0.16412,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0029645,0.17597,0.17334,0,0
2,GO SHORT TERM MEMORY,0.010279,0.17567,0.18152,0,0
2,GO MYOBLAST MIGRATION,0.1754,0.175,0.10534,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0056958,0.17472,0.22143,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.17029,0.17406,0.10033,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.1453,0.17357,0.092162,0,0
2,GO COCHLEA DEVELOPMENT,8.2686e-06,0.17316,0.26418,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.0070192,0.17288,0.19577,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00059648,0.17112,0.18984,0,0
2,GO NEUROMUSCULAR PROCESS,1.996e-06,0.17077,0.22432,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.20122,0.17075,0.12513,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,6.7461e-07,0.17043,0.1896,0,0
2,GO CELL MORPHOGENESIS,2.7078e-07,0.17008,0.20625,0,0
2,GO STEM CELL PROLIFERATION,0.0081133,0.16887,0.14045,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,9.6129e-06,0.1683,0.18533,0,0
2,GO NEURON FATE COMMITMENT,0.009139,0.16812,0.2053,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.0005211,0.1679,0.15558,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0057669,0.16733,0.1493,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.13027,0.16725,0.10679,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.01128,0.16629,0.1865,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.062114,0.1658,0.25924,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.10385,0.16476,0.11036,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0030839,0.16406,0.18092,0,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0010408,0.16378,0.19145,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.9044e-05,0.16118,0.20206,0,0
2,GO HISTONE H3 K36 METHYLATION,0.0011021,0.161,0.21101,0,0
2,GO CELL PROJECTION ORGANIZATION,2.3784e-07,0.16056,0.18793,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.019312,0.16006,0.15188,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.25078,0.15996,0.10312,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.03429,0.15954,0.12196,0,0
2,GO SKIN MORPHOGENESIS,0.22348,0.15875,0.091563,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0073682,0.15828,0.22038,0,0
2,GO G0 TO G1 TRANSITION,0.00031414,0.15821,0.17894,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.00046872,0.15806,0.15366,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.2114,0.15777,0.1146,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00054518,0.15711,0.21483,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,5.4356e-06,0.15711,0.20824,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,3.8246e-05,0.15682,0.19734,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0011021,0.15653,0.16693,0,0
2,GO CELL FATE SPECIFICATION,0.0077327,0.15633,0.15838,0,0
2,GO NEPHRON TUBULE FORMATION,0.090782,0.15632,0.13127,0,0
2,GO REPLICATION FORK PROCESSING,0.013546,0.15534,0.14741,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.5293e-05,0.1553,0.23543,0,0
2,GO CELL JUNCTION MAINTENANCE,0.012653,0.15419,0.16062,0,0
2,GO MEMBRANE DISASSEMBLY,0.10912,0.15385,0.10023,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00053704,0.15343,0.17991,0,0
2,GO SYNAPTIC VESICLE PRIMING,0.022446,0.15287,0.20454,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.00071283,0.15223,0.19538,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.018693,0.15172,0.15705,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.001235,0.15115,0.20867,0,0
2,GO MICROTUBULE BUNDLE FORMATION,0.00010497,0.15077,0.19496,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.18595,0.15073,0.099109,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.21437,0.15037,0.077474,0,0
2,GO AORTA DEVELOPMENT,0.09714,0.15031,0.1019,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.037139,0.14994,0.14281,0,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0048405,0.14963,0.22458,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.015501,0.1494,0.16798,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0035146,0.14794,0.20136,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.031311,0.14784,0.12952,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.037509,0.14783,0.13178,0,0
2,GO ESTROUS CYCLE,0.012087,0.14776,0.17032,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.020828,0.14761,0.11084,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.017699,0.14749,0.15985,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,9.03e-05,0.14705,0.19254,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0042095,0.14642,0.15734,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.6691,0.14603,0.0079291,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0066039,0.14554,0.16283,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.03429,0.14478,0.12953,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0015249,0.14455,0.16517,0,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.76899,0.14424,-0.01357,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.093126,0.14356,0.17254,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.0071051,0.14263,0.14848,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.16163,0.14211,0.093204,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.0001862,0.14192,0.17423,0,0
2,GO REGULATION OF OOGENESIS,0.0040509,0.14083,0.11695,0,0
2,GO MITOTIC RECOMBINATION,0.26267,0.1401,0.086568,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.0054192,0.13997,0.13961,0,0
2,GO BONE MATURATION,0.0018256,0.13971,0.17707,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.093126,0.13966,0.15239,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0037498,0.13935,0.18782,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,3.6924e-05,0.13925,0.16677,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.30446,0.13897,0.074382,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.00075607,0.1388,0.2564,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.00029976,0.13836,0.15732,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.20992,0.13808,0.084557,0,0
2,GO CHROMATIN DISASSEMBLY,0.030368,0.13803,0.12881,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.086981,0.13794,0.11586,0,0
2,GO EYE MORPHOGENESIS,0.0045438,0.13719,0.12996,0,0
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.15921,0.13688,0.1071,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.1262,0.13682,0.089976,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.091558,0.13672,0.10623,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.9306,0.13468,-0.013763,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.00072342,0.13366,0.15807,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16042,0.13312,0.087062,0,0
2,GO OOGENESIS,0.0044298,0.1329,0.1173,0,0
2,GO NEURON PROJECTION REGENERATION,0.001955,0.13221,0.17896,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0074579,0.13196,0.12684,0,0
2,GO SEX DETERMINATION,0.043444,0.13142,0.14253,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.08331,0.13108,0.12664,0,0
2,GO DETECTION OF VISIBLE LIGHT,4.0314e-05,0.12954,0.11073,0,0
2,GO DNA REPLICATION CHECKPOINT,0.026013,0.12924,0.12341,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.11742,0.12858,0.11696,0,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.1793,0.12853,0.097804,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.02174,0.12842,0.12983,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.0065235,0.12788,0.12384,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.029754,0.1275,0.13986,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0137,0.12723,0.13836,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.00010152,0.12655,0.15461,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.00015083,0.12599,0.16082,0,0
2,GO DETECTION OF CALCIUM ION,0.12322,0.12529,0.12545,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0016575,0.12476,0.18985,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.00029976,0.12404,0.16547,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00037835,0.1234,0.15342,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00091404,0.12312,0.11989,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.0030436,0.12292,0.16992,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0042636,0.12263,0.13384,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.008211,0.12154,0.15686,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.015159,0.12122,0.14822,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.02945,0.12114,0.11792,0,0
2,GO REGIONALIZATION,0.0020929,0.12065,0.13552,0,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.22658,0.12052,0.099218,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.048285,0.12051,0.10937,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0069343,0.12031,0.14625,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0062877,0.12029,0.13443,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.058787,0.12003,0.14428,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0086125,0.11974,0.12974,0,0
2,GO SEGMENT SPECIFICATION,0.051111,0.11969,0.14383,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0018006,0.11964,0.12948,0,0
2,GO RESPONSE TO GLUCAGON,0.0018764,0.11953,0.1593,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0066851,0.11915,0.17342,0,0
2,GO GENETIC IMPRINTING,0.057179,0.11889,0.099983,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.11837,0.11875,0.17979,0,0
2,GO RESPONSE TO INSECTICIDE,0.22971,0.11819,0.096217,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0026663,0.11728,0.14234,0,0
2,GO REGULATION OF MRNA PROCESSING,0.00015838,0.11707,0.15427,0,0
2,GO ARTERY DEVELOPMENT,0.13656,0.11703,0.076403,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.036048,0.11699,0.11816,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.099614,0.11675,0.10234,0,0
2,GO LACTATE METABOLIC PROCESS,0.30829,0.11672,0.05217,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.0084096,0.11668,0.1235,0,0
2,GO DIENCEPHALON DEVELOPMENT,0.0028118,0.11656,0.189,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.056128,0.11656,0.092782,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.0042095,0.1163,0.14429,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.027401,0.11572,0.14054,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.010895,0.11479,0.095036,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.37827,0.11476,0.047049,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.40514,0.11472,0.054981,0,0
2,GO RETINA LAYER FORMATION,0.052575,0.11433,0.16394,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00067188,0.11356,0.13805,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13549,0.11327,0.11459,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.064418,0.11293,0.10771,0,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.085497,0.11282,0.093558,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.05063,0.11259,0.11566,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.073043,0.11251,0.15054,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.027686,0.11228,0.17224,0,0
2,GO PROTEIN KINASE C SIGNALING,0.077698,0.11222,0.10918,0,0
2,GO VISUAL BEHAVIOR,0.00069207,0.112,0.14251,0,0
2,GO PIRNA METABOLIC PROCESS,0.08331,0.112,0.11797,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.076344,0.11193,0.10874,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.024687,0.11157,0.21095,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.11933,0.11102,0.088214,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0013633,0.11081,0.12378,0,0
2,GO CELL FATE COMMITMENT,0.0020929,0.1108,0.13768,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.063258,0.1108,0.094583,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.054074,0.11037,0.090967,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.11092,0.11018,0.11045,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.0005133,0.10961,0.14798,0,0
2,GO MEMBRANE FISSION,0.09796,0.1096,0.090738,0,0
2,GO CHONDROCYTE PROLIFERATION,0.32993,0.10944,0.067658,0,0
2,GO MIDBRAIN DEVELOPMENT,0.0013255,0.1093,0.11757,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.014332,0.10869,0.11259,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.11092,0.10834,0.084394,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.001483,0.10794,0.17855,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.23766,0.10792,0.092314,0,0
2,GO MRNA METHYLATION,0.062114,0.10785,0.10338,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,4.1751e-05,0.10752,0.12942,0,0
2,GO HEART FORMATION,0.086981,0.1074,0.13375,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.015501,0.1074,0.11611,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0069343,0.10714,0.11225,0,0
2,GO CILIUM ORGANIZATION,0.0011021,0.10704,0.14192,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.15447,0.10697,0.079515,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0093576,0.10666,0.15174,0,0
2,GO PANCREAS DEVELOPMENT,0.0099244,0.10638,0.16795,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.0011503,0.10606,0.10792,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.076344,0.10576,0.10952,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.013243,0.10567,0.10896,0,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.26095,0.10564,0.086924,0,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.51819,0.10546,0.058072,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.026013,0.10506,0.08545,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.096327,0.10474,0.10765,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.0093576,0.10405,0.13405,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.033948,0.10396,0.11303,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.0098086,0.10395,0.12066,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.51557,0.1039,0.04387,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.24252,0.10383,0.097172,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.016938,0.10365,0.12578,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.14869,0.10355,0.061984,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00074504,0.10313,0.1285,0,0
2,GO REGULATION OF MRNA BINDING,0.1653,0.10302,0.052591,0,0
2,GO MOLTING CYCLE,0.24089,0.10286,0.051282,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.27317,0.10268,0.058393,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.0092477,0.10263,0.1383,0,0
2,GO MESENCHYME DEVELOPMENT,0.011813,0.10262,0.11079,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.098784,0.10248,0.094455,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.054074,0.1024,0.14102,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.079071,0.10207,0.10867,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0029645,0.10142,0.13601,0,0
2,GO VESICLE DOCKING,0.011411,0.10142,0.12038,0,0
2,GO BONE MORPHOGENESIS,0.0054872,0.10138,0.15309,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0019023,0.10137,0.12262,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.056128,0.10137,0.15633,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.12721,0.10114,0.075751,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0099244,0.10101,0.088937,0,0
2,GO KINETOCHORE ORGANIZATION,0.40514,0.10065,0.080209,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0054192,0.10057,0.12922,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.19697,0.10036,0.069974,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.001568,0.10026,0.16187,0,0
2,GO RESPONSE TO AXON INJURY,0.0039992,0.099962,0.13545,0,0
2,GO MACROPHAGE PROLIFERATION,0.33599,0.099761,0.093261,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.022686,0.099758,0.15277,0,0
2,GO DNA REPLICATION INITIATION,0.19278,0.099633,0.07525,0,0
2,GO CONVERGENT EXTENSION,0.048285,0.099418,0.12692,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.098784,0.099271,0.093155,0,0
2,GO REGULATION OF MITOPHAGY,0.15214,0.099231,0.066471,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.19557,0.099227,0.096546,0,0
2,GO RESPONSE TO CAFFEINE,0.13234,0.09895,0.08864,0,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.10214,0.098931,0.12586,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.086237,0.098857,0.075181,0,0
2,GO CELL AGGREGATION,0.030994,0.098488,0.11634,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.10299,0.098451,0.10253,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.068619,0.098182,0.12443,0,0
2,GO TAXIS,0.0015038,0.098149,0.12461,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.026013,0.097985,0.12018,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.034636,0.097906,0.10273,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.31604,0.097747,0.068075,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.16042,0.097684,0.079164,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00098255,0.097614,0.12763,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.0021215,0.097433,0.10795,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.045591,0.09735,0.11582,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.02915,0.097293,0.11171,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.5314,0.097197,0.036338,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.0031247,0.097071,0.10942,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.090011,0.09705,0.086403,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.12126,0.096752,0.092193,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.28945,0.096687,0.067478,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0022701,0.096479,0.12647,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.079071,0.096105,0.12937,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.023173,0.096031,0.11047,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.073694,0.095912,0.14037,0,0
2,GO PODOSOME ASSEMBLY,0.29502,0.095198,0.0937,0,0
2,GO REGULATION OF MYELINATION,0.01829,0.095165,0.10962,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.0033361,0.095115,0.1051,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.015501,0.094732,0.11102,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.028264,0.094706,0.12388,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.7659,0.094406,-0.012854,0,0
2,GO REGULATION OF VASCULOGENESIS,0.4451,0.094334,0.058159,0,0
2,GO SEX DIFFERENTIATION,0.00073415,0.094294,0.1322,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.039406,0.094069,0.12744,0,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.09714,0.094022,0.093702,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.30446,0.093959,0.061497,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.013093,0.093923,0.14475,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.0032501,0.093904,0.15528,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.31021,0.093867,0.076305,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.18194,0.09383,0.095344,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.26267,0.093389,0.07591,0,0
2,GO NEURON APOPTOTIC PROCESS,0.00057029,0.093031,0.11978,0,0
2,GO REGULATION OF TRANSPOSITION,0.22971,0.092885,0.081507,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.15565,0.0928,0.15352,0,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.56376,0.092524,0.041736,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.018898,0.092168,0.11266,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.001422,0.092,0.16719,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.13338,0.091626,0.08837,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0071918,0.091192,0.13207,0,0
2,GO V D J RECOMBINATION,0.22971,0.091138,0.085717,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.26789,0.091098,0.074988,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0057669,0.090961,0.12463,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.10646,0.09047,0.10497,0,0
2,GO RESPONSE TO IRON ION,0.26095,0.090468,0.07317,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.10214,0.090322,0.090064,0,0
2,GO AORTA MORPHOGENESIS,0.63408,0.09014,0.0022816,0,0
2,GO MATURATION OF LSU RRNA,0.97899,0.089959,-0.02883,0,0
2,GO CHROMOSOME SEPARATION,0.077698,0.089853,0.098551,0,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.46962,0.089836,0.042853,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.0014624,0.089796,0.16212,0,0
2,GO RENAL FILTRATION,0.2114,0.089638,0.14082,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.52345,0.089588,0.045597,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0047198,0.089458,0.10431,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.027118,0.089393,0.1103,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.35886,0.089379,0.074697,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0077327,0.089336,0.18919,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.15565,0.08922,0.095744,0,0
2,GO REPLACEMENT OSSIFICATION,0.38488,0.089025,0.046568,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.18194,0.088863,0.099137,0,0
2,GO RHYTHMIC BEHAVIOR,0.0076401,0.088808,0.12647,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.069238,0.088766,0.088839,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.014494,0.088535,0.10044,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.21738,0.088346,0.092369,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.004156,0.088328,0.1496,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.019523,0.088137,0.12411,0,0
2,GO NOSE DEVELOPMENT,0.42602,0.088064,0.06229,0,0
2,GO HISTONE H3 K4 METHYLATION,0.010895,0.088057,0.12542,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.36098,0.087847,0.085285,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.081877,0.08775,0.084674,0,0
2,GO PROTEIN ACYLATION,2.9859e-05,0.087725,0.13239,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.069238,0.087646,0.13434,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.11742,0.087558,0.11763,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.34008,0.087556,0.06715,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.094715,0.087523,0.079982,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.39606,0.08739,0.049832,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.27673,0.08733,0.060392,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.70185,0.086933,0.030162,0,0
2,GO INNER EAR MORPHOGENESIS,0.017699,0.086925,0.14373,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0099244,0.086923,0.14467,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.0094686,0.086915,0.13016,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.1313,0.086852,0.052118,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.11183,0.08668,0.069489,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.054582,0.086614,0.1287,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.21288,0.086452,0.088962,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.075674,0.086366,0.085441,0,0
2,GO MICROTUBULE NUCLEATION,0.098784,0.086111,0.10913,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.006444,0.085954,0.14945,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.31021,0.085953,0.050273,0,0
2,GO ERYTHROCYTE MATURATION,0.15565,0.085786,0.084879,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.070488,0.085763,0.10478,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.38933,0.085716,0.043405,0,0
2,GO ENAMEL MINERALIZATION,0.20554,0.08565,0.11074,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0012177,0.085536,0.0944,0,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.1313,0.085513,0.077466,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0099244,0.085357,0.10928,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.17669,0.08535,0.079054,0,0
2,GO DOSAGE COMPENSATION,0.13763,0.085263,0.088898,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.22658,0.084836,0.12486,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.0059116,0.084761,0.062271,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.00019229,0.084686,0.16937,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.17029,0.084614,0.084126,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.033948,0.084576,0.11257,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.08331,0.084481,0.13657,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.28761,0.084418,0.074576,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.090782,0.084183,0.12438,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.046921,0.084135,0.12791,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.0099244,0.084086,0.12665,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.19697,0.084001,0.0904,0,0
2,GO HEART DEVELOPMENT,0.0099244,0.083993,0.10362,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.33803,0.083863,0.042652,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.075009,0.08374,0.099443,0,0
2,GO CHOLESTEROL STORAGE,0.27495,0.083702,0.054419,0,0
2,GO NEPHRON MORPHOGENESIS,0.040981,0.083586,0.10827,0,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.6055,0.083574,0.01319,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.17029,0.083449,0.077691,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.83158,0.083439,0.023317,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.48976,0.083068,0.081475,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.24252,0.082895,0.07594,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.099614,0.082878,0.090973,0,0
2,GO COPULATION,0.13338,0.082587,0.087306,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.004156,0.082509,0.12413,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.13549,0.082123,0.10747,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.59986,0.082107,0.048326,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.01829,0.081923,0.11988,0,0
2,GO STEROID HORMONE SECRETION,0.41203,0.081809,0.042585,0,0
2,GO RESPONSE TO AMINE,0.20409,0.081809,0.063521,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.010645,0.081528,0.11244,0,0
2,GO NEURAL TUBE FORMATION,0.47461,0.081516,0.046929,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0030839,0.081464,0.13522,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.27853,0.081298,0.06821,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.19417,0.081273,0.089591,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.36526,0.08112,0.061407,0,0
2,GO PRO B CELL DIFFERENTIATION,0.36956,0.080762,0.062299,0,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.45972,0.080525,0.014882,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.25924,0.080488,0.061077,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.12822,0.080377,0.094229,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.037509,0.080244,0.085832,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.14869,0.080078,0.077075,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,1,0.07991,-0.011254,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.27673,0.079858,0.090965,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0062877,0.079795,0.14766,0,0
2,GO EMBRYO DEVELOPMENT,0.014332,0.07977,0.090285,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.014013,0.079629,0.13831,0,0
2,GO CELL PROJECTION ASSEMBLY,0.0089251,0.079458,0.1017,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.75664,0.079394,0.013846,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.015159,0.07937,0.11514,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.28761,0.079321,0.065844,0,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.013093,0.079303,0.13048,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.1653,0.078927,0.058148,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.011813,0.078918,0.11526,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.081168,0.078676,0.07271,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.089246,0.078495,0.10158,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.35463,0.07838,0.053406,0,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.22042,0.078273,0.056049,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.30255,0.078244,0.086358,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.074349,0.078068,0.1263,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.58585,0.077616,0.050661,0,0
2,GO REGULATION OF NEURON MATURATION,0.23128,0.077503,0.092395,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.020605,0.077394,0.10879,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.042197,0.077137,0.084318,0,0
2,GO N GLYCAN PROCESSING,0.14088,0.077127,0.1217,0,0
2,GO KERATINOCYTE PROLIFERATION,0.52609,0.076946,0.018962,0,0
2,GO NUCLEOSOME ORGANIZATION,0.027118,0.076909,0.11403,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.52874,0.076609,0.042058,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.15921,0.076063,0.070197,0,0
2,GO HISTONE H2A UBIQUITINATION,0.017699,0.076004,0.11729,0,0
2,GO RESPONSE TO VITAMIN D,0.24911,0.075808,0.087548,0,0
2,GO KINETOCHORE ASSEMBLY,0.38933,0.075743,0.069798,0,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.48722,0.075731,0.012214,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.34835,0.075671,0.058895,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.16778,0.075522,0.083262,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.27673,0.075472,0.04293,0,0
2,GO CERAMIDE TRANSPORT,0.5,0.075419,0.031806,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0062108,0.075398,0.1663,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.55287,0.075257,0.027672,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.50258,0.075232,0.0103,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.087731,0.075212,0.11087,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.58307,0.075151,0.034034,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.11647,0.075136,0.087009,0,0
2,GO HISTONE H4 DEACETYLATION,0.075674,0.075067,0.092048,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.16407,0.074891,0.086918,0,0
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.71693,0.074626,0.0087202,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.046921,0.074438,0.11905,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.056652,0.074427,0.10712,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.26095,0.074396,0.070927,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.11183,0.074375,0.12123,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.88565,0.074261,0.00078267,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.53406,0.074189,0.025072,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.29502,0.074185,0.053843,0,0
2,GO LACTATION,0.061549,0.073968,0.095991,0,0
2,GO CELL CYCLE DNA REPLICATION,0.11002,0.073818,0.084717,0,0
2,GO OOCYTE MATURATION,0.21288,0.07364,0.086414,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.039406,0.073597,0.11989,0,0
2,GO HISTONE H2A ACETYLATION,0.056128,0.073493,0.082198,0,0
2,GO HISTONE MRNA METABOLIC PROCESS,0.15683,0.073413,0.055721,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.032938,0.073387,0.11716,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.068006,0.073369,0.076591,0,0
2,GO T CELL EXTRAVASATION,0.46466,0.073366,-0.077381,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.10045,0.073299,0.082699,0,0
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.011949,0.073293,0.096447,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.09714,0.073257,0.074837,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0066039,0.073254,0.1739,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.6691,0.072773,0.048033,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.012798,0.072736,0.11585,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.10734,0.072525,0.073158,0,0
2,GO HISTONE UBIQUITINATION,0.028852,0.072451,0.093438,0,0
2,GO RNA SPLICING,0.01128,0.072401,0.09245,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.15802,0.072389,0.086435,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.076344,0.072274,0.074359,0,0
2,GO SPINDLE ORGANIZATION,0.23128,0.072186,0.083952,0,0
2,GO MALE MEIOSIS I,0.15214,0.072175,0.12466,0,0
2,GO GTP METABOLIC PROCESS,0.11837,0.072153,0.084856,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.1387,0.072067,0.096207,0,0
2,GO ARTERY MORPHOGENESIS,0.82842,0.072033,0.01284,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.14869,0.071872,0.10509,0,0
2,GO SERTOLI CELL DIFFERENTIATION,0.23766,0.07186,0.072094,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.078382,0.0718,0.12197,0,0
2,GO HISTONE H3 DEACETYLATION,0.0088198,0.071765,0.13139,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.24416,0.071544,0.066254,0,0
2,GO MRNA PROCESSING,0.012798,0.071501,0.092989,0,0
2,GO EAR MORPHOGENESIS,0.044292,0.071386,0.11882,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.6312,0.071371,0.017254,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.17029,0.071275,0.12653,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.08331,0.071115,0.087639,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.24252,0.070835,0.10334,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.15098,0.070694,0.096941,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.47211,0.070491,0.044537,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.30637,0.070413,0.062502,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.0062877,0.07028,0.11682,0,0
2,GO RRNA TRANSCRIPTION,0.25753,0.070205,0.047674,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.089246,0.070188,0.071597,0,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.68988,0.07018,-0.0049161,0,0
2,GO PRIMARY MIRNA PROCESSING,0.1914,0.070126,0.065627,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.036409,0.070093,0.12146,0,0
2,GO CELLULAR RESPONSE TO PH,0.084034,0.070089,0.067884,0,0
2,GO RECOMBINATIONAL REPAIR,0.13549,0.069983,0.086513,0,0
2,GO PEPTIDE SECRETION,0.084763,0.069946,0.067311,0,0
2,GO PROTEIN ACETYLATION,0.00046165,0.069885,0.12205,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.13979,0.069879,0.11575,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.28578,0.069729,0.091558,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.11933,0.069595,0.069771,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.12224,0.069522,0.067489,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.15447,0.069474,0.099724,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.013546,0.069348,0.12358,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.38488,0.069191,0.047362,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.21889,0.069056,0.058683,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.0038977,0.069054,0.1053,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.5394,0.068978,0.030324,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.13979,0.068937,0.060599,0,0
2,GO ACTIN FILAMENT BASED PROCESS,0.12029,0.068866,0.070307,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.077698,0.068714,0.071523,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.024947,0.068589,0.12944,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.76899,0.068505,-0.0013485,0,0
2,GO TISSUE MORPHOGENESIS,0.090011,0.068488,0.06995,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.41666,0.068297,0.069905,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.10734,0.068241,0.060467,0,0
2,GO ENDODERM DEVELOPMENT,0.27317,0.068233,0.062399,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.17029,0.068161,0.15535,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.26789,0.068055,0.047984,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.14983,0.068029,0.058098,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.29502,0.068019,0.071612,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.054074,0.067994,0.10666,0,0
2,GO CARTILAGE DEVELOPMENT,0.1754,0.067965,0.060985,0,0
2,GO RNA STABILIZATION,0.069238,0.067762,0.072747,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.1262,0.067737,0.07938,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.6312,0.067708,0.030277,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.12822,0.06767,0.067188,0,0
2,GO REGULATION OF CYTOKINESIS,0.084763,0.067586,0.099661,0,0
2,GO DEMETHYLATION,0.021509,0.067413,0.096979,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.13549,0.067256,0.13469,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.22042,0.067227,0.071244,0,0
2,GO STEROL HOMEOSTASIS,0.88565,0.067064,0.0078309,0,0
2,GO NEUROBLAST DIVISION,0.16778,0.066967,0.1018,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.16904,0.066938,0.076324,0,0
2,GO VIRAL TRANSLATION,0.61402,0.066717,0.019204,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.11002,0.066695,0.073784,0,0
2,GO CELLULAR RESPONSE TO UV,0.11837,0.066554,0.07637,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.18461,0.066285,0.090089,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.15802,0.066245,0.059759,0,0
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.25414,0.065776,0.049343,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.52609,0.065713,0.037889,0,0
2,GO REGULATION OF HEART RATE,0.20554,0.065708,0.065182,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.55287,0.065674,0.047128,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.24252,0.06567,0.042637,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.11092,0.065521,0.063847,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.081168,0.065376,0.10722,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.1533,0.065348,0.0676,0,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.068006,0.06516,0.085271,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.11742,0.064882,0.094005,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.10734,0.06488,0.078325,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.18194,0.064861,0.081657,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.08331,0.064798,0.12067,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.06986,0.064618,0.098963,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.29502,0.064591,0.048988,0,0
2,GO TORC1 SIGNALING,0.0058389,0.064573,0.13533,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.15098,0.064469,0.065581,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.15565,0.064269,0.10841,0,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.18866,0.064069,0.080873,0,0
2,GO DNA METHYLATION,0.1793,0.064054,0.051403,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.37827,0.063892,0.055361,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.28578,0.063746,0.064454,0,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.89846,0.063729,-0.018303,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.28761,0.063688,0.061068,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.18194,0.06367,0.070088,0,0
2,GO RESPONSE TO ETHANOL,0.11092,0.063614,0.068232,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.25924,0.06357,0.080342,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.39606,0.063492,0.067938,0,0
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.14308,0.063434,0.054706,0,0
2,GO AMINO ACID TRANSPORT,0.014494,0.063427,0.10296,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.18595,0.063178,0.081288,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.1262,0.063099,0.10356,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.32993,0.063084,0.061941,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.42838,0.063054,0.045892,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.31997,0.063015,0.076402,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.081877,0.062971,0.070622,0,0
2,GO ACTIN FILAMENT ORGANIZATION,0.36956,0.062896,0.053516,0,0
2,GO MRNA TRANSCRIPTION,0.32195,0.062832,0.064082,0,0
2,GO GLAND MORPHOGENESIS,0.33803,0.062826,0.060108,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.39832,0.062795,0.041156,0,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.015674,0.06259,0.12901,0,0
2,GO GLUCOSE IMPORT,0.12029,0.062439,0.066882,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.093126,0.062115,0.15283,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.036772,0.062108,0.076722,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.31409,0.062086,0.042901,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.19417,0.061947,0.083317,0,0
2,GO PROTEIN SUMOYLATION,0.074349,0.061878,0.078614,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.5,0.061751,0.048205,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.1653,0.061733,0.086017,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.072397,0.061732,0.062649,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.0018508,0.061503,0.12071,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.15802,0.061252,0.068569,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.093126,0.061237,0.080083,0,0
2,GO MITOCHONDRIAL FISSION,0.15098,0.061182,0.062993,0,0
2,GO SNORNA METABOLIC PROCESS,0.69885,0.061058,-1.3109e-05,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.13338,0.061025,0.091335,0,0
2,GO PROTEIN POLYMERIZATION,0.016386,0.060997,0.088862,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.18327,0.060961,0.055619,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0059116,0.060955,0.10831,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.51035,0.060926,0.063813,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.17156,0.06082,0.056152,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.13549,0.060784,0.063905,0,0
2,GO HISTONE PHOSPHORYLATION,0.093918,0.060783,0.076653,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.43075,0.060775,0.042229,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.34008,0.060735,0.058481,0,0
2,GO DNA DEMETHYLATION,0.19697,0.060659,0.072241,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.012945,0.0605,0.15407,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.047827,0.060349,0.098491,0,0
2,GO LEUKOCYTE AGGREGATION,0.84107,0.060336,-0.0039477,0,0
2,GO OXIDATIVE DEMETHYLATION,0.06986,0.060327,0.060757,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.16654,0.060298,0.076881,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.084763,0.060255,0.066674,0,0
2,GO ACETYL COA METABOLIC PROCESS,0.36311,0.060255,0.050639,0,0
2,GO BIOMINERALIZATION,0.17283,0.060245,0.069457,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.25583,0.060241,0.061075,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.1533,0.060187,0.08005,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.50516,0.060116,0.030441,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.2114,0.060052,0.070175,0,0
2,GO METAL ION HOMEOSTASIS,0.14642,0.06004,0.04994,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.13549,0.06003,0.057583,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.10214,0.060024,0.094088,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.30446,0.059876,0.043037,0,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.17411,0.059821,0.076755,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.093126,0.059743,0.063347,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.20122,0.059713,0.074331,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.043444,0.05967,0.10464,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.043866,0.059654,0.07843,0,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.33599,0.059358,0.050612,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.30066,0.059249,0.092091,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.1146,0.059178,0.1624,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.25414,0.05913,0.056387,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.090011,0.059082,0.080676,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.51035,0.059038,0.027998,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.027118,0.058988,0.059776,0,0
2,GO RESPONSE TO STARVATION,0.089246,0.058938,0.071802,0,0
2,GO ION HOMEOSTASIS,0.11837,0.058903,0.05177,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.42602,0.058843,0.037474,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.15098,0.058796,0.059018,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.29877,0.058791,0.094745,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.52345,0.058764,0.076561,0,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.9693,0.058752,-0.021367,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.063836,0.058675,0.071103,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0096941,0.058565,0.12056,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.26267,0.05838,0.08585,0,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.49231,0.058378,0.03806,0,0
2,GO CELL MOTILITY,0.16285,0.058283,0.061143,0,0
2,GO RESPONSE TO ZINC ION,0.052083,0.058274,0.10108,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.071119,0.058262,0.072002,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.32993,0.058045,0.049302,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.069238,0.057857,0.11412,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.037882,0.057838,0.10789,0,0
2,GO FIBROBLAST APOPTOTIC PROCESS,0.73212,0.057782,0.021175,0,0
2,GO METANEPHROS DEVELOPMENT,0.61687,0.057731,0.033651,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0076401,0.057698,0.089097,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.99515,0.057631,0.0040352,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.50776,0.057574,0.047005,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.36311,0.057509,0.041283,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.52345,0.057502,0.047036,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.6055,0.05744,0.030421,0,0
2,GO CELLULAR EXTRAVASATION,0.41434,0.057424,0.033722,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.089246,0.057415,0.088604,0,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.073043,0.057375,0.085486,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.17411,0.057256,0.057757,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.35253,0.057164,0.056756,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.97576,0.056948,-0.022358,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.1754,0.056798,0.056151,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.28213,0.056782,0.067809,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.077698,0.056672,0.077991,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.037509,0.056593,0.090729,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.13027,0.056559,0.061204,0,0
2,GO DNA LIGATION,0.71996,0.056485,0.011673,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.091558,0.056442,0.062678,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.59705,0.056416,0.04328,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.048285,0.056349,0.089496,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.25246,0.056156,0.045048,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.12924,0.056132,0.12257,0,0
2,GO ZINC ION HOMEOSTASIS,0.49487,0.05599,0.025694,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.52874,0.055937,0.042054,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.12924,0.055882,0.11217,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.54208,0.055829,0.030666,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.37608,0.055818,0.036462,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.2114,0.055814,0.055846,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.27853,0.055775,0.052499,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.17669,0.055564,0.061229,0,0
2,GO RESPONSE TO UV,0.089246,0.055554,0.072633,0,0
2,GO REFLEX,0.66028,0.055533,-0.041709,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.070488,0.055445,0.080936,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.079765,0.055427,0.092414,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.30255,0.055419,0.058448,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.23445,0.055307,0.049894,0,0
2,GO TUBE MORPHOGENESIS,0.22658,0.055304,0.059758,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.16042,0.055295,0.062697,0,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.71693,0.055249,0.0036246,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.72907,0.05515,0.030038,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.34008,0.054992,0.037892,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.20699,0.054984,0.065315,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.24745,0.054906,0.04832,0,0
2,GO RESPONSE TO ETHER,0.30446,0.054796,0.047061,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.13338,0.054717,0.062095,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.88245,0.054686,0.020103,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.27853,0.054638,0.059054,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.079071,0.054477,0.084621,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.17156,0.054366,0.065658,0,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.18461,0.054361,0.06735,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.1252,0.054277,0.052525,0,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.73212,0.054255,-0.035835,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.15802,0.054143,0.075702,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.318,0.053985,0.057377,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.11647,0.053916,0.061869,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.11742,0.053873,0.11485,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.90809,0.053854,-0.020821,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.35043,0.053785,0.043278,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.10471,0.053759,0.088987,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.052575,0.053752,0.11521,0,0
2,GO RRNA 3 END PROCESSING,0.93704,0.053566,-0.0033008,0,0
2,GO REGULATION OF CELL MATURATION,0.18327,0.053513,0.058309,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.43789,0.053495,0.037525,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.25246,0.053476,0.078869,0,0
2,GO ORGANELLE FISSION,0.13338,0.053284,0.07308,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.70185,0.053206,0.037755,0,0
2,GO L AMINO ACID TRANSPORT,0.44028,0.053068,0.031182,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.16904,0.053023,0.096632,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.19003,0.053012,0.058974,0,0
2,GO POSITIVE REGULATION OF BINDING,0.027973,0.052955,0.082499,0,0
2,GO CHEMICAL HOMEOSTASIS,0.24911,0.052885,0.042572,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.81896,0.052846,0.006346,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.28761,0.052789,0.06211,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.034636,0.052753,0.14077,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.22195,0.052724,0.066394,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.16407,0.052631,0.05992,0,0
2,GO VESICLE LOCALIZATION,0.063258,0.052615,0.069274,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.22348,0.052562,0.061571,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.41899,0.052518,0.043888,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.14983,0.052507,0.065277,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.4451,0.05249,0.05141,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.22503,0.052436,0.11703,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.23286,0.052388,0.043128,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.041383,0.052298,0.1059,0,0
2,GO LIPID STORAGE,0.68094,0.052233,0.031636,0,0
2,GO SODIUM ION HOMEOSTASIS,0.3871,0.052212,0.052068,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.80639,0.052192,-0.025409,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.16778,0.052072,0.1163,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.012798,0.051955,0.12366,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.97253,0.051937,-0.015907,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.21889,0.05191,0.05515,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.86968,0.051904,-0.0010864,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.33396,0.051872,0.048477,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.5394,0.051611,0.0251,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.14419,0.051556,0.061669,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.19417,0.051427,0.04639,0,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.318,0.051414,0.054948,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.30637,0.051276,0.088806,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.20992,0.05125,0.041488,0,0
2,GO VAGINA DEVELOPMENT,0.12822,0.051209,0.12195,0,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.36311,0.0512,0.048743,0,0
2,GO VIRAL GENE EXPRESSION,0.97576,0.051116,-0.0092444,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.1653,0.050971,0.053167,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.14755,0.050916,0.049046,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.038637,0.05082,0.067986,0,0
2,GO POSITIVE REGULATION OF SECRETION,0.17283,0.050755,0.053561,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.32393,0.050741,0.051004,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.20554,0.050706,0.055468,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.051595,0.050664,0.078303,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.46218,0.050615,0.053663,0,0
2,GO LIPID HOMEOSTASIS,0.80326,0.050552,0.019773,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.11092,0.050456,0.056571,0,0
2,GO REGULATION OF BINDING,0.021509,0.050347,0.085404,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.64276,0.050277,0.037749,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.098784,0.050206,0.083632,0,0
2,GO REGULATION OF DNA REPLICATION,0.074349,0.050135,0.08329,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.24252,0.050093,0.060935,0,0
2,GO TELOMERE CAPPING,0.55287,0.050027,0.03048,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.11553,0.049938,0.068835,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.79387,0.049864,0.024789,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.12126,0.049846,0.094556,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.30255,0.049801,0.082893,0,0
2,GO RESPONSE TO ACTIVITY,0.41666,0.049698,0.040296,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.10045,0.049604,0.085143,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.10129,0.049544,0.07979,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.14197,0.049403,0.077248,0,0
2,GO GLUTAMINE METABOLIC PROCESS,0.35674,0.049361,0.035933,0,0
2,GO ENDODERM FORMATION,0.52609,0.049248,0.034325,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.1533,0.049182,0.056776,0,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.084034,0.049105,0.074339,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.13027,0.048941,0.055186,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.46218,0.048882,0.058876,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.071756,0.048861,0.093451,0,0
2,GO BLASTOCYST FORMATION,0.86331,0.048854,-0.00035526,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.69586,0.04871,0.026759,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.21437,0.048681,0.062593,0,0
2,GO PROTEIN REFOLDING,0.35674,0.048674,0.055367,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.2714,0.048666,0.067307,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.45727,0.048659,0.030489,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.12822,0.048605,0.063986,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.25246,0.048552,0.052728,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.39156,0.048494,0.049081,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.48976,0.048468,0.064653,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.60834,0.048364,0.055359,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.091558,0.048332,0.069074,0,0
2,GO GMP METABOLIC PROCESS,0.30066,0.048319,0.051674,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.073694,0.048318,0.057353,0,0
2,GO ALANINE TRANSPORT,0.5583,0.048275,-0.034753,0,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.16407,0.048201,0.063728,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.35674,0.048147,0.060319,0,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.21738,0.048135,0.073938,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.82842,0.048104,0.012224,0,0
2,GO RESPONSE TO PEPTIDE,0.40743,0.048023,0.041816,0,0
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.10734,0.047995,0.073448,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.44752,0.04799,0.036757,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.086981,0.047965,0.11103,0,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.22348,0.047857,0.055239,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.93382,0.047776,-0.013822,0,0
2,GO TRABECULA MORPHOGENESIS,0.74435,0.047517,0.025865,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.2644,0.047494,0.053265,0,0
2,GO CHROMOSOME SEGREGATION,0.090782,0.047434,0.092471,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.62258,0.047343,0.042307,0,0
2,GO RESPONSE TO SALT,0.35253,0.047247,0.043256,0,0
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.24252,0.047239,0.053059,0,0
2,GO OSSIFICATION,0.28945,0.047191,0.045296,0,0
2,GO RETINA HOMEOSTASIS,0.16163,0.04718,0.044564,0,0
2,GO BIOLOGICAL ADHESION,0.28578,0.047163,0.052418,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.13763,0.047155,0.063812,0,0
2,GO GLAND DEVELOPMENT,0.25583,0.047131,0.059599,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.13234,0.047088,0.071024,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.19417,0.047035,0.065782,0,0
2,GO PHOTOPERIODISM,0.15683,0.047023,0.067663,0,0
2,GO CELLULAR HOMEOSTASIS,0.10214,0.046984,0.053122,0,0
2,GO ZINC ION TRANSPORT,0.10471,0.046972,0.075409,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.1387,0.046968,0.082635,0,0
2,GO REGULATION OF CELL SHAPE,0.35674,0.046923,0.051963,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.21738,0.046903,0.05208,0,0
2,GO CHROMOSOME CONDENSATION,0.54208,0.046793,0.043978,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.1653,0.04678,0.06239,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.12224,0.046646,0.10246,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.30255,0.04656,0.079834,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.31021,0.046546,0.096598,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.11367,0.04645,0.0697,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.88565,0.046399,-0.013113,0,0
2,GO MRNA TRANSPORT,0.11367,0.046362,0.070725,0,0
2,GO TRNA CATABOLIC PROCESS,0.1793,0.046297,0.11378,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.23766,0.046261,0.059916,0,0
2,GO VIRAL RNA GENOME REPLICATION,0.38488,0.046246,0.037843,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.68988,0.046241,0.014459,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.22195,0.046239,0.057074,0,0
2,GO TRANSPOSITION,0.20265,0.046233,0.088038,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.19979,0.046208,0.07114,0,0
2,GO REGULATION OF HORMONE LEVELS,0.073043,0.046206,0.066939,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.41899,0.046205,0.04051,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.12721,0.046193,0.096211,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.31021,0.046156,0.074692,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.28761,0.046116,0.071464,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.30829,0.04605,0.04915,0,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.77209,0.045866,0.020082,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.24252,0.045837,0.10077,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.099614,0.045829,0.070208,0,0
2,GO CENTRIOLE ASSEMBLY,0.09714,0.045812,0.10655,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.32393,0.045783,0.07187,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.87606,0.045751,-0.032272,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.25246,0.045626,0.066365,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.58307,0.045598,0.042231,0,0
2,GO RNA METHYLATION,0.50258,0.045565,0.033804,0,0
2,GO MYELIN ASSEMBLY,0.1533,0.045504,0.11223,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0099244,0.045391,0.064041,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.10385,0.045355,0.07186,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.13234,0.045215,0.05895,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.25078,0.045092,0.043451,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.39381,0.04503,0.058005,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.18866,0.044995,0.083367,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.64276,0.04487,0.037595,0,0
2,GO RESPONSE TO ESTRADIOL,0.17669,0.044848,0.058884,0,0
2,GO CELL SUBSTRATE ADHESION,0.38933,0.044831,0.047904,0,0
2,GO DNA STRAND ELONGATION,0.54746,0.044729,0.044247,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.06986,0.044548,0.073276,0,0
2,GO RNA LOCALIZATION,0.29877,0.044465,0.045258,0,0
2,GO RESPONSE TO LEAD ION,0.12029,0.04444,0.08295,0,0
2,GO MESONEPHROS DEVELOPMENT,0.26614,0.044322,0.07707,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.12924,0.044302,0.063351,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.17029,0.044263,0.075493,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.021509,0.04417,0.09225,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.31021,0.044007,0.060257,0,0
2,GO REGULATION OF PROTEIN BINDING,0.20122,0.043957,0.060368,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.96607,0.043934,-0.0024875,0,0
2,GO LIPID TRANSLOCATION,0.98546,0.043835,0.010172,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.21437,0.043807,0.097883,0,0
2,GO PROTEIN MANNOSYLATION,0.15683,0.04378,0.071044,0,0
2,GO MUSCLE CELL MIGRATION,0.94671,0.043641,0.0067012,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.48468,0.043618,0.028895,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.11275,0.043549,0.091474,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.30255,0.043495,0.043816,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.2913,0.043473,0.059281,0,0
2,GO AMELOGENESIS,0.66028,0.043423,0.029229,0,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.44994,0.043421,0.039455,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.69286,0.043413,0.017858,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.22042,0.043396,0.058657,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.22503,0.043382,0.06815,0,0
2,GO REGULATION OF MAPK CASCADE,0.17411,0.043241,0.058317,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.86012,0.043186,0.014362,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.090782,0.043009,0.080842,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.48722,0.042969,0.033623,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.58029,0.042907,0.044527,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.29502,0.042885,0.060332,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.31215,0.042823,0.044544,0,0
2,GO DNA REPLICATION,0.09796,0.042783,0.084504,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.41434,0.042762,0.039887,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.068006,0.042755,0.098658,0,0
2,GO VACUOLAR TRANSPORT,0.32393,0.042603,0.046921,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.82842,0.042603,-0.024172,0,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.74128,0.042505,0.026189,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.74435,0.04241,0.0049345,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.52609,0.042309,0.029561,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.27317,0.042245,0.079458,0,0
2,GO APOPTOTIC PROCESS,0.73212,0.042225,0.025119,0,0
2,GO RESPONSE TO HORMONE,0.48976,0.042224,0.037132,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.80639,0.042208,0.0096217,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.44994,0.042195,0.028515,0,0
2,GO MANNOSYLATION,0.56376,0.042187,0.020653,0,0
2,GO LUNG MORPHOGENESIS,0.42838,0.042161,0.046494,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.75048,0.042072,0.026251,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.23927,0.041983,0.068952,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.46218,0.041918,0.0448,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.22503,0.041802,0.046887,0,0
2,GO ERK1 AND ERK2 CASCADE,0.41899,0.041752,0.041389,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.36956,0.041742,0.039072,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.1754,0.0416,0.045903,0,0
2,GO REGULATION OF DNA METHYLATION,0.5314,0.041591,-0.057257,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.51557,0.04148,0.051466,0,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.94348,0.041446,0.013926,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.1793,0.04144,0.047954,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.032278,0.041361,0.074776,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.18461,0.041319,0.11981,0,0
2,GO RESPONSE TO INSULIN,0.39381,0.041223,0.043624,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.15921,0.0412,0.079908,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.92738,0.040953,0.0028053,0,0
2,GO REGULATION OF CELL DEATH,0.797,0.040937,0.023057,0,0
2,GO CALCIUM ION IMPORT,0.084763,0.040804,0.087358,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.22042,0.0408,0.089646,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.55287,0.040791,0.056015,0,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.30637,0.040669,0.061348,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0098086,0.040621,0.088339,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.14419,0.040593,0.094221,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.61402,0.040531,0.048946,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.033608,0.040386,0.081435,0,0
2,GO ENDOCYTIC RECYCLING,0.318,0.040291,0.056734,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.20699,0.040289,0.077607,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.16163,0.04022,0.14283,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.52609,0.040218,0.039382,0,0
2,GO AMINO ACID IMPORT,0.98869,0.04021,-0.0036539,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.25414,0.040187,0.044906,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.49231,0.040176,0.044181,0,0
2,GO DNA GEOMETRIC CHANGE,0.25078,0.040154,0.070391,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.60834,0.039916,0.036311,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32993,0.03975,0.05258,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.48976,0.039747,0.033875,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.5314,0.039614,0.041365,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.21738,0.039609,0.062272,0,0
2,GO GOLGI LOCALIZATION,0.74435,0.039586,0.012907,0,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.92738,0.039564,-0.021849,0,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.24911,0.039562,0.050699,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.11367,0.039532,0.071633,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.46713,0.039525,0.039029,0,0
2,GO PHOTOTRANSDUCTION,0.12822,0.039433,0.028885,0,0
2,GO PROTEIN TRIMERIZATION,0.13444,0.039327,0.10064,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.33396,0.03929,0.046537,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.178,0.039276,0.067933,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.97576,0.039256,-0.0034155,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.33194,0.038968,0.044214,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.14642,0.038965,0.15996,0,0
2,GO RNA PROCESSING,0.22503,0.038935,0.046708,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.47963,0.038921,0.031393,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.18866,0.03889,0.055576,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.1453,0.038844,0.083068,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.24089,0.038831,0.079094,0,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.32592,0.038762,0.048909,0,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.59144,0.038636,0.032707,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.21587,0.038615,0.059256,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.084034,0.038538,0.065043,0,0
2,GO NEPHRON DEVELOPMENT,0.69586,0.038472,0.031805,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.13979,0.038445,0.07991,0,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.20409,0.038389,0.054963,0,0
2,GO MYOBLAST DIFFERENTIATION,0.65734,0.038349,0.014703,0,0
2,GO RESPONSE TO FATTY ACID,0.16163,0.03825,0.067756,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.66616,0.038214,0.025952,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.68988,0.038153,0.022849,0,0
2,GO MEIOTIC CELL CYCLE,0.076344,0.03814,0.091858,0,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.94026,0.038137,-0.010539,0,0
2,GO DNA PACKAGING,0.11002,0.038091,0.098851,0,0
2,GO HISTONE MONOUBIQUITINATION,0.16654,0.038082,0.072156,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.75048,0.038056,0.025068,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.3739,0.038032,0.062553,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.20122,0.037944,0.074292,0,0
2,GO REGULATION OF GENE SILENCING,0.40973,0.037797,0.035453,0,0
2,GO REGULATION OF CELL AGING,0.1533,0.037791,0.071538,0,0
2,GO SISTER CHROMATID SEGREGATION,0.1873,0.03779,0.075161,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.12924,0.037738,0.080034,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.45972,0.037697,0.04063,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.31604,0.037679,0.052392,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.38933,0.037636,0.06831,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.22195,0.037611,0.072158,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.076344,0.037604,0.11267,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.6312,0.037497,0.0097225,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.46713,0.037474,0.029137,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.70787,0.037446,0.02425,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.62832,0.0374,0.029755,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.35463,0.037368,0.045719,0,0
2,GO NCRNA TRANSCRIPTION,0.096327,0.037359,0.062568,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.55287,0.03732,0.046309,0,0
2,GO CHROMATIN REMODELING,0.027118,0.037171,0.10244,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.3442,0.037141,0.047044,0,0
2,GO REGULATION OF CELL DIVISION,0.066792,0.037107,0.086708,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.47211,0.037006,0.038088,0,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.48215,0.036966,0.042131,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.70185,0.036961,0.028109,0,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.43789,0.036923,0.067128,0,0
2,GO REGULATION OF OSSIFICATION,0.33194,0.03686,0.046039,0,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.97576,0.036803,0.017671,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.35043,0.036707,0.058672,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.30829,0.036705,0.051986,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.14197,0.036673,0.095941,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.080464,0.036632,0.10879,0,0
2,GO HISTONE H4 ACETYLATION,0.027401,0.036626,0.09812,0,0
2,GO GASTRULATION,0.50516,0.036469,0.038929,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.021509,0.036436,0.085303,0,0
2,GO MUSCLE FILAMENT SLIDING,0.1793,0.036407,0.07341,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.32393,0.036257,0.029099,0,0
2,GO HEART FIELD SPECIFICATION,0.13234,0.036231,0.14791,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.2114,0.036184,0.081094,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.84107,0.03607,0.014475,0,0
2,GO DIET INDUCED THERMOGENESIS,0.36526,0.035985,0.066131,0,0
2,GO RESPONSE TO CADMIUM ION,0.50516,0.035928,0.029859,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.66616,0.03592,0.049909,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.30255,0.035883,0.050076,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.98546,0.035809,0.0041906,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.72299,0.035749,0.011448,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.68094,0.03571,0.028236,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.23128,0.035674,0.067401,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.10558,0.035502,0.081097,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.18327,0.035502,0.084073,0,0
2,GO EXIT FROM MITOSIS,0.22042,0.035488,0.062812,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.25924,0.035484,0.070673,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.55287,0.035475,0.02994,0,0
2,GO DE NOVO PROTEIN FOLDING,0.44752,0.035469,0.040485,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.21587,0.035436,0.052546,0,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.3739,0.035427,0.050657,0,0
2,GO T CELL HOMEOSTASIS,0.4355,0.035381,0.03591,0,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.572,0.035362,-0.029131,0,0
2,GO CELLULAR RESPONSE TO LIPID,0.79075,0.035343,0.017719,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.6055,0.035162,0.036848,0,0
2,GO RESPONSE TO METAL ION,0.35886,0.035143,0.04096,0,0
2,GO STRESS FIBER ASSEMBLY,0.28395,0.03514,0.061064,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.32792,0.035044,0.057385,0,0
2,GO NUCLEAR EXPORT,0.19417,0.035037,0.058228,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.57752,0.034924,0.025402,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.56376,0.034883,0.023029,0,0
2,GO MRNA CLEAVAGE,0.29877,0.034836,0.053854,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.45727,0.034781,0.040243,0,0
2,GO DNA RECOMBINATION,0.27853,0.034769,0.064346,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.38488,0.034722,0.041662,0,0
2,GO REGULATION OF URINE VOLUME,0.34213,0.034687,0.044503,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.42838,0.034652,0.037418,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.58029,0.034544,0.034481,0,0
2,GO HOMEOSTATIC PROCESS,0.42133,0.034541,0.032872,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.98546,0.034427,0.0039749,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.76899,0.034399,0.024037,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.87287,0.034344,0.0035371,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.1533,0.034271,0.036737,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.2458,0.034169,0.064143,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.37827,0.034121,0.049718,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.42367,0.034046,0.041287,0,0
2,GO LUNG CELL DIFFERENTIATION,0.73517,0.034015,-0.01099,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.28395,0.033966,0.0456,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.91772,0.03393,-0.016006,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.5,0.033919,0.05541,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.37173,0.033834,0.043569,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.36741,0.033819,0.052766,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.090782,0.033802,0.059513,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.68988,0.033774,0.027508,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.56103,0.033661,0.039646,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.35253,0.033644,0.052706,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.33396,0.033532,0.042859,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.46218,0.03346,0.036623,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.48468,0.033411,0.04477,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.5665,0.033362,0.036873,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.61117,0.033291,0.036405,0,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.9113,0.033282,-0.015765,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.19278,0.033217,0.081728,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.35886,0.033206,0.036995,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.52082,0.033168,0.078207,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.86331,0.033058,-0.0091711,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.80012,0.032999,-0.018127,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.36741,0.032978,0.043751,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.1313,0.032933,0.097365,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.35463,0.032918,0.030142,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.29502,0.032897,0.056346,0,0
2,GO TRACHEA MORPHOGENESIS,0.21587,0.032863,0.079334,0,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.40058,0.032814,0.044392,0,0
2,GO MEMBRANE DOCKING,0.020605,0.032729,0.10459,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.57476,0.03272,0.026693,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.76899,0.032677,0.022898,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.24416,0.032655,0.099894,0,0
2,GO TUBE DEVELOPMENT,0.2644,0.032588,0.056595,0,0
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.22348,0.032481,0.054792,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.30446,0.032382,0.045846,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.17669,0.032315,0.12621,0,0
2,GO METHYLATION,0.053071,0.032307,0.078557,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.62545,0.032281,0.053597,0,0
2,GO GLIAL CELL ACTIVATION,0.34008,0.032262,0.046194,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.14755,0.032247,0.11513,0,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.34627,0.03219,0.057778,0,0
2,GO CARNITINE SHUTTLE,0.17029,0.03219,0.096775,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.32993,0.032182,0.065496,0,0
2,GO CHROMOSOME ORGANIZATION,0.030368,0.032073,0.095116,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.95961,0.032066,-0.0025972,0,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.72603,0.032031,0.0065977,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.093126,0.031966,0.06282,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.13027,0.031906,0.069966,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.66616,0.031905,0.016484,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.37608,0.031843,0.038964,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.82842,0.031776,0.022452,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.64276,0.031667,0.028286,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.37827,0.031656,0.042564,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.76899,0.031512,-0.010492,0,0
2,GO RESPONSE TO TESTOSTERONE,0.89205,0.031476,0.0089945,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.67798,0.031445,0.047184,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.35463,0.031439,0.074457,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.22195,0.031436,0.071689,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.67501,0.03141,0.040665,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.1252,0.031392,0.056232,0,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.90167,0.031348,-0.0020989,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.6312,0.031326,-0.021573,0,0
2,GO STEROID CATABOLIC PROCESS,0.81267,0.031324,9.4294e-06,0,0
2,GO AMYLOID BETA FORMATION,0.318,0.031211,0.077706,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.5583,0.031202,0.032297,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.97899,0.031168,-0.0053753,0,0
2,GO RNA CATABOLIC PROCESS,0.49231,0.031164,0.019913,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.33194,0.031048,0.073201,0,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.59705,0.030859,0.021559,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.084763,0.03084,0.085957,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.31604,0.030768,0.046007,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.572,0.030646,0.054717,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.20554,0.030585,0.092401,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.51035,0.03056,0.042855,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.25414,0.030524,0.053042,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.5665,0.030482,0.024748,0,0
2,GO P38MAPK CASCADE,0.68689,0.030471,0.0231,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.24911,0.030454,0.072674,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.14419,0.030404,0.12129,0,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.80012,0.030376,0.022415,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.25924,0.030312,0.079516,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.18461,0.030287,0.053505,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.59424,0.030269,-0.017892,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.47211,0.030252,0.028155,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15921,0.030227,0.057763,0,0
2,GO AMYLOID FIBRIL FORMATION,0.78451,0.030225,0.036487,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.21437,0.030204,0.05285,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.99838,0.03019,-0.0076826,0,0
2,GO BODY MORPHOGENESIS,0.48976,0.030068,0.040468,0,0
2,GO ORGANELLE ASSEMBLY,0.0096941,0.029955,0.087913,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.42367,0.029939,0.041775,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.7659,0.029895,0.027968,0,0
2,GO PARENTAL BEHAVIOR,0.74128,0.029746,0.034837,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.3871,0.029738,0.060248,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.19979,0.029701,0.050088,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.94671,0.029649,0.030624,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.24089,0.029646,0.057933,0,0
2,GO DNA DEALKYLATION,0.24745,0.029574,0.057572,0,0
2,GO RESPONSE TO DRUG,0.29502,0.029503,0.052873,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.047827,0.029493,0.075477,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.32195,0.029489,0.034093,0,0
2,GO APOPTOTIC CELL CLEARANCE,0.74435,0.029393,-0.037123,0,0
2,GO GRANULOCYTE DIFFERENTIATION,0.81896,0.029384,-0.015517,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.50776,0.029382,0.037467,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.95639,0.029372,0.011659,0,0
2,GO RESPONSE TO ALCOHOL,0.27673,0.029355,0.049471,0,0
2,GO ANION TRANSPORT,0.5,0.02919,0.032194,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.069238,0.029043,0.073679,0,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.68094,0.02896,0.027334,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.5314,0.028941,0.053356,0,0
2,GO SULFATION,0.27673,0.028912,0.07491,0,0
2,GO SNORNA 3 END PROCESSING,0.82211,0.028907,-0.0046081,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.35674,0.028808,0.047205,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.7814,0.028699,-0.031854,0,0
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.75048,0.028689,0.02017,0,0
2,GO CAMP METABOLIC PROCESS,0.25246,0.028643,0.079957,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.21587,0.028594,0.089956,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.23286,0.028505,0.05305,0,0
2,GO NUCLEUS ORGANIZATION,0.34835,0.028428,0.048407,0,0
2,GO SECRETION,0.95639,0.02842,0.013762,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.54208,0.028403,0.043251,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.81896,0.028376,0.0019174,0,0
2,GO NCRNA CATABOLIC PROCESS,0.71391,0.028361,0.021187,0,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.41434,0.028229,0.043085,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.91451,0.028207,0.020128,0,0
2,GO DNA CONFORMATION CHANGE,0.20845,0.028191,0.082016,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.13027,0.028175,0.0698,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.48976,0.028117,0.05728,0,0
2,GO MEMBRANE ORGANIZATION,0.24089,0.028107,0.049539,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.48722,0.028012,0.034504,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.9306,0.027967,0.001093,0,0
2,GO PROSTAGLANDIN SECRETION,0.91451,0.027889,0.0056286,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.48722,0.027865,0.04285,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.51296,0.027834,0.054735,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.30446,0.027745,0.046114,0,0
2,GO IMPORT INTO NUCLEUS,0.20554,0.027659,0.052761,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.6515,0.027513,0.041581,0,0
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.6055,0.0275,0.028825,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.22348,0.027471,0.054117,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.99838,0.02747,0.018952,0,0
2,GO RIBOSOME BIOGENESIS,0.6691,0.027358,-0.030542,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.80639,0.027349,0.035954,0,0
2,GO REGULATION OF TOR SIGNALING,0.071756,0.027242,0.080899,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.68689,0.027231,0.052146,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.15683,0.027146,0.0525,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.62545,0.027106,0.030638,0,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.22348,0.027085,0.054802,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.45972,0.027055,0.032004,0,0
2,GO TOR SIGNALING,0.10646,0.026991,0.071742,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.90488,0.026896,-0.0058179,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.95639,0.026862,-0.0036321,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.318,0.026687,0.086888,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.11647,0.026551,0.064011,0,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.68094,0.026497,0.023381,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.69885,0.02648,0.023727,0,0
2,GO POLYOL METABOLIC PROCESS,0.33396,0.026385,0.04948,0,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.47461,0.026359,0.041472,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.30066,0.026289,0.082855,0,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.69286,0.026279,0.022509,0,0
2,GO CYTOKINESIS,0.079765,0.026265,0.076238,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.31604,0.026158,0.039885,0,0
2,GO LIVER MORPHOGENESIS,0.91451,0.026104,0.0050072,0,0
2,GO AUTOPHAGIC CELL DEATH,0.42133,0.025976,0.046898,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.23766,0.025938,0.074608,0,0
2,GO CENTROSOME DUPLICATION,0.49231,0.025817,0.053483,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.27673,0.025723,0.049737,0,0
2,GO NUCLEAR TRANSPORT,0.075009,0.025654,0.069165,0,0
2,GO MUSCLE HYPERTROPHY,0.4355,0.0256,0.047341,0,0
2,GO SPINDLE LOCALIZATION,0.22971,0.025405,0.061641,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.081168,0.025375,0.12267,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.86968,0.025371,-0.0035382,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.6055,0.025355,0.03332,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.75664,0.025319,0.045584,0,0
2,GO RESPONSE TO ESTROGEN,0.50516,0.025306,0.039904,0,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.84107,0.025303,-0.039272,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.88565,0.025237,0.0036187,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.40286,0.025212,0.041928,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.64858,0.025187,0.034179,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.20265,0.025115,0.070463,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.178,0.025077,0.063894,0,0
2,GO TRNA TRANSPORT,0.5314,0.024996,0.041294,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.33803,0.024969,0.038816,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.46466,0.024956,0.035514,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.49743,0.024928,0.036069,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.47461,0.024826,0.035822,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.36956,0.024795,0.04493,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.56103,0.024795,0.060317,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.82211,0.024792,0.018634,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.13763,0.024759,0.064014,0,0
2,GO HISTONE DEUBIQUITINATION,0.090782,0.024723,0.091762,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.23605,0.024688,0.05745,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.26789,0.024655,0.046897,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.39832,0.024597,0.040975,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.49743,0.024585,0.047211,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.70185,0.024559,0.020172,0,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.78763,0.024433,0.019019,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.71391,0.024339,0.024254,0,0
2,GO PIGMENTATION,0.69885,0.024302,0.02434,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.77209,0.024204,0.018652,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.89846,0.0242,0.0008262,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.36956,0.024141,0.046215,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.97576,0.024113,0.040036,0,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.65734,0.024088,0.019213,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.69286,0.024065,0.028335,0,0
2,GO DNA REPAIR,0.20409,0.024063,0.06807,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.56103,0.024038,0.057578,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.41203,0.024014,0.051731,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.51557,0.023968,0.032171,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.14088,0.023945,0.13045,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.28578,0.02388,0.066609,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.024428,0.02383,0.076423,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.30446,0.023816,0.045946,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.52345,0.023795,0.048635,0,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.17156,0.023779,0.064757,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23766,0.023625,0.066686,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.83474,0.023504,0.024381,0,0
2,GO SLEEP,0.5,0.023434,0.03162,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.24911,0.023351,0.049785,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.84741,0.023318,0.0094619,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.65734,0.023257,0.026929,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.75048,0.023207,0.018069,0,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.51296,0.023184,0.04105,0,0
2,GO ADAPTIVE THERMOGENESIS,0.6691,0.023162,0.03053,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.26614,0.023069,0.05032,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.67501,0.023046,0.04769,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.82526,0.023021,0.013876,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.48722,0.022772,0.041401,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.61972,0.022751,0.031866,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.62545,0.022731,0.035297,0,0
2,GO STEROL TRANSPORT,0.81581,0.022677,0.018095,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.99515,0.022665,-0.0065413,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.41899,0.022501,0.059948,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.63697,0.022482,0.027412,0,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.45972,0.022408,-0.1037,0,0
2,GO RNA SURVEILLANCE,0.99515,0.022393,-0.0082965,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.52874,0.022325,0.080813,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.67501,0.022312,0.030098,0,0
2,GO HEAD MORPHOGENESIS,0.797,0.022305,0.024655,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.67798,0.022298,0.021636,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.87606,0.022297,0.017381,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.52082,0.022265,0.048221,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.25753,0.022217,0.052278,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.62832,0.022215,-0.03988,0,0
2,GO VASCULATURE DEVELOPMENT,0.32993,0.022186,0.048098,0,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.58307,0.022149,0.033577,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.58029,0.022066,0.039356,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.078382,0.022053,0.054993,0,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.23286,0.02204,0.070823,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.99515,0.021946,0.00527,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.98546,0.02191,0.013132,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.46218,0.021776,0.038415,0,0
2,GO RNA 3 END PROCESSING,0.24089,0.02163,0.050742,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.6055,0.021623,-0.023011,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.35463,0.021618,0.041961,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.98222,0.021615,-0.0017835,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.56925,0.021501,0.031285,0,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.86331,0.021358,0.0053626,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.42838,0.021342,0.036037,0,0
2,GO RESPONSE TO KETONE,0.78763,0.021323,0.021853,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.33194,0.021252,0.044818,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.11092,0.02119,0.066963,0,0
2,GO L SERINE METABOLIC PROCESS,0.49231,0.02109,0.06033,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.47712,0.020985,0.041948,0,0
2,GO MATURATION OF 5 8S RRNA,0.46218,0.020971,-0.050171,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.70486,0.020849,0.027577,0,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.47963,0.020795,0.024039,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.74741,0.020735,0.026676,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.71089,0.020666,0.028571,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.79075,0.020563,0.034824,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.14419,0.020534,0.065732,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.50776,0.020494,0.043741,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.43789,0.020457,0.042826,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.28578,0.020302,0.1041,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.46218,0.020297,0.034868,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.6312,0.020287,0.02682,0,0
2,GO POLYOL CATABOLIC PROCESS,0.29877,0.020265,0.05014,0,0
2,GO RNA EXPORT FROM NUCLEUS,0.27495,0.020256,0.054166,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.31604,0.020234,0.056669,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.29877,0.020215,0.047818,0,0
2,GO PANCREATIC JUICE SECRETION,0.70486,0.020209,0.012765,0,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.64567,0.020128,0.03573,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.99515,0.02007,-0.0015874,0,0
2,GO BICARBONATE TRANSPORT,0.62258,0.020034,0.029965,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.22503,0.020016,0.079381,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.85059,0.019994,0.046635,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.39832,0.019989,0.035102,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.21288,0.019954,0.096686,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.81896,0.019857,0.027939,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.30255,0.019781,0.056476,0,0
2,GO MICROVILLUS ASSEMBLY,0.85694,0.019769,-0.0088331,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.73212,0.019697,0.024463,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.088486,0.019691,0.059035,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.62545,0.019674,0.032576,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.34835,0.019652,0.048847,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.93382,0.019485,-0.015466,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.81896,0.019479,-0.0096766,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.37827,0.019388,0.042177,0,0
2,GO RENAL SYSTEM PROCESS,0.7814,0.019382,0.031561,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.10299,0.019374,0.14267,0,0
2,GO ORGANELLE LOCALIZATION,0.034984,0.01932,0.082966,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.77519,0.019314,0.022529,0,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.35253,0.019283,0.055494,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.44994,0.01913,0.042017,0,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.18461,0.01906,-0.10928,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.29502,0.018941,0.040591,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.3739,0.018918,0.07073,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.75048,0.01891,0.030326,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.41899,0.018887,0.055116,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.74435,0.018864,0.031402,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.54208,0.018686,0.038849,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.36098,0.01866,0.083053,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.9113,0.018645,0.015326,0,0
2,GO DNA METABOLIC PROCESS,0.2644,0.018641,0.058333,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.70486,0.018633,0.02554,0,0
2,GO RESPONSE TO RADIATION,0.23605,0.018576,0.046366,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.52609,0.018567,0.019735,0,0
2,GO DETECTION OF STIMULUS,0.73212,0.018552,0.018382,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.66321,0.018527,0.044038,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.43075,0.018256,0.091791,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.56376,0.018203,0.019196,0,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.40743,0.018132,0.045717,0,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.8379,0.018117,0.0019429,0,0
2,GO MITOTIC DNA REPLICATION,0.87606,0.017918,0.012626,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.42838,0.017914,0.049421,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.44269,0.017896,-0.058441,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.61972,0.017873,0.038195,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.68392,0.017871,0.024042,0,0
2,GO HISTONE H2B UBIQUITINATION,0.87606,0.017803,0.017936,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.41203,0.017783,0.035226,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.6055,0.017433,0.028063,0,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.50776,0.01742,0.040466,0,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.52874,0.017349,0.025001,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.75664,0.017258,0.027484,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.62832,0.017228,0.023133,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.43789,0.017216,-0.031084,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.64567,0.017205,0.027228,0,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.63986,0.017194,-0.038005,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.89205,0.017184,-0.01208,0,0
2,GO TRANSLATIONAL INITIATION,0.81896,0.017088,0.0093112,0,0
2,GO BASE EXCISION REPAIR,0.58585,0.017056,0.023546,0,0
2,GO NOTCH SIGNALING PATHWAY,0.68988,0.017,0.02802,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.44752,0.01699,0.044296,0,0
2,GO RELAXATION OF MUSCLE,0.22971,0.016807,0.086253,0,0
2,GO REGULATION OF LIPID STORAGE,0.72907,0.016752,0.024261,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.797,0.016738,0.014844,0,0
2,GO COENZYME A METABOLIC PROCESS,0.50516,0.016688,0.062852,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.98222,0.016675,-0.014342,0,0
2,GO LOCOMOTOR RHYTHM,0.99515,0.016673,0.052764,0,0
2,GO MATURATION OF SSU RRNA,0.94671,0.016597,-0.015063,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.7659,0.016448,0.029154,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.21437,0.016292,0.090329,0,0
2,GO MAGNESIUM ION TRANSPORT,0.95316,0.016157,-0.0020081,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.95639,0.016136,0.010999,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.54208,0.016092,0.041866,0,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.67501,0.016081,0.00021187,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.38267,0.016059,0.050845,0,0
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.93382,0.015935,0.0094405,0,0
2,GO CELL FATE DETERMINATION,0.6691,0.015896,0.033914,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.72603,0.015869,0.047701,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.61972,0.015759,-0.0087809,0,0
2,GO CELL CYCLE CHECKPOINT,0.17669,0.015735,0.071801,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.29689,0.015713,0.071482,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.41203,0.015661,0.03929,0,0
2,GO SEQUESTERING OF METAL ION,0.9113,0.015639,-0.0082487,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.797,0.015532,0.031918,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.75356,0.015493,0.02923,0,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.98546,0.015441,0.0117,0,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.5314,0.015226,-0.011996,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.36956,0.015219,0.036785,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.44752,0.015183,0.02865,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.23445,0.015173,0.08214,0,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.28578,0.014933,0.058672,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.45238,0.014855,0.049809,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.94993,0.014835,0.0076249,0,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.72907,0.014731,-0.0056385,0,0
2,GO REGULATION OF ACROSOME REACTION,0.99192,0.014647,0.011164,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.70185,0.014527,0.017514,0,0
2,GO I KAPPAB PHOSPHORYLATION,0.70185,0.014506,-0.020355,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.2714,0.014364,0.069837,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.48468,0.014361,0.026301,0,0
2,GO SPINDLE ASSEMBLY,0.5665,0.014345,0.058836,0,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.90488,0.01429,-0.050745,0,0
2,GO LIPID EXPORT FROM CELL,0.70787,0.01427,-0.024191,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.42838,0.014201,0.036521,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.23766,0.014186,0.050781,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.50516,0.014104,0.033416,0,0
2,GO CYTOSOLIC TRANSPORT,0.3442,0.014071,0.056568,0,0
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.79075,0.014064,0.013833,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.79387,0.01406,-0.021672,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.79075,0.013934,-0.020477,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.47712,0.013862,0.041309,0,0
2,GO CHOLESTEROL EFFLUX,0.94993,0.01386,0.0069076,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.51819,0.013665,0.038176,0,0
2,GO NEURONAL ACTION POTENTIAL,0.48215,0.013519,0.070304,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.80953,0.013515,0.013316,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.89205,0.013488,-0.0081978,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.27853,0.01341,0.097321,0,0
2,GO JNK CASCADE,0.1754,0.013302,0.060572,0,0
2,GO PROTEIN TETRAMERIZATION,0.51035,0.013298,0.031839,0,0
2,GO MITOPHAGY,0.6055,0.013179,0.032607,0,0
2,GO LINOLEIC ACID METABOLIC PROCESS,0.68392,0.013158,-0.026636,0,0
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.09714,0.013157,0.10116,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.14755,0.013065,0.060502,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.56103,0.013065,0.023733,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.35043,0.013054,0.035748,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.25078,0.013024,0.063423,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.99515,0.01302,0.021279,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.37608,0.012871,0.04211,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.94671,0.012868,0.0043745,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.87926,0.012747,0.0097591,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.6691,0.012745,-0.019377,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.20409,0.012658,0.06064,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.62545,0.012543,0.021356,0,0
2,GO ORGANELLE INHERITANCE,0.70486,0.012542,-0.0075562,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.98222,0.012445,0.010597,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.69286,0.012408,0.032692,0,0
2,GO REGULATION OF HAIR CYCLE,0.40286,0.012357,0.046963,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.70787,0.01231,0.02002,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.6055,0.012301,0.024927,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.9306,0.012295,-0.018554,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.28033,0.012283,0.055044,0,0
2,GO TRNA METHYLATION,0.78451,0.012253,0.008858,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.49487,0.012226,0.056841,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.33599,0.012182,0.065049,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.98546,0.012126,0.015837,0,0
2,GO RESPONSE TO CAMP,0.22195,0.012026,0.064473,0,0
2,GO ORGANIC ANION TRANSPORT,0.77519,0.011878,0.02119,0,0
2,GO NUCLEOSOME ASSEMBLY,0.15447,0.01187,0.10546,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.29689,0.011785,0.037866,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.12224,0.011769,0.05176,0,0
2,GO POSITIVE CHEMOTAXIS,0.76899,0.011666,-0.0062418,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.93704,0.011648,0.017135,0,0
2,GO CELLULAR RESPONSE TO DRUG,0.58585,0.011565,0.039955,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.22658,0.011487,0.091192,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.23766,0.011468,0.066327,0,0
2,GO PROTEIN TARGETING,0.4355,0.011338,0.020318,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.76899,0.011176,0.031957,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.35674,0.01109,0.051267,0,0
2,GO BODY FLUID SECRETION,0.91772,0.011053,0.01278,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.84424,0.011051,-0.011285,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.47461,0.011017,-0.039131,0,0
2,GO TELOMERE ORGANIZATION,0.80639,0.010987,0.017859,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.56376,0.010901,0.037508,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.44752,0.010881,0.057866,0,0
2,GO REGULATION OF TUBE SIZE,0.97899,0.010862,0.01199,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.51035,0.010827,0.027639,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.42602,0.010661,0.049223,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.70787,0.010547,0.021281,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.63408,0.010479,0.039766,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.77519,0.010464,0.0041472,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.97253,0.010396,0.032119,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.38047,0.010324,0.056561,0,0
2,GO MITOTIC CYTOKINESIS,0.64567,0.010292,0.021531,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.86331,0.010265,0.01035,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.88885,0.010249,-0.0030768,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.61687,0.010215,0.03046,0,0
2,GO ASTROCYTE ACTIVATION,0.16042,0.010155,0.085065,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.59424,0.010117,0.040406,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.80639,0.010086,0.02329,0,0
2,GO LIPID METABOLIC PROCESS,0.67798,0.010067,-0.00089254,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.4451,0.010047,0.042766,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.27673,0.010046,0.060156,0,0
2,GO T CELL MIGRATION,0.50776,0.010017,-0.033577,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.44994,0.00997,0.053347,0,0
2,GO RESPONSE TO UV B,0.58864,0.0099352,0.058357,0,0
2,GO CELL MATRIX ADHESION,0.74741,0.0099302,0.029714,0,0
2,GO REGULATION OF GTP BINDING,0.88565,0.0098856,0.022599,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.5665,0.0098848,0.027013,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.77519,0.0098398,0.0094955,0,0
2,GO MIRNA METABOLIC PROCESS,0.81581,0.0097582,0.013627,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.11553,0.0097444,0.09484,0,0
2,GO MUSCLE ADAPTATION,0.95639,0.0096474,0.020049,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.73822,0.009599,-0.031742,0,0
2,GO RESPONSE TO NUTRIENT,0.97899,0.00954,0.01063,0,0
2,GO RRNA METABOLIC PROCESS,0.84424,0.0095127,-0.017384,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.59424,0.0094688,0.030485,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.80639,0.0094374,0.0028689,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.56103,0.0094154,-0.014732,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.39606,0.0093237,-0.05925,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.71693,0.0093094,0.017234,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.99838,0.0092741,0.014304,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.81896,0.0090773,0.014287,0,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.91451,0.0090483,0.016585,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.99515,0.0090127,0.0046744,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.63408,0.0090103,0.047754,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.73822,0.0090074,0.019675,0,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.87287,0.0089847,-0.022658,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.54208,0.0089278,0.06624,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.80012,0.0089187,-0.010978,0,0
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.58864,0.0088774,-0.032775,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.80326,0.0088742,-0.011213,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.55558,0.0087703,0.037715,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.91772,0.0085265,-0.0051137,0,0
2,GO ORGAN INDUCTION,0.75048,0.008516,0.048353,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.41434,0.008484,0.037899,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.48722,0.0084623,0.033074,0,0
2,GO CELL CELL ADHESION,0.46466,0.0084471,0.039531,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.58864,0.0084221,0.030816,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.38933,0.0082147,0.049153,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.77209,0.0082023,0.024997,0,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.66321,0.0081739,0.021206,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.66028,0.0081587,0.0016252,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.9113,0.008147,0.017409,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.70486,0.0081196,0.022923,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.90809,0.0080668,-0.00027371,0,0
2,GO REGENERATION,0.51035,0.008039,0.036077,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.70185,0.0080366,0.02055,0,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.83158,0.0080171,-0.0051834,0,0
2,GO LYMPHOCYTE MIGRATION,0.54746,0.0079977,-0.023017,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.71391,0.0078851,0.034829,0,0
2,GO DNA MODIFICATION,0.69885,0.0078211,0.030357,0,0
2,GO THIOESTER METABOLIC PROCESS,0.75356,0.0078186,0.014099,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.68988,0.0077204,0.046435,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.9306,0.0076523,0.011546,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.59144,0.0076406,0.046936,0,0
2,GO MAINTENANCE OF LOCATION,0.55287,0.0076103,0.037072,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.54208,0.0076085,-0.076118,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.84424,0.0075873,0.014602,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.18062,0.0075708,0.091362,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.76899,0.0075645,0.021152,0,0
2,GO ACID SECRETION,0.22814,0.0075253,0.06026,0,0
2,GO REGULATION OF AUTOPHAGY,0.49487,0.0074863,0.038439,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.84107,0.0074438,0.02068,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.9693,0.0073766,0.0079853,0,0
2,GO FIBROBLAST PROLIFERATION,0.66321,0.0072395,0.031013,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.98546,0.0072176,0.011156,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.8379,0.007133,0.0146,0,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.52345,0.0071182,-0.034098,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.99838,0.0071148,0.011138,0,0
2,GO REGULATION OF LIPASE ACTIVITY,0.7659,0.0070057,0.020479,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.50516,0.0069064,0.038242,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.76281,0.0069061,0.026203,0,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.85376,0.0069022,0.049885,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.59424,0.0068668,0.067926,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.82526,0.0067691,0.014863,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.33803,0.0065863,0.082047,0,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.72603,0.0065377,0.016639,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.6691,0.0064645,0.024312,0,0
2,GO CYTOPLASMIC TRANSLATION,0.6312,0.0064404,0.021242,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.68392,0.0063872,-0.0081457,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.46218,0.0063854,0.036753,0,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.94993,0.0063777,0.019553,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.75972,0.0063754,0.02693,0,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.45972,0.0063528,-0.057838,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.49487,0.0063444,0.047504,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.71089,0.0063179,0.032368,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.4355,0.0063098,0.055043,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.8379,0.0061498,0.005554,0,0
2,GO ANOIKIS,0.22971,0.0061223,-0.061733,0,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.81581,0.0061187,-0.006748,0,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.83474,0.0060282,0.004813,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.33396,0.0060112,0.058881,0,0
2,GO HAIR FOLLICLE MATURATION,0.85376,0.005938,0.0091521,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.83474,0.0059048,0.016285,0,0
2,GO REGULATION OF CELL ADHESION,0.74741,0.0057769,-0.0039311,0,0
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.70486,0.0057023,0.026333,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.78451,0.0056965,0.021085,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.27317,0.005631,0.053447,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.73212,0.0056185,0.0012739,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.70185,0.0055742,0.024469,0,0
2,GO MESODERM MORPHOGENESIS,0.91772,0.0054723,0.010866,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.57476,0.0053521,0.0337,0,0
2,GO EPIDERMIS DEVELOPMENT,0.23605,0.0051932,-0.067136,0,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.90809,0.0051717,0.0019257,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.5314,0.0049826,0.050091,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.53672,0.004921,0.038957,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.47461,0.0048636,-0.049518,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.70787,0.0046905,0.037762,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.73212,0.0046526,0.036594,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54746,0.0046164,0.029981,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.50776,0.0046162,0.028205,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.98869,0.0046051,-0.0015985,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.45238,0.0045699,0.072873,0,0
2,GO RENAL SODIUM EXCRETION,0.6312,0.0044995,0.02725,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.93704,0.0044829,-0.00091761,0,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,1,0.0044417,0.014691,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.32592,0.0043354,0.05022,0,0
2,GO SNRNA PROCESSING,0.38488,0.0043237,-0.060282,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.71693,0.0042959,0.027739,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.82526,0.0042617,-0.020744,0,0
2,GO RESPONSE TO AMPHETAMINE,0.52082,0.0041547,0.035885,0,0
2,GO SPROUTING ANGIOGENESIS,0.61687,0.0041252,0.036921,0,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.33803,0.0040531,-0.065664,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.88885,0.0040456,0.022142,0,0
2,GO STEROL METABOLIC PROCESS,0.87926,0.003964,0.0049362,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.81267,0.003856,0.025045,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.69286,0.00385,-0.016544,0,0
2,GO WATER TRANSPORT,0.89205,0.0038377,0.0031364,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.44994,0.0037956,0.067808,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.72603,0.0037744,0.028471,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.6312,0.0037204,0.030964,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.9693,0.0037178,0.010887,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.75048,0.0037126,0.018925,0,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.4355,0.0036951,0.096342,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.93382,0.0036893,0.0036783,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.81267,0.003687,0.015859,0,0
2,GO GDP METABOLIC PROCESS,0.94993,0.0036859,0.016824,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.87287,0.0036773,-0.0026733,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.41666,0.003653,0.049812,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,1,0.0036017,0.011756,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.6312,0.0035922,0.026807,0,0
2,GO LYMPHANGIOGENESIS,0.61972,0.0035384,0.044924,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.44269,0.0034782,0.043846,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.63986,0.0032001,-0.024944,0,0
2,GO NODAL SIGNALING PATHWAY,0.31215,0.0031732,0.070958,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.67798,0.0031183,0.02835,0,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.15683,0.0030829,-0.16595,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.70787,0.0030483,-0.026013,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.65442,0.002991,-0.023241,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.80953,0.0029799,0.0059512,0,0
2,GO ORGANIC ACID TRANSPORT,0.48215,0.0029538,0.030556,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.48722,0.0029148,-0.022975,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.90809,0.0029103,0.02215,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.90809,0.0027961,0.011783,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.89846,0.002725,0.0044438,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.71391,0.0027205,0.03072,0,0
2,GO PROTEIN AUTOPROCESSING,0.64567,0.0026952,0.028179,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.75972,0.0026901,0.019052,0,0
2,GO PROTEIN IMPORT,0.63986,0.0026691,0.031752,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.75972,0.0026279,0.0069337,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86968,0.0026182,-0.010088,0,0
2,GO RESPONSE TO INTERLEUKIN 7,0.9693,0.0025757,0.0096044,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.52082,0.0025479,0.042779,0,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.61687,0.0024885,-0.0047398,0,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.92094,0.0024512,-0.011503,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.30637,0.0023966,0.049454,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.99838,0.0023493,0.044648,0,0
2,GO PORE COMPLEX ASSEMBLY,0.4451,0.0023412,0.035378,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.46218,0.0022692,-0.031343,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.52345,0.0022659,-0.023596,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.72907,0.0022171,-0.013026,0,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.52082,0.002065,-0.050158,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.88565,0.0020235,0.0097782,0,0
2,GO COMPLEMENT ACTIVATION,0.35253,0.0019802,-0.076013,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.28945,0.0019557,-0.048359,0,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.48976,0.0018013,0.033233,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.84741,0.0017464,0.038669,0,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.72907,0.0017258,0.020733,0,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.7814,0.0016209,0.020976,0,0
2,GO RESPONSE TO ANTIBIOTIC,0.60268,0.0015615,-0.010449,0,0
2,GO INTRACELLULAR TRANSPORT,0.19838,0.001424,0.046137,0,0
2,GO TISSUE REGENERATION,0.73517,0.0013865,0.022159,0,0
2,GO RESPONSE TO LIPID,0.97899,0.001378,0.012524,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.070488,0.0012946,0.19364,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.79387,0.001274,0.007645,0,0
2,GO OOCYTE DIFFERENTIATION,0.81896,0.0011983,0.023862,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.40286,0.0010105,-0.061381,0,0
2,GO EPITHELIUM DEVELOPMENT,0.96284,0.0010021,0.016154,0,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.88245,0.00097667,-0.0068312,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.2913,0.00094517,0.05635,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.94026,0.00088579,0.0018032,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.5394,0.00087362,0.058805,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.62832,0.00065397,-0.0076943,0,0
2,GO PROTEIN ADP RIBOSYLATION,0.82526,0.00064027,-0.0073252,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.86649,0.00055234,0.018184,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.8379,0.0005411,0.019001,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.36741,0.00050836,0.048234,0,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.79387,0.00046787,-0.0031447,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.71089,0.00040717,0.026119,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.49231,0.0003963,0.049409,0,0
2,GO METHIONINE METABOLIC PROCESS,0.74435,0.00038081,0.021682,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.21288,0.0003246,-0.099233,0,0
2,GO ORGANELLE FUSION,0.91772,0.00031236,0.009478,0,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.84741,0.00024547,0.0056329,0,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.93704,8.0955e-05,0.014871,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.74741,7.4279e-05,0.00055503,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.85694,-9.417e-05,0.021538,0,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.62832,-0.00021283,0.02549,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.60834,-0.00022756,0.023902,0,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.69885,-0.00039164,0.022791,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.84107,-0.00044011,-0.0030539,0,0
2,GO RNA MODIFICATION,0.76899,-0.00055131,-0.0066076,0,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.78763,-0.00062254,-0.0069919,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.80953,-0.00070784,0.027112,0,0
2,GO REGULATION OF RESPONSE TO STRESS,0.5583,-0.00071962,-0.0020074,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.56103,-0.00076072,0.031044,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.42367,-0.00082433,-0.039221,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.52082,-0.00088584,0.043113,0,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.95316,-0.00090739,0.0094627,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.51819,-0.00093439,0.037118,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.72907,-0.00096779,0.024856,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.49231,-0.00098539,0.034748,0,0
2,GO PLATELET DEGRANULATION,0.48468,-0.0010404,-0.037598,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.9306,-0.0012118,-0.018891,0,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.98546,-0.0012667,0.016993,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.95639,-0.0014011,-0.0085255,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.39381,-0.0014549,0.049997,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.71089,-0.0015022,-0.002288,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.67206,-0.0015051,-0.069422,0,0
2,GO PLACENTA DEVELOPMENT,0.67501,-0.0016084,-0.010876,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.67206,-0.0020649,0.031344,0,0
2,GO MEMBRANE FUSION,0.59705,-0.0020897,-0.0038807,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.68392,-0.0021056,-0.0061753,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.87926,-0.0021096,0.02316,0,0
2,GO LIPID MODIFICATION,0.71996,-0.0021403,0.028645,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.98546,-0.0022132,0.01004,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.76899,-0.0022264,0.029058,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.77519,-0.0022439,-0.0028644,0,0
2,GO RESPONSE TO HEAT,0.73517,-0.0022906,0.024897,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.95316,-0.0023972,0.017178,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.61972,-0.0024202,-0.028945,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.70185,-0.0024416,-0.022372,0,0
2,GO SNRNA TRANSCRIPTION,0.29877,-0.0024919,0.050016,0,0
2,GO RESPONSE TO X RAY,0.72907,-0.0025034,0.01449,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.80953,-0.0025288,0.0098717,0,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.59144,-0.0025441,0.042885,0,0
2,GO POSITIVE T CELL SELECTION,0.318,-0.0026096,-0.044883,0,0
2,GO KERATINOCYTE MIGRATION,0.797,-0.0027272,-0.0060805,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.82211,-0.0027923,0.034742,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.56376,-0.00294,-0.028572,0,0
2,GO T CELL DIFFERENTIATION,0.87926,-0.0029683,-0.0024148,0,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.66028,-0.0030854,-0.015183,0,0
2,GO RESPONSE TO STEROID HORMONE,0.76281,-0.003172,0.023326,0,0
2,GO ERBB SIGNALING PATHWAY,0.68392,-0.0032705,-0.0068508,0,0
2,GO NUCLEAR PORE ORGANIZATION,0.32592,-0.0033078,0.079927,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.83474,-0.0033446,0.0037756,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.75972,-0.0033866,0.033359,0,0
2,GO FAT CELL PROLIFERATION,0.68094,-0.0033918,-0.058752,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.92738,-0.0034124,0.02131,0,0
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.92094,-0.0034411,-0.013913,0,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.37608,-0.0036342,-0.066687,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.8379,-0.0036545,0.024838,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.90809,-0.0036907,0.011395,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.67206,-0.0037133,-0.010801,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.79387,-0.003786,0.028012,0,0
2,GO NCRNA PROCESSING,0.61687,-0.0038066,-0.023217,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.58307,-0.0038858,-0.002664,0,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.60268,-0.0039001,-0.028974,0,0
2,GO REGULATION OF ODONTOGENESIS,0.79075,-0.0039899,0.0081488,0,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.53406,-0.0041313,0.051088,0,0
2,GO REGULATION OF PHAGOCYTOSIS,0.71693,-0.0041337,-0.023932,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.68988,-0.0042383,0.032906,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75664,-0.0042426,0.024272,0,0
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.75664,-0.0042609,-0.01147,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.30066,-0.0043025,-0.046269,0,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.53672,-0.0043746,0.031434,0,0
2,GO ATP METABOLIC PROCESS,0.99192,-0.0044815,0.010976,0,0
2,GO MACROPHAGE ACTIVATION,0.80012,-0.0045337,-0.0065545,0,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.90809,-0.0046313,0.014412,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.85694,-0.0046612,0.0092758,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.64276,-0.0047339,-0.041876,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.86331,-0.0049107,0.01594,0,0
2,GO REGULATION OF ANION TRANSPORT,0.85059,-0.0049309,0.016315,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.43789,-0.0049334,-0.090692,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.28395,-0.0049386,0.055021,0,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.85059,-0.0050484,-0.0052571,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.97253,-0.0050857,0.012322,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.88565,-0.0051556,0.020818,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.78763,-0.0051751,0.018487,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.64567,-0.0052675,-0.022887,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.82526,-0.0053039,0.002459,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.99515,-0.0053463,0.0069652,0,0
2,GO RNA CAPPING,0.72299,-0.005387,-0.006336,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.64567,-0.0054143,-0.027517,0,0
2,GO FIBRINOLYSIS,0.52874,-0.0054301,-0.086714,0,0
2,GO EPIBOLY,0.89205,-0.0054636,-0.0066885,0,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.53672,-0.0054904,0.030573,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.45972,-0.0055068,0.059015,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.79075,-0.0055827,0.023609,0,0
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.49231,-0.0057102,-0.034631,0,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.99838,-0.0057816,0.0108,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.42602,-0.0058173,-0.048191,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.46713,-0.0058177,-0.04371,0,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.97899,-0.0058954,-0.0017837,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.74435,-0.0058967,-0.0020837,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.56925,-0.0058979,0.055387,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.32393,-0.0059395,0.045496,0,0
2,GO INOSITOL METABOLIC PROCESS,0.46466,-0.0059915,0.066585,0,0
2,GO POSITIVE REGULATION OF TRANSLATION,0.3739,-0.0060634,-0.026724,0,0
2,GO MULTI ORGANISM LOCALIZATION,0.70486,-0.0060937,0.019557,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.82211,-0.0061054,-0.017014,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.66616,-0.0061236,-0.017325,0,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.59144,-0.0061609,0.046228,0,0
2,GO PENTOSE METABOLIC PROCESS,0.51035,-0.0063203,-0.020791,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.34213,-0.006369,0.058407,0,0
2,GO NON RECOMBINATIONAL REPAIR,0.61687,-0.0063813,0.053395,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.99192,-0.0064092,0.013277,0,0
2,GO BLASTOCYST DEVELOPMENT,0.62258,-0.0064751,-0.0055747,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.71996,-0.0064814,0.026152,0,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.6312,-0.0065331,-0.0088998,0,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.6312,-0.0065728,-0.048652,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.87287,-0.0066352,0.046317,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.84107,-0.0066886,0.031248,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.70486,-0.0067035,-0.0086035,0,0
2,GO VESICLE CARGO LOADING,0.97899,-0.0068263,0.0062535,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.38267,-0.0068479,-0.035662,0,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.94026,-0.0069549,0.010221,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.81581,-0.00696,0.011775,0,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.43312,-0.0069891,-0.029021,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.29877,-0.0070294,0.046716,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.70185,-0.0070773,0.0049886,0,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.59424,-0.0071966,-0.017863,0,0
2,GO PARTURITION,0.80326,-0.0072966,0.0035501,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.99838,-0.007614,-0.0014904,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.51035,-0.0076363,0.068284,0,0
2,GO RENAL WATER HOMEOSTASIS,0.72907,-0.0077171,0.043189,0,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.87606,-0.0077174,0.019174,0,0
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.94671,-0.0078936,0.026994,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.32393,-0.0079217,0.069108,0,0
2,GO SPERM CAPACITATION,0.98546,-0.007927,0.0021759,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.93382,-0.0079876,0.016687,0,0
2,GO CRISTAE FORMATION,0.40058,-0.0079972,-0.047429,0,0
2,GO RESPONSE TO VITAMIN,0.98869,-0.0080067,0.0086436,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.6515,-0.0080598,0.031556,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.42838,-0.0081754,-0.041387,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.70787,-0.0082588,-0.015576,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.84424,-0.0082778,0.0068065,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.43312,-0.0084357,0.035201,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.86649,-0.0084419,-0.0074693,0,0
2,GO T CELL APOPTOTIC PROCESS,0.53672,-0.008499,-0.038549,0,0
2,GO HYPEROSMOTIC RESPONSE,0.95961,-0.008538,0.0066157,0,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.99515,-0.0085735,0.016086,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.58029,-0.008651,-0.011137,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.99838,-0.0087615,0.0038792,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.90488,-0.0088183,0.0057098,0,0
2,GO TRNA MODIFICATION,0.98869,-0.0089098,-0.0036812,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.6055,-0.008958,0.034105,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.64567,-0.0090032,-0.0092308,0,0
2,GO MACROPHAGE CHEMOTAXIS,0.96284,-0.0090611,-0.0037244,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.82526,-0.0091503,-0.01651,0,0
2,GO REGULATION OF T CELL MIGRATION,0.23605,-0.0092439,-0.056122,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.68094,-0.0093028,0.020794,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.5,-0.0093213,-0.025363,0,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.42602,-0.0093551,-0.018527,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.66028,-0.0093605,-0.02588,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.34835,-0.0094202,-0.040673,0,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.38488,-0.0094561,-0.020947,0,0
2,GO MEMBRANE INVAGINATION,0.89205,-0.0094585,0.00075581,0,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.74128,-0.0095238,-0.015634,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.69885,-0.0095617,0.0015968,0,0
2,GO PEPTIDE METABOLIC PROCESS,0.40286,-0.0097201,-0.018289,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.86012,-0.0097303,0.017334,0,0
2,GO REGULATION OF GASTRULATION,0.96607,-0.0097548,0.0005828,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.65442,-0.0097622,0.052907,0,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.38267,-0.0099116,-0.020402,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.99192,-0.010003,0.0080148,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.11367,-0.010018,-0.13422,0,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.55016,-0.010282,-0.0087987,0,0
2,GO GLYCOSYLATION,0.89846,-0.010358,-0.0041959,0,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.50516,-0.010372,-0.0036152,0,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.48468,-0.010378,-0.0071674,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.51819,-0.01043,0.034653,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.47963,-0.010461,0.043738,0,0
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.42133,-0.010507,-0.021654,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.73517,-0.010525,0.062681,0,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.33194,-0.01055,-0.085923,0,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.91772,-0.010642,0.018126,0,0
2,GO VACUOLE ORGANIZATION,0.45238,-0.010702,-0.0064287,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.50516,-0.010816,0.055686,0,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.81267,-0.010883,0.00067482,0,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.96607,-0.011003,0.014237,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.75664,-0.011091,-0.0061713,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.80012,-0.011111,0.011146,0,0
2,GO T CELL CYTOKINE PRODUCTION,0.48468,-0.011111,-0.041474,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.68988,-0.011116,0.021818,0,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.40058,-0.01112,-0.013263,0,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.93704,-0.011197,-0.0040102,0,0
2,GO FAT CELL DIFFERENTIATION,0.79387,-0.011227,0.026134,0,0
2,GO LIPID OXIDATION,0.89846,-0.011297,0.0021023,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.88885,-0.011329,-0.018392,0,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.2114,-0.011339,-0.1174,0,0
2,GO DRUG CATABOLIC PROCESS,0.68988,-0.011546,-0.02335,0,0
2,GO FATTY ACID TRANSPORT,0.80326,-0.011564,0.0037181,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.68094,-0.011585,0.027091,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.6515,-0.011656,-0.022233,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.80639,-0.011758,0.020755,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.36741,-0.011763,-0.042223,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.8379,-0.011774,0.020412,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.77519,-0.011794,0.027866,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.74128,-0.011799,-0.015708,0,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.69885,-0.011815,-0.015175,0,0
2,GO NCRNA METABOLIC PROCESS,0.6691,-0.011876,-0.015405,0,0
2,GO GOLGI VESICLE TRANSPORT,0.86331,-0.011908,0.0085007,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.87287,-0.011946,0.028404,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.84424,-0.011952,0.011716,0,0
2,GO PROTEIN STABILIZATION,0.66028,-0.01204,0.028771,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.96284,-0.012196,0.014005,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.30829,-0.01231,-0.04791,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.88245,-0.012312,0.019932,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.56376,-0.012422,0.045257,0,0
2,GO RESPONSE TO INTERLEUKIN 6,0.52345,-0.012424,-0.012745,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.57752,-0.012706,-0.017394,0,0
2,GO NEUTROPHIL MIGRATION,0.13027,-0.012903,-0.06892,0,0
2,GO PROTEIN MONOUBIQUITINATION,0.34008,-0.012931,0.06922,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.81896,-0.012996,0.018922,0,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.78451,-0.013166,0.0036595,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.95639,-0.013275,0.020109,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.70787,-0.013292,0.025611,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.97576,-0.013298,0.013897,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.29315,-0.013325,-0.065043,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.32393,-0.013355,-0.034942,0,0
2,GO VESICLE ORGANIZATION,0.84424,-0.013359,0.0043002,0,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.87606,-0.013462,0.0054653,0,0
2,GO TERPENOID METABOLIC PROCESS,0.67501,-0.013519,0.021715,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.86012,-0.013542,0.013528,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.98869,-0.013559,0.015312,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.77519,-0.013611,0.0088453,0,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.75972,-0.013612,0.019007,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.81581,-0.013618,0.025629,0,0
2,GO RESPONSE TO COLD,0.92738,-0.013698,0.0029819,0,0
2,GO TELOMERASE RNA LOCALIZATION,0.5665,-0.013713,-0.034192,0,0
2,GO RESPONSE TO WOUNDING,0.85376,-0.013762,0.0058001,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.63986,-0.013813,-0.048617,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.797,-0.013878,0.025246,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.73212,-0.014034,0.044315,0,0
2,GO FOAM CELL DIFFERENTIATION,0.59144,-0.014107,-0.045166,0,0
2,GO B CELL DIFFERENTIATION,0.59986,-0.01412,-0.014423,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.55016,-0.014257,0.055954,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.9113,-0.014272,0.015087,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.1914,-0.014385,-0.050381,0,0
2,GO PROTEIN NEDDYLATION,0.86331,-0.014443,-0.0067916,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.80012,-0.014627,0.02845,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.30637,-0.014715,-0.029071,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.56103,-0.01474,-0.013508,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.75356,-0.014941,0.034586,0,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.48976,-0.014979,-0.030337,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.41434,-0.014992,-0.02532,0,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.98222,-0.015042,0.007061,0,0
2,GO RESPONSE TO THYROID HORMONE,0.7659,-0.015047,-0.02096,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.86968,-0.015076,0.018686,0,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.56103,-0.015268,-0.020204,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.59705,-0.015301,0.056134,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.64567,-0.015413,-0.0067273,0,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.6515,-0.015451,-0.0032569,0,0
2,GO STEROID METABOLIC PROCESS,0.28945,-0.015474,-0.033672,0,0
2,GO LIPID CATABOLIC PROCESS,0.71391,-0.015569,-0.0032729,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.76899,-0.015739,0.025995,0,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.19278,-0.015753,-0.051136,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.96607,-0.015784,0.027354,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.70486,-0.015833,-0.0015796,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.55558,-0.015984,0.032018,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.99192,-0.016001,0.0089728,0,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.94671,-0.016088,-0.0012899,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.42367,-0.016218,-0.042613,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.73212,-0.016333,-0.01282,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.37173,-0.016377,-0.031244,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.59705,-0.01638,-0.021714,0,0
2,GO REGULATION OF EXCRETION,0.98546,-0.016406,0.013376,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.39156,-0.016424,-0.014298,0,0
2,GO LEUKOCYTE DIFFERENTIATION,0.69586,-0.016479,-0.006026,0,0
2,GO LIPID BIOSYNTHETIC PROCESS,0.57752,-0.01651,-0.0058357,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.22814,-0.016556,-0.048592,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.78763,-0.016566,0.0069954,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.95961,-0.016862,0.017795,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.77209,-0.016881,-0.013067,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.87926,-0.017091,0.004942,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.25924,-0.017109,-0.05053,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.87926,-0.017185,0.020202,0,0
2,GO GLYCINE METABOLIC PROCESS,0.60268,-0.017214,-0.040367,0,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.42838,-0.017342,-0.019427,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.29689,-0.017348,-0.069992,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.18062,-0.017352,-0.037712,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.797,-0.017453,0.0075461,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.95639,-0.017547,0.024426,0,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.83158,-0.017664,0.0025052,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.74741,-0.017687,0.024533,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.74128,-0.017715,0.0030775,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.25924,-0.017959,0.051477,0,0
2,GO EXOCYTOSIS,0.30446,-0.017966,-0.026263,0,0
2,GO RECEPTOR CATABOLIC PROCESS,0.92416,-0.017974,0.0094281,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.27853,-0.018026,0.051961,0,0
2,GO TISSUE HOMEOSTASIS,0.54477,-0.018083,-0.0083751,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.88245,-0.018113,0.0082587,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.52345,-0.018189,0.17268,0,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.80953,-0.018218,-0.0055237,0,0
2,GO ENDOSOMAL TRANSPORT,0.89846,-0.018226,0.024269,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.65734,-0.018234,0.026525,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.95961,-0.018268,0.0036969,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.98222,-0.018316,0.011368,0,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.87606,-0.018338,-0.014718,0,0
2,GO MACROPHAGE MIGRATION,0.86649,-0.01835,0.0036885,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.18866,-0.018587,-0.078294,0,0
2,GO CARBOHYDRATE TRANSPORT,0.32592,-0.018708,-0.017992,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.88565,-0.018879,0.011702,0,0
2,GO STEROID ESTERIFICATION,0.54208,-0.018898,-0.063038,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.48722,-0.018951,0.038407,0,0
2,GO LIPID LOCALIZATION,0.68094,-0.01897,-0.0050161,0,0
2,GO CELLULAR RESPONSE TO VIRUS,0.42367,-0.018982,-0.038882,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.60834,-0.019029,0.027694,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.9113,-0.019042,0.034585,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.81267,-0.019279,0.01367,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.44269,-0.019335,-0.0083507,0,0
2,GO CHROMOSOME LOCALIZATION,0.74435,-0.019465,0.033721,0,0
2,GO MANGANESE ION TRANSPORT,0.46962,-0.019478,-0.036376,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.70787,-0.019504,-0.013139,0,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.61117,-0.01955,-0.0036457,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.77519,-0.019563,0.0078366,0,0
2,GO MITOCHONDRION ORGANIZATION,0.42367,-0.019625,-0.0050378,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.93704,-0.019625,0.0031194,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.38267,-0.019651,-0.057819,0,0
2,GO GLYCEROLIPID METABOLIC PROCESS,0.43312,-0.019725,-0.0061088,0,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.88245,-0.019746,0.0069811,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.81267,-0.019756,-0.0001642,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.84107,-0.019758,0.017689,0,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.33803,-0.019797,-0.037288,0,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.48976,-0.019818,-0.01352,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.41899,-0.01982,-0.030366,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.54477,-0.019841,0.050641,0,0
2,GO REGULATION OF HEMOPOIESIS,0.65734,-0.019858,-0.0071568,0,0
2,GO RESPONSE TO CORTICOSTEROID,0.80953,-0.020006,0.0073275,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.51819,-0.020163,-0.017784,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.84741,-0.020227,0.005834,0,0
2,GO MITOCHONDRIAL TRANSCRIPTION,0.42367,-0.020311,-0.041804,0,0
2,GO ANIMAL ORGAN REGENERATION,0.59986,-0.020316,-0.013141,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.74128,-0.020415,0.010607,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.90809,-0.020464,0.0057631,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.72603,-0.020478,-0.010536,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.56103,-0.020503,-0.0097226,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.99838,-0.020507,0.016994,0,0
2,GO HAIR CELL DIFFERENTIATION,0.95639,-0.020515,0.046748,0,0
2,GO AMINE CATABOLIC PROCESS,0.5,-0.020596,-0.047724,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.97899,-0.020653,0.021424,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.72907,-0.020658,0.029704,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.32195,-0.020706,-0.031071,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.43312,-0.020751,-0.037888,0,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.43312,-0.020787,-0.017587,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.90488,-0.020885,0.023386,0,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.68988,-0.020944,0.025523,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.84741,-0.021174,-0.000664,0,0
2,GO MUSCLE CELL PROLIFERATION,0.77519,-0.02122,0.0013618,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.86649,-0.021247,0.0044603,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.28033,-0.021278,-0.0366,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.74128,-0.021281,0.029349,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.77209,-0.021322,0.030843,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.5665,-0.021342,-0.030569,0,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.46713,-0.021376,-0.017777,0,0
2,GO MACROAUTOPHAGY,0.99192,-0.021625,0.017116,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.76281,-0.021656,-0.013841,0,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.318,-0.021674,-0.022153,0,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.19278,-0.021702,-0.050193,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.94348,-0.021731,0.030265,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.59144,-0.021829,-0.0076378,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.97253,-0.021938,0.021269,0,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.39156,-0.021969,-0.009897,0,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.24089,-0.021975,-0.046207,0,0
2,GO SYMBIOTIC PROCESS,0.19838,-0.021982,-0.031345,0,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.81267,-0.022092,-0.00853,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.77209,-0.022108,0.0041797,0,0
2,GO SNRNA METABOLIC PROCESS,0.38267,-0.022229,-0.044064,0,0
2,GO LYSOSOME LOCALIZATION,0.68689,-0.02234,-0.0021805,0,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.52609,-0.022434,-0.024645,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.55287,-0.022552,-0.0064454,0,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.28761,-0.022646,-0.03063,0,0
2,GO ERAD PATHWAY,0.25583,-0.022659,-0.030264,0,0
2,GO GAS TRANSPORT,0.55016,-0.02266,-0.053147,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.98869,-0.022678,-0.0003565,0,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.67206,-0.02278,-0.041591,0,0
2,GO PROTEOLYSIS,0.49743,-0.022786,-0.0052082,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.9693,-0.022851,0.011158,0,0
2,GO REGULATION OF PROTEIN IMPORT,0.7659,-0.022936,-0.0084699,0,0
2,GO ALCOHOL METABOLIC PROCESS,0.56103,-0.023071,-0.013543,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.30637,-0.023186,-0.038629,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.84424,-0.023576,0.020418,0,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.98546,-0.023603,0.010596,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.29877,-0.023889,0.038892,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.61402,-0.023989,-0.0067175,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.7659,-0.024058,0.020072,0,0
2,GO ERBB2 SIGNALING PATHWAY,0.79075,-0.024066,-0.0093872,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.68094,-0.024116,0.0039164,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.9693,-0.024207,0.010092,0,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.93704,-0.024215,0.017485,0,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.52345,-0.024378,0.00058322,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.32993,-0.024593,-0.017951,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.32792,-0.024634,-0.03376,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.70185,-0.024651,0.0241,0,0
2,GO MYELOID CELL DIFFERENTIATION,0.58864,-0.024673,-0.0063571,0,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.38488,-0.024675,-0.063963,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.40286,-0.024765,-0.032885,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.80639,-0.024774,0.0030336,0,0
2,GO RRNA MODIFICATION,0.25753,-0.024806,-0.056199,0,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.52345,-0.024983,-0.052545,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.81267,-0.024993,0.01481,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.33396,-0.025019,-0.062075,0,0
2,GO METAPHASE PLATE CONGRESSION,0.92094,-0.025036,0.024252,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.079765,-0.025085,-0.080405,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.82526,-0.025101,0.00030551,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.73822,-0.025173,0.044086,0,0
2,GO RESPONSE TO PAIN,0.87287,-0.025233,0.0034746,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.99515,-0.025249,0.013926,0,0
2,GO TRNA PROCESSING,0.46218,-0.025346,-0.026372,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.50776,-0.02544,-0.0057395,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.52609,-0.025507,-0.043402,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.69586,-0.02568,0.0017378,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.95961,-0.025706,0.013757,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.52609,-0.025781,-0.046318,0,0
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.52609,-0.025785,-0.0067166,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.44752,-0.026006,-0.062365,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.92416,-0.026014,0.014467,0,0
2,GO THYMIC T CELL SELECTION,0.44028,-0.026015,-0.036889,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.77519,-0.026041,-0.0051413,0,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.63986,-0.02607,-0.0080141,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.80326,-0.026295,0.0056546,0,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.59144,-0.026412,-0.011744,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.28761,-0.026639,-0.072503,0,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.096327,-0.026694,-0.096238,0,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.35674,-0.026806,-0.020232,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.14419,-0.026971,-0.10921,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.80953,-0.027119,-0.0057981,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.96607,-0.027141,0.012213,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.86331,-0.027222,0.022691,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.55558,-0.027324,-0.049092,0,0
2,GO CELLULAR SENESCENCE,0.95961,-0.027355,0.012949,0,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.63408,-0.027423,-0.033955,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.33194,-0.027593,-0.036314,0,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.93382,-0.027659,0.0011042,0,0
2,GO FATTY ACID METABOLIC PROCESS,0.45727,-0.0277,-0.020643,0,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.29502,-0.02778,-0.016311,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.22971,-0.027794,-0.049483,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.9693,-0.027892,0.019235,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.54208,-0.027963,-0.031055,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.31604,-0.028146,-0.061786,0,0
2,GO NCRNA 3 END PROCESSING,0.45727,-0.028247,-0.045592,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.72299,-0.02835,0.0014968,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,1,-0.028406,0.013637,0,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.27673,-0.028428,-0.033158,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.56376,-0.028498,0.039265,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.99515,-0.02863,0.023685,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.45238,-0.028713,-0.011717,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.46713,-0.028747,-0.036373,0,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.34627,-0.028779,-0.013817,0,0
2,GO RESPONSE TO INTERLEUKIN 15,0.35886,-0.028845,-0.059811,0,0
2,GO LYMPHOCYTE ACTIVATION,0.69286,-0.028884,-0.010305,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.50776,-0.029023,-0.039069,0,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.98869,-0.029028,0.015345,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.28213,-0.029033,-0.047636,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.16778,-0.029038,-0.039244,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.33803,-0.029043,-0.026144,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.58585,-0.029067,-0.019849,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.20122,-0.029179,-0.070396,0,0
2,GO DETOXIFICATION,0.36098,-0.029285,-0.03272,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.39381,-0.029291,-0.024747,0,0
2,GO PSEUDOPODIUM ORGANIZATION,0.94348,-0.029316,0.0042811,0,0
2,GO T CELL ACTIVATION,0.5394,-0.029333,-0.023907,0,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.6055,-0.029387,-0.028015,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.97253,-0.029566,0.01097,0,0
2,GO REGULATION OF PINOCYTOSIS,0.62545,-0.029738,-0.032912,0,0
2,GO VIRAL LATENCY,0.94671,-0.029831,0.0067313,0,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.97253,-0.029922,0.0074431,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.29689,-0.029932,-0.054563,0,0
2,GO RESPONSE TO INTERLEUKIN 12,0.30829,-0.02995,-0.053426,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.69586,-0.029958,-0.040666,0,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.90488,-0.029969,0.020965,0,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.52609,-0.029974,-0.028128,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.55016,-0.030134,-0.026303,0,0
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.12721,-0.030154,-0.084602,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.77209,-0.030317,0.0079027,0,0
2,GO NOTOCHORD DEVELOPMENT,0.46962,-0.030353,0.06222,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.57752,-0.03059,0.041302,0,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.5394,-0.030653,-0.008146,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.80639,-0.030707,0.023544,0,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.83158,-0.030708,0.061332,0,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.45972,-0.030862,-0.059866,0,0
2,GO AMYLOID BETA CLEARANCE,0.30637,-0.030899,-0.063751,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.73822,-0.030916,0.0047698,0,0
2,GO OXIDATION REDUCTION PROCESS,0.1313,-0.030991,-0.032335,0,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.63986,-0.031081,-0.049781,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.44269,-0.031144,-0.04307,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.58307,-0.031165,-0.037683,0,0
2,GO CELL AGING,0.66028,-0.031231,-0.0071192,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.70185,-0.031353,-0.003336,0,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.30446,-0.031397,-0.04247,0,0
2,GO MESENCHYME MORPHOGENESIS,0.89846,-0.031437,0.011465,0,0
2,GO RESPONSE TO OXYGEN RADICAL,0.34835,-0.03147,-0.023335,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.95316,-0.031515,0.020579,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.99192,-0.031574,0.010417,0,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.30066,-0.031672,-0.077061,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.61117,-0.031711,-0.031705,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.87287,-0.031928,0.0046397,0,0
2,GO SULFATE TRANSPORT,0.53672,-0.031973,-0.0056275,0,0
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.95316,-0.031978,0.011284,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.91451,-0.032028,0.019079,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.61687,-0.03204,-0.022789,0,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.29315,-0.032087,-0.038954,0,0
2,GO REGULATION OF BODY FLUID LEVELS,0.23445,-0.032171,-0.032424,0,0
2,GO BONE REMODELING,0.42367,-0.032173,-0.029507,0,0
2,GO PROTEIN HYDROXYLATION,0.21738,-0.032181,-0.089421,0,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.80326,-0.032194,0.050213,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.37827,-0.03241,-0.025289,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.63986,-0.032429,0.020276,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.55016,-0.03247,-0.044835,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.27853,-0.0325,-0.047971,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.2644,-0.032558,-0.023562,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.5314,-0.032565,-0.01724,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.41666,-0.032566,-0.036884,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.97899,-0.032621,0.011267,0,0
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.19278,-0.032764,-0.030217,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.94026,-0.032802,0.0028964,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.38933,-0.032806,-0.05011,0,0
2,GO PEROXISOME ORGANIZATION,0.25924,-0.032824,-0.040881,0,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.72907,-0.032947,0.0033878,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.60834,-0.033007,0.0024208,0,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.22042,-0.033011,-0.091492,0,0
2,GO GOLGI ORGANIZATION,0.5583,-0.033029,-0.0011272,0,0
2,GO SYNCYTIUM FORMATION,0.33599,-0.033113,-0.036666,0,0
2,GO CARNITINE METABOLIC PROCESS,0.66028,-0.033139,-0.015945,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.87926,-0.03316,-0.0021081,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.28578,-0.033223,-0.03848,0,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.35674,-0.033224,-0.096322,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.65442,-0.033273,-0.0072917,0,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.34835,-0.033474,-0.096453,0,0
2,GO REGULATION OF CELL CELL ADHESION,0.45972,-0.033636,-0.023817,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.10471,-0.033648,-0.058875,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.59986,-0.033668,-0.035544,0,0
2,GO NIK NF KAPPAB SIGNALING,0.12822,-0.033688,-0.062377,0,0
2,GO BRONCHUS DEVELOPMENT,0.68689,-0.033798,-0.0068588,0,0
2,GO AGING,0.52345,-0.033812,-0.0057324,0,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.56103,-0.033918,-0.03485,0,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.2114,-0.033963,-0.042873,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.27673,-0.034022,-0.02485,0,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.16654,-0.034084,-0.049993,0,0
2,GO VASCULAR WOUND HEALING,0.5665,-0.034179,-0.053414,0,0
2,GO DENDRITIC CELL MIGRATION,0.75972,-0.034216,-0.029762,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.63408,-0.034243,0.0055413,0,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.079765,-0.034372,-0.071422,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.41203,-0.034533,-0.02318,0,0
2,GO PROTEIN OXIDATION,0.85376,-0.034558,-0.014504,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.39381,-0.034571,0.07575,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.99192,-0.034662,0.00501,0,0
2,GO RESPONSE TO UV C,0.76281,-0.034704,-0.022477,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.23286,-0.034727,-0.03952,0,0
2,GO MYOFIBRIL ASSEMBLY,0.87606,-0.034776,0.012922,0,0
2,GO TISSUE MIGRATION,0.47461,-0.03478,-0.019623,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.797,-0.034823,0.031953,0,0
2,GO ORGANELLE DISASSEMBLY,0.40514,-0.034846,-0.0077047,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.97253,-0.034849,0.017887,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.98222,-0.034935,0.00028575,0,0
2,GO REGULATION OF FERTILIZATION,0.86331,-0.03496,-0.0012153,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.87287,-0.035078,0.0097718,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.45972,-0.035405,-0.012002,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.26964,-0.035438,-0.038819,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.40973,-0.035468,-0.011124,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.41434,-0.03575,-0.034848,0,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.45972,-0.035822,-0.039332,0,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.6691,-0.035962,-0.015017,0,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.23286,-0.036119,-0.022899,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.5394,-0.036151,-0.0034171,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.38933,-0.036291,-0.062207,0,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.68988,-0.036425,0.0049504,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.53406,-0.036469,-0.029645,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.61687,-0.036474,-0.0050109,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.87926,-0.036491,0.0042202,0,0
2,GO ER OVERLOAD RESPONSE,0.70787,-0.036515,-0.0061715,0,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.9113,-0.0366,0.01313,0,0
2,GO PROTEIN FOLDING,0.94671,-0.036673,0.0056798,0,0
2,GO RESPONSE TO WATER,0.18194,-0.036712,-0.088,0,0
2,GO INTERFERON GAMMA PRODUCTION,0.25078,-0.036718,-0.054602,0,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.87926,-0.037029,0.019981,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.9113,-0.037202,0.016575,0,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.40743,-0.03722,-0.028428,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.66616,-0.037292,0.013991,0,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.71996,-0.037329,-0.01312,0,0
2,GO RIBOSOME ASSEMBLY,0.31604,-0.037376,-0.060747,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.20265,-0.037449,-0.05027,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.16163,-0.03745,-0.071166,0,0
2,GO SECONDARY METABOLIC PROCESS,0.318,-0.037486,-0.038205,0,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.53406,-0.037491,-0.015897,0,0
2,GO T CELL SELECTION,0.19557,-0.0375,-0.04642,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.46466,-0.037537,-0.033254,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.67798,-0.037754,0.0042725,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.26964,-0.037762,-0.046501,0,0
2,GO MYELOID CELL DEVELOPMENT,0.20265,-0.037815,-0.030839,0,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.98546,-0.037852,-0.02832,0,0
2,GO PROTEIN MATURATION,0.24252,-0.037887,-0.021585,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.33599,-0.037961,-0.044361,0,0
2,GO SPLEEN DEVELOPMENT,0.25078,-0.038004,-0.040131,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.38267,-0.038324,-0.032148,0,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.85376,-0.038398,0.022539,0,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.49487,-0.03852,-0.019804,0,0
2,GO SKIN DEVELOPMENT,0.18461,-0.038524,-0.072142,0,0
2,GO INFLAMMATORY RESPONSE,0.1387,-0.038532,-0.053038,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.95639,-0.03873,0.011848,0,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.54477,-0.038771,-0.01515,0,0
2,GO POSTREPLICATION REPAIR,0.75048,-0.038781,0.0011051,0,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.33396,-0.038972,-0.017153,0,0
2,GO T CELL CHEMOTAXIS,0.54746,-0.038979,-0.03009,0,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.74435,-0.03902,-0.0039079,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.20699,-0.039067,-0.025936,0,0
2,GO REGULATION OF CELL ACTIVATION,0.31215,-0.039175,-0.036377,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.6515,-0.039271,-0.007475,0,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.33396,-0.03929,-0.025377,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.89846,-0.039293,0.010443,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.59986,-0.039328,0.059706,0,0
2,GO RESPONSE TO REDOX STATE,0.36098,-0.039401,-0.049244,0,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.18461,-0.03944,-0.096315,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.51557,-0.039553,-0.0097329,0,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.6515,-0.039612,-0.034686,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.30066,-0.039673,-0.046781,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.23605,-0.03978,-0.046163,0,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.55287,-0.039793,-0.01786,0,0
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.17669,-0.03996,-0.076129,0,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.37173,-0.040002,-0.024698,0,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.10912,-0.040009,-0.058055,0,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.85376,-0.040068,0.0059355,0,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.95639,-0.040181,0.0094193,0,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.68988,-0.04027,-0.016046,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.093918,-0.040293,-0.055222,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.49231,-0.040552,-0.047109,0,0
2,GO HORMONE METABOLIC PROCESS,0.56925,-0.04061,-0.01323,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.59986,-0.040773,-0.036181,0,0
2,GO RESPONSE TO EPINEPHRINE,0.75664,-0.040815,-0.018337,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.75048,-0.040822,0.0011913,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.21437,-0.040926,-0.064982,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.73822,-0.040966,-0.015868,0,0
2,GO PEROXISOMAL TRANSPORT,0.20845,-0.040992,-0.04521,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.178,-0.041026,-0.064067,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.71996,-0.04113,-0.004611,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.57476,-0.04127,-0.031391,0,0
2,GO TRANSFERRIN TRANSPORT,0.089246,-0.041337,-0.055261,0,0
2,GO PSEUDOURIDINE SYNTHESIS,0.13763,-0.041549,-0.10049,0,0
2,GO CELL ACTIVATION,0.16163,-0.04158,-0.045828,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.36956,-0.04163,-0.052304,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.39606,-0.041728,-0.030042,0,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.57752,-0.041791,-0.0036607,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.12822,-0.041842,-0.07755,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.91451,-0.042009,0.0082628,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.77519,-0.042032,-0.026321,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.71089,-0.042064,0.0054923,0,0
2,GO FACE DEVELOPMENT,0.41899,-0.042292,-0.015672,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.28395,-0.042322,-0.032826,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.99838,-0.04234,0.017496,0,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.44269,-0.042341,-0.083081,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.40514,-0.042372,-0.0010986,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.40973,-0.042419,-0.032492,0,0
2,GO PHAGOCYTOSIS,0.32993,-0.04247,-0.032184,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.64567,-0.042553,-0.0060195,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.58029,-0.042569,-0.002593,0,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.9693,-0.042821,0.010278,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.318,-0.042899,-0.074316,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.89205,-0.042906,0.017596,0,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.46466,-0.042911,-0.043557,0,0
2,GO LYSINE METABOLIC PROCESS,0.14869,-0.042931,-0.13498,0,0
2,GO IRON ION TRANSPORT,0.25753,-0.043008,-0.022466,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.40743,-0.043011,-0.043309,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.5,-0.043023,-0.03234,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.98222,-0.04317,0.019287,0,0
2,GO INTERACTION WITH SYMBIONT,0.18461,-0.043223,-0.045994,0,0
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.20554,-0.043273,-0.066592,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.89526,-0.04334,0.016074,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.99515,-0.043472,0.0010779,0,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.32195,-0.043483,-0.029068,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.50776,-0.043699,-0.034073,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.54746,-0.043753,-0.044503,0,0
2,GO REPLICATIVE SENESCENCE,0.23128,-0.043799,-0.074845,0,0
2,GO WOUND HEALING,0.51296,-0.043884,-0.01656,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.78451,-0.043892,-0.0041568,0,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.53672,-0.043915,-0.029147,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.47211,-0.043933,-0.024318,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.71693,-0.043943,-0.0054824,0,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.15214,-0.043961,-0.027705,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.15683,-0.04398,-0.059538,0,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.51557,-0.044048,-0.0023412,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.45238,-0.044099,-0.082038,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.71089,-0.044124,0.0045276,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.51296,-0.044145,-0.027018,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.6055,-0.044151,-0.022223,0,0
2,GO REGULATION OF TISSUE REMODELING,0.28761,-0.044195,-0.051544,0,0
2,GO RRNA METHYLATION,0.37827,-0.044224,-0.040386,0,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.20845,-0.044277,-0.063713,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.75664,-0.044292,-0.0098249,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.20122,-0.04432,-0.072618,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.23445,-0.044445,-0.036717,0,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.54208,-0.044489,-0.017318,0,0
2,GO ALPHA BETA T CELL ACTIVATION,0.15565,-0.044616,-0.065951,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.86331,-0.044656,-0.019554,0,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.23128,-0.044797,-0.015553,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.92094,-0.044879,-0.0082847,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.35886,-0.044888,-0.026275,0,0
2,GO REGULATION OF PROTEOLYSIS,0.32792,-0.044965,-0.024831,0,0
2,GO LYMPHOCYTE COSTIMULATION,0.52874,-0.045032,-0.023044,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.8379,-0.045165,0.0047547,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.14983,-0.045269,-0.065825,0,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.41666,-0.045312,-0.036123,0,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.76899,-0.045347,0.0031551,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.16285,-0.045509,-0.10138,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.19417,-0.04563,-0.013755,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.47963,-0.045632,-0.050801,0,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.35253,-0.045658,-0.067347,0,0
2,GO BLEB ASSEMBLY,0.63697,-0.045698,-0.086702,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.99838,-0.045714,0.015595,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.30829,-0.045748,-0.078326,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.10129,-0.045836,-0.045391,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.5583,-0.045847,0.001756,0,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.16042,-0.045848,-0.057295,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.41899,-0.045934,-0.023003,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.46962,-0.046032,0.0025331,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.12224,-0.046182,-0.051627,0,0
2,GO PROTEIN KINASE B SIGNALING,0.86649,-0.046304,0.0075511,0,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.34008,-0.046394,-0.034961,0,0
2,GO TRNA METABOLIC PROCESS,0.39832,-0.04649,-0.029063,0,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.18461,-0.046493,-0.049714,0,0
2,GO COAGULATION,0.30066,-0.046495,-0.032784,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.76281,-0.046572,0.0060874,0,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.98546,-0.046578,-0.0082231,0,0
2,GO RESPONSE TO CHEMOKINE,0.46218,-0.046584,-0.028165,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.61972,-0.046593,0.005731,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.42133,-0.046619,-0.020545,0,0
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.087731,-0.046632,-0.044657,0,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.90809,-0.046665,0.013815,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.74435,-0.046741,-0.0052954,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.82842,-0.046804,0.010575,0,0
2,GO PHOSPHATE ION TRANSPORT,0.24089,-0.046906,-0.024534,0,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.58307,-0.046929,-0.026912,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.15802,-0.046992,-0.046084,0,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.19979,-0.047009,-0.057884,0,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.16042,-0.047161,-0.056644,0,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.090782,-0.047229,-0.057697,0,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.096327,-0.047397,-0.062943,0,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.13549,-0.04744,-0.053912,0,0
2,GO REGULATION OF IMMUNE RESPONSE,0.17669,-0.047599,-0.050025,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.16654,-0.047605,-0.089106,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.10734,-0.047835,-0.069248,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.25246,-0.047872,-0.020078,0,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.16163,-0.047918,-0.066816,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.97576,-0.047926,0.024692,0,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.14642,-0.048077,-0.028247,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.87926,-0.048211,0.0025782,0,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.22814,-0.048261,-0.017422,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.9113,-0.048314,0.043484,0,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.35253,-0.048383,-0.047811,0,0
2,GO INTERLEUKIN 2 PRODUCTION,0.16407,-0.04844,-0.072671,0,0
2,GO ACTIN NUCLEATION,0.14419,-0.04845,-0.047193,0,0
2,GO ACUTE PHASE RESPONSE,0.30066,-0.048513,-0.047077,0,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.32393,-0.048519,-0.046086,0,0
2,GO RESPONSE TO PH,0.43312,-0.048615,-0.015771,0,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.38933,-0.04868,-0.06777,0,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.20122,-0.048779,-0.02396,0,0
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.32792,-0.048799,-0.074751,0,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.43312,-0.048995,-0.027172,0,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.29502,-0.048997,-0.078459,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.82526,-0.049028,0.021143,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.50776,-0.049049,-0.0048576,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.40743,-0.049087,-0.036544,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42367,-0.049149,-0.037228,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.22814,-0.049225,-0.052363,0,0
2,GO RESPONSE TO RETINOIC ACID,0.49231,-0.049497,-0.0098994,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.19838,-0.049532,-0.076488,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.42133,-0.049551,-0.018422,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.30829,-0.049906,-0.043198,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.38047,-0.05008,-0.047207,0,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.14755,-0.0501,-0.068824,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.21437,-0.050105,-0.032238,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.38933,-0.050141,-0.021239,0,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.42838,-0.050149,-0.012084,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.39832,-0.050159,-0.044039,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.22348,-0.050181,-0.070051,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.52874,-0.050184,-0.016581,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.20699,-0.05031,-0.050231,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.16285,-0.050389,-0.053921,0,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.32195,-0.050568,-0.03119,0,0
2,GO SELECTIVE AUTOPHAGY,0.080464,-0.050578,-0.050694,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.35674,-0.050687,-0.019664,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.52082,-0.050749,-0.07765,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.25246,-0.050784,-0.058976,0,0
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.10558,-0.051018,-0.084218,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.60834,-0.051176,-0.0065941,0,0
2,GO TYPE 2 IMMUNE RESPONSE,0.19979,-0.051216,-0.1117,0,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.19417,-0.05145,-0.040976,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.57752,-0.051455,-0.015853,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.53406,-0.051465,-0.020269,0,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.090782,-0.051486,-0.070326,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.11092,-0.051505,-0.089562,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.16285,-0.051536,-0.078355,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.87287,-0.051545,-0.027274,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.13338,-0.051546,-0.05961,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.13549,-0.051754,-0.081928,0,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.23445,-0.051889,-0.061494,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.12924,-0.051893,-0.063668,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.33194,-0.051916,-0.020341,0,0
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.11742,-0.051954,-0.049241,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.61972,-0.051993,-0.02864,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.26267,-0.05201,-0.057089,0,0
2,GO ENDOSOME ORGANIZATION,0.18595,-0.052028,-0.037638,0,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.10912,-0.052084,-0.064883,0,0
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.081168,-0.05212,-0.071776,0,0
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.075009,-0.05215,-0.073052,0,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.5583,-0.052222,-0.010688,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.92416,-0.052371,-0.028624,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.46962,-0.052422,-0.012964,0,0
2,GO EMBRYO IMPLANTATION,0.32393,-0.052585,-0.039224,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.40514,-0.052657,-0.01931,0,0
2,GO BONE CELL DEVELOPMENT,0.19557,-0.052688,-0.0455,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.25753,-0.052844,-0.061713,0,0
2,GO REGULATION OF CHEMOTAXIS,0.65734,-0.052927,0.0013799,0,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.15802,-0.053135,-0.08155,0,0
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.098784,-0.053165,-0.071269,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.046474,-0.0532,-0.086325,0,0
2,GO FATTY ACID BETA OXIDATION,0.42367,-0.053413,-0.027088,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.36526,-0.053521,-0.023001,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.25246,-0.053695,-0.027064,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.34835,-0.053797,-0.068325,0,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.20122,-0.053798,-0.091098,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.36741,-0.053862,-0.073692,0,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.17029,-0.053872,-0.058192,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.24089,-0.054209,-0.060365,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.090011,-0.054252,-0.041859,0,0
2,GO RESPONSE TO VIRUS,0.17411,-0.054389,-0.059725,0,0
2,GO TRANSLATIONAL ELONGATION,0.018898,-0.0544,-0.092466,0,0
2,GO RESPONSE TO COPPER ION,0.70486,-0.054557,-0.023874,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.28945,-0.054678,-0.023378,0,0
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.19278,-0.054715,-0.073525,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.59424,-0.054766,-0.0048594,0,0
2,GO REGULATION OF ERAD PATHWAY,0.25078,-0.054775,-0.033742,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.41666,-0.054776,-0.079685,0,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.23927,-0.054872,-0.040402,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.086237,-0.054873,-0.061058,0,0
2,GO RESPONSE TO PROGESTERONE,0.86649,-0.054875,0.0048046,0,0
2,GO REGULATION OF T CELL ACTIVATION,0.38047,-0.054894,-0.035201,0,0
2,GO TRABECULA FORMATION,0.89526,-0.054923,-0.0067314,0,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.13338,-0.05493,-0.058841,0,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.19979,-0.054943,-0.088199,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.095518,-0.055046,-0.083275,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.9306,-0.055056,0.010099,0,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.089246,-0.055183,-0.083202,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.28213,-0.055222,-0.036543,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.65442,-0.055248,0.0028518,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.4355,-0.055248,-0.027773,0,0
2,GO REGULATION OF BONE REMODELING,0.38933,-0.055279,-0.045706,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.95961,-0.055452,-0.011812,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.31021,-0.055502,-0.039372,0,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.09796,-0.055761,-0.072107,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.099614,-0.055884,-0.093692,0,0
2,GO IRON ION HOMEOSTASIS,0.19979,-0.055885,-0.036912,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.54746,-0.056049,-0.035277,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.48722,-0.056213,-0.029379,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.48468,-0.056513,-0.015507,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.99515,-0.056689,0.02415,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.32993,-0.056692,-0.043942,0,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.068619,-0.056699,-0.050265,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.23605,-0.056739,-0.085717,0,0
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.13656,-0.056803,-0.076233,0,0
2,GO PROTEIN POLYUBIQUITINATION,0.86968,-0.056812,0.024434,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.65442,-0.056858,0.0016699,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.081877,-0.056969,-0.024765,0,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.46218,-0.056983,-0.014683,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.10558,-0.057116,-0.03923,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.31215,-0.057144,-0.0079227,0,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.32993,-0.057298,-0.043712,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.70486,-0.057308,0.0060433,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.26789,-0.057316,-0.066555,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.46218,-0.057492,-0.05391,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.82526,-0.057524,0.043519,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.70185,-0.057524,-0.010296,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.2114,-0.057684,-0.054909,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.52345,-0.057905,-0.0026045,0,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.068619,-0.058087,-0.087399,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.4355,-0.05809,-0.014256,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.50258,-0.058169,-0.020633,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.27853,-0.0582,-0.034296,0,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.19697,-0.058572,-0.074718,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.797,-0.058618,-0.012068,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.23445,-0.058766,-0.048592,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.19979,-0.058798,-0.083708,0,0
2,GO DIGESTIVE SYSTEM PROCESS,0.36098,-0.05886,-0.027474,0,0
2,GO OSTEOBLAST PROLIFERATION,0.1793,-0.059097,-0.067641,0,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.10129,-0.059169,-0.057642,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.32993,-0.059276,-0.03185,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.68094,-0.059278,-0.012345,0,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.094715,-0.059369,-0.060442,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.26095,-0.059475,-0.04438,0,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.22814,-0.059483,-0.047073,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.81581,-0.059484,-0.0040494,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.59144,-0.059611,-0.042848,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.31215,-0.059618,-0.057284,0,0
2,GO XENOBIOTIC TRANSPORT,0.81581,-0.05964,-0.00014599,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.51296,-0.0597,-0.016045,0,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.81267,-0.059859,0.0096679,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.39606,-0.059891,-0.062981,0,0
2,GO VIRAL LIFE CYCLE,0.14642,-0.059996,-0.058509,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.61402,-0.060052,-0.048404,0,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.43789,-0.060085,-0.045662,0,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.28945,-0.060087,-0.037666,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.46466,-0.060249,-0.03787,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.31409,-0.060263,-0.05748,0,0
2,GO RESPONSE TO OSMOTIC STRESS,0.38933,-0.060368,-0.017,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.4355,-0.060389,-0.040915,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.25583,-0.060412,-0.060776,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.2458,-0.060668,-0.033058,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.55016,-0.060676,-0.022294,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.23128,-0.060729,-0.041883,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.24745,-0.060801,-0.04211,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.10823,-0.060862,-0.043012,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.13549,-0.060917,-0.0442,0,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.16904,-0.060975,-0.035368,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.13027,-0.061105,-0.062306,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.30255,-0.061415,-0.034855,0,0
2,GO ATP TRANSPORT,0.54208,-0.061531,0.0040399,0,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.13234,-0.061536,-0.13223,0,0
2,GO NUCLEOSIDE SALVAGE,0.45727,-0.061603,-0.0088617,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.1793,-0.061639,-0.055593,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.042609,-0.061685,-0.084513,0,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.49231,-0.061707,-0.026158,0,0
2,GO NADPH REGENERATION,0.20992,-0.061837,-0.06682,0,0
2,GO AMP METABOLIC PROCESS,0.21288,-0.061862,-0.077115,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.22348,-0.062116,-0.038778,0,0
2,GO REGULATION OF DEFENSE RESPONSE,0.08331,-0.06266,-0.061526,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.78451,-0.062727,0.0096314,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.318,-0.062741,-0.027965,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.36741,-0.062803,-0.033746,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.98869,-0.06297,0.011723,0,0
2,GO ALDITOL METABOLIC PROCESS,0.60268,-0.062985,-0.026582,0,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.40514,-0.063036,-0.029925,0,0
2,GO LYMPH NODE DEVELOPMENT,0.44028,-0.06304,-0.023426,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.19697,-0.063044,-0.086934,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.34627,-0.063086,-0.037095,0,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.45727,-0.063091,-0.054278,0,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.12721,-0.063145,-0.080039,0,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.090782,-0.06328,-0.075002,0,0
2,GO RESPONSE TO MANGANESE ION,0.19697,-0.063341,-0.055236,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.64567,-0.063375,-0.010082,0,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.33194,-0.063488,-0.062092,0,0
2,GO ARACHIDONIC ACID SECRETION,0.20554,-0.063629,-0.040805,0,0
2,GO RNA DECAPPING,0.68988,-0.063703,0.014684,0,0
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.15802,-0.063731,-0.074771,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.090782,-0.06382,-0.061941,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.15214,-0.064473,-0.0658,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.21889,-0.064473,-0.058785,0,0
2,GO MYOTUBE DIFFERENTIATION,0.2458,-0.064487,-0.037041,0,0
2,GO PLATELET ACTIVATION,0.1754,-0.064611,-0.047926,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.28578,-0.064677,-0.058728,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.5,-0.064889,-0.020586,0,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.20845,-0.065031,-0.023603,0,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.13763,-0.065262,-0.072332,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.38267,-0.065348,-0.066522,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.098784,-0.065388,-0.067755,0,0
2,GO RESPONSE TO LEPTIN,0.22042,-0.06545,-0.042351,0,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.48722,-0.065508,-0.028483,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.68392,-0.065856,-0.01678,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.63408,-0.065942,-0.032348,0,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.069238,-0.065979,-0.08782,0,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.24745,-0.066008,-0.040991,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.27317,-0.066232,-0.078226,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.18461,-0.066328,-0.059943,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.94993,-0.066433,0.0069697,0,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.23286,-0.066572,-0.087448,0,0
2,GO CENTROSOME SEPARATION,0.82526,-0.066611,-0.01688,0,0
2,GO INTERFERON BETA PRODUCTION,0.27853,-0.066764,-0.041028,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.11367,-0.066868,-0.073004,0,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.19417,-0.066901,-0.071777,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.42367,-0.066929,-0.017944,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.38047,-0.067194,-0.050834,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.49743,-0.06725,-0.032613,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.34835,-0.067304,-0.054186,0,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.13027,-0.067387,-0.084543,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.1387,-0.067499,-0.079551,0,0
2,GO CYTOKINE SECRETION,0.26095,-0.067501,-0.039996,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.11275,-0.067506,-0.053225,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.22348,-0.06759,-0.062329,0,0
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.17411,-0.067726,-0.069951,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.33599,-0.068079,-0.074766,0,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.24911,-0.06824,-0.037239,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.1914,-0.068387,-0.057563,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.98869,-0.068389,0.01871,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.48976,-0.06857,-0.011594,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.35043,-0.068636,-0.056188,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.9306,-0.068637,0.022313,0,0
2,GO RESPONSE TO SALT STRESS,0.35674,-0.068836,-0.034195,0,0
2,GO MYELOID CELL HOMEOSTASIS,0.29877,-0.068898,-0.023241,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.18595,-0.068933,-0.058724,0,0
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.10558,-0.069071,-0.033544,0,0
2,GO LIPID IMPORT INTO CELL,0.82526,-0.069196,0.0080038,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.75048,-0.069225,-0.019106,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092339,-0.069285,-0.037843,0,0
2,GO RETINOL METABOLIC PROCESS,0.072397,-0.069481,-0.10456,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.27495,-0.069574,-0.067169,0,0
2,GO RESPONSE TO ISCHEMIA,0.67206,-0.069644,0.0032923,0,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.28213,-0.069652,-0.062638,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.5394,-0.069681,-0.01568,0,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.25078,-0.069732,-0.040993,0,0
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.13444,-0.069794,-0.080403,0,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.15802,-0.069857,-0.066125,0,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.073694,-0.069968,-0.090814,0,0
2,GO DEFENSE RESPONSE,0.09796,-0.069998,-0.058847,0,0
2,GO DNA DEAMINATION,0.24745,-0.070072,-0.10418,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.41666,-0.070102,-0.046877,0,0
2,GO T CELL PROLIFERATION,0.1653,-0.07012,-0.057917,0,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.33396,-0.070154,-0.071639,0,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.079071,-0.070155,-0.06924,0,0
2,GO CELLULAR PIGMENTATION,0.20122,-0.070367,-0.040861,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.62258,-0.070395,0.0023486,0,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.58029,-0.070395,-0.045926,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.19697,-0.070522,-0.068237,0,0
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.071119,-0.07061,-0.062494,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.83474,-0.070613,-0.015115,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.16407,-0.070688,-0.069544,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.54208,-0.07108,-0.025115,0,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.12924,-0.071379,-0.11908,0,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.1793,-0.071619,-0.052087,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.2458,-0.072052,-0.02841,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.17411,-0.072083,-0.074638,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.21738,-0.072439,-0.072217,0,0
2,GO RESPONSE TO TUMOR CELL,0.23927,-0.072668,-0.073727,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.97253,-0.07267,0.031934,0,0
2,GO CELL CHEMOTAXIS,0.090011,-0.072753,-0.057208,0,0
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.68094,-0.072754,-0.0073394,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.15565,-0.072778,-0.065036,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.49487,-0.072901,-0.031986,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.11837,-0.073019,-0.061901,0,0
2,GO TRANSLESION SYNTHESIS,0.39381,-0.073048,-0.017817,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12421,-0.073138,-0.048337,0,0
2,GO BILE ACID METABOLIC PROCESS,0.44752,-0.073262,-0.0332,0,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.2644,-0.073467,-0.093342,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.27495,-0.073519,-0.042826,0,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.1146,-0.073541,-0.077499,0,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.40743,-0.073566,-0.068179,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.17156,-0.073571,-0.072296,0,0
2,GO RESPONSE TO FORSKOLIN,0.68689,-0.0738,-0.012693,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.22195,-0.073884,-0.080421,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.18327,-0.074053,-0.04267,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.98546,-0.07413,0.01885,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.17411,-0.074511,-0.10442,0,0
2,GO VASODILATION,0.12126,-0.07455,-0.0933,0,0
2,GO RESPONSE TO INACTIVITY,0.93382,-0.07461,0.011618,0,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.32792,-0.074797,-0.057784,0,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.61117,-0.074804,-0.016914,0,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.11002,-0.075315,-0.049017,0,0
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.32195,-0.075371,-0.095899,0,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.24745,-0.075402,-0.098468,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.28578,-0.075413,-0.046726,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.13338,-0.075431,-0.042574,0,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.45238,-0.07552,-0.052016,0,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.15098,-0.07562,-0.087563,0,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.21889,-0.07564,-0.091382,0,0
2,GO SUPEROXIDE ANION GENERATION,0.20122,-0.075887,-0.07504,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.31604,-0.076126,-0.043634,0,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.16654,-0.076129,-0.054313,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.35674,-0.076325,-0.045761,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.1754,-0.076344,-0.04213,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.1387,-0.076459,-0.056857,0,0
2,GO LEUKOCYTE PROLIFERATION,0.11933,-0.076509,-0.062845,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.37827,-0.076667,-0.059197,0,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.66028,-0.076752,-0.034802,0,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.33396,-0.076839,-0.048928,0,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.33803,-0.076848,-0.084466,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.50776,-0.076953,-0.01091,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.13444,-0.076956,-0.056893,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.66616,-0.077131,-0.0018109,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.48722,-0.077454,-0.063883,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.1387,-0.077515,-0.079051,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.070488,-0.077555,-0.081296,0,0
2,GO RESPONSE TO FUNGUS,0.31409,-0.077599,-0.019192,0,0
2,GO MITOCHONDRIAL FUSION,0.16042,-0.077614,-0.033664,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.44752,-0.077632,-0.018787,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.45727,-0.07768,-0.035488,0,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.088486,-0.077683,-0.084821,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.23605,-0.077825,-0.071328,0,0
2,GO VIRAL GENOME REPLICATION,0.39606,-0.078315,-0.046317,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.62258,-0.07832,-0.029704,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.6312,-0.078351,-0.0039991,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.075674,-0.078408,-0.11622,0,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.1754,-0.078453,-0.069669,0,0
2,GO LEUKOCYTE MIGRATION,0.082591,-0.078501,-0.060499,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.33599,-0.078813,-0.039422,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.27673,-0.078817,-0.050232,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.60834,-0.078884,-0.0071007,0,0
2,GO BLASTOCYST GROWTH,0.13763,-0.07889,-0.062585,0,0
2,GO DEFENSE RESPONSE TO VIRUS,0.12029,-0.079003,-0.080276,0,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.096327,-0.079476,-0.080908,0,0
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.1387,-0.079491,-0.071621,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.20845,-0.079832,-0.040066,0,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.15565,-0.07985,-0.074919,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.64567,-0.079981,-0.040644,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.80326,-0.080001,0.0053466,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.69586,-0.080011,0.010967,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.020385,-0.080053,-0.089599,0,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.31604,-0.080136,-0.061139,0,0
2,GO RESPONSE TO GONADOTROPIN,0.3442,-0.080279,-0.047389,0,0
2,GO ADRENAL GLAND DEVELOPMENT,0.20992,-0.080656,-0.043661,0,0
2,GO B CELL HOMEOSTASIS,0.096327,-0.080683,-0.0836,0,0
2,GO SECRETION BY TISSUE,0.16042,-0.080714,-0.060896,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.55287,-0.080762,-0.034223,0,0
2,GO RESPONSE TO CYTOKINE,0.090782,-0.080782,-0.061143,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.22971,-0.080912,-0.034876,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.20699,-0.080966,-0.1467,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.18062,-0.080992,-0.080251,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.38047,-0.081071,-0.035729,0,0
2,GO IMP METABOLIC PROCESS,0.46962,-0.081292,-0.050571,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.084034,-0.081372,-0.12074,0,0
2,GO ENDOCRINE PROCESS,0.20554,-0.081398,-0.044868,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.12822,-0.081413,-0.11245,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.13338,-0.081433,-0.070091,0,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.48468,-0.081486,-0.040442,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.31021,-0.081518,-0.02998,0,0
2,GO GLOMERULUS DEVELOPMENT,0.49231,-0.081655,-0.027665,0,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.22503,-0.08176,-0.060512,0,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.1653,-0.081921,-0.067874,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.042197,-0.082286,-0.091719,0,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.17156,-0.082377,-0.14817,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.071119,-0.082477,-0.067576,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.28945,-0.082628,-0.059595,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.46466,-0.082709,-0.0069492,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.16407,-0.082931,-0.11437,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.22348,-0.083041,-0.041835,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.32993,-0.083269,-0.036869,0,0
2,GO MAST CELL ACTIVATION,0.25414,-0.083437,-0.06737,0,0
2,GO GASTRIC ACID SECRETION,0.46218,-0.083628,-0.019635,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.48722,-0.083683,-0.048683,0,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.093918,-0.08374,-0.051173,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.17283,-0.084039,-0.083035,0,0
2,GO FIBROBLAST ACTIVATION,0.3871,-0.084312,-0.025948,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.57752,-0.084842,-0.01905,0,0
2,GO CYTOPLASM ORGANIZATION,0.25078,-0.08493,-0.072342,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.2644,-0.085041,-0.050051,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.17029,-0.085173,-0.039283,0,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.13338,-0.085189,-0.039231,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.20122,-0.085189,-0.086827,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.1873,-0.085492,-0.08644,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.14088,-0.085647,-0.09715,0,0
2,GO INTERLEUKIN 1 PRODUCTION,0.079071,-0.08576,-0.10085,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.20554,-0.086171,-0.044429,0,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.10646,-0.086525,-0.10272,0,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.090782,-0.08671,-0.11996,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0089251,-0.086978,-0.099495,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.24089,-0.087438,-0.075031,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.27317,-0.087474,-0.029268,0,0
2,GO PROTEIN DENEDDYLATION,0.078382,-0.087557,-0.07186,0,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.080464,-0.087658,-0.068571,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.044722,-0.087663,-0.12348,0,0
2,GO DIGESTION,0.35253,-0.087687,-0.033254,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.094715,-0.087839,-0.06585,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.25246,-0.087914,-0.055954,0,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.16407,-0.088136,-0.066272,0,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.20554,-0.08821,-0.078372,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.23766,-0.088213,-0.079263,0,0
2,GO PROTEIN DESTABILIZATION,0.18461,-0.088295,-0.030982,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.32393,-0.088329,-0.083303,0,0
2,GO OXYGEN TRANSPORT,0.25753,-0.088524,-0.10375,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.010645,-0.088968,-0.083485,0,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.13979,-0.089261,-0.062941,0,0
2,GO INTERFERON ALPHA PRODUCTION,0.12224,-0.089283,-0.084817,0,0
2,GO MYELOID CELL APOPTOTIC PROCESS,0.22814,-0.089399,-0.055953,0,0
2,GO CELLULAR RESPIRATION,0.042609,-0.089418,-0.062004,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.1387,-0.089517,-0.089732,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.27673,-0.089561,-0.047103,0,0
2,GO VIRAL BUDDING,0.010279,-0.089737,-0.098286,0,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.068006,-0.089854,-0.052088,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.077018,-0.089898,-0.15096,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.050154,-0.089986,-0.10182,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.24089,-0.090165,-0.055227,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.24911,-0.09018,-0.042584,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.012087,-0.090246,-0.11686,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.40514,-0.090505,-0.031469,0,0
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.099614,-0.090516,-0.091514,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.25924,-0.090657,-0.066274,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.12224,-0.090739,-0.069839,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.5665,-0.090782,-0.043591,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.58307,-0.090804,-0.038814,0,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.11837,-0.090989,-0.07654,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.22042,-0.091512,-0.054999,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.084034,-0.091791,-0.073793,0,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.40743,-0.091799,-0.048364,0,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.090782,-0.092227,-0.074267,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.08331,-0.092471,-0.14491,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.36741,-0.0925,-0.056495,0,0
2,GO CYTOKINE PRODUCTION,0.094715,-0.092838,-0.067141,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.077698,-0.092909,-0.078456,0,0
2,GO FLUID TRANSPORT,0.10734,-0.092977,-0.064973,0,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.1252,-0.093172,-0.052846,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.30829,-0.093438,-0.046977,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.23445,-0.093582,-0.041477,0,0
2,GO HEART TRABECULA FORMATION,0.29877,-0.094236,-0.093895,0,0
2,GO B CELL ACTIVATION,0.14755,-0.094652,-0.049089,0,0
2,GO LEUKOCYTE CHEMOTAXIS,0.070488,-0.094656,-0.066746,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.28761,-0.094766,-0.019316,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.20699,-0.094942,-0.059781,0,0
2,GO AEROBIC RESPIRATION,0.016938,-0.095164,-0.080469,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.42367,-0.095266,-0.076052,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.087731,-0.09593,-0.099033,0,0
2,GO MAST CELL MEDIATED IMMUNITY,0.1754,-0.095974,-0.077961,0,0
2,GO TISSUE REMODELING,0.1252,-0.096047,-0.07004,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0094686,-0.096339,-0.084023,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.078382,-0.096627,-0.056479,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.1754,-0.096923,-0.087237,0,0
2,GO QUINONE METABOLIC PROCESS,0.11933,-0.097003,-0.072803,0,0
2,GO MITOCHONDRIAL TRANSLATION,0.0005789,-0.097209,-0.14989,0,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.12421,-0.097517,-0.078341,0,0
2,GO CYCLOOXYGENASE PATHWAY,0.50776,-0.097756,-0.071774,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.29689,-0.097823,-0.050263,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.69286,-0.098093,-0.0080151,0,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.1754,-0.098425,-0.093504,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.08331,-0.098566,-0.14538,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.25753,-0.098581,-0.025781,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.10471,-0.09912,-0.070957,0,0
2,GO CELLULAR RESPONSE TO DSRNA,0.09796,-0.099375,-0.089518,0,0
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.19417,-0.099662,-0.068216,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25924,-0.099827,-0.037326,0,0
2,GO PROTEIN DEGLYCOSYLATION,0.076344,-0.099883,-0.099599,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.21288,-0.10003,-0.11245,0,0
2,GO REGULATION OF ACTIN NUCLEATION,0.090782,-0.10015,-0.069585,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.15802,-0.10018,-0.11033,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.0038478,-0.10028,-0.10981,0,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.11553,-0.10042,-0.099382,0,0
2,GO PLASMINOGEN ACTIVATION,0.34213,-0.10055,-0.077002,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.99192,-0.10066,0.022861,0,0
2,GO REGULATION OF WOUND HEALING,0.076344,-0.10088,-0.0837,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.85694,-0.1009,0.059632,0,0
2,GO SARCOMERE ORGANIZATION,0.30637,-0.10095,-0.030851,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.1146,-0.10114,-0.14718,0,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.087731,-0.10136,-0.097466,0,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.49743,-0.10139,-0.08981,0,0
2,GO DECIDUALIZATION,0.13979,-0.10159,-0.10298,0,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.090782,-0.10185,-0.11099,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.17156,-0.10213,-0.095753,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.70185,-0.10225,-0.031553,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.63408,-0.10262,-0.04508,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.075009,-0.10291,-0.092687,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.11647,-0.10302,-0.089302,0,0
2,GO TOXIN METABOLIC PROCESS,0.30637,-0.10321,-0.0625,0,0
2,GO EPITHELIAL CELL CELL ADHESION,0.20992,-0.10334,-0.087822,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.010041,-0.10371,-0.085477,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.1146,-0.10405,-0.063854,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.059879,-0.10461,-0.096146,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.086981,-0.10464,-0.088877,0,0
2,GO ZYMOGEN INHIBITION,0.080464,-0.10473,-0.13044,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.39381,-0.105,-0.043435,0,0
2,GO MYOBLAST FUSION,0.1146,-0.10516,-0.08168,0,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.073694,-0.10539,-0.071066,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.31997,-0.10557,-0.087818,0,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.17669,-0.10559,-0.1294,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.12421,-0.10624,-0.088929,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.13549,-0.10687,-0.11205,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.35674,-0.10725,-0.069149,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.22042,-0.1079,-0.032687,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.20122,-0.10835,-0.097205,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.16904,-0.10835,-0.079677,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.51557,-0.10863,-0.053277,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.16407,-0.10864,-0.083492,0,0
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.073043,-0.10869,-0.098443,0,0
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.29315,-0.1089,-0.10071,0,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.095518,-0.10896,-0.072134,0,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.10299,-0.10992,-0.066731,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.20699,-0.11008,-0.038893,0,0
2,GO DIOL METABOLIC PROCESS,0.21738,-0.11042,-0.043289,0,0
2,GO PROTEIN DEMANNOSYLATION,0.11837,-0.11085,-0.086329,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.049681,-0.11091,-0.13141,0,0
2,GO RESPONSE TO HYPEROXIA,0.7814,-0.11109,0.0050812,0,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.10734,-0.11165,-0.093967,0,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.28395,-0.11174,-0.076391,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.67501,-0.1118,-0.0097139,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.10471,-0.11193,-0.080898,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.093918,-0.11197,-0.061992,0,0
2,GO GLYCINE TRANSPORT,0.48468,-0.11204,-0.055307,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.067397,-0.1121,-0.10596,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.73517,-0.11264,-0.012531,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0087156,-0.11297,-0.10038,0,0
2,GO REGULATION OF TOLERANCE INDUCTION,0.091558,-0.11318,-0.14225,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.068619,-0.11342,-0.096094,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.2114,-0.11358,-0.11302,0,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.42838,-0.1136,-0.052244,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.073043,-0.11417,-0.11412,0,0
2,GO BIOLOGICAL PHASE,0.572,-0.11431,-0.056471,0,0
2,GO TRANSLATIONAL TERMINATION,0.00021511,-0.11449,-0.16242,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.13549,-0.1147,-0.090378,0,0
2,GO INTERLEUKIN 4 PRODUCTION,0.076344,-0.11516,-0.093434,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.25924,-0.11525,-0.07116,0,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.075009,-0.11539,-0.10123,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.016027,-0.11585,-0.096067,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.071119,-0.1163,-0.089218,0,0
2,GO HORMONE CATABOLIC PROCESS,0.28033,-0.11635,-0.083854,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.17411,-0.1165,-0.066748,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.20122,-0.11757,-0.047215,0,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.10646,-0.11784,-0.10254,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.24089,-0.1179,-0.049163,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.28395,-0.1184,-0.073329,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.11367,-0.11868,-0.09003,0,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.018091,-0.11896,-0.088323,0,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.37608,-0.11979,-0.03745,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.48215,-0.11985,-0.034752,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.29877,-0.1202,-0.097798,0,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.071756,-0.12097,-0.097455,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.13549,-0.12242,-0.056343,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.082591,-0.1225,-0.1366,0,0
2,GO COPPER ION HOMEOSTASIS,0.095518,-0.12281,-0.069702,0,0
2,GO RESPONSE TO ANGIOTENSIN,0.09714,-0.12336,-0.084683,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.14869,-0.12398,-0.088371,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.24745,-0.12411,-0.069241,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0012705,-0.12455,-0.12381,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.084034,-0.12473,-0.070166,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.28213,-0.12492,-0.038526,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090782,-0.12502,-0.11425,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.11002,-0.1257,-0.055477,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.45238,-0.12571,-0.014087,0,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.13027,-0.1268,-0.11147,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.51035,-0.12686,-0.066324,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.29502,-0.12698,-0.054878,0,0
2,GO MATURE B CELL DIFFERENTIATION,0.092339,-0.12751,-0.10602,0,0
2,GO POLYAMINE METABOLIC PROCESS,0.0057669,-0.12923,-0.092101,0,0
2,GO RESPIRATORY BURST,0.078382,-0.1293,-0.09623,0,0
2,GO GONADOTROPIN SECRETION,0.46466,-0.12958,-0.026442,0,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.17283,-0.12992,-0.090299,0,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.11367,-0.12999,-0.076869,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.12924,-0.13003,-0.12614,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.088486,-0.13024,-0.12672,0,0
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.19003,-0.13109,-0.091519,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.092339,-0.13181,-0.1053,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.12924,-0.13251,-0.073243,0,0
2,GO CYTOLYSIS,0.20265,-0.13277,-0.10138,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.0052854,-0.1328,-0.089764,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0088198,-0.13291,-0.1593,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.11742,-0.13341,-0.11541,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.016752,-0.13511,-0.13813,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.70486,-0.13512,-0.0034269,0,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.11183,-0.13555,-0.079128,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0033799,-0.13659,-0.12754,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.11092,-0.1372,-0.068883,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.099614,-0.13722,-0.066231,0,0
2,GO HEART INDUCTION,0.65442,-0.13848,-0.018773,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.35043,-0.13865,-0.039666,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.24745,-0.13872,-0.077406,0,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.071119,-0.13901,-0.1338,0,0
2,GO PLATELET MORPHOGENESIS,0.019523,-0.13959,-0.1295,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.018898,-0.13982,-0.1176,0,0
2,GO VITAMIN TRANSPORT,0.070488,-0.13996,-0.07156,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.10385,-0.1401,-0.098281,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.37608,-0.14137,-0.048229,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.11183,-0.14278,-0.13889,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.26964,-0.14361,-0.092335,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.074349,-0.14558,-0.11429,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.001776,-0.14647,-0.13153,0,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.022446,-0.14693,-0.10656,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.42602,-0.1472,-0.075222,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.39832,-0.14805,-0.050898,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.10912,-0.14815,-0.16472,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.041383,-0.14991,-0.12419,0,0
2,GO POSITIVE REGULATION OF CELL MATURATION,0.095518,-0.15187,-0.11296,0,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.23927,-0.15549,-0.085207,0,0
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.034984,-0.15816,-0.15402,0,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.070488,-0.15868,-0.091619,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.081168,-0.1591,-0.14498,0,0
2,GO MIDBODY ABSCISSION,0.0012527,-0.15961,-0.16105,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.10129,-0.16062,-0.12079,0,0
2,GO REGULATION OF PLATELET ACTIVATION,0.069238,-0.16181,-0.13925,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.1653,-0.16248,-0.081928,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.14197,-0.16502,-0.10167,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.085497,-0.1685,-0.11168,0,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.02521,-0.17066,-0.10859,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.071119,-0.17549,-0.12759,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.086237,-0.18046,-0.10867,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.094715,-0.18184,-0.13439,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.16042,-0.18309,-0.14376,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.18866,-0.18326,-0.13192,0,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.095518,-0.18367,-0.079519,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.71089,-0.18395,-0.011724,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.16904,-0.18617,-0.11128,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.071756,-0.1865,-0.15641,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.13234,-0.18674,-0.17984,0,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.077018,-0.18804,-0.19211,0,0
2,GO RETINAL METABOLIC PROCESS,0.19278,-0.19443,-0.11484,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,3.2631e-05,-0.19511,-0.19877,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.1252,-0.19673,-0.13547,0,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.022209,-0.19847,-0.13441,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.13338,-0.20551,-0.11192,0,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.15214,-0.20986,-0.12475,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.17156,-0.21162,-0.10841,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.068619,-0.21265,-0.13399,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.014658,-0.22667,-0.14309,0,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.082591,-0.23228,-0.23095,0,0
2,GO RENAL ABSORPTION,0.14308,-0.23975,-0.12004,0,0
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.18595,-0.24354,-0.12381,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.003166,-0.26205,-0.29393,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.44269,-0.27085,-0.029351,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.013243,0.20147,0.18596,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.016386,0.18082,0.1434,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.027973,0.16095,0.081438,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.057711,0.15341,0.1093,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.033948,0.14948,0.081229,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.043866,0.10291,0.074179,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.064418,-0.028501,-0.13273,1,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.055093,-0.048599,-0.08226,1,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.056128,-0.051136,-0.16327,1,0
3,GO METHIONINE METABOLIC PROCESS,0.031311,-0.056404,-0.13919,1,0
3,GO RNA 3 END PROCESSING,0.020605,-0.063087,-0.1497,1,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0052854,-0.064818,-0.18434,1,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.020166,-0.067272,-0.13535,1,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0088198,-0.068165,-0.11317,1,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0056958,-0.068546,-0.13926,1,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.042609,-0.069862,-0.12766,1,0
3,GO UBIQUINONE METABOLIC PROCESS,0.01251,-0.071705,-0.15788,1,0
3,GO TRNA METHYLATION,0.031631,-0.075442,-0.1617,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0065235,-0.077938,-0.18787,1,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.026838,-0.079919,-0.12039,1,0
3,GO CHROMATIN SILENCING,0.017125,-0.080369,-0.15876,1,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.026561,-0.08143,-0.15098,1,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.021053,-0.081539,-0.21455,1,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0080166,-0.082919,-0.15413,1,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.01128,-0.083512,-0.17129,1,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.010769,-0.085127,-0.11795,1,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.040981,-0.085215,-0.15031,1,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.016386,-0.086205,-0.12583,1,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.043444,-0.087537,-0.14687,1,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.012087,-0.087859,-0.12655,1,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.011411,-0.088924,-0.18574,1,0
3,GO BASE EXCISION REPAIR,0.033271,-0.089165,-0.12235,1,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0016122,-0.089783,-0.1973,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.017894,-0.090906,-0.14582,1,0
3,GO TRNA MODIFICATION,0.061549,-0.092405,-0.13323,1,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00099681,-0.093928,-0.12732,1,0
3,GO REGULATION OF RNA SPLICING,0.00026024,-0.094503,-0.22008,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0012005,-0.095545,-0.16989,1,0
3,GO SNRNA TRANSCRIPTION,0.0032501,-0.095562,-0.16415,1,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.061549,-0.097312,-0.22899,1,0
3,GO RRNA METHYLATION,0.03068,-0.09864,-0.15758,1,0
3,GO REGULATION OF MRNA BINDING,0.003166,-0.099477,-0.19238,1,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.017506,-0.10049,-0.14792,1,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.040582,-0.10055,-0.11432,1,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.0033361,-0.10182,-0.13767,1,0
3,GO QUINONE METABOLIC PROCESS,0.010279,-0.10277,-0.17653,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.01016,-0.10307,-0.15303,1,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0020929,-0.10328,-0.22447,1,0
3,GO SPERM AXONEME ASSEMBLY,0.0104,-0.10334,-0.16363,1,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0015038,-0.10335,-0.22986,1,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.01499,-0.10347,-0.16139,1,0
3,GO RNA PROCESSING,0.0052854,-0.10376,-0.16081,1,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0067673,-0.10388,-0.25133,1,0
3,GO RNA METHYLATION,0.0068504,-0.10395,-0.1855,1,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.026838,-0.10454,-0.12611,1,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.048285,-0.10461,-0.1276,1,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.054074,-0.10623,-0.11798,1,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0005211,-0.10624,-0.14499,1,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.013093,-0.10674,-0.1435,1,0
3,GO GROOMING BEHAVIOR,0.031631,-0.10792,-0.16151,1,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.0065235,-0.10832,-0.15748,1,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.0035146,-0.10863,-0.22192,1,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0024281,-0.1093,-0.1537,1,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0020092,-0.11008,-0.17735,1,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0041031,-0.11132,-0.20672,1,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.2824e-05,-0.11137,-0.21502,1,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0007901,-0.11303,-0.1717,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0052197,-0.11311,-0.16548,1,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.039795,-0.11358,-0.14227,1,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.037882,-0.11397,-0.19482,1,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.011949,-0.11404,-0.12533,1,0
3,GO RNA MODIFICATION,0.002631,-0.11418,-0.18686,1,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0054192,-0.11419,-0.17633,1,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.015501,-0.1143,-0.16228,1,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.00021511,-0.11443,-0.2151,1,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0005056,-0.11505,-0.29319,1,0
3,GO RNA INTERFERENCE,0.0084096,-0.11683,-0.15509,1,0
3,GO PROTEIN MONOUBIQUITINATION,1.8363e-05,-0.11695,-0.24728,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.021053,-0.11783,-0.15139,1,0
3,GO MRNA METABOLIC PROCESS,0.00055343,-0.11813,-0.15045,1,0
3,GO NEGATIVE T CELL SELECTION,0.00081356,-0.1189,-0.24422,1,0
3,GO POSTREPLICATION REPAIR,0.0001862,-0.11899,-0.17356,1,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0019285,-0.11916,-0.1784,1,0
3,GO VIRAL TRANSLATION,0.026013,-0.11929,-0.16475,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0057669,-0.12012,-0.17255,1,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.022686,-0.12037,-0.13672,1,0
3,GO AMIDE BIOSYNTHETIC PROCESS,7.3739e-05,-0.12057,-0.15944,1,0
3,GO RRNA TRANSCRIPTION,0.004156,-0.12094,-0.20913,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0029256,-0.12098,-0.17533,1,0
3,GO NCRNA TRANSCRIPTION,0.00159,-0.12107,-0.17804,1,0
3,GO RNA CATABOLIC PROCESS,0.000662,-0.12111,-0.12252,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.017506,-0.1212,-0.12853,1,0
3,GO RESPONSE TO LITHIUM ION,0.0137,-0.12161,-0.23214,1,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0017517,-0.12162,-0.14156,1,0
3,GO MRNA 3 END PROCESSING,0.001955,-0.12218,-0.19393,1,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.020828,-0.12264,-0.12872,1,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0019285,-0.12281,-0.14754,1,0
3,GO DNA GEOMETRIC CHANGE,0.0018764,-0.12337,-0.2,1,0
3,GO DNA REPAIR,0.0002443,-0.12389,-0.20072,1,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0019819,-0.12396,-0.16671,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.5756e-08,-0.12412,-0.26509,1,0
3,GO MRNA EXPORT FROM NUCLEUS,0.010041,-0.12439,-0.17288,1,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00083767,-0.12529,-0.16426,1,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,3.0395e-05,-0.12548,-0.21456,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.8419e-06,-0.12607,-0.24789,1,0
3,GO DNA METABOLIC PROCESS,1.0169e-05,-0.12617,-0.21905,1,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.034984,-0.12719,-0.16139,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,1.1375e-05,-0.12747,-0.23643,1,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0044298,-0.12766,-0.10877,1,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.00038422,-0.12785,-0.17731,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.00029976,-0.1282,-0.19721,1,0
3,GO RESPONSE TO ETHER,0.00042777,-0.1292,-0.20178,1,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.043025,-0.12928,-0.11298,1,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,9.4341e-06,-0.13013,-0.18866,1,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.043444,-0.13044,-0.20145,1,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,1.1806e-05,-0.13049,-0.23141,1,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.01585,-0.13077,-0.14951,1,0
3,GO DNA MODIFICATION,1.1375e-05,-0.13108,-0.2201,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.039795,-0.13116,-0.13552,1,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.015159,-0.13117,-0.15102,1,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.016568,-0.13205,-0.17234,1,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,9.5677e-09,-0.13236,-0.2829,1,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,9.7991e-09,-0.13247,-0.2821,1,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0092477,-0.1327,-0.20625,1,0
3,GO SPERM EGG RECOGNITION,0.00039018,-0.13319,-0.15313,1,0
3,GO HISTONE H3 K27 METHYLATION,7.2497e-05,-0.1332,-0.26753,1,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,7.7586e-05,-0.13325,-0.20389,1,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.1121e-10,-0.13342,-0.27752,1,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,4.7172e-05,-0.13345,-0.2521,1,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00010152,-0.13427,-0.19975,1,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.3325e-06,-0.13482,-0.16777,1,0
3,GO SINGLE STRAND BREAK REPAIR,0.058247,-0.13493,-0.17568,1,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.026561,-0.13556,-0.16903,1,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.00082553,-0.13564,-0.19844,1,0
3,GO DNA METHYLATION OR DEMETHYLATION,7.3739e-05,-0.13568,-0.23041,1,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,1.9044e-05,-0.13584,-0.25042,1,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,3.2162e-07,-0.13608,-0.28889,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,6.5837e-06,-0.13697,-0.13867,1,0
3,GO MANNOSYLATION,0.00045468,-0.13702,-0.2404,1,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00010852,-0.13711,-0.21045,1,0
3,GO RNA POLYADENYLATION,6.1119e-05,-0.13807,-0.26368,1,0
3,GO RNA EXPORT FROM NUCLEUS,0.013243,-0.13834,-0.16544,1,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,1.2716e-05,-0.13844,-0.21659,1,0
3,GO DOUBLE STRAND BREAK REPAIR,0.0001862,-0.13879,-0.22722,1,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0016122,-0.13885,-0.21383,1,0
3,GO GENE SILENCING,4.2487e-05,-0.14008,-0.22729,1,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0038977,-0.14041,-0.16308,1,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0023637,-0.14058,-0.18079,1,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.00070238,-0.14073,-0.19635,1,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00036686,-0.1409,-0.26173,1,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,1.2032e-06,-0.14145,-0.25657,1,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0054872,-0.14183,-0.18422,1,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,8.3013e-05,-0.14218,-0.24465,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00049802,-0.14234,-0.1698,1,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.0037985,-0.14237,-0.18511,1,0
3,GO PORE COMPLEX ASSEMBLY,3.9613e-05,-0.14249,-0.26739,1,0
3,GO PEPTIDE METABOLIC PROCESS,6.4592e-06,-0.14278,-0.16942,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0033361,-0.14287,-0.21659,1,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.0042636,-0.14301,-0.16756,1,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0081133,-0.14313,-0.19361,1,0
3,GO REGULATION OF RNA BINDING,0.0017517,-0.14342,-0.19255,1,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00072342,-0.14399,-0.18787,1,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.0070192,-0.14402,-0.22308,1,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00022927,-0.14463,-0.1858,1,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,6.5837e-06,-0.14472,-0.21101,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.001704,-0.14504,-0.2757,1,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00039018,-0.14519,-0.1893,1,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0013069,-0.1457,-0.16017,1,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00024819,-0.14581,-0.19021,1,0
3,GO MRNA SPLICE SITE SELECTION,0.0104,-0.14646,-0.18615,1,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0026663,-0.14693,-0.18452,1,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00049802,-0.14715,-0.21368,1,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,1.1034e-07,-0.14725,-0.25975,1,0
3,GO RNA LOCALIZATION,0.0012005,-0.14772,-0.19529,1,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0002117,-0.14775,-0.18971,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00016098,-0.1478,-0.27156,1,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0013826,-0.14814,-0.25841,1,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0049019,-0.14828,-0.16127,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,3.2094e-09,-0.14829,-0.27922,1,0
3,GO PHAGOSOME ACIDIFICATION,0.0012177,-0.1483,-0.2076,1,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.0018256,-0.14859,-0.18623,1,0
3,GO NON RECOMBINATIONAL REPAIR,4.7488e-06,-0.14862,-0.25669,1,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0021215,-0.14892,-0.16548,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0010408,-0.14926,-0.24845,1,0
3,GO TELOMERE ORGANIZATION,0.0007901,-0.14935,-0.19194,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0030436,-0.14955,-0.22024,1,0
3,GO MULTI ORGANISM LOCALIZATION,1.3056e-06,-0.15002,-0.25241,1,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00092737,-0.15023,-0.23383,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.011151,-0.15025,-0.15925,1,0
3,GO MIRNA METABOLIC PROCESS,0.00098255,-0.15027,-0.22463,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00017176,-0.15053,-0.23063,1,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0066851,-0.15078,-0.26182,1,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.0058389,-0.15079,-0.162,1,0
3,GO VITAMIN CATABOLIC PROCESS,0.026286,-0.15085,-0.20881,1,0
3,GO TRANSLESION SYNTHESIS,0.00011033,-0.15086,-0.19412,1,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.00092737,-0.15128,-0.26992,1,0
3,GO REGULATION OF FERTILIZATION,0.0002117,-0.15179,-0.22072,1,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0024609,-0.15187,-0.1978,1,0
3,GO RESPONSE TO OXYGEN RADICAL,3.1494e-05,-0.15199,-0.20871,1,0
3,GO RESPONSE TO FOOD,0.0054192,-0.15229,-0.14476,1,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.01499,-0.15232,-0.21495,1,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,2.8814e-05,-0.15238,-0.19301,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.001235,-0.15241,-0.26469,1,0
3,GO REGULATION OF DNA REPAIR,2.6352e-05,-0.15274,-0.2518,1,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0013826,-0.15279,-0.19075,1,0
3,GO MITOCHONDRION ORGANIZATION,1.0424e-06,-0.15301,-0.21455,1,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00067188,-0.15394,-0.26825,1,0
3,GO REGULATION OF CILIUM MOVEMENT,0.00044781,-0.15404,-0.14997,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00070238,-0.15416,-0.2402,1,0
3,GO DNA RECOMBINATION,0.00020178,-0.1542,-0.21298,1,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.048746,-0.15446,-0.11383,1,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.0058389,-0.15493,-0.20037,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00011596,-0.15495,-0.17553,1,0
3,GO REGULATION OF ERAD PATHWAY,2.856e-06,-0.15514,-0.32332,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.017125,-0.1555,-0.15462,1,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011151,-0.15643,-0.20956,1,0
3,GO CYTOKINESIS,1.7922e-07,-0.15682,-0.28813,1,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00031907,-0.15715,-0.1765,1,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,2.5066e-09,-0.15755,-0.25421,1,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.00015838,-0.15758,-0.25087,1,0
3,GO NUCLEAR EXPORT,9.3381e-05,-0.15771,-0.2285,1,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,5.6245e-08,-0.15778,-0.1832,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,1.0422e-09,-0.15793,-0.28196,1,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.004156,-0.15803,-0.20803,1,0
3,GO HISTONE H2B UBIQUITINATION,1.1806e-05,-0.15856,-0.26601,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,4.2784e-08,-0.15861,-0.29634,1,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,1.8723e-07,-0.15864,-0.2062,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00014129,-0.15894,-0.19701,1,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.0050269,-0.1593,-0.18291,1,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0030839,-0.15935,-0.17836,1,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.7693e-06,-0.15981,-0.23599,1,0
3,GO DNA CATABOLIC PROCESS,3.152e-06,-0.15985,-0.21692,1,0
3,GO NUCLEAR TRANSPORT,1.0861e-06,-0.15988,-0.25156,1,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0020646,-0.16014,-0.19713,1,0
3,GO NUCLEUS ORGANIZATION,1.7693e-06,-0.16049,-0.27513,1,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,1.0004e-06,-0.16055,-0.24049,1,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,4.9069e-08,-0.16062,-0.26565,1,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00099681,-0.16084,-0.23075,1,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,1.2792e-06,-0.16088,-0.2562,1,0
3,GO MITOTIC RECOMBINATION,0.0003557,-0.1609,-0.24772,1,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.052083,-0.16149,-0.11312,1,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,2.7312e-05,-0.16155,-0.22652,1,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.001704,-0.16169,-0.25752,1,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00044781,-0.16174,-0.21018,1,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00069207,-0.16186,-0.25966,1,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0015249,-0.1619,-0.24835,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0086125,-0.16212,-0.23166,1,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,2.4528e-05,-0.16215,-0.19266,1,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.01995,-0.16247,-0.20063,1,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.0014022,-0.1632,-0.21812,1,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.012087,-0.16327,-0.21138,1,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00064263,-0.16336,-0.17842,1,0
3,GO PH REDUCTION,1.6158e-05,-0.16337,-0.22079,1,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.000286,-0.1634,-0.25354,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00034485,-0.16391,-0.21053,1,0
3,GO CELL CYCLE PHASE TRANSITION,4.6578e-06,-0.16429,-0.23411,1,0
3,GO NUCLEOSIDE METABOLIC PROCESS,2.9332e-05,-0.16456,-0.20445,1,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,9.086e-06,-0.16477,-0.24207,1,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.00045468,-0.16488,-0.24962,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00086244,-0.16524,-0.23513,1,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,3.6361e-10,-0.16528,-0.26081,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.0395e-05,-0.16534,-0.22645,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.00025617,-0.16536,-0.21698,1,0
3,GO CELL CYCLE,3.0295e-08,-0.16557,-0.27253,1,0
3,GO REGULATION OF CIRCADIAN RHYTHM,2.1624e-06,-0.16578,-0.28459,1,0
3,GO FEEDING BEHAVIOR,2.8001e-06,-0.16616,-0.26316,1,0
3,GO REGULATION OF CELL CYCLE,2.0546e-09,-0.1664,-0.28563,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00024045,-0.16662,-0.18647,1,0
3,GO CELL CYCLE PROCESS,2.3274e-07,-0.16677,-0.26159,1,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,8.0256e-05,-0.16688,-0.24792,1,0
3,GO CELL CYCLE CHECKPOINT,1.5052e-06,-0.16725,-0.26019,1,0
3,GO AMINE METABOLIC PROCESS,4.9228e-07,-0.16725,-0.20987,1,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,9.1829e-05,-0.16749,-0.18632,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,3.8301e-10,-0.1675,-0.3068,1,0
3,GO ATP METABOLIC PROCESS,1.6457e-05,-0.16751,-0.19676,1,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0033799,-0.16753,-0.22367,1,0
3,GO REGULATION OF CELL CYCLE PROCESS,3.357e-07,-0.16801,-0.25527,1,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.010895,-0.16819,-0.15029,1,0
3,GO MICROTUBULE BASED PROCESS,3.247e-08,-0.16841,-0.28719,1,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00026438,-0.16874,-0.21823,1,0
3,GO REGULATION OF MITOTIC CELL CYCLE,5.02e-08,-0.16889,-0.26449,1,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,3.0905e-06,-0.16928,-0.30843,1,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,3.9822e-07,-0.16961,-0.27424,1,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00037257,-0.16967,-0.21415,1,0
3,GO MRNA TRANSPORT,0.00046165,-0.17006,-0.21703,1,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,6.1119e-05,-0.17011,-0.24016,1,0
3,GO GAMETE GENERATION,2.1064e-09,-0.17044,-0.26523,1,0
3,GO REGULATION OF AMINO ACID TRANSPORT,7.0072e-05,-0.17091,-0.28376,1,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,1.9064e-09,-0.17099,-0.24816,1,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00031414,-0.17102,-0.24897,1,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,5.7059e-05,-0.17119,-0.22057,1,0
3,GO TRNA TRANSPORT,0.0085105,-0.17168,-0.192,1,0
3,GO CEREBELLAR CORTEX FORMATION,0.001422,-0.17189,-0.26123,1,0
3,GO DNA BIOSYNTHETIC PROCESS,5.2445e-07,-0.17196,-0.25493,1,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,2.1807e-07,-0.17197,-0.31751,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE,1.4677e-08,-0.1721,-0.2825,1,0
3,GO HISTONE H3 ACETYLATION,1.4741e-05,-0.17212,-0.26853,1,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00010497,-0.17258,-0.18838,1,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0018764,-0.17287,-0.18644,1,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001483,-0.1729,-0.21456,1,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.0343e-10,-0.17291,-0.3192,1,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0011021,-0.17297,-0.19602,1,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.00049802,-0.17302,-0.26003,1,0
3,GO REGULATION OF DNA METABOLIC PROCESS,1.6654e-06,-0.17327,-0.26224,1,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.000662,-0.17334,-0.23894,1,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,2.8814e-05,-0.17339,-0.25712,1,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0032078,-0.17354,-0.17233,1,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,3.628e-05,-0.17366,-0.2365,1,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,6.4592e-06,-0.17367,-0.26381,1,0
3,GO REGULATION OF GENE SILENCING,5.1446e-05,-0.17378,-0.23598,1,0
3,GO CHROMATIN ORGANIZATION,2.971e-06,-0.17379,-0.27185,1,0
3,GO SENSORY PERCEPTION OF TASTE,0.00031907,-0.17382,-0.16699,1,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,9.6562e-05,-0.17385,-0.19572,1,0
3,GO VIRION ASSEMBLY,3.152e-06,-0.17398,-0.21392,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00046165,-0.174,-0.19944,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,4.3997e-05,-0.1742,-0.22702,1,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00012804,-0.17431,-0.23094,1,0
3,GO TRANSFERRIN TRANSPORT,1.4472e-05,-0.17434,-0.26979,1,0
3,GO MITOTIC CELL CYCLE,8.3066e-07,-0.17468,-0.25543,1,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0029256,-0.17481,-0.18606,1,0
3,GO SEXUAL REPRODUCTION,2.8753e-10,-0.17482,-0.27234,1,0
3,GO VACUOLAR ACIDIFICATION,3.152e-06,-0.17544,-0.2757,1,0
3,GO DNA DEALKYLATION,4.5558e-05,-0.17569,-0.24813,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012945,-0.17608,-0.26601,1,0
3,GO WALKING BEHAVIOR,0.0013443,-0.17626,-0.24253,1,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,5.77e-09,-0.17672,-0.30284,1,0
3,GO DNA INTEGRITY CHECKPOINT,4.5233e-07,-0.17722,-0.2774,1,0
3,GO MACROMOLECULE CATABOLIC PROCESS,1.0241e-10,-0.17728,-0.28088,1,0
3,GO POSITIVE REGULATION OF CELL AGING,0.00048316,-0.17743,-0.19043,1,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,3.4409e-05,-0.17759,-0.28318,1,0
3,GO POSITIVE THYMIC T CELL SELECTION,3.3214e-05,-0.17769,-0.27026,1,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.0019819,-0.17772,-0.25313,1,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.1806e-05,-0.17777,-0.28015,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0007901,-0.1778,-0.20298,1,0
3,GO DNA METHYLATION,0.00064263,-0.17788,-0.2226,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.010041,-0.17826,-0.24058,1,0
3,GO PROTEIN POLYUBIQUITINATION,6.205e-09,-0.17848,-0.28614,1,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,2.0853e-05,-0.17855,-0.22763,1,0
3,GO PROTEIN N LINKED GLYCOSYLATION,1.0004e-06,-0.17908,-0.29016,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001442,-0.17919,-0.26272,1,0
3,GO NUCLEAR PORE ORGANIZATION,0.050154,-0.17931,-0.17485,1,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,6.2565e-10,-0.17953,-0.31878,1,0
3,GO PROTEIN METHYLATION,0.00012594,-0.1797,-0.24776,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,3.2146e-06,-0.17972,-0.23189,1,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,7.3803e-06,-0.17979,-0.19379,1,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.1789e-06,-0.17999,-0.29874,1,0
3,GO PROTEIN TARGETING,1.8419e-06,-0.18013,-0.16424,1,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,5.9056e-05,-0.18022,-0.26526,1,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.0022095,-0.18074,-0.21762,1,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0023321,-0.18081,-0.18385,1,0
3,GO ZINC ION TRANSPORT,1.4207e-05,-0.18106,-0.2659,1,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00044103,-0.18119,-0.21199,1,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0033361,-0.18147,-0.2907,1,0
3,GO PIGMENT GRANULE LOCALIZATION,2.5884e-05,-0.18178,-0.26981,1,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,1.9044e-05,-0.18197,-0.21996,1,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.011813,-0.18198,-0.1497,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,8.4805e-07,-0.18211,-0.27893,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,2.4091e-05,-0.18232,-0.23373,1,0
3,GO COVALENT CHROMATIN MODIFICATION,6.4699e-07,-0.1824,-0.2868,1,0
3,GO CELL DIVISION,2.3784e-07,-0.18247,-0.26993,1,0
3,GO PRIMARY MIRNA PROCESSING,0.00042128,-0.18256,-0.24973,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,2.8262e-08,-0.18347,-0.28251,1,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.011e-05,-0.18355,-0.21847,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.3256e-05,-0.18359,-0.26467,1,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00013451,-0.18373,-0.2,1,0
3,GO NADPH REGENERATION,0.00037835,-0.18383,-0.26432,1,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,2.9859e-05,-0.18391,-0.23874,1,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.00037257,-0.18445,-0.20342,1,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,1.7687e-09,-0.18446,-0.25549,1,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,6.5125e-09,-0.18506,-0.27742,1,0
3,GO BLASTOCYST DEVELOPMENT,2.2286e-07,-0.18507,-0.22705,1,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,4.1025e-09,-0.18508,-0.24532,1,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0054192,-0.18515,-0.23317,1,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.0071051,-0.18533,-0.17814,1,0
3,GO DRUG CATABOLIC PROCESS,1.8701e-05,-0.18537,-0.22855,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,3.8347e-06,-0.18551,-0.22621,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,3.0296e-10,-0.18587,-0.29189,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,2.7668e-07,-0.18592,-0.27464,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00094089,-0.18637,-0.22399,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,3.9035e-08,-0.18639,-0.19988,1,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,5.8049e-05,-0.18643,-0.24213,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,4.9228e-07,-0.18657,-0.32132,1,0
3,GO REGULATION OF PROTEIN SUMOYLATION,1.9558e-07,-0.18669,-0.32213,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE,6.4341e-05,-0.18672,-0.23918,1,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.00071283,-0.18716,-0.25657,1,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,3.1729e-08,-0.18717,-0.29358,1,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.7125e-10,-0.18729,-0.31764,1,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,2.2015e-05,-0.18733,-0.29401,1,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,1.3468e-07,-0.18738,-0.22759,1,0
3,GO MITOTIC CYTOKINESIS,2.8886e-07,-0.18745,-0.2815,1,0
3,GO BLASTOCYST FORMATION,7.8052e-07,-0.18763,-0.26308,1,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,5.2445e-07,-0.18781,-0.23615,1,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00029976,-0.18783,-0.22193,1,0
3,GO RESPONSE TO ATP,1.8135e-09,-0.18784,-0.30013,1,0
3,GO NUCLEOSIDE SALVAGE,0.0070192,-0.18785,-0.14539,1,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,8.2543e-08,-0.18798,-0.24394,1,0
3,GO REGULATION OF LIGASE ACTIVITY,0.00044103,-0.18809,-0.21451,1,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.034984,-0.18821,-0.12908,1,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.00040235,-0.18836,-0.23883,1,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,2.3239e-05,-0.18858,-0.24115,1,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00041488,-0.18863,-0.20904,1,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.055093,-0.18898,-0.22167,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,8.9166e-06,-0.18935,-0.24989,1,0
3,GO AXONAL TRANSPORT,7.6657e-06,-0.18936,-0.34321,1,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,1.2032e-06,-0.1894,-0.28495,1,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.00014129,-0.18983,-0.25676,1,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,2.8814e-05,-0.1902,-0.23251,1,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.5052e-06,-0.19028,-0.26832,1,0
3,GO NIK NF KAPPAB SIGNALING,3.6435e-08,-0.1904,-0.282,1,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,3.5794e-07,-0.19042,-0.29077,1,0
3,GO PROTEIN HETEROOLIGOMERIZATION,3.628e-05,-0.19046,-0.25395,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,9.404e-07,-0.19064,-0.27527,1,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,4.5558e-05,-0.19065,-0.25881,1,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,1.4472e-05,-0.19075,-0.30742,1,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,3.9822e-07,-0.19086,-0.27057,1,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.536e-06,-0.19102,-0.2473,1,0
3,GO REGULATION OF PH,2.2397e-08,-0.19122,-0.26815,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.0084096,-0.19151,-0.20052,1,0
3,GO CELLULAR RESPONSE TO HEAT,2.7452e-06,-0.19154,-0.28136,1,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,6.2169e-06,-0.19168,-0.29153,1,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,5.6487e-06,-0.1918,-0.25131,1,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,7.3803e-06,-0.19187,-0.26121,1,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,5.2303e-06,-0.19191,-0.21664,1,0
3,GO BLASTOCYST GROWTH,0.0015038,-0.19199,-0.23349,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,6.8885e-07,-0.19233,-0.26088,1,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011341,-0.19234,-0.24427,1,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,1.3468e-07,-0.19262,-0.23362,1,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,1.8723e-07,-0.19265,-0.28022,1,0
3,GO REGULATION OF PROTEIN FOLDING,1.1588e-05,-0.19302,-0.26791,1,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.004e-09,-0.19313,-0.31711,1,0
3,GO POLYOL CATABOLIC PROCESS,7.2414e-06,-0.19328,-0.3041,1,0
3,GO PROTEIN CATABOLIC PROCESS,8.2618e-11,-0.19334,-0.31997,1,0
3,GO ORGANELLE INHERITANCE,8.7502e-06,-0.19356,-0.24575,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.1479e-07,-0.19371,-0.31989,1,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.0022396,-0.19392,-0.25636,1,0
3,GO TRANSPORT ALONG MICROTUBULE,2.4371e-06,-0.19444,-0.29814,1,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,4.9361e-06,-0.1947,-0.28886,1,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,1.2058e-07,-0.19479,-0.2529,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00017457,-0.19481,-0.2788,1,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.9905e-10,-0.19506,-0.33025,1,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.0478e-05,-0.19525,-0.25163,1,0
3,GO THYMIC T CELL SELECTION,1.2716e-05,-0.19528,-0.24481,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2169e-06,-0.1953,-0.29616,1,0
3,GO POSITIVE REGULATION OF DNA BINDING,2.8271e-07,-0.19555,-0.27274,1,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,2.2926e-08,-0.19556,-0.28382,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,2.65e-07,-0.19562,-0.25064,1,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,3.8246e-05,-0.19567,-0.25454,1,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,7.8124e-06,-0.19586,-0.24783,1,0
3,GO INTRACILIARY TRANSPORT,0.00070238,-0.19593,-0.23204,1,0
3,GO ERAD PATHWAY,3.4296e-07,-0.19594,-0.33339,1,0
3,GO RESPONSE TO LIGHT STIMULUS,3.7319e-10,-0.19594,-0.29427,1,0
3,GO MALE GAMETE GENERATION,1.4677e-08,-0.19606,-0.25075,1,0
3,GO ENDOCARDIUM DEVELOPMENT,0.0002443,-0.19607,-0.29036,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00046872,-0.19612,-0.28996,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,8.9047e-09,-0.19639,-0.28096,1,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.00076726,-0.19665,-0.26157,1,0
3,GO P BODY ASSEMBLY,3.2631e-05,-0.19683,-0.28667,1,0
3,GO HISTONE METHYLATION,0.00015331,-0.19684,-0.25736,1,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.2058e-07,-0.19702,-0.27706,1,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,1.3693e-05,-0.19712,-0.34164,1,0
3,GO SEQUESTERING OF METAL ION,5.1446e-05,-0.19717,-0.24501,1,0
3,GO SUCKLING BEHAVIOR,0.0085105,-0.19747,-0.27559,1,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.6907e-08,-0.19755,-0.27027,1,0
3,GO ORGANELLE DISASSEMBLY,3.9822e-07,-0.19758,-0.27307,1,0
3,GO DENSE CORE GRANULE TRANSPORT,0.0068504,-0.19777,-0.34613,1,0
3,GO ACETYL COA METABOLIC PROCESS,7.9617e-06,-0.19791,-0.30173,1,0
3,GO RESPONSE TO RADIATION,5.3602e-11,-0.19795,-0.29985,1,0
3,GO AXO DENDRITIC TRANSPORT,2.6914e-06,-0.19848,-0.33981,1,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.00029511,-0.19863,-0.27333,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,1.3878e-06,-0.19897,-0.26498,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,2.4371e-06,-0.19912,-0.32613,1,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,2.4893e-11,-0.19915,-0.32896,1,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,1.1535e-07,-0.19923,-0.26019,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,3.0156e-07,-0.19925,-0.2407,1,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,4.6578e-06,-0.19936,-0.24919,1,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00035024,-0.19944,-0.23479,1,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,5.2303e-06,-0.19956,-0.30153,1,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,3.2894e-09,-0.19994,-0.30925,1,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0019285,-0.2,-0.27951,1,0
3,GO PROTEIN MANNOSYLATION,0.00042777,-0.2001,-0.26196,1,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,7.0337e-07,-0.20021,-0.3223,1,0
3,GO RNA DECAPPING,3.6924e-05,-0.20034,-0.27631,1,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.0035605,-0.20034,-0.32088,1,0
3,GO HISTONE H4 DEACETYLATION,2.2958e-06,-0.20042,-0.29676,1,0
3,GO GERM CELL DEVELOPMENT,4.5822e-08,-0.20052,-0.25248,1,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00032408,-0.2006,-0.26205,1,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.5066e-09,-0.20095,-0.29444,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,4.3355e-07,-0.20101,-0.27192,1,0
3,GO GTP METABOLIC PROCESS,0.001955,-0.20102,-0.21798,1,0
3,GO POSITIVE REGULATION OF TRANSLATION,2.7078e-07,-0.20148,-0.25782,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1282e-07,-0.20204,-0.2516,1,0
3,GO MICROTUBULE BASED MOVEMENT,1.3174e-07,-0.20207,-0.2793,1,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,1.7154e-07,-0.20228,-0.26206,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION,2.801e-10,-0.20236,-0.33676,1,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,4.0033e-09,-0.2024,-0.30002,1,0
3,GO REGULATION OF CELLULAR PH,1.0094e-07,-0.20259,-0.26817,1,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00020504,-0.2026,-0.20816,1,0
3,GO ATP BIOSYNTHETIC PROCESS,0.0017277,-0.20268,-0.24927,1,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,6.3088e-12,-0.20309,-0.33243,1,0
3,GO GLUTATHIONE METABOLIC PROCESS,3.758e-05,-0.20352,-0.25203,1,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.004156,-0.20354,-0.21853,1,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.0049019,-0.20367,-0.23515,1,0
3,GO DNA DEMETHYLATION,0.00022565,-0.20394,-0.25028,1,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,4.6202e-07,-0.2041,-0.34296,1,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00016361,-0.20422,-0.23995,1,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.5646e-05,-0.20459,-0.43488,1,0
3,GO REGULATION OF ACROSOME REACTION,0.0014624,-0.20467,-0.27952,1,0
3,GO STEROID BIOSYNTHETIC PROCESS,5.9834e-06,-0.2049,-0.26398,1,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00099681,-0.20495,-0.23891,1,0
3,GO ONE CARBON METABOLIC PROCESS,2.011e-05,-0.20514,-0.24225,1,0
3,GO SYMBIOTIC PROCESS,7.6205e-11,-0.20528,-0.27882,1,0
3,GO CELLULAR KETONE METABOLIC PROCESS,2.8262e-08,-0.20529,-0.26224,1,0
3,GO PEPTIDYL LYSINE METHYLATION,0.00039622,-0.2053,-0.2486,1,0
3,GO ENDOSOMAL TRANSPORT,1.5217e-09,-0.20535,-0.3329,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0033799,-0.20542,-0.16839,1,0
3,GO REGULATION OF CELL MATURATION,7.892e-08,-0.20552,-0.26389,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,1.9393e-05,-0.20556,-0.2456,1,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,3.9717e-11,-0.20564,-0.33095,1,0
3,GO SYNAPTIC VESICLE TRANSPORT,1.6158e-05,-0.20603,-0.30682,1,0
3,GO SENSORY PERCEPTION OF SMELL,2.5359e-06,-0.20607,-0.23957,1,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,3.5038e-07,-0.20637,-0.34274,1,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,3.8924e-05,-0.20654,-0.27529,1,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00030449,-0.20659,-0.22649,1,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.00019541,-0.20659,-0.23953,1,0
3,GO NEUTRAL AMINO ACID TRANSPORT,6.0991e-06,-0.20662,-0.35451,1,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0058389,-0.2067,-0.22026,1,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.00016098,-0.20698,-0.19716,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,2.7804e-05,-0.20701,-0.26621,1,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.0007901,-0.20707,-0.25784,1,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,3.9309e-10,-0.20714,-0.32814,1,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,8.8389e-07,-0.20732,-0.2841,1,0
3,GO SINGLE FERTILIZATION,3.9064e-09,-0.20759,-0.26947,1,0
3,GO GOLGI ORGANIZATION,7.5451e-08,-0.20767,-0.34564,1,0
3,GO MULTI ORGANISM PROCESS,3.1896e-11,-0.20772,-0.30189,1,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,1.1034e-07,-0.20805,-0.27588,1,0
3,GO GOLGI VESICLE TRANSPORT,2.7286e-10,-0.20811,-0.34083,1,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.0004e-06,-0.20845,-0.28538,1,0
3,GO FEMALE GAMETE GENERATION,2.5066e-09,-0.20897,-0.27221,1,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,7.3476e-09,-0.20909,-0.26963,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0028118,-0.20912,-0.20466,1,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00010852,-0.20955,-0.21046,1,0
3,GO CILIUM MOVEMENT,2.538e-07,-0.20977,-0.24404,1,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,6.2175e-05,-0.20984,-0.28287,1,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.0044298,-0.20993,-0.20488,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.6782e-07,-0.21014,-0.31462,1,0
3,GO IMPORT INTO NUCLEUS,1.1307e-08,-0.21033,-0.28807,1,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,2.634e-09,-0.21049,-0.36396,1,0
3,GO TRANSITION METAL ION TRANSPORT,2.7e-09,-0.2105,-0.2765,1,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00013899,-0.21055,-0.23824,1,0
3,GO TRANSCYTOSIS,4.3946e-06,-0.21059,-0.34706,1,0
3,GO REGULATION OF DNA RECOMBINATION,9.2118e-07,-0.2107,-0.29136,1,0
3,GO PROTEIN SUMOYLATION,2.7804e-05,-0.21074,-0.27029,1,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,3.019e-11,-0.21079,-0.30557,1,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.0037498,-0.21101,-0.19638,1,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.00023667,-0.21119,-0.24765,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.8885e-07,-0.21127,-0.24777,1,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,5.0563e-05,-0.21135,-0.28708,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,1.5753e-08,-0.21138,-0.35583,1,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.0025617,-0.21151,-0.2459,1,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,7.6446e-07,-0.2117,-0.30261,1,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00028155,-0.21174,-0.27405,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.8198e-07,-0.212,-0.35517,1,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.7804e-05,-0.21214,-0.26875,1,0
3,GO CELL REDOX HOMEOSTASIS,6.7724e-05,-0.21222,-0.19804,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,1.2733e-08,-0.21235,-0.35415,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.7909e-10,-0.21242,-0.33674,1,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,4.3236e-05,-0.21253,-0.42821,1,0
3,GO PEROXISOME ORGANIZATION,5.7051e-07,-0.21275,-0.25809,1,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,9.03e-05,-0.21283,-0.25302,1,0
3,GO GLYCOSYLATION,1.069e-09,-0.21313,-0.34435,1,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0015463,-0.21314,-0.26152,1,0
3,GO SPERMATID DIFFERENTIATION,7.4873e-07,-0.21316,-0.23221,1,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.00014362,-0.21316,-0.28392,1,0
3,GO REGULATION OF ACTIN NUCLEATION,1.1588e-05,-0.21319,-0.3007,1,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00030928,-0.2132,-0.20538,1,0
3,GO REGULATION OF HISTONE UBIQUITINATION,3.8347e-06,-0.21328,-0.25051,1,0
3,GO CELLULAR RESPONSE TO ATP,8.2864e-09,-0.21334,-0.30047,1,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.9859e-05,-0.21341,-0.30029,1,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.010041,-0.21351,-0.18447,1,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,8.7502e-06,-0.21363,-0.24433,1,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,5.0278e-07,-0.21379,-0.21772,1,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,2.5359e-06,-0.21385,-0.26451,1,0
3,GO PROTEIN IMPORT,1.7687e-09,-0.21421,-0.29856,1,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,2.0853e-05,-0.21437,-0.32278,1,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,1.0202e-11,-0.21452,-0.34292,1,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00076726,-0.21457,-0.23469,1,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,5.8262e-07,-0.21458,-0.27821,1,0
3,GO NCRNA CATABOLIC PROCESS,4.2271e-06,-0.21461,-0.27532,1,0
3,GO REGULATION OF DNA BINDING,6.586e-10,-0.21499,-0.29114,1,0
3,GO EATING BEHAVIOR,4.7488e-06,-0.21509,-0.25283,1,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.5164e-08,-0.2151,-0.30448,1,0
3,GO OXIDATION REDUCTION PROCESS,5.1101e-09,-0.21519,-0.26655,1,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.2015e-05,-0.2152,-0.22615,1,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00063314,-0.21533,-0.35551,1,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00014129,-0.2157,-0.30128,1,0
3,GO SPERM MOTILITY,4.2444e-07,-0.21575,-0.23526,1,0
3,GO GLUTAMATE METABOLIC PROCESS,2.342e-06,-0.21586,-0.26265,1,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.2926e-08,-0.21588,-0.31197,1,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,3.055e-09,-0.21599,-0.31738,1,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,1.0422e-09,-0.21604,-0.32866,1,0
3,GO MAINTENANCE OF CELL NUMBER,1.6907e-08,-0.21606,-0.33597,1,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,8.4262e-06,-0.21619,-0.25073,1,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0073682,-0.21624,-0.27646,1,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,9.2321e-08,-0.2163,-0.32769,1,0
3,GO SECRETORY GRANULE LOCALIZATION,0.00039018,-0.21635,-0.38292,1,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0023321,-0.21646,-0.23261,1,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.0019285,-0.21655,-0.20218,1,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,5.6245e-08,-0.21697,-0.27284,1,0
3,GO RESPONSE TO ALKALOID,3.5038e-07,-0.21708,-0.28158,1,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,6.8348e-09,-0.21728,-0.35263,1,0
3,GO HISTONE PHOSPHORYLATION,1.5372e-07,-0.21736,-0.27353,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,1.4677e-08,-0.21746,-0.28661,1,0
3,GO MACROAUTOPHAGY,1.5217e-09,-0.21752,-0.32402,1,0
3,GO ORGANIC ACID METABOLIC PROCESS,1.1398e-10,-0.21756,-0.3013,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,8.8389e-07,-0.21762,-0.3517,1,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,3.2057e-05,-0.21765,-0.26404,1,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0019819,-0.2177,-0.18974,1,0
3,GO CIRCADIAN RHYTHM,2.004e-09,-0.2178,-0.33137,1,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,6.2175e-05,-0.21789,-0.27565,1,0
3,GO NERVOUS SYSTEM PROCESS,6.3074e-11,-0.21797,-0.32565,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.3239e-05,-0.21798,-0.31163,1,0
3,GO CELLULAR COMPONENT DISASSEMBLY,1.5217e-09,-0.21833,-0.28832,1,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,1.7309e-08,-0.21866,-0.31541,1,0
3,GO SPERM CAPACITATION,1.1165e-05,-0.2187,-0.24853,1,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,5.6594e-11,-0.2187,-0.29605,1,0
3,GO MUSCLE FIBER DEVELOPMENT,5.2359e-09,-0.21881,-0.34173,1,0
3,GO ENDOSOME ORGANIZATION,1.2058e-07,-0.21887,-0.3023,1,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,4.719e-07,-0.21897,-0.29075,1,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,7.969e-07,-0.21915,-0.31702,1,0
3,GO TELENCEPHALON REGIONALIZATION,0.034984,-0.2192,-0.1973,1,0
3,GO MISMATCH REPAIR,3.2784e-06,-0.21938,-0.25778,1,0
3,GO MICROTUBULE BASED TRANSPORT,6.2046e-07,-0.21988,-0.30359,1,0
3,GO TOR SIGNALING,1.1245e-09,-0.21999,-0.3319,1,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.7282e-08,-0.22009,-0.28779,1,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,4.5684e-06,-0.22025,-0.28403,1,0
3,GO RESPONSE TO COCAINE,4.2271e-06,-0.22038,-0.30418,1,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,4.0678e-07,-0.22039,-0.31908,1,0
3,GO THIOESTER METABOLIC PROCESS,2.4371e-06,-0.22057,-0.26774,1,0
3,GO ORGANIC ACID CATABOLIC PROCESS,1.1533e-09,-0.22067,-0.29947,1,0
3,GO REGULATION OF CATABOLIC PROCESS,5.815e-11,-0.22092,-0.32547,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.6435e-08,-0.22093,-0.31584,1,0
3,GO GLYCINE METABOLIC PROCESS,0.0010259,-0.22123,-0.22379,1,0
3,GO DETECTION OF STIMULUS,7.2964e-10,-0.22161,-0.25834,1,0
3,GO PROTEOLYSIS,3.6667e-12,-0.22161,-0.3337,1,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00019857,-0.22164,-0.24768,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,1.2131e-09,-0.22174,-0.29862,1,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00011596,-0.22211,-0.29948,1,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00035024,-0.22218,-0.26008,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.055e-09,-0.22228,-0.33832,1,0
3,GO PROTEIN TETRAMERIZATION,7.2964e-10,-0.22231,-0.29771,1,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,3.5427e-10,-0.22251,-0.31879,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.8142e-08,-0.22264,-0.28469,1,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,6.8888e-05,-0.22267,-0.21975,1,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00020504,-0.22267,-0.23609,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,6.4805e-11,-0.22276,-0.33882,1,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,6.7724e-05,-0.2229,-0.23305,1,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.0314e-05,-0.22311,-0.30143,1,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00049802,-0.22313,-0.23439,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,1.6158e-05,-0.22323,-0.22289,1,0
3,GO SENSORY PERCEPTION,1.8881e-10,-0.2233,-0.28112,1,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,9.3415e-09,-0.22338,-0.28981,1,0
3,GO ANTEROGRADE AXONAL TRANSPORT,2.2505e-06,-0.22353,-0.34336,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,5.4724e-12,-0.22374,-0.35242,1,0
3,GO CELL CYCLE ARREST,9.3752e-12,-0.2238,-0.34529,1,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00095459,-0.22388,-0.27894,1,0
3,GO INTERACTION WITH SYMBIONT,1.2328e-07,-0.22389,-0.27984,1,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,4.249e-10,-0.22397,-0.29523,1,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,2.004e-09,-0.22403,-0.34124,1,0
3,GO RESPONSE TO HEAT,8.6328e-08,-0.22406,-0.30242,1,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,6.4434e-08,-0.2241,-0.3254,1,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,3.9035e-08,-0.22423,-0.32411,1,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,2.4452e-09,-0.22427,-0.31153,1,0
3,GO CYTOSOLIC TRANSPORT,3.6293e-09,-0.22428,-0.38593,1,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,4.7488e-06,-0.22445,-0.24465,1,0
3,GO POSITIVE REGULATION OF DNA REPAIR,2.2824e-05,-0.22451,-0.27668,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.7693e-06,-0.22459,-0.25738,1,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,8.3013e-05,-0.22499,-0.26715,1,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,1.4487e-10,-0.22504,-0.33955,1,0
3,GO FERTILIZATION,8.5043e-10,-0.22509,-0.27146,1,0
3,GO MULTICELLULAR ORGANISM AGING,6.6066e-07,-0.22526,-0.28928,1,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.0030839,-0.22527,-0.27449,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,3.1479e-07,-0.22529,-0.34,1,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,4.4771e-05,-0.22533,-0.34315,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.7721e-08,-0.22553,-0.3609,1,0
3,GO CYTOKINETIC PROCESS,1.996e-06,-0.22555,-0.29242,1,0
3,GO RESPONSE TO INTERLEUKIN 1,1.7687e-09,-0.22579,-0.28274,1,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,1.9014e-08,-0.22589,-0.27443,1,0
3,GO CD40 SIGNALING PATHWAY,9.795e-06,-0.22612,-0.30453,1,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,8.7316e-05,-0.22615,-0.21429,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0035605,-0.22622,-0.17916,1,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,5.6085e-05,-0.22623,-0.30119,1,0
3,GO REGULATION OF MACROAUTOPHAGY,2.3268e-09,-0.22635,-0.34049,1,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.5922e-10,-0.22669,-0.30788,1,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,7.0279e-11,-0.22673,-0.32809,1,0
3,GO REGULATION OF TOR SIGNALING,1.5604e-09,-0.22683,-0.34981,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,5.6487e-06,-0.22692,-0.28921,1,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00010673,-0.22697,-0.2584,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,6.0759e-07,-0.22722,-0.3428,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,6.8396e-06,-0.22736,-0.28293,1,0
3,GO FATTY ACID BETA OXIDATION,2.5164e-08,-0.22755,-0.32447,1,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.5078e-11,-0.22764,-0.34411,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.77e-09,-0.22774,-0.33175,1,0
3,GO TETRAPYRROLE METABOLIC PROCESS,7.0522e-08,-0.22781,-0.29729,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.342e-06,-0.22786,-0.34495,1,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,1.8701e-05,-0.22805,-0.29998,1,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,4.8673e-09,-0.22816,-0.31311,1,0
3,GO PROTEIN STABILIZATION,2.5066e-09,-0.22822,-0.30005,1,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,2.3268e-09,-0.22828,-0.29893,1,0
3,GO REGULATION OF TRANSPORT,2.9979e-12,-0.22842,-0.35784,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9078e-09,-0.22842,-0.30273,1,0
3,GO CELL AGING,6.4192e-10,-0.22855,-0.31396,1,0
3,GO DIOL METABOLIC PROCESS,0.0001862,-0.22866,-0.29282,1,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,2.8262e-08,-0.22867,-0.29907,1,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,6.3359e-07,-0.22873,-0.31581,1,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,3.3629e-10,-0.22931,-0.31622,1,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.006444,-0.22943,-0.31765,1,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,1.9465e-08,-0.2296,-0.28581,1,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,4.0033e-09,-0.22971,-0.31925,1,0
3,GO RIG I SIGNALING PATHWAY,4.1552e-07,-0.22982,-0.31463,1,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,3.7605e-06,-0.22985,-0.30779,1,0
3,GO DIGESTION,2.2397e-08,-0.22995,-0.2755,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.8369e-09,-0.23018,-0.32966,1,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,2.1807e-07,-0.23029,-0.2742,1,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,6.4592e-06,-0.23045,-0.31555,1,0
3,GO SULFATE TRANSPORT,2.6352e-05,-0.23057,-0.26518,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,1.5293e-05,-0.23059,-0.28584,1,0
3,GO HEME METABOLIC PROCESS,4.4807e-06,-0.23066,-0.32104,1,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,2.6828e-05,-0.23077,-0.28576,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,1.5372e-07,-0.23077,-0.30445,1,0
3,GO VIRAL RELEASE FROM HOST CELL,4.4787e-08,-0.23091,-0.30015,1,0
3,GO PEROXISOMAL TRANSPORT,5.4701e-07,-0.23092,-0.26769,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,1.7534e-07,-0.23132,-0.2918,1,0
3,GO DETOXIFICATION,8.8389e-07,-0.23132,-0.25732,1,0
3,GO RESPONSE TO IONIZING RADIATION,2.5893e-10,-0.2314,-0.32949,1,0
3,GO DENDRITE SELF AVOIDANCE,6.7724e-05,-0.23144,-0.31871,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00029511,-0.23187,-0.24731,1,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,3.8645e-11,-0.23195,-0.32132,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.7125e-10,-0.23215,-0.29719,1,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.0001803,-0.23225,-0.34664,1,0
3,GO HISTONE DEUBIQUITINATION,0.00016098,-0.23227,-0.29412,1,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.00088789,-0.23246,-0.25693,1,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.5674e-06,-0.23253,-0.33133,1,0
3,GO LIVER REGENERATION,7.8976e-09,-0.23261,-0.30341,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,3.6924e-05,-0.23275,-0.25456,1,0
3,GO FC RECEPTOR SIGNALING PATHWAY,7.8778e-10,-0.23291,-0.33221,1,0
3,GO REPRODUCTION,1.5968e-11,-0.23293,-0.32037,1,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.9044e-05,-0.23321,-0.25969,1,0
3,GO HINDBRAIN DEVELOPMENT,6.1583e-08,-0.2335,-0.33792,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,1.3769e-07,-0.2336,-0.28325,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,7.0671e-12,-0.23361,-0.34922,1,0
3,GO FOREBRAIN REGIONALIZATION,0.0013069,-0.23375,-0.24282,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,2.1196e-06,-0.23389,-0.29578,1,0
3,GO REGULATION OF CELL AGING,2.5164e-08,-0.23402,-0.31442,1,0
3,GO FEVER GENERATION,2.6828e-05,-0.23408,-0.19229,1,0
3,GO ACTIN NUCLEATION,5.02e-08,-0.23413,-0.30793,1,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.3133e-11,-0.23415,-0.3289,1,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.5604e-09,-0.23419,-0.34408,1,0
3,GO DIGESTIVE SYSTEM PROCESS,1.6407e-09,-0.23431,-0.3032,1,0
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00029976,-0.23433,-0.29526,1,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00012186,-0.23434,-0.29798,1,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.0027381,-0.23443,-0.36152,1,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00010673,-0.23451,-0.26871,1,0
3,GO ORGANIC ACID TRANSPORT,2.1543e-10,-0.23462,-0.33885,1,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,2.0546e-09,-0.2348,-0.30041,1,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,2.3467e-08,-0.23493,-0.337,1,0
3,GO PIGMENT METABOLIC PROCESS,3.2859e-07,-0.23498,-0.29838,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,1.5372e-07,-0.2351,-0.24643,1,0
3,GO NEURAL TUBE PATTERNING,2.1375e-08,-0.23524,-0.34192,1,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00075607,-0.23547,-0.2799,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,8.0424e-11,-0.23547,-0.35584,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.026561,-0.2355,-0.2734,1,0
3,GO NUCLEOTIDE TRANSPORT,1.2328e-07,-0.23557,-0.328,1,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00034485,-0.23572,-0.26682,1,0
3,GO NADP METABOLIC PROCESS,4.6578e-06,-0.23582,-0.30468,1,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,2.7614e-08,-0.23582,-0.36623,1,0
3,GO CELLULAR RESPONSE TO UV,5.3747e-08,-0.23599,-0.31606,1,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,1.5014e-05,-0.23604,-0.3234,1,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,2.5756e-08,-0.23615,-0.30541,1,0
3,GO PYRUVATE METABOLIC PROCESS,2.7668e-07,-0.23619,-0.32463,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,7.9617e-06,-0.2362,-0.28174,1,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,3.6586e-11,-0.23637,-0.31292,1,0
3,GO RHYTHMIC PROCESS,7.4177e-11,-0.23637,-0.34817,1,0
3,GO CELLULAR HOMEOSTASIS,7.0671e-12,-0.2364,-0.32362,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.9175e-06,-0.23648,-0.34737,1,0
3,GO STRESS GRANULE ASSEMBLY,0.00011596,-0.23663,-0.30017,1,0
3,GO CELL CELL SIGNALING,1.3888e-11,-0.23669,-0.35573,1,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.00017457,-0.23674,-0.25332,1,0
3,GO ARACHIDONIC ACID SECRETION,6.8396e-06,-0.2371,-0.29648,1,0
3,GO DEPHOSPHORYLATION,4.0817e-11,-0.23715,-0.3485,1,0
3,GO PROTEIN AUTOUBIQUITINATION,1.1533e-09,-0.23725,-0.31407,1,0
3,GO COPII COATED VESICLE BUDDING,3.2764e-10,-0.23751,-0.33136,1,0
3,GO RETINA HOMEOSTASIS,2.8925e-08,-0.23754,-0.21943,1,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,1.3039e-08,-0.23755,-0.29462,1,0
3,GO O GLYCAN PROCESSING,2.7078e-07,-0.23758,-0.37721,1,0
3,GO T CELL APOPTOTIC PROCESS,1.6782e-07,-0.23762,-0.30778,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,5.4701e-07,-0.2377,-0.29069,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1.725e-09,-0.23771,-0.31165,1,0
3,GO REGULATION OF INSULIN SECRETION,1.6907e-08,-0.23783,-0.33729,1,0
3,GO HOMEOSTATIC PROCESS,1.4092e-12,-0.23794,-0.33958,1,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.0050269,-0.23815,-0.21325,1,0
3,GO CELLULAR RESPONSE TO RADIATION,1.7687e-09,-0.23822,-0.2984,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.0657e-06,-0.23831,-0.3291,1,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,1.5386e-08,-0.23841,-0.31813,1,0
3,GO REGULATION OF PROTEIN STABILITY,1.1245e-09,-0.23854,-0.30806,1,0
3,GO CELLULAR RESPONSE TO ALKALOID,8.4262e-06,-0.23864,-0.2519,1,0
3,GO BILE ACID METABOLIC PROCESS,1.0212e-06,-0.239,-0.29767,1,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,2.4837e-07,-0.23905,-0.34298,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00082553,-0.23909,-0.31986,1,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,2.4305e-07,-0.23922,-0.303,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.5822e-08,-0.23923,-0.31743,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,8.6579e-07,-0.23929,-0.27061,1,0
3,GO REGULATION OF MRNA 3 END PROCESSING,4.1552e-07,-0.23934,-0.31776,1,0
3,GO RESPONSE TO CHEMOKINE,1.9905e-10,-0.23937,-0.27738,1,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,9.2585e-06,-0.23955,-0.2716,1,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.8673e-09,-0.23962,-0.30099,1,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00015083,-0.23968,-0.25535,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,9.404e-07,-0.24019,-0.32476,1,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00011986,-0.2402,-0.26167,1,0
3,GO SPLEEN DEVELOPMENT,3.1729e-08,-0.24033,-0.31284,1,0
3,GO NEUROTRANSMITTER SECRETION,1.7071e-05,-0.24046,-0.32337,1,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,2.7041e-11,-0.2406,-0.36907,1,0
3,GO VITAMIN METABOLIC PROCESS,1.3085e-09,-0.24065,-0.30562,1,0
3,GO RESPONSE TO ABIOTIC STIMULUS,1.785e-11,-0.24065,-0.33056,1,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,2.2707e-10,-0.24119,-0.36438,1,0
3,GO GOLGI VESICLE BUDDING,6.4192e-10,-0.24128,-0.34174,1,0
3,GO RESPONSE TO AUDITORY STIMULUS,7.2497e-05,-0.24133,-0.37014,1,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00012594,-0.24139,-0.21147,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,1.9175e-06,-0.24154,-0.37601,1,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,1.155e-06,-0.24154,-0.33401,1,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,4.2271e-06,-0.2417,-0.30812,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.6062e-07,-0.24181,-0.27915,1,0
3,GO PROTEIN AUTOPROCESSING,5.6085e-05,-0.2419,-0.23488,1,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.7411e-08,-0.24201,-0.32479,1,0
3,GO PHOSPHATE ION TRANSPORT,3.2162e-07,-0.24201,-0.29758,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,4.0657e-06,-0.24211,-0.29339,1,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0046604,-0.24217,-0.25898,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,9.4157e-10,-0.24222,-0.35725,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.2143e-08,-0.24227,-0.32025,1,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,7.479e-12,-0.24233,-0.29125,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,7.71e-09,-0.24246,-0.31592,1,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,3.6361e-10,-0.24251,-0.27272,1,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,1.2328e-07,-0.24255,-0.33799,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,7.3803e-06,-0.24256,-0.26701,1,0
3,GO LYTIC VACUOLE ORGANIZATION,4.2784e-08,-0.24256,-0.36201,1,0
3,GO MITOCHONDRION DISTRIBUTION,1.6321e-06,-0.24263,-0.34956,1,0
3,GO REGULATION OF HISTONE METHYLATION,7.6657e-06,-0.24265,-0.29182,1,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.0012005,-0.24266,-0.25806,1,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,8.3013e-05,-0.24268,-0.30567,1,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.4305e-07,-0.243,-0.42552,1,0
3,GO PROTEIN HOMOTETRAMERIZATION,6.4192e-10,-0.24338,-0.30748,1,0
3,GO TRANSMEMBRANE TRANSPORT,1.736e-11,-0.24342,-0.32454,1,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0062877,-0.24366,-0.16887,1,0
3,GO DE NOVO PROTEIN FOLDING,0.00059648,-0.24367,-0.24199,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,3.3806e-05,-0.24374,-0.30306,1,0
3,GO DETECTION OF ABIOTIC STIMULUS,7.7166e-08,-0.24376,-0.29129,1,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00022927,-0.24381,-0.26489,1,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,9.5677e-09,-0.24385,-0.35617,1,0
3,GO ANDROGEN METABOLIC PROCESS,0.003166,-0.2439,-0.21742,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0026663,-0.244,-0.33949,1,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,4.2487e-05,-0.24403,-0.24225,1,0
3,GO FATTY ACID TRANSPORT,3.2764e-10,-0.24407,-0.34463,1,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,6.1119e-05,-0.24417,-0.25074,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,5.3256e-05,-0.24424,-0.28639,1,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.00055343,-0.24451,-0.24905,1,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,3.192e-10,-0.24458,-0.3131,1,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.1751e-05,-0.24511,-0.32803,1,0
3,GO REGULATION OF MICROTUBULE BINDING,0.00090088,-0.24515,-0.30929,1,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,1.3442e-05,-0.24524,-0.33634,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,1.2716e-05,-0.24528,-0.34381,1,0
3,GO MACROMOLECULE DEACYLATION,2.0881e-08,-0.24534,-0.33229,1,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.0395e-05,-0.24541,-0.23528,1,0
3,GO PROTEIN DESTABILIZATION,8.2864e-09,-0.24543,-0.35479,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,2.1595e-09,-0.24554,-0.32152,1,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,2.1234e-05,-0.24558,-0.21044,1,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,1.1828e-09,-0.2456,-0.32958,1,0
3,GO REGULATION OF SECRETION,4.6784e-11,-0.24565,-0.34994,1,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.8301e-10,-0.24569,-0.32773,1,0
3,GO HEAD DEVELOPMENT,9.4157e-10,-0.24571,-0.35719,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.2792e-06,-0.24577,-0.29915,1,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,1.9387e-10,-0.24586,-0.33049,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,2.1085e-11,-0.24591,-0.34726,1,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,4.6784e-11,-0.24599,-0.35421,1,0
3,GO RESPONSE TO MUSCLE ACTIVITY,5.4184e-05,-0.24613,-0.29898,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0010259,-0.2462,-0.28792,1,0
3,GO LIPOPROTEIN METABOLIC PROCESS,1.0241e-10,-0.2462,-0.3388,1,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,4.5239e-09,-0.24636,-0.30943,1,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00015583,-0.24668,-0.25561,1,0
3,GO VESICLE CARGO LOADING,1.2027e-05,-0.24672,-0.34418,1,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.5713e-07,-0.24691,-0.32605,1,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,9.4157e-10,-0.24708,-0.38086,1,0
3,GO ADULT BEHAVIOR,6.8885e-07,-0.24714,-0.32859,1,0
3,GO KERATINIZATION,0.0012527,-0.24715,-0.22797,1,0
3,GO REFLEX,0.0067673,-0.24718,-0.33644,1,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00033955,-0.24723,-0.28099,1,0
3,GO CELL CELL RECOGNITION,5.8856e-08,-0.24734,-0.26257,1,0
3,GO DENDRITE EXTENSION,0.0015463,-0.24757,-0.25532,1,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.7582e-06,-0.24779,-0.31477,1,0
3,GO REGULATION OF HISTONE MODIFICATION,3.5606e-08,-0.24793,-0.3094,1,0
3,GO CELLULAR SENESCENCE,1.2143e-08,-0.24799,-0.30489,1,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,3.5022e-05,-0.24836,-0.31414,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,4.3549e-12,-0.24855,-0.35214,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.342e-06,-0.24856,-0.39697,1,0
3,GO CELLULAR OXIDANT DETOXIFICATION,7.71e-09,-0.24857,-0.26917,1,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,5.3602e-11,-0.24869,-0.35307,1,0
3,GO INTERLEUKIN 2 PRODUCTION,3.6293e-09,-0.24872,-0.34244,1,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0025277,-0.24877,-0.18175,1,0
3,GO RESPONSE TO GAMMA RADIATION,1.1858e-08,-0.24878,-0.32529,1,0
3,GO HISTONE H3 K9 METHYLATION,5.8049e-05,-0.24878,-0.32291,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.7923e-10,-0.24878,-0.32961,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,2.2707e-10,-0.24884,-0.34748,1,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,8.7502e-06,-0.24884,-0.32191,1,0
3,GO BRAIN MORPHOGENESIS,5.7051e-07,-0.24894,-0.33233,1,0
3,GO SIGNAL RELEASE,5.2359e-09,-0.24909,-0.33057,1,0
3,GO HISTONE H3 K9 MODIFICATION,1.0557e-05,-0.24912,-0.31457,1,0
3,GO VACUOLAR TRANSPORT,2.457e-10,-0.2493,-0.37772,1,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,1.3769e-07,-0.24941,-0.35572,1,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.8001e-06,-0.24941,-0.29524,1,0
3,GO GLUCOSE METABOLIC PROCESS,7.1726e-09,-0.24943,-0.3492,1,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,6.205e-09,-0.2495,-0.34077,1,0
3,GO SODIUM ION HOMEOSTASIS,1.5037e-07,-0.24967,-0.29045,1,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.1245e-09,-0.24982,-0.28765,1,0
3,GO RESPONSE TO UV C,9.9844e-05,-0.24986,-0.28597,1,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,1.2534e-06,-0.24991,-0.28707,1,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.0279e-08,-0.24997,-0.28485,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,4.0033e-09,-0.25014,-0.37975,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,7.1819e-07,-0.25016,-0.29249,1,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.9872e-06,-0.25022,-0.30183,1,0
3,GO POSITIVE REGULATION OF TRANSPORT,1.5383e-12,-0.25035,-0.37263,1,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,3.1896e-11,-0.25036,-0.3247,1,0
3,GO ER OVERLOAD RESPONSE,0.00060545,-0.25037,-0.25547,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.00013016,-0.25045,-0.29186,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.9069e-08,-0.2505,-0.33908,1,0
3,GO RESPONSE TO UV,5.6317e-09,-0.25052,-0.32078,1,0
3,GO REGULATION OF CELLULAR LOCALIZATION,8.3747e-12,-0.25059,-0.36475,1,0
3,GO PEPTIDE HORMONE SECRETION,1.3769e-07,-0.25073,-0.32692,1,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,1.2434e-08,-0.25108,-0.31971,1,0
3,GO CARBOHYDRATE METABOLIC PROCESS,1.7442e-10,-0.25112,-0.34303,1,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0015249,-0.25125,-0.25654,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,4.3606e-10,-0.25132,-0.36146,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.725e-09,-0.25141,-0.35098,1,0
3,GO REGULATION OF CELL CYCLE ARREST,1.6782e-07,-0.25144,-0.28082,1,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,3.3806e-05,-0.25167,-0.31455,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,8.6328e-08,-0.25173,-0.30926,1,0
3,GO LIPID EXPORT FROM CELL,5.6245e-08,-0.25174,-0.31275,1,0
3,GO AXONEME ASSEMBLY,4.1751e-05,-0.25177,-0.26927,1,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.332e-06,-0.25178,-0.34343,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,7.4873e-07,-0.25179,-0.35793,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.2886e-07,-0.25199,-0.36481,1,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,8.0898e-09,-0.25208,-0.3347,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.3639e-12,-0.25231,-0.32572,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,2.1807e-07,-0.25236,-0.31709,1,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,9.9705e-11,-0.25238,-0.30102,1,0
3,GO AUTOPHAGIC CELL DEATH,3.9872e-06,-0.25239,-0.32003,1,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,1.0422e-09,-0.25243,-0.33063,1,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.4837e-07,-0.25257,-0.34261,1,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,1.1282e-07,-0.25257,-0.29377,1,0
3,GO LIPID BIOSYNTHETIC PROCESS,3.1098e-10,-0.25264,-0.3278,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,1.277e-11,-0.25268,-0.32876,1,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00013451,-0.2527,-0.2692,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,4.7172e-05,-0.25278,-0.24601,1,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,7.8778e-10,-0.25283,-0.34822,1,0
3,GO PROTEIN HOMOOLIGOMERIZATION,1.736e-11,-0.25284,-0.32518,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,5.3647e-09,-0.25287,-0.33805,1,0
3,GO NUCLEOTIDE PHOSPHORYLATION,2.1338e-07,-0.25316,-0.31735,1,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,7.0017e-09,-0.25326,-0.32133,1,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,7.6446e-07,-0.25352,-0.27447,1,0
3,GO ATP TRANSPORT,1.9465e-08,-0.25356,-0.34478,1,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,3.6567e-07,-0.25362,-0.31337,1,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.0712e-08,-0.25367,-0.27216,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,1.8881e-10,-0.25369,-0.34381,1,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00010323,-0.25371,-0.33155,1,0
3,GO HEAT GENERATION,1.6321e-06,-0.25373,-0.2487,1,0
3,GO ALCOHOL CATABOLIC PROCESS,4.5239e-09,-0.25386,-0.32857,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,4.0817e-11,-0.25386,-0.35463,1,0
3,GO LEYDIG CELL DIFFERENTIATION,0.00035024,-0.25411,-0.39458,1,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,9.5999e-07,-0.25412,-0.26454,1,0
3,GO APOPTOTIC PROCESS,8.0609e-13,-0.25424,-0.35678,1,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0020092,-0.25428,-0.31714,1,0
3,GO MUSCLE CELL DIFFERENTIATION,5.6304e-12,-0.25429,-0.39533,1,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.003607,-0.25443,-0.23395,1,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.011678,-0.25453,-0.35178,1,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,9.4157e-10,-0.25453,-0.33976,1,0
3,GO VIRAL LIFE CYCLE,1.2682e-10,-0.25459,-0.36526,1,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0062108,-0.25484,-0.24361,1,0
3,GO ERYTHROCYTE MATURATION,3.5038e-07,-0.25496,-0.37347,1,0
3,GO CHEMOSENSORY BEHAVIOR,3.2162e-07,-0.25502,-0.26449,1,0
3,GO IRON ION TRANSPORT,1.7687e-09,-0.25505,-0.30457,1,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,7.2202e-11,-0.25509,-0.31573,1,0
3,GO NEUROTRANSMITTER TRANSPORT,5.2303e-06,-0.25513,-0.32589,1,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.174e-11,-0.25515,-0.36259,1,0
3,GO RETINOL METABOLIC PROCESS,7.105e-06,-0.25518,-0.25963,1,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,3.0905e-06,-0.25522,-0.34319,1,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,5.1101e-09,-0.25523,-0.25552,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.7668e-07,-0.25524,-0.31273,1,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.0279e-08,-0.25535,-0.35377,1,0
3,GO PROSTAGLANDIN SECRETION,1.996e-06,-0.25536,-0.28581,1,0
3,GO CYTOSKELETON ORGANIZATION,3.7735e-12,-0.2554,-0.39542,1,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,1.7442e-10,-0.25541,-0.34979,1,0
3,GO IMMUNOGLOBULIN SECRETION,1.1282e-07,-0.25542,-0.35105,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,2.8886e-07,-0.25564,-0.34327,1,0
3,GO POSITIVE REGULATION OF SECRETION,6.8406e-11,-0.25609,-0.35045,1,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,3.1098e-10,-0.25623,-0.32769,1,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.00025215,-0.25624,-0.26461,1,0
3,GO MACROPHAGE MIGRATION,3.6293e-09,-0.25634,-0.35904,1,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,1.6109e-10,-0.25634,-0.33872,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.2303e-06,-0.25634,-0.33986,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,5.6317e-09,-0.25635,-0.30504,1,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,1.1398e-10,-0.25636,-0.37666,1,0
3,GO NEURON DEATH,1.887e-11,-0.25644,-0.3722,1,0
3,GO ION TRANSPORT,7.9144e-12,-0.25664,-0.34379,1,0
3,GO NEURAL RETINA DEVELOPMENT,3.2162e-07,-0.25665,-0.34756,1,0
3,GO LIPID DIGESTION,0.00022927,-0.25675,-0.3582,1,0
3,GO ADULT HEART DEVELOPMENT,0.0029256,-0.25681,-0.26475,1,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,3.8924e-05,-0.25692,-0.28426,1,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,6.1583e-08,-0.25714,-0.33055,1,0
3,GO CELLULAR DEFENSE RESPONSE,7.7166e-08,-0.25726,-0.31196,1,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,6.5906e-08,-0.25731,-0.33187,1,0
3,GO INSULIN SECRETION,3.9035e-08,-0.25743,-0.33763,1,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.6129e-08,-0.25743,-0.36919,1,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,2.5893e-10,-0.25744,-0.35066,1,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,8.3013e-05,-0.25745,-0.32832,1,0
3,GO ETHER METABOLIC PROCESS,1.1086e-06,-0.25776,-0.32266,1,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,6.4434e-08,-0.25778,-0.39625,1,0
3,GO HUMORAL IMMUNE RESPONSE,4.249e-10,-0.25779,-0.34361,1,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,3.1494e-05,-0.25799,-0.31421,1,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,4.1948e-11,-0.25824,-0.32498,1,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,1.0279e-08,-0.25828,-0.34218,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,3.1312e-09,-0.25839,-0.38621,1,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,1.736e-11,-0.25846,-0.35909,1,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,9.6562e-05,-0.2586,-0.2598,1,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.7442e-10,-0.25862,-0.38141,1,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,9.4407e-08,-0.25862,-0.3212,1,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.8142e-08,-0.25869,-0.37858,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,2.2505e-06,-0.25872,-0.26618,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,3.2785e-11,-0.2588,-0.35427,1,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,1.6782e-07,-0.25891,-0.28547,1,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.801e-10,-0.25893,-0.3133,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.6823e-09,-0.25896,-0.33072,1,0
3,GO CATION TRANSPORT,3.019e-11,-0.25898,-0.33892,1,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,6.757e-10,-0.259,-0.35392,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,9.4341e-06,-0.25902,-0.33932,1,0
3,GO RESPONSE TO MANGANESE ION,3.247e-08,-0.25909,-0.34915,1,0
3,GO REGULATION OF GLUCOSE IMPORT,3.1729e-08,-0.25929,-0.33885,1,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,4.5526e-11,-0.2593,-0.31683,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.0557e-05,-0.25932,-0.29795,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,8.6579e-07,-0.25943,-0.29877,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.030994,-0.25959,-0.21658,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,1.8573e-08,-0.2599,-0.34984,1,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,5.5016e-10,-0.26008,-0.35746,1,0
3,GO STARTLE RESPONSE,0.0013255,-0.26012,-0.26298,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,9.9064e-10,-0.26017,-0.34174,1,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,4.1815e-08,-0.26026,-0.2975,1,0
3,GO INTERLEUKIN 10 PRODUCTION,1.6994e-06,-0.26044,-0.30248,1,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,2.2416e-05,-0.26054,-0.292,1,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,9.7068e-11,-0.26063,-0.34784,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5217e-09,-0.26076,-0.32914,1,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,6.7461e-07,-0.26093,-0.3646,1,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,3.9963e-12,-0.26101,-0.39069,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,1.7721e-08,-0.26109,-0.32933,1,0
3,GO MULTICELLULAR ORGANISM GROWTH,2.4893e-11,-0.2611,-0.40802,1,0
3,GO ANION TRANSPORT,1.2417e-11,-0.26123,-0.35018,1,0
3,GO CELL MATURATION,2.9515e-10,-0.26139,-0.33101,1,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.8673e-09,-0.26143,-0.37358,1,0
3,GO ACROSOME REACTION,3.6877e-06,-0.26153,-0.33426,1,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,5.3747e-08,-0.26162,-0.29848,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.1494e-05,-0.26171,-0.24368,1,0
3,GO RESPONSE TO NITROGEN COMPOUND,1.8863e-12,-0.26179,-0.37128,1,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.3747e-12,-0.2618,-0.39571,1,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0001179,-0.26211,-0.29194,1,0
3,GO UV DAMAGE EXCISION REPAIR,8.8389e-07,-0.26221,-0.3057,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,2.0437e-10,-0.26231,-0.33768,1,0
3,GO REGULATION OF NEURON MATURATION,6.4592e-06,-0.26246,-0.36342,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,1.1041e-08,-0.26249,-0.31499,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,8.0815e-10,-0.26258,-0.38996,1,0
3,GO ACTIN CROSSLINK FORMATION,4.9872e-09,-0.26265,-0.4732,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,4.2784e-08,-0.26269,-0.31251,1,0
3,GO CELLULAR ION HOMEOSTASIS,3.8833e-12,-0.26269,-0.3346,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.2023e-10,-0.26276,-0.35897,1,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.6407e-09,-0.26287,-0.33108,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,2.5934e-07,-0.26305,-0.3457,1,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,7.0072e-05,-0.26331,-0.22903,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,3.1479e-07,-0.26341,-0.32048,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,3.758e-05,-0.26343,-0.27705,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.6581e-10,-0.26344,-0.3372,1,0
3,GO REGULATION OF ANION TRANSPORT,3.9309e-10,-0.26347,-0.34134,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.1858e-08,-0.26356,-0.34747,1,0
3,GO ETHANOL OXIDATION,0.00030928,-0.26371,-0.37705,1,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,2.1543e-10,-0.26385,-0.33089,1,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,2.1624e-06,-0.26389,-0.29456,1,0
3,GO REGULATION OF ATP METABOLIC PROCESS,1.4677e-08,-0.26389,-0.31689,1,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.1375e-05,-0.26396,-0.36236,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,4.7963e-08,-0.26397,-0.42427,1,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,1.475e-06,-0.26408,-0.32743,1,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,6.9522e-13,-0.26413,-0.37618,1,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,1.9064e-09,-0.26416,-0.33671,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,5.9602e-12,-0.26424,-0.35794,1,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,5.9498e-07,-0.2643,-0.34374,1,0
3,GO PALLIUM DEVELOPMENT,1.1086e-06,-0.26434,-0.31791,1,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.2328e-07,-0.26443,-0.31605,1,0
3,GO FATTY ACID CATABOLIC PROCESS,1.3039e-08,-0.26458,-0.32618,1,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,4.3549e-12,-0.26466,-0.39804,1,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.5461e-06,-0.26471,-0.2693,1,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.00016098,-0.26474,-0.27144,1,0
3,GO RUFFLE ASSEMBLY,1.3671e-08,-0.26476,-0.38018,1,0
3,GO CELLULAR LIPID METABOLIC PROCESS,1.174e-11,-0.26476,-0.34294,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00016361,-0.26484,-0.29839,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,8.3066e-07,-0.26493,-0.27202,1,0
3,GO VIRAL RNA GENOME REPLICATION,3.6567e-07,-0.26495,-0.32751,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,5.77e-09,-0.26497,-0.33176,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,2.7078e-07,-0.26509,-0.33814,1,0
3,GO RRNA CATABOLIC PROCESS,9.6129e-06,-0.26509,-0.28887,1,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00022927,-0.26511,-0.23271,1,0
3,GO METAL ION TRANSPORT,1.4282e-11,-0.26524,-0.34387,1,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,6.586e-10,-0.26533,-0.2967,1,0
3,GO FOREBRAIN DEVELOPMENT,1.2733e-08,-0.26542,-0.35451,1,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,3.9941e-08,-0.26543,-0.3734,1,0
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,3.1494e-05,-0.26546,-0.25948,1,0
3,GO ADULT LOCOMOTORY BEHAVIOR,1.5052e-06,-0.26546,-0.32131,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00039622,-0.26548,-0.38671,1,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,4.1815e-08,-0.26562,-0.33345,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.5906e-08,-0.26567,-0.35496,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.0094e-07,-0.26576,-0.37526,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,8.4877e-09,-0.26593,-0.34603,1,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,3.0296e-10,-0.26607,-0.30871,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,1.0791e-07,-0.26631,-0.32967,1,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,1.5968e-11,-0.26635,-0.39529,1,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00024045,-0.26643,-0.29475,1,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,1.0519e-10,-0.26645,-0.36675,1,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,4.0678e-07,-0.26651,-0.29347,1,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,6.6717e-09,-0.26652,-0.35602,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.815e-11,-0.26665,-0.35269,1,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,2.6306e-11,-0.26668,-0.40288,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,1.3737e-10,-0.26672,-0.35169,1,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,2.8925e-08,-0.26675,-0.30053,1,0
3,GO RESPONSE TO MONOSACCHARIDE,6.6581e-11,-0.26678,-0.38207,1,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,3.4098e-06,-0.26681,-0.31363,1,0
3,GO ASSOCIATIVE LEARNING,6.895e-08,-0.26681,-0.34488,1,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,1.2534e-12,-0.26684,-0.40249,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,3.1757e-12,-0.26696,-0.38504,1,0
3,GO ECTODERM DEVELOPMENT,3.1312e-09,-0.26697,-0.31678,1,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,1.5372e-07,-0.26699,-0.33104,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,2.8925e-08,-0.26699,-0.34536,1,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,1.0792e-11,-0.26702,-0.38649,1,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,4.0657e-06,-0.26706,-0.34437,1,0
3,GO MICROTUBULE DEPOLYMERIZATION,1.0958e-05,-0.26706,-0.35574,1,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,1.451e-12,-0.26707,-0.38177,1,0
3,GO ER NUCLEUS SIGNALING PATHWAY,5.1304e-06,-0.26713,-0.30986,1,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,4.4148e-09,-0.26716,-0.35217,1,0
3,GO SECRETION,1.942e-12,-0.26721,-0.37016,1,0
3,GO ORGANELLE FUSION,2.5756e-08,-0.2673,-0.35792,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.1793e-10,-0.2674,-0.37735,1,0
3,GO HEPATOCYTE DIFFERENTIATION,1.8032e-05,-0.2675,-0.28681,1,0
3,GO COPII COATED VESICLE CARGO LOADING,3.6877e-06,-0.26771,-0.35715,1,0
3,GO VESICLE ORGANIZATION,1.642e-11,-0.26786,-0.38408,1,0
3,GO PROTEIN MATURATION,3.1032e-11,-0.26795,-0.3385,1,0
3,GO REGULATION OF PROTEIN IMPORT,1.8135e-09,-0.26802,-0.36569,1,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,1.451e-12,-0.26807,-0.40205,1,0
3,GO ION HOMEOSTASIS,1.8863e-12,-0.26821,-0.34822,1,0
3,GO EPITHELIUM DEVELOPMENT,8.1414e-12,-0.2683,-0.38892,1,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,4.9694e-05,-0.26835,-0.32764,1,0
3,GO EAR DEVELOPMENT,9.5677e-09,-0.26838,-0.33646,1,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,3.5597e-11,-0.26847,-0.36894,1,0
3,GO FEAR RESPONSE,1.1579e-08,-0.26855,-0.30987,1,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,5.8049e-05,-0.26856,-0.30053,1,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,3.4296e-07,-0.2687,-0.31171,1,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,9.1996e-11,-0.26878,-0.33804,1,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,5.4701e-07,-0.26912,-0.31721,1,0
3,GO PEPTIDE SECRETION,5.5078e-11,-0.26913,-0.3655,1,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.4091e-05,-0.26922,-0.35497,1,0
3,GO PATTERN SPECIFICATION PROCESS,6.586e-10,-0.26925,-0.34936,1,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,1.0527e-08,-0.26926,-0.34614,1,0
3,GO RESPONSE TO INTERLEUKIN 7,1.5372e-07,-0.26948,-0.33866,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.815e-11,-0.26951,-0.37184,1,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.6792e-10,-0.26985,-0.35969,1,0
3,GO MACROPHAGE CHEMOTAXIS,1.5027e-08,-0.26997,-0.33397,1,0
3,GO FATTY ACID METABOLIC PROCESS,6.4805e-11,-0.27001,-0.3229,1,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,2.5695e-09,-0.27004,-0.3116,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00072342,-0.2701,-0.3118,1,0
3,GO REGULATION OF HORMONE LEVELS,1.6823e-09,-0.27017,-0.32044,1,0
3,GO POSITIVE REGULATION OF SIGNALING,6.3604e-13,-0.27024,-0.37798,1,0
3,GO RESPONSE TO DSRNA,1.3174e-07,-0.27042,-0.3445,1,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,1.5102e-11,-0.27044,-0.33485,1,0
3,GO LEFT RIGHT PATTERN FORMATION,1.8363e-05,-0.27046,-0.32169,1,0
3,GO ORGANIC ANION TRANSPORT,2.2286e-11,-0.27046,-0.35444,1,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,8.4871e-11,-0.27048,-0.3567,1,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,3.3435e-06,-0.27049,-0.314,1,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,4.3774e-08,-0.2705,-0.30506,1,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,4.4302e-11,-0.27053,-0.36364,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,1.785e-11,-0.27057,-0.36145,1,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,4.31e-06,-0.27073,-0.33384,1,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,9.3415e-09,-0.27073,-0.37325,1,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0013255,-0.27106,-0.36514,1,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,4.4285e-07,-0.27111,-0.28403,1,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,7.598e-13,-0.27126,-0.38338,1,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,6.6581e-11,-0.27131,-0.33596,1,0
3,GO CALCIUM MEDIATED SIGNALING,1.0202e-11,-0.27153,-0.31389,1,0
3,GO LIMBIC SYSTEM DEVELOPMENT,9.8716e-08,-0.27155,-0.3321,1,0
3,GO L GLUTAMATE IMPORT,3.9941e-08,-0.27158,-0.34035,1,0
3,GO LIPID OXIDATION,1.1706e-10,-0.2717,-0.34133,1,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,2.4837e-07,-0.27172,-0.31228,1,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,8.9558e-11,-0.27173,-0.34733,1,0
3,GO HORMONE TRANSPORT,2.2397e-08,-0.27177,-0.32575,1,0
3,GO RESPONSE TO PEPTIDE HORMONE,2.7494e-12,-0.27181,-0.3947,1,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,5.8698e-06,-0.27194,-0.32857,1,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,8.0609e-13,-0.27201,-0.4001,1,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,6.1321e-12,-0.27204,-0.33788,1,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,7.3803e-06,-0.27207,-0.31912,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,1.2907e-12,-0.27213,-0.39476,1,0
3,GO RESPONSE TO PEPTIDE,8.8075e-13,-0.27223,-0.40641,1,0
3,GO RESPONSE TO TOXIC SUBSTANCE,1.4107e-10,-0.27232,-0.30288,1,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.7721e-08,-0.27242,-0.31716,1,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,1.9064e-09,-0.27245,-0.32605,1,0
3,GO RNA DESTABILIZATION,6.0991e-06,-0.27251,-0.33553,1,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00011406,-0.27255,-0.33444,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00026438,-0.27259,-0.33055,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1041e-08,-0.27268,-0.40682,1,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00029976,-0.27281,-0.32198,1,0
3,GO ANATOMICAL STRUCTURE MATURATION,1.174e-11,-0.27282,-0.36543,1,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,8.1361e-07,-0.2729,-0.38169,1,0
3,GO HEXOSE CATABOLIC PROCESS,1.8701e-05,-0.27292,-0.31765,1,0
3,GO NEGATIVE REGULATION OF TRANSPORT,1.6307e-12,-0.27297,-0.3408,1,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00028155,-0.27298,-0.34943,1,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,1.5027e-08,-0.27304,-0.3406,1,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,5.6451e-10,-0.27306,-0.38156,1,0
3,GO MANGANESE ION TRANSPORT,5.6487e-06,-0.27309,-0.27244,1,0
3,GO PEPTIDYL SERINE MODIFICATION,3.3639e-12,-0.27312,-0.40255,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,1.9989e-07,-0.27319,-0.3571,1,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,7.1613e-13,-0.27323,-0.38971,1,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,1.0792e-11,-0.27337,-0.39327,1,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.7494e-12,-0.2734,-0.39809,1,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,1.9905e-10,-0.2734,-0.36165,1,0
3,GO ANION TRANSMEMBRANE TRANSPORT,5.5078e-11,-0.27342,-0.35034,1,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,2.634e-09,-0.27348,-0.34454,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0017517,-0.27354,-0.30679,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00027716,-0.27361,-0.33173,1,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,6.895e-08,-0.27382,-0.32165,1,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,2.0478e-05,-0.27392,-0.35092,1,0
3,GO CATECHOLAMINE METABOLIC PROCESS,7.5217e-06,-0.27397,-0.31537,1,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,2.4586e-08,-0.27402,-0.36124,1,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,3.1004e-08,-0.27405,-0.3681,1,0
3,GO STEROL METABOLIC PROCESS,3.3713e-09,-0.27406,-0.33659,1,0
3,GO MUSCLE CELL FATE COMMITMENT,3.2146e-06,-0.27408,-0.31462,1,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,1.7922e-07,-0.27412,-0.31796,1,0
3,GO CIRCULATORY SYSTEM PROCESS,1.182e-12,-0.2742,-0.40521,1,0
3,GO T CELL SELECTION,5.3562e-07,-0.27423,-0.28868,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0078263,-0.27429,-0.26152,1,0
3,GO NUCLEOTIDE SALVAGE,0.0011503,-0.27442,-0.25501,1,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,1.0422e-09,-0.27444,-0.35752,1,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.3888e-11,-0.27449,-0.33061,1,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,2.011e-05,-0.27452,-0.27207,1,0
3,GO REGULATION OF PROTEIN TARGETING,7.4854e-10,-0.27454,-0.34654,1,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,3.6162e-06,-0.27457,-0.32746,1,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,3.6667e-12,-0.27467,-0.36691,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4107e-10,-0.27478,-0.33158,1,0
3,GO ACTIVATION OF MAPK ACTIVITY,9.6219e-13,-0.27481,-0.42312,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.2775e-07,-0.27489,-0.39721,1,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,6.4592e-06,-0.27491,-0.33443,1,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.4686e-11,-0.27492,-0.38104,1,0
3,GO REGULATION OF PEPTIDE SECRETION,7.4177e-11,-0.27498,-0.36055,1,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,7.71e-09,-0.27511,-0.34715,1,0
3,GO HINDBRAIN MORPHOGENESIS,3.8161e-07,-0.27516,-0.325,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.71e-09,-0.27523,-0.34279,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.8611e-12,-0.27532,-0.35736,1,0
3,GO PROTEIN KINASE A SIGNALING,1.7687e-09,-0.27533,-0.33512,1,0
3,GO RESPONSE TO CADMIUM ION,1.2716e-05,-0.27535,-0.3006,1,0
3,GO KERATINOCYTE DIFFERENTIATION,6.2046e-07,-0.27552,-0.33517,1,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00015083,-0.27554,-0.29453,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7602e-11,-0.27558,-0.37857,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,1.484e-09,-0.27561,-0.36353,1,0
3,GO COPPER ION TRANSPORT,2.7668e-07,-0.27563,-0.31247,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,6.4699e-07,-0.27563,-0.35201,1,0
3,GO RESPONSE TO OXIDATIVE STRESS,1.8863e-12,-0.27566,-0.36666,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,3.9822e-07,-0.2757,-0.40992,1,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,2.8262e-08,-0.27572,-0.32184,1,0
3,GO STEROID METABOLIC PROCESS,6.5125e-09,-0.27572,-0.3169,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,4.9228e-07,-0.27574,-0.32491,1,0
3,GO ION TRANSMEMBRANE TRANSPORT,2.4893e-11,-0.27578,-0.3459,1,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,1.7534e-07,-0.27589,-0.37403,1,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,2.0398e-08,-0.27592,-0.33903,1,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.5223e-10,-0.27592,-0.38519,1,0
3,GO ENERGY HOMEOSTASIS,2.1338e-07,-0.2761,-0.41188,1,0
3,GO GLYCEROLIPID METABOLIC PROCESS,4.9403e-11,-0.27612,-0.34428,1,0
3,GO SPINDLE LOCALIZATION,1.996e-06,-0.27613,-0.31902,1,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,1.8863e-12,-0.27614,-0.4073,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.2764e-10,-0.27626,-0.3364,1,0
3,GO CYTOPLASM ORGANIZATION,9.795e-06,-0.27632,-0.37908,1,0
3,GO MRNA TRANSCRIPTION,2.2824e-05,-0.27635,-0.3663,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.1188e-12,-0.27636,-0.38537,1,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,1.3599e-06,-0.2767,-0.36376,1,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.0582e-12,-0.27671,-0.39722,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.7676e-09,-0.27672,-0.35565,1,0
3,GO REGULATION OF AUTOPHAGY,4.4302e-11,-0.2768,-0.36711,1,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,1.5968e-11,-0.27683,-0.35689,1,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,9.086e-06,-0.27684,-0.29143,1,0
3,GO RESPONSE TO INSULIN,1.4686e-11,-0.27698,-0.3891,1,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,1.1478e-12,-0.27699,-0.39709,1,0
3,GO MOTILE CILIUM ASSEMBLY,0.00011986,-0.27703,-0.32001,1,0
3,GO REGULATION OF CHROMATIN BINDING,7.8052e-07,-0.27706,-0.3561,1,0
3,GO CHEMICAL HOMEOSTASIS,1.679e-12,-0.27717,-0.35379,1,0
3,GO RESPONSE TO CARBOHYDRATE,1.0493e-11,-0.27719,-0.39342,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,1.6062e-07,-0.27722,-0.33145,1,0
3,GO REGULATION OF HORMONE SECRETION,1.8573e-08,-0.27723,-0.32175,1,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,5.5412e-06,-0.27742,-0.3063,1,0
3,GO PURINE NUCLEOTIDE TRANSPORT,2.8886e-07,-0.27746,-0.3418,1,0
3,GO RESPONSE TO INTERLEUKIN 4,4.4148e-09,-0.27753,-0.33737,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,4.5684e-06,-0.2777,-0.32453,1,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,9.3381e-05,-0.27774,-0.31607,1,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.2321e-08,-0.27775,-0.40286,1,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,7.0337e-07,-0.27784,-0.28538,1,0
3,GO REGULATION OF DEFENSE RESPONSE,4.6784e-11,-0.27785,-0.34643,1,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,8.2903e-10,-0.27786,-0.39774,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,5.2303e-06,-0.27794,-0.28948,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,1.4741e-05,-0.278,-0.29591,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,9.7991e-09,-0.27804,-0.34909,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.6129e-08,-0.27812,-0.30122,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING,9.2321e-08,-0.27817,-0.29885,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,4.6881e-08,-0.2782,-0.41684,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,4.7501e-09,-0.27821,-0.33158,1,0
3,GO REGULATION OF PROTEOLYSIS,2.7494e-12,-0.27826,-0.3756,1,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,2.2926e-08,-0.27826,-0.3265,1,0
3,GO HEART TRABECULA FORMATION,0.00010323,-0.27836,-0.3308,1,0
3,GO HORMONE METABOLIC PROCESS,2.3853e-09,-0.27838,-0.31107,1,0
3,GO HIPPOCAMPUS DEVELOPMENT,1.5014e-05,-0.27844,-0.28913,1,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,1.3761e-09,-0.27854,-0.37566,1,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,6.552e-13,-0.27858,-0.38763,1,0
3,GO EPIDERMIS DEVELOPMENT,1.9546e-09,-0.27868,-0.36261,1,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.00064263,-0.27871,-0.25771,1,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.3274e-07,-0.27879,-0.32879,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,4.5922e-10,-0.2788,-0.31175,1,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,6.3074e-11,-0.27884,-0.35811,1,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,1.2172e-12,-0.27885,-0.38134,1,0
3,GO L SERINE METABOLIC PROCESS,0.012945,-0.27888,-0.22129,1,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,1.2131e-09,-0.27888,-0.3182,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,8.0898e-09,-0.27891,-0.34524,1,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00017457,-0.27891,-0.31179,1,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,3.8924e-05,-0.27894,-0.29092,1,0
3,GO MEMBRANE ORGANIZATION,2.1812e-12,-0.27896,-0.38266,1,0
3,GO PREPULSE INHIBITION,0.00033955,-0.279,-0.37573,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.1196e-06,-0.27909,-0.31138,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.9014e-08,-0.27912,-0.35846,1,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.8182e-13,-0.2793,-0.37613,1,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,8.2618e-11,-0.27944,-0.33333,1,0
3,GO REGULATION OF GLUCONEOGENESIS,3.0295e-08,-0.27947,-0.35568,1,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,9.4407e-08,-0.2797,-0.34826,1,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,2.8305e-05,-0.27975,-0.30893,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.7614e-08,-0.27975,-0.34647,1,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00017457,-0.27992,-0.30602,1,0
3,GO HAIR CELL DIFFERENTIATION,3.5646e-05,-0.27993,-0.33696,1,0
3,GO SPECIFICATION OF SYMMETRY,3.4553e-09,-0.28002,-0.32761,1,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,8.2618e-11,-0.28003,-0.38038,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,5.6487e-06,-0.28006,-0.32103,1,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,3.152e-06,-0.28013,-0.34876,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1.6001e-09,-0.28028,-0.30957,1,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,7.6283e-05,-0.28028,-0.2651,1,0
3,GO ALCOHOL METABOLIC PROCESS,1.1398e-10,-0.28033,-0.33905,1,0
3,GO EXTRACELLULAR TRANSPORT,1.3325e-06,-0.28045,-0.32529,1,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,2.3784e-07,-0.28047,-0.37928,1,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,4.5684e-06,-0.28059,-0.33296,1,0
3,GO CARBOHYDRATE TRANSPORT,1.2131e-09,-0.28078,-0.36026,1,0
3,GO DOPAMINE METABOLIC PROCESS,1.8701e-05,-0.28104,-0.31975,1,0
3,GO RESPONSE TO CORTICOSTERONE,9.5999e-07,-0.28105,-0.3483,1,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,2.5164e-08,-0.28106,-0.38982,1,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,2.2416e-05,-0.28122,-0.32152,1,0
3,GO SECRETORY GRANULE ORGANIZATION,2.6362e-08,-0.28124,-0.38527,1,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,4.3355e-07,-0.28134,-0.37568,1,0
3,GO REGULATION OF CELL DEATH,8.8075e-13,-0.28154,-0.36526,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,7.2202e-11,-0.28159,-0.36631,1,0
3,GO REGULATION OF DEPHOSPHORYLATION,1.0519e-10,-0.2817,-0.37238,1,0
3,GO CHRONIC INFLAMMATORY RESPONSE,1.3948e-05,-0.28171,-0.34991,1,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,9.7991e-09,-0.28177,-0.31521,1,0
3,GO REGULATION OF HEAT GENERATION,1.7706e-05,-0.28191,-0.27581,1,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,9.0235e-07,-0.28202,-0.3409,1,0
3,GO LIPID METABOLIC PROCESS,7.6937e-12,-0.28205,-0.34882,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.1041e-08,-0.28206,-0.32517,1,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,1.8323e-12,-0.28207,-0.40873,1,0
3,GO GRANULOCYTE MIGRATION,3.5427e-10,-0.28211,-0.36187,1,0
3,GO ACIDIC AMINO ACID TRANSPORT,2.1624e-06,-0.28215,-0.32408,1,0
3,GO ACID SECRETION,2.65e-07,-0.28222,-0.25778,1,0
3,GO TELENCEPHALON DEVELOPMENT,1.7721e-08,-0.28224,-0.35049,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00088789,-0.28231,-0.34125,1,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.0509e-11,-0.28235,-0.35585,1,0
3,GO OVULATION CYCLE PROCESS,2.801e-10,-0.28255,-0.39952,1,0
3,GO COGNITION,2.5223e-10,-0.28256,-0.37022,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,2.0429e-07,-0.28273,-0.30777,1,0
3,GO HEART GROWTH,8.3747e-12,-0.28285,-0.42696,1,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0005133,-0.28288,-0.37944,1,0
3,GO DRUG METABOLIC PROCESS,9.8716e-08,-0.28293,-0.29247,1,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,3.5794e-07,-0.28293,-0.30608,1,0
3,GO DNA DEAMINATION,0.009139,-0.28297,-0.28677,1,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.9905e-10,-0.28318,-0.37489,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.5359e-06,-0.28323,-0.39762,1,0
3,GO GLUCOSE IMPORT,1.5604e-09,-0.28339,-0.36086,1,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,1.9948e-11,-0.2834,-0.34913,1,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,3.9717e-11,-0.28341,-0.38232,1,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,9.3381e-05,-0.28356,-0.2973,1,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00033955,-0.28357,-0.30163,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,1.7309e-08,-0.28362,-0.31577,1,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,1.0036e-08,-0.28367,-0.34282,1,0
3,GO PIGMENTATION,1.2417e-11,-0.28369,-0.36686,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,9.2118e-07,-0.28371,-0.33778,1,0
3,GO REGULATION OF EXOCYTOSIS,2.0546e-09,-0.28381,-0.37302,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,3.0905e-06,-0.28391,-0.39605,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,2.5695e-09,-0.28393,-0.31574,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,1.4092e-12,-0.28412,-0.41396,1,0
3,GO GLIAL CELL FATE COMMITMENT,0.00076726,-0.28415,-0.32769,1,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,5.8856e-08,-0.28417,-0.33305,1,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00072342,-0.28423,-0.21551,1,0
3,GO NOTCH SIGNALING PATHWAY,4.8359e-10,-0.28434,-0.41358,1,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,2.9859e-05,-0.28434,-0.27723,1,0
3,GO HISTONE DEACETYLATION,4.2784e-08,-0.28434,-0.34846,1,0
3,GO REGULATION OF PHOSPHORYLATION,6.7492e-13,-0.28435,-0.39436,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,2.5893e-10,-0.28436,-0.33796,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.4787e-08,-0.28442,-0.37207,1,0
3,GO EXPLORATION BEHAVIOR,2.6914e-06,-0.28447,-0.36776,1,0
3,GO REGULATION OF CELL PROJECTION SIZE,8.7316e-05,-0.28452,-0.31332,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,7.6446e-07,-0.28455,-0.35168,1,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,5.6487e-06,-0.28459,-0.37503,1,0
3,GO NECROTIC CELL DEATH,6.7411e-08,-0.28478,-0.34843,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.9546e-09,-0.28483,-0.34624,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00029976,-0.28486,-0.27873,1,0
3,GO T CELL MEDIATED IMMUNITY,2.1807e-07,-0.28487,-0.35428,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,4.6578e-06,-0.28489,-0.33939,1,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.8833e-12,-0.28502,-0.36977,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,2.1543e-10,-0.28503,-0.35252,1,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,8.0815e-10,-0.28506,-0.33744,1,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,5.332e-06,-0.28511,-0.40728,1,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,9.5999e-07,-0.28513,-0.31853,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,3.1896e-11,-0.28514,-0.37881,1,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,2.1064e-09,-0.28515,-0.45676,1,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,2.9371e-11,-0.28527,-0.35486,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,4.3774e-08,-0.28536,-0.39578,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,5.3747e-08,-0.28545,-0.31735,1,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,3.1312e-09,-0.28552,-0.36078,1,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,7.6792e-10,-0.28553,-0.33048,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.2785e-11,-0.28557,-0.36684,1,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,5.2165e-11,-0.28561,-0.36779,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,1.5968e-11,-0.28564,-0.34513,1,0
3,GO AGING,5.9602e-12,-0.2857,-0.36043,1,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,9.819e-05,-0.28594,-0.27259,1,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,4.2271e-06,-0.28594,-0.37271,1,0
3,GO REGULATION OF HYDROLASE ACTIVITY,6.9522e-13,-0.28596,-0.39988,1,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.451e-12,-0.28596,-0.37426,1,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.801e-10,-0.28598,-0.33966,1,0
3,GO BEHAVIOR,2.2707e-10,-0.28601,-0.37253,1,0
3,GO CELLULAR PIGMENTATION,1.9014e-08,-0.28604,-0.32055,1,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,1.9136e-07,-0.28612,-0.33598,1,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,3.1032e-11,-0.28616,-0.34625,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,6.5906e-08,-0.28639,-0.38002,1,0
3,GO TRANSITION METAL ION HOMEOSTASIS,9.9064e-10,-0.28641,-0.33099,1,0
3,GO ERYTHROCYTE DEVELOPMENT,6.8885e-07,-0.28652,-0.39756,1,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,4.249e-10,-0.28655,-0.32972,1,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,1.5383e-12,-0.28659,-0.36132,1,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,1.2172e-12,-0.28662,-0.40161,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,1.2441e-09,-0.28667,-0.35615,1,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,7.8052e-07,-0.28669,-0.27752,1,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00099681,-0.28682,-0.32195,1,0
3,GO RESPONSE TO STARVATION,6.757e-10,-0.28691,-0.36707,1,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.6356e-09,-0.28698,-0.42291,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.0322e-07,-0.28708,-0.32042,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.8369e-09,-0.28714,-0.3742,1,0
3,GO SULFUR COMPOUND TRANSPORT,1.6514e-08,-0.28722,-0.37859,1,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,4.9624e-10,-0.28724,-0.35865,1,0
3,GO MAINTENANCE OF LOCATION,2.6711e-12,-0.28732,-0.37688,1,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,9.1996e-11,-0.28733,-0.33476,1,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,5.8856e-08,-0.28738,-0.35585,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.6386e-06,-0.28739,-0.4052,1,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,5.0237e-12,-0.2874,-0.34739,1,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,9.1205e-09,-0.28742,-0.27438,1,0
3,GO MICROVILLUS ORGANIZATION,4.2271e-06,-0.28748,-0.41914,1,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,8.0256e-05,-0.28751,-0.28314,1,0
3,GO TONGUE DEVELOPMENT,0.00046872,-0.28752,-0.26306,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,2.1375e-08,-0.2876,-0.3773,1,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.0279e-08,-0.28761,-0.42702,1,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0015038,-0.28763,-0.32507,1,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.0905e-06,-0.28763,-0.34932,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,9.6538e-08,-0.28766,-0.31721,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.7687e-09,-0.28766,-0.37941,1,0
3,GO ACTIVATED T CELL PROLIFERATION,8.6937e-09,-0.2878,-0.37374,1,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,2.4091e-05,-0.28788,-0.30088,1,0
3,GO CELLULAR RESPONSE TO PEPTIDE,5.9937e-13,-0.2881,-0.41778,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3769e-07,-0.28812,-0.40684,1,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00020504,-0.28813,-0.32255,1,0
3,GO INTERACTION WITH HOST,3.5597e-11,-0.28817,-0.39617,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,4.3549e-12,-0.28825,-0.35721,1,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,7.8976e-09,-0.28835,-0.37669,1,0
3,GO PHAGOSOME MATURATION,5.4982e-08,-0.28857,-0.352,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,2.2416e-05,-0.2886,-0.35184,1,0
3,GO ENDOCYTOSIS,7.3765e-13,-0.28864,-0.43133,1,0
3,GO NEGATIVE REGULATION OF CELL AGING,1.0036e-08,-0.28867,-0.40039,1,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.9941e-08,-0.28867,-0.36878,1,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,3.247e-08,-0.28881,-0.36074,1,0
3,GO VESICLE TARGETING,5.7923e-10,-0.28881,-0.36622,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.2585e-06,-0.28884,-0.32694,1,0
3,GO GOLGI TO VACUOLE TRANSPORT,3.7605e-06,-0.28884,-0.35653,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,2.8369e-09,-0.28911,-0.3405,1,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,2.2505e-06,-0.28921,-0.35366,1,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,1.2733e-08,-0.28927,-0.31119,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,2.5066e-09,-0.28932,-0.31496,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00059648,-0.28933,-0.32355,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,8.0712e-08,-0.28943,-0.31584,1,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,9.3415e-09,-0.28944,-0.33469,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00020178,-0.28949,-0.31077,1,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,1.5383e-12,-0.28953,-0.38362,1,0
3,GO PANCREATIC JUICE SECRETION,2.8925e-08,-0.28958,-0.34525,1,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,1.6158e-05,-0.2896,-0.33746,1,0
3,GO TERPENOID METABOLIC PROCESS,2.2697e-09,-0.28966,-0.33296,1,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,2.5756e-08,-0.28974,-0.3084,1,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,6.8888e-05,-0.28974,-0.34504,1,0
3,GO EPITHELIAL CELL MATURATION,1.0004e-06,-0.28975,-0.3319,1,0
3,GO MUSCLE CONTRACTION,3.8833e-12,-0.28976,-0.3965,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,8.2864e-09,-0.28979,-0.39926,1,0
3,GO METAL ION HOMEOSTASIS,1.8863e-12,-0.28979,-0.35179,1,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,4.2444e-07,-0.29004,-0.39653,1,0
3,GO SYNAPTIC SIGNALING,2.6362e-08,-0.29005,-0.35554,1,0
3,GO REGULATION OF CELL KILLING,2.65e-07,-0.29008,-0.34727,1,0
3,GO DEVELOPMENTAL INDUCTION,1.3769e-07,-0.29008,-0.35301,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00075607,-0.29011,-0.34455,1,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,1.2907e-12,-0.29022,-0.40475,1,0
3,GO CELL VOLUME HOMEOSTASIS,2.2707e-10,-0.29025,-0.39873,1,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,6.757e-10,-0.29039,-0.31546,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.5906e-08,-0.29043,-0.35411,1,0
3,GO REGULATION OF CYCLASE ACTIVITY,2.7668e-07,-0.29045,-0.32847,1,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.5217e-06,-0.29054,-0.33302,1,0
3,GO REGULATION OF SYSTEM PROCESS,9.3752e-12,-0.29067,-0.38741,1,0
3,GO NEGATIVE REGULATION OF SIGNALING,6.3604e-13,-0.29071,-0.4047,1,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,4.9069e-08,-0.29075,-0.3379,1,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,1.069e-09,-0.29076,-0.32623,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,3.2894e-09,-0.29079,-0.3614,1,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,5.4821e-13,-0.29091,-0.39425,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,4.7963e-08,-0.29104,-0.35131,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,2.004e-09,-0.2911,-0.37638,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,8.4805e-07,-0.29111,-0.3476,1,0
3,GO REGULATION OF GLIOGENESIS,4.4749e-10,-0.29113,-0.33804,1,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.00016098,-0.29118,-0.31136,1,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,3.7735e-12,-0.29121,-0.39186,1,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,3.5629e-12,-0.29127,-0.38758,1,0
3,GO STEM CELL DIFFERENTIATION,1.1097e-10,-0.29133,-0.34441,1,0
3,GO EXOCYTOSIS,3.1757e-12,-0.29136,-0.39353,1,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.5037e-07,-0.29141,-0.3271,1,0
3,GO SPHINGOLIPID METABOLIC PROCESS,2.3853e-09,-0.29146,-0.38384,1,0
3,GO CATION TRANSMEMBRANE TRANSPORT,4.3109e-11,-0.29157,-0.3476,1,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,4.7125e-10,-0.2916,-0.35492,1,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,2.3661e-05,-0.29165,-0.34714,1,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,4.5922e-10,-0.29165,-0.34588,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,3.1729e-08,-0.29187,-0.39986,1,0
3,GO RESPONSE TO DOPAMINE,2.0429e-07,-0.29203,-0.3234,1,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,6.545e-05,-0.29207,-0.38744,1,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00010152,-0.29214,-0.32183,1,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,6.1744e-13,-0.29219,-0.39379,1,0
3,GO LINOLEIC ACID METABOLIC PROCESS,9.4341e-06,-0.2922,-0.39815,1,0
3,GO CERAMIDE METABOLIC PROCESS,8.9487e-10,-0.29226,-0.38675,1,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,6.7492e-13,-0.29229,-0.45355,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,9.2321e-08,-0.29229,-0.38131,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.0582e-12,-0.29231,-0.37824,1,0
3,GO TRANSPOSITION,6.3249e-05,-0.29232,-0.32499,1,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,3.1032e-11,-0.29247,-0.35668,1,0
3,GO RESPONSE TO HORMONE,1.4092e-12,-0.29248,-0.39778,1,0
3,GO REGULATION OF CELL DIFFERENTIATION,6.9522e-13,-0.29259,-0.40939,1,0
3,GO MYOBLAST PROLIFERATION,2.8886e-07,-0.29263,-0.35024,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.6654e-06,-0.29263,-0.3397,1,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,7.7166e-08,-0.29267,-0.42564,1,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.2094e-09,-0.29272,-0.36278,1,0
3,GO REGULATION OF DOPAMINE SECRETION,0.0013255,-0.29287,-0.31745,1,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,2.2912e-11,-0.29312,-0.41058,1,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.0004e-06,-0.29316,-0.39719,1,0
3,GO LIPID DROPLET ORGANIZATION,1.1794e-07,-0.29319,-0.33113,1,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,3.2859e-07,-0.29323,-0.38056,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.8301e-10,-0.29334,-0.37076,1,0
3,GO RESPONSE TO ISCHEMIA,1.3024e-10,-0.29339,-0.44292,1,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,1.3761e-09,-0.29348,-0.33047,1,0
3,GO RESPONSE TO FUNGUS,3.1479e-07,-0.2935,-0.271,1,0
3,GO PROTEIN PROCESSING,2.0509e-11,-0.29351,-0.37879,1,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,2.1375e-08,-0.29356,-0.44357,1,0
3,GO T CELL HOMEOSTASIS,1.8142e-08,-0.29359,-0.30663,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,1.2434e-08,-0.29361,-0.32512,1,0
3,GO NEURON RECOGNITION,1.0554e-07,-0.29363,-0.42368,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,1.9948e-11,-0.29366,-0.36678,1,0
3,GO RESPONSE TO ANTIBIOTIC,2.801e-10,-0.29386,-0.335,1,0
3,GO METENCEPHALON DEVELOPMENT,4.0678e-07,-0.29389,-0.32559,1,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,2.3793e-12,-0.29397,-0.41652,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,4.7963e-08,-0.29415,-0.36897,1,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.9989e-07,-0.29436,-0.36831,1,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00035024,-0.29456,-0.27785,1,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,2.1196e-06,-0.29463,-0.33475,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.2286e-07,-0.29464,-0.34028,1,0
3,GO NEUTROPHIL MIGRATION,1.9064e-09,-0.29469,-0.34241,1,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.5684e-06,-0.29471,-0.38857,1,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,1.5277e-10,-0.29472,-0.34839,1,0
3,GO PROTEIN HYDROXYLATION,0.00011596,-0.29476,-0.36374,1,0
3,GO SMOOTHENED SIGNALING PATHWAY,1.069e-09,-0.2948,-0.36419,1,0
3,GO INORGANIC ANION TRANSPORT,8.4871e-11,-0.2949,-0.33293,1,0
3,GO LOCOMOTORY BEHAVIOR,6.5125e-09,-0.29498,-0.38225,1,0
3,GO ISOPRENOID METABOLIC PROCESS,1.1307e-08,-0.29499,-0.29945,1,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,1.9175e-06,-0.29514,-0.40459,1,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.8723e-07,-0.29522,-0.37342,1,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,6.6774e-12,-0.29528,-0.3635,1,0
3,GO LEARNING,1.3671e-08,-0.29537,-0.37212,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.8753e-10,-0.29539,-0.35983,1,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,1.8318e-07,-0.29542,-0.34734,1,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,4.7125e-10,-0.29543,-0.35654,1,0
3,GO NEUTROPHIL CHEMOTAXIS,5.2359e-09,-0.29545,-0.33144,1,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,2.3312e-10,-0.2955,-0.38075,1,0
3,GO REGULATION OF RESPONSE TO STRESS,2.8299e-12,-0.29555,-0.35882,1,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,1.5027e-08,-0.2956,-0.33436,1,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00096848,-0.29564,-0.28078,1,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,3.3806e-05,-0.29581,-0.30287,1,0
3,GO RESPONSE TO UV B,4.2444e-07,-0.29588,-0.41798,1,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,4.249e-10,-0.29608,-0.35774,1,0
3,GO LIPID CATABOLIC PROCESS,2.1678e-11,-0.29609,-0.34923,1,0
3,GO I KAPPAB PHOSPHORYLATION,2.3268e-09,-0.29613,-0.3954,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,3.8149e-08,-0.29618,-0.38077,1,0
3,GO GLAND DEVELOPMENT,4.232e-12,-0.29633,-0.41645,1,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.2733e-08,-0.29637,-0.34903,1,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,1.0824e-12,-0.29639,-0.42375,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,2.7494e-12,-0.29644,-0.39277,1,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,1.6654e-06,-0.2965,-0.31426,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,8.0424e-11,-0.29651,-0.34182,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,4.6784e-11,-0.29653,-0.33904,1,0
3,GO RESPONSE TO ETHANOL,2.0509e-11,-0.2966,-0.3222,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,2.6981e-08,-0.29665,-0.32801,1,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,8.4805e-07,-0.29673,-0.41492,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,3.1896e-11,-0.29682,-0.36058,1,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,6.3359e-07,-0.29684,-0.35261,1,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,2.4214e-11,-0.29692,-0.35949,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,1.2023e-10,-0.29692,-0.35127,1,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0025617,-0.29695,-0.25152,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.7051e-07,-0.2971,-0.40632,1,0
3,GO MEMBRANE DISASSEMBLY,1.3693e-05,-0.29712,-0.34512,1,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,3.5597e-11,-0.29737,-0.3643,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.0337e-07,-0.2974,-0.32348,1,0
3,GO RECEPTOR METABOLIC PROCESS,1.1478e-12,-0.29753,-0.41401,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.4749e-10,-0.29759,-0.41284,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.5713e-07,-0.2976,-0.37012,1,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,2.9371e-11,-0.29768,-0.35372,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,3.6667e-12,-0.29772,-0.39097,1,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,7.598e-13,-0.29796,-0.40473,1,0
3,GO PLASMA MEMBRANE TUBULATION,7.8976e-09,-0.29803,-0.4725,1,0
3,GO AMINE CATABOLIC PROCESS,8.4415e-08,-0.29805,-0.34868,1,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,7.6446e-07,-0.29811,-0.39753,1,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,5.7923e-10,-0.29819,-0.36601,1,0
3,GO CORNIFICATION,0.001704,-0.29823,-0.25659,1,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,2.1807e-07,-0.29835,-0.41364,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,1.9402e-11,-0.2984,-0.36291,1,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,2.8925e-08,-0.29847,-0.34458,1,0
3,GO MEMBRANE REPOLARIZATION,3.2784e-06,-0.2986,-0.36161,1,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.0437e-10,-0.29862,-0.4277,1,0
3,GO PROTEIN ADP RIBOSYLATION,5.3747e-08,-0.29863,-0.37492,1,0
3,GO REGULATION OF HEMOPOIESIS,3.2685e-12,-0.29867,-0.37862,1,0
3,GO NEGATIVE REGULATION OF BINDING,6.6774e-12,-0.29868,-0.37451,1,0
3,GO REGULATION OF STEM CELL PROLIFERATION,5.9432e-10,-0.29898,-0.39077,1,0
3,GO CELL GROWTH,1.2907e-12,-0.29902,-0.42378,1,0
3,GO TYPE I INTERFERON PRODUCTION,2.5066e-09,-0.29903,-0.38948,1,0
3,GO REGULATION OF METAL ION TRANSPORT,1.3685e-12,-0.29918,-0.38122,1,0
3,GO THALAMUS DEVELOPMENT,9.4959e-05,-0.29924,-0.31609,1,0
3,GO REGULATION OF IMMUNE RESPONSE,1.5102e-11,-0.29926,-0.37319,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,3.152e-06,-0.29935,-0.34833,1,0
3,GO NEURON CELLULAR HOMEOSTASIS,9.9803e-06,-0.29936,-0.34984,1,0
3,GO NAD METABOLIC PROCESS,5.0563e-05,-0.29939,-0.32575,1,0
3,GO FOREGUT MORPHOGENESIS,1.471e-07,-0.2995,-0.35312,1,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,3.5597e-11,-0.29954,-0.40608,1,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,1.9989e-07,-0.29972,-0.36495,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,9.7068e-11,-0.29982,-0.36075,1,0
3,GO RUFFLE ORGANIZATION,2.2139e-09,-0.29983,-0.38392,1,0
3,GO T CELL CHEMOTAXIS,7.0017e-09,-0.29991,-0.32569,1,0
3,GO FIBROBLAST ACTIVATION,9.7998e-07,-0.29991,-0.35858,1,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,2.9514e-07,-0.30002,-0.32708,1,0
3,GO MALE SEX DIFFERENTIATION,5.9602e-12,-0.30004,-0.3906,1,0
3,GO ACUTE PHASE RESPONSE,2.4586e-08,-0.30004,-0.31032,1,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,5.9834e-06,-0.3001,-0.40751,1,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,3.1098e-10,-0.3002,-0.34112,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,2.8271e-07,-0.30035,-0.32138,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.1912e-13,-0.3004,-0.389,1,0
3,GO GRANULOCYTE CHEMOTAXIS,5.0922e-10,-0.30053,-0.35665,1,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0001179,-0.30055,-0.28536,1,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,1.2032e-06,-0.30063,-0.32647,1,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.4494e-13,-0.30074,-0.40276,1,0
3,GO PROTEIN LOCALIZATION TO CILIUM,4.7488e-06,-0.30083,-0.32305,1,0
3,GO MATING,3.5412e-09,-0.30096,-0.32666,1,0
3,GO B CELL PROLIFERATION,8.2864e-09,-0.3011,-0.36375,1,0
3,GO INTERLEUKIN 12 PRODUCTION,8.4415e-08,-0.30113,-0.34404,1,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,7.6205e-11,-0.30123,-0.37681,1,0
3,GO PEPTIDE CROSS LINKING,1.2733e-08,-0.30126,-0.46237,1,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0012886,-0.30131,-0.32086,1,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,3.462e-12,-0.30134,-0.34987,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,5.3647e-09,-0.30135,-0.37154,1,0
3,GO SECONDARY METABOLIC PROCESS,5.6245e-08,-0.30141,-0.32603,1,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,1.7442e-10,-0.30157,-0.37429,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,9.2321e-08,-0.30157,-0.3428,1,0
3,GO CELLULAR RESPONSE TO STARVATION,3.9309e-10,-0.3016,-0.38379,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.2202e-11,-0.3016,-0.37956,1,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,2.0881e-08,-0.30162,-0.34706,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,1.2172e-12,-0.30164,-0.39249,1,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,1.5576e-05,-0.30189,-0.31437,1,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,2.6362e-08,-0.30217,-0.32438,1,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,7.598e-13,-0.30217,-0.41711,1,0
3,GO CELL CELL SIGNALING BY WNT,1.4092e-12,-0.30221,-0.40056,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,6.8406e-11,-0.30232,-0.33632,1,0
3,GO MICROTUBULE ANCHORING,7.2129e-08,-0.30256,-0.38245,1,0
3,GO RESPONSE TO REDOX STATE,0.0015038,-0.30272,-0.28077,1,0
3,GO TONGUE MORPHOGENESIS,0.03006,-0.30273,-0.17845,1,0
3,GO MESODERMAL CELL DIFFERENTIATION,7.8778e-10,-0.3028,-0.39704,1,0
3,GO DEVELOPMENTAL MATURATION,7.6205e-11,-0.30286,-0.37902,1,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,4.1403e-10,-0.30291,-0.3539,1,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.4076e-07,-0.30294,-0.37693,1,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.9487e-10,-0.30296,-0.34892,1,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.5223e-10,-0.30298,-0.32966,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,1.9387e-10,-0.30302,-0.41871,1,0
3,GO CELL KILLING,6.5906e-08,-0.30308,-0.31797,1,0
3,GO SPINAL CORD DEVELOPMENT,2.3784e-07,-0.30322,-0.34123,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.0804e-10,-0.30332,-0.3642,1,0
3,GO REGULATION OF BEHAVIOR,1.3468e-07,-0.3035,-0.31684,1,0
3,GO RESPONSE TO L GLUTAMATE,0.00029052,-0.30352,-0.30137,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,1.4207e-05,-0.30358,-0.35584,1,0
3,GO REGULATION OF ICOSANOID SECRETION,7.6657e-06,-0.30359,-0.30987,1,0
3,GO MAINTENANCE OF LOCATION IN CELL,6.1321e-12,-0.30364,-0.36554,1,0
3,GO AXIS SPECIFICATION,6.2993e-08,-0.30377,-0.31455,1,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,6.8348e-09,-0.30383,-0.37108,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,8.7237e-10,-0.30392,-0.39331,1,0
3,GO NEGATIVE REGULATION OF CELL DEATH,2.1812e-12,-0.30396,-0.35256,1,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,5.8698e-06,-0.30401,-0.34711,1,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.00057029,-0.30402,-0.27314,1,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,3.0156e-07,-0.30413,-0.36643,1,0
3,GO CELL PROLIFERATION IN HINDBRAIN,1.9175e-06,-0.30418,-0.33342,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,4.3082e-09,-0.30427,-0.41899,1,0
3,GO RESPONSE TO VIRUS,9.4157e-10,-0.30429,-0.37454,1,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,5.0237e-12,-0.3043,-0.35342,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,2.1338e-07,-0.30443,-0.34752,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,5.6085e-05,-0.30446,-0.38071,1,0
3,GO FUCOSE METABOLIC PROCESS,7.892e-08,-0.30456,-0.34638,1,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.4967e-09,-0.30461,-0.3221,1,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,3.4516e-10,-0.30465,-0.40664,1,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,6.3088e-12,-0.30479,-0.3548,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,1.8573e-08,-0.30488,-0.34542,1,0
3,GO VASODILATION,6.8885e-07,-0.30509,-0.35071,1,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.7232e-13,-0.30511,-0.40247,1,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.1588e-05,-0.30511,-0.39083,1,0
3,GO RESPONSE TO INTERLEUKIN 12,4.3355e-07,-0.30513,-0.30257,1,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,9.7068e-11,-0.30514,-0.35005,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,4.4285e-07,-0.30515,-0.34853,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,1.1535e-07,-0.30523,-0.35433,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,7.5266e-09,-0.30523,-0.33033,1,0
3,GO LEUKOTRIENE METABOLIC PROCESS,1.1307e-08,-0.30523,-0.39269,1,0
3,GO CELLULAR RESPONSE TO DSRNA,1.0036e-08,-0.30525,-0.39411,1,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.188e-08,-0.30527,-0.32966,1,0
3,GO TUBE FORMATION,2.9515e-10,-0.30539,-0.3884,1,0
3,GO REGULATION OF GROWTH,1.3291e-12,-0.30544,-0.39706,1,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,6.4192e-10,-0.30548,-0.34349,1,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.9905e-10,-0.30551,-0.39916,1,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,1.679e-12,-0.30555,-0.39932,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.2165e-11,-0.30562,-0.38976,1,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,4.8662e-13,-0.30569,-0.40794,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.5277e-10,-0.30572,-0.37842,1,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,1.5713e-07,-0.30575,-0.33881,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.793e-12,-0.30583,-0.38008,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,9.2118e-07,-0.30584,-0.35245,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,8.9558e-11,-0.30592,-0.39484,1,0
3,GO NEURONAL ACTION POTENTIAL,1.5293e-05,-0.30595,-0.35573,1,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,4.5526e-11,-0.30599,-0.44738,1,0
3,GO RESPONSE TO AMPHETAMINE,1.3599e-06,-0.30605,-0.31814,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.3647e-09,-0.30605,-0.39118,1,0
3,GO OSTEOBLAST DEVELOPMENT,9.4407e-08,-0.30605,-0.34785,1,0
3,GO RESPONSE TO METAL ION,3.5597e-11,-0.30612,-0.35902,1,0
3,GO TOXIN TRANSPORT,2.2697e-09,-0.30624,-0.38809,1,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,6.6774e-12,-0.30624,-0.32203,1,0
3,GO MESODERM DEVELOPMENT,1.642e-11,-0.3063,-0.36843,1,0
3,GO MUSCLE CELL DEVELOPMENT,3.3629e-10,-0.30635,-0.37632,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.3376e-10,-0.30653,-0.40103,1,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,1.2434e-08,-0.30661,-0.39348,1,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,8.7237e-10,-0.30661,-0.39122,1,0
3,GO VITAMIN TRANSPORT,6.5906e-08,-0.30671,-0.34171,1,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,1.0519e-10,-0.30687,-0.35329,1,0
3,GO LYSOSOMAL TRANSPORT,1.3376e-10,-0.30697,-0.42621,1,0
3,GO INTERLEUKIN 4 PRODUCTION,1.1034e-07,-0.30701,-0.3215,1,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.0817e-11,-0.30716,-0.38217,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.4749e-10,-0.30726,-0.35734,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,2.0582e-12,-0.30732,-0.37837,1,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1.5576e-05,-0.30746,-0.29712,1,0
3,GO RESPONSE TO OXYGEN LEVELS,3.8645e-11,-0.30754,-0.35823,1,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0018764,-0.30756,-0.30202,1,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00049053,-0.30759,-0.30403,1,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,8.5514e-13,-0.3076,-0.40546,1,0
3,GO RESPONSE TO AMINO ACID STARVATION,2.3274e-07,-0.30762,-0.35135,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.3435e-06,-0.30767,-0.35837,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.1912e-13,-0.30785,-0.40809,1,0
3,GO MAGNESIUM ION TRANSPORT,9.2585e-06,-0.30796,-0.33802,1,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,1.536e-06,-0.30805,-0.36083,1,0
3,GO RENAL SODIUM EXCRETION,1.3671e-08,-0.30816,-0.35167,1,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,9.4499e-11,-0.3082,-0.34818,1,0
3,GO MYOTUBE DIFFERENTIATION,9.9185e-12,-0.30821,-0.4173,1,0
3,GO NADH METABOLIC PROCESS,0.00026024,-0.30826,-0.29253,1,0
3,GO ORGANELLE MEMBRANE FUSION,2.3268e-09,-0.30829,-0.40339,1,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,9.9705e-11,-0.30838,-0.34328,1,0
3,GO T HELPER CELL LINEAGE COMMITMENT,4.9361e-06,-0.30839,-0.30472,1,0
3,GO REGULATION OF BONE DEVELOPMENT,3.3713e-09,-0.30843,-0.39296,1,0
3,GO MUSCLE SYSTEM PROCESS,4.6112e-12,-0.30849,-0.404,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.8753e-10,-0.30865,-0.4161,1,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.9361e-06,-0.30869,-0.39707,1,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,9.1829e-05,-0.30872,-0.25642,1,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,5.6317e-09,-0.30873,-0.38511,1,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,6.6581e-11,-0.30881,-0.40959,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.6654e-06,-0.30883,-0.3467,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.1819e-07,-0.30891,-0.39782,1,0
3,GO REGULATION OF CALCIUM ION IMPORT,1.7687e-09,-0.30897,-0.3949,1,0
3,GO RECEPTOR RECYCLING,1.4487e-10,-0.30897,-0.38344,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,1.3325e-06,-0.30924,-0.37245,1,0
3,GO IRON ION HOMEOSTASIS,2.4214e-11,-0.3093,-0.36287,1,0
3,GO MEMBRANE FUSION,1.6986e-10,-0.30951,-0.39364,1,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.8262e-08,-0.30953,-0.33687,1,0
3,GO NEURAL TUBE DEVELOPMENT,2.3933e-10,-0.30961,-0.40979,1,0
3,GO ETHANOL METABOLIC PROCESS,1.8419e-06,-0.30962,-0.35564,1,0
3,GO CARDIAC CELL DEVELOPMENT,5.4982e-08,-0.30963,-0.36851,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.5277e-10,-0.30964,-0.37382,1,0
3,GO RESPONSE TO NICOTINE,3.0302e-06,-0.30964,-0.2939,1,0
3,GO NEGATIVE REGULATION OF SECRETION,2.521e-12,-0.30974,-0.34217,1,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,2.7e-09,-0.30976,-0.38421,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.7602e-11,-0.30982,-0.38613,1,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.00010323,-0.30984,-0.31857,1,0
3,GO RESPONSE TO ALCOHOL,2.1188e-12,-0.30989,-0.37379,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,7.2414e-06,-0.30995,-0.32602,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.1446e-05,-0.30995,-0.29458,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,3.8645e-11,-0.30996,-0.38067,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.6792e-10,-0.30998,-0.36764,1,0
3,GO SOMITOGENESIS,1.5027e-08,-0.31003,-0.34793,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,8.9166e-06,-0.31009,-0.33932,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.634e-09,-0.31015,-0.37681,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,1.0527e-08,-0.31016,-0.39468,1,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,1.5277e-10,-0.31026,-0.33795,1,0
3,GO ETHER BIOSYNTHETIC PROCESS,9.9803e-06,-0.31029,-0.35829,1,0
3,GO SODIUM ION TRANSPORT,3.1098e-10,-0.31032,-0.34677,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,2.8573e-11,-0.31037,-0.40137,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.2859e-07,-0.31038,-0.357,1,0
3,GO INNATE IMMUNE RESPONSE,2.5223e-10,-0.31046,-0.37631,1,0
3,GO RESPONSE TO X RAY,1.1535e-07,-0.31061,-0.34755,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,6.6717e-09,-0.31076,-0.40441,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.3039e-08,-0.31083,-0.37897,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,4.3997e-05,-0.31084,-0.29352,1,0
3,GO ACTIN FILAMENT BASED PROCESS,7.1613e-13,-0.31092,-0.46137,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,3.055e-09,-0.31094,-0.36947,1,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,8.2618e-11,-0.31097,-0.32814,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.2907e-12,-0.31103,-0.41858,1,0
3,GO RESPONSE TO OSMOTIC STRESS,2.801e-10,-0.31121,-0.3698,1,0
3,GO CGMP METABOLIC PROCESS,5.9056e-05,-0.31123,-0.35979,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,1.0493e-11,-0.31153,-0.42115,1,0
3,GO POLYOL METABOLIC PROCESS,8.0424e-11,-0.31162,-0.35848,1,0
3,GO ORGAN GROWTH,1.3505e-11,-0.31167,-0.41967,1,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.6158e-05,-0.31168,-0.36686,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,1.9402e-11,-0.3117,-0.40543,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.6981e-08,-0.31175,-0.37035,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,1.0202e-11,-0.31176,-0.39055,1,0
3,GO DETECTION OF CALCIUM ION,0.0055559,-0.31177,-0.25377,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.3376e-10,-0.31188,-0.38296,1,0
3,GO RESPONSE TO COPPER ION,0.00010152,-0.31191,-0.33137,1,0
3,GO PROSTAGLANDIN TRANSPORT,5.4701e-07,-0.31201,-0.33554,1,0
3,GO REGULATION OF ENDOCRINE PROCESS,3.7319e-10,-0.3121,-0.39391,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.7998e-07,-0.3121,-0.45421,1,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,2.4452e-09,-0.31211,-0.36942,1,0
3,GO CLATHRIN COAT ASSEMBLY,5.332e-06,-0.3122,-0.37626,1,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,1.1535e-07,-0.31225,-0.39222,1,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0019023,-0.31234,-0.27891,1,0
3,GO DEFENSE RESPONSE,1.887e-11,-0.31258,-0.37125,1,0
3,GO EPITHELIAL TUBE FORMATION,1.2441e-09,-0.31263,-0.37946,1,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,2.1338e-07,-0.31264,-0.39617,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.8833e-12,-0.31269,-0.3749,1,0
3,GO TUMOR NECROSIS FACTOR SECRETION,8.9487e-10,-0.31279,-0.34423,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,7.1726e-09,-0.31283,-0.45406,1,0
3,GO LIPID MODIFICATION,4.4812e-12,-0.31284,-0.38414,1,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.3765e-13,-0.31287,-0.43069,1,0
3,GO GROWTH,1.2907e-12,-0.31298,-0.40046,1,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.0361e-05,-0.31301,-0.35998,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,8.2618e-11,-0.31302,-0.42387,1,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,1.9563e-06,-0.31314,-0.3945,1,0
3,GO RESPONSE TO CATECHOLAMINE,6.5906e-08,-0.31319,-0.33621,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,3.9309e-10,-0.31326,-0.42139,1,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,5.4356e-06,-0.31334,-0.3641,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,8.5043e-10,-0.31338,-0.38787,1,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.3784e-07,-0.31343,-0.33361,1,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,1.2074e-11,-0.31368,-0.37105,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,2.4893e-11,-0.31369,-0.36856,1,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5968e-11,-0.31381,-0.36147,1,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,1.0241e-10,-0.31388,-0.36022,1,0
3,GO RESPONSE TO CYTOKINE,1.0493e-11,-0.31388,-0.39405,1,0
3,GO URETER DEVELOPMENT,3.5606e-08,-0.3139,-0.37335,1,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.7923e-10,-0.31397,-0.39993,1,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011668,-0.3141,-0.2928,1,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,3.5646e-05,-0.31415,-0.33604,1,0
3,GO BICARBONATE TRANSPORT,1.0781e-08,-0.31423,-0.33175,1,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,1.5604e-09,-0.31427,-0.36931,1,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,6.3604e-13,-0.31429,-0.42478,1,0
3,GO POTASSIUM ION TRANSPORT,9.5677e-09,-0.3143,-0.33625,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.7676e-09,-0.31438,-0.40023,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.1356e-08,-0.3144,-0.35895,1,0
3,GO MEMBRANE FISSION,2.1338e-07,-0.31442,-0.40779,1,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.2397e-08,-0.31448,-0.40379,1,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,2.3554e-11,-0.31449,-0.41609,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.3113e-12,-0.31449,-0.39058,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.2202e-11,-0.3145,-0.38799,1,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,7.6792e-10,-0.31452,-0.42702,1,0
3,GO ADAPTIVE THERMOGENESIS,1.174e-11,-0.31454,-0.37955,1,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,2.6306e-11,-0.31454,-0.35599,1,0
3,GO STEROID ESTERIFICATION,2.2775e-07,-0.31468,-0.413,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,1.8881e-10,-0.31471,-0.37927,1,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,1.9563e-06,-0.31478,-0.39002,1,0
3,GO TEMPERATURE HOMEOSTASIS,5.4724e-12,-0.31483,-0.38356,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.1041e-08,-0.31486,-0.39015,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.9478e-13,-0.31498,-0.40422,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,3.8161e-07,-0.315,-0.33848,1,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,4.3997e-05,-0.31502,-0.31002,1,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,3.1098e-10,-0.3151,-0.32833,1,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,3.3629e-10,-0.31513,-0.35168,1,0
3,GO NEUROTRANSMITTER UPTAKE,5.1356e-08,-0.31517,-0.3519,1,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,3.3713e-09,-0.31518,-0.4327,1,0
3,GO CALCIUM ION IMPORT,1.4334e-08,-0.31529,-0.36098,1,0
3,GO REGULATION OF B CELL PROLIFERATION,2.0398e-08,-0.31531,-0.38042,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,2.595e-12,-0.31533,-0.38888,1,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,2.5223e-10,-0.31539,-0.3826,1,0
3,GO CARBOHYDRATE HOMEOSTASIS,1.2131e-09,-0.3154,-0.35354,1,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,2.4214e-11,-0.31546,-0.40786,1,0
3,GO REGULATION OF CELL ACTIVATION,6.6774e-12,-0.31546,-0.40041,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00010152,-0.31548,-0.36042,1,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.3468e-07,-0.31548,-0.38924,1,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,3.0856e-12,-0.31548,-0.45822,1,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,1.1034e-07,-0.31549,-0.32146,1,0
3,GO RESPIRATORY SYSTEM PROCESS,3.2162e-07,-0.31572,-0.3853,1,0
3,GO SKIN EPIDERMIS DEVELOPMENT,2.5893e-10,-0.31575,-0.40905,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.2397e-08,-0.31575,-0.35759,1,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,5.7536e-08,-0.31581,-0.36025,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.9309e-10,-0.31583,-0.32568,1,0
3,GO ERBB2 SIGNALING PATHWAY,1.3039e-08,-0.31595,-0.40697,1,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,9.1793e-10,-0.31599,-0.40488,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00034485,-0.316,-0.3587,1,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.152e-06,-0.316,-0.32634,1,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.6986e-10,-0.31605,-0.40305,1,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,4.0677e-13,-0.31611,-0.39869,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.0241e-10,-0.31616,-0.3866,1,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.9514e-07,-0.31617,-0.41726,1,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.055093,-0.31617,-0.19361,1,0
3,GO ORGANIC CATION TRANSPORT,6.8406e-11,-0.31621,-0.4053,1,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,6.7492e-13,-0.31641,-0.40479,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,1.3737e-10,-0.31675,-0.39635,1,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.4686e-11,-0.31689,-0.36973,1,0
3,GO PROTEIN ACTIVATION CASCADE,3.6293e-09,-0.31695,-0.44655,1,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,4.5233e-07,-0.31701,-0.30741,1,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.8416e-06,-0.31703,-0.29383,1,0
3,GO EPITHELIAL CELL FATE COMMITMENT,9.9844e-05,-0.31709,-0.37502,1,0
3,GO AUTOPHAGOSOME MATURATION,2.8369e-09,-0.31714,-0.34765,1,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,4.8359e-10,-0.31715,-0.37362,1,0
3,GO CELL RECOGNITION,2.0509e-11,-0.31721,-0.35887,1,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,6.3569e-09,-0.31729,-0.31245,1,0
3,GO REGULATION OF CELL FATE COMMITMENT,1.0004e-06,-0.31738,-0.31678,1,0
3,GO B CELL ACTIVATION,1.9402e-11,-0.31744,-0.40451,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,4.6202e-07,-0.31746,-0.38354,1,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,9.4157e-10,-0.31748,-0.34892,1,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,2.7e-09,-0.31749,-0.39589,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.559e-11,-0.3176,-0.39072,1,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,9.5999e-07,-0.31768,-0.28124,1,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,1.3085e-09,-0.31785,-0.36684,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.7909e-10,-0.31788,-0.36489,1,0
3,GO ENDOCRINE HORMONE SECRETION,3.2764e-10,-0.31793,-0.37291,1,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,3.8313e-13,-0.31805,-0.40751,1,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,9.0235e-07,-0.31809,-0.40281,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,6.3074e-11,-0.31811,-0.39218,1,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,9.6219e-13,-0.31817,-0.39455,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,1.5386e-08,-0.31822,-0.41092,1,0
3,GO EXOCYTIC PROCESS,1.0557e-05,-0.31823,-0.33079,1,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.4341e-06,-0.31838,-0.39268,1,0
3,GO VACUOLE ORGANIZATION,1.4487e-10,-0.31842,-0.39321,1,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.3554e-11,-0.31844,-0.38806,1,0
3,GO MUSCLE ORGAN MORPHOGENESIS,6.4192e-10,-0.31863,-0.4113,1,0
3,GO CELLULAR RESPONSE TO VIRUS,7.71e-09,-0.31864,-0.34624,1,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,3.6293e-09,-0.31869,-0.39128,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,4.8198e-07,-0.31875,-0.39432,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,9.658e-10,-0.31876,-0.4182,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.2434e-08,-0.31881,-0.37392,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.479e-12,-0.31881,-0.37038,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,4.3082e-09,-0.31885,-0.39358,1,0
3,GO PROSTANOID METABOLIC PROCESS,2.7452e-06,-0.3189,-0.34213,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0001803,-0.31899,-0.33303,1,0
3,GO OVULATION CYCLE,8.2618e-11,-0.31901,-0.41911,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,1.5102e-11,-0.31909,-0.38858,1,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.598e-13,-0.31912,-0.41769,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.3085e-09,-0.31922,-0.35218,1,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,9.9844e-05,-0.31926,-0.34587,1,0
3,GO MUSCLE FILAMENT SLIDING,5.6245e-08,-0.31933,-0.29835,1,0
3,GO SEROTONIN SECRETION,0.00052901,-0.31936,-0.24981,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.2444e-07,-0.31951,-0.40123,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,1.451e-12,-0.31956,-0.43243,1,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.7442e-10,-0.31971,-0.45317,1,0
3,GO DEVELOPMENTAL GROWTH,3.7735e-12,-0.31972,-0.41405,1,0
3,GO RESPONSE TO PROTOZOAN,4.7963e-08,-0.31976,-0.40965,1,0
3,GO RESPONSE TO BACTERIUM,1.2074e-11,-0.31977,-0.37073,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.3647e-09,-0.31978,-0.37756,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,4.9872e-09,-0.31994,-0.37326,1,0
3,GO REGULATION OF T CELL ACTIVATION,2.7797e-11,-0.32,-0.38492,1,0
3,GO CELL ACTIVATION,3.9963e-12,-0.32018,-0.39815,1,0
3,GO B CELL APOPTOTIC PROCESS,1.2253e-05,-0.32019,-0.35511,1,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,5.0135e-13,-0.32019,-0.42144,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.0322e-07,-0.32023,-0.4843,1,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,3.5412e-09,-0.3203,-0.39608,1,0
3,GO WATER HOMEOSTASIS,1.9546e-09,-0.32033,-0.39092,1,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0030839,-0.32037,-0.30448,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,5.2253e-10,-0.3204,-0.37129,1,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,5.2253e-10,-0.32041,-0.41261,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.1097e-10,-0.32043,-0.43134,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,9.8716e-08,-0.32047,-0.34996,1,0
3,GO LATERAL MESODERM DEVELOPMENT,1.3948e-05,-0.3205,-0.35363,1,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,1.7442e-10,-0.32056,-0.35698,1,0
3,GO TISSUE MORPHOGENESIS,8.1414e-12,-0.32058,-0.41061,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.6112e-12,-0.32059,-0.38514,1,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,3.8645e-11,-0.32062,-0.37776,1,0
3,GO LIPID LOCALIZATION,3.3639e-12,-0.32067,-0.39138,1,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,4.5822e-08,-0.32071,-0.4481,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,5.6245e-08,-0.32079,-0.43461,1,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,1.3039e-08,-0.32085,-0.33405,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.8318e-07,-0.32089,-0.36208,1,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0032078,-0.32091,-0.29049,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,7.1726e-09,-0.32097,-0.36073,1,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00069207,-0.32114,-0.34203,1,0
3,GO ICOSANOID METABOLIC PROCESS,6.5125e-09,-0.32123,-0.33802,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,3.7735e-12,-0.32127,-0.38997,1,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,1.7442e-10,-0.32133,-0.35449,1,0
3,GO SELECTIVE AUTOPHAGY,2.5066e-09,-0.32141,-0.37118,1,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,1.8793e-06,-0.32154,-0.38081,1,0
3,GO SENSORY PERCEPTION OF PAIN,1.8881e-10,-0.32163,-0.34082,1,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,9.9064e-10,-0.32169,-0.40761,1,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,3.8313e-13,-0.32174,-0.46358,1,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,2.8299e-12,-0.32176,-0.43288,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,2.2453e-12,-0.32179,-0.38284,1,0
3,GO RESPONSE TO CAMP,5.9748e-11,-0.32182,-0.38705,1,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.2094e-09,-0.32183,-0.37664,1,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.9624e-10,-0.32188,-0.37769,1,0
3,GO REGULATION OF BLOOD PRESSURE,8.1414e-12,-0.32193,-0.38893,1,0
3,GO POTASSIUM ION HOMEOSTASIS,7.0522e-08,-0.32195,-0.3495,1,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,1.8723e-07,-0.32195,-0.38761,1,0
3,GO ESTROGEN METABOLIC PROCESS,1.7922e-07,-0.32203,-0.29041,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.3468e-07,-0.32208,-0.39499,1,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.1165e-05,-0.32208,-0.34613,1,0
3,GO LYMPHOCYTE HOMEOSTASIS,4.1403e-10,-0.32218,-0.38032,1,0
3,GO CORTICOSTEROID HORMONE SECRETION,1.0958e-05,-0.32227,-0.33394,1,0
3,GO PLASMA MEMBRANE FUSION,4.2271e-06,-0.32234,-0.37414,1,0
3,GO REGULATION OF ION TRANSPORT,1.736e-11,-0.32238,-0.36093,1,0
3,GO REGULATION OF TRANSPOSITION,0.00013673,-0.32243,-0.33654,1,0
3,GO HISTAMINE SECRETION,0.0023009,-0.32246,-0.29627,1,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,1.3468e-07,-0.32247,-0.38497,1,0
3,GO SOMITE DEVELOPMENT,2.2286e-07,-0.32247,-0.32915,1,0
3,GO ANIMAL ORGAN FORMATION,1.2759e-09,-0.32271,-0.38055,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.3697e-11,-0.32277,-0.39746,1,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,3.1098e-10,-0.32282,-0.36153,1,0
3,GO LYMPHOCYTE ACTIVATION,3.9963e-12,-0.32284,-0.39675,1,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,4.1815e-08,-0.32287,-0.34186,1,0
3,GO MOLTING CYCLE,6.4805e-11,-0.32298,-0.39405,1,0
3,GO ACTIN FILAMENT ORGANIZATION,8.5514e-13,-0.32311,-0.45772,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,3.1479e-07,-0.32312,-0.37807,1,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.0856e-12,-0.32317,-0.44969,1,0
3,GO APPENDAGE DEVELOPMENT,1.0519e-10,-0.32325,-0.42761,1,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,7.479e-12,-0.32334,-0.39682,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,1.8353e-11,-0.32343,-0.3779,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,4.2444e-07,-0.32345,-0.39643,1,0
3,GO T CELL CYTOKINE PRODUCTION,3.4553e-09,-0.3235,-0.35248,1,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,2.4528e-05,-0.32355,-0.32968,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,2.4214e-11,-0.32359,-0.39688,1,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,3.9941e-08,-0.32364,-0.32745,1,0
3,GO REGULATION OF T CELL MIGRATION,3.019e-11,-0.32365,-0.40168,1,0
3,GO RESPONSE TO AMINE,8.9047e-09,-0.32365,-0.33687,1,0
3,GO JNK CASCADE,5.9937e-13,-0.32389,-0.43273,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,1.155e-06,-0.32403,-0.39646,1,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,3.6361e-10,-0.32409,-0.39234,1,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,8.3747e-12,-0.32411,-0.37856,1,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,4.3549e-12,-0.32412,-0.39691,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,1.2604e-07,-0.32416,-0.39536,1,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00023294,-0.32424,-0.37042,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.2286e-07,-0.32427,-0.39734,1,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,1.5027e-08,-0.32427,-0.40908,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,4.3082e-09,-0.32428,-0.40196,1,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,3.2894e-09,-0.3243,-0.39755,1,0
3,GO NATURAL KILLER CELL ACTIVATION,5.3647e-09,-0.32433,-0.37885,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.3948e-05,-0.32443,-0.31186,1,0
3,GO RESPONSE TO ESTRADIOL,6.4905e-12,-0.32445,-0.39281,1,0
3,GO DENDRITIC TRANSPORT,0.00013016,-0.32448,-0.37152,1,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,6.205e-09,-0.32448,-0.41995,1,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.2534e-06,-0.32451,-0.37908,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,1.9136e-07,-0.32454,-0.43854,1,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.00073415,-0.32462,-0.33459,1,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,5.02e-08,-0.32466,-0.37044,1,0
3,GO INTERLEUKIN 17 PRODUCTION,7.892e-08,-0.32466,-0.38489,1,0
3,GO LIPID PHOSPHORYLATION,6.3088e-12,-0.32467,-0.44369,1,0
3,GO REGULATION OF SENSORY PERCEPTION,4.7963e-08,-0.32478,-0.28189,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,2.4452e-09,-0.32481,-0.36283,1,0
3,GO RESPONSE TO ACTIVITY,5.5016e-10,-0.32488,-0.34852,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.996e-06,-0.32493,-0.35301,1,0
3,GO MYELOID CELL DIFFERENTIATION,2.3113e-12,-0.325,-0.41583,1,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,7.9144e-12,-0.32502,-0.36444,1,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,8.6579e-07,-0.32507,-0.35628,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,5.815e-11,-0.32509,-0.3887,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,8.0898e-09,-0.32525,-0.31321,1,0
3,GO STEROID CATABOLIC PROCESS,9.795e-06,-0.32531,-0.35021,1,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,2.7078e-07,-0.32532,-0.36127,1,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,1.0519e-10,-0.32561,-0.42068,1,0
3,GO ACYLGLYCEROL HOMEOSTASIS,1.7309e-08,-0.32566,-0.37322,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,1.5604e-09,-0.32567,-0.33472,1,0
3,GO PROGESTERONE METABOLIC PROCESS,0.001442,-0.32586,-0.34475,1,0
3,GO POSITIVE REGULATION OF CELL GROWTH,3.019e-11,-0.3259,-0.39246,1,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,2.9979e-12,-0.32592,-0.40934,1,0
3,GO REGULATION OF PROTEIN BINDING,7.3765e-13,-0.32595,-0.43547,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,2.3554e-11,-0.32605,-0.37575,1,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,8.4871e-11,-0.32606,-0.41806,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,5.3647e-09,-0.32606,-0.39037,1,0
3,GO APICAL JUNCTION ASSEMBLY,1.0781e-08,-0.32609,-0.43479,1,0
3,GO RESPONSE TO MISFOLDED PROTEIN,8.6937e-09,-0.32628,-0.4245,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,2.206e-06,-0.32628,-0.32428,1,0
3,GO RESPONSE TO VITAMIN A,5.2538e-08,-0.32657,-0.3495,1,0
3,GO REGULATION OF FATTY ACID TRANSPORT,7.5266e-09,-0.32659,-0.38211,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.6304e-12,-0.32664,-0.43141,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.9602e-08,-0.32665,-0.36878,1,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,4.6202e-07,-0.32676,-0.38707,1,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,2.2505e-06,-0.32697,-0.33946,1,0
3,GO THYMOCYTE APOPTOTIC PROCESS,4.7488e-06,-0.32703,-0.36544,1,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,3.462e-12,-0.32716,-0.38396,1,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0066851,-0.32739,-0.38329,1,0
3,GO EMBRYONIC MORPHOGENESIS,1.736e-11,-0.32743,-0.41274,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,7.0671e-12,-0.32744,-0.42492,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,1.4686e-11,-0.32749,-0.39962,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.8573e-11,-0.32765,-0.40185,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,7.5451e-08,-0.32768,-0.40216,1,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,6.3074e-11,-0.32771,-0.4222,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.5604e-09,-0.32788,-0.43153,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.6792e-10,-0.32794,-0.40378,1,0
3,GO CYTOKINE METABOLIC PROCESS,1.1099e-11,-0.32797,-0.42048,1,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.1535e-07,-0.32804,-0.34811,1,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,2.7286e-10,-0.32812,-0.38536,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0033361,-0.32813,-0.36036,1,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,7.0279e-11,-0.32814,-0.40315,1,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,1.1579e-08,-0.32817,-0.42021,1,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,2.1064e-09,-0.32822,-0.40076,1,0
3,GO MESODERM MORPHOGENESIS,1.2023e-10,-0.32826,-0.41376,1,0
3,GO ENDOCYTIC RECYCLING,7.4177e-11,-0.32832,-0.44407,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,1.6109e-10,-0.32833,-0.39267,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.6112e-12,-0.32833,-0.38152,1,0
3,GO CYSTEINE METABOLIC PROCESS,0.00027284,-0.32853,-0.32884,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,5.9748e-11,-0.32857,-0.41605,1,0
3,GO REGULATION OF TUBE SIZE,9.6431e-12,-0.32859,-0.37494,1,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,9.3415e-09,-0.32867,-0.38038,1,0
3,GO DENDRITIC CELL CHEMOTAXIS,3.2894e-09,-0.32867,-0.38212,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,4.9403e-11,-0.32868,-0.37284,1,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,1.2482e-05,-0.3287,-0.32997,1,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,7.8976e-09,-0.32875,-0.30411,1,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,7.2129e-08,-0.32875,-0.45708,1,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,9.4157e-10,-0.32876,-0.36023,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,4.9069e-08,-0.32881,-0.4012,1,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.0237e-12,-0.32884,-0.42662,1,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00013899,-0.32906,-0.33327,1,0
3,GO ANIMAL ORGAN MORPHOGENESIS,6.9522e-13,-0.32927,-0.42131,1,0
3,GO PROSTATE GLAND GROWTH,4.9694e-05,-0.3293,-0.32389,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,8.9558e-11,-0.32933,-0.4616,1,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.2785e-11,-0.32934,-0.36742,1,0
3,GO REGULATION OF GASTRULATION,1.9905e-10,-0.32938,-0.46085,1,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,4.8076e-11,-0.3295,-0.36462,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,1.3196e-05,-0.3295,-0.38125,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,4.3236e-05,-0.32958,-0.35947,1,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1.7442e-10,-0.3296,-0.39132,1,0
3,GO VIRAL GENOME REPLICATION,1.0279e-08,-0.32962,-0.38896,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.1552e-07,-0.32962,-0.39043,1,0
3,GO RESPONSE TO MINERALOCORTICOID,1.9014e-08,-0.32984,-0.34184,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,5.5078e-11,-0.33005,-0.38347,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.0983e-10,-0.33006,-0.39368,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.7922e-07,-0.33008,-0.4055,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8976e-09,-0.33011,-0.36938,1,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,8.5858e-05,-0.33016,-0.29745,1,0
3,GO MITOPHAGY,8.8282e-08,-0.33028,-0.3582,1,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,9.819e-05,-0.33034,-0.34262,1,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,6.4192e-10,-0.33039,-0.40116,1,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,9.3425e-13,-0.33048,-0.43822,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.2903e-10,-0.33048,-0.41327,1,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.1828e-09,-0.33052,-0.34289,1,0
3,GO RESPONSE TO GONADOTROPIN,1.4334e-08,-0.33052,-0.37213,1,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,3.0295e-08,-0.3306,-0.42967,1,0
3,GO PROTEIN AUTOPHOSPHORYLATION,9.9094e-13,-0.33093,-0.46491,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,4.1815e-08,-0.33103,-0.34601,1,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,2.9805e-09,-0.33112,-0.37327,1,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,1.5674e-06,-0.33112,-0.32896,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.5604e-09,-0.33124,-0.43386,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,8.9558e-11,-0.33125,-0.40619,1,0
3,GO THYROID HORMONE METABOLIC PROCESS,4.5239e-09,-0.33127,-0.35037,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,3.247e-08,-0.33132,-0.37024,1,0
3,GO OVULATION,2.5756e-08,-0.33145,-0.36622,1,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,4.3997e-05,-0.33147,-0.33528,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9963e-12,-0.33148,-0.40926,1,0
3,GO CANONICAL WNT SIGNALING PATHWAY,1.8863e-12,-0.33148,-0.41366,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.3312e-10,-0.33155,-0.34877,1,0
3,GO FAT CELL DIFFERENTIATION,2.9127e-12,-0.33156,-0.43268,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,4.249e-10,-0.33157,-0.35601,1,0
3,GO NEURAL TUBE FORMATION,7.5266e-09,-0.33162,-0.39757,1,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00054518,-0.33165,-0.35135,1,0
3,GO REGULATION OF LIPASE ACTIVITY,7.6205e-11,-0.33168,-0.35996,1,0
3,GO LYMPHOCYTE COSTIMULATION,1.0964e-09,-0.33173,-0.4023,1,0
3,GO MYOBLAST DIFFERENTIATION,7.8286e-11,-0.33174,-0.39892,1,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,1.1099e-11,-0.33184,-0.41152,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,1.4112e-09,-0.3319,-0.43365,1,0
3,GO DENTATE GYRUS DEVELOPMENT,0.00013673,-0.3319,-0.32457,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.719e-07,-0.33191,-0.35185,1,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,8.4415e-08,-0.33201,-0.39181,1,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,6.1744e-13,-0.33202,-0.42148,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,8.5514e-13,-0.33206,-0.44314,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.6581e-10,-0.33224,-0.38012,1,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,9.9064e-10,-0.33224,-0.369,1,0
3,GO DENDRITE DEVELOPMENT,7.8976e-09,-0.33236,-0.40725,1,0
3,GO REGULATION OF SODIUM ION TRANSPORT,1.5688e-10,-0.3324,-0.42202,1,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,1.4472e-05,-0.33243,-0.40036,1,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,9.1996e-11,-0.33243,-0.39385,1,0
3,GO POSITIVE REGULATION OF CELL DIVISION,1.5604e-09,-0.33244,-0.37697,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.8573e-08,-0.33264,-0.44874,1,0
3,GO MYELOID CELL HOMEOSTASIS,9.1996e-11,-0.33283,-0.40597,1,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,2.634e-09,-0.33308,-0.41,1,0
3,GO AMINO SUGAR CATABOLIC PROCESS,4.3082e-09,-0.33309,-0.36981,1,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.1807e-07,-0.33312,-0.37486,1,0
3,GO SKIN DEVELOPMENT,1.0161e-09,-0.33315,-0.38983,1,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,5.4701e-07,-0.33315,-0.43395,1,0
3,GO CATECHOLAMINE SECRETION,6.7724e-05,-0.33326,-0.31814,1,0
3,GO CHLORIDE TRANSPORT,4.8076e-11,-0.33335,-0.35626,1,0
3,GO LONG TERM SYNAPTIC DEPRESSION,3.0302e-06,-0.33353,-0.34954,1,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.232e-12,-0.33353,-0.37571,1,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,3.462e-12,-0.33354,-0.39188,1,0
3,GO REGULATION OF BLOOD CIRCULATION,4.6784e-11,-0.33377,-0.39548,1,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,6.8885e-07,-0.33385,-0.36103,1,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,3.8347e-06,-0.33393,-0.38273,1,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.5753e-08,-0.33393,-0.40306,1,0
3,GO LIPID IMPORT INTO CELL,3.0156e-07,-0.33406,-0.38241,1,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,3.9064e-09,-0.33418,-0.41572,1,0
3,GO EXCRETION,6.3074e-11,-0.33423,-0.37948,1,0
3,GO HEART PROCESS,3.8645e-11,-0.33426,-0.38933,1,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.0478e-05,-0.33432,-0.31247,1,0
3,GO NOREPINEPHRINE TRANSPORT,1.9563e-06,-0.33438,-0.36722,1,0
3,GO AMINE TRANSPORT,2.3661e-05,-0.33441,-0.29286,1,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,1.1316e-06,-0.33442,-0.33605,1,0
3,GO CYTOKINE PRODUCTION,1.0493e-11,-0.33445,-0.40536,1,0
3,GO REGULATION OF VESICLE FUSION,5.0323e-06,-0.33451,-0.42566,1,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,3.5018e-13,-0.33462,-0.45219,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,5.3186e-12,-0.33466,-0.4113,1,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.586e-10,-0.33481,-0.39174,1,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,1.642e-11,-0.33482,-0.39219,1,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,3.6586e-11,-0.33483,-0.40929,1,0
3,GO IMMUNE EFFECTOR PROCESS,2.4214e-11,-0.33496,-0.39641,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.1815e-08,-0.335,-0.35289,1,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,3.0296e-10,-0.33501,-0.37354,1,0
3,GO CELL JUNCTION ORGANIZATION,2.2453e-12,-0.33505,-0.47552,1,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00020835,-0.33511,-0.32636,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.8198e-07,-0.33514,-0.46871,1,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,1.6994e-06,-0.33524,-0.406,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,7.3772e-08,-0.33534,-0.41171,1,0
3,GO DEFENSE RESPONSE TO VIRUS,2.0881e-08,-0.33541,-0.39949,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.634e-09,-0.33542,-0.40473,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.004e-09,-0.33545,-0.41774,1,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,8.0424e-11,-0.3355,-0.3826,1,0
3,GO INTERFERON GAMMA PRODUCTION,4.1025e-09,-0.33552,-0.36561,1,0
3,GO SKELETAL SYSTEM DEVELOPMENT,8.5514e-13,-0.33552,-0.44535,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,7.5266e-09,-0.33552,-0.40655,1,0
3,GO ENTRY INTO HOST,5.3602e-11,-0.33561,-0.4617,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,7.6792e-10,-0.33571,-0.40551,1,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,7.1726e-09,-0.33576,-0.44538,1,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,1.439e-07,-0.33584,-0.36464,1,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,1.1245e-09,-0.33591,-0.39971,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.4634e-11,-0.33594,-0.43862,1,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,9.028e-08,-0.33598,-0.38212,1,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,5.1652e-13,-0.33616,-0.43352,1,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,9.4407e-08,-0.33618,-0.4621,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,5.5078e-11,-0.33634,-0.392,1,0
3,GO RESPONSE TO STEROL DEPLETION,3.1479e-07,-0.33641,-0.38889,1,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,3.2785e-11,-0.33642,-0.43235,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,2.8369e-09,-0.33644,-0.4062,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2074e-11,-0.33644,-0.41976,1,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,6.6066e-07,-0.33654,-0.35057,1,0
3,GO AMMONIUM ION METABOLIC PROCESS,1.6761e-05,-0.33657,-0.3232,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.9834e-06,-0.33657,-0.41623,1,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,7.7166e-08,-0.3366,-0.35211,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,3.6586e-11,-0.33668,-0.39449,1,0
3,GO ENERGY RESERVE METABOLIC PROCESS,1.0964e-09,-0.33674,-0.38818,1,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,1.9948e-11,-0.33677,-0.44184,1,0
3,GO RESPONSE TO WATER,6.1119e-05,-0.33682,-0.34334,1,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,1.5838e-12,-0.33688,-0.44311,1,0
3,GO SEQUESTERING OF CALCIUM ION,7.2202e-11,-0.33691,-0.39185,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.9309e-10,-0.33696,-0.35914,1,0
3,GO MONONUCLEAR CELL MIGRATION,3.2094e-09,-0.3371,-0.36309,1,0
3,GO KIDNEY MORPHOGENESIS,5.2253e-10,-0.33722,-0.39572,1,0
3,GO DENDRITE MORPHOGENESIS,2.7614e-08,-0.33722,-0.41455,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.3933e-10,-0.3373,-0.40969,1,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,8.4871e-11,-0.33748,-0.36918,1,0
3,GO POSITIVE T CELL SELECTION,1.5994e-06,-0.33751,-0.29845,1,0
3,GO SMOOTH MUSCLE CONTRACTION,6.6774e-12,-0.33757,-0.39164,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.2434e-08,-0.33759,-0.39642,1,0
3,GO WHITE FAT CELL DIFFERENTIATION,8.7184e-11,-0.33761,-0.39537,1,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,3.9309e-10,-0.33777,-0.44385,1,0
3,GO AMINO SUGAR METABOLIC PROCESS,6.586e-10,-0.33785,-0.36503,1,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,1.9989e-07,-0.33789,-0.34267,1,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,3.1004e-08,-0.3379,-0.40659,1,0
3,GO STEROL HOMEOSTASIS,2.457e-10,-0.33794,-0.40301,1,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,1.2032e-06,-0.33798,-0.35504,1,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,1.4686e-11,-0.33804,-0.41408,1,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,3.8833e-12,-0.33805,-0.42224,1,0
3,GO CELLULAR RESPONSE TO X RAY,1.5713e-07,-0.33807,-0.35219,1,0
3,GO RESPONSE TO ACIDIC PH,7.6446e-07,-0.3381,-0.42784,1,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,1.1245e-09,-0.33814,-0.42111,1,0
3,GO T CELL DIFFERENTIATION,1.277e-11,-0.33821,-0.38753,1,0
3,GO REGULATION OF HISTONE DEACETYLATION,1.9558e-07,-0.33827,-0.37587,1,0
3,GO MESONEPHROS DEVELOPMENT,5.1101e-09,-0.33827,-0.39772,1,0
3,GO RESPONSE TO LIPID,9.3425e-13,-0.33831,-0.40163,1,0
3,GO POSITIVE REGULATION OF CELL DEATH,4.3184e-13,-0.33832,-0.41244,1,0
3,GO REGULATION OF MAPK CASCADE,6.7492e-13,-0.33833,-0.4325,1,0
3,GO REGULATION OF B CELL ACTIVATION,1.6109e-10,-0.33834,-0.39943,1,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,4.3355e-07,-0.33842,-0.39711,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,1.2131e-09,-0.33847,-0.37256,1,0
3,GO RESPONSE TO STEROID HORMONE,1.494e-12,-0.33861,-0.41275,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2348e-10,-0.33863,-0.39827,1,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,6.2993e-08,-0.33863,-0.46769,1,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,7.5266e-09,-0.33877,-0.40218,1,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00015083,-0.33884,-0.25842,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,2.457e-10,-0.33889,-0.38942,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.5223e-10,-0.33906,-0.42485,1,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,3.247e-08,-0.33913,-0.42846,1,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,3.0296e-10,-0.33922,-0.39291,1,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,2.8573e-11,-0.33945,-0.37359,1,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,1.069e-09,-0.33971,-0.42628,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,9.1146e-12,-0.33975,-0.38695,1,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.2046e-07,-0.33985,-0.39904,1,0
3,GO RECEPTOR INTERNALIZATION,3.6667e-12,-0.33987,-0.41572,1,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,3.7319e-10,-0.33988,-0.36117,1,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,2.1543e-10,-0.33989,-0.41571,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.0424e-11,-0.33993,-0.43532,1,0
3,GO CELLULAR RESPONSE TO CAMP,2.8753e-10,-0.33993,-0.37872,1,0
3,GO COPPER ION HOMEOSTASIS,1.3671e-08,-0.33994,-0.39093,1,0
3,GO REGULATION OF ENDOCYTOSIS,2.3793e-12,-0.33996,-0.4382,1,0
3,GO REGULATION OF CARDIAC CONDUCTION,2.1375e-08,-0.34005,-0.36368,1,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.069e-09,-0.34007,-0.36309,1,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.1726e-09,-0.34008,-0.45256,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,6.205e-09,-0.3401,-0.39886,1,0
3,GO REGENERATION,1.5383e-12,-0.3401,-0.41124,1,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,4.1403e-10,-0.34016,-0.34803,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,2.1085e-11,-0.34019,-0.42241,1,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,5.3747e-08,-0.3402,-0.38949,1,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,3.5038e-07,-0.34021,-0.37704,1,0
3,GO AUTOPHAGY OF NUCLEUS,5.9116e-09,-0.3404,-0.38822,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.2143e-08,-0.34042,-0.45176,1,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,7.3476e-09,-0.3405,-0.40974,1,0
3,GO MALE GENITALIA DEVELOPMENT,5.7536e-08,-0.34056,-0.38141,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4454e-06,-0.34068,-0.37572,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.4741e-05,-0.34081,-0.44232,1,0
3,GO CENTRIOLE CENTRIOLE COHESION,6.8885e-07,-0.34081,-0.4046,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.2707e-10,-0.34082,-0.40204,1,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,1.3351e-08,-0.34082,-0.40316,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,1.5217e-09,-0.34084,-0.38648,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0020929,-0.3409,-0.2672,1,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,2.9515e-10,-0.34091,-0.41314,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,1.6062e-07,-0.34094,-0.41741,1,0
3,GO PRO B CELL DIFFERENTIATION,7.892e-08,-0.34095,-0.43853,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,2.3312e-10,-0.34105,-0.43939,1,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,8.5867e-06,-0.34109,-0.38759,1,0
3,GO RESPONSE TO FATTY ACID,6.3074e-11,-0.34112,-0.38615,1,0
3,GO LEUKOCYTE DIFFERENTIATION,2.1812e-12,-0.3412,-0.41432,1,0
3,GO ACROSOME ASSEMBLY,6.9711e-06,-0.34123,-0.32588,1,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,9.1205e-09,-0.34127,-0.40268,1,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.1858e-08,-0.34134,-0.38518,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.9487e-10,-0.34137,-0.42744,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,1.7309e-08,-0.3414,-0.40208,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,8.3013e-05,-0.3414,-0.38284,1,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.5893e-10,-0.34157,-0.3939,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.4157e-10,-0.34163,-0.41335,1,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,1.2328e-07,-0.34167,-0.41375,1,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,6.3604e-13,-0.3417,-0.4618,1,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,2.7e-09,-0.34171,-0.39288,1,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.3554e-11,-0.34172,-0.36832,1,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,5.4724e-12,-0.3418,-0.40811,1,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,9.4407e-08,-0.34187,-0.4162,1,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,5.0237e-12,-0.34192,-0.4428,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,7.479e-12,-0.34195,-0.3869,1,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,3.9717e-11,-0.34198,-0.43397,1,0
3,GO MECHANORECEPTOR DIFFERENTIATION,5.7051e-07,-0.34205,-0.34563,1,0
3,GO PRESYNAPSE ORGANIZATION,1.2604e-07,-0.34211,-0.39295,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.3737e-10,-0.34218,-0.40596,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,6.5906e-08,-0.3422,-0.36055,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.6001e-09,-0.34237,-0.44791,1,0
3,GO REGULATION OF CELL CELL ADHESION,3.0856e-12,-0.34244,-0.43511,1,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,8.0424e-11,-0.34255,-0.38057,1,0
3,GO CELL JUNCTION ASSEMBLY,2.3793e-12,-0.34257,-0.47563,1,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,9.9185e-12,-0.34264,-0.39195,1,0
3,GO REGULATION OF DENDRITE EXTENSION,0.0014624,-0.34265,-0.27249,1,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,2.3933e-10,-0.34286,-0.44611,1,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,1.2682e-10,-0.34292,-0.40631,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.6306e-11,-0.34306,-0.42387,1,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,7.0017e-09,-0.34309,-0.39584,1,0
3,GO RESPONSE TO DRUG,5.1691e-12,-0.34316,-0.4002,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00034485,-0.34331,-0.4354,1,0
3,GO BODY FLUID SECRETION,4.1948e-11,-0.34342,-0.3646,1,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,1.0241e-10,-0.34344,-0.39613,1,0
3,GO TISSUE HOMEOSTASIS,1.0493e-11,-0.34344,-0.37868,1,0
3,GO GLIAL CELL DIFFERENTIATION,1.2074e-11,-0.34348,-0.42496,1,0
3,GO REGULATION OF MITOPHAGY,2.538e-07,-0.34353,-0.37514,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.7442e-10,-0.34358,-0.44292,1,0
3,GO INTERLEUKIN 8 PRODUCTION,5.1101e-09,-0.3437,-0.42202,1,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.1552e-07,-0.3437,-0.44805,1,0
3,GO GENITALIA DEVELOPMENT,1.0493e-11,-0.34378,-0.39697,1,0
3,GO MEMORY,2.3554e-11,-0.34378,-0.41701,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,1.8863e-12,-0.34382,-0.44271,1,0
3,GO CELLULAR RESPONSE TO LIPID,1.2534e-12,-0.34402,-0.40645,1,0
3,GO IRON COORDINATION ENTITY TRANSPORT,6.0759e-07,-0.34405,-0.38161,1,0
3,GO REGULATION OF HEART GROWTH,1.9402e-11,-0.34409,-0.41452,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,2.7e-09,-0.34417,-0.53641,1,0
3,GO GOLGI RIBBON FORMATION,3.2859e-07,-0.3442,-0.43238,1,0
3,GO CYTOKINE SECRETION,2.5893e-10,-0.34422,-0.35805,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.6109e-10,-0.34426,-0.36476,1,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,5.4967e-09,-0.34432,-0.33403,1,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,6.0979e-10,-0.34433,-0.36563,1,0
3,GO ENSHEATHMENT OF NEURONS,3.2685e-12,-0.34435,-0.43392,1,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,1.7706e-05,-0.34441,-0.33411,1,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,7.5451e-08,-0.34463,-0.39081,1,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,4.5843e-13,-0.34479,-0.41603,1,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,5.2359e-09,-0.34483,-0.41199,1,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,2.0853e-05,-0.34484,-0.47609,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.7286e-10,-0.34495,-0.43686,1,0
3,GO POSITIVE REGULATION OF HEART GROWTH,8.7184e-11,-0.34504,-0.41689,1,0
3,GO CARDIOCYTE DIFFERENTIATION,3.5427e-10,-0.34506,-0.40772,1,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,6.8396e-06,-0.34508,-0.37477,1,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,1.439e-07,-0.34515,-0.39346,1,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00024045,-0.34517,-0.33686,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.9064e-09,-0.34518,-0.42767,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.7797e-11,-0.34519,-0.40459,1,0
3,GO CELL PART MORPHOGENESIS,6.9323e-10,-0.34526,-0.42352,1,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,1.9948e-11,-0.34529,-0.43911,1,0
3,GO GLIOGENESIS,3.1757e-12,-0.34532,-0.42375,1,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.1032e-11,-0.34539,-0.43603,1,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,7.8976e-09,-0.34546,-0.36183,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,6.552e-13,-0.34553,-0.46137,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,2.9078e-09,-0.34554,-0.43826,1,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,4.0817e-11,-0.34555,-0.42632,1,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,4.7232e-13,-0.34557,-0.45376,1,0
3,GO T CELL PROLIFERATION,4.4749e-10,-0.34571,-0.37558,1,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,8.6145e-12,-0.34574,-0.40041,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.484e-09,-0.34574,-0.42515,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0424e-06,-0.34586,-0.36617,1,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1.2716e-05,-0.34591,-0.41584,1,0
3,GO LEUKOCYTE CHEMOTAXIS,2.4214e-11,-0.34594,-0.3915,1,0
3,GO RESPONSE TO DIETARY EXCESS,6.6578e-05,-0.34604,-0.32675,1,0
3,GO IMPORT INTO CELL,8.4871e-11,-0.34604,-0.39188,1,0
3,GO TRANSMISSION OF NERVE IMPULSE,4.0678e-07,-0.34605,-0.36611,1,0
3,GO ERBB SIGNALING PATHWAY,4.3549e-12,-0.34612,-0.44163,1,0
3,GO FOREBRAIN NEURON DEVELOPMENT,9.086e-06,-0.34619,-0.44017,1,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.758e-05,-0.34629,-0.36693,1,0
3,GO INFLAMMATORY RESPONSE,1.0202e-11,-0.34634,-0.39624,1,0
3,GO CARNITINE SHUTTLE,6.2993e-08,-0.34635,-0.42042,1,0
3,GO CGMP MEDIATED SIGNALING,7.8976e-09,-0.34636,-0.38977,1,0
3,GO DORSAL AORTA DEVELOPMENT,3.9102e-06,-0.3464,-0.47098,1,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00017457,-0.34649,-0.34755,1,0
3,GO SYNAPSE ASSEMBLY,1.6907e-08,-0.34651,-0.40602,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,1.8318e-07,-0.34664,-0.42299,1,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,8.3026e-13,-0.34665,-0.44913,1,0
3,GO LYSOSOME LOCALIZATION,4.8359e-10,-0.34676,-0.39521,1,0
3,GO REGULATION OF PROTEIN DEACETYLATION,1.1858e-08,-0.34693,-0.38947,1,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,1.1579e-08,-0.34699,-0.43569,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,2.7668e-07,-0.34703,-0.42352,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,3.7195e-09,-0.34708,-0.43626,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,1.4207e-05,-0.34714,-0.37338,1,0
3,GO REGULATION OF LIPID TRANSPORT,5.2165e-11,-0.34716,-0.37622,1,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,9.7998e-07,-0.34719,-0.3782,1,0
3,GO T CELL ACTIVATION,1.5968e-11,-0.34726,-0.40109,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.6293e-09,-0.34728,-0.40348,1,0
3,GO ACTION POTENTIAL,1.9465e-08,-0.34729,-0.3851,1,0
3,GO NEUROINFLAMMATORY RESPONSE,1.5102e-11,-0.34732,-0.40358,1,0
3,GO LEUKOCYTE PROLIFERATION,1.4877e-10,-0.34734,-0.39051,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,6.9323e-10,-0.34744,-0.35866,1,0
3,GO ADRENAL GLAND DEVELOPMENT,3.4409e-05,-0.34745,-0.39613,1,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,1.996e-06,-0.34747,-0.40469,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,1.5529e-11,-0.34752,-0.41259,1,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.3933e-10,-0.34764,-0.40722,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.7286e-10,-0.34765,-0.34763,1,0
3,GO KERATINOCYTE MIGRATION,2.7797e-11,-0.34767,-0.43382,1,0
3,GO LEUKOCYTE TETHERING OR ROLLING,1.1533e-09,-0.3478,-0.3409,1,0
3,GO FRUCTOSE METABOLIC PROCESS,0.0012886,-0.34782,-0.36415,1,0
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,8.5043e-10,-0.34788,-0.36234,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,3.3228e-08,-0.3481,-0.43005,1,0
3,GO FILOPODIUM ASSEMBLY,2.5223e-10,-0.34812,-0.47847,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.6245e-08,-0.34819,-0.39735,1,0
3,GO RETINAL METABOLIC PROCESS,0.00029052,-0.34821,-0.3594,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,3.4634e-11,-0.34833,-0.40766,1,0
3,GO REGULATION OF MAP KINASE ACTIVITY,1.2534e-12,-0.3485,-0.45339,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.2792e-06,-0.34852,-0.32194,1,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,7.2414e-06,-0.34865,-0.29351,1,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.0013826,-0.34869,-0.3143,1,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,9.1205e-09,-0.34904,-0.3754,1,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,1.9014e-08,-0.34906,-0.3875,1,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,2.011e-05,-0.3491,-0.38601,1,0
3,GO T CELL LINEAGE COMMITMENT,6.2169e-06,-0.34921,-0.29728,1,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,7.2964e-10,-0.34926,-0.47039,1,0
3,GO REGULATORY T CELL DIFFERENTIATION,1.4076e-07,-0.34936,-0.41573,1,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,3.2094e-09,-0.34947,-0.42364,1,0
3,GO MONOAMINE TRANSPORT,7.3803e-06,-0.34952,-0.33529,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,1.5217e-09,-0.34952,-0.47508,1,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,7.8261e-13,-0.34955,-0.44395,1,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,5.9834e-06,-0.34956,-0.35675,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,2.1595e-09,-0.34966,-0.47794,1,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,9.658e-10,-0.3497,-0.4277,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.9717e-11,-0.3498,-0.4371,1,0
3,GO RESPONSE TO TESTOSTERONE,1.3769e-07,-0.34999,-0.34389,1,0
3,GO PHAGOCYTOSIS RECOGNITION,2.5756e-08,-0.35001,-0.43983,1,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,2.9602e-08,-0.35003,-0.38834,1,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,3.6586e-11,-0.35004,-0.36785,1,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.3056e-06,-0.35012,-0.32613,1,0
3,GO REGULATION OF PINOCYTOSIS,2.1807e-07,-0.35023,-0.40583,1,0
3,GO ADIPOSE TISSUE DEVELOPMENT,1.6514e-08,-0.35029,-0.38753,1,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,1.0791e-07,-0.35036,-0.37887,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.8662e-13,-0.35043,-0.42903,1,0
3,GO REGULATION OF ORGAN GROWTH,1.736e-11,-0.35052,-0.4041,1,0
3,GO INOSITOL METABOLIC PROCESS,2.2958e-06,-0.3506,-0.36334,1,0
3,GO FIBROBLAST APOPTOTIC PROCESS,9.5677e-09,-0.35069,-0.42334,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.3468e-07,-0.35071,-0.37313,1,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0013826,-0.35078,-0.34866,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,9.7068e-11,-0.35084,-0.40765,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0027747,-0.35099,-0.35009,1,0
3,GO LIPID HOMEOSTASIS,1.5102e-11,-0.35142,-0.38794,1,0
3,GO AMYLOID BETA METABOLIC PROCESS,1.3737e-10,-0.35146,-0.46137,1,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,2.2286e-11,-0.35159,-0.43864,1,0
3,GO RESPONSE TO ACID CHEMICAL,1.5968e-11,-0.35169,-0.40438,1,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,2.4452e-09,-0.35184,-0.3792,1,0
3,GO CELL PROLIFERATION IN FOREBRAIN,3.0811e-07,-0.35188,-0.4116,1,0
3,GO MACROPHAGE DIFFERENTIATION,1.1415e-11,-0.35199,-0.44674,1,0
3,GO ANIMAL ORGAN REGENERATION,3.2764e-10,-0.35203,-0.36748,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,1.3761e-09,-0.35206,-0.37522,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,6.4905e-12,-0.35222,-0.40053,1,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.6884e-11,-0.35228,-0.40728,1,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,2.0582e-12,-0.3523,-0.47397,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,2.9371e-11,-0.35238,-0.43708,1,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,1.0557e-05,-0.35243,-0.29831,1,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,6.0565e-09,-0.35249,-0.37837,1,0
3,GO PHOSPHOLIPID TRANSPORT,1.785e-11,-0.35257,-0.44524,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.4076e-07,-0.3526,-0.39136,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.5822e-08,-0.35265,-0.38651,1,0
3,GO REGULATION OF LIPID LOCALIZATION,1.0792e-11,-0.35289,-0.38998,1,0
3,GO ENDOCRINE PROCESS,6.8406e-11,-0.35289,-0.40383,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,1.5102e-11,-0.3529,-0.42384,1,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,3.7195e-09,-0.35295,-0.39521,1,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,4.0343e-10,-0.35305,-0.37452,1,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.1085e-11,-0.35327,-0.42534,1,0
3,GO CARDIAC CONDUCTION,3.7195e-09,-0.3533,-0.38643,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,3.8983e-07,-0.35335,-0.40376,1,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,9.1996e-11,-0.35337,-0.39838,1,0
3,GO REGULATION OF GTPASE ACTIVITY,9.3425e-13,-0.35345,-0.46839,1,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,7.2702e-12,-0.35348,-0.46672,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.6001e-09,-0.35351,-0.4452,1,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,2.2775e-07,-0.35353,-0.37809,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,8.1138e-06,-0.35353,-0.39331,1,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,4.719e-07,-0.35363,-0.36209,1,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,1.6407e-09,-0.35374,-0.41451,1,0
3,GO MAMMARY GLAND DEVELOPMENT,8.3747e-12,-0.35374,-0.45799,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,1.9948e-11,-0.3538,-0.40165,1,0
3,GO INTRACELLULAR LIPID TRANSPORT,5.2253e-10,-0.35391,-0.432,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,1.3888e-11,-0.35403,-0.41861,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,5.7582e-06,-0.35404,-0.37368,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,8.0712e-08,-0.35409,-0.38719,1,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,7.2414e-06,-0.35423,-0.38976,1,0
3,GO PLACENTA DEVELOPMENT,4.5922e-10,-0.35427,-0.40767,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.2359e-09,-0.35431,-0.41317,1,0
3,GO SECRETION BY TISSUE,1.2733e-08,-0.35442,-0.34235,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,8.2543e-08,-0.35448,-0.41386,1,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,8.0898e-09,-0.35457,-0.37293,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2131e-09,-0.35462,-0.41916,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0071051,-0.35463,-0.3129,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00043435,-0.35472,-0.38585,1,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,6.552e-13,-0.35473,-0.46762,1,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,8.8389e-07,-0.35478,-0.40665,1,0
3,GO ALPHA BETA T CELL ACTIVATION,6.9323e-10,-0.35482,-0.39412,1,0
3,GO HYALURONAN METABOLIC PROCESS,8.9558e-11,-0.35487,-0.42525,1,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.1812e-12,-0.35489,-0.41211,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,6.1583e-08,-0.35491,-0.44798,1,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.8983e-07,-0.35491,-0.38108,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,4.4749e-10,-0.35494,-0.4308,1,0
3,GO LIPOXYGENASE PATHWAY,0.00080175,-0.35512,-0.30523,1,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,5.3747e-08,-0.35512,-0.4033,1,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,2.1338e-07,-0.35522,-0.37256,1,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00036124,-0.35524,-0.33061,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.4634e-11,-0.3553,-0.39127,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.2784e-08,-0.3554,-0.43654,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.9078e-09,-0.35545,-0.42339,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.5037e-07,-0.35547,-0.42272,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,5.3617e-10,-0.35549,-0.41825,1,0
3,GO NEURON MIGRATION,8.0712e-08,-0.35561,-0.4025,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.7449e-12,-0.35569,-0.43553,1,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.8824e-12,-0.35574,-0.40582,1,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.2912e-11,-0.35574,-0.40616,1,0
3,GO EPITHELIAL CELL DEVELOPMENT,6.6774e-12,-0.35578,-0.49046,1,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,9.4407e-08,-0.3558,-0.41426,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.2129e-08,-0.35591,-0.39271,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,4.0033e-09,-0.35591,-0.39869,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.0493e-11,-0.35605,-0.45371,1,0
3,GO SYNAPSE ORGANIZATION,6.586e-10,-0.35613,-0.43396,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,7.2414e-06,-0.35615,-0.42222,1,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0011668,-0.3562,-0.35168,1,0
3,GO PINOCYTOSIS,1.3671e-08,-0.35625,-0.44116,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,3.1032e-11,-0.35631,-0.45382,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.462e-12,-0.35645,-0.42854,1,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,5.5078e-11,-0.35654,-0.42115,1,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.3355e-07,-0.35664,-0.389,1,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,6.3074e-11,-0.35665,-0.44779,1,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,5.1691e-12,-0.35676,-0.40089,1,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,1.6761e-05,-0.35681,-0.42333,1,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,3.6084e-13,-0.35682,-0.44332,1,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,8.2864e-09,-0.35693,-0.45583,1,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,1.6823e-09,-0.35694,-0.4041,1,0
3,GO STEROID HORMONE SECRETION,7.2129e-08,-0.35696,-0.37828,1,0
3,GO RESPONSE TO PROSTAGLANDIN E,4.5526e-11,-0.35703,-0.40361,1,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,1.2328e-07,-0.35729,-0.40205,1,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,2.3268e-09,-0.35736,-0.34829,1,0
3,GO REGULATION OF RECEPTOR RECYCLING,1.484e-09,-0.35738,-0.39284,1,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,1.1535e-07,-0.35743,-0.43148,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,2.402e-08,-0.35773,-0.4109,1,0
3,GO CALCINEURIN MEDIATED SIGNALING,3.7602e-11,-0.35801,-0.42363,1,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.1621e-05,-0.35807,-0.37188,1,0
3,GO STORE OPERATED CALCIUM ENTRY,1.5753e-08,-0.35811,-0.43105,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,7.7166e-08,-0.35816,-0.40857,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,7.71e-09,-0.35838,-0.3968,1,0
3,GO B CELL HOMEOSTASIS,1.0964e-09,-0.35843,-0.45232,1,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.6307e-12,-0.35861,-0.39875,1,0
3,GO SEGMENTATION,1.4487e-10,-0.35874,-0.38763,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.3133e-11,-0.35874,-0.39448,1,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,5.4701e-07,-0.35883,-0.34692,1,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.856e-06,-0.35895,-0.42452,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3085e-09,-0.35907,-0.40001,1,0
3,GO APPENDAGE MORPHOGENESIS,5.7923e-10,-0.35909,-0.43824,1,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,3.6435e-08,-0.35917,-0.42653,1,0
3,GO RESPONSE TO ESTROGEN,7.4177e-11,-0.3592,-0.42627,1,0
3,GO POST ANAL TAIL MORPHOGENESIS,1.0557e-05,-0.35929,-0.34299,1,0
3,GO NEGATIVE REGULATION OF GROWTH,6.1321e-12,-0.35952,-0.43456,1,0
3,GO INTERLEUKIN 13 PRODUCTION,6.4699e-07,-0.35962,-0.44145,1,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,1.0169e-05,-0.35972,-0.36169,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.4334e-08,-0.35978,-0.42599,1,0
3,GO T HELPER 1 CELL DIFFERENTIATION,9.404e-07,-0.35981,-0.49098,1,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.3793e-12,-0.35995,-0.43056,1,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,1.182e-12,-0.36017,-0.47112,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,6.7461e-07,-0.36021,-0.36529,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,5.2538e-08,-0.36021,-0.38994,1,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,3.1004e-08,-0.36024,-0.44307,1,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,2.5164e-08,-0.36025,-0.4309,1,0
3,GO POSITIVE REGULATION OF MYELINATION,1.069e-09,-0.36037,-0.39169,1,0
3,GO EOSINOPHIL MIGRATION,4.9694e-05,-0.36037,-0.36832,1,0
3,GO GROWTH HORMONE SECRETION,0.00063314,-0.36038,-0.38533,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,7.2202e-11,-0.36039,-0.40767,1,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,3.1032e-11,-0.36039,-0.41408,1,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,3.2764e-10,-0.36042,-0.42288,1,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.9989e-07,-0.36045,-0.39552,1,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,1.3085e-09,-0.36045,-0.42864,1,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,9.3415e-09,-0.36047,-0.39714,1,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,6.205e-09,-0.36056,-0.41268,1,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,6.586e-10,-0.36056,-0.45311,1,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.0011836,-0.36078,-0.30741,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.7602e-11,-0.3609,-0.41018,1,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.9926e-08,-0.36099,-0.40243,1,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,1.5994e-06,-0.36112,-0.43995,1,0
3,GO STRIATED MUSCLE CONTRACTION,9.4157e-10,-0.36117,-0.38366,1,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.1948e-11,-0.36152,-0.41635,1,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,2.9332e-05,-0.36153,-0.33955,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.3599e-06,-0.36155,-0.40943,1,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,3.7319e-10,-0.36156,-0.46383,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,5.9834e-06,-0.36166,-0.39662,1,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,1.9989e-07,-0.3617,-0.38879,1,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,7.0671e-12,-0.36172,-0.39682,1,0
3,GO DIVALENT METAL ION EXPORT,4.7963e-08,-0.3618,-0.42766,1,0
3,GO AMINO ACID IMPORT,3.7282e-08,-0.36214,-0.41062,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,5.02e-08,-0.36216,-0.41933,1,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,6.6581e-11,-0.3623,-0.37855,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,3.7195e-09,-0.36242,-0.40584,1,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,1.2682e-10,-0.3625,-0.43212,1,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.9941e-08,-0.36255,-0.43683,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.4305e-07,-0.36263,-0.41475,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,3.1032e-11,-0.36276,-0.44625,1,0
3,GO MUSCLE ADAPTATION,2.0983e-10,-0.36277,-0.43947,1,0
3,GO ZYMOGEN INHIBITION,1.8573e-08,-0.3629,-0.42355,1,0
3,GO REGULATION OF MAST CELL ACTIVATION,8.0712e-08,-0.36306,-0.3929,1,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0060595,-0.36306,-0.26514,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,5.793e-12,-0.3632,-0.46344,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,3.2685e-12,-0.36354,-0.44113,1,0
3,GO MONOCYTE CHEMOTAXIS,7.6446e-07,-0.36364,-0.3494,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.5526e-11,-0.3637,-0.38589,1,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,2.3784e-07,-0.36374,-0.35114,1,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,4.5822e-08,-0.36376,-0.35986,1,0
3,GO RESPONSE TO COLD,1.9563e-06,-0.36381,-0.37153,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,9.4341e-06,-0.36392,-0.38644,1,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,4.1026e-05,-0.3641,-0.41493,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.5164e-08,-0.36411,-0.4591,1,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,2.8753e-10,-0.36419,-0.46501,1,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,1.8723e-07,-0.36434,-0.41628,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,1.6062e-07,-0.36449,-0.41539,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0036e-08,-0.36461,-0.40487,1,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,3.8833e-12,-0.36474,-0.43412,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00030928,-0.36474,-0.31579,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.1099e-11,-0.36474,-0.38821,1,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.7693e-06,-0.36475,-0.34462,1,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,7.2702e-12,-0.36499,-0.47446,1,0
3,GO CATECHOLAMINE UPTAKE,2.0364e-06,-0.36502,-0.36282,1,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.8753e-10,-0.36518,-0.37898,1,0
3,GO VITAMIN D METABOLIC PROCESS,1.3468e-07,-0.36524,-0.42559,1,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.1729e-08,-0.36526,-0.42212,1,0
3,GO NEURON PROJECTION EXTENSION,5.0922e-10,-0.36527,-0.44716,1,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,1.2434e-08,-0.36542,-0.39633,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.1245e-09,-0.36543,-0.40718,1,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,8.1138e-06,-0.36543,-0.42742,1,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,1.7693e-06,-0.36544,-0.36406,1,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,4.7488e-06,-0.36545,-0.41739,1,0
3,GO RESPONSE TO CALCIUM ION,8.2618e-11,-0.36555,-0.40146,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,1.9136e-07,-0.36561,-0.41705,1,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,6.6717e-09,-0.3657,-0.41196,1,0
3,GO POSITIVE REGULATION OF JNK CASCADE,4.0677e-13,-0.3657,-0.46971,1,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,6.5906e-08,-0.3658,-0.34104,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,2.4491e-12,-0.36592,-0.45588,1,0
3,GO CELL CELL ADHESION,5.0135e-13,-0.36594,-0.45051,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,5.2344e-05,-0.36601,-0.3568,1,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.2954e-05,-0.36607,-0.38042,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.2118e-07,-0.36609,-0.37751,1,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,1.5713e-07,-0.36612,-0.40688,1,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,3.5412e-09,-0.3662,-0.40708,1,0
3,GO TRANSEPITHELIAL TRANSPORT,8.7184e-11,-0.36624,-0.38348,1,0
3,GO LIPOPROTEIN LOCALIZATION,1.2682e-10,-0.36625,-0.45976,1,0
3,GO FEMALE SEX DIFFERENTIATION,6.6581e-11,-0.36635,-0.3856,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,1.2482e-05,-0.36658,-0.38146,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.5629e-12,-0.3666,-0.53459,1,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,3.2146e-06,-0.3667,-0.3758,1,0
3,GO LEUKOCYTE HOMEOSTASIS,4.0817e-11,-0.36672,-0.41586,1,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.4371e-06,-0.36683,-0.39769,1,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,1.1789e-06,-0.36686,-0.43634,1,0
3,GO RESPONSE TO CAFFEINE,6.0991e-06,-0.36693,-0.31252,1,0
3,GO PROTEIN KINASE B SIGNALING,3.1757e-12,-0.36696,-0.42194,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,6.9323e-10,-0.36699,-0.44894,1,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,1.471e-07,-0.36709,-0.44222,1,0
3,GO RESPONSE TO INACTIVITY,2.3784e-07,-0.36712,-0.45981,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,2.1543e-10,-0.36714,-0.41398,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,2.7797e-11,-0.36717,-0.48022,1,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,3.2057e-05,-0.36728,-0.41797,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,8.4424e-05,-0.36738,-0.34032,1,0
3,GO HISTAMINE TRANSPORT,0.00022927,-0.36741,-0.33524,1,0
3,GO NEUROBLAST PROLIFERATION,2.5164e-08,-0.36741,-0.4096,1,0
3,GO RESPONSE TO PH,1.6109e-10,-0.36748,-0.45074,1,0
3,GO TRNA CATABOLIC PROCESS,1.1806e-05,-0.3676,-0.39836,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.5043e-10,-0.36773,-0.41723,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,8.7184e-11,-0.36775,-0.42935,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,8.0424e-11,-0.36775,-0.41949,1,0
3,GO ENGULFMENT OF APOPTOTIC CELL,7.4177e-11,-0.36776,-0.45009,1,0
3,GO REGULATION OF URINE VOLUME,8.8611e-12,-0.36777,-0.4097,1,0
3,GO KETONE BIOSYNTHETIC PROCESS,8.4805e-07,-0.3678,-0.34364,1,0
3,GO PRESYNAPTIC ENDOCYTOSIS,1.7154e-07,-0.36788,-0.39996,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.8701e-05,-0.36791,-0.3418,1,0
3,GO XENOBIOTIC TRANSPORT,5.815e-11,-0.36805,-0.46232,1,0
3,GO TISSUE REGENERATION,4.3606e-10,-0.36807,-0.39025,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00021857,-0.36815,-0.34758,1,0
3,GO PROTEIN TARGETING TO VACUOLE,1.2348e-10,-0.36828,-0.45461,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,9.7068e-11,-0.36828,-0.46992,1,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,8.4877e-09,-0.36832,-0.41806,1,0
3,GO CHEMOKINE PRODUCTION,1.3376e-10,-0.36836,-0.4151,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,6.4805e-11,-0.36839,-0.41896,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,8.9166e-06,-0.36851,-0.41381,1,0
3,GO CELL MOTILITY,4.1912e-13,-0.36864,-0.45267,1,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,5.8856e-08,-0.36866,-0.37408,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,4.8198e-07,-0.36866,-0.37158,1,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,3.7735e-12,-0.36869,-0.45274,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.4634e-11,-0.36874,-0.4347,1,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,5.0237e-12,-0.36875,-0.46784,1,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,1.1375e-05,-0.3688,-0.35225,1,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,6.1583e-08,-0.36894,-0.45201,1,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,3.6667e-12,-0.36894,-0.46226,1,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,5.5016e-10,-0.36908,-0.41464,1,0
3,GO ESTABLISHMENT OF CELL POLARITY,1.3737e-10,-0.36912,-0.43657,1,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.4773e-06,-0.36916,-0.41213,1,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,5.5016e-10,-0.36926,-0.47752,1,0
3,GO AMYLOID BETA CLEARANCE,9.6431e-12,-0.36935,-0.46045,1,0
3,GO HORMONE CATABOLIC PROCESS,2.9859e-05,-0.36945,-0.33177,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,6.4805e-11,-0.36946,-0.47444,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.249e-10,-0.36956,-0.40883,1,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,1.1086e-06,-0.36978,-0.33043,1,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,1.7693e-06,-0.37002,-0.39383,1,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,3.4098e-06,-0.37004,-0.39048,1,0
3,GO REGULATION OF VASCULAR PERMEABILITY,6.3088e-12,-0.37011,-0.52339,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.3133e-11,-0.37014,-0.45761,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,4.6784e-11,-0.37018,-0.42903,1,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,6.2046e-07,-0.37019,-0.3929,1,0
3,GO SPHINGOID METABOLIC PROCESS,6.5906e-08,-0.3702,-0.42737,1,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,9.6129e-06,-0.37021,-0.36116,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.8888e-05,-0.37032,-0.42353,1,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,2.521e-12,-0.37036,-0.41295,1,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,1.051e-12,-0.3708,-0.49117,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.4821e-13,-0.37089,-0.44992,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.9602e-12,-0.3709,-0.45959,1,0
3,GO GRANULOCYTE DIFFERENTIATION,9.2118e-07,-0.37098,-0.37149,1,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.7319e-10,-0.37104,-0.47946,1,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,6.8348e-09,-0.37109,-0.39605,1,0
3,GO FUCOSYLATION,2.4586e-08,-0.37111,-0.40587,1,0
3,GO RESPONSE TO KETONE,4.7449e-12,-0.37112,-0.40895,1,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,8.1138e-06,-0.37113,-0.34577,1,0
3,GO B CELL DIFFERENTIATION,1.0804e-10,-0.37116,-0.43413,1,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,2.4837e-07,-0.37128,-0.46854,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,1.7154e-07,-0.37131,-0.3932,1,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,6.6717e-09,-0.37148,-0.41694,1,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,3.8833e-12,-0.37154,-0.48025,1,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.3554e-11,-0.37168,-0.44355,1,0
3,GO SEROTONIN TRANSPORT,2.5359e-06,-0.37171,-0.36529,1,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,1.8723e-07,-0.37177,-0.35839,1,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,7.2414e-06,-0.37184,-0.29973,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,2.2912e-11,-0.37207,-0.41056,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,5.2538e-08,-0.37211,-0.36873,1,0
3,GO REGULATION OF BODY FLUID LEVELS,7.1613e-13,-0.37234,-0.45038,1,0
3,GO SKELETAL MUSCLE ADAPTATION,5.8049e-05,-0.37234,-0.30191,1,0
3,GO POSITIVE CHEMOTAXIS,9.3752e-12,-0.37237,-0.44198,1,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.3351e-08,-0.37253,-0.41372,1,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,9.6538e-08,-0.37265,-0.38915,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.7797e-11,-0.37275,-0.45015,1,0
3,GO ASYMMETRIC CELL DIVISION,2.4452e-09,-0.37292,-0.43338,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.1533e-09,-0.37299,-0.44848,1,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,2.4972e-05,-0.37302,-0.35722,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.6158e-05,-0.37311,-0.46729,1,0
3,GO INTERLEUKIN 1 PRODUCTION,1.1828e-09,-0.37313,-0.44479,1,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.6407e-09,-0.37315,-0.4755,1,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,7.6446e-07,-0.37316,-0.42855,1,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,5.6487e-06,-0.37331,-0.35096,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.8301e-10,-0.37341,-0.41385,1,0
3,GO SNARE COMPLEX ASSEMBLY,3.2859e-07,-0.37402,-0.39458,1,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.8286e-11,-0.37403,-0.49182,1,0
3,GO REGULATION OF GLIAL CELL MIGRATION,8.0424e-11,-0.37405,-0.39176,1,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,2.1196e-06,-0.37406,-0.49353,1,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,8.2903e-10,-0.37408,-0.39866,1,0
3,GO TOXIN METABOLIC PROCESS,1.8701e-05,-0.37424,-0.35149,1,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,8.0898e-09,-0.37429,-0.42279,1,0
3,GO MAST CELL MIGRATION,8.2686e-06,-0.37432,-0.43773,1,0
3,GO INTERLEUKIN 6 PRODUCTION,6.4805e-11,-0.37445,-0.41718,1,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,5.7536e-08,-0.37448,-0.39999,1,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.0958e-05,-0.37462,-0.35118,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.1064e-09,-0.37469,-0.41563,1,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,7.0017e-09,-0.37474,-0.41707,1,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,9.3425e-13,-0.37475,-0.46695,1,0
3,GO REGULATION OF JUN KINASE ACTIVITY,2.595e-12,-0.37485,-0.47549,1,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,2.8814e-05,-0.37488,-0.37497,1,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.9624e-10,-0.37489,-0.45738,1,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,1.0804e-10,-0.37498,-0.39973,1,0
3,GO REGULATION OF CELL SIZE,6.3088e-12,-0.37502,-0.45942,1,0
3,GO STEROL TRANSPORT,1.2074e-11,-0.37521,-0.45091,1,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,2.6306e-11,-0.37531,-0.49623,1,0
3,GO CARNITINE METABOLIC PROCESS,2.6914e-06,-0.37541,-0.35114,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,3.3228e-08,-0.37554,-0.40921,1,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,6.2169e-06,-0.37573,-0.45046,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,8.5043e-10,-0.37579,-0.35741,1,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.0099244,-0.37599,-0.32034,1,0
3,GO TUBE DEVELOPMENT,1.051e-12,-0.37603,-0.45989,1,0
3,GO RESPONSE TO DEXAMETHASONE,1.069e-09,-0.37605,-0.41584,1,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,1.0279e-08,-0.37607,-0.43272,1,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,3.9717e-11,-0.37627,-0.42044,1,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.5277e-10,-0.37629,-0.46735,1,0
3,GO SKELETAL MUSCLE CONTRACTION,1.0036e-08,-0.3763,-0.35855,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.0519e-10,-0.37641,-0.48266,1,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,4.1125e-12,-0.37643,-0.45311,1,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,3.9717e-11,-0.37649,-0.42332,1,0
3,GO NOREPINEPHRINE SECRETION,6.2175e-05,-0.37657,-0.32695,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.2434e-08,-0.37666,-0.46976,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,1.2023e-10,-0.37695,-0.40516,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,9.5999e-07,-0.377,-0.4467,1,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,8.7184e-11,-0.37706,-0.44625,1,0
3,GO HYPOTHALAMUS DEVELOPMENT,1.5037e-07,-0.37739,-0.38348,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,4.6578e-06,-0.37749,-0.41228,1,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,1.3737e-10,-0.37752,-0.38847,1,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,3.5038e-07,-0.3776,-0.44795,1,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,2.7668e-07,-0.3778,-0.40932,1,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,1.1282e-07,-0.37793,-0.41448,1,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,1.4334e-08,-0.37797,-0.50497,1,0
3,GO HISTONE H3 K9 DEMETHYLATION,3.9941e-08,-0.37818,-0.44943,1,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.1245e-09,-0.37819,-0.45685,1,0
3,GO ACTIVATION OF MAPKKK ACTIVITY,3.055e-09,-0.37862,-0.52266,1,0
3,GO HYPOTONIC RESPONSE,2.4452e-09,-0.37877,-0.45786,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.2417e-11,-0.37878,-0.40896,1,0
3,GO HYPEROSMOTIC RESPONSE,2.3933e-10,-0.37888,-0.40471,1,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,1.7687e-09,-0.379,-0.40318,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.4634e-11,-0.37912,-0.47464,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,5.0766e-11,-0.37916,-0.44803,1,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,1.8135e-09,-0.37931,-0.50372,1,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,9.6431e-12,-0.37941,-0.44436,1,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.8161e-07,-0.37953,-0.41273,1,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,3.8118e-09,-0.37953,-0.37533,1,0
3,GO HEART MORPHOGENESIS,1.5968e-11,-0.37956,-0.44206,1,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.2926e-08,-0.37963,-0.44018,1,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,1.3419e-09,-0.37964,-0.44539,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.4967e-09,-0.37983,-0.37094,1,0
3,GO RESPONSE TO GROWTH FACTOR,1.9993e-12,-0.37991,-0.44808,1,0
3,GO MUSCLE HYPERTROPHY,4.8359e-10,-0.38002,-0.43945,1,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,5.6594e-11,-0.38003,-0.45477,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,9.9064e-10,-0.38045,-0.49896,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.6361e-10,-0.38052,-0.45589,1,0
3,GO MICROVILLUS ASSEMBLY,7.892e-08,-0.38052,-0.50531,1,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,3.9941e-08,-0.3806,-0.38233,1,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,2.634e-09,-0.38073,-0.44887,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.65e-07,-0.38079,-0.4359,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,4.1751e-05,-0.38083,-0.38917,1,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,3.8347e-06,-0.38083,-0.40935,1,0
3,GO REGULATION OF GONAD DEVELOPMENT,3.7319e-10,-0.38086,-0.41321,1,0
3,GO PROTEIN DEMETHYLATION,5.3562e-07,-0.38087,-0.3951,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,5.3747e-08,-0.38092,-0.48643,1,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.6145e-12,-0.38092,-0.42431,1,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,2.342e-06,-0.38093,-0.39968,1,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,6.1583e-08,-0.38097,-0.38944,1,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,1.2281e-06,-0.38112,-0.41938,1,0
3,GO HORMONE BIOSYNTHETIC PROCESS,1.155e-06,-0.38112,-0.33716,1,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,1.051e-12,-0.38116,-0.47738,1,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,1.5277e-10,-0.38117,-0.44237,1,0
3,GO LYMPHOCYTE MIGRATION,3.2685e-12,-0.38125,-0.41729,1,0
3,GO ANION HOMEOSTASIS,4.8076e-11,-0.38127,-0.42467,1,0
3,GO INTEGRIN ACTIVATION,5.2359e-09,-0.3814,-0.47155,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0033799,-0.38145,-0.24974,1,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,2.0546e-09,-0.38146,-0.405,1,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,1.6823e-09,-0.3817,-0.41509,1,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,4.8198e-07,-0.38196,-0.38747,1,0
3,GO FATTY ACID HOMEOSTASIS,1.2534e-06,-0.38199,-0.38825,1,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,2.5164e-08,-0.38216,-0.39463,1,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,9.2321e-08,-0.38217,-0.45145,1,0
3,GO COMPLEMENT ACTIVATION,2.801e-10,-0.38218,-0.48636,1,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,7.8124e-06,-0.38221,-0.28599,1,0
3,GO INTESTINAL ABSORPTION,4.6202e-07,-0.38229,-0.43503,1,0
3,GO REGULATION OF STEROL TRANSPORT,4.249e-10,-0.38231,-0.4021,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,6.7461e-07,-0.38242,-0.35145,1,0
3,GO CELLULAR RESPONSE TO IRON ION,1.6129e-08,-0.38275,-0.43953,1,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,4.8673e-09,-0.38281,-0.42164,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.2117e-10,-0.38285,-0.46214,1,0
3,GO INTERMEMBRANE LIPID TRANSFER,2.2286e-11,-0.38285,-0.45879,1,0
3,GO REGULATION OF SYNAPSE MATURATION,2.342e-06,-0.38287,-0.44901,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,1.3133e-11,-0.38301,-0.43723,1,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,2.342e-06,-0.38305,-0.42105,1,0
3,GO NEUROTRANSMITTER REUPTAKE,1.0791e-07,-0.38315,-0.37992,1,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.4112e-09,-0.38317,-0.47709,1,0
3,GO MACROPHAGE ACTIVATION,2.1085e-11,-0.38318,-0.43687,1,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,2.6914e-06,-0.38331,-0.44639,1,0
3,GO SCHWANN CELL DEVELOPMENT,2.1595e-09,-0.38351,-0.46254,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,8.9487e-10,-0.38356,-0.44343,1,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,4.9228e-07,-0.3836,-0.34387,1,0
3,GO REGULATION OF PROTEIN MATURATION,4.9403e-11,-0.38362,-0.43595,1,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.2482e-05,-0.38371,-0.41093,1,0
3,GO RESPONSE TO INTERLEUKIN 15,2.9805e-09,-0.38392,-0.45841,1,0
3,GO CHOLESTEROL EFFLUX,3.4634e-11,-0.38393,-0.41533,1,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,3.7195e-09,-0.38398,-0.42396,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,3.628e-05,-0.38407,-0.44384,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.9805e-09,-0.38415,-0.42254,1,0
3,GO MYELOID CELL DEVELOPMENT,2.9078e-09,-0.38417,-0.4367,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,2.559e-11,-0.38418,-0.45324,1,0
3,GO INTERFERON ALPHA PRODUCTION,2.3268e-09,-0.38426,-0.41269,1,0
3,GO INTERFERON BETA PRODUCTION,1.9905e-10,-0.38445,-0.44266,1,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,1.6418e-07,-0.38448,-0.39821,1,0
3,GO MEMBRANE HYPERPOLARIZATION,1.9175e-06,-0.38461,-0.36901,1,0
3,GO REGULATION OF TUBULIN DEACETYLATION,1.3442e-05,-0.38462,-0.38225,1,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,5.3747e-08,-0.38462,-0.44247,1,0
3,GO CELL CHEMOTAXIS,6.1321e-12,-0.38481,-0.42613,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,1.5217e-09,-0.38487,-0.5027,1,0
3,GO BONE RESORPTION,8.2903e-10,-0.385,-0.42913,1,0
3,GO DOPAMINE TRANSPORT,0.00020178,-0.3851,-0.32545,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,1.0964e-09,-0.38512,-0.4075,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.2162e-07,-0.38514,-0.47917,1,0
3,GO FORELIMB MORPHOGENESIS,2.6362e-08,-0.38536,-0.40789,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,9.9185e-12,-0.38552,-0.52669,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.7309e-08,-0.38575,-0.40789,1,0
3,GO REGULATION OF COLLATERAL SPROUTING,2.206e-06,-0.38575,-0.44847,1,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.5461e-06,-0.3858,-0.38177,1,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,1.0792e-11,-0.38609,-0.45782,1,0
3,GO LAMELLIPODIUM ASSEMBLY,8.7184e-11,-0.38612,-0.44475,1,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,3.247e-08,-0.38615,-0.3716,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,6.2046e-07,-0.3863,-0.41361,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,5.9056e-05,-0.38654,-0.42799,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,2.7286e-10,-0.38657,-0.41671,1,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,1.9465e-08,-0.38676,-0.38038,1,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,6.0205e-08,-0.3868,-0.4367,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,7.1274e-05,-0.38688,-0.3459,1,0
3,GO REGULATION OF CHEMOTAXIS,4.7449e-12,-0.38714,-0.43084,1,0
3,GO RECEPTOR CATABOLIC PROCESS,4.1403e-10,-0.38716,-0.48804,1,0
3,GO OSTEOCLAST DIFFERENTIATION,3.6667e-12,-0.38716,-0.4429,1,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,5.4724e-12,-0.38717,-0.45897,1,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,3.8149e-08,-0.38721,-0.40724,1,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.4686e-11,-0.3873,-0.41682,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,2.8886e-07,-0.38731,-0.48619,1,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,1.7687e-09,-0.3877,-0.50532,1,0
3,GO REGULATION OF FATTY ACID OXIDATION,7.8976e-09,-0.38771,-0.39194,1,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,1.2058e-07,-0.38774,-0.46476,1,0
3,GO PROTEIN OXIDATION,3.9822e-07,-0.38785,-0.45287,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,2.6828e-05,-0.38799,-0.40241,1,0
3,GO REPLICATIVE SENESCENCE,1.4741e-05,-0.38801,-0.33896,1,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.00014839,-0.38814,-0.36529,1,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,6.6717e-09,-0.38818,-0.51213,1,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,7.1613e-13,-0.38834,-0.46581,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,3.6924e-05,-0.38841,-0.33899,1,0
3,GO ALANINE TRANSPORT,2.402e-08,-0.38843,-0.5148,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,7.2702e-12,-0.38856,-0.50328,1,0
3,GO COAGULATION,1.5838e-12,-0.38894,-0.47462,1,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,2.7614e-08,-0.38901,-0.47382,1,0
3,GO RELAXATION OF MUSCLE,4.8198e-07,-0.38929,-0.37804,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,4.8824e-12,-0.38934,-0.50356,1,0
3,GO INTRACELLULAR MRNA LOCALIZATION,4.1552e-07,-0.38946,-0.41989,1,0
3,GO NEURAL CREST FORMATION,8.4262e-06,-0.38954,-0.35453,1,0
3,GO GLIAL CELL ACTIVATION,5.815e-11,-0.38966,-0.4214,1,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,3.4516e-10,-0.38977,-0.44042,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00020504,-0.38982,-0.44798,1,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.1579e-08,-0.38995,-0.4194,1,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,9.3415e-09,-0.38999,-0.45988,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.1794e-07,-0.39003,-0.42286,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,1.734e-06,-0.39008,-0.41748,1,0
3,GO CARDIAC MUSCLE CONTRACTION,3.2894e-09,-0.39012,-0.39204,1,0
3,GO REGULATION OF FIBRINOLYSIS,4.9624e-10,-0.39012,-0.48409,1,0
3,GO OSSIFICATION,4.7449e-12,-0.39028,-0.45011,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,3.5794e-07,-0.39034,-0.45495,1,0
3,GO CARDIAC CHAMBER FORMATION,1.2954e-05,-0.39082,-0.40346,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.2785e-11,-0.39091,-0.43637,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.5753e-08,-0.39092,-0.50126,1,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,1.182e-12,-0.39103,-0.51471,1,0
3,GO INTERLEUKIN 5 PRODUCTION,8.1361e-07,-0.3911,-0.43333,1,0
3,GO DENDRITIC CELL MIGRATION,5.9432e-10,-0.39116,-0.4301,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.0879e-07,-0.39118,-0.51366,1,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,1.4487e-10,-0.39146,-0.48762,1,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1.5277e-10,-0.39156,-0.3729,1,0
3,GO NOTCH RECEPTOR PROCESSING,3.5646e-05,-0.39162,-0.38635,1,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.2784e-06,-0.3917,-0.37454,1,0
3,GO ACTIN FILAMENT SEVERING,3.2162e-07,-0.39191,-0.49536,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,3.9941e-08,-0.39199,-0.35084,1,0
3,GO REGULATION OF CELL ADHESION,6.3604e-13,-0.39202,-0.48785,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.277e-11,-0.39213,-0.47828,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,4.1815e-08,-0.39219,-0.42896,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,3.247e-08,-0.39222,-0.421,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.4586e-08,-0.39223,-0.42792,1,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,1.5102e-11,-0.39242,-0.51675,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,9.1996e-11,-0.39249,-0.45939,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.6567e-07,-0.39281,-0.41814,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,6.1583e-08,-0.39292,-0.47684,1,0
3,GO T CELL DIFFERENTIATION IN THYMUS,3.019e-11,-0.39297,-0.3939,1,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,1.9546e-09,-0.39308,-0.40394,1,0
3,GO MAINTENANCE OF CELL POLARITY,4.4148e-09,-0.39311,-0.41287,1,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,3.1032e-11,-0.39318,-0.46517,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.536e-06,-0.39327,-0.49516,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.0853e-05,-0.39329,-0.40744,1,0
3,GO RESPONSE TO CORTICOSTEROID,4.7449e-12,-0.39336,-0.4167,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.3629e-10,-0.39336,-0.42653,1,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,6.5906e-08,-0.39337,-0.39532,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,7.4854e-10,-0.39358,-0.481,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,2.4452e-09,-0.39376,-0.45716,1,0
3,GO SCHWANN CELL DIFFERENTIATION,2.5893e-10,-0.39377,-0.4558,1,0
3,GO REGULATION OF AXONOGENESIS,1.6001e-09,-0.39389,-0.469,1,0
3,GO REGULATION OF VACUOLE ORGANIZATION,3.9064e-09,-0.3939,-0.41387,1,0
3,GO PROSTATE GLAND DEVELOPMENT,7.2964e-10,-0.39398,-0.47438,1,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,2.2286e-11,-0.39422,-0.46416,1,0
3,GO NEURON MATURATION,5.7536e-08,-0.39425,-0.38117,1,0
3,GO RESPONSE TO MAGNESIUM ION,5.9498e-07,-0.39432,-0.49484,1,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.0322e-07,-0.39434,-0.46777,1,0
3,GO MITOCHONDRIAL DEPOLARIZATION,2.0429e-07,-0.39444,-0.37079,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.6407e-09,-0.39455,-0.45755,1,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,3.9035e-08,-0.3946,-0.48099,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.9963e-12,-0.39464,-0.44846,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5277e-10,-0.39465,-0.50934,1,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,1.3024e-10,-0.39481,-0.43748,1,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,4.0033e-09,-0.39483,-0.41668,1,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.5052e-06,-0.39504,-0.48653,1,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,1.0519e-10,-0.39507,-0.45895,1,0
3,GO VAGINA DEVELOPMENT,2.2697e-09,-0.39514,-0.44109,1,0
3,GO CARTILAGE DEVELOPMENT,1.0792e-11,-0.39517,-0.48168,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,7.2964e-10,-0.39518,-0.43551,1,0
3,GO RENAL TUBULE DEVELOPMENT,1.0241e-10,-0.39529,-0.43762,1,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.7602e-11,-0.39531,-0.44872,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.1729e-08,-0.39568,-0.38872,1,0
3,GO RESPONSE TO INTERLEUKIN 2,1.6514e-08,-0.3957,-0.43516,1,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,9.6538e-08,-0.39571,-0.37505,1,0
3,GO MAST CELL MEDIATED IMMUNITY,1.8142e-08,-0.39576,-0.42698,1,0
3,GO GLIAL CELL MIGRATION,5.6304e-12,-0.39581,-0.49672,1,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,1.1828e-09,-0.39584,-0.41133,1,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,5.3602e-11,-0.39601,-0.42917,1,0
3,GO COCHLEA MORPHOGENESIS,1.2434e-08,-0.39601,-0.41807,1,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,2.3891e-06,-0.39607,-0.34848,1,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.2414e-06,-0.39619,-0.438,1,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,5.815e-11,-0.39621,-0.47802,1,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,5.0237e-12,-0.39622,-0.43036,1,0
3,GO BIOLOGICAL ADHESION,3.1054e-13,-0.3963,-0.48414,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.402e-08,-0.39663,-0.44372,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,2.1812e-12,-0.39664,-0.47347,1,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.0527e-08,-0.3967,-0.42874,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,2.1338e-07,-0.3967,-0.45413,1,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,1.277e-11,-0.39676,-0.51214,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9064e-09,-0.39679,-0.41606,1,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,8.0898e-09,-0.39698,-0.4477,1,0
3,GO RESPONSE TO BMP,7.8286e-11,-0.39701,-0.45934,1,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2565e-10,-0.39702,-0.5155,1,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,9.9803e-06,-0.39703,-0.36224,1,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,6.4592e-06,-0.39709,-0.34393,1,0
3,GO ARTERY MORPHOGENESIS,3.5427e-10,-0.39713,-0.46847,1,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,2.188e-08,-0.39738,-0.38738,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,7.5266e-09,-0.39764,-0.45287,1,0
3,GO MEMBRANE DEPOLARIZATION,2.4586e-08,-0.39766,-0.41598,1,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.5604e-09,-0.39766,-0.47155,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,7.0279e-11,-0.39772,-0.4619,1,0
3,GO REGULATION OF LIPID STORAGE,2.1085e-11,-0.39776,-0.44102,1,0
3,GO LAMELLIPODIUM ORGANIZATION,3.019e-11,-0.39788,-0.45976,1,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.1398e-10,-0.39792,-0.46494,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,8.8389e-07,-0.39811,-0.39818,1,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,1.0791e-07,-0.39817,-0.41182,1,0
3,GO PIGMENT ACCUMULATION,1.0322e-07,-0.39823,-0.42668,1,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,1.5052e-06,-0.39835,-0.44561,1,0
3,GO OLIGODENDROCYTE DEVELOPMENT,9.2321e-08,-0.39837,-0.41225,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,5.9602e-12,-0.39878,-0.45873,1,0
3,GO CELLULAR RESPONSE TO FATTY ACID,2.5695e-09,-0.39884,-0.40826,1,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,6.4434e-08,-0.39914,-0.36603,1,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,1.3737e-10,-0.39923,-0.42449,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,2.9371e-11,-0.3993,-0.41944,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,4.8839e-05,-0.39937,-0.37875,1,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,2.1196e-06,-0.39938,-0.41125,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,9.1996e-11,-0.39945,-0.45538,1,0
3,GO STEM CELL DIVISION,1.1097e-10,-0.39961,-0.49176,1,0
3,GO GALACTOSE METABOLIC PROCESS,4.6578e-06,-0.39969,-0.44431,1,0
3,GO RESPONSE TO NUTRIENT,7.6205e-11,-0.3998,-0.40443,1,0
3,GO CARDIAC ATRIUM DEVELOPMENT,1.2434e-08,-0.39987,-0.4608,1,0
3,GO FIBRINOLYSIS,1.0161e-09,-0.39999,-0.54878,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,2.7614e-08,-0.40003,-0.45136,1,0
3,GO CHLORIDE ION HOMEOSTASIS,3.9064e-09,-0.40015,-0.48633,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.9717e-11,-0.40017,-0.48579,1,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,1.1535e-07,-0.40019,-0.42123,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.2958e-06,-0.40026,-0.41141,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.8881e-10,-0.40031,-0.48016,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,4.4302e-11,-0.4006,-0.43887,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,1.3948e-05,-0.40081,-0.3753,1,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,3.2146e-06,-0.40087,-0.46593,1,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,6.1583e-08,-0.40124,-0.45251,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,1.2886e-07,-0.40128,-0.42025,1,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,1.1415e-11,-0.40139,-0.4437,1,0
3,GO REGULATION OF VASOCONSTRICTION,4.1948e-11,-0.4015,-0.44897,1,0
3,GO REGULATION OF BONE REMODELING,2.7e-09,-0.40167,-0.45578,1,0
3,GO OSTEOBLAST DIFFERENTIATION,1.642e-11,-0.40174,-0.45049,1,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,6.2046e-07,-0.40194,-0.41219,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.4686e-11,-0.4021,-0.57323,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.887e-11,-0.4022,-0.45991,1,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.9175e-06,-0.40228,-0.38655,1,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.4516e-10,-0.4025,-0.45436,1,0
3,GO PROTEIN PALMITOYLATION,7.5451e-08,-0.40256,-0.39095,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.1415e-11,-0.40267,-0.46037,1,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,4.0033e-09,-0.40301,-0.42123,1,0
3,GO RESPONSE TO FLUID SHEAR STRESS,5.4724e-12,-0.40321,-0.58302,1,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.0033e-09,-0.4033,-0.51879,1,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,1.5037e-07,-0.40334,-0.46248,1,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,3.9064e-09,-0.40338,-0.5078,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,5.3617e-10,-0.4034,-0.52888,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,5.332e-06,-0.40346,-0.408,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.8299e-12,-0.40364,-0.49299,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.6418e-07,-0.40388,-0.41719,1,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.462e-12,-0.40401,-0.48857,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.8032e-05,-0.4041,-0.45641,1,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,1.5027e-08,-0.40437,-0.50116,1,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,5.4982e-08,-0.40452,-0.40667,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.00029052,-0.40461,-0.35455,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.6361e-10,-0.405,-0.48015,1,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,3.9035e-08,-0.40501,-0.44915,1,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,1.7797e-12,-0.40508,-0.49734,1,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,1.4686e-11,-0.40519,-0.49439,1,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,7.0279e-11,-0.40562,-0.50871,1,0
3,GO CERAMIDE TRANSPORT,5.6451e-10,-0.40567,-0.45527,1,0
3,GO MYELIN ASSEMBLY,8.0712e-08,-0.40573,-0.49558,1,0
3,GO AMINOGLYCAN METABOLIC PROCESS,1.174e-11,-0.40578,-0.4507,1,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,2.9371e-11,-0.40587,-0.41878,1,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,1.6986e-10,-0.40607,-0.47445,1,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,3.4516e-10,-0.40611,-0.41373,1,0
3,GO ERK1 AND ERK2 CASCADE,9.9094e-13,-0.40615,-0.46391,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,9.6538e-08,-0.40621,-0.4799,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.2094e-09,-0.40624,-0.42841,1,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.4796e-08,-0.40632,-0.42123,1,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,8.0898e-09,-0.40653,-0.35905,1,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.00034485,-0.40673,-0.30702,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.634e-09,-0.40678,-0.41153,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.1312e-09,-0.40685,-0.41648,1,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,1.9563e-06,-0.40686,-0.4022,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,8.1414e-12,-0.40696,-0.43535,1,0
3,GO TUBE MORPHOGENESIS,1.1146e-12,-0.40703,-0.47769,1,0
3,GO REGULATION OF PHAGOCYTOSIS,3.8833e-12,-0.40729,-0.46943,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,8.5043e-10,-0.40735,-0.45971,1,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,1.1588e-05,-0.40753,-0.39523,1,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.2057e-05,-0.40755,-0.36749,1,0
3,GO COLLATERAL SPROUTING,5.4982e-08,-0.40756,-0.48389,1,0
3,GO CARDIAC CHAMBER DEVELOPMENT,2.457e-10,-0.40757,-0.46291,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.0582e-12,-0.40763,-0.49503,1,0
3,GO ACTIVATION OF MAPKK ACTIVITY,3.1032e-11,-0.40766,-0.49098,1,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,1.8318e-07,-0.40797,-0.45976,1,0
3,GO CYTOLYSIS,8.6579e-07,-0.40807,-0.43151,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,3.5461e-06,-0.40839,-0.3502,1,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.2604e-07,-0.40844,-0.44373,1,0
3,GO POSTSYNAPSE ORGANIZATION,3.9309e-10,-0.40885,-0.44246,1,0
3,GO NEPHRIC DUCT DEVELOPMENT,9.4407e-08,-0.40886,-0.46519,1,0
3,GO NEPHRIC DUCT MORPHOGENESIS,9.4341e-06,-0.409,-0.41843,1,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,4.1948e-11,-0.40912,-0.44772,1,0
3,GO SYNCYTIUM FORMATION,2.595e-12,-0.40913,-0.50382,1,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,2.0879e-07,-0.40936,-0.41358,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.247e-08,-0.4094,-0.46559,1,0
3,GO BIOMINERALIZATION,5.0237e-12,-0.40972,-0.47257,1,0
3,GO GLIAL CELL PROLIFERATION,2.5893e-10,-0.40986,-0.40869,1,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.3793e-12,-0.41007,-0.48585,1,0
3,GO BONE DEVELOPMENT,1.2417e-11,-0.41015,-0.47813,1,0
3,GO DENDRITIC SPINE DEVELOPMENT,3.2764e-10,-0.41023,-0.45514,1,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.4487e-10,-0.41025,-0.43954,1,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,1.484e-09,-0.41043,-0.45328,1,0
3,GO REGULATION OF TISSUE REMODELING,1.3737e-10,-0.41055,-0.49359,1,0
3,GO RESPONSE TO SALT STRESS,7.1726e-09,-0.41071,-0.38272,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,2.7286e-10,-0.41073,-0.45094,1,0
3,GO PEPTIDE CATABOLIC PROCESS,1.1097e-10,-0.41081,-0.47801,1,0
3,GO LIPID STORAGE,4.7449e-12,-0.41085,-0.43234,1,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,3.8149e-08,-0.41098,-0.38327,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,9.658e-10,-0.41122,-0.39945,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2733e-08,-0.41142,-0.49972,1,0
3,GO OSTEOCLAST DEVELOPMENT,3.2764e-10,-0.41147,-0.5247,1,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,9.4341e-06,-0.4115,-0.37986,1,0
3,GO ASTROCYTE DIFFERENTIATION,1.0202e-11,-0.41198,-0.45078,1,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,4.7963e-08,-0.4121,-0.4239,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,3.6435e-08,-0.41212,-0.52367,1,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,7.2964e-10,-0.41243,-0.43861,1,0
3,GO REGULATION OF OSSIFICATION,2.9127e-12,-0.41249,-0.47413,1,0
3,GO TOLERANCE INDUCTION,4.5558e-05,-0.41264,-0.4626,1,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,1.4334e-08,-0.41266,-0.46895,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,2.3312e-10,-0.41271,-0.44352,1,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,1.0202e-11,-0.41279,-0.4538,1,0
3,GO LEUKOCYTE MIGRATION,3.2685e-12,-0.41295,-0.45094,1,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.9905e-10,-0.41306,-0.52097,1,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,1.1097e-10,-0.41312,-0.51987,1,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.1097e-10,-0.41316,-0.45862,1,0
3,GO REGULATION OF HIPPO SIGNALING,7.2414e-06,-0.41341,-0.45548,1,0
3,GO GASTRULATION,4.3109e-11,-0.41353,-0.47584,1,0
3,GO MUSCLE CELL MIGRATION,5.3617e-10,-0.41381,-0.49089,1,0
3,GO PIGMENT GRANULE ORGANIZATION,9.3415e-09,-0.4139,-0.39099,1,0
3,GO GANGLIOSIDE METABOLIC PROCESS,1.5386e-08,-0.41404,-0.46138,1,0
3,GO ASTROCYTE ACTIVATION,2.8925e-08,-0.41404,-0.41971,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.9465e-08,-0.41415,-0.41075,1,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,4.2042e-09,-0.41425,-0.49669,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,9.658e-10,-0.41435,-0.41412,1,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,1.0804e-10,-0.41449,-0.46057,1,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,9.1793e-10,-0.41456,-0.50955,1,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.6542e-10,-0.41461,-0.41709,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,3.7282e-08,-0.4147,-0.46198,1,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,6.4805e-11,-0.41494,-0.5297,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,2.9514e-07,-0.41502,-0.49993,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,3.2785e-11,-0.4151,-0.50911,1,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,1.6514e-08,-0.41514,-0.47247,1,0
3,GO CARTILAGE MORPHOGENESIS,1.0861e-06,-0.41532,-0.50032,1,0
3,GO RESPONSE TO THYROID HORMONE,3.6435e-08,-0.41544,-0.44702,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.3606e-10,-0.41545,-0.46127,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,5.1652e-13,-0.41561,-0.47947,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0014624,-0.41562,-0.3963,1,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,1.1579e-08,-0.41578,-0.42401,1,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,9.5999e-07,-0.41598,-0.45277,1,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.3769e-07,-0.41601,-0.43106,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.3784e-07,-0.41614,-0.53322,1,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,1.4487e-10,-0.41621,-0.47664,1,0
3,GO PIGMENT CELL DIFFERENTIATION,4.0817e-11,-0.41622,-0.42911,1,0
3,GO CARDIAC VENTRICLE FORMATION,2.3239e-05,-0.41624,-0.41892,1,0
3,GO CARDIOBLAST DIFFERENTIATION,3.2784e-06,-0.41627,-0.38105,1,0
3,GO KERATAN SULFATE METABOLIC PROCESS,1.8353e-11,-0.41642,-0.49646,1,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,7.5451e-08,-0.41642,-0.3898,1,0
3,GO GENITALIA MORPHOGENESIS,4.6356e-09,-0.41653,-0.48745,1,0
3,GO UTERUS DEVELOPMENT,9.4407e-08,-0.41658,-0.4128,1,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,5.2303e-06,-0.41664,-0.40934,1,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,4.0314e-05,-0.41666,-0.38232,1,0
3,GO ANOIKIS,3.192e-10,-0.41676,-0.50047,1,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,1.2482e-05,-0.41704,-0.4582,1,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.4812e-12,-0.41717,-0.47288,1,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,6.9522e-13,-0.41728,-0.51949,1,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,4.3946e-06,-0.41728,-0.41745,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,5.0135e-13,-0.41742,-0.48629,1,0
3,GO REGULATION OF ACTION POTENTIAL,5.4967e-09,-0.41745,-0.45317,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,8.3026e-13,-0.41757,-0.51689,1,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.1245e-09,-0.41773,-0.45705,1,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,2.188e-08,-0.41778,-0.53165,1,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,5.2165e-11,-0.41793,-0.47004,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,2.5066e-09,-0.41809,-0.45236,1,0
3,GO REGULATION OF HEART RATE,1.471e-07,-0.41811,-0.36585,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,1.6158e-05,-0.41814,-0.38243,1,0
3,GO RESPONSE TO RETINOIC ACID,2.8299e-12,-0.41831,-0.47738,1,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,6.552e-13,-0.41876,-0.52273,1,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,1.3376e-10,-0.41878,-0.45723,1,0
3,GO LUNG CELL DIFFERENTIATION,2.2505e-06,-0.41896,-0.43433,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00061456,-0.41902,-0.42204,1,0
3,GO OSTEOBLAST PROLIFERATION,2.1064e-09,-0.41906,-0.52041,1,0
3,GO MECHANOSENSORY BEHAVIOR,0.0005133,-0.41922,-0.40787,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00022565,-0.41925,-0.41805,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,1.0781e-08,-0.41929,-0.47385,1,0
3,GO MUCUS SECRETION,0.0032928,-0.41941,-0.36019,1,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,1.3468e-07,-0.41953,-0.5212,1,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,5.3562e-07,-0.41954,-0.49726,1,0
3,GO TYPE 2 IMMUNE RESPONSE,8.9487e-10,-0.41955,-0.47296,1,0
3,GO REGULATION OF NEURON MIGRATION,1.1034e-07,-0.41966,-0.45663,1,0
3,GO DETECTION OF MECHANICAL STIMULUS,4.719e-07,-0.41977,-0.39151,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00021857,-0.41993,-0.46237,1,0
3,GO PHAGOLYSOSOME ASSEMBLY,1.475e-06,-0.42014,-0.45777,1,0
3,GO AMYLOID BETA FORMATION,5.3602e-11,-0.42063,-0.46525,1,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,4.4807e-06,-0.42067,-0.38976,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.5233e-07,-0.42079,-0.42633,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,9.3415e-09,-0.42089,-0.46942,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.2912e-11,-0.42131,-0.47284,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,5.815e-11,-0.42139,-0.54779,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,2.2912e-11,-0.42147,-0.45989,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.1321e-12,-0.42197,-0.48763,1,0
3,GO PHOSPHOLIPID HOMEOSTASIS,3.357e-07,-0.42211,-0.38377,1,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,8.5858e-05,-0.4222,-0.39249,1,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,1.2281e-06,-0.42233,-0.40157,1,0
3,GO GLIAL CELL DEVELOPMENT,4.4302e-11,-0.42235,-0.45269,1,0
3,GO HETEROTYPIC CELL CELL ADHESION,4.9624e-10,-0.42244,-0.44801,1,0
3,GO BONE CELL DEVELOPMENT,2.5066e-09,-0.42281,-0.48981,1,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.0519e-10,-0.42287,-0.46474,1,0
3,GO B CELL MEDIATED IMMUNITY,3.5597e-11,-0.42305,-0.46976,1,0
3,GO HEART TRABECULA MORPHOGENESIS,1.1535e-07,-0.42319,-0.44724,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.4207e-05,-0.42331,-0.40279,1,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,5.8182e-13,-0.42338,-0.50653,1,0
3,GO MAST CELL ACTIVATION,8.0898e-09,-0.42338,-0.42008,1,0
3,GO CELLULAR EXTRAVASATION,4.5526e-11,-0.4235,-0.44337,1,0
3,GO RESPONSE TO PAIN,1.5604e-09,-0.42351,-0.42458,1,0
3,GO LOCOMOTOR RHYTHM,2.1196e-06,-0.42354,-0.466,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,1.484e-09,-0.4239,-0.47271,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,4.3355e-07,-0.42392,-0.55184,1,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,6.4805e-11,-0.42402,-0.50513,1,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,2.3554e-11,-0.42405,-0.47586,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,9.9064e-10,-0.42415,-0.46274,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,1.182e-12,-0.42424,-0.50429,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.6667e-12,-0.42439,-0.47546,1,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.8353e-11,-0.42459,-0.46951,1,0
3,GO NEURON PROJECTION GUIDANCE,5.2253e-10,-0.42468,-0.45881,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,8.5867e-06,-0.42472,-0.4226,1,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.586e-10,-0.42487,-0.42034,1,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,4.2784e-08,-0.42492,-0.42532,1,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.7922e-07,-0.42501,-0.44679,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,1.8353e-11,-0.42506,-0.4498,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.9872e-09,-0.42525,-0.4428,1,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,4.4749e-10,-0.42528,-0.45201,1,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,5.8182e-13,-0.42534,-0.50842,1,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,2.6352e-05,-0.42536,-0.35707,1,0
3,GO PLASMINOGEN ACTIVATION,6.3569e-09,-0.42548,-0.49751,1,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,1.3056e-06,-0.42551,-0.42138,1,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.494e-12,-0.42601,-0.49117,1,0
3,GO POSITIVE REGULATION OF COAGULATION,3.5427e-10,-0.42602,-0.47255,1,0
3,GO STRESS FIBER ASSEMBLY,3.7182e-13,-0.42605,-0.5699,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.3024e-10,-0.42664,-0.55394,1,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,6.4699e-07,-0.42703,-0.39849,1,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8001e-06,-0.42723,-0.47886,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.2058e-07,-0.42731,-0.4421,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,6.9522e-13,-0.42733,-0.51366,1,0
3,GO MITRAL VALVE DEVELOPMENT,5.3747e-08,-0.42743,-0.46749,1,0
3,GO RESPONSE TO WOUNDING,7.3765e-13,-0.42756,-0.49855,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,1.8793e-06,-0.42773,-0.56028,1,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.8301e-10,-0.42792,-0.50077,1,0
3,GO T CELL MIGRATION,2.3554e-11,-0.42811,-0.4572,1,0
3,GO INCLUSION BODY ASSEMBLY,3.0302e-06,-0.42818,-0.4425,1,0
3,GO MUSCLE CELL PROLIFERATION,1.0824e-12,-0.4282,-0.46395,1,0
3,GO ARGININE METABOLIC PROCESS,1.2733e-08,-0.42862,-0.44609,1,0
3,GO ANIMAL ORGAN MATURATION,5.5078e-11,-0.42865,-0.47961,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.6112e-12,-0.4287,-0.50214,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,7.2964e-10,-0.42881,-0.47749,1,0
3,GO REGULATION OF HAIR CYCLE,1.0161e-09,-0.42885,-0.42962,1,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,1.0519e-10,-0.42953,-0.47118,1,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,1.4454e-06,-0.42975,-0.42966,1,0
3,GO APOPTOTIC CELL CLEARANCE,3.3639e-12,-0.43007,-0.53985,1,0
3,GO DENDRITIC SPINE MORPHOGENESIS,7.3476e-09,-0.43013,-0.44348,1,0
3,GO RESPONSE TO HYDROPEROXIDE,3.1312e-09,-0.43027,-0.48401,1,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,1.5674e-06,-0.43041,-0.39751,1,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,6.2993e-08,-0.43051,-0.50891,1,0
3,GO OPTIC NERVE DEVELOPMENT,3.1479e-07,-0.43052,-0.45703,1,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,9.7068e-11,-0.43063,-0.45359,1,0
3,GO LUNG MORPHOGENESIS,7.4177e-11,-0.43068,-0.49853,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,5.6451e-10,-0.43083,-0.43411,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,1.4487e-10,-0.43096,-0.4602,1,0
3,GO FIBROBLAST MIGRATION,1.4877e-10,-0.43107,-0.48271,1,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,1.4677e-08,-0.43188,-0.42341,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,2.801e-10,-0.43201,-0.4934,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,9.9185e-12,-0.43228,-0.49248,1,0
3,GO ARTERY DEVELOPMENT,6.8406e-11,-0.43237,-0.50922,1,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,2.0509e-11,-0.43243,-0.52515,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.5424e-05,-0.43272,-0.44601,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,9.1205e-09,-0.43275,-0.44753,1,0
3,GO BONE REMODELING,4.3109e-11,-0.43286,-0.49832,1,0
3,GO RESPONSE TO INTERLEUKIN 6,8.0815e-10,-0.43309,-0.46243,1,0
3,GO ACTIN FILAMENT BASED MOVEMENT,2.1085e-11,-0.43312,-0.45744,1,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.5934e-07,-0.43326,-0.3982,1,0
3,GO HEPARIN METABOLIC PROCESS,7.1819e-07,-0.43334,-0.43649,1,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,3.1479e-07,-0.43349,-0.42127,1,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.4192e-10,-0.4335,-0.57925,1,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,1.174e-11,-0.43354,-0.52969,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,1.4877e-10,-0.43363,-0.59463,1,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,3.4773e-06,-0.43392,-0.47805,1,0
3,GO AXON EXTENSION,3.5427e-10,-0.43431,-0.481,1,0
3,GO PROTEIN DEGLYCOSYLATION,1.5688e-10,-0.43436,-0.51973,1,0
3,GO RENAL VESICLE DEVELOPMENT,4.6356e-09,-0.43474,-0.45617,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.0279e-08,-0.43478,-0.48775,1,0
3,GO ENDOTHELIAL CELL PROLIFERATION,1.7286e-12,-0.43478,-0.5332,1,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,5.8856e-08,-0.4349,-0.43741,1,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,5.7536e-08,-0.4349,-0.45567,1,0
3,GO PHAGOCYTOSIS,1.5838e-12,-0.43492,-0.47376,1,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.8573e-08,-0.43492,-0.43331,1,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,7.6792e-10,-0.4351,-0.50145,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,9.5999e-07,-0.4355,-0.4947,1,0
3,GO PROTEIN DEMANNOSYLATION,3.055e-09,-0.43556,-0.49789,1,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,7.2964e-10,-0.43558,-0.5008,1,0
3,GO RESPONSE TO ANGIOTENSIN,9.4157e-10,-0.43568,-0.47353,1,0
3,GO AORTA DEVELOPMENT,3.8118e-09,-0.4357,-0.52116,1,0
3,GO RENAL SYSTEM PROCESS,6.9522e-13,-0.43576,-0.52548,1,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,2.8305e-05,-0.43576,-0.38519,1,0
3,GO RESPONSE TO AMYLOID BETA,2.3113e-12,-0.43577,-0.52693,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0007786,-0.43592,-0.35354,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,2.4861e-06,-0.43623,-0.39667,1,0
3,GO VASCULATURE DEVELOPMENT,9.6219e-13,-0.4363,-0.51344,1,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,6.586e-10,-0.4364,-0.46739,1,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,5.3186e-12,-0.43652,-0.55,1,0
3,GO STRIATED MUSCLE ADAPTATION,2.9805e-09,-0.43655,-0.44278,1,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00028155,-0.43657,-0.45011,1,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,8.6328e-08,-0.43664,-0.46056,1,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,2.8373e-13,-0.43684,-0.52687,1,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,7.479e-12,-0.43685,-0.50479,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,4.6881e-08,-0.43714,-0.56282,1,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.8925e-08,-0.43747,-0.46956,1,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,4.8824e-12,-0.43747,-0.50622,1,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.8662e-13,-0.43749,-0.5213,1,0
3,GO HEART VALVE FORMATION,8.6328e-08,-0.43759,-0.50952,1,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,5.3747e-08,-0.43772,-0.52993,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,1.4282e-11,-0.43783,-0.47985,1,0
3,GO FORMATION OF PRIMARY GERM LAYER,1.3133e-11,-0.43791,-0.52131,1,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,1.6129e-08,-0.43793,-0.48878,1,0
3,GO POSTSYNAPSE ASSEMBLY,1.3599e-06,-0.43815,-0.4991,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,9.6538e-08,-0.43835,-0.475,1,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,6.4192e-10,-0.43847,-0.49569,1,0
3,GO KERATINOCYTE PROLIFERATION,2.3268e-09,-0.43855,-0.48981,1,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,4.0343e-10,-0.43856,-0.56772,1,0
3,GO REGULATION OF BIOMINERALIZATION,5.1691e-12,-0.43856,-0.47539,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.6129e-08,-0.43888,-0.44366,1,0
3,GO RESPONSE TO ACETYLCHOLINE,3.9035e-08,-0.43903,-0.43711,1,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,6.1321e-12,-0.43909,-0.50243,1,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,2.9371e-11,-0.43916,-0.43449,1,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,5.6085e-05,-0.4392,-0.38835,1,0
3,GO BONE MINERALIZATION,3.1896e-11,-0.43922,-0.45497,1,0
3,GO BLOOD VESSEL MORPHOGENESIS,9.6219e-13,-0.43923,-0.51928,1,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,4.1025e-09,-0.43936,-0.47608,1,0
3,GO MYOBLAST FUSION,5.6304e-12,-0.43936,-0.55051,1,0
3,GO RESPONSE TO TUMOR CELL,1.9465e-08,-0.43939,-0.46637,1,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,1.9014e-08,-0.43942,-0.43827,1,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.0343e-10,-0.43948,-0.475,1,0
3,GO REGULATION OF FIBROBLAST MIGRATION,1.9546e-09,-0.43965,-0.48228,1,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.182e-12,-0.43979,-0.52156,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,7.479e-12,-0.43984,-0.49606,1,0
3,GO RELAXATION OF CARDIAC MUSCLE,9.7998e-07,-0.43985,-0.45659,1,0
3,GO PLATELET ACTIVATION,2.4491e-12,-0.43989,-0.51948,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.7166e-08,-0.4399,-0.52812,1,0
3,GO CELLULAR RESPONSE TO KETONE,3.3697e-11,-0.44005,-0.43524,1,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,2.4305e-07,-0.44011,-0.39949,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,2.0509e-11,-0.44018,-0.5184,1,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,2.9805e-09,-0.44036,-0.57423,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.9064e-09,-0.44064,-0.53378,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.3174e-07,-0.44088,-0.4509,1,0
3,GO REGULATION OF RECEPTOR CLUSTERING,1.8053e-06,-0.44101,-0.5094,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.2286e-11,-0.44117,-0.51546,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,5.6304e-12,-0.44122,-0.48943,1,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.7449e-12,-0.44125,-0.48533,1,0
3,GO SUPEROXIDE ANION GENERATION,1.9926e-08,-0.44141,-0.4375,1,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,2.9514e-07,-0.44144,-0.42935,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.7166e-08,-0.44149,-0.44611,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.8888e-05,-0.44153,-0.46544,1,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,3.3214e-05,-0.44167,-0.41302,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00010323,-0.44168,-0.44451,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.0804e-10,-0.44195,-0.57646,1,0
3,GO MEMBRANE INVAGINATION,8.8611e-12,-0.44201,-0.49139,1,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,6.3074e-11,-0.44203,-0.48075,1,0
3,GO RESPONSE TO IRON ION,2.2707e-10,-0.44209,-0.46132,1,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,1.0792e-11,-0.44218,-0.50758,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,2.2707e-10,-0.4424,-0.51686,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.4487e-10,-0.44242,-0.49176,1,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,2.004e-09,-0.44244,-0.43892,1,0
3,GO GAP JUNCTION ASSEMBLY,2.3268e-09,-0.44253,-0.57503,1,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,3.7319e-10,-0.44264,-0.50916,1,0
3,GO LIVER MORPHOGENESIS,7.5266e-09,-0.44311,-0.45532,1,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,4.3082e-09,-0.4432,-0.41189,1,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,2.9127e-12,-0.44349,-0.51185,1,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,1.1794e-07,-0.44365,-0.45419,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.7286e-10,-0.44369,-0.48537,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,2.2707e-10,-0.44387,-0.44646,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,3.462e-12,-0.44396,-0.48466,1,0
3,GO RESPONSE TO INTERFERON GAMMA,2.7676e-09,-0.44408,-0.49791,1,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,1.3351e-08,-0.44418,-0.49133,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,2.3268e-09,-0.44426,-0.52679,1,0
3,GO PROSTATE GLAND MORPHOGENESIS,2.9805e-09,-0.4444,-0.55884,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.2764e-10,-0.44452,-0.4577,1,0
3,GO FOAM CELL DIFFERENTIATION,2.3312e-10,-0.44458,-0.47406,1,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,1.3878e-06,-0.44467,-0.38947,1,0
3,GO TISSUE MIGRATION,6.7492e-13,-0.44477,-0.54646,1,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,4.249e-10,-0.44504,-0.51703,1,0
3,GO LENS FIBER CELL DEVELOPMENT,7.4177e-11,-0.44504,-0.52252,1,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,1.4107e-10,-0.44518,-0.53131,1,0
3,GO LUNG EPITHELIUM DEVELOPMENT,1.0036e-08,-0.44551,-0.46906,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.9127e-12,-0.44557,-0.49296,1,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,1.3174e-07,-0.44564,-0.49311,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,6.552e-13,-0.44589,-0.50617,1,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,1.182e-12,-0.44593,-0.49919,1,0
3,GO REGULATION OF HEART MORPHOGENESIS,2.402e-08,-0.44599,-0.43761,1,0
3,GO REGULATION OF ANOIKIS,1.2131e-09,-0.44607,-0.57037,1,0
3,GO SPROUTING ANGIOGENESIS,2.0509e-11,-0.44614,-0.51436,1,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,3.6586e-11,-0.44617,-0.46622,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.4677e-08,-0.44619,-0.51581,1,0
3,GO CHONDROCYTE DEVELOPMENT,4.4749e-10,-0.44632,-0.54952,1,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,3.8118e-09,-0.44681,-0.4831,1,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.2023e-10,-0.44708,-0.5297,1,0
3,GO SOMATIC STEM CELL DIVISION,2.4371e-06,-0.44757,-0.53312,1,0
3,GO CYCLOOXYGENASE PATHWAY,6.4699e-07,-0.44786,-0.45394,1,0
3,GO CRANIAL NERVE DEVELOPMENT,1.1307e-08,-0.44787,-0.45752,1,0
3,GO SERTOLI CELL DIFFERENTIATION,7.6205e-11,-0.44801,-0.49509,1,0
3,GO NEURONAL ION CHANNEL CLUSTERING,3.2631e-05,-0.44826,-0.45925,1,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.00092737,-0.44859,-0.40379,1,0
3,GO ANATOMICAL STRUCTURE REGRESSION,9.3415e-09,-0.44863,-0.56554,1,0
3,GO INNER DYNEIN ARM ASSEMBLY,4.7999e-05,-0.44882,-0.38378,1,0
3,GO RESPONSE TO PROGESTERONE,4.9403e-11,-0.44891,-0.4791,1,0
3,GO EPITHELIAL CELL PROLIFERATION,1.2907e-12,-0.44908,-0.47333,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,1.3351e-08,-0.44926,-0.4455,1,0
3,GO HEART VALVE DEVELOPMENT,2.1085e-11,-0.44926,-0.57162,1,0
3,GO P38MAPK CASCADE,1.4107e-10,-0.44929,-0.51124,1,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.3268e-09,-0.44947,-0.49089,1,0
3,GO NEURON PROJECTION ORGANIZATION,9.9064e-10,-0.44949,-0.46659,1,0
3,GO RESPONSE TO VITAMIN,5.3617e-10,-0.4499,-0.46567,1,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,1.6542e-10,-0.44996,-0.49359,1,0
3,GO POSITIVE REGULATION OF OSSIFICATION,2.0509e-11,-0.45001,-0.48409,1,0
3,GO WOUND HEALING,1.0824e-12,-0.45005,-0.51348,1,0
3,GO PROTEIN LOCALIZATION TO AXON,2.1234e-05,-0.45037,-0.48066,1,0
3,GO REPLACEMENT OSSIFICATION,1.5529e-11,-0.45044,-0.54887,1,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,1.3761e-09,-0.45054,-0.47724,1,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,8.6579e-07,-0.45079,-0.4794,1,0
3,GO COLLAGEN CATABOLIC PROCESS,2.6306e-11,-0.45094,-0.53723,1,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,1.4334e-08,-0.45133,-0.48904,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,2.457e-10,-0.45143,-0.52976,1,0
3,GO HYALURONAN CATABOLIC PROCESS,7.6792e-10,-0.45185,-0.54445,1,0
3,GO ENDOTHELIUM DEVELOPMENT,1.277e-11,-0.45203,-0.52906,1,0
3,GO ENDOTHELIAL CELL MIGRATION,6.7492e-13,-0.45249,-0.56356,1,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4686e-11,-0.45266,-0.52698,1,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,4.9624e-10,-0.45273,-0.53406,1,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,1.0424e-06,-0.45291,-0.40901,1,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,3.9941e-08,-0.45308,-0.51811,1,0
3,GO SYNAPSE MATURATION,2.2505e-06,-0.4535,-0.47856,1,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,7.4177e-11,-0.45364,-0.49313,1,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,8.2618e-11,-0.45373,-0.51268,1,0
3,GO CELLULAR RESPONSE TO SALT STRESS,3.247e-08,-0.45387,-0.48492,1,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,2.559e-11,-0.45414,-0.51198,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.001422,-0.45421,-0.46411,1,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0011668,-0.45448,-0.33738,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.725e-09,-0.45468,-0.5045,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.5037e-07,-0.45479,-0.40504,1,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,1.9948e-11,-0.45556,-0.49395,1,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,3.055e-09,-0.45583,-0.46197,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00020835,-0.45605,-0.38929,1,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,5.793e-12,-0.45606,-0.58369,1,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.3468e-07,-0.45613,-0.44996,1,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,1.9014e-08,-0.45617,-0.48617,1,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,3.9941e-08,-0.45659,-0.51528,1,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,3.8983e-07,-0.45665,-0.53802,1,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,4.1456e-06,-0.45666,-0.43066,1,0
3,GO RESPONSE TO INTERFERON BETA,2.2416e-05,-0.45675,-0.52073,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,3.055e-09,-0.45687,-0.46341,1,0
3,GO REGULATION OF COAGULATION,3.1896e-11,-0.45711,-0.53281,1,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,3.5597e-11,-0.45721,-0.47485,1,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,8.0815e-10,-0.45726,-0.48888,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.4877e-10,-0.4574,-0.50256,1,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,1.5713e-07,-0.45752,-0.53686,1,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,1.0792e-11,-0.45783,-0.54215,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,6.6774e-12,-0.45784,-0.5246,1,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,1.1307e-08,-0.45791,-0.4815,1,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,2.0546e-09,-0.45795,-0.48189,1,0
3,GO GLYCINE TRANSPORT,1.7071e-05,-0.45818,-0.4488,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,8.8282e-08,-0.45823,-0.58985,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,3.7602e-11,-0.45824,-0.50671,1,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,2.7614e-08,-0.45834,-0.49319,1,0
3,GO LEUKOCYTE AGGREGATION,1.6321e-06,-0.45843,-0.51904,1,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,5.793e-12,-0.45854,-0.51041,1,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,9.7068e-11,-0.45885,-0.48602,1,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.4787e-08,-0.45942,-0.5257,1,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.0279e-08,-0.45949,-0.4377,1,0
3,GO POSITIVE REGULATION OF MITOPHAGY,3.0295e-08,-0.45957,-0.44525,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,1.0205e-12,-0.45957,-0.52366,1,0
3,GO LENS FIBER CELL DIFFERENTIATION,2.7797e-11,-0.45967,-0.50121,1,0
3,GO REGULATION OF BONE MINERALIZATION,2.2286e-11,-0.4597,-0.49207,1,0
3,GO MULTI ORGANISM CELLULAR PROCESS,5.793e-12,-0.45983,-0.56405,1,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,8.4262e-06,-0.46004,-0.46645,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.8886e-07,-0.46004,-0.56966,1,0
3,GO PLATELET DEGRANULATION,3.019e-11,-0.46012,-0.51247,1,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,2.9979e-12,-0.46032,-0.54993,1,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,4.1403e-10,-0.46047,-0.49547,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.2414e-06,-0.4607,-0.45649,1,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,5.2538e-08,-0.46084,-0.50021,1,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,2.4091e-05,-0.461,-0.46588,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,9.6538e-08,-0.4612,-0.52075,1,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,3.7195e-09,-0.46124,-0.46127,1,0
3,GO NUCLEAR MIGRATION,1.3878e-06,-0.46138,-0.46784,1,0
3,GO ACTIVATION OF JNKK ACTIVITY,1.9546e-09,-0.46138,-0.50491,1,0
3,GO INTRACELLULAR STEROL TRANSPORT,6.0565e-09,-0.4614,-0.45753,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,1.9558e-07,-0.46145,-0.49822,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.6001e-09,-0.46183,-0.58863,1,0
3,GO RENAL ABSORPTION,1.3468e-07,-0.46204,-0.56341,1,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,1.6418e-07,-0.46214,-0.45338,1,0
3,GO NEGATIVE REGULATION OF COAGULATION,7.6205e-11,-0.46257,-0.56499,1,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,3.6567e-07,-0.46367,-0.47744,1,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.2707e-10,-0.46386,-0.46555,1,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00048316,-0.46394,-0.35624,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,1.3671e-08,-0.46411,-0.51864,1,0
3,GO REGULATION OF CELL SHAPE,3.5629e-12,-0.46437,-0.51251,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,2.8814e-05,-0.46475,-0.40889,1,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,2.2139e-09,-0.46496,-0.45742,1,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.2907e-12,-0.46502,-0.56266,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,7.598e-13,-0.46505,-0.55943,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,7.6657e-06,-0.46557,-0.47005,1,0
3,GO TROPHOBLAST CELL MIGRATION,2.1807e-07,-0.4656,-0.45608,1,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,4.4302e-11,-0.46671,-0.48606,1,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,1.5386e-08,-0.46688,-0.53956,1,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,1.6514e-08,-0.46708,-0.4736,1,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,1.5753e-08,-0.4673,-0.50143,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.2434e-08,-0.46768,-0.52502,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,3.7319e-10,-0.46769,-0.49476,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,9.1996e-11,-0.46773,-0.49724,1,0
3,GO PLASMA MEMBRANE ORGANIZATION,2.2453e-12,-0.46789,-0.54446,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,1.494e-12,-0.46813,-0.58214,1,0
3,GO SECONDARY PALATE DEVELOPMENT,1.8594e-09,-0.46816,-0.49711,1,0
3,GO RESPONSE TO POTASSIUM ION,4.5558e-05,-0.46841,-0.36865,1,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.2441e-09,-0.4685,-0.45699,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,1.0161e-09,-0.46853,-0.45393,1,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,2.7797e-11,-0.46859,-0.49893,1,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,5.0766e-11,-0.46865,-0.46604,1,0
3,GO POSITIVE REGULATION OF HEART RATE,6.545e-05,-0.46887,-0.32238,1,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,3.2685e-12,-0.46889,-0.51236,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.5646e-05,-0.46904,-0.46308,1,0
3,GO REGULATION OF WOUND HEALING,5.793e-12,-0.47024,-0.52124,1,0
3,GO ODONTOGENESIS,5.9602e-12,-0.4704,-0.51249,1,0
3,GO NEPHRON DEVELOPMENT,1.4686e-11,-0.47093,-0.50199,1,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,1.0861e-06,-0.47105,-0.49114,1,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,5.2253e-10,-0.47119,-0.48732,1,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.5427e-10,-0.47146,-0.49009,1,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,1.5277e-10,-0.47155,-0.57127,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.1757e-12,-0.47204,-0.49886,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,4.0817e-11,-0.47222,-0.54498,1,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4677e-08,-0.47238,-0.54544,1,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,3.3713e-09,-0.47239,-0.48083,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,2.8753e-10,-0.4726,-0.51281,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,1.9546e-09,-0.47263,-0.4678,1,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,3.357e-07,-0.47269,-0.47215,1,0
3,GO VASCULOGENESIS,3.1757e-12,-0.4727,-0.55669,1,0
3,GO LYMPH VESSEL MORPHOGENESIS,1.2682e-10,-0.47295,-0.52761,1,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,9.4499e-11,-0.47303,-0.48091,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,6.8406e-11,-0.47311,-0.56442,1,0
3,GO ASTROCYTE DEVELOPMENT,2.2912e-11,-0.47325,-0.50512,1,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,6.1389e-11,-0.47381,-0.51465,1,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.2094e-09,-0.47398,-0.47423,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,1.6884e-11,-0.47417,-0.5583,1,0
3,GO RESPONSE TO GROWTH HORMONE,3.2764e-10,-0.47449,-0.50884,1,0
3,GO HIPPO SIGNALING,9.4407e-08,-0.47449,-0.53021,1,0
3,GO METANEPHROS MORPHOGENESIS,2.2707e-10,-0.47459,-0.49807,1,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,9.4157e-10,-0.47467,-0.52969,1,0
3,GO NERVE DEVELOPMENT,2.3268e-09,-0.47471,-0.50032,1,0
3,GO MEMBRANE BIOGENESIS,2.559e-11,-0.47484,-0.54607,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,3.192e-10,-0.47486,-0.52225,1,0
3,GO TRACHEA DEVELOPMENT,8.0815e-10,-0.47507,-0.5191,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.232e-12,-0.47507,-0.49575,1,0
3,GO RESPONSE TO FORSKOLIN,2.0879e-07,-0.47511,-0.48455,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,6.4192e-10,-0.47514,-0.55482,1,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,2.5893e-10,-0.47534,-0.5012,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.8594e-09,-0.47539,-0.54319,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3467e-08,-0.47582,-0.57003,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.0278e-07,-0.47583,-0.46575,1,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,1.7286e-12,-0.47624,-0.53516,1,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.942e-12,-0.4765,-0.5471,1,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,4.7125e-10,-0.47654,-0.54249,1,0
3,GO FIBROBLAST PROLIFERATION,1.0493e-11,-0.47657,-0.48025,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,8.6145e-12,-0.47675,-0.50556,1,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,6.205e-09,-0.47679,-0.55412,1,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,9.9064e-10,-0.47685,-0.51935,1,0
3,GO MESENCHYMAL CELL PROLIFERATION,6.8348e-09,-0.47724,-0.52365,1,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.4677e-08,-0.47726,-0.5081,1,0
3,GO RESPONSE TO LEUCINE,2.7668e-07,-0.47737,-0.4457,1,0
3,GO DISACCHARIDE METABOLIC PROCESS,8.4877e-09,-0.47741,-0.46722,1,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,2.2397e-08,-0.47744,-0.5121,1,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,1.0422e-09,-0.47776,-0.50116,1,0
3,GO LUNG ALVEOLUS DEVELOPMENT,2.9078e-09,-0.47779,-0.53431,1,0
3,GO LIPID TRANSLOCATION,1.069e-09,-0.47783,-0.49408,1,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,2.8369e-09,-0.47794,-0.56395,1,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,3.1479e-07,-0.47795,-0.52571,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,2.9979e-12,-0.47815,-0.5276,1,0
3,GO MATERNAL PLACENTA DEVELOPMENT,1.2886e-07,-0.47826,-0.45714,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.4112e-09,-0.47879,-0.47745,1,0
3,GO CELL SUBSTRATE ADHESION,3.9478e-13,-0.47882,-0.5901,1,0
3,GO PLATELET AGGREGATION,6.8406e-11,-0.47882,-0.5259,1,0
3,GO RESPONSE TO INTERFERON ALPHA,2.206e-06,-0.47909,-0.64981,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.6667e-12,-0.47917,-0.57688,1,0
3,GO HAIR FOLLICLE MATURATION,2.1375e-08,-0.47948,-0.4755,1,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,2.4837e-07,-0.48053,-0.50536,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,4.1815e-08,-0.48063,-0.43953,1,0
3,GO MIDGUT DEVELOPMENT,2.3467e-08,-0.48065,-0.50331,1,0
3,GO ATRIAL SEPTUM DEVELOPMENT,8.8282e-08,-0.48092,-0.49987,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,6.4805e-11,-0.481,-0.51054,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.9035e-08,-0.4811,-0.59221,1,0
3,GO NUCLEUS LOCALIZATION,2.3784e-07,-0.48151,-0.46169,1,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,4.4807e-06,-0.48194,-0.48121,1,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,1.8135e-09,-0.48292,-0.54158,1,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,3.5461e-06,-0.48333,-0.46672,1,0
3,GO TRACHEA MORPHOGENESIS,2.9515e-10,-0.48334,-0.52405,1,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,5.6245e-08,-0.4834,-0.50126,1,0
3,GO CELL MATRIX ADHESION,8.8075e-13,-0.48346,-0.59043,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.182e-12,-0.48356,-0.57821,1,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,3.6667e-12,-0.48374,-0.63089,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,3.2685e-12,-0.48391,-0.55504,1,0
3,GO REGULATION OF AMYLOID BETA FORMATION,1.4487e-10,-0.48395,-0.49402,1,0
3,GO CELLULAR RESPONSE TO STEROL,8.0815e-10,-0.48459,-0.49529,1,0
3,GO ACTIN MEDIATED CELL CONTRACTION,8.4871e-11,-0.48492,-0.44087,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00016901,-0.48496,-0.4227,1,0
3,GO TISSUE REMODELING,1.0202e-11,-0.48511,-0.53502,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,1.1828e-09,-0.48544,-0.52198,1,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.8645e-11,-0.48546,-0.58516,1,0
3,GO NOTOCHORD DEVELOPMENT,2.634e-09,-0.48549,-0.53883,1,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,6.1321e-12,-0.48586,-0.51151,1,0
3,GO ENDODERM DEVELOPMENT,1.6884e-11,-0.4859,-0.58639,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.7309e-08,-0.48636,-0.48823,1,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,3.5461e-06,-0.48645,-0.43619,1,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,3.9035e-08,-0.48661,-0.60141,1,0
3,GO UV PROTECTION,3.6435e-08,-0.48673,-0.46618,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,3.5412e-09,-0.4868,-0.52962,1,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,3.1004e-08,-0.48695,-0.56279,1,0
3,GO CAMP METABOLIC PROCESS,8.0424e-11,-0.48736,-0.52854,1,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,1.1579e-08,-0.4876,-0.54476,1,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,5.1101e-09,-0.48772,-0.57296,1,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,8.6145e-12,-0.48784,-0.50132,1,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.1858e-08,-0.4879,-0.5338,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.6877e-06,-0.488,-0.4951,1,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,1.734e-06,-0.48891,-0.52415,1,0
3,GO PROTEIN TARGETING TO LYSOSOME,5.7923e-10,-0.48905,-0.54282,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.634e-09,-0.49075,-0.48813,1,0
3,GO ENDODERM FORMATION,2.7041e-11,-0.49076,-0.61395,1,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,9.1205e-09,-0.4909,-0.56958,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,3.0856e-12,-0.49094,-0.50406,1,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.8793e-06,-0.49146,-0.57925,1,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,2.8925e-08,-0.49149,-0.483,1,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,5.1356e-08,-0.49206,-0.55918,1,0
3,GO EPITHELIAL CELL MORPHOGENESIS,1.3769e-07,-0.49221,-0.55147,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,1.942e-12,-0.49256,-0.52099,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.6907e-08,-0.49273,-0.42711,1,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,5.4724e-12,-0.49311,-0.5555,1,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0013255,-0.49341,-0.32289,1,0
3,GO CHONDROCYTE DIFFERENTIATION,1.3505e-11,-0.4936,-0.54042,1,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,1.0861e-06,-0.49398,-0.47173,1,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,2.9371e-11,-0.49423,-0.52488,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,1.1533e-09,-0.49443,-0.56758,1,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.2286e-07,-0.49457,-0.46109,1,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,5.9498e-07,-0.49461,-0.4583,1,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,2.1678e-11,-0.49464,-0.54947,1,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,1.736e-11,-0.49499,-0.51272,1,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,4.4787e-08,-0.4955,-0.44468,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,1.0756e-05,-0.49589,-0.55022,1,0
3,GO EMBRYO IMPLANTATION,2.2707e-10,-0.49631,-0.5018,1,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,3.3713e-09,-0.49632,-0.49145,1,0
3,GO CARDIAC SEPTUM DEVELOPMENT,5.5016e-10,-0.49641,-0.5194,1,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,2.0546e-09,-0.49643,-0.50991,1,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,3.1757e-12,-0.49649,-0.57495,1,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,9.4499e-11,-0.49665,-0.50613,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.2912e-11,-0.49703,-0.6227,1,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.8359e-10,-0.49714,-0.53095,1,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,2.3467e-08,-0.49733,-0.43298,1,0
3,GO MATURE B CELL DIFFERENTIATION,2.188e-08,-0.49771,-0.52662,1,0
3,GO N GLYCAN PROCESSING,3.192e-10,-0.49782,-0.56688,1,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,2.3933e-10,-0.49783,-0.59167,1,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,2.5066e-09,-0.49789,-0.49123,1,0
3,GO LYMPHANGIOGENESIS,1.0781e-08,-0.49806,-0.48139,1,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,1.2792e-06,-0.4983,-0.54393,1,0
3,GO T CELL EXTRAVASATION,1.0781e-08,-0.49875,-0.54586,1,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,3.5606e-08,-0.49902,-0.47685,1,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,8.3747e-12,-0.49905,-0.57315,1,0
3,GO AMELOGENESIS,2.8573e-11,-0.49946,-0.55663,1,0
3,GO RESPONSE TO INTERLEUKIN 18,3.357e-07,-0.49968,-0.58166,1,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,9.9064e-10,-0.5,-0.49452,1,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,3.7195e-09,-0.50041,-0.56625,1,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,4.7172e-05,-0.5005,-0.48341,1,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,5.9602e-12,-0.50095,-0.53549,1,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,7.0671e-12,-0.50119,-0.59569,1,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,9.3752e-12,-0.50123,-0.61403,1,0
3,GO NEURAL CREST CELL DIFFERENTIATION,8.7184e-11,-0.5013,-0.48663,1,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,1.3999e-08,-0.50147,-0.53252,1,0
3,GO ENDODERMAL CELL DIFFERENTIATION,8.0424e-11,-0.50152,-0.64603,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.2434e-08,-0.50198,-0.45328,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,3.9309e-10,-0.50222,-0.50521,1,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.2348e-10,-0.50236,-0.51525,1,0
3,GO BLOOD VESSEL REMODELING,2.4491e-12,-0.50256,-0.60709,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,1.8881e-10,-0.50276,-0.5949,1,0
3,GO TRABECULA FORMATION,1.0804e-10,-0.50298,-0.54498,1,0
3,GO ADHERENS JUNCTION ASSEMBLY,1.6654e-06,-0.50308,-0.50815,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.4192e-10,-0.50341,-0.55281,1,0
3,GO NEUROBLAST DIVISION,1.9926e-08,-0.50428,-0.54531,1,0
3,GO REGULATION OF MYOBLAST FUSION,3.2094e-09,-0.50444,-0.5048,1,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,4.5233e-07,-0.50465,-0.44436,1,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,3.9064e-09,-0.50467,-0.54879,1,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,1.2954e-05,-0.5048,-0.4473,1,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,5.5016e-10,-0.50503,-0.52245,1,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,3.5427e-10,-0.50544,-0.5226,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.1415e-11,-0.50728,-0.56222,1,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,3.4796e-08,-0.50762,-0.56746,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,3.055e-09,-0.50859,-0.59561,1,0
3,GO GAMMA DELTA T CELL ACTIVATION,4.3355e-07,-0.51013,-0.43583,1,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.1812e-12,-0.51054,-0.63328,1,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,3.2764e-10,-0.51184,-0.57928,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,1.0241e-10,-0.51196,-0.58415,1,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,2.6362e-08,-0.51206,-0.53068,1,0
3,GO AORTIC VALVE DEVELOPMENT,1.6109e-10,-0.51221,-0.60101,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,1.7922e-07,-0.51284,-0.54959,1,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,2.8262e-08,-0.51295,-0.48734,1,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,1.3671e-08,-0.51298,-0.48099,1,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,4.6784e-11,-0.51334,-0.49702,1,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,3.8301e-10,-0.51377,-0.53183,1,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,1.8053e-06,-0.51384,-0.49088,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.7909e-10,-0.51397,-0.61142,1,0
3,GO ADHESION OF SYMBIONT TO HOST,2.5756e-08,-0.51426,-0.51368,1,0
3,GO RESPONSE TO MUSCLE STRETCH,0.00014839,-0.51426,-0.4153,1,0
3,GO DETECTION OF BIOTIC STIMULUS,5.3647e-09,-0.51442,-0.52494,1,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,2.9078e-09,-0.51468,-0.56068,1,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,4.6881e-08,-0.51497,-0.49318,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,8.6145e-12,-0.51551,-0.60049,1,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,1.1282e-07,-0.5159,-0.54566,1,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4092e-12,-0.51617,-0.6017,1,0
3,GO EPITHELIAL CELL CELL ADHESION,1.2604e-07,-0.51622,-0.59726,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.6307e-12,-0.51628,-0.57215,1,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,1.7693e-06,-0.51639,-0.65292,1,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,9.4499e-11,-0.51642,-0.53678,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.4877e-10,-0.51711,-0.56087,1,0
3,GO PERICARDIUM DEVELOPMENT,7.7166e-08,-0.51717,-0.51183,1,0
3,GO GLAND MORPHOGENESIS,2.9979e-12,-0.51804,-0.57671,1,0
3,GO DECIDUALIZATION,8.4805e-07,-0.51816,-0.47253,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.5102e-11,-0.51868,-0.5294,1,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,8.4877e-09,-0.51897,-0.4871,1,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.4163e-06,-0.51921,-0.40003,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.2094e-09,-0.51944,-0.51277,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,3.8161e-07,-0.5208,-0.50947,1,0
3,GO FOCAL ADHESION ASSEMBLY,3.1757e-12,-0.5211,-0.60687,1,0
3,GO REVERSE CHOLESTEROL TRANSPORT,1.4471e-09,-0.52129,-0.60273,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.1706e-10,-0.5216,-0.57992,1,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,1.996e-06,-0.52166,-0.58144,1,0
3,GO RESPONSE TO STEROL,7.8286e-11,-0.5219,-0.5217,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,4.5239e-09,-0.52204,-0.6411,1,0
3,GO T HELPER 2 CELL DIFFERENTIATION,6.6717e-09,-0.5225,-0.57068,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.1398e-10,-0.52277,-0.62422,1,0
3,GO COLLAGEN METABOLIC PROCESS,1.8323e-12,-0.5234,-0.60454,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,6.3088e-12,-0.52414,-0.61544,1,0
3,GO VOCALIZATION BEHAVIOR,5.4356e-06,-0.52422,-0.50239,1,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.3554e-11,-0.52435,-0.52267,1,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,1.0094e-07,-0.52481,-0.50803,1,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,3.192e-10,-0.5249,-0.58276,1,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,4.8673e-09,-0.52498,-0.56244,1,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,1.2328e-07,-0.52526,-0.48124,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.8389e-10,-0.5254,-0.55505,1,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,2.2117e-10,-0.52566,-0.53625,1,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,9.3415e-09,-0.52575,-0.58665,1,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,3.4553e-09,-0.5259,-0.64949,1,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,4.3355e-07,-0.52689,-0.64637,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,2.4586e-08,-0.5274,-0.54901,1,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,5.793e-12,-0.52749,-0.51042,1,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.4076e-07,-0.5278,-0.49466,1,0
3,GO RESPONSE TO TYPE I INTERFERON,1.9563e-06,-0.5279,-0.55001,1,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,1.5217e-09,-0.52866,-0.58195,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,4.6578e-06,-0.52891,-0.69106,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.6112e-12,-0.52916,-0.53494,1,0
3,GO FACE DEVELOPMENT,9.1996e-11,-0.52949,-0.5646,1,0
3,GO CORONARY VASCULATURE DEVELOPMENT,6.2565e-10,-0.52963,-0.51034,1,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.9035e-08,-0.52965,-0.48498,1,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.457e-10,-0.52988,-0.5256,1,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,7.6792e-10,-0.5302,-0.54845,1,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.4415e-08,-0.53033,-0.51167,1,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,7.8976e-09,-0.53066,-0.52748,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,1.3761e-09,-0.53072,-0.59195,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,8.4262e-06,-0.53073,-0.58834,1,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0005618,-0.53106,-0.36275,1,0
3,GO CHOLESTEROL STORAGE,4.7125e-10,-0.53108,-0.54923,1,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.402e-08,-0.53115,-0.55209,1,0
3,GO MACROPHAGE PROLIFERATION,4.4749e-10,-0.53187,-0.5811,1,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,4.5922e-10,-0.53237,-0.4942,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,4.8662e-13,-0.53266,-0.60467,1,0
3,GO INNERVATION,2.0429e-07,-0.533,-0.60622,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.6129e-08,-0.53353,-0.57695,1,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,6.4805e-11,-0.53562,-0.62149,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,1.9558e-07,-0.53565,-0.56007,1,0
3,GO BEHAVIORAL RESPONSE TO PAIN,2.3268e-09,-0.53569,-0.53805,1,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,8.1414e-12,-0.53583,-0.55951,1,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.9432e-10,-0.53645,-0.51312,1,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.6986e-10,-0.53678,-0.54636,1,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,3.2764e-10,-0.53717,-0.49585,1,0
3,GO SERTOLI CELL DEVELOPMENT,1.8881e-10,-0.5373,-0.54287,1,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9136e-07,-0.53843,-0.61593,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,1.0493e-11,-0.53864,-0.60598,1,0
3,GO AXONAL FASCICULATION,2.402e-08,-0.53878,-0.51151,1,0
3,GO RESPONSE TO HYPEROXIA,1.0202e-11,-0.53898,-0.53523,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,3.1098e-10,-0.5391,-0.50007,1,0
3,GO LYMPH VESSEL DEVELOPMENT,4.0343e-10,-0.53914,-0.58028,1,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.2286e-07,-0.53932,-0.47483,1,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.8573e-08,-0.53934,-0.60851,1,0
3,GO NEURAL CREST CELL MIGRATION,9.4499e-11,-0.54023,-0.5421,1,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,2.2926e-08,-0.54055,-0.67766,1,0
3,GO SEQUESTERING OF TRIGLYCERIDE,7.71e-09,-0.54056,-0.45798,1,0
3,GO RESPONSE TO EPINEPHRINE,2.6352e-05,-0.54062,-0.39411,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.7922e-07,-0.54064,-0.54169,1,0
3,GO GERMINAL CENTER FORMATION,5.4967e-09,-0.54065,-0.57665,1,0
3,GO ZYMOGEN ACTIVATION,1.4487e-10,-0.54177,-0.573,1,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.0804e-10,-0.54196,-0.57924,1,0
3,GO LAMELLIPODIUM MORPHOGENESIS,2.6362e-08,-0.54217,-0.52659,1,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,9.5677e-09,-0.5427,-0.57719,1,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,4.8839e-05,-0.54292,-0.48991,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,2.2286e-11,-0.54293,-0.6092,1,0
3,GO NEGATIVE CHEMOTAXIS,1.4877e-10,-0.54323,-0.58197,1,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.3468e-07,-0.54333,-0.46838,1,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,5.77e-09,-0.54367,-0.4966,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.0279e-08,-0.54435,-0.53912,1,0
3,GO BONE GROWTH,1.5217e-09,-0.54515,-0.55069,1,0
3,GO LIMB BUD FORMATION,5.332e-06,-0.54519,-0.51219,1,0
3,GO OLIGOPEPTIDE TRANSPORT,2.9602e-08,-0.54549,-0.50386,1,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,7.6792e-10,-0.54577,-0.52904,1,0
3,GO NEUTROPHIL HOMEOSTASIS,4.9624e-10,-0.54581,-0.63792,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,6.3604e-13,-0.54622,-0.62858,1,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,1.1282e-07,-0.54635,-0.52583,1,0
3,GO REGULATION OF RECEPTOR BINDING,8.4871e-11,-0.5464,-0.61951,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.65e-07,-0.54658,-0.51962,1,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,3.1098e-10,-0.54733,-0.5535,1,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,2.004e-09,-0.54804,-0.56198,1,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,1.9546e-09,-0.54805,-0.53675,1,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,2.8573e-11,-0.54838,-0.60847,1,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,4.4812e-12,-0.54841,-0.55439,1,0
3,GO CERAMIDE CATABOLIC PROCESS,1.471e-07,-0.54945,-0.51171,1,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.5893e-10,-0.54987,-0.51803,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,1.2131e-09,-0.54987,-0.55325,1,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,3.9613e-05,-0.55071,-0.42292,1,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,6.9323e-10,-0.55131,-0.54077,1,0
3,GO CELLULAR RESPONSE TO ETHANOL,4.0868e-08,-0.55167,-0.45422,1,0
3,GO NEURON CELL CELL ADHESION,2.3239e-05,-0.55193,-0.47607,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,9.4407e-08,-0.55198,-0.50298,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,5.1101e-09,-0.5533,-0.51917,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,2.8925e-08,-0.55394,-0.57623,1,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,1.785e-11,-0.55448,-0.62407,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.5529e-11,-0.5549,-0.55917,1,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,3.055e-09,-0.55536,-0.71488,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,2.3274e-07,-0.55742,-0.50122,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,2.5893e-10,-0.55812,-0.59986,1,0
3,GO REGULATION OF VASCULOGENESIS,3.1479e-07,-0.55896,-0.53063,1,0
3,GO PROSTATIC BUD FORMATION,8.1361e-07,-0.5597,-0.53353,1,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.5239e-09,-0.56116,-0.55884,1,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.4112e-09,-0.56131,-0.73656,1,0
3,GO EMBRYONIC EYE MORPHOGENESIS,7.8778e-10,-0.56193,-0.52175,1,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,9.1793e-10,-0.56286,-0.64847,1,0
3,GO DENDRITIC SPINE MAINTENANCE,3.055e-09,-0.5632,-0.53889,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,6.1321e-12,-0.56388,-0.63884,1,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,3.7319e-10,-0.56404,-0.56778,1,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.0398e-08,-0.56491,-0.52959,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,9.1996e-11,-0.56503,-0.66021,1,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.785e-11,-0.56544,-0.65243,1,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,6.757e-10,-0.56587,-0.62333,1,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,6.0565e-09,-0.56678,-0.52453,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00034485,-0.56695,-0.63566,1,0
3,GO CORPUS CALLOSUM DEVELOPMENT,1.5713e-07,-0.5694,-0.51625,1,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,4.3355e-07,-0.56941,-0.53967,1,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,1.2023e-10,-0.56945,-0.58175,1,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.9993e-12,-0.56948,-0.6247,1,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,8.0898e-09,-0.57061,-0.58232,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,5.6451e-10,-0.57146,-0.68598,1,0
3,GO MEMBRANE RAFT ORGANIZATION,7.71e-09,-0.5715,-0.61911,1,0
3,GO GLYCOLIPID CATABOLIC PROCESS,1.6782e-07,-0.5718,-0.54445,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,8.5043e-10,-0.57226,-0.62073,1,0
3,GO EPIBOLY,4.6112e-12,-0.57274,-0.63036,1,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,2.4452e-09,-0.5731,-0.61385,1,0
3,GO CRANIAL NERVE MORPHOGENESIS,2.3312e-10,-0.57581,-0.58865,1,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.9078e-09,-0.57588,-0.58278,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.3468e-07,-0.5773,-0.64256,1,0
3,GO PODOSOME ASSEMBLY,2.1064e-09,-0.57757,-0.60405,1,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,4.4285e-07,-0.57803,-0.56974,1,0
3,GO CHONDROCYTE PROLIFERATION,4.1552e-07,-0.57827,-0.48628,1,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,6.3088e-12,-0.57861,-0.65075,1,0
3,GO REGULATION OF PLATELET AGGREGATION,2.7676e-09,-0.57997,-0.61201,1,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,5.1101e-09,-0.57999,-0.52498,1,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,6.2175e-05,-0.58001,-0.40257,1,0
3,GO COLLAGEN FIBRIL ORGANIZATION,5.9748e-11,-0.58012,-0.66268,1,0
3,GO PROTEIN KINASE C SIGNALING,9.6431e-12,-0.58032,-0.59733,1,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,1.1533e-09,-0.58045,-0.5441,1,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,3.4796e-08,-0.58092,-0.48261,1,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,8.8075e-13,-0.58158,-0.6078,1,0
3,GO DETECTION OF OTHER ORGANISM,2.5934e-07,-0.58371,-0.54008,1,0
3,GO REGULATION OF PLATELET ACTIVATION,3.4516e-10,-0.58414,-0.59076,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.232e-12,-0.58417,-0.59613,1,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.6711e-12,-0.58427,-0.70783,1,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,1.1794e-07,-0.58456,-0.58948,1,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,2.011e-05,-0.58477,-0.46402,1,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.6219e-13,-0.58586,-0.69395,1,0
3,GO LATERAL VENTRICLE DEVELOPMENT,2.65e-07,-0.58647,-0.51084,1,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,6.7411e-08,-0.58648,-0.61595,1,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.1595e-09,-0.58682,-0.6073,1,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1.9558e-07,-0.58826,-0.57369,1,0
3,GO KERATINOCYTE DEVELOPMENT,2.5424e-05,-0.5886,-0.44123,1,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,2.0398e-08,-0.58958,-0.59391,1,0
3,GO AMYLOID FIBRIL FORMATION,8.9558e-11,-0.58972,-0.62604,1,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,1.7154e-07,-0.58975,-0.53177,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,5.0766e-11,-0.59011,-0.63025,1,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.1398e-10,-0.59091,-0.63318,1,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,7.2964e-10,-0.59095,-0.65367,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.3109e-11,-0.59137,-0.64867,1,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,2.2397e-08,-0.59277,-0.66711,1,0
3,GO BIOLOGICAL PHASE,2.3274e-07,-0.59343,-0.50676,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.3761e-09,-0.59356,-0.56996,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,1.439e-07,-0.59383,-0.55991,1,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.9905e-10,-0.59413,-0.63972,1,0
3,GO INACTIVATION OF MAPK ACTIVITY,2.2697e-09,-0.59484,-0.54435,1,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,2.6828e-05,-0.59614,-0.50619,1,0
3,GO SIALYLATION,4.1815e-08,-0.59753,-0.54969,1,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.3737e-10,-0.5994,-0.60969,1,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,7.8778e-10,-0.6007,-0.63558,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.402e-08,-0.60101,-0.54737,1,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,3.6586e-11,-0.60104,-0.65811,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,3.5427e-10,-0.60106,-0.67924,1,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,6.2565e-10,-0.60498,-0.59789,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.4472e-05,-0.60569,-0.64376,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,5.77e-09,-0.60629,-0.68354,1,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,6.6717e-09,-0.60694,-0.56228,1,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,2.595e-12,-0.60866,-0.63469,1,0
3,GO VASCULAR WOUND HEALING,1.1579e-08,-0.60916,-0.53756,1,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,4.5239e-09,-0.60972,-0.54298,1,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.5695e-09,-0.61153,-0.60657,1,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,3.0395e-05,-0.61272,-0.45802,1,0
3,GO BLASTODERM SEGMENTATION,1.4471e-09,-0.61362,-0.58415,1,0
3,GO CELL CELL JUNCTION MAINTENANCE,5.3747e-08,-0.61427,-0.58135,1,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,2.1188e-12,-0.61451,-0.71903,1,0
3,GO BASEMENT MEMBRANE ORGANIZATION,1.2074e-11,-0.61536,-0.72851,1,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,3.0295e-08,-0.61683,-0.65224,1,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,7.2202e-11,-0.6187,-0.63711,1,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,1.7797e-12,-0.61902,-0.65783,1,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,6.4699e-07,-0.61976,-0.55878,1,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,6.6774e-12,-0.62013,-0.63824,1,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,3.7356e-07,-0.62021,-0.56867,1,0
3,GO PULMONARY VALVE DEVELOPMENT,5.3747e-08,-0.62055,-0.59021,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,4.8359e-10,-0.62492,-0.72745,1,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,2.6581e-10,-0.62506,-0.68049,1,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,5.1101e-09,-0.62518,-0.6007,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6407e-09,-0.62563,-0.63581,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,5.02e-08,-0.62568,-0.63152,1,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,5.2253e-10,-0.62919,-0.67334,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,3.0296e-10,-0.62932,-0.58367,1,0
3,GO GLOMERULUS DEVELOPMENT,7.9144e-12,-0.63129,-0.68154,1,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,1.2907e-12,-0.63323,-0.78837,1,0
3,GO REGULATION OF PODOSOME ASSEMBLY,1.4677e-08,-0.63408,-0.61888,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,3.0296e-10,-0.63465,-0.61331,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.3606e-10,-0.64033,-0.59253,1,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.0169e-05,-0.64585,-0.57733,1,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.9064e-09,-0.65012,-0.64739,1,0
3,GO SKIN MORPHOGENESIS,2.0437e-10,-0.65066,-0.78059,1,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,1.9014e-08,-0.65222,-0.64524,1,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,3.1098e-10,-0.65481,-0.71954,1,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,9.1996e-11,-0.66033,-0.70693,1,0
3,GO HEMIDESMOSOME ASSEMBLY,5.8262e-07,-0.6608,-0.70015,1,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,8.4805e-07,-0.66207,-0.60759,1,0
3,GO TOOTH MINERALIZATION,4.6112e-12,-0.66941,-0.69708,1,0
3,GO SALIVARY GLAND DEVELOPMENT,1.3505e-11,-0.67355,-0.64487,1,0
3,GO BONE TRABECULA MORPHOGENESIS,2.1678e-11,-0.68162,-0.73932,1,0
3,GO FACIAL NERVE MORPHOGENESIS,1.2733e-08,-0.68561,-0.68996,1,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,6.4192e-10,-0.69013,-0.75924,1,0
3,GO BLEB ASSEMBLY,2.8262e-08,-0.69367,-0.74141,1,0
3,GO MYELIN MAINTENANCE,8.2903e-10,-0.69481,-0.67153,1,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.6306e-11,-0.69912,-0.69918,1,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,2.65e-07,-0.70271,-0.63243,1,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.5968e-11,-0.7031,-0.78538,1,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,2.0879e-07,-0.70636,-0.60452,1,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.3761e-09,-0.70639,-0.64618,1,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.3933e-10,-0.70901,-0.80497,1,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,9.658e-10,-0.71786,-0.64489,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,6.8348e-09,-0.72338,-0.77996,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00058763,-0.72749,-0.65166,1,0
3,GO ELASTIC FIBER ASSEMBLY,4.7501e-09,-0.72999,-0.75182,1,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,2.457e-10,-0.73544,-0.78022,1,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,2.3554e-11,-0.73674,-0.75318,1,0
3,GO ENAMEL MINERALIZATION,8.0424e-11,-0.74341,-0.73674,1,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,6.757e-10,-0.74382,-0.70321,1,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,7.6937e-12,-0.75687,-0.79359,1,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.642e-11,-0.75906,-0.87189,1,0
3,GO BASEMENT MEMBRANE ASSEMBLY,1.6109e-10,-0.78473,-0.81289,1,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.3761e-09,-0.79711,-0.79453,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0007786,-0.81566,-0.74571,1,0
3,GO REGULATION OF GLOMERULAR FILTRATION,1.9402e-11,-0.83981,-0.87503,1,0
3,GO TRANSLATIONAL TERMINATION,0.095518,0.089765,0.043565,0,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.1262,0.082453,0.039446,0,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.11647,0.079625,0.063059,0,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.11933,0.078527,0.054439,0,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.1262,0.11164,0.074757,0,0
3,GO PROTEIN NEDDYLATION,0.090782,0.08306,0.068292,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.22042,0.080567,0.054304,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.094715,0.076908,0.051805,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.075674,0.07379,0.062839,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.20699,0.058973,0.022287,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.12421,0.055188,0.042133,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.95639,0.05508,-0.047102,0,0
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.47211,0.052027,0.038698,0,0
3,GO MATURATION OF LSU RRNA,0.69286,0.051181,-0.033741,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.77209,0.047503,-0.0090435,0,0
3,GO PROTEASOME ASSEMBLY,0.087731,0.047007,0.04723,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.36098,0.046863,-0.093202,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.23605,0.045509,0.063001,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.572,0.045022,0.031458,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.71693,0.043044,-0.0032896,0,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.77519,0.037058,0.0083321,0,0
3,GO TRANSLATIONAL ELONGATION,0.40514,0.033516,0.0056757,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.41899,0.031717,0.0025575,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.81267,0.027494,-0.033548,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.92738,0.026711,-0.022734,0,0
3,GO PROTEIN DENEDDYLATION,0.74128,0.026312,-0.037209,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.97576,0.025098,-0.023497,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.89526,0.022741,-0.01256,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.94993,0.02272,-0.029282,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.63408,0.021156,0.018021,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.72603,0.019795,-0.049334,0,0
3,GO RIBOSOME ASSEMBLY,0.56103,0.016971,0.01515,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.67501,0.015027,-0.026113,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.98869,0.013592,-0.018754,0,0
3,GO TRNA 5 LEADER REMOVAL,0.69586,0.013225,-0.003158,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.61117,0.011726,-0.054017,0,0
3,GO TRANSLATIONAL INITIATION,0.70185,0.0098186,0.014507,0,0
3,GO SNORNA 3 END PROCESSING,0.46466,0.0070075,-0.073594,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.55287,0.0046444,-0.062487,0,0
3,GO MALE MEIOSIS I,0.5665,0.0046077,-0.10258,0,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.5665,0.0037647,-0.066063,0,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.4451,0.0023697,-0.053493,0,0
3,GO KINETOCHORE ORGANIZATION,0.45727,0.0019082,-0.064497,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.47461,-0.0016326,-0.094389,0,0
3,GO TRNA 5 END PROCESSING,0.96607,-0.0029232,-0.030181,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.39156,-0.0032955,-0.083175,0,0
3,GO REGULATION OF APPETITE,0.33803,-0.003461,-0.063043,0,0
3,GO CYTOPLASMIC TRANSLATION,0.7814,-0.0037295,-0.011159,0,0
3,GO RRNA 3 END PROCESSING,0.96607,-0.0050067,-0.021296,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5583,-0.0053787,-0.057636,0,0
3,GO NEURON FATE SPECIFICATION,0.53406,-0.0082968,-0.073537,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.19003,-0.0083375,-0.10878,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.61117,-0.0088046,-0.023888,0,0
3,GO AMINO ACID ACTIVATION,0.22348,-0.011436,-0.097678,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.23927,-0.012812,-0.10176,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.3739,-0.014333,-0.063491,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.31409,-0.015453,-0.099519,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.71996,-0.01609,-0.02114,0,0
3,GO HISTONE EXCHANGE,0.48722,-0.016294,-0.04163,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.42133,-0.018389,-0.040782,0,0
3,GO MITOCHONDRIAL RNA PROCESSING,0.76281,-0.019601,-0.0698,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.318,-0.02236,-0.06269,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.79075,-0.022805,-0.037558,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.26964,-0.023156,-0.10205,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48468,-0.023992,-0.063004,0,0
3,GO NCRNA 3 END PROCESSING,0.46466,-0.024738,-0.056239,0,0
3,GO SNRNA PROCESSING,0.27495,-0.027346,-0.075874,0,0
3,GO PIRNA METABOLIC PROCESS,0.49231,-0.028691,-0.074183,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.86649,-0.028919,-0.026214,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.17283,-0.029454,-0.079603,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.42602,-0.03197,-0.23246,0,0
3,GO RNA SURVEILLANCE,0.42838,-0.033115,-0.074918,0,0
3,GO SNORNA METABOLIC PROCESS,0.178,-0.033203,-0.12051,0,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.18327,-0.034036,-0.061187,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.55287,-0.036308,-0.050821,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.26267,-0.036877,-0.11289,0,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.40743,-0.036975,-0.067759,0,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.99192,-0.037051,-0.029687,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.28945,-0.041118,-0.067235,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.28761,-0.042495,-0.12182,0,0
3,GO RNA 5 END PROCESSING,0.318,-0.042706,-0.087339,0,0
3,GO MYOBLAST MIGRATION,0.27495,-0.043568,-0.12329,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.45727,-0.044701,-0.072765,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.61402,-0.045393,-0.043156,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.40973,-0.045622,-0.047589,0,0
3,GO KINETOCHORE ASSEMBLY,0.30446,-0.046254,-0.076354,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.13549,-0.046301,-0.10574,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.16904,-0.047607,-0.13636,0,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.19417,-0.048729,-0.088771,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.22814,-0.050218,-0.062759,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.44994,-0.050253,-0.062492,0,0
3,GO TRNA PROCESSING,0.11367,-0.050405,-0.11148,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.1146,-0.051533,-0.093494,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.3739,-0.052923,-0.079665,0,0
3,GO RRNA MODIFICATION,0.12721,-0.054176,-0.12921,0,0
3,GO VIRAL GENE EXPRESSION,0.43789,-0.055015,-0.031378,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.1387,-0.055108,-0.12251,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.10214,-0.055304,-0.072655,0,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.027118,-0.056385,-0.13813,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.52874,-0.05646,-0.018797,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.088486,-0.056714,-0.091723,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.46962,-0.056746,-0.056835,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.26964,-0.057091,-0.074907,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.14308,-0.058874,-0.088092,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.055609,-0.059297,-0.1147,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.1313,-0.06018,-0.078104,0,0
3,GO CELLULAR RESPIRATION,0.075674,-0.060722,-0.10014,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.041383,-0.062086,-0.1676,0,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.29502,-0.062154,-0.11429,0,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.10823,-0.062986,-0.11431,0,0
3,GO RIBOSOME BIOGENESIS,0.30446,-0.063242,-0.080042,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.15802,-0.063548,-0.10241,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.074349,-0.063725,-0.11377,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.019523,-0.065601,-0.090328,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.1533,-0.067055,-0.10088,0,0
3,GO MATURATION OF SSU RRNA,0.18327,-0.067069,-0.10548,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.20265,-0.067506,-0.11695,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.16778,-0.06757,-0.055337,0,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.27853,-0.067661,-0.088776,0,0
3,GO TRNA METABOLIC PROCESS,0.075674,-0.067714,-0.12215,0,0
3,GO NCRNA PROCESSING,0.14755,-0.068036,-0.10914,0,0
3,GO SNRNA METABOLIC PROCESS,0.24252,-0.068629,-0.088113,0,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.028264,-0.068927,-0.14661,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.045591,-0.069581,-0.14241,0,0
3,GO RNA CAPPING,0.044722,-0.069838,-0.10677,0,0
3,GO NUCLEOSOME ASSEMBLY,0.077018,-0.071031,-0.10885,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12029,-0.071267,-0.16563,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.017506,-0.071653,-0.12853,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.0085105,-0.071972,-0.17534,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.032278,-0.073667,-0.15777,0,0
3,GO RRNA METABOLIC PROCESS,0.1252,-0.074736,-0.11018,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.20554,-0.075697,-0.098581,0,0
3,GO TELOMERASE RNA LOCALIZATION,0.28945,-0.075889,-0.07212,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.061549,-0.076764,-0.1286,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.084763,-0.076882,-0.14258,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.33599,-0.076942,-0.23496,0,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.35886,-0.079006,-0.068876,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.098784,-0.079717,-0.099978,0,0
3,GO RNA SPLICING,0.0059852,-0.080046,-0.1607,0,0
3,GO MATURATION OF 5 8S RRNA,0.31409,-0.080784,-0.082713,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.22042,-0.081018,-0.098652,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.11367,-0.082755,-0.11784,0,0
3,GO PENTOSE METABOLIC PROCESS,0.12126,-0.082821,-0.12058,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.11742,-0.084308,-0.1309,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.0022396,-0.084312,-0.20693,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.10646,-0.084316,-0.1145,0,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.16904,-0.084459,-0.10369,0,0
3,GO LACTATE METABOLIC PROCESS,0.10558,-0.084514,-0.12786,0,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15565,-0.084679,-0.093176,0,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.016568,-0.084696,-0.11019,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.14642,-0.084941,-0.094357,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0088198,-0.084971,-0.10041,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.057711,-0.085182,-0.1373,0,0
3,GO VIRAL LATENCY,0.17669,-0.085269,-0.090198,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.057179,-0.08535,-0.13381,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0071918,-0.085412,-0.16634,0,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.19979,-0.087394,-0.1141,0,0
3,GO NCRNA METABOLIC PROCESS,0.070488,-0.087697,-0.12097,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.032607,-0.087724,-0.13627,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.0085105,-0.089135,-0.18282,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.0084096,-0.089702,-0.16003,0,0
3,GO AEROBIC RESPIRATION,0.016205,-0.089777,-0.13682,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.063836,-0.090615,-0.12763,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.012227,-0.092501,-0.16233,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.20699,-0.092502,-0.085705,0,0
3,GO CRISTAE FORMATION,0.014494,-0.093069,-0.23355,0,0
3,GO DNA REPLICATION INITIATION,0.14088,-0.093095,-0.089045,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.16654,-0.093192,-0.11774,0,0
3,GO NUCLEOSOME ORGANIZATION,0.010645,-0.093722,-0.14841,0,0
3,GO SPINDLE ASSEMBLY,0.00026024,-0.094546,-0.217,0,0
3,GO IMP METABOLIC PROCESS,0.22503,-0.094596,-0.16781,0,0
3,GO MRNA PROCESSING,0.0025617,-0.0948,-0.17622,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.0034243,-0.096264,-0.16911,0,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.10129,-0.097506,-0.10974,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.00099681,-0.097849,-0.23569,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.31215,-0.097855,-0.07649,0,0
3,GO CELL CYCLE DNA REPLICATION,0.094715,-0.098312,-0.12119,0,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.056128,-0.098574,-0.13446,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.00021857,-0.099084,-0.21603,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.001422,-0.099127,-0.19996,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.054582,-0.099587,-0.26694,0,0
3,GO CHROMOSOME SEGREGATION,0.0038977,-0.10126,-0.16959,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.11837,-0.10233,-0.1191,0,0
3,GO MITOTIC DNA REPLICATION,0.073694,-0.10241,-0.16681,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.058247,-0.1025,-0.14346,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.093126,-0.10331,-0.081344,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.16285,-0.10451,-0.076,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0005133,-0.10589,-0.16743,0,0
3,GO MITOCHONDRIAL FUSION,0.013243,-0.10647,-0.21196,0,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.14308,-0.10711,-0.0901,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0068504,-0.10747,-0.20345,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.19278,-0.10818,-0.12088,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.032607,-0.10882,-0.21354,0,0
3,GO SISTER CHROMATID COHESION,0.010895,-0.10899,-0.16362,0,0
3,GO METAPHASE PLATE CONGRESSION,0.019104,-0.10949,-0.1501,0,0
3,GO RECOMBINATIONAL REPAIR,0.0041031,-0.10975,-0.19594,0,0
3,GO DNA LIGATION,0.087731,-0.10986,-0.10917,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0025277,-0.10996,-0.16863,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0010259,-0.11003,-0.18743,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0019285,-0.11089,-0.15919,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.0005211,-0.11135,-0.17975,0,0
3,GO CENTROSOME DUPLICATION,0.00071283,-0.11143,-0.23466,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.1146,-0.11153,-0.106,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.021509,-0.11208,-0.15019,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0029256,-0.1121,-0.1839,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.002702,-0.11233,-0.21742,0,0
3,GO MEIOTIC CELL CYCLE,6.0079e-05,-0.11261,-0.20054,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.023919,-0.11317,-0.18257,0,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.66321,-0.11333,-0.046307,0,0
3,GO REGULATION OF MRNA PROCESSING,0.0007786,-0.11334,-0.22356,0,0
3,GO G0 TO G1 TRANSITION,0.0020646,-0.1148,-0.21691,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.010769,-0.11495,-0.15765,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.48976,-0.11623,-0.23486,0,0
3,GO MRNA MODIFICATION,0.032938,-0.11625,-0.17101,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.00039622,-0.11639,-0.18599,0,0
3,GO SISTER CHROMATID SEGREGATION,0.018091,-0.11716,-0.15556,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.0032501,-0.11787,-0.20337,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.01016,-0.11825,-0.15994,0,0
3,GO SPINDLE ORGANIZATION,2.9859e-05,-0.1185,-0.24017,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.015159,-0.11852,-0.14707,0,0
3,GO DNA PACKAGING,0.003607,-0.11875,-0.17325,0,0
3,GO CENTROSOME SEPARATION,0.024428,-0.11924,-0.17877,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0073682,-0.1195,-0.17102,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.00041488,-0.11953,-0.21723,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.00014129,-0.12133,-0.19426,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.0023321,-0.12153,-0.151,0,0
3,GO REGULATION OF DNA METHYLATION,0.013093,-0.1219,-0.238,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.054582,-0.12253,-0.093055,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0019285,-0.12253,-0.18935,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.001442,-0.12264,-0.16334,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.00017457,-0.12268,-0.1975,0,0
3,GO REPLICATION FORK PROCESSING,0.011411,-0.12349,-0.20258,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0093576,-0.124,-0.1865,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00028155,-0.12485,-0.2089,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.0067673,-0.12516,-0.16664,0,0
3,GO PHOTOTRANSDUCTION,5.0563e-05,-0.12592,-0.20909,0,0
3,GO DNA STRAND ELONGATION,0.17283,-0.12594,-0.092449,0,0
3,GO DNA CONFORMATION CHANGE,0.0020929,-0.12621,-0.1934,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.0038977,-0.12649,-0.2077,0,0
3,GO NEURON FATE COMMITMENT,0.10823,-0.12677,-0.15908,0,0
3,GO ORGANELLE FISSION,6.4341e-05,-0.12701,-0.21515,0,0
3,GO SIGNAL PEPTIDE PROCESSING,0.13549,-0.12726,-0.12213,0,0
3,GO OXIDATIVE DEMETHYLATION,0.078382,-0.12739,-0.11754,0,0
3,GO DETECTION OF VISIBLE LIGHT,3.4409e-05,-0.1279,-0.20401,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.080464,-0.12915,-0.1092,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00062378,-0.12951,-0.20797,0,0
3,GO HISTONE H3 K9 ACETYLATION,6.6578e-05,-0.13018,-0.25153,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.013856,-0.13022,-0.17995,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0024281,-0.13073,-0.17469,0,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.040582,-0.13144,-0.12961,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.003654,-0.13184,-0.2198,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.056652,-0.13231,-0.1538,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0066851,-0.13263,-0.19927,0,0
3,GO DNA REPLICATION CHECKPOINT,0.013546,-0.13301,-0.14412,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.01016,-0.13366,-0.16355,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.11275,-0.13393,-0.16476,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.00030449,-0.13432,-0.22163,0,0
3,GO MIDBODY ABSCISSION,0.0056958,-0.13506,-0.16499,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0018006,-0.13512,-0.15299,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0039481,-0.1354,-0.1709,0,0
3,GO METHYLATION,9.4341e-06,-0.13541,-0.22822,0,0
3,GO MRNA METHYLATION,0.011813,-0.13625,-0.22965,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,4.7963e-08,-0.13657,-0.22535,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.057179,-0.13726,-0.1478,0,0
3,GO HISTONE MONOUBIQUITINATION,0.00032916,-0.1379,-0.23598,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.00080175,-0.13869,-0.20121,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.20265,-0.13876,-0.11088,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,6.6578e-05,-0.13924,-0.23317,0,0
3,GO CHROMOSOME ORGANIZATION,4.3997e-05,-0.13935,-0.23429,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0021798,-0.13947,-0.19149,0,0
3,GO PROTEIN ACYLATION,7.333e-07,-0.14025,-0.28214,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0013826,-0.14038,-0.19035,0,0
3,GO MITOCHONDRION LOCALIZATION,9.819e-05,-0.14044,-0.27804,0,0
3,GO TELOMERE CAPPING,0.00014839,-0.14057,-0.25482,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.0095807,-0.14094,-0.15494,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.0056255,-0.14142,-0.16494,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0012005,-0.14256,-0.20284,0,0
3,GO HISTONE UBIQUITINATION,6.2175e-05,-0.14339,-0.23896,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.030994,-0.14396,-0.18717,0,0
3,GO RNA STABILIZATION,0.00036124,-0.1441,-0.22045,0,0
3,GO MITOCHONDRIAL TRANSPORT,6.9711e-06,-0.14482,-0.21306,0,0
3,GO REGULATION OF TELOMERE CAPPING,7.3739e-05,-0.14515,-0.26851,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,6.6578e-05,-0.1452,-0.20182,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0012005,-0.14695,-0.2468,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0018508,-0.14702,-0.25275,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,9.1829e-05,-0.1476,-0.25844,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.014823,-0.14778,-0.16278,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.023919,-0.14829,-0.22972,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0016122,-0.14889,-0.2342,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00016098,-0.14934,-0.17627,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.001071,-0.14991,-0.20004,0,0
3,GO PROTEIN ACETYLATION,5.5127e-05,-0.15012,-0.26337,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,6.2175e-05,-0.15069,-0.27844,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.040582,-0.15083,-0.13095,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.00049053,-0.15139,-0.21103,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.031953,-0.15239,-0.13396,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,5.4184e-05,-0.15277,-0.19299,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.0424e-06,-0.15296,-0.24739,0,0
3,GO DETECTION OF LIGHT STIMULUS,5.0323e-06,-0.15349,-0.22472,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0023637,-0.15362,-0.25194,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,7.6446e-07,-0.15369,-0.30251,0,0
3,GO VIRAL BUDDING,7.8911e-05,-0.1537,-0.20869,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,5.2344e-05,-0.15371,-0.26607,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0037498,-0.15377,-0.17764,0,0
3,GO ORGANELLE LOCALIZATION,9.658e-10,-0.15384,-0.3146,0,0
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,9.1829e-05,-0.1551,-0.31475,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.068006,-0.15526,-0.12052,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.14308,-0.15536,-0.122,0,0
3,GO CHROMOSOME SEPARATION,0.0043737,-0.15663,-0.17671,0,0
3,GO CHROMOSOME LOCALIZATION,0.008211,-0.15671,-0.17062,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00013451,-0.15793,-0.23906,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.00099681,-0.15842,-0.22715,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,3.758e-05,-0.15993,-0.2643,0,0
3,GO CHROMOSOME CONDENSATION,0.0051547,-0.15995,-0.17287,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00082553,-0.16,-0.20195,0,0
3,GO CENTRIOLE ASSEMBLY,0.00040235,-0.16019,-0.26584,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00020504,-0.16049,-0.21715,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.030994,-0.16075,-0.15742,0,0
3,GO REGULATION OF CYTOKINESIS,2.3239e-05,-0.1612,-0.27323,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00010152,-0.16261,-0.26802,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,3.3214e-05,-0.16358,-0.25719,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.0043184,-0.16385,-0.21418,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,6.2046e-07,-0.1647,-0.26093,0,0
3,GO OOCYTE MATURATION,0.00033955,-0.16487,-0.19789,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.0005056,-0.16525,-0.26186,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.00028155,-0.16601,-0.24898,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,7.6283e-05,-0.16669,-0.20796,0,0
3,GO HISTONE H4 ACETYLATION,0.00054518,-0.16789,-0.24545,0,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.038258,-0.16806,-0.11948,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,9.819e-05,-0.16812,-0.26207,0,0
3,GO ALDITOL METABOLIC PROCESS,0.015501,-0.16842,-0.21822,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.00016901,-0.16843,-0.16419,0,0
3,GO MRNA CLEAVAGE,0.00025215,-0.1697,-0.22362,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.0031247,-0.16986,-0.18953,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.0023009,-0.17156,-0.20321,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0005618,-0.17165,-0.21427,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.012945,-0.17205,-0.26201,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00029052,-0.17221,-0.23506,0,0
3,GO REGULATION OF DNA REPLICATION,5.4184e-05,-0.17229,-0.24589,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,1.536e-06,-0.17237,-0.25521,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00023667,-0.17325,-0.22904,0,0
3,GO PHOTOPERIODISM,2.7312e-05,-0.17401,-0.25725,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,3.2859e-07,-0.17401,-0.2597,0,0
3,GO PROTEIN FOLDING,3.9872e-06,-0.17416,-0.25488,0,0
3,GO REGULATION OF NUCLEAR DIVISION,3.3435e-06,-0.17422,-0.23225,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,1.0861e-06,-0.17533,-0.28557,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,4.5922e-10,-0.17561,-0.31641,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0005789,-0.17579,-0.23746,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.055093,-0.17753,-0.21909,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,8.1361e-07,-0.1787,-0.23896,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.9361e-06,-0.17879,-0.23523,0,0
3,GO FOLIC ACID METABOLIC PROCESS,1.5865e-05,-0.17906,-0.28514,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.0085105,-0.17917,-0.22474,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,5.9498e-07,-0.17936,-0.22537,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,3.3435e-06,-0.17946,-0.2499,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00055343,-0.17948,-0.17718,0,0
3,GO INTRACELLULAR TRANSPORT,2.1543e-10,-0.17953,-0.28062,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.4207e-05,-0.17973,-0.29621,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.00043435,-0.17988,-0.20893,0,0
3,GO NODAL SIGNALING PATHWAY,0.013394,-0.18057,-0.13436,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.0059116,-0.18076,-0.25637,0,0
3,GO CHROMATIN REMODELING,0.00011218,-0.18123,-0.22404,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,1.0169e-05,-0.1816,-0.24184,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,4.8673e-09,-0.18199,-0.2602,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00018323,-0.18217,-0.31779,0,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.016205,-0.18224,-0.20044,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.00037835,-0.18256,-0.23496,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,5.6085e-05,-0.18264,-0.25332,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00069207,-0.18284,-0.22554,0,0
3,GO GOLGI LOCALIZATION,1.8363e-05,-0.18285,-0.2667,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.021973,-0.18295,-0.26915,0,0
3,GO MEMBRANE DOCKING,2.1338e-07,-0.18303,-0.29918,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.00040235,-0.18304,-0.20817,0,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.05357,-0.18338,-0.19931,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0020929,-0.18351,-0.19485,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0037498,-0.18359,-0.22268,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.00022565,-0.18457,-0.25307,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.001071,-0.18487,-0.20003,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,2.1234e-05,-0.18488,-0.22599,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,4.1552e-07,-0.18525,-0.24368,0,0
3,GO HISTONE H2A UBIQUITINATION,5.3256e-05,-0.18576,-0.24742,0,0
3,GO SLEEP,5.6085e-05,-0.18677,-0.2291,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,7.8124e-06,-0.18692,-0.24999,0,0
3,GO RESPONSE TO SALT,0.00011986,-0.18762,-0.22228,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.6352e-05,-0.1884,-0.23385,0,0
3,GO ORGANELLE ASSEMBLY,5.3617e-10,-0.18885,-0.29083,0,0
3,GO DNA REPLICATION,0.00025215,-0.18917,-0.21911,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.00022208,-0.18967,-0.20029,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0037016,-0.1907,-0.23234,0,0
3,GO CILIUM ORGANIZATION,5.3562e-07,-0.1914,-0.29014,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,2.4972e-05,-0.1915,-0.26567,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00063314,-0.19177,-0.278,0,0
3,GO POLYAMINE METABOLIC PROCESS,0.00019541,-0.19189,-0.24054,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0019285,-0.1924,-0.25577,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0013443,-0.19262,-0.29094,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,7.8124e-06,-0.19353,-0.27908,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.048285,-0.19363,-0.15814,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.042609,-0.19394,-0.3012,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,3.247e-08,-0.19432,-0.26766,0,0
3,GO RESPONSE TO LEPTIN,6.3249e-05,-0.19533,-0.29296,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00074504,-0.19689,-0.26397,0,0
3,GO OOGENESIS,3.7356e-07,-0.19692,-0.24722,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,3.1479e-07,-0.19711,-0.22049,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,3.2631e-05,-0.19773,-0.33986,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.023173,-0.19784,-0.20848,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,9.086e-06,-0.19807,-0.24994,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0011021,-0.19825,-0.21101,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.027401,-0.19884,-0.14138,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00084997,-0.19897,-0.24441,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,1.6761e-05,-0.20035,-0.24419,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.00016098,-0.20039,-0.18923,0,0
3,GO MICROTUBULE NUCLEATION,0.00074504,-0.20042,-0.31342,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0020092,-0.20057,-0.18193,0,0
3,GO REGULATION OF MRNA POLYADENYLATION,5.332e-06,-0.20073,-0.29891,0,0
3,GO AMP METABOLIC PROCESS,0.012798,-0.20081,-0.18929,0,0
3,GO HISTONE H2A ACETYLATION,0.0027747,-0.20102,-0.1714,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00065224,-0.20122,-0.20105,0,0
3,GO FAT CELL PROLIFERATION,0.0040509,-0.20136,-0.23345,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,2.7614e-08,-0.20207,-0.29335,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00018323,-0.20245,-0.2628,0,0
3,GO HETEROCHROMATIN ORGANIZATION,5.4356e-06,-0.20272,-0.29456,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00031414,-0.20346,-0.22498,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,1.0169e-05,-0.20384,-0.26212,0,0
3,GO RESPONSE TO NITRIC OXIDE,6.7411e-08,-0.20486,-0.26366,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0015463,-0.20496,-0.24667,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.9941e-08,-0.20524,-0.27946,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.029754,-0.20558,-0.16525,0,0
3,GO HISTONE H3 K4 METHYLATION,0.0018256,-0.2057,-0.2002,0,0
3,GO VISUAL BEHAVIOR,1.471e-07,-0.20695,-0.32409,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,1.9989e-07,-0.20755,-0.27717,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.00081356,-0.20761,-0.28027,0,0
3,GO OOCYTE DIFFERENTIATION,9.4959e-05,-0.2079,-0.21984,0,0
3,GO NUCLEAR BODY ORGANIZATION,2.0478e-05,-0.20959,-0.32663,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,2.7614e-08,-0.21084,-0.31745,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.3997e-05,-0.21098,-0.24688,0,0
3,GO DOSAGE COMPENSATION,0.00014129,-0.2112,-0.27128,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,3.3806e-05,-0.21165,-0.27431,0,0
3,GO HISTONE H3 K14 ACETYLATION,7.1274e-05,-0.21201,-0.25757,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.0017277,-0.21206,-0.33046,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.06986,-0.21234,-0.32565,0,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.1165e-05,-0.21288,-0.27963,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.0060595,-0.21311,-0.21882,0,0
3,GO PROTEIN REFOLDING,0.0039481,-0.21449,-0.2001,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0013255,-0.2156,-0.34544,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,2.2117e-10,-0.2158,-0.29725,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,6.0991e-06,-0.21588,-0.30824,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,4.9361e-06,-0.21652,-0.30462,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.001776,-0.21676,-0.21644,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0001179,-0.2168,-0.30495,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.1316e-06,-0.21717,-0.28999,0,0
3,GO LYSINE METABOLIC PROCESS,0.0065235,-0.21763,-0.21878,0,0
3,GO COENZYME A METABOLIC PROCESS,0.00055343,-0.21772,-0.24247,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00048316,-0.21817,-0.24483,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,2.4214e-11,-0.21821,-0.33975,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.00043435,-0.21839,-0.24822,0,0
3,GO PROTEIN POLYMERIZATION,2.595e-12,-0.21872,-0.37909,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0014624,-0.21927,-0.18064,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.5412e-06,-0.2193,-0.27072,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,1.1316e-06,-0.21937,-0.29829,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,5.7059e-05,-0.21982,-0.24996,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,3.4773e-06,-0.22088,-0.30855,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,1.2482e-05,-0.22108,-0.29634,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,2.1621e-05,-0.22137,-0.26647,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,4.9694e-05,-0.22148,-0.25807,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0033361,-0.2215,-0.27314,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,3.0905e-06,-0.22155,-0.27702,0,0
3,GO GLUTAMINE METABOLIC PROCESS,2.1621e-05,-0.22245,-0.27627,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,9.5999e-07,-0.22321,-0.28154,0,0
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0022701,-0.22435,-0.26607,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,5.4701e-07,-0.2256,-0.34244,0,0
3,GO EXIT FROM MITOSIS,4.7488e-06,-0.22638,-0.25215,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0095807,-0.2269,-0.18848,0,0
3,GO THYMUS DEVELOPMENT,1.4454e-06,-0.2271,-0.29066,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00010673,-0.22786,-0.24162,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,1.6457e-05,-0.22863,-0.27794,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.020385,-0.22932,-0.19462,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,7.1819e-07,-0.22967,-0.3354,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0013443,-0.22967,-0.23739,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,1.2027e-05,-0.23093,-0.34113,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,3.2162e-07,-0.23151,-0.29772,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,4.3946e-06,-0.23196,-0.25941,0,0
3,GO SEX DETERMINATION,3.8347e-06,-0.2326,-0.27246,0,0
3,GO REGULATION OF OOGENESIS,1.064e-06,-0.23268,-0.25776,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00016629,-0.23325,-0.2511,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0022095,-0.23335,-0.21264,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.0033799,-0.23369,-0.19625,0,0
3,GO MICROTUBULE POLYMERIZATION,1.8419e-06,-0.23417,-0.34129,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.00025215,-0.2344,-0.24045,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.00013899,-0.23443,-0.26398,0,0
3,GO CHROMATIN DISASSEMBLY,7.1274e-05,-0.23626,-0.30196,0,0
3,GO REPRODUCTIVE BEHAVIOR,9.8716e-08,-0.23692,-0.33033,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,9.5677e-09,-0.23698,-0.31467,0,0
3,GO CELL FATE SPECIFICATION,2.6828e-05,-0.23716,-0.25311,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.0026663,-0.2373,-0.23248,0,0
3,GO MICROTUBULE SEVERING,0.00010152,-0.23767,-0.2881,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00059648,-0.2377,-0.28506,0,0
3,GO PROTEIN DEPHOSPHORYLATION,4.4302e-11,-0.23783,-0.34878,0,0
3,GO EAR MORPHOGENESIS,1.1794e-07,-0.23843,-0.29912,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00060545,-0.23849,-0.298,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,9.5999e-07,-0.23864,-0.31717,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,2.5164e-08,-0.23903,-0.28414,0,0
3,GO VESICLE LOCALIZATION,2.8573e-11,-0.24017,-0.36902,0,0
3,GO RHYTHMIC BEHAVIOR,1.0527e-08,-0.24045,-0.3561,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,2.1807e-07,-0.24116,-0.35262,0,0
3,GO COBALAMIN METABOLIC PROCESS,8.3066e-07,-0.24121,-0.28822,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.00038422,-0.2416,-0.31612,0,0
3,GO L AMINO ACID TRANSPORT,1.3671e-08,-0.24232,-0.36541,0,0
3,GO SEGMENT SPECIFICATION,0.0018764,-0.24233,-0.25262,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,8.1361e-07,-0.24239,-0.30133,0,0
3,GO MIDBRAIN DEVELOPMENT,2.559e-11,-0.2429,-0.33415,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,6.545e-05,-0.24333,-0.29109,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.3661e-05,-0.24349,-0.26577,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,7.3739e-05,-0.24473,-0.28161,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,3.8924e-05,-0.24477,-0.28068,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,8.7502e-06,-0.2451,-0.24984,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.003166,-0.24546,-0.25548,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,1.0004e-06,-0.2463,-0.29982,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.022928,-0.24696,-0.18896,0,0
3,GO REGULATION OF PROTON TRANSPORT,1.3878e-06,-0.24702,-0.30417,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,1.1415e-11,-0.24704,-0.37957,0,0
3,GO PROTEIN DEPOLYMERIZATION,8.6937e-09,-0.24706,-0.39415,0,0
3,GO CELL PROJECTION ASSEMBLY,1.2348e-10,-0.2474,-0.36138,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,2.5868e-06,-0.24745,-0.31387,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.00010673,-0.24779,-0.27683,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,2.7e-09,-0.24809,-0.28521,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,5.8049e-05,-0.24833,-0.30195,0,0
3,GO NEURON APOPTOTIC PROCESS,3.3629e-10,-0.2489,-0.34131,0,0
3,GO MATING BEHAVIOR,4.6202e-07,-0.249,-0.32033,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.012087,-0.24943,-0.20399,0,0
3,GO PROTEIN NITROSYLATION,1.064e-06,-0.2501,-0.29092,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00026024,-0.25022,-0.28101,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0011021,-0.25027,-0.23494,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,5.332e-06,-0.25037,-0.32975,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,3.8924e-05,-0.25045,-0.26756,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,1.8323e-12,-0.25074,-0.39653,0,0
3,GO MALE SEX DETERMINATION,3.8924e-05,-0.25085,-0.27547,0,0
3,GO ORGAN INDUCTION,2.206e-06,-0.25086,-0.31551,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,4.9069e-08,-0.25131,-0.34711,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,1.9948e-11,-0.25214,-0.36886,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0011836,-0.25249,-0.25171,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,1.0169e-05,-0.25298,-0.3405,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,6.1321e-12,-0.2531,-0.39459,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.031311,-0.25343,-0.20889,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,6.0991e-06,-0.25356,-0.30979,0,0
3,GO PENILE ERECTION,0.00011596,-0.25378,-0.26444,0,0
3,GO MYOTUBE CELL DEVELOPMENT,4.8198e-07,-0.25379,-0.28928,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,5.3562e-07,-0.25386,-0.3478,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,2.7452e-06,-0.25501,-0.34115,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,7.2414e-06,-0.25594,-0.27524,0,0
3,GO HISTONE H3 DEACETYLATION,6.5906e-08,-0.25624,-0.34601,0,0
3,GO MICROTUBULE BUNDLE FORMATION,1.7922e-07,-0.25675,-0.29974,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,7.969e-07,-0.25734,-0.36913,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,6.3569e-09,-0.25805,-0.26895,0,0
3,GO GENETIC IMPRINTING,5.2303e-06,-0.25855,-0.30969,0,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,1.6158e-05,-0.25945,-0.33363,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.5461e-06,-0.25991,-0.34413,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,1.1579e-08,-0.25994,-0.32169,0,0
3,GO AMINO ACID TRANSPORT,9.8716e-08,-0.2604,-0.33168,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,1.1245e-09,-0.26105,-0.37816,0,0
3,GO GLUTAMATE SECRETION,6.2175e-05,-0.26155,-0.30826,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,2.3793e-12,-0.26162,-0.37667,0,0
3,GO INNER EAR MORPHOGENESIS,7.5451e-08,-0.26181,-0.3201,0,0
3,GO REGULATION OF CELL DIVISION,6.4192e-10,-0.26213,-0.33977,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.064e-06,-0.26276,-0.31075,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.00059648,-0.26305,-0.22021,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,9.5677e-09,-0.26313,-0.30953,0,0
3,GO SARCOMERE ORGANIZATION,6.0759e-07,-0.26435,-0.30698,0,0
3,GO ZINC ION HOMEOSTASIS,0.0016806,-0.26526,-0.25738,0,0
3,GO GANGLION DEVELOPMENT,0.020166,-0.26543,-0.2984,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.3228e-08,-0.26547,-0.37725,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,2.65e-07,-0.26574,-0.31423,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,2.6386e-06,-0.26594,-0.28107,0,0
3,GO RESPONSE TO GLUCAGON,8.9047e-09,-0.26605,-0.37913,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1.4107e-10,-0.26608,-0.38605,0,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,5.2253e-10,-0.2669,-0.38973,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,3.2162e-07,-0.2671,-0.34313,0,0
3,GO V D J RECOMBINATION,0.0046018,-0.26712,-0.218,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,3.628e-05,-0.26749,-0.34305,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,2.402e-08,-0.26808,-0.32324,0,0
3,GO DEMETHYLATION,7.4873e-07,-0.26847,-0.31014,0,0
3,GO GASTRIC ACID SECRETION,6.3249e-05,-0.26847,-0.2157,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,1.3056e-06,-0.2687,-0.27386,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.00069207,-0.26913,-0.29918,0,0
3,GO CELL FATE DETERMINATION,1.2716e-05,-0.26921,-0.321,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00040857,-0.26944,-0.27213,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,4.5233e-07,-0.26961,-0.29676,0,0
3,GO CELL FATE COMMITMENT,1.6823e-09,-0.27161,-0.32797,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,3.4634e-11,-0.2717,-0.37335,0,0
3,GO SPINAL CORD PATTERNING,0.00040235,-0.27194,-0.34933,0,0
3,GO EMBRYO DEVELOPMENT,4.8824e-12,-0.27199,-0.3845,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,1.6994e-06,-0.27238,-0.3283,0,0
3,GO RESPONSE TO LEAD ION,2.8886e-07,-0.27288,-0.367,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,2.9514e-07,-0.27321,-0.32684,0,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,8.4871e-11,-0.27353,-0.38974,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,2.9078e-09,-0.27386,-0.37563,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00099681,-0.27387,-0.24919,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,3.5794e-07,-0.27488,-0.2826,0,0
3,GO CELLULAR RESPONSE TO PH,1.8053e-06,-0.27618,-0.27438,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.734e-06,-0.27654,-0.35866,0,0
3,GO DIET INDUCED THERMOGENESIS,6.2046e-07,-0.27668,-0.29217,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.6446e-07,-0.27712,-0.335,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.0020929,-0.27776,-0.25505,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0018508,-0.27791,-0.30156,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,2.0853e-05,-0.27803,-0.27252,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,1.7534e-07,-0.27815,-0.40908,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.0012886,-0.27829,-0.29659,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0016575,-0.27866,-0.27067,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,1.6761e-05,-0.27923,-0.31378,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,2.1338e-07,-0.27934,-0.33658,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,1.725e-09,-0.27934,-0.35114,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,1.2131e-09,-0.27937,-0.3885,0,0
3,GO NEURAL NUCLEUS DEVELOPMENT,7.8052e-07,-0.27947,-0.33808,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,4.2784e-08,-0.27954,-0.36037,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,7.3739e-05,-0.27962,-0.26279,0,0
3,GO HEART FORMATION,1.9175e-06,-0.27981,-0.37263,0,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,7.5451e-08,-0.28052,-0.30093,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,5.6085e-05,-0.28076,-0.34863,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8793e-06,-0.2814,-0.2984,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,1.1535e-07,-0.28152,-0.36094,0,0
3,GO REGULATION OF LYASE ACTIVITY,5.3747e-08,-0.28155,-0.32634,0,0
3,GO NEUROMUSCULAR PROCESS,1.5753e-08,-0.28156,-0.34331,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,1.3671e-08,-0.2819,-0.34349,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,2.3784e-07,-0.28241,-0.29713,0,0
3,GO NEPHRON TUBULE FORMATION,0.0023637,-0.28257,-0.21652,0,0
3,GO REGULATION OF BINDING,9.3425e-13,-0.28318,-0.37537,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,2.1812e-12,-0.28335,-0.41527,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,1.5277e-10,-0.28339,-0.37958,0,0
3,GO REGULATION OF TORC1 SIGNALING,4.4787e-08,-0.28398,-0.40335,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.00021857,-0.28418,-0.32045,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,2.6581e-10,-0.28422,-0.37712,0,0
3,GO NEUROGENESIS,1.1097e-10,-0.28453,-0.3956,0,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.3039e-08,-0.28566,-0.36054,0,0
3,GO MITOCHONDRIAL FISSION,1.3056e-06,-0.28582,-0.35363,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,7.9617e-06,-0.28601,-0.31229,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,7.3476e-09,-0.28865,-0.31343,0,0
3,GO RESPONSE TO INSECTICIDE,0.00031907,-0.28925,-0.30368,0,0
3,GO NOSE DEVELOPMENT,0.044292,-0.28949,-0.23986,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,4.3082e-09,-0.28981,-0.34727,0,0
3,GO SEX DIFFERENTIATION,7.479e-12,-0.28997,-0.35008,0,0
3,GO SYNAPTIC VESICLE MATURATION,0.0005056,-0.29014,-0.37868,0,0
3,GO VESICLE DOCKING,5.2303e-06,-0.29114,-0.34542,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,5.6487e-06,-0.29125,-0.34585,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,5.6451e-10,-0.29128,-0.39394,0,0
3,GO CELL PROJECTION ORGANIZATION,1.785e-11,-0.29169,-0.40003,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,1.6907e-08,-0.29181,-0.34599,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00159,-0.2921,-0.29157,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.155e-06,-0.29287,-0.29865,0,0
3,GO CELLULAR RESPONSE TO DRUG,3.8118e-09,-0.29357,-0.35571,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,4.4812e-12,-0.29418,-0.38821,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,1.069e-09,-0.29479,-0.34004,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,5.9116e-09,-0.29491,-0.38478,0,0
3,GO NEURON DIFFERENTIATION,2.801e-10,-0.29494,-0.39492,0,0
3,GO RETROGRADE AXONAL TRANSPORT,1.5293e-05,-0.29518,-0.40321,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.00076726,-0.29588,-0.24789,0,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,9.2321e-08,-0.29606,-0.30815,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,4.3236e-05,-0.29639,-0.31513,0,0
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,6.0079e-05,-0.29664,-0.44231,0,0
3,GO HEART FIELD SPECIFICATION,3.2631e-05,-0.29679,-0.41091,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,2.8925e-08,-0.29682,-0.37672,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,2.0776e-06,-0.29689,-0.37453,0,0
3,GO REGIONALIZATION,1.4471e-09,-0.29703,-0.34858,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,4.3946e-06,-0.29746,-0.28607,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,9.5999e-07,-0.29812,-0.30859,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,1.3999e-08,-0.29822,-0.26827,0,0
3,GO DEVELOPMENTAL CELL GROWTH,1.8881e-10,-0.29822,-0.43543,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,5.5078e-11,-0.29828,-0.34919,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,3.9613e-05,-0.29844,-0.28458,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,4.2042e-09,-0.29951,-0.36939,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,8.5043e-10,-0.29982,-0.41751,0,0
3,GO NAD BIOSYNTHETIC PROCESS,1.3056e-06,-0.30006,-0.34052,0,0
3,GO REGULATION OF CELL DEVELOPMENT,2.3554e-11,-0.30017,-0.40768,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.0002117,-0.30034,-0.42066,0,0
3,GO HEART DEVELOPMENT,1.0792e-11,-0.30054,-0.42183,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,3.4634e-11,-0.30064,-0.43162,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,1.4207e-05,-0.30091,-0.31275,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,2.4091e-05,-0.30241,-0.31673,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,2.1595e-09,-0.30264,-0.38376,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.1389e-11,-0.30298,-0.40528,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00028155,-0.30344,-0.29445,0,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.5217e-06,-0.30415,-0.40224,0,0
3,GO WATER TRANSPORT,1.2131e-09,-0.30457,-0.38196,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,1.9948e-11,-0.30467,-0.3956,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,7.6937e-12,-0.30472,-0.413,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00076726,-0.30482,-0.32197,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,9.7998e-07,-0.30534,-0.29567,0,0
3,GO THYROID GLAND DEVELOPMENT,2.8305e-05,-0.30574,-0.33279,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,9.658e-10,-0.30574,-0.43903,0,0
3,GO REGULATION OF ODONTOGENESIS,3.357e-07,-0.30579,-0.37376,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,7.6937e-12,-0.30589,-0.41313,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,9.0235e-07,-0.30608,-0.31383,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,4.8198e-07,-0.30634,-0.34755,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.9309e-10,-0.30641,-0.37362,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,2.2139e-09,-0.3066,-0.38008,0,0
3,GO RESPONSE TO ZINC ION,3.0905e-06,-0.30684,-0.28958,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00023667,-0.30787,-0.30831,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,5.3213e-13,-0.3086,-0.44532,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,3.6435e-08,-0.30868,-0.38489,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,2.6386e-06,-0.30901,-0.27787,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0024941,-0.30919,-0.30028,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,1.2434e-08,-0.31007,-0.39907,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.1282e-07,-0.31046,-0.32481,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,6.4592e-06,-0.31066,-0.33241,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,5.4701e-07,-0.31068,-0.29512,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,1.6986e-10,-0.31079,-0.445,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.00038422,-0.31096,-0.28435,0,0
3,GO SYNAPTIC VESICLE PRIMING,0.00159,-0.31105,-0.33785,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.3948e-05,-0.31312,-0.28435,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,7.8052e-07,-0.31328,-0.34329,0,0
3,GO NEURON DEVELOPMENT,1.7909e-10,-0.31346,-0.41132,0,0
3,GO NEPHRON MORPHOGENESIS,2.634e-09,-0.31359,-0.37534,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,9.4499e-11,-0.31365,-0.40299,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,4.7449e-12,-0.31374,-0.42537,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,2.3554e-11,-0.31377,-0.38955,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,9.404e-07,-0.31421,-0.34992,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.7687e-09,-0.31437,-0.36059,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,2.5756e-08,-0.31441,-0.36096,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.001442,-0.31505,-0.34491,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,4.5822e-08,-0.31576,-0.36025,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.2482e-05,-0.31601,-0.38544,0,0
3,GO REGULATION OF EXCRETION,7.3772e-08,-0.3163,-0.35787,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,1.0205e-12,-0.31633,-0.4318,0,0
3,GO CELL AGGREGATION,3.357e-07,-0.31655,-0.36443,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,1.0241e-10,-0.317,-0.41569,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,2.6828e-05,-0.31771,-0.35256,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,3.1032e-11,-0.31782,-0.43318,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,4.4302e-11,-0.31823,-0.36641,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,2.8814e-05,-0.31923,-0.35062,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,3.4098e-06,-0.32043,-0.43512,0,0
3,GO TUBULIN DEACETYLATION,4.0657e-06,-0.32147,-0.40855,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00011406,-0.32157,-0.29029,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.3236e-05,-0.32218,-0.44845,0,0
3,GO FLUID TRANSPORT,3.3697e-11,-0.3224,-0.3868,0,0
3,GO POSITIVE REGULATION OF BINDING,5.793e-12,-0.32261,-0.37289,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,2.8262e-08,-0.32351,-0.38662,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,2.5868e-06,-0.32366,-0.39575,0,0
3,GO SENSORY ORGAN DEVELOPMENT,5.3602e-11,-0.32534,-0.38696,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.6884e-11,-0.32568,-0.41436,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00035024,-0.32646,-0.33673,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,6.757e-10,-0.32694,-0.35145,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,2.004e-09,-0.32812,-0.37812,0,0
3,GO DIENCEPHALON DEVELOPMENT,3.5794e-07,-0.32865,-0.36839,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.9926e-08,-0.32957,-0.42686,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00062378,-0.32998,-0.27907,0,0
3,GO MYOFIBRIL ASSEMBLY,2.5695e-09,-0.33005,-0.37448,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,1.7909e-10,-0.33011,-0.42236,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.5526e-11,-0.33013,-0.41572,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,5.1356e-08,-0.33036,-0.3603,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,2.5893e-10,-0.33071,-0.42109,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.6356e-09,-0.3308,-0.39874,0,0
3,GO ETHANOL CATABOLIC PROCESS,2.1196e-06,-0.33091,-0.32509,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,1.9926e-08,-0.33121,-0.42667,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,4.1025e-09,-0.33161,-0.38264,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,1.6109e-10,-0.33187,-0.43089,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.3312e-10,-0.33224,-0.38289,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.892e-08,-0.33282,-0.3574,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.6782e-07,-0.33309,-0.33132,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0037016,-0.33337,-0.37821,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.7411e-08,-0.33368,-0.35542,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,1.9905e-10,-0.33401,-0.38196,0,0
3,GO STRIATUM DEVELOPMENT,8.6328e-08,-0.33466,-0.40302,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,5.8262e-07,-0.33469,-0.38306,0,0
3,GO POSITIVE REGULATION OF GROWTH,3.6667e-12,-0.33533,-0.41199,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,1.1794e-07,-0.33541,-0.41188,0,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,5.4701e-07,-0.33658,-0.34253,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,6.7105e-06,-0.33693,-0.45667,0,0
3,GO LACTATION,3.3228e-08,-0.33704,-0.39344,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,5.7051e-07,-0.33706,-0.37087,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,6.2169e-06,-0.33727,-0.4016,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,1.3419e-09,-0.33832,-0.40384,0,0
3,GO PROTEIN TRIMERIZATION,1.1794e-07,-0.33873,-0.34007,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,9.658e-10,-0.3401,-0.41536,0,0
3,GO PITUITARY GLAND DEVELOPMENT,9.4959e-05,-0.34038,-0.34684,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,7.0072e-05,-0.34066,-0.35686,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,6.1744e-13,-0.34083,-0.47849,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,1.5838e-12,-0.34098,-0.40486,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,1.2328e-07,-0.34115,-0.40536,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.0005133,-0.3412,-0.31323,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,1.3291e-12,-0.34183,-0.42896,0,0
3,GO TORC1 SIGNALING,8.4415e-08,-0.34207,-0.38461,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,1.182e-12,-0.34421,-0.43071,0,0
3,GO BASIC AMINO ACID TRANSPORT,1.9136e-07,-0.34432,-0.4789,0,0
3,GO SYNAPTIC VESICLE BUDDING,1.7922e-07,-0.34443,-0.40516,0,0
3,GO PARENTAL BEHAVIOR,2.9332e-05,-0.34481,-0.35102,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,8.6937e-09,-0.34497,-0.40139,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.679e-12,-0.34505,-0.40767,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,1.5027e-08,-0.34522,-0.37002,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,2.7e-09,-0.34703,-0.37603,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,4.1403e-10,-0.3471,-0.44053,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,1.6109e-10,-0.34718,-0.4484,0,0
3,GO EYE MORPHOGENESIS,9.4499e-11,-0.34756,-0.42162,0,0
3,GO INTESTINAL LIPID ABSORPTION,8.3013e-05,-0.3478,-0.42024,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,5.0278e-07,-0.34794,-0.32218,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,4.5233e-07,-0.34938,-0.44469,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,1.5604e-09,-0.35097,-0.46018,0,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,3.7602e-11,-0.35124,-0.43908,0,0
3,GO HISTONE H3 K36 METHYLATION,1.3948e-05,-0.35215,-0.35505,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,9.6562e-05,-0.35215,-0.40293,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00012388,-0.35325,-0.31495,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,1.736e-11,-0.35403,-0.42068,0,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,2.1234e-05,-0.35469,-0.35281,0,0
3,GO GMP METABOLIC PROCESS,6.4699e-07,-0.35493,-0.33857,0,0
3,GO CELL MORPHOGENESIS,1.5968e-11,-0.35564,-0.44908,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,1.0804e-10,-0.35566,-0.4,0,0
3,GO PANCREAS DEVELOPMENT,1.2131e-09,-0.35603,-0.40952,0,0
3,GO FOREBRAIN CELL MIGRATION,2.0881e-08,-0.35612,-0.39093,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.9748e-11,-0.35621,-0.44654,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,2.8925e-08,-0.35629,-0.37933,0,0
3,GO RETINA LAYER FORMATION,3.8924e-05,-0.3581,-0.38327,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.9948e-11,-0.35966,-0.41984,0,0
3,GO RECEPTOR CLUSTERING,1.1245e-09,-0.35973,-0.46945,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,4.5684e-06,-0.3615,-0.45057,0,0
3,GO PARTURITION,9.7991e-09,-0.36165,-0.38561,0,0
3,GO DEVELOPMENTAL PIGMENTATION,4.8076e-11,-0.36223,-0.3887,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,4.1456e-06,-0.36233,-0.39136,0,0
3,GO RESPONSE TO VITAMIN D,3.1479e-07,-0.36263,-0.43137,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,2.3312e-10,-0.36382,-0.37112,0,0
3,GO SYNAPTIC VESICLE RECYCLING,1.4076e-07,-0.36398,-0.40222,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.9136e-07,-0.36522,-0.4361,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,6.1119e-05,-0.36595,-0.35682,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,2.7078e-07,-0.3661,-0.38401,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,1.2143e-08,-0.36672,-0.35623,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,8.1414e-12,-0.36728,-0.4241,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,5.9498e-07,-0.36804,-0.39479,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,1.069e-09,-0.36807,-0.44422,0,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,2.2926e-08,-0.36812,-0.42578,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,9.4407e-08,-0.36832,-0.37263,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00015331,-0.36882,-0.40712,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00068191,-0.36932,-0.34938,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,1.0279e-08,-0.3695,-0.38884,0,0
3,GO AXON DEVELOPMENT,5.0922e-10,-0.37034,-0.43448,0,0
3,GO SHORT TERM MEMORY,8.5858e-05,-0.37155,-0.368,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,4.31e-06,-0.37188,-0.31508,0,0
3,GO COCHLEA DEVELOPMENT,4.1025e-09,-0.37217,-0.39004,0,0
3,GO RESPONSE TO PROSTAGLANDIN,2.6581e-10,-0.37339,-0.39955,0,0
3,GO LYMPH NODE DEVELOPMENT,2.4452e-09,-0.37363,-0.41376,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,8.6328e-08,-0.37446,-0.38457,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,2.3467e-08,-0.37454,-0.37603,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,4.9069e-08,-0.37455,-0.40219,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,4.0314e-05,-0.37637,-0.35681,0,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,1.3056e-06,-0.37708,-0.42999,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00032408,-0.37716,-0.31114,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,2.7494e-12,-0.37756,-0.48378,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,6.4434e-08,-0.37873,-0.41711,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,2.2117e-10,-0.37882,-0.44236,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,3.8347e-06,-0.38046,-0.42023,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,6.895e-08,-0.38065,-0.41089,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,5.2165e-11,-0.38075,-0.45007,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,1.2417e-11,-0.38122,-0.48202,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,3.6567e-07,-0.38169,-0.34748,0,0
3,GO RENAL WATER HOMEOSTASIS,2.6581e-10,-0.38184,-0.44827,0,0
3,GO SYNAPTIC VESICLE DOCKING,0.0019285,-0.38234,-0.35922,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,1.1086e-06,-0.38277,-0.41071,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,9.9185e-12,-0.38287,-0.46758,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,1.0527e-08,-0.38303,-0.47207,0,0
3,GO BONE MORPHOGENESIS,3.3697e-11,-0.38397,-0.47941,0,0
3,GO GONADOTROPIN SECRETION,6.4592e-06,-0.3841,-0.3509,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,3.1312e-09,-0.38479,-0.3943,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,4.0657e-06,-0.38624,-0.35853,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00021857,-0.38648,-0.43897,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,2.188e-08,-0.38704,-0.40255,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.2505e-06,-0.38756,-0.41495,0,0
3,GO CELL JUNCTION DISASSEMBLY,5.3617e-10,-0.3883,-0.46629,0,0
3,GO EMBRYONIC HEMOPOIESIS,2.8262e-08,-0.38865,-0.43707,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,3.4003e-08,-0.38918,-0.39802,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,1.5372e-07,-0.38933,-0.42122,0,0
3,GO RESPONSE TO AXON INJURY,9.3752e-12,-0.39,-0.46345,0,0
3,GO HINDLIMB MORPHOGENESIS,9.7991e-09,-0.39054,-0.42863,0,0
3,GO CELL JUNCTION MAINTENANCE,2.1807e-07,-0.39093,-0.44116,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00027716,-0.39188,-0.34413,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,7.3765e-13,-0.39291,-0.5116,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,7.969e-07,-0.39304,-0.402,0,0
3,GO REGULATION OF STEM CELL DIVISION,2.5756e-08,-0.39423,-0.39504,0,0
3,GO PLATELET MORPHOGENESIS,2.8369e-09,-0.39431,-0.51265,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00033432,-0.39531,-0.28263,0,0
3,GO MITOTIC CELL CYCLE ARREST,1.0781e-08,-0.39611,-0.42205,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,2.65e-07,-0.39612,-0.38299,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00067188,-0.39629,-0.36672,0,0
3,GO RESPIRATORY BURST,1.4112e-09,-0.39635,-0.41302,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,1.4112e-09,-0.3987,-0.52479,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,4.4148e-09,-0.3997,-0.42347,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,5.4701e-07,-0.39999,-0.35144,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,2.8925e-08,-0.40111,-0.41866,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00010497,-0.40343,-0.40226,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,4.5922e-10,-0.40441,-0.46796,0,0
3,GO EPIDERMIS MORPHOGENESIS,2.3853e-09,-0.40492,-0.47746,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,1.3671e-08,-0.40574,-0.42907,0,0
3,GO PSEUDOPODIUM ORGANIZATION,8.5867e-06,-0.40641,-0.41785,0,0
3,GO REGULATION OF MYELINATION,5.9432e-10,-0.40701,-0.39461,0,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0084096,-0.40713,-0.30798,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,8.1138e-06,-0.40733,-0.39061,0,0
3,GO STEM CELL PROLIFERATION,1.6823e-09,-0.40798,-0.41528,0,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,5.4982e-08,-0.40863,-0.50549,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,3.0295e-08,-0.40889,-0.46377,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,3.2631e-05,-0.40891,-0.34317,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,2.4972e-05,-0.40978,-0.41726,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0015038,-0.40989,-0.32326,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,3.2162e-07,-0.41024,-0.41882,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,3.4003e-08,-0.4105,-0.43072,0,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,5.9116e-09,-0.41057,-0.36097,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,7.6446e-07,-0.41074,-0.45262,0,0
3,GO LONG TERM MEMORY,2.2707e-10,-0.41135,-0.47715,0,0
3,GO MELANOCYTE DIFFERENTIATION,5.3617e-10,-0.41196,-0.42409,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,6.0979e-10,-0.41273,-0.45249,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,1.2131e-09,-0.41306,-0.44875,0,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,2.4837e-07,-0.41318,-0.45156,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,1.6418e-07,-0.4139,-0.43389,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,4.5239e-09,-0.41499,-0.44286,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,1.0781e-08,-0.41513,-0.49375,0,0
3,GO MOTOR NEURON AXON GUIDANCE,4.0868e-08,-0.41563,-0.4193,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,8.0898e-09,-0.4157,-0.44943,0,0
3,GO COLLECTING DUCT DEVELOPMENT,4.3774e-08,-0.41619,-0.52073,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00082553,-0.41631,-0.33209,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00015583,-0.41639,-0.40548,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,1.6823e-09,-0.41678,-0.44462,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,9.4341e-06,-0.41685,-0.51465,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,9.3415e-09,-0.41704,-0.44962,0,0
3,GO MESENCHYME DEVELOPMENT,6.3088e-12,-0.41714,-0.45659,0,0
3,GO GAS TRANSPORT,0.00036686,-0.41757,-0.29191,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,9.404e-07,-0.4191,-0.45819,0,0
3,GO COPULATION,3.7605e-06,-0.41943,-0.32952,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,1.7909e-10,-0.41962,-0.42668,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,1.9546e-09,-0.41993,-0.44497,0,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,6.6717e-09,-0.42026,-0.41925,0,0
3,GO TAXIS,6.7492e-13,-0.42086,-0.4329,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,3.192e-10,-0.42237,-0.48921,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,1.2733e-08,-0.42327,-0.44033,0,0
3,GO AXIS ELONGATION,1.7721e-08,-0.42347,-0.4303,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,1.1307e-08,-0.42379,-0.49649,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,2.0398e-08,-0.42414,-0.44606,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,1.0958e-05,-0.42422,-0.51157,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,4.4812e-12,-0.42441,-0.50732,0,0
3,GO POST EMBRYONIC DEVELOPMENT,1.4282e-11,-0.42518,-0.4758,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,1.4112e-09,-0.42582,-0.44105,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,1.2348e-10,-0.42686,-0.48104,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,1.0792e-11,-0.42836,-0.47571,0,0
3,GO NEURON REMODELING,8.2864e-09,-0.42876,-0.4436,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,1.0422e-09,-0.43051,-0.46905,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,3.0856e-12,-0.43128,-0.49411,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,5.2538e-08,-0.4314,-0.47869,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,6.0205e-08,-0.43181,-0.4535,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,1.6907e-08,-0.43203,-0.47584,0,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,3.0156e-07,-0.43236,-0.54468,0,0
3,GO SULFATION,1.2143e-08,-0.43342,-0.39139,0,0
3,GO REGULATION OF RESPIRATORY BURST,1.0527e-08,-0.43679,-0.41568,0,0
3,GO AORTA MORPHOGENESIS,3.0811e-07,-0.43751,-0.45083,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,5.5412e-06,-0.43882,-0.48433,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,1.2441e-09,-0.44049,-0.54719,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,2.5934e-07,-0.44081,-0.45837,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,1.2143e-08,-0.44155,-0.47962,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,2.8271e-07,-0.44346,-0.44622,0,0
3,GO OXYGEN TRANSPORT,0.0034692,-0.44357,-0.28195,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,4.719e-07,-0.44392,-0.39221,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,1.7154e-07,-0.44582,-0.51495,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,7.892e-08,-0.45226,-0.46416,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.6317e-09,-0.45341,-0.44922,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.1678e-11,-0.45361,-0.49152,0,0
3,GO DEFINITIVE HEMOPOIESIS,1.8594e-09,-0.4553,-0.51094,0,0
3,GO ESTROUS CYCLE,5.1351e-07,-0.45607,-0.39129,0,0
3,GO METANEPHROS DEVELOPMENT,5.9748e-11,-0.45654,-0.45248,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,9.4499e-11,-0.45659,-0.52111,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.6435e-08,-0.4568,-0.45364,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,2.8814e-05,-0.45692,-0.32333,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,1.2682e-10,-0.4578,-0.53208,0,0
3,GO GDP METABOLIC PROCESS,1.8318e-07,-0.46113,-0.40326,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,1.2886e-07,-0.46167,-0.4445,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,1.8594e-09,-0.46358,-0.4573,0,0
3,GO MESENCHYME MORPHOGENESIS,1.2733e-08,-0.46383,-0.45377,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.4982e-08,-0.46429,-0.43299,0,0
3,GO REGULATION OF GTP BINDING,2.4586e-08,-0.46445,-0.45739,0,0
3,GO BONE MATURATION,5.2253e-10,-0.46505,-0.4699,0,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,1.4334e-08,-0.46822,-0.52773,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,3.357e-07,-0.47038,-0.4643,0,0
3,GO TRABECULA MORPHOGENESIS,5.0922e-10,-0.47146,-0.53081,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2058e-07,-0.4723,-0.44961,0,0
3,GO HEART INDUCTION,0.00016901,-0.47288,-0.39752,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,2.0879e-07,-0.47386,-0.44426,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,6.0565e-09,-0.47456,-0.48847,0,0
3,GO CONVERGENT EXTENSION,8.0898e-09,-0.47502,-0.44841,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,6.2993e-08,-0.47558,-0.45065,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,3.628e-05,-0.47799,-0.36239,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,1.1794e-07,-0.47937,-0.54775,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,1.0527e-08,-0.47961,-0.47245,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.6307e-12,-0.48137,-0.51116,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,5.6451e-10,-0.48251,-0.50556,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.4749e-10,-0.48809,-0.50002,0,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,7.8052e-07,-0.48816,-0.40387,0,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00029511,-0.49317,-0.44365,0,0
3,GO NEURON PROJECTION ARBORIZATION,4.0868e-08,-0.49394,-0.53095,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,2.004e-09,-0.49471,-0.50947,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.6109e-10,-0.49697,-0.49428,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,8.6328e-08,-0.49927,-0.51204,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,3.357e-07,-0.50363,-0.4678,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,1.1282e-07,-0.5055,-0.45982,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,3.6567e-07,-0.50604,-0.45776,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,9.2321e-08,-0.50834,-0.51348,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.9948e-11,-0.51356,-0.54082,0,0
3,GO NEURON PROJECTION REGENERATION,2.4893e-11,-0.51365,-0.5266,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,1.2131e-09,-0.51637,-0.58152,0,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,4.1026e-05,-0.52216,-0.4501,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.0337e-07,-0.52982,-0.47315,0,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,4.1751e-05,-0.53203,-0.42163,0,0
3,GO REGULATION OF AXON GUIDANCE,7.6792e-10,-0.53445,-0.53061,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.6407e-09,-0.54233,-0.52584,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,7.4177e-11,-0.55469,-0.54618,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,4.7125e-10,-0.55964,-0.64415,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,9.9705e-11,-0.56147,-0.6042,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,9.1793e-10,-0.56624,-0.58839,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,1.5027e-08,-0.56719,-0.53349,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,1.5688e-10,-0.57246,-0.56515,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,2.0364e-06,-0.58056,-0.49228,0,0
3,GO BODY MORPHOGENESIS,5.3602e-11,-0.58591,-0.5488,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,2.1543e-10,-0.58632,-0.59085,0,0
3,GO BRONCHUS DEVELOPMENT,4.5239e-09,-0.59134,-0.60312,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,1.5037e-07,-0.59265,-0.46671,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,1.7071e-05,-0.61491,-0.45791,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.2143e-08,-0.61882,-0.63244,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,3.1312e-09,-0.62072,-0.59216,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,1.4877e-10,-0.63235,-0.66791,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,7.7166e-08,-0.64217,-0.62017,0,0
3,GO HEAD MORPHOGENESIS,1.3085e-09,-0.64363,-0.56331,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,2.4893e-11,-0.65571,-0.67729,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,1.3174e-07,-0.67486,-0.61554,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,1.0493e-11,-0.81529,-0.81276,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,4.1552e-07,-0.84165,-0.71236,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,1.725e-09,-0.87335,-0.8265,0,0
3,GO RENAL FILTRATION,1.942e-12,-0.90119,-0.91222,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,1.6109e-10,-0.92192,-0.8781,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,5.2359e-09,-0.92456,-0.9192,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.8416e-06,1.2219,1.0612,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,2.7452e-06,0.96801,0.94622,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.8793e-06,0.81543,0.81286,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.2444e-07,0.80615,0.85797,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.8839e-05,0.7649,0.59297,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,6.7724e-05,0.69323,0.62361,1,1
4,GO HISTAMINE SECRETION,6.586e-10,0.68516,0.66002,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,4.9624e-10,0.65798,0.74534,1,1
4,GO TOLERANCE INDUCTION,3.7356e-07,0.6405,0.58528,1,1
4,GO RESPONSE TO TYPE I INTERFERON,4.6881e-08,0.63633,0.58365,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.4877e-10,0.63621,0.60173,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,4.4148e-09,0.63546,0.58628,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.1729e-08,0.63328,0.57442,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.8032e-05,0.61212,0.4694,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.457e-10,0.60984,0.5986,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.2416e-05,0.59998,0.5052,1,1
4,GO HISTAMINE TRANSPORT,1.6986e-10,0.59743,0.61775,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,2.7078e-07,0.59501,0.60536,1,1
4,GO DETECTION OF OTHER ORGANISM,4.9069e-08,0.59224,0.54875,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.5052e-06,0.58629,0.51031,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00010852,0.58134,0.49821,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,6.1583e-08,0.5759,0.60493,1,1
4,GO MUCUS SECRETION,1.4741e-05,0.56486,0.50617,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.7385e-05,0.562,0.54134,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.2958e-06,0.54551,0.45255,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.3468e-07,0.54082,0.55848,1,1
4,GO NEGATIVE REGULATION OF CELL KILLING,0.00038422,0.53797,0.41428,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,5.4982e-08,0.53567,0.5414,1,1
4,GO O GLYCAN PROCESSING,5.793e-12,0.53566,0.53456,1,1
4,GO RENAL ABSORPTION,1.7534e-07,0.53281,0.52361,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.6981e-08,0.52752,0.53214,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,1.9926e-08,0.52497,0.45308,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,9.5999e-07,0.52331,0.48598,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.8573e-08,0.52318,0.61421,1,1
4,GO REGULATION OF PLATELET AGGREGATION,6.7411e-08,0.52237,0.50101,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,4.9228e-07,0.5213,0.51035,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.9822e-07,0.52078,0.50376,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,2.4972e-05,0.51948,0.43393,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,5.4967e-09,0.51807,0.51113,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,4.5239e-09,0.51578,0.64744,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.6129e-08,0.50534,0.5413,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.5864e-07,0.50511,0.45978,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,1.1165e-05,0.50498,0.47702,1,1
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00084997,0.50106,0.33183,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.9393e-05,0.49948,0.45475,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,2.0364e-06,0.49813,0.49152,1,1
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.7605e-06,0.49373,0.43583,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.0036e-08,0.48917,0.48454,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.8032e-05,0.48891,0.45291,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,1.3599e-06,0.48767,0.48091,1,1
4,GO INTESTINAL ABSORPTION,3.9064e-09,0.48248,0.53487,1,1
4,GO REFLEX,1.2281e-06,0.47944,0.48205,1,1
4,GO RESPONSE TO INTERFERON BETA,1.6761e-05,0.47856,0.4686,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,1.9926e-08,0.47827,0.46767,1,1
4,GO MICROVILLUS ORGANIZATION,2.6362e-08,0.47685,0.42936,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,1.5014e-05,0.47622,0.36447,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.9822e-07,0.47458,0.4961,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,2.5934e-07,0.47328,0.48176,1,1
4,GO REGULATION OF PLATELET ACTIVATION,7.892e-08,0.47275,0.43544,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,1.5674e-06,0.47107,0.47768,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.00016098,0.46843,0.42848,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,7.1819e-07,0.4684,0.42227,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,2.188e-08,0.46702,0.48351,1,1
4,GO TOXIN METABOLIC PROCESS,1.8881e-10,0.46515,0.50126,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,1.4334e-08,0.46395,0.45766,1,1
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0012886,0.46341,0.30793,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.7282e-08,0.46338,0.55024,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.4454e-06,0.46293,0.4492,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,5.8698e-06,0.46084,0.45878,1,1
4,GO GALACTOSE METABOLIC PROCESS,3.4296e-07,0.45971,0.46641,1,1
4,GO GERMINAL CENTER FORMATION,2.1375e-08,0.45666,0.50057,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,4.6202e-07,0.4558,0.5236,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,5.9056e-05,0.45306,0.41809,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,9.9064e-10,0.45055,0.44154,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.6386e-06,0.45027,0.41022,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.8161e-07,0.44997,0.41493,1,1
4,GO REGULATION OF ANOIKIS,1.0527e-08,0.44732,0.49611,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,3.2162e-07,0.44641,0.40321,1,1
4,GO EOSINOPHIL MIGRATION,6.4699e-07,0.44639,0.41826,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,7.105e-06,0.44627,0.37638,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0036e-08,0.44625,0.47277,1,1
4,GO EOSINOPHIL CHEMOTAXIS,3.7356e-07,0.44461,0.44134,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.734e-06,0.44298,0.39865,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.2444e-07,0.44258,0.48612,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.402e-08,0.4404,0.41701,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,1.475e-06,0.43962,0.47966,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,3.3228e-08,0.43948,0.4696,1,1
4,GO LIPOXYGENASE PATHWAY,0.00012186,0.43936,0.369,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,7.5451e-08,0.439,0.44051,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.2792e-06,0.43898,0.40894,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,9.7998e-07,0.43869,0.4112,1,1
4,GO VITAMIN D METABOLIC PROCESS,7.892e-08,0.43833,0.41318,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,5.1304e-06,0.43597,0.42775,1,1
4,GO GAP JUNCTION ASSEMBLY,2.7804e-05,0.43531,0.34545,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.1494e-05,0.43465,0.38345,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,2.1807e-07,0.43314,0.51035,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.332e-06,0.43256,0.39625,1,1
4,GO REGULATION OF VASCULOGENESIS,1.8318e-07,0.43219,0.43915,1,1
4,GO CELLULAR DEFENSE RESPONSE,5.9116e-09,0.43151,0.38174,1,1
4,GO NEURONAL ACTION POTENTIAL,2.5164e-08,0.43108,0.45677,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,5.4184e-05,0.4307,0.37421,1,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,7.5217e-06,0.43069,0.42503,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.6386e-06,0.42999,0.40068,1,1
4,GO MATURE B CELL DIFFERENTIATION,8.9166e-06,0.42998,0.34815,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,4.6881e-08,0.42994,0.4008,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,8.4877e-09,0.42828,0.493,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,2.0776e-06,0.42798,0.42752,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.6162e-06,0.42738,0.36012,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,6.0991e-06,0.42607,0.46373,1,1
4,GO RESPONSE TO THYROID HORMONE,4.8839e-05,0.42606,0.30059,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,2.5695e-09,0.42523,0.42412,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,6.0205e-08,0.42397,0.39003,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,2.2416e-05,0.42294,0.42541,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.9803e-06,0.42281,0.34011,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,4.7488e-06,0.41825,0.39832,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,4.7172e-05,0.41793,0.42859,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.3056e-06,0.41735,0.40113,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,5.9498e-07,0.41716,0.42451,1,1
4,GO RESPONSE TO PAIN,1.0964e-09,0.41661,0.42212,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.4967e-09,0.41658,0.43366,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,4.9228e-07,0.4147,0.36333,1,1
4,GO RESPONSE TO MAGNESIUM ION,2.1807e-07,0.41413,0.43914,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,7.7166e-08,0.41259,0.39688,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.3174e-07,0.4125,0.37689,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,1.7154e-07,0.41099,0.47214,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.001568,0.41053,0.35287,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.1282e-07,0.40673,0.37308,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,2.0853e-05,0.4061,0.38645,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,7.9617e-06,0.4054,0.36805,1,1
4,GO RESPONSE TO DIETARY EXCESS,5.9116e-09,0.40525,0.43003,1,1
4,GO RESPONSE TO INTERFERON GAMMA,1.4163e-06,0.40227,0.35394,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,7.0522e-08,0.40157,0.35674,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,1.8363e-05,0.40146,0.37582,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.3442e-05,0.40094,0.36162,1,1
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00033955,0.40052,0.33466,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.5684e-06,0.4001,0.33838,1,1
4,GO REGULATION OF BONE REMODELING,1.9546e-09,0.39967,0.40113,1,1
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.015329,0.39939,0.24745,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,5.2165e-11,0.39908,0.3876,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.064e-06,0.39885,0.36944,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,9.819e-05,0.39713,0.36698,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,7.8052e-07,0.39658,0.40449,1,1
4,GO RESPONSE TO COLD,1.9402e-11,0.39654,0.40195,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9228e-07,0.39644,0.36481,1,1
4,GO REGULATION OF TISSUE REMODELING,1.8135e-09,0.3953,0.38107,1,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0017517,0.39479,0.3769,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.00022208,0.39453,0.28886,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,4.9361e-06,0.39449,0.3544,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,8.4262e-06,0.394,0.394,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,3.4098e-06,0.39339,0.4048,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,4.6359e-05,0.39198,0.39952,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.2444e-07,0.39058,0.46873,1,1
4,GO ADHESION OF SYMBIONT TO HOST,4.0678e-07,0.39039,0.45728,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,4.5233e-07,0.39018,0.42772,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.01128,0.38778,0.18571,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,1.7154e-07,0.38699,0.38531,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,9.7998e-07,0.38695,0.37696,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,2.856e-06,0.38605,0.38221,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.2505e-06,0.38408,0.35317,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0013633,0.3835,0.30116,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.003654,0.38286,0.25211,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,1.6062e-07,0.38278,0.33868,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,1.8573e-08,0.38233,0.45346,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,8.0712e-08,0.38151,0.40745,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,1.2482e-05,0.38052,0.3656,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.7582e-06,0.38003,0.38678,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,3.2057e-05,0.37794,0.33922,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,6.2993e-08,0.37676,0.40635,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,4.9872e-09,0.37657,0.40213,1,1
4,GO ZYMOGEN ACTIVATION,7.4873e-07,0.37337,0.38565,1,1
4,GO SUPEROXIDE ANION GENERATION,2.8271e-07,0.37334,0.38135,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.8198e-07,0.3733,0.40377,1,1
4,GO STEROID ESTERIFICATION,5.2303e-06,0.3732,0.45167,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,4.3236e-05,0.37175,0.37239,1,1
4,GO MAGNESIUM ION TRANSPORT,3.4796e-08,0.37112,0.34856,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.8419e-06,0.37097,0.36576,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,3.5461e-06,0.37096,0.37098,1,1
4,GO CORNIFICATION,3.3435e-06,0.36984,0.33601,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00011033,0.36729,0.42136,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.3948e-05,0.3667,0.3713,1,1
4,GO PROTEIN DEGLYCOSYLATION,1.8723e-07,0.36638,0.35455,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.7536e-08,0.36611,0.35493,1,1
4,GO IMMUNOGLOBULIN SECRETION,2.2505e-06,0.36599,0.31891,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.2686e-06,0.36564,0.39785,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.2482e-05,0.36479,0.33501,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,9.4341e-06,0.36479,0.47281,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.00017176,0.36424,0.39521,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,2.0881e-08,0.36363,0.35124,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,7.6657e-06,0.36333,0.35207,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.342e-06,0.36312,0.41185,1,1
4,GO LIPID TRANSLOCATION,3.8118e-09,0.36119,0.35268,1,1
4,GO B CELL APOPTOTIC PROCESS,1.3351e-08,0.36092,0.3832,1,1
4,GO LIPID DIGESTION,8.3013e-05,0.36043,0.45993,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.7963e-08,0.35997,0.3338,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,6.4434e-08,0.35992,0.33079,1,1
4,GO INTERLEUKIN 10 PRODUCTION,1.064e-06,0.35972,0.29234,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.2604e-07,0.35942,0.37834,1,1
4,GO FOAM CELL DIFFERENTIATION,1.6418e-07,0.35905,0.35369,1,1
4,GO LUNG CELL DIFFERENTIATION,9.2118e-07,0.35881,0.41169,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.3214e-05,0.3587,0.33816,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,5.02e-08,0.35758,0.37048,1,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00015083,0.3571,0.32891,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,1.0557e-05,0.35516,0.36474,1,1
4,GO CERAMIDE CATABOLIC PROCESS,9.9803e-06,0.35497,0.39497,1,1
4,GO MEMBRANE RAFT ORGANIZATION,0.00065224,0.35482,0.30281,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,2.2958e-06,0.35401,0.37014,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,6.7105e-06,0.3534,0.39888,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,1.0212e-06,0.35318,0.40404,1,1
4,GO LIVER MORPHOGENESIS,1.6321e-06,0.35304,0.37942,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,6.0759e-07,0.35273,0.43115,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.00032408,0.35266,0.48098,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,5.6487e-06,0.35197,0.32891,1,1
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.6162e-06,0.35193,0.32037,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,2.7676e-09,0.35133,0.43954,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.018091,0.35109,0.31575,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,4.7999e-05,0.35062,0.34102,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0018256,0.34986,0.29715,1,1
4,GO RESPONSE TO INTERLEUKIN 15,1.2954e-05,0.34938,0.29209,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,4.2271e-06,0.34896,0.26209,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,4.8359e-10,0.34819,0.38387,1,1
4,GO DNA DEAMINATION,0.0005211,0.34672,0.31557,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.3774e-08,0.34607,0.36797,1,1
4,GO PLASMINOGEN ACTIVATION,0.00010852,0.34603,0.33307,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,4.7999e-05,0.34598,0.36584,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,4.1026e-05,0.34594,0.32019,1,1
4,GO TISSUE REMODELING,2.5164e-08,0.34515,0.33008,1,1
4,GO MAST CELL ACTIVATION,1.7922e-07,0.34473,0.32171,1,1
4,GO RESPONSE TO EPINEPHRINE,3.6877e-06,0.3441,0.38592,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,6.7105e-06,0.34342,0.34596,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.4516e-10,0.34339,0.40529,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,1.5014e-05,0.34286,0.38748,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,2.3891e-06,0.34285,0.28784,1,1
4,GO MICROVILLUS ASSEMBLY,0.00011596,0.3426,0.30397,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.5052e-06,0.34239,0.31448,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,9.03e-05,0.34195,0.27973,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0001803,0.3413,0.38165,1,1
4,GO DETECTION OF BIOTIC STIMULUS,1.1165e-05,0.34126,0.3414,1,1
4,GO KERATINIZATION,5.4701e-07,0.34097,0.32127,1,1
4,GO MYELIN MAINTENANCE,2.5424e-05,0.34076,0.37562,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,2.3274e-07,0.34044,0.39247,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.7172e-05,0.34006,0.31472,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,6.895e-08,0.33885,0.35635,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,3.2631e-05,0.33796,0.32772,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,3.6924e-05,0.33794,0.30854,1,1
4,GO REGULATION OF CELL KILLING,1.8419e-06,0.33743,0.29494,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,4.2444e-07,0.33707,0.33294,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,3.6924e-05,0.33704,0.34936,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00019541,0.33682,0.26585,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,9.2118e-07,0.33615,0.286,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.2824e-05,0.33603,0.33241,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,8.9166e-06,0.33553,0.3431,1,1
4,GO REGULATION OF NEURON MATURATION,1.1282e-07,0.33524,0.34043,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.5906e-08,0.33519,0.33025,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.0212e-06,0.33504,0.28448,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.7963e-08,0.33477,0.41176,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,3.2057e-05,0.33443,0.37418,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,3.094e-05,0.33412,0.27054,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,8.4415e-08,0.3341,0.30876,1,1
4,GO OPTIC NERVE DEVELOPMENT,3.2631e-05,0.33383,0.33037,1,1
4,GO REGULATION OF COAGULATION,3.2146e-06,0.33377,0.31892,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.155e-06,0.3335,0.29019,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,2.0776e-06,0.33325,0.30073,1,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0042636,0.33323,0.24908,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,1.5576e-05,0.33303,0.39307,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0012177,0.33297,0.28163,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,1.0958e-05,0.33185,0.32859,1,1
4,GO BONE RESORPTION,4.6356e-09,0.33123,0.35904,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00011406,0.33122,0.37132,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,1.2032e-06,0.33102,0.30154,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,3.9613e-05,0.33095,0.28572,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.9047e-09,0.33053,0.35763,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,3.3713e-09,0.33034,0.3136,1,1
4,GO KERATINOCYTE DEVELOPMENT,7.1274e-05,0.33029,0.37144,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00042777,0.33001,0.24939,1,1
4,GO MYOBLAST FUSION,1.4163e-06,0.32979,0.30788,1,1
4,GO BLOOD VESSEL REMODELING,3.0302e-06,0.32956,0.29903,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,2.342e-06,0.3283,0.29294,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,1.9175e-06,0.32799,0.32148,1,1
4,GO PLASMA MEMBRANE FUSION,1.0361e-05,0.32785,0.33839,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,4.3236e-05,0.32737,0.30991,1,1
4,GO MAST CELL MEDIATED IMMUNITY,3.4098e-06,0.32707,0.29292,1,1
4,GO VASCULAR WOUND HEALING,3.0302e-06,0.32688,0.34969,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,6.3569e-09,0.32654,0.35417,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,3.1494e-05,0.3265,0.26654,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.0005618,0.32643,0.27189,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.00047589,0.3264,0.30493,1,1
4,GO N GLYCAN PROCESSING,5.8698e-06,0.32623,0.35858,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,1.2058e-07,0.32588,0.32309,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,3.2146e-06,0.3257,0.35261,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,7.0337e-07,0.32545,0.34168,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,4.3946e-06,0.32538,0.30505,1,1
4,GO RESPONSE TO TUMOR CELL,6.9711e-06,0.3252,0.34935,1,1
4,GO RESPONSE TO LITHIUM ION,3.4003e-08,0.32512,0.38075,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,5.7582e-06,0.32484,0.33108,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,9.4959e-05,0.32483,0.28162,1,1
4,GO REGULATION OF B CELL PROLIFERATION,7.7166e-08,0.32481,0.31817,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.001118,0.32386,0.2829,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,2.0398e-08,0.32374,0.32038,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.6407e-09,0.32369,0.32983,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00015331,0.32303,0.27507,1,1
4,GO REGULATION OF MYOBLAST FUSION,1.0212e-06,0.32183,0.35194,1,1
4,GO RESPONSE TO MUSCLE STRETCH,3.152e-06,0.32171,0.40163,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.0212e-06,0.32169,0.28735,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,5.1304e-06,0.32119,0.32118,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,3.0905e-06,0.32103,0.29522,1,1
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,7.1274e-05,0.32095,0.36177,1,1
4,GO DEFENSE RESPONSE TO VIRUS,2.7452e-06,0.32053,0.27315,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00040235,0.3202,0.31277,1,1
4,GO LEYDIG CELL DIFFERENTIATION,2.011e-05,0.3201,0.40502,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,4.1552e-07,0.3201,0.43475,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.2397e-08,0.31958,0.38198,1,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0007901,0.31896,0.29117,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,2.206e-06,0.31814,0.30507,1,1
4,GO STEROID HORMONE SECRETION,9.9803e-06,0.31802,0.30461,1,1
4,GO REGULATION OF ACROSOME REACTION,8.1138e-06,0.3177,0.29743,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.7804e-05,0.31749,0.266,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00011406,0.31722,0.28812,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.012227,0.31703,0.19806,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,4.5822e-08,0.31641,0.27601,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.5713e-07,0.31635,0.32302,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0023321,0.31622,0.26058,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,2.1621e-05,0.31581,0.33109,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,9.2321e-08,0.31543,0.31709,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.0169e-05,0.31542,0.29605,1,1
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.022446,0.31537,0.29567,1,1
4,GO BONE REMODELING,9.7991e-09,0.31531,0.36051,1,1
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00069207,0.31507,0.27764,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.6881e-08,0.3149,0.30249,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,5.2344e-05,0.31451,0.29706,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,3.0302e-06,0.3144,0.31554,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,8.5858e-05,0.3139,0.33016,1,1
4,GO T CELL EXTRAVASATION,0.00012804,0.31377,0.3653,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,7.6446e-07,0.31372,0.31217,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.5233e-07,0.31349,0.33265,1,1
4,GO ADRENAL GLAND DEVELOPMENT,1.536e-06,0.31348,0.3622,1,1
4,GO OSTEOBLAST PROLIFERATION,1.5052e-06,0.31323,0.32946,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.3806e-05,0.31309,0.2365,1,1
4,GO GLIAL CELL FATE COMMITMENT,0.0025961,0.31305,0.31398,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,1.5037e-07,0.31195,0.30836,1,1
4,GO ACTIN FILAMENT SEVERING,0.00053704,0.31177,0.29143,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00020835,0.31143,0.40854,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,2.1196e-06,0.31138,0.27597,1,1
4,GO ANOIKIS,3.0295e-08,0.31118,0.36766,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,5.5412e-06,0.31101,0.29483,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,1.1588e-05,0.3108,0.26344,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.2859e-07,0.31077,0.3076,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,4.7963e-08,0.31077,0.31095,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.1621e-05,0.31072,0.28415,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,3.4098e-06,0.31036,0.25023,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.3948e-05,0.3103,0.27357,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.1456e-06,0.31022,0.25725,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.8419e-06,0.31003,0.29024,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,8.8796e-05,0.30998,0.27109,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.000286,0.30986,0.30206,1,1
4,GO T CELL MEDIATED IMMUNITY,3.4098e-06,0.30983,0.30323,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,2.8886e-07,0.30938,0.32032,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.011022,0.30899,0.23625,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,7.71e-09,0.30869,0.3474,1,1
4,GO APICAL JUNCTION ASSEMBLY,3.9941e-08,0.3085,0.32882,1,1
4,GO VASODILATION,1.7534e-07,0.30812,0.35022,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,2.7804e-05,0.30744,0.28211,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,2.2775e-07,0.30722,0.31966,1,1
4,GO RESPONSE TO STEROL DEPLETION,1.4677e-08,0.30708,0.38142,1,1
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00032408,0.30698,0.31377,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,4.2271e-06,0.30694,0.28757,1,1
4,GO ENTRY INTO HOST,8.9166e-06,0.30602,0.27853,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,4.4771e-05,0.30464,0.29707,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.5674e-06,0.3046,0.26918,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.5359e-06,0.30424,0.2956,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,5.4356e-06,0.30412,0.32152,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,4.31e-06,0.30386,0.33131,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.6828e-05,0.30371,0.23558,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,1.734e-06,0.3037,0.30815,1,1
4,GO ICOSANOID METABOLIC PROCESS,3.6567e-07,0.30361,0.30528,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.01585,0.3035,0.21644,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.8983e-07,0.30339,0.28131,1,1
4,GO CELL KILLING,4.4285e-07,0.30334,0.25972,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,4.2487e-05,0.30229,0.30815,1,1
4,GO RESPONSE TO COPPER ION,5.5127e-05,0.30199,0.35143,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,6.4592e-06,0.30183,0.29787,1,1
4,GO SENSORY PERCEPTION OF SMELL,5.2538e-08,0.30166,0.28784,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010152,0.30156,0.22322,1,1
4,GO REGULATION OF B CELL ACTIVATION,1.4076e-07,0.30156,0.25928,1,1
4,GO RESPONSE TO ACIDIC PH,3.758e-05,0.30108,0.31003,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,7.8911e-05,0.3004,0.26722,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00011986,0.30028,0.2166,1,1
4,GO TYPE 2 IMMUNE RESPONSE,0.00013673,0.30022,0.30464,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,2.8814e-05,0.30017,0.33789,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,4.4771e-05,0.30015,0.25237,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,2.402e-08,0.30012,0.27702,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,7.1819e-07,0.30004,0.29187,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,1.155e-06,0.30003,0.30885,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00017741,0.29991,0.26863,1,1
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00069207,0.29985,0.19462,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.00099681,0.29968,0.21841,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.3803e-06,0.29946,0.27371,1,1
4,GO STEROL HOMEOSTASIS,9.2118e-07,0.2992,0.27571,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.7706e-05,0.29905,0.25837,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,7.8124e-06,0.29852,0.29674,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,2.7078e-07,0.29847,0.25348,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,2.6362e-08,0.29835,0.26567,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,6.5837e-06,0.2983,0.30639,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,1.2032e-06,0.29825,0.31067,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.094e-05,0.29776,0.26468,1,1
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0012177,0.29697,0.22837,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.00017176,0.29676,0.30851,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.155e-06,0.29654,0.27104,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,6.2046e-07,0.29653,0.25861,1,1
4,GO RESPONSE TO REDOX STATE,0.00020835,0.29652,0.23966,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.8389e-07,0.29644,0.27019,1,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00040235,0.29627,0.29798,1,1
4,GO GLYCOSYLATION,2.1543e-10,0.2952,0.29497,1,1
4,GO POSITIVE REGULATION OF COAGULATION,4.7999e-05,0.29506,0.27468,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,9.819e-05,0.29453,0.27758,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.3806e-05,0.29441,0.33413,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0005133,0.29434,0.27014,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.795e-06,0.29433,0.25858,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.1338e-07,0.29426,0.29791,1,1
4,GO B CELL PROLIFERATION,2.5934e-07,0.29419,0.27355,1,1
4,GO INTERLEUKIN 12 PRODUCTION,7.8052e-07,0.29402,0.28071,1,1
4,GO FUCOSE METABOLIC PROCESS,8.7502e-06,0.29397,0.30189,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00012594,0.29353,0.29955,1,1
4,GO RESPONSE TO WATER,3.3435e-06,0.29336,0.31754,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.3239e-05,0.29324,0.24663,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,1.471e-07,0.29309,0.38285,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,1.9393e-05,0.29288,0.30211,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,5.4701e-07,0.29284,0.23079,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,5.4184e-05,0.2927,0.36712,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.5424e-05,0.29221,0.27801,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,7.5451e-08,0.29183,0.31068,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.1004e-08,0.29178,0.29349,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,3.8347e-06,0.29169,0.28748,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.2057e-05,0.29159,0.28243,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00016361,0.2914,0.28236,1,1
4,GO PROTEIN DEMANNOSYLATION,2.3274e-07,0.29136,0.36138,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.6418e-07,0.29122,0.25167,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,4.5233e-07,0.29058,0.26525,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.971e-06,0.2904,0.25447,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.0905e-06,0.29032,0.22589,1,1
4,GO INTERLEUKIN 8 PRODUCTION,5.332e-06,0.29029,0.26758,1,1
4,GO CHEMOKINE PRODUCTION,3.2784e-06,0.28932,0.26216,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,5.1351e-07,0.28921,0.3055,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,6.545e-05,0.28899,0.29399,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00010323,0.28887,0.23735,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,3.0811e-07,0.28877,0.30897,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.357e-07,0.28865,0.38781,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.9332e-05,0.2886,0.25158,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,4.3946e-06,0.28853,0.30101,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,3.4773e-06,0.28839,0.24178,1,1
4,GO INTERLEUKIN 5 PRODUCTION,0.00086244,0.28817,0.26866,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.00024819,0.28804,0.29981,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,3.7605e-06,0.288,0.35408,1,1
4,GO INNATE IMMUNE RESPONSE,5.1351e-07,0.28759,0.24626,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.5674e-06,0.28757,0.26636,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.5695e-09,0.28744,0.27035,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,4.4771e-05,0.28743,0.28418,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,1.9749e-05,0.2866,0.31583,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,9.3415e-09,0.28651,0.37163,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,1.155e-06,0.28637,0.27317,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,2.913e-06,0.28587,0.29469,1,1
4,GO REGULATION OF DENDRITE EXTENSION,2.1621e-05,0.28585,0.31271,1,1
4,GO VIRAL GENOME REPLICATION,3.8347e-06,0.28582,0.25126,1,1
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0019819,0.28565,0.25004,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,2.4091e-05,0.28551,0.26834,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,5.1446e-05,0.28505,0.25267,1,1
4,GO LEUKOCYTE PROLIFERATION,3.2146e-06,0.28431,0.22562,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,9.6129e-06,0.2842,0.30291,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00099681,0.28419,0.2331,1,1
4,GO PROTEIN KINASE C SIGNALING,0.00025617,0.28417,0.25672,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.971e-06,0.28412,0.30223,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00016629,0.28396,0.19437,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,5.02e-08,0.28368,0.26821,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,3.3435e-06,0.2835,0.29489,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,0.00026858,0.28341,0.23239,1,1
4,GO T CELL PROLIFERATION,1.4472e-05,0.28271,0.21807,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,4.2271e-06,0.28242,0.26695,1,1
4,GO PROTEIN HYDROXYLATION,0.00031414,0.28229,0.26034,1,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,9.819e-05,0.28222,0.267,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.3325e-06,0.28178,0.27814,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.6066e-07,0.28176,0.24531,1,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0043737,0.28134,0.24605,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,6.7105e-06,0.2812,0.2478,1,1
4,GO B CELL MEDIATED IMMUNITY,1.6654e-06,0.28097,0.30017,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,2.5934e-07,0.28077,0.26352,1,1
4,GO IMMUNE EFFECTOR PROCESS,5.5864e-07,0.28017,0.24139,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.7582e-06,0.28007,0.23776,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,1.996e-06,0.27966,0.2605,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.0811e-07,0.27893,0.25766,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,2.4371e-06,0.27859,0.26743,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,6.6066e-07,0.27851,0.28877,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,8.0256e-05,0.27851,0.28802,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,8.3066e-07,0.27849,0.26884,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.332e-06,0.27793,0.23266,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00040857,0.27786,0.21637,1,1
4,GO B CELL HOMEOSTASIS,4.5684e-06,0.27768,0.26281,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,2.2015e-05,0.27758,0.25556,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,9.2585e-06,0.27713,0.26276,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,4.3236e-05,0.27698,0.33387,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,7.3803e-06,0.27673,0.2632,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,9.9844e-05,0.27664,0.24901,1,1
4,GO TRANSPOSITION,8.5858e-05,0.27662,0.29777,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00011218,0.27659,0.23531,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00019541,0.27658,0.30643,1,1
4,GO REGULATION OF ICOSANOID SECRETION,2.7614e-08,0.27646,0.31006,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.5674e-06,0.27623,0.24943,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.1535e-07,0.27621,0.28071,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,1.7385e-05,0.27619,0.28712,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,5.7582e-06,0.27593,0.28816,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.6487e-06,0.27572,0.25701,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.206e-06,0.2757,0.35956,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.3435e-06,0.2757,0.23163,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,2.7668e-07,0.27526,0.29372,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,1.7693e-06,0.27503,0.2533,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,8.1138e-06,0.27484,0.25008,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.2146e-06,0.27444,0.23196,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,4.7172e-05,0.27423,0.24617,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.1494e-05,0.27403,0.25702,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,4.5233e-07,0.27399,0.26588,1,1
4,GO CYTOKINE METABOLIC PROCESS,2.206e-06,0.27376,0.2567,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,3.3214e-05,0.27373,0.25935,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,1.0756e-05,0.2734,0.21759,1,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.00021511,0.27335,0.22881,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,2.2416e-05,0.27307,0.25733,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.7154e-07,0.27282,0.26863,1,1
4,GO AMYLOID BETA CLEARANCE,0.00011986,0.27249,0.2226,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.4972e-05,0.27245,0.21366,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00027716,0.2724,0.28301,1,1
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00159,0.27239,0.22652,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00016361,0.27234,0.23772,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00015331,0.27234,0.26887,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,2.4528e-05,0.2723,0.24757,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.2954e-05,0.27207,0.25736,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,8.7316e-05,0.27196,0.23573,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,9.6129e-06,0.2717,0.31938,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,1.5576e-05,0.27141,0.2273,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,2.5359e-06,0.27136,0.25485,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,5.8262e-07,0.27121,0.23713,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.00039018,0.27116,0.21333,1,1
4,GO HAIR CELL DIFFERENTIATION,4.31e-06,0.2707,0.24315,1,1
4,GO LINOLEIC ACID METABOLIC PROCESS,5.2344e-05,0.27046,0.30693,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.8053e-06,0.27045,0.23688,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.6994e-06,0.27035,0.32851,1,1
4,GO POSITIVE REGULATION OF HEART RATE,4.5684e-06,0.26971,0.29718,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.00033432,0.26945,0.29043,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.9393e-05,0.26941,0.25282,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.4091e-05,0.26936,0.291,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.0905e-06,0.26924,0.26182,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.028e-08,0.26922,0.27792,1,1
4,GO ZYMOGEN INHIBITION,4.2487e-05,0.26918,0.27108,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.2444e-07,0.26876,0.25552,1,1
4,GO DIOL METABOLIC PROCESS,2.971e-06,0.26855,0.29395,1,1
4,GO AMYLOID FIBRIL FORMATION,8.7316e-05,0.26819,0.32467,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0001803,0.2679,0.22422,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00011596,0.26739,0.27882,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.3769e-07,0.26727,0.2844,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,9.028e-08,0.26727,0.28483,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.31e-06,0.26724,0.27298,1,1
4,GO DETECTION OF CALCIUM ION,4.7999e-05,0.2668,0.31037,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0023321,0.26666,0.27205,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,9.3381e-05,0.2666,0.30112,1,1
4,GO RESPONSE TO INTERLEUKIN 6,5.5412e-06,0.26658,0.24627,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.7051e-07,0.26651,0.25603,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.3891e-06,0.26636,0.25047,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,3.9822e-07,0.26619,0.2759,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.4454e-06,0.26617,0.26706,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,4.9228e-07,0.26605,0.23501,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,4.4807e-06,0.266,0.24345,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,9.03e-05,0.26598,0.33744,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00014599,0.26592,0.20631,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00028155,0.26586,0.27453,1,1
4,GO TYPE I INTERFERON PRODUCTION,2.2505e-06,0.26586,0.23248,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,6.4341e-05,0.26579,0.24173,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,4.5684e-06,0.26578,0.23039,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,3.8161e-07,0.26521,0.27042,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.0072e-05,0.265,0.24152,1,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.6359e-05,0.26496,0.31916,1,1
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00069207,0.26495,0.32025,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00011406,0.26494,0.21378,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,3.2057e-05,0.26479,0.19863,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,7.2414e-06,0.26475,0.32233,1,1
4,GO RESPONSE TO VIRUS,4.0657e-06,0.26467,0.23213,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00084997,0.26448,0.25396,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,9.5677e-09,0.26429,0.25302,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00015083,0.26421,0.27532,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00020504,0.26394,0.24997,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,5.5412e-06,0.26356,0.25013,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.2954e-05,0.26331,0.23264,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,2.7804e-05,0.26275,0.28185,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00044103,0.26251,0.25406,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.1588e-05,0.26243,0.34891,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,3.9613e-05,0.26213,0.2861,1,1
4,GO REGULATION OF CELL CELL ADHESION,6.8396e-06,0.26203,0.2185,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,4.6578e-06,0.26191,0.25454,1,1
4,GO KERATINOCYTE DIFFERENTIATION,3.0156e-07,0.26189,0.27442,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00029052,0.26177,0.22271,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,3.8246e-05,0.26168,0.26649,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00013673,0.26164,0.1851,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,7.8124e-06,0.26162,0.21567,1,1
4,GO RESPONSE TO GONADOTROPIN,1.4163e-06,0.26154,0.26528,1,1
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.001422,0.26144,0.29867,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3236e-05,0.26142,0.25819,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,9.4341e-06,0.2614,0.28001,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,1.9749e-05,0.26136,0.29654,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,1.5576e-05,0.26135,0.22973,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.6567e-07,0.26128,0.2708,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.0958e-05,0.26118,0.24352,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.00013899,0.26109,0.27834,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.2175e-05,0.26093,0.22616,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0037985,0.26091,0.23674,1,1
4,GO ENDOCARDIUM DEVELOPMENT,0.00017741,0.2606,0.25849,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0023957,0.26055,0.1821,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,3.2162e-07,0.26025,0.24962,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,4.7488e-06,0.26008,0.31872,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.4528e-05,0.25993,0.34929,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,7.892e-08,0.25989,0.26673,1,1
4,GO HEART TRABECULA FORMATION,0.0014022,0.25976,0.24791,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00062378,0.25967,0.22721,1,1
4,GO ANDROGEN METABOLIC PROCESS,2.538e-07,0.25964,0.34967,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,2.4972e-05,0.25957,0.21552,1,1
4,GO INTERLEUKIN 6 PRODUCTION,3.8161e-07,0.25953,0.24157,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,5.6487e-06,0.25936,0.27134,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1.2716e-05,0.25911,0.27236,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,7.2497e-05,0.25902,0.28757,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.7154e-07,0.25876,0.25502,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.4677e-08,0.2587,0.30229,1,1
4,GO PLATELET DEGRANULATION,2.2015e-05,0.25869,0.26908,1,1
4,GO RESPONSE TO PROTOZOAN,9.819e-05,0.25833,0.2336,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.7105e-06,0.25822,0.24536,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.0025961,0.2582,0.21896,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,2.971e-06,0.25819,0.28531,1,1
4,GO DOPAMINE TRANSPORT,3.8924e-05,0.25811,0.33554,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,9.4341e-06,0.2579,0.28366,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0012705,0.25777,0.17665,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.5217e-06,0.25769,0.22738,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0049019,0.25767,0.20696,1,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0005133,0.25762,0.22448,1,1
4,GO SPHINGOID METABOLIC PROCESS,1.4207e-05,0.25747,0.27825,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,2.3467e-08,0.25725,0.24857,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.5646e-05,0.25719,0.20212,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.0013443,0.25713,0.2498,1,1
4,GO FUCOSYLATION,4.2271e-06,0.257,0.27114,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,5.4982e-08,0.25669,0.25121,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,7.969e-07,0.25628,0.26881,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,5.6487e-06,0.25569,0.28698,1,1
4,GO PHOSPHOLIPID TRANSPORT,1.6907e-08,0.25567,0.27055,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,7.3803e-06,0.25565,0.25855,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,8.6579e-07,0.25535,0.26723,1,1
4,GO RESPONSE TO GROWTH HORMONE,8.4805e-07,0.25525,0.31313,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00016629,0.25501,0.40143,1,1
4,GO PLATELET ACTIVATION,2.8305e-05,0.2546,0.21762,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.2321e-08,0.25454,0.28665,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00016361,0.25438,0.20903,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00036124,0.25414,0.27516,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.6386e-06,0.25411,0.23787,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,1.7721e-08,0.25409,0.26101,1,1
4,GO CYTOKINE PRODUCTION,2.7452e-06,0.254,0.21908,1,1
4,GO NECROTIC CELL DEATH,1.6418e-07,0.25397,0.27367,1,1
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.017699,0.25388,0.20037,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,2.0776e-06,0.25385,0.27106,1,1
4,GO RESPONSE TO FORSKOLIN,0.0035146,0.25374,0.22636,1,1
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00019857,0.25373,0.48248,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,8.0712e-08,0.25363,0.25326,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0018508,0.25309,0.17503,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,1.8419e-06,0.25307,0.25867,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,2.3891e-06,0.25305,0.24648,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,3.1479e-07,0.25281,0.28568,1,1
4,GO CATECHOLAMINE UPTAKE,0.00019857,0.25269,0.2836,1,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.00068191,0.25267,0.20109,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.4003e-08,0.2525,0.23607,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,5.0323e-06,0.25249,0.27197,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,1.9558e-07,0.25237,0.29695,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00017741,0.25222,0.2696,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,1.5293e-05,0.2522,0.24907,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.1446e-05,0.25211,0.24351,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,3.2162e-07,0.25199,0.27195,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.1274e-05,0.25198,0.2426,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.6877e-06,0.25196,0.25629,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0047798,0.2517,0.16951,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,2.4091e-05,0.25162,0.20734,1,1
4,GO RETINAL METABOLIC PROCESS,0.0077327,0.25157,0.33942,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0015249,0.25136,0.22347,1,1
4,GO ALPHA BETA T CELL ACTIVATION,2.8814e-05,0.25135,0.20224,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0279e-08,0.25127,0.32246,1,1
4,GO STEROID METABOLIC PROCESS,1.4334e-08,0.25102,0.27055,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,1.6457e-05,0.25099,0.26454,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0054192,0.25099,0.35468,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.002631,0.25086,0.22573,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00012594,0.2508,0.29095,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,2.7668e-07,0.25048,0.24521,1,1
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0048405,0.25042,0.1802,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5753e-08,0.25025,0.34746,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.8347e-06,0.24974,0.23123,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,4.5558e-05,0.24974,0.20959,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.4454e-06,0.24964,0.23195,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.7172e-05,0.24947,0.24262,1,1
4,GO PLATELET AGGREGATION,2.1621e-05,0.24911,0.25728,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,4.3946e-06,0.24876,0.23873,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,3.1479e-07,0.24872,0.22868,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,3.4773e-06,0.24868,0.22566,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.2497e-05,0.24849,0.21114,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0078263,0.2482,0.20431,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.4262e-06,0.24816,0.20773,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.00092737,0.24811,0.19448,1,1
4,GO AMELOGENESIS,0.00095459,0.24803,0.22573,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0019819,0.24801,0.3271,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00013673,0.24791,0.25298,1,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0048405,0.24789,0.22086,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,2.4305e-07,0.24762,0.25377,1,1
4,GO ALANINE TRANSPORT,9.9844e-05,0.24755,0.2598,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.7582e-06,0.24754,0.23525,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,5.9116e-09,0.24745,0.25658,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,3.5038e-07,0.24743,0.22661,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,4.1456e-06,0.24742,0.30281,1,1
4,GO REGULATION OF WOUND HEALING,4.6202e-07,0.24733,0.29756,1,1
4,GO INTERLEUKIN 1 PRODUCTION,7.3739e-05,0.24697,0.23052,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.0557e-05,0.24674,0.23443,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,2.7078e-07,0.24669,0.25318,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,9.6562e-05,0.24668,0.21553,1,1
4,GO REGULATION OF RECEPTOR CLUSTERING,0.011151,0.24628,0.23038,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.6283e-05,0.24624,0.20166,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.2497e-05,0.24593,0.23258,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,4.8416e-06,0.24587,0.28053,1,1
4,GO GLYCINE TRANSPORT,0.041789,0.24586,0.15771,1,1
4,GO MANNOSYLATION,5.0278e-07,0.24515,0.25186,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,9.795e-06,0.24514,0.31896,1,1
4,GO REGULATION OF MEMBRANE REPOLARIZATION,5.8049e-05,0.24514,0.23078,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.4472e-05,0.24506,0.26768,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.3774e-08,0.24502,0.2999,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00010323,0.24493,0.23668,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,2.1234e-05,0.24491,0.2531,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.014658,0.24488,0.15451,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00011406,0.24485,0.24025,1,1
4,GO DEFENSE RESPONSE,1.5037e-07,0.24481,0.22822,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,1.5865e-05,0.24475,0.2177,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,1.5027e-08,0.24471,0.23721,1,1
4,GO ETHER METABOLIC PROCESS,9.9803e-06,0.24466,0.23185,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,3.357e-07,0.24443,0.2642,1,1
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.013856,0.24407,0.22286,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,6.0565e-09,0.24401,0.25364,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00042777,0.24386,0.17258,1,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.0018006,0.24382,0.22084,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,6.1583e-08,0.24376,0.23427,1,1
4,GO RESPONSE TO INTERLEUKIN 2,7.5217e-06,0.24375,0.24691,1,1
4,GO CYTOPLASM ORGANIZATION,0.00016901,0.24367,0.23338,1,1
4,GO B CELL ACTIVATION,1.5674e-06,0.24364,0.2047,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,1.3468e-07,0.24344,0.27806,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00080175,0.24316,0.17258,1,1
4,GO LEUKOCYTE MIGRATION,6.4699e-07,0.24305,0.23649,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,9.404e-07,0.24276,0.28794,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.2482e-05,0.24271,0.2443,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00010852,0.2423,0.20688,1,1
4,GO REGULATION OF CELL ADHESION,4.3236e-05,0.24209,0.19579,1,1
4,GO CERAMIDE METABOLIC PROCESS,1.0322e-07,0.24168,0.24498,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,1.1806e-05,0.24149,0.2375,1,1
4,GO REGULATION OF HEART RATE,3.1479e-07,0.24128,0.24468,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00023294,0.24103,0.21629,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,9.1793e-10,0.24092,0.26269,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,9.086e-06,0.24077,0.23299,1,1
4,GO RESPONSE TO FATTY ACID,5.8049e-05,0.24065,0.19163,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,2.7452e-06,0.24056,0.21722,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,5.0278e-07,0.24054,0.22712,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.020166,0.24048,0.17826,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,1.3468e-07,0.24045,0.24249,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00069207,0.24019,0.19456,1,1
4,GO ACROSOME REACTION,0.00027284,0.24017,0.18539,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.628e-05,0.24003,0.21253,1,1
4,GO MYOTUBE DIFFERENTIATION,7.6446e-07,0.24003,0.23277,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00091404,0.23997,0.28219,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.4098e-06,0.23985,0.22455,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,3.4773e-06,0.23978,0.24049,1,1
4,GO PHAGOSOME ACIDIFICATION,3.8983e-07,0.2396,0.26104,1,1
4,GO LIPID LOCALIZATION,1.6907e-08,0.23954,0.24193,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,5.2344e-05,0.23926,0.20759,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0010865,0.23922,0.24552,1,1
4,GO DIGESTIVE SYSTEM PROCESS,2.3784e-07,0.23904,0.2496,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,4.3997e-05,0.23904,0.19925,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,6.5837e-06,0.23899,0.2031,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,2.5868e-06,0.23898,0.19618,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,3.2859e-07,0.23883,0.31377,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,8.3013e-05,0.23882,0.29182,1,1
4,GO REGULATION OF TRANSPOSITION,0.00045468,0.23861,0.29282,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00033432,0.23857,0.28915,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,1.5293e-05,0.23843,0.28881,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.5372e-07,0.23837,0.22964,1,1
4,GO CYTOKINE SECRETION,3.7356e-07,0.23833,0.24319,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011596,0.23832,0.21714,1,1
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0033799,0.23821,0.25339,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,2.0478e-05,0.23816,0.23638,1,1
4,GO NUCLEOTIDE TRANSPORT,2.2775e-07,0.23815,0.22269,1,1
4,GO LYTIC VACUOLE ORGANIZATION,6.586e-10,0.23815,0.30037,1,1
4,GO SECONDARY METABOLIC PROCESS,1.9393e-05,0.23812,0.27876,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,4.6881e-08,0.23805,0.23647,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,9.2118e-07,0.23793,0.21877,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,4.1456e-06,0.23744,0.22529,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0002443,0.23713,0.23695,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.0861e-06,0.2371,0.24665,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,8.5858e-05,0.23708,0.20763,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.00013451,0.23701,0.2353,1,1
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00048316,0.23683,0.20146,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.000286,0.23682,0.21846,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00031907,0.23668,0.20655,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0001179,0.23664,0.19782,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.4091e-05,0.23662,0.2111,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00017457,0.2366,0.2583,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00013232,0.23656,0.23135,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,7.3739e-05,0.23653,0.24387,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.3599e-06,0.23652,0.2309,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,4.9694e-05,0.23628,0.25314,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,9.3381e-05,0.23627,0.18875,1,1
4,GO STEROL METABOLIC PROCESS,2.5756e-08,0.23622,0.24943,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.00016361,0.23575,0.2219,1,1
4,GO INTEGRIN ACTIVATION,6.4699e-07,0.23559,0.28613,1,1
4,GO SIGNAL PEPTIDE PROCESSING,2.4371e-06,0.23553,0.29806,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.2497e-05,0.23548,0.22898,1,1
4,GO RESPONSE TO CYTOKINE,3.0302e-06,0.23545,0.20286,1,1
4,GO REGULATION OF T CELL ACTIVATION,6.3249e-05,0.23539,0.18095,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,1.3196e-05,0.23496,0.26953,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,7.105e-06,0.23495,0.23161,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,8.4262e-06,0.23491,0.21202,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,4.249e-10,0.23488,0.26458,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1588e-05,0.23457,0.32847,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,2.2958e-06,0.23436,0.32151,1,1
4,GO WATER HOMEOSTASIS,4.9228e-07,0.23429,0.26601,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.0004e-06,0.23425,0.27928,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,2.7676e-09,0.23402,0.26086,1,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.000286,0.23388,0.19147,1,1
4,GO LIPID STORAGE,5.6487e-06,0.2334,0.21668,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.4807e-06,0.23339,0.24591,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.03006,0.23297,0.18563,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.00036124,0.23289,0.34302,1,1
4,GO REGULATION OF FERTILIZATION,7.969e-07,0.23284,0.2422,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0019023,0.23281,0.22208,1,1
4,GO INFLAMMATORY RESPONSE,5.2445e-07,0.23227,0.22352,1,1
4,GO UBIQUINONE METABOLIC PROCESS,6.4592e-06,0.23226,0.22386,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,4.1751e-05,0.23225,0.2788,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.4296e-07,0.23223,0.22795,1,1
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00055343,0.23213,0.23686,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,8.4877e-09,0.23207,0.24414,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,5.1351e-07,0.2319,0.24939,1,1
4,GO RESPONSE TO ISCHEMIA,1.3056e-06,0.23168,0.23612,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,1.3599e-06,0.23148,0.21969,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,4.9228e-07,0.23141,0.2742,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00039622,0.23101,0.24766,1,1
4,GO SYNCYTIUM FORMATION,2.8305e-05,0.23084,0.23259,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.0563e-05,0.23078,0.22346,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00042777,0.23067,0.20744,1,1
4,GO LEUKOCYTE CHEMOTAXIS,4.6578e-06,0.23061,0.2027,1,1
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,5.7059e-05,0.23051,0.25457,1,1
4,GO INTERFERON ALPHA PRODUCTION,7.4873e-07,0.23049,0.2775,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,4.8839e-05,0.23037,0.21188,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00030928,0.23036,0.20663,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,6.0079e-05,0.23024,0.17402,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,7.3803e-06,0.23023,0.2218,1,1
4,GO NUCLEOTIDE SALVAGE,0.0074579,0.23014,0.16858,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0074579,0.23,0.18792,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.4296e-07,0.22996,0.22904,1,1
4,GO DIGESTION,3.8161e-07,0.22983,0.25664,1,1
4,GO T CELL ACTIVATION,2.2824e-05,0.2297,0.18627,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.1729e-08,0.22966,0.22362,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0016347,0.22952,0.1568,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.00018923,0.22947,0.22835,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0013826,0.22915,0.24712,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00031907,0.22914,0.22067,1,1
4,GO ENDOCRINE PROCESS,1.2534e-06,0.22892,0.24559,1,1
4,GO HUMORAL IMMUNE RESPONSE,5.7051e-07,0.22891,0.23708,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0078263,0.22864,0.30207,1,1
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.00041488,0.22835,0.26528,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.001704,0.22818,0.19471,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00064263,0.22817,0.25972,1,1
4,GO CELL ACTIVATION,5.0323e-06,0.22816,0.19685,1,1
4,GO PEPTIDE SECRETION,2.5756e-08,0.22805,0.2101,1,1
4,GO BILE ACID METABOLIC PROCESS,1.0861e-06,0.22788,0.28412,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,7.3739e-05,0.22773,0.25675,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00033955,0.22769,0.19924,1,1
4,GO NERVE DEVELOPMENT,0.0005211,0.22767,0.21623,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,1.3599e-06,0.22753,0.22571,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0005789,0.22748,0.17356,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,4.8416e-06,0.22733,0.21221,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,5.1304e-06,0.22703,0.19733,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,1.3599e-06,0.22697,0.20351,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00090088,0.22691,0.20502,1,1
4,GO T CELL MIGRATION,0.00040857,0.22691,0.18502,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,2.0853e-05,0.22691,0.26085,1,1
4,GO EPIDERMIS DEVELOPMENT,2.8001e-06,0.22655,0.21543,1,1
4,GO CELL CHEMOTAXIS,2.913e-06,0.22649,0.21347,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.4861e-06,0.22647,0.2508,1,1
4,GO MEMBRANE DEPOLARIZATION,8.1361e-07,0.22622,0.25933,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,2.0429e-07,0.22592,0.21674,1,1
4,GO SKIN DEVELOPMENT,5.5412e-06,0.22587,0.21726,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,6.2169e-06,0.22586,0.22151,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00021511,0.22585,0.21801,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,1.0554e-07,0.22576,0.2494,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,1.4677e-08,0.22572,0.23543,1,1
4,GO CD40 SIGNALING PATHWAY,0.00082553,0.22555,0.16684,1,1
4,GO QUINONE METABOLIC PROCESS,0.00037835,0.2255,0.32011,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.5052e-06,0.22542,0.26468,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.000662,0.22533,0.23041,1,1
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00015838,0.22523,0.17197,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,1.3599e-06,0.22491,0.227,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00036686,0.22482,0.25042,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,4.2444e-07,0.22478,0.24601,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0041031,0.22465,0.20714,1,1
4,GO INTERFERON BETA PRODUCTION,7.0072e-05,0.22449,0.20694,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,8.4805e-07,0.2244,0.22391,1,1
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.0010865,0.22439,0.20944,1,1
4,GO STEROL TRANSPORT,6.8396e-06,0.2242,0.22735,1,1
4,GO RESPONSE TO CAFFEINE,0.00016361,0.22417,0.19936,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,9.086e-06,0.22405,0.18598,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0052854,0.22402,0.25055,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,9.7998e-07,0.22389,0.21341,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,1.8701e-05,0.22371,0.25386,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,4.7999e-05,0.22361,0.25973,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0088198,0.2235,0.1953,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00063314,0.22343,0.21974,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5164e-08,0.22331,0.26137,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,5.8049e-05,0.22326,0.21319,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0046018,0.2231,0.14929,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,2.2015e-05,0.22308,0.21217,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00034485,0.22301,0.17926,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0013443,0.223,0.42179,1,1
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0046018,0.22298,0.25746,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,3.3435e-06,0.22284,0.20245,1,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0077327,0.22278,0.17624,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,5.8049e-05,0.22277,0.21018,1,1
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.01251,0.2227,0.1798,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,7.3739e-05,0.2227,0.17777,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00012594,0.22261,0.27078,1,1
4,GO LIPID OXIDATION,9.086e-06,0.22248,0.19131,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.2416e-05,0.22234,0.2115,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,4.5233e-07,0.22226,0.23273,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.8716e-08,0.22224,0.22017,1,1
4,GO PIGMENT ACCUMULATION,0.018693,0.22218,0.15068,1,1
4,GO SECRETION BY TISSUE,0.00014362,0.22207,0.20394,1,1
4,GO MONOCYTE CHEMOTAXIS,0.00029052,0.22187,0.19147,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.1456e-06,0.22182,0.1914,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0001179,0.22166,0.24052,1,1
4,GO REGULATION OF ACTION POTENTIAL,4.0314e-05,0.22166,0.23588,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,2.8305e-05,0.22163,0.24046,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0137,0.22124,0.17504,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,9.6129e-06,0.22122,0.26228,1,1
4,GO DOPAMINE METABOLIC PROCESS,2.2015e-05,0.22113,0.25903,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,2.342e-06,0.22109,0.20858,1,1
4,GO CELL CELL ADHESION,3.8924e-05,0.22109,0.18055,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.0478e-05,0.22095,0.19517,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,3.3806e-05,0.22085,0.23278,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0001803,0.22081,0.21656,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.734e-06,0.22067,0.2626,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,7.8124e-06,0.22061,0.22241,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,1.9044e-05,0.22057,0.18691,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,6.2169e-06,0.22047,0.31875,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.6761e-05,0.22043,0.25597,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,1.0756e-05,0.22042,0.22708,1,1
4,GO COMPLEMENT ACTIVATION,0.001704,0.22026,0.23548,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7452e-06,0.22017,0.21316,1,1
4,GO LIPID EXPORT FROM CELL,2.9332e-05,0.22004,0.23251,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00010323,0.21995,0.2605,1,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,9.1829e-05,0.21989,0.21883,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,7.105e-06,0.21975,0.22778,1,1
4,GO HORMONE METABOLIC PROCESS,8.4262e-06,0.21975,0.22347,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,6.8885e-07,0.21975,0.2136,1,1
4,GO REGULATION OF CELL ACTIVATION,2.6828e-05,0.21972,0.1751,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0055559,0.21963,0.22681,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.0005056,0.21955,0.19536,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,2.1624e-06,0.21952,0.27335,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0012705,0.21951,0.1826,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,8.4262e-06,0.21928,0.29093,1,1
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0028118,0.2192,0.20038,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.004964,0.21914,0.34394,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.00026858,0.21886,0.20285,1,1
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0098086,0.21865,0.205,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,1.2253e-05,0.21841,0.22082,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,3.758e-05,0.2183,0.18338,1,1
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.011022,0.21826,0.1418,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00020504,0.21816,0.2063,1,1
4,GO T CELL CYTOKINE PRODUCTION,0.00029052,0.21786,0.19593,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,3.8347e-06,0.21783,0.2228,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.00011218,0.21778,0.18723,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00017741,0.2172,0.27643,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,2.5884e-05,0.21704,0.26348,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.00041488,0.21684,0.15496,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,5.4184e-05,0.21679,0.19629,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00034485,0.21651,0.21898,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0001803,0.21649,0.19684,1,1
4,GO CARBOHYDRATE TRANSPORT,3.5606e-08,0.21646,0.21924,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.00014129,0.21636,0.1758,1,1
4,GO HEPARIN METABOLIC PROCESS,0.027118,0.21634,0.1417,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,1.5052e-06,0.21629,0.24377,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.0958e-05,0.21629,0.17875,1,1
4,GO ISOPRENOID METABOLIC PROCESS,2.5884e-05,0.21621,0.19505,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,3.628e-05,0.21614,0.18193,1,1
4,GO ACUTE PHASE RESPONSE,2.7804e-05,0.216,0.21923,1,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00040857,0.21586,0.22998,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.011949,0.21573,0.24502,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,5.6085e-05,0.2157,0.25941,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.01251,0.21549,0.19221,1,1
4,GO CHOLESTEROL STORAGE,0.00019229,0.21547,0.23266,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.5867e-06,0.21527,0.18908,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0081133,0.2152,0.14896,1,1
4,GO DRUG METABOLIC PROCESS,1.6158e-05,0.21518,0.25507,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,3.6567e-07,0.21491,0.24367,1,1
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0023957,0.2148,0.14672,1,1
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.00088789,0.2148,0.19773,1,1
4,GO REGULATION OF ANION TRANSPORT,1.3599e-06,0.21461,0.20483,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,1.4472e-05,0.21439,0.21198,1,1
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.020385,0.21426,0.15508,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0062877,0.21414,0.22155,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.9613e-05,0.2141,0.20303,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00082553,0.21392,0.25058,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,5.2303e-06,0.21375,0.21973,1,1
4,GO MACROPHAGE PROLIFERATION,0.0086125,0.21366,0.23125,1,1
4,GO TRANSCYTOSIS,0.00026858,0.21359,0.20031,1,1
4,GO REGULATION OF IMMUNE RESPONSE,1.1165e-05,0.2135,0.18545,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,3.357e-07,0.21341,0.21424,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0042095,0.21339,0.15571,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.0001803,0.21312,0.18278,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,4.1751e-05,0.2131,0.17367,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00073415,0.21294,0.18234,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0042636,0.21267,0.20136,1,1
4,GO RESPONSE TO METAL ION,1.1858e-08,0.21259,0.20681,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00046872,0.21248,0.17061,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00014599,0.21247,0.20561,1,1
4,GO GRANULOCYTE CHEMOTAXIS,3.8924e-05,0.21227,0.17718,1,1
4,GO LUNG EPITHELIUM DEVELOPMENT,2.8814e-05,0.21216,0.27428,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.2482e-05,0.21216,0.1914,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.758e-05,0.21206,0.18157,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.6877e-06,0.21189,0.21315,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00010852,0.2118,0.20334,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.8049e-05,0.2118,0.2036,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0010408,0.21159,0.18316,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0012705,0.21133,0.19507,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,9.6129e-06,0.2111,0.22983,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,8.1623e-05,0.21107,0.22408,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.0007786,0.21066,0.19649,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,3.628e-05,0.21048,0.16355,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0005618,0.21036,0.2464,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00026438,0.21032,0.21976,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.7804e-05,0.21028,0.25556,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,5.0563e-05,0.21023,0.16146,1,1
4,GO TISSUE HOMEOSTASIS,7.969e-07,0.20983,0.19628,1,1
4,GO RENAL SYSTEM PROCESS,2.6352e-05,0.20981,0.20763,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0005211,0.20979,0.17954,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001422,0.20964,0.18163,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00039018,0.20962,0.15444,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,7.8911e-05,0.20949,0.20094,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,2.2505e-06,0.20941,0.2058,1,1
4,GO CRANIAL NERVE DEVELOPMENT,0.0016347,0.20923,0.19208,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0007786,0.20907,0.17535,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.00099681,0.209,0.21253,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00017741,0.20899,0.21884,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.0032501,0.20897,0.15827,1,1
4,GO AMINE METABOLIC PROCESS,1.0527e-08,0.20897,0.20984,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0003557,0.20892,0.25509,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,3.2631e-05,0.20874,0.28593,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.001568,0.20871,0.21723,1,1
4,GO MEMBRANE FUSION,5.1351e-07,0.20856,0.20637,1,1
4,GO REGULATION OF DEFENSE RESPONSE,4.9228e-07,0.20851,0.20399,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,4.2271e-06,0.20847,0.21435,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,1.2328e-07,0.20847,0.22227,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.0056255,0.20844,0.1697,1,1
4,GO WOUND HEALING,0.0001179,0.20824,0.19236,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,5.7582e-06,0.2082,0.25228,1,1
4,GO CYTOLYSIS,0.020166,0.20794,0.16498,1,1
4,GO RESPONSE TO BACTERIUM,2.4861e-06,0.20794,0.20134,1,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0015463,0.20788,0.19974,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.3442e-05,0.20781,0.23383,1,1
4,GO RESPONSE TO INACTIVITY,0.0029645,0.20771,0.20942,1,1
4,GO ACTIVATED T CELL PROLIFERATION,6.8888e-05,0.2077,0.19794,1,1
4,GO ORGANELLE MEMBRANE FUSION,4.2271e-06,0.20764,0.199,1,1
4,GO COPPER ION TRANSPORT,0.00060545,0.20716,0.20995,1,1
4,GO ACTION POTENTIAL,3.4773e-06,0.207,0.20818,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.00013232,0.20692,0.18374,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,2.5424e-05,0.20666,0.21321,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.00018323,0.20656,0.22731,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0052197,0.20655,0.16923,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,8.0256e-05,0.20654,0.19189,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00016361,0.2064,0.23228,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,2.4861e-06,0.20625,0.28159,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.012227,0.20612,0.24506,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,7.5001e-05,0.20607,0.20229,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.6877e-06,0.20601,0.21001,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,9.2585e-06,0.20598,0.17958,1,1
4,GO MEMBRANE FISSION,0.002631,0.20573,0.17362,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0022095,0.20537,0.21615,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0020646,0.20536,0.1695,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0018006,0.20529,0.19893,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0096941,0.20527,0.15124,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.0712e-08,0.20526,0.21655,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.00074504,0.20521,0.22415,1,1
4,GO AMYLOID BETA FORMATION,0.00022927,0.205,0.21633,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,9.086e-06,0.20491,0.2654,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,9.2118e-07,0.20465,0.20897,1,1
4,GO HYALURONAN CATABOLIC PROCESS,0.047827,0.20464,0.13455,1,1
4,GO GAMMA DELTA T CELL ACTIVATION,0.0047198,0.20448,0.2091,1,1
4,GO PHAGOSOME MATURATION,5.8698e-06,0.20412,0.23089,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0021215,0.20412,0.20721,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.00039622,0.2041,0.1677,1,1
4,GO B CELL DIFFERENTIATION,2.3891e-06,0.204,0.19442,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,6.5906e-08,0.20389,0.20045,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.8573e-08,0.2037,0.20342,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00025617,0.20358,0.20733,1,1
4,GO REGULATION OF PEPTIDE SECRETION,2.4586e-08,0.20355,0.20386,1,1
4,GO VIRAL LIFE CYCLE,2.0478e-05,0.20342,0.18382,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,6.3359e-07,0.20328,0.22282,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0022396,0.20323,0.16521,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,1.8363e-05,0.20312,0.20853,1,1
4,GO PROTEIN AUTOPROCESSING,5.1304e-06,0.20286,0.23228,1,1
4,GO MUSCLE HYPERTROPHY,1.3878e-06,0.20284,0.22105,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00022565,0.20257,0.20234,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.7804e-05,0.20256,0.18941,1,1
4,GO RESPONSE TO CADMIUM ION,0.00076726,0.20248,0.19581,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.00017457,0.20221,0.19493,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.00027716,0.20221,0.19093,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,2.2286e-07,0.20218,0.19355,1,1
4,GO LIPID HOMEOSTASIS,3.6162e-06,0.20208,0.20817,1,1
4,GO CELLULAR RESPONSE TO STEROL,3.094e-05,0.202,0.23467,1,1
4,GO ENERGY HOMEOSTASIS,0.00018323,0.20185,0.21733,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.2057e-05,0.2018,0.2099,1,1
4,GO FIBRINOLYSIS,0.05357,0.20177,0.14987,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.00021511,0.20173,0.20944,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00044103,0.20169,0.1994,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0005618,0.20162,0.22472,1,1
4,GO LYMPHOCYTE ACTIVATION,4.2487e-05,0.20145,0.1599,1,1
4,GO REGULATION OF BLOOD PRESSURE,2.971e-06,0.20144,0.18784,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,9.4341e-06,0.20142,0.22281,1,1
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.001568,0.20127,0.24076,1,1
4,GO MUSCLE ADAPTATION,3.0302e-06,0.20091,0.21201,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.0048405,0.20086,0.14139,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0022701,0.20083,0.14234,1,1
4,GO GRANULOCYTE MIGRATION,9.9803e-06,0.20083,0.2016,1,1
4,GO GLOMERULUS DEVELOPMENT,0.0014624,0.20057,0.22023,1,1
4,GO EXOCYTOSIS,2.3784e-07,0.20049,0.20918,1,1
4,GO TISSUE MIGRATION,0.00029976,0.20043,0.18323,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.020385,0.20042,0.18323,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.1588e-05,0.20031,0.19641,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0099244,0.20005,0.2284,1,1
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0034692,0.19987,0.16215,1,1
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,3.9102e-06,0.19975,0.21147,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.6761e-05,0.19972,0.16744,1,1
4,GO POSITIVE REGULATION OF SECRETION,5.7536e-08,0.19971,0.20124,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.003654,0.19959,0.15635,1,1
4,GO RESPONSE TO NUTRIENT,4.6359e-05,0.19956,0.18282,1,1
4,GO METHIONINE METABOLIC PROCESS,0.00018323,0.19955,0.18883,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00020504,0.19944,0.21999,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0012886,0.19939,0.19216,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.2534e-06,0.19936,0.2022,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,6.7411e-08,0.19934,0.20799,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0005056,0.1993,0.2164,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.0314e-05,0.19921,0.18504,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.019523,0.19917,0.15869,1,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.012087,0.19885,0.14075,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00087508,0.1988,0.18656,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00040857,0.19877,0.16869,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,4.5822e-08,0.19867,0.23663,1,1
4,GO FATTY ACID CATABOLIC PROCESS,8.9166e-06,0.19861,0.19993,1,1
4,GO LYMPHOCYTE MIGRATION,2.2416e-05,0.19843,0.18434,1,1
4,GO NADP METABOLIC PROCESS,0.0011341,0.19826,0.2001,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.0020367,0.19804,0.27704,1,1
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.00082553,0.19803,0.28765,1,1
4,GO BONE CELL DEVELOPMENT,0.044722,0.19803,0.12612,1,1
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0015038,0.1978,0.16681,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0001862,0.19773,0.21228,1,1
4,GO PARAXIAL MESODERM DEVELOPMENT,0.0081133,0.19757,0.16617,1,1
4,GO PROTEIN PROCESSING,1.8318e-07,0.1975,0.22775,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0066851,0.1975,0.29555,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.8262e-08,0.19746,0.19778,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0086125,0.19732,0.13408,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,1.0958e-05,0.19729,0.16689,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.00023294,0.19726,0.17015,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00011986,0.19716,0.17154,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,6.5837e-06,0.19715,0.17342,1,1
4,GO BIOMINERALIZATION,0.00012594,0.19715,0.18833,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00025617,0.19706,0.1971,1,1
4,GO PROTEIN ADP RIBOSYLATION,0.00059648,0.19706,0.17196,1,1
4,GO RESPONSE TO PH,3.2057e-05,0.19691,0.21611,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.00075607,0.19672,0.19917,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,1.2281e-06,0.19668,0.21294,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00099681,0.19645,0.22136,1,1
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00091404,0.19643,0.26415,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.9749e-05,0.19638,0.21464,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.0010865,0.19637,0.27417,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0011021,0.19637,0.2026,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00044103,0.19627,0.14092,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0050269,0.19625,0.17796,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,3.0905e-06,0.19603,0.22675,1,1
4,GO VACUOLAR ACIDIFICATION,6.7105e-06,0.19597,0.23316,1,1
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0031247,0.19596,0.24664,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,2.8814e-05,0.19595,0.2354,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0003557,0.19591,0.18909,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.1446e-05,0.19591,0.19163,1,1
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.012087,0.19589,0.18303,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0054872,0.19586,0.17169,1,1
4,GO REGULATION OF ISOTYPE SWITCHING,0.00019229,0.19586,0.19987,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,7.9617e-06,0.19581,0.18361,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00046872,0.19567,0.20074,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,6.7724e-05,0.19566,0.19231,1,1
4,GO CARNITINE METABOLIC PROCESS,0.006444,0.1956,0.16625,1,1
4,GO RESPONSE TO WOUNDING,0.00020178,0.19553,0.18018,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,2.2416e-05,0.19551,0.17048,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.000662,0.19533,0.20023,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.8698e-06,0.19527,0.22819,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.3066e-07,0.19516,0.19421,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.2686e-06,0.19513,0.18563,1,1
4,GO SODIUM ION HOMEOSTASIS,1.7071e-05,0.19512,0.18619,1,1
4,GO PANCREATIC JUICE SECRETION,0.0099244,0.19501,0.14973,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.5934e-07,0.19486,0.2019,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.6828e-05,0.19481,0.18292,1,1
4,GO VESICLE TARGETING,5.2344e-05,0.19467,0.18076,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0027747,0.1946,0.18119,1,1
4,GO INTERACTION WITH HOST,2.0853e-05,0.19459,0.1991,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.004156,0.19452,0.1707,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.2534e-06,0.19446,0.20944,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.5999e-07,0.19443,0.18207,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00037835,0.19427,0.19102,1,1
4,GO PROSTAGLANDIN SECRETION,0.0010259,0.19411,0.18021,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,2.4837e-07,0.19409,0.18638,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00043435,0.19391,0.16081,1,1
4,GO MACROPHAGE DIFFERENTIATION,0.0015463,0.19391,0.17146,1,1
4,GO STEROID CATABOLIC PROCESS,0.0002117,0.19355,0.28563,1,1
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0016347,0.19346,0.17675,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00040235,0.19333,0.20789,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00070238,0.19328,0.17729,1,1
4,GO MACROPHAGE ACTIVATION,1.2716e-05,0.19323,0.22791,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.00040857,0.19302,0.20415,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00039622,0.19299,0.19774,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00026024,0.19288,0.18037,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0016347,0.19282,0.19121,1,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.01585,0.19277,0.1422,1,1
4,GO BIOLOGICAL ADHESION,0.00034485,0.1927,0.15941,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0005056,0.19255,0.17644,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.00043435,0.19247,0.23632,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0038977,0.1923,0.13467,1,1
4,GO DEVELOPMENTAL INDUCTION,0.00065224,0.19203,0.17215,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.4091e-05,0.19188,0.2732,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.00045468,0.19174,0.20737,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.0007901,0.19171,0.15213,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,7.8124e-06,0.19167,0.27897,1,1
4,GO RESPONSE TO MUSCLE ACTIVITY,0.020385,0.1916,0.1515,1,1
4,GO RESPONSE TO INSULIN,2.206e-06,0.19153,0.17381,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00023667,0.1915,0.19225,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,7.6283e-05,0.19146,0.22564,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,8.4805e-07,0.19145,0.24643,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,9.404e-07,0.19143,0.26609,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,4.3997e-05,0.19135,0.19624,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001704,0.19122,0.17151,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,8.6328e-08,0.19117,0.19272,1,1
4,GO REGULATION OF LIPID TRANSPORT,1.9749e-05,0.1911,0.19462,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0050904,0.19107,0.14404,1,1
4,GO GLIAL CELL PROLIFERATION,0.00090088,0.19101,0.1809,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00052901,0.19096,0.24165,1,1
4,GO PEROXISOMAL TRANSPORT,2.7312e-05,0.19095,0.18221,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,4.31e-06,0.19093,0.20615,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.5052e-06,0.19089,0.25837,1,1
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014624,0.19089,0.24151,1,1
4,GO SPERM CAPACITATION,2.3239e-05,0.19089,0.23573,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00098255,0.1908,0.15609,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.0001862,0.19076,0.17445,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00029052,0.19075,0.23481,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.0235e-07,0.19072,0.19596,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,4.3946e-06,0.1907,0.24953,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00037257,0.19066,0.189,1,1
4,GO MULTICELLULAR ORGANISM AGING,5.0563e-05,0.19066,0.17986,1,1
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.013546,0.19062,0.11787,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.014658,0.19055,0.17996,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,7.6283e-05,0.19044,0.19779,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,2.8001e-06,0.1903,0.18741,1,1
4,GO PROTEIN DESTABILIZATION,3.5461e-06,0.19027,0.18752,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.7721e-08,0.19016,0.20587,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,9.9803e-06,0.19014,0.2074,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00013232,0.19014,0.22264,1,1
4,GO DETOXIFICATION,0.0029256,0.19011,0.14821,1,1
4,GO DETECTION OF STIMULUS,8.0712e-08,0.18981,0.16633,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.001442,0.1898,0.17049,1,1
4,GO REGULATION OF BODY FLUID LEVELS,1.4207e-05,0.18955,0.18654,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,5.9056e-05,0.18941,0.28815,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,2.8305e-05,0.18924,0.17515,1,1
4,GO PLACENTA DEVELOPMENT,0.0010865,0.18909,0.15491,1,1
4,GO NEUTROPHIL MIGRATION,1.7706e-05,0.18889,0.18141,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,7.7586e-05,0.18889,0.20724,1,1
4,GO REGULATION OF HORMONE LEVELS,1.2328e-07,0.18887,0.19761,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,5.9834e-06,0.18883,0.19486,1,1
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,8.3013e-05,0.1888,0.21007,1,1
4,GO LIPID DROPLET ORGANIZATION,1.0958e-05,0.18865,0.23078,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,1.0169e-05,0.1886,0.17255,1,1
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00058763,0.1885,0.19782,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0028872,0.18842,0.17173,1,1
4,GO SECONDARY PALATE DEVELOPMENT,0.0065235,0.18842,0.17026,1,1
4,GO LIPID CATABOLIC PROCESS,1.3878e-06,0.18838,0.20055,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.8198e-07,0.18831,0.1908,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.00019229,0.18822,0.19795,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.00064263,0.18812,0.16406,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.0879e-07,0.18804,0.19776,1,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0044864,0.18792,0.15874,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0023637,0.18789,0.18161,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,1.6457e-05,0.18782,0.19227,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.0023321,0.18778,0.14187,1,1
4,GO BICARBONATE TRANSPORT,2.6352e-05,0.18755,0.22416,1,1
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0041031,0.18738,0.1307,1,1
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.013394,0.18726,0.22016,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.00039622,0.18725,0.14643,1,1
4,GO SENSORY PERCEPTION OF TASTE,7.6657e-06,0.18718,0.17738,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00011033,0.18717,0.21671,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,3.2631e-05,0.18701,0.2184,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00018923,0.18691,0.20363,1,1
4,GO CELL CELL RECOGNITION,0.00011596,0.18684,0.16336,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,1.0361e-05,0.18683,0.20777,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0023957,0.18681,0.17295,1,1
4,GO ENDOCRINE HORMONE SECRETION,1.0169e-05,0.18667,0.20878,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.00062378,0.18665,0.14754,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,2.4972e-05,0.18662,0.15975,1,1
4,GO ER OVERLOAD RESPONSE,0.00023294,0.18659,0.22514,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.1588e-05,0.18656,0.19322,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00033955,0.18652,0.17238,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,1.3196e-05,0.18618,0.19535,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.00037257,0.18618,0.20128,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00014129,0.18613,0.18421,1,1
4,GO ORGANIC ANION TRANSPORT,1.3174e-07,0.18566,0.18803,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0013633,0.18565,0.23904,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00076726,0.18563,0.16267,1,1
4,GO GLUCOSE METABOLIC PROCESS,5.3747e-08,0.1856,0.20977,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0084096,0.18549,0.15097,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,1.1375e-05,0.18546,0.19838,1,1
4,GO COAGULATION,8.7316e-05,0.18542,0.18462,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.1234e-05,0.18535,0.17969,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.00042777,0.18525,0.22017,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,9.795e-06,0.18523,0.19451,1,1
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0034243,0.18515,0.14646,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00040235,0.18513,0.1762,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0032928,0.1851,0.25743,1,1
4,GO TRANSFERRIN TRANSPORT,6.7461e-07,0.18509,0.22388,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.00075607,0.18501,0.1557,1,1
4,GO I KAPPAB PHOSPHORYLATION,0.0098086,0.18495,0.13427,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,2.971e-06,0.18487,0.18032,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00033955,0.18468,0.16506,1,1
4,GO ADAPTIVE THERMOGENESIS,4.1815e-08,0.18465,0.20124,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,3.0395e-05,0.1846,0.17577,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.00011406,0.18451,0.20222,1,1
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.00040857,0.18443,0.1564,1,1
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0021798,0.18432,0.19401,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00017457,0.18421,0.17796,1,1
4,GO TERPENOID METABOLIC PROCESS,0.00017176,0.18409,0.18436,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.00048316,0.18396,0.19274,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.003166,0.18385,0.16568,1,1
4,GO RETINOL METABOLIC PROCESS,0.0003557,0.18374,0.25058,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,5.9056e-05,0.18354,0.23207,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00019541,0.18344,0.17259,1,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0020646,0.18336,0.18295,1,1
4,GO RESPONSE TO ANGIOTENSIN,0.0020646,0.18326,0.19196,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,4.5558e-05,0.18317,0.21243,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,3.5646e-05,0.183,0.20813,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,3.357e-07,0.18293,0.22147,1,1
4,GO HYALURONAN METABOLIC PROCESS,0.00064263,0.18281,0.16251,1,1
4,GO RESPONSE TO STEROL,0.00013451,0.18267,0.19909,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0019285,0.18265,0.1423,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,8.1138e-06,0.18244,0.21281,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.1338e-07,0.18238,0.23346,1,1
4,GO RESPONSE TO FUNGUS,1.9749e-05,0.18221,0.17816,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0083098,0.18202,0.15557,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.03006,0.18187,0.098089,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0087156,0.18185,0.19133,1,1
4,GO PHAGOCYTOSIS,0.00055343,0.18179,0.16397,1,1
4,GO AMINO ACID IMPORT,0.0038977,0.1817,0.14911,1,1
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0028118,0.18169,0.14995,1,1
4,GO RESPONSE TO CALCIUM ION,7.105e-06,0.18158,0.18752,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00011596,0.18145,0.19375,1,1
4,GO RENAL TUBULE DEVELOPMENT,0.0011836,0.1812,0.15798,1,1
4,GO MYELIN ASSEMBLY,0.00044781,0.18102,0.23534,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,3.8924e-05,0.181,0.14889,1,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0047798,0.18096,0.19246,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.017894,0.18089,0.15074,1,1
4,GO SECRETION,1.1535e-07,0.18076,0.18636,1,1
4,GO CHEMICAL HOMEOSTASIS,1.8723e-07,0.18061,0.16783,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00055343,0.1806,0.16625,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,3.3806e-05,0.18033,0.21495,1,1
4,GO PIGMENTATION,6.4341e-05,0.18022,0.15043,1,1
4,GO LEUKOCYTE DIFFERENTIATION,2.0853e-05,0.17998,0.16484,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00029511,0.17997,0.1889,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.000662,0.17995,0.20694,1,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0011341,0.17994,0.16007,1,1
4,GO INOSITOL METABOLIC PROCESS,0.00065224,0.17992,0.19401,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00034485,0.17968,0.18849,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00091404,0.17962,0.20208,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,3.2146e-06,0.17953,0.20271,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.2886e-07,0.17945,0.20926,1,1
4,GO REGULATION OF T CELL MIGRATION,0.00019857,0.17942,0.19121,1,1
4,GO CELL MATRIX ADHESION,0.00073415,0.1794,0.17963,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00020835,0.17922,0.1619,1,1
4,GO MUSCLE CELL MIGRATION,0.00027716,0.17919,0.2057,1,1
4,GO POSITIVE CHEMOTAXIS,8.4424e-05,0.17899,0.19425,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.3249e-05,0.17884,0.17267,1,1
4,GO ANION TRANSPORT,2.0429e-07,0.17876,0.17394,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.4091e-05,0.17866,0.1944,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,1.1806e-05,0.17866,0.17874,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,5.4701e-07,0.17863,0.1832,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00068191,0.17861,0.18393,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.00088789,0.17823,0.16021,1,1
4,GO REGULATION OF PROTEOLYSIS,7.3803e-06,0.17815,0.16833,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.000286,0.17772,0.169,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,3.9872e-06,0.17769,0.20668,1,1
4,GO XENOBIOTIC TRANSPORT,0.00033955,0.17766,0.20491,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.012227,0.17747,0.1747,1,1
4,GO ENDOCYTIC RECYCLING,0.00013451,0.17744,0.16577,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.00011033,0.17718,0.16492,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0001179,0.17713,0.19949,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00021511,0.17697,0.21252,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00013673,0.17688,0.18182,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00014839,0.17686,0.15647,1,1
4,GO CAMP METABOLIC PROCESS,0.0045438,0.17679,0.16864,1,1
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.0025277,0.17676,0.24738,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0007786,0.17672,0.20822,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.9749e-05,0.17668,0.15991,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00047589,0.17666,0.16867,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,6.8885e-07,0.1766,0.21265,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.0478e-05,0.17659,0.15646,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.00033432,0.17655,0.20498,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.00031414,0.1765,0.18408,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.001955,0.17649,0.15009,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.000662,0.17632,0.17683,1,1
4,GO PROTEIN ACTIVATION CASCADE,0.036772,0.17623,0.14398,1,1
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0018508,0.17617,0.18005,1,1
4,GO LIPID METABOLIC PROCESS,2.9514e-07,0.1761,0.18405,1,1
4,GO GLAND DEVELOPMENT,0.00011986,0.17608,0.15224,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,2.4972e-05,0.17606,0.20185,1,1
4,GO BONE MINERALIZATION,0.00080175,0.17589,0.1779,1,1
4,GO GLIAL CELL DEVELOPMENT,0.00018923,0.17588,0.18348,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00044103,0.17567,0.16198,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,8.5867e-06,0.17548,0.22152,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.7693e-06,0.17545,0.1972,1,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022396,0.17538,0.15699,1,1
4,GO SKELETAL MUSCLE ADAPTATION,0.0015249,0.17529,0.18487,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.00026438,0.17528,0.17085,1,1
4,GO VITAMIN TRANSPORT,0.00037257,0.17517,0.18231,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0016575,0.17511,0.16352,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001776,0.17504,0.21205,1,1
4,GO ENAMEL MINERALIZATION,0.027401,0.17496,0.18747,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,2.8305e-05,0.17491,0.2054,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00069207,0.17483,0.18972,1,1
4,GO TUMOR NECROSIS FACTOR SECRETION,0.0014022,0.17473,0.13812,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,9.4959e-05,0.17426,0.16564,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0010408,0.17407,0.20728,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00017176,0.17407,0.19613,1,1
4,GO T CELL APOPTOTIC PROCESS,0.0025617,0.17398,0.14895,1,1
4,GO VESICLE ORGANIZATION,7.2414e-06,0.17392,0.16855,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,2.6352e-05,0.1737,0.18107,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,3.3214e-05,0.17368,0.21011,1,1
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0092477,0.17364,0.24119,1,1
4,GO GANGLIOSIDE METABOLIC PROCESS,0.019312,0.17355,0.13192,1,1
4,GO OUTER DYNEIN ARM ASSEMBLY,0.021509,0.17346,0.12664,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0361e-05,0.17346,0.22057,1,1
4,GO REGULATION OF LIPID LOCALIZATION,3.4409e-05,0.17339,0.17755,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0073682,0.17328,0.18435,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,3.094e-05,0.17321,0.17734,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.5293e-05,0.1731,0.1731,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.003654,0.17303,0.15748,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00019229,0.17279,0.20647,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.1446e-05,0.17274,0.17066,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.000662,0.17272,0.14015,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00011986,0.17261,0.15933,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,2.9859e-05,0.17258,0.17059,1,1
4,GO INTERLEUKIN 17 PRODUCTION,0.012227,0.17241,0.15257,1,1
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.0027381,0.1724,0.14174,1,1
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00098255,0.17239,0.17603,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00041488,0.17233,0.17444,1,1
4,GO DENDRITIC CELL MIGRATION,0.01128,0.17222,0.13132,1,1
4,GO RESPONSE TO INTERLEUKIN 1,4.0314e-05,0.17205,0.14877,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,4.719e-07,0.17198,0.19207,1,1
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0048405,0.17189,0.13396,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,2.5359e-06,0.17188,0.18675,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00064263,0.17162,0.18162,1,1
4,GO NEPHRON DEVELOPMENT,0.0050269,0.17161,0.14202,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.8305e-05,0.17154,0.20383,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,5.1446e-05,0.17143,0.16278,1,1
4,GO EATING BEHAVIOR,7.1274e-05,0.17141,0.17783,1,1
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0030038,0.17128,0.2186,1,1
4,GO LYSOSOME LOCALIZATION,0.00011218,0.17116,0.17218,1,1
4,GO FATTY ACID METABOLIC PROCESS,9.2118e-07,0.1711,0.20523,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.00017457,0.17108,0.14497,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.00016901,0.17094,0.14933,1,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,9.9844e-05,0.17069,0.19163,1,1
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.013546,0.17054,0.11095,1,1
4,GO ALCOHOL METABOLIC PROCESS,2.7452e-06,0.17052,0.19275,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.00032408,0.17049,0.21939,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0049019,0.17018,0.21675,1,1
4,GO REGULATION OF LIPID STORAGE,0.00013673,0.17017,0.17573,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,4.8416e-06,0.17016,0.19835,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.3196e-05,0.17015,0.16517,1,1
4,GO RESPONSE TO PROGESTERONE,0.00017741,0.17008,0.2058,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0011341,0.16998,0.1505,1,1
4,GO REGULATION OF OSSIFICATION,0.00059648,0.16994,0.17339,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.9332e-05,0.16994,0.20333,1,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.0015249,0.16987,0.26927,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.008211,0.16976,0.1591,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00040857,0.16974,0.13822,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,6.9711e-06,0.16972,0.17257,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,7.1819e-07,0.16937,0.22071,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,5.4356e-06,0.16931,0.20872,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,1.1086e-06,0.16926,0.19292,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,9.795e-06,0.16923,0.20135,1,1
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0037016,0.16922,0.16227,1,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0056958,0.16908,0.1628,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.027973,0.16907,0.16259,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00053704,0.16904,0.17676,1,1
4,GO LOCOMOTOR RHYTHM,0.0037985,0.16885,0.17607,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,1.7071e-05,0.1688,0.18683,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.00011986,0.16877,0.17428,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0018764,0.16872,0.19257,1,1
4,GO NEURON MATURATION,0.002702,0.16868,0.16768,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00029511,0.16859,0.15661,1,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.014823,0.1685,0.11295,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.001235,0.16849,0.14539,1,1
4,GO FIBROBLAST PROLIFERATION,0.00068191,0.16834,0.19388,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7804e-05,0.168,0.19516,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0051547,0.16786,0.15133,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.5424e-05,0.16785,0.18686,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0020092,0.16763,0.18502,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00021857,0.16757,0.16526,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,1.2058e-07,0.16747,0.1736,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00159,0.16743,0.19524,1,1
4,GO AMINE TRANSPORT,9.1829e-05,0.16742,0.2357,1,1
4,GO INSULIN SECRETION,4.4807e-06,0.16739,0.18602,1,1
4,GO FATTY ACYL COA METABOLIC PROCESS,4.3236e-05,0.16739,0.22109,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00042128,0.16738,0.19287,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00021857,0.16719,0.14588,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0002443,0.16701,0.1458,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00048316,0.16698,0.16595,1,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00025215,0.16689,0.17609,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,8.7316e-05,0.16669,0.16634,1,1
4,GO RESPONSE TO DSRNA,0.0002117,0.16632,0.15402,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0012527,0.16632,0.14298,1,1
4,GO REGULATION OF HORMONE SECRETION,5.5412e-06,0.16611,0.17374,1,1
4,GO PROTEIN KINASE B SIGNALING,0.00026438,0.1659,0.15296,1,1
4,GO CELLULAR RESPONSE TO STARVATION,4.5233e-07,0.16581,0.18675,1,1
4,GO RESPONSE TO AMPHETAMINE,0.0031247,0.1658,0.18231,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.00011596,0.1658,0.15864,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.047827,0.16574,0.12798,1,1
4,GO TEMPERATURE HOMEOSTASIS,1.1789e-06,0.16569,0.17942,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,5.2445e-07,0.16564,0.17404,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.00057029,0.16557,0.19122,1,1
4,GO MONOAMINE TRANSPORT,0.00037835,0.16555,0.23504,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0023637,0.16535,0.15155,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,4.3236e-05,0.1653,0.22173,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.00091404,0.16529,0.15842,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.026013,0.16521,0.16186,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,3.2631e-05,0.16519,0.15227,1,1
4,GO MESONEPHROS DEVELOPMENT,0.00057029,0.16519,0.16885,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,1.7071e-05,0.16518,0.17546,1,1
4,GO T CELL DIFFERENTIATION,5.6085e-05,0.16508,0.15587,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00017176,0.16503,0.14988,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,6.0991e-06,0.16491,0.20016,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.023173,0.16479,0.1419,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,1.7071e-05,0.16455,0.20073,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.0050269,0.16454,0.18349,1,1
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0037985,0.16443,0.2328,1,1
4,GO REGULATION OF CELLULAR PH,1.4076e-07,0.16428,0.19018,1,1
4,GO RESPONSE TO IRON ION,7.6283e-05,0.16422,0.20752,1,1
4,GO DNA DEMETHYLATION,0.023919,0.16411,0.11869,1,1
4,GO NOTCH SIGNALING PATHWAY,8.1138e-06,0.1641,0.1925,1,1
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.036048,0.16398,0.13988,1,1
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.027401,0.16391,0.12687,1,1
4,GO PROTEIN MANNOSYLATION,0.00014839,0.16389,0.1945,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.004964,0.16383,0.19673,1,1
4,GO CIRCULATORY SYSTEM PROCESS,5.8698e-06,0.16361,0.16384,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,1.5037e-07,0.16359,0.19343,1,1
4,GO EPITHELIUM DEVELOPMENT,4.5558e-05,0.16356,0.1546,1,1
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0040509,0.16346,0.13272,1,1
4,GO MANGANESE ION TRANSPORT,0.00043435,0.16331,0.16666,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.00040857,0.16321,0.19248,1,1
4,GO ION HOMEOSTASIS,2.3891e-06,0.16305,0.14776,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,2.5884e-05,0.16294,0.20952,1,1
4,GO DRUG CATABOLIC PROCESS,0.00060545,0.16293,0.20203,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,5.5127e-05,0.16285,0.19497,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.00039622,0.16273,0.17616,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,1.7071e-05,0.16261,0.13763,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.00014362,0.1625,0.1437,1,1
4,GO PEROXISOME ORGANIZATION,5.3256e-05,0.1625,0.16991,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.002702,0.16236,0.14716,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00035024,0.16222,0.18748,1,1
4,GO RIG I SIGNALING PATHWAY,0.0013069,0.16218,0.14204,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0099244,0.16215,0.16464,1,1
4,GO REGULATION OF SECRETION,4.719e-07,0.16204,0.17057,1,1
4,GO REGULATION OF TUBE SIZE,1.3693e-05,0.16202,0.17177,1,1
4,GO NEUROINFLAMMATORY RESPONSE,0.00036686,0.16178,0.16619,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.001704,0.16178,0.14846,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0062108,0.16172,0.13648,1,1
4,GO METAL ION HOMEOSTASIS,5.8698e-06,0.16169,0.14276,1,1
4,GO RESPONSE TO AMINE,0.0095807,0.16169,0.12232,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,6.2169e-06,0.16162,0.16136,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00075607,0.16156,0.14059,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,1.1165e-05,0.16139,0.17837,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.064418,0.16127,0.11865,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,2.0879e-07,0.16088,0.18125,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,4.3997e-05,0.16071,0.17942,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0023637,0.16063,0.14904,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0015038,0.16061,0.15967,1,1
4,GO ION TRANSPORT,9.404e-07,0.16057,0.15435,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.016027,0.1605,0.14204,1,1
4,GO GLIAL CELL ACTIVATION,0.00091404,0.16007,0.17623,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.0016806,0.16,0.15979,1,1
4,GO REGULATION OF PH,5.2538e-08,0.15978,0.19225,1,1
4,GO INNERVATION,0.062684,0.15956,0.19859,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,3.9613e-05,0.15925,0.16734,1,1
4,GO LUNG MORPHOGENESIS,0.0075485,0.15912,0.15046,1,1
4,GO FATTY ACID BETA OXIDATION,0.00081356,0.15909,0.15216,1,1
4,GO GOLGI VESICLE BUDDING,1.7385e-05,0.15887,0.17595,1,1
4,GO REGULATION OF BIOMINERALIZATION,0.0067673,0.15882,0.14284,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0078263,0.15866,0.1574,1,1
4,GO MEMBRANE REPOLARIZATION,0.0007901,0.15862,0.19071,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,3.9613e-05,0.15852,0.15329,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00075607,0.1585,0.17714,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0010259,0.15842,0.13441,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.01829,0.15838,0.12175,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.001955,0.15837,0.12872,1,1
4,GO LIPID MODIFICATION,1.9749e-05,0.15836,0.15407,1,1
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0072795,0.15831,0.17002,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,3.3214e-05,0.1583,0.1633,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0010865,0.1583,0.16711,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,8.8796e-05,0.15829,0.14178,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00012594,0.15822,0.19598,1,1
4,GO PEPTIDE HORMONE SECRETION,2.4528e-05,0.15805,0.17383,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,9.795e-06,0.15804,0.17546,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,3.8347e-06,0.15782,0.16206,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.6386e-06,0.15779,0.15924,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,3.8246e-05,0.15777,0.19222,1,1
4,GO RESPONSE TO STARVATION,1.2792e-06,0.15774,0.17673,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,9.3381e-05,0.15771,0.13844,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.0025617,0.15767,0.15247,1,1
4,GO REGULATION OF BLOOD CIRCULATION,1.6158e-05,0.15766,0.173,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,8.8796e-05,0.15765,0.22145,1,1
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0024609,0.15758,0.15223,1,1
4,GO STRIATED MUSCLE ADAPTATION,5.9056e-05,0.15742,0.2092,1,1
4,GO PROTEIN MATURATION,1.1086e-06,0.15741,0.17899,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.00010673,0.1573,0.15855,1,1
4,GO FATTY ACID TRANSPORT,3.8924e-05,0.15725,0.17047,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,2.0776e-06,0.15722,0.157,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0013255,0.1572,0.15063,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.8262e-07,0.15718,0.17085,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,7.8911e-05,0.15716,0.14226,1,1
4,GO INCLUSION BODY ASSEMBLY,0.012945,0.15711,0.18447,1,1
4,GO THYMIC T CELL SELECTION,0.0020646,0.15706,0.12657,1,1
4,GO HORMONE TRANSPORT,1.1789e-06,0.15699,0.19018,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,3.6162e-06,0.15693,0.20066,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,5.5864e-07,0.1569,0.17097,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00016901,0.15688,0.14195,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0018006,0.15688,0.1938,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0037498,0.15678,0.13797,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0013633,0.15672,0.14815,1,1
4,GO ASTROCYTE ACTIVATION,0.010041,0.15664,0.16444,1,1
4,GO POSITIVE REGULATION OF SIGNALING,1.7071e-05,0.15662,0.13854,1,1
4,GO PH REDUCTION,3.9872e-06,0.15659,0.18932,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00030449,0.15639,0.14618,1,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0017277,0.15629,0.21597,1,1
4,GO RESPONSE TO ALCOHOL,0.000286,0.15628,0.13423,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.00019541,0.15624,0.15153,1,1
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0012886,0.15624,0.15467,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.5868e-06,0.15623,0.15842,1,1
4,GO ERK1 AND ERK2 CASCADE,0.0021798,0.15622,0.15947,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.054582,0.15594,0.11905,1,1
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.057711,0.15593,0.15687,1,1
4,GO ORGANELLE FUSION,1.6761e-05,0.15578,0.16127,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.001776,0.15566,0.15539,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,4.5684e-06,0.15558,0.19161,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,8.3066e-07,0.15554,0.17714,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.4296e-07,0.1554,0.1701,1,1
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00021857,0.15538,0.16926,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00040857,0.15535,0.17688,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00060545,0.15524,0.16768,1,1
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0030436,0.15521,0.12085,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.050154,0.15513,0.10273,1,1
4,GO POLYOL CATABOLIC PROCESS,0.001442,0.15502,0.14266,1,1
4,GO MAMMARY GLAND MORPHOGENESIS,0.0054872,0.15495,0.16833,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00020178,0.15489,0.14427,1,1
4,GO FAT CELL DIFFERENTIATION,6.3249e-05,0.15483,0.18411,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00017176,0.15461,0.16879,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0022095,0.1546,0.1802,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.0066039,0.1546,0.18175,1,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0013443,0.15459,0.16025,1,1
4,GO RESPONSE TO KETONE,0.00020504,0.15459,0.15366,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0012177,0.1542,0.14969,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0013255,0.15402,0.14488,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.7172e-05,0.154,0.15172,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0076401,0.15391,0.12086,1,1
4,GO REGULATION OF HEMOPOIESIS,9.819e-05,0.15378,0.14683,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.00046872,0.15351,0.1388,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,3.4098e-06,0.15342,0.15237,1,1
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0071918,0.15337,0.14364,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.00011596,0.15335,0.18232,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.01128,0.1533,0.1539,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00030928,0.15311,0.17367,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,3.7605e-06,0.15308,0.19272,1,1
4,GO OSTEOCLAST DIFFERENTIATION,0.0071918,0.15302,0.11727,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0013443,0.15298,0.13773,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,8.5858e-05,0.15287,0.14438,1,1
4,GO ERBB SIGNALING PATHWAY,0.0029645,0.15284,0.14187,1,1
4,GO GLAND MORPHOGENESIS,0.004156,0.15284,0.1848,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.00088789,0.15268,0.1369,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.00011218,0.15267,0.14831,1,1
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0059116,0.15266,0.17588,1,1
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0058389,0.15248,0.16387,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.4771e-05,0.15247,0.21569,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00019857,0.15232,0.15108,1,1
4,GO MIDGUT DEVELOPMENT,0.063836,0.15229,0.14969,1,1
4,GO INORGANIC ANION TRANSPORT,2.206e-06,0.15209,0.15556,1,1
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0012177,0.15199,0.12868,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00015331,0.15195,0.1867,1,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00053704,0.15179,0.20167,1,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0037498,0.15171,0.13406,1,1
4,GO VACUOLE ORGANIZATION,9.4407e-08,0.15163,0.20513,1,1
4,GO RESPONSE TO AMYLOID BETA,0.059331,0.15163,0.11056,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00024045,0.15158,0.1359,1,1
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.05357,0.15158,0.12328,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,2.8814e-05,0.15152,0.14879,1,1
4,GO REGULATION OF GLUCONEOGENESIS,3.0302e-06,0.15139,0.2124,1,1
4,GO RESPONSE TO LIPID,0.00010497,0.15131,0.14768,1,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.03429,0.15123,0.10949,1,1
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0005618,0.15116,0.14501,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,6.6578e-05,0.15101,0.16425,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.019735,0.15094,0.16045,1,1
4,GO POSITIVE THYMIC T CELL SELECTION,0.0047198,0.1509,0.16425,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00013451,0.15082,0.16889,1,1
4,GO PROTEOLYSIS,7.6657e-06,0.1508,0.14071,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0067673,0.15075,0.12853,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.1456e-06,0.15074,0.16266,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.038637,0.15059,0.1653,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0010113,0.15057,0.14835,1,1
4,GO RESPONSE TO CARBOHYDRATE,4.7999e-05,0.15055,0.14497,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00033432,0.15049,0.13278,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00058763,0.15048,0.19557,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0032078,0.15041,0.15669,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,3.8924e-05,0.15029,0.14903,1,1
4,GO GRANULOCYTE DIFFERENTIATION,0.043444,0.15027,0.12618,1,1
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.0037498,0.15019,0.13171,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.006444,0.15013,0.15805,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0018764,0.14993,0.18664,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0080166,0.1499,0.16283,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.00065224,0.14977,0.18336,1,1
4,GO NEGATIVE T CELL SELECTION,0.0032501,0.14971,0.15602,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,5.6085e-05,0.14969,0.166,1,1
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0090315,0.14962,0.13696,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0011021,0.14949,0.12836,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,3.0905e-06,0.1494,0.21265,1,1
4,GO MACROPHAGE MIGRATION,0.0021505,0.14934,0.14366,1,1
4,GO RESPONSE TO HORMONE,6.1119e-05,0.14917,0.14461,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,7.9617e-06,0.14909,0.14204,1,1
4,GO GLUCOSE IMPORT,0.00041488,0.14898,0.13734,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.00010323,0.1489,0.13996,1,1
4,GO COPII COATED VESICLE BUDDING,7.1274e-05,0.14883,0.16,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.8363e-05,0.14873,0.18396,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00010152,0.14865,0.20139,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00011596,0.14862,0.12533,1,1
4,GO CELL MOTILITY,0.00058763,0.14861,0.13693,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0001179,0.14856,0.17242,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.031953,0.14838,0.10275,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0050904,0.14837,0.14097,1,1
4,GO REGULATION OF CHEMOTAXIS,0.00015331,0.14833,0.15999,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0012005,0.14823,0.12039,1,1
4,GO ETHER BIOSYNTHETIC PROCESS,0.033608,0.14819,0.107,1,1
4,GO SULFUR COMPOUND TRANSPORT,5.2344e-05,0.14814,0.1796,1,1
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0023009,0.14812,0.18649,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00040235,0.14808,0.1543,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00011986,0.14793,0.14307,1,1
4,GO POTASSIUM ION HOMEOSTASIS,0.015159,0.14774,0.11537,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.00014839,0.14769,0.14839,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,8.1138e-06,0.14761,0.17347,1,1
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.017506,0.14761,0.12432,1,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.0062108,0.14741,0.18373,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,1.7693e-06,0.1473,0.16223,1,1
4,GO ENDOTHELIAL CELL PROLIFERATION,0.0013443,0.14729,0.1645,1,1
4,GO HOMEOSTATIC PROCESS,3.6162e-06,0.14727,0.13771,1,1
4,GO ZINC ION TRANSPORT,0.00087508,0.14725,0.15823,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.00024819,0.14725,0.1896,1,1
4,GO PRO B CELL DIFFERENTIATION,0.015329,0.14714,0.15706,1,1
4,GO SPLEEN DEVELOPMENT,0.0013443,0.14683,0.14425,1,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.00029511,0.14678,0.15733,1,1
4,GO CATECHOLAMINE SECRETION,0.00063314,0.14671,0.25825,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.1274e-05,0.1467,0.15977,1,1
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.001235,0.1465,0.14368,1,1
4,GO REGULATION OF INSULIN SECRETION,5.5127e-05,0.14645,0.1577,1,1
4,GO MYELOID CELL HOMEOSTASIS,0.00060545,0.14644,0.14662,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00065224,0.14634,0.16891,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00086244,0.14618,0.17188,1,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.006444,0.14613,0.12448,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0020367,0.14606,0.20009,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,8.5867e-06,0.14599,0.16429,1,1
4,GO CHLORIDE TRANSPORT,1.1375e-05,0.14598,0.15565,1,1
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0059116,0.14596,0.14103,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,7.1274e-05,0.14585,0.13542,1,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.032938,0.14585,0.18762,1,1
4,GO CELLULAR PIGMENTATION,0.00045468,0.14575,0.14881,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00035024,0.1457,0.14282,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00018323,0.14562,0.14356,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0019023,0.14543,0.17128,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,9.3381e-05,0.14536,0.14223,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001422,0.14535,0.14663,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,1.4207e-05,0.14534,0.14161,1,1
4,GO POSITIVE REGULATION OF OSSIFICATION,0.0025961,0.1452,0.1795,1,1
4,GO RESPONSE TO HYPEROXIA,0.049681,0.14514,0.11125,1,1
4,GO ERAD PATHWAY,0.00086244,0.14504,0.1268,1,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0044298,0.14501,0.13896,1,1
4,GO FATTY ACID HOMEOSTASIS,0.0070192,0.14485,0.20865,1,1
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0056958,0.14478,0.18458,1,1
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.032278,0.14474,0.15288,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,9.1829e-05,0.14464,0.14776,1,1
4,GO SERTOLI CELL DIFFERENTIATION,0.0099244,0.14454,0.18824,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.012798,0.14443,0.16455,1,1
4,GO KERATINOCYTE MIGRATION,0.00049802,0.14439,0.16381,1,1
4,GO CELLULAR ION HOMEOSTASIS,1.0756e-05,0.14436,0.1317,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00023294,0.14429,0.15637,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.0015249,0.14419,0.14722,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0022701,0.14417,0.18601,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,3.9872e-06,0.14398,0.15207,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0022095,0.14396,0.1527,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00067188,0.14379,0.17387,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.003607,0.1436,0.12913,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00037257,0.14358,0.14696,1,1
4,GO HEART PROCESS,4.5558e-05,0.14331,0.16181,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00017457,0.14325,0.16236,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.029754,0.14317,0.16098,1,1
4,GO REGULATION OF MAPK CASCADE,0.00016098,0.14305,0.15123,1,1
4,GO NOREPINEPHRINE TRANSPORT,0.032607,0.14302,0.14055,1,1
4,GO LYMPHOCYTE CHEMOTAXIS,0.0018508,0.14288,0.12512,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0005789,0.14286,0.16932,1,1
4,GO REGULATION OF RECEPTOR RECYCLING,0.0028492,0.14281,0.16324,1,1
4,GO RESPONSE TO VITAMIN,0.020385,0.1428,0.13431,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,3.1494e-05,0.14276,0.15999,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00058763,0.14255,0.1225,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,3.0905e-06,0.14246,0.16346,1,1
4,GO CELL JUNCTION ASSEMBLY,0.0016122,0.14242,0.13177,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.7502e-06,0.14229,0.17981,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0016347,0.14199,0.1208,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0045438,0.14197,0.1262,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,4.9694e-05,0.14186,0.15149,1,1
4,GO VACUOLAR TRANSPORT,0.00010323,0.14184,0.15326,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00025617,0.14184,0.12928,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,1.3442e-05,0.14181,0.14564,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,1.8363e-05,0.14167,0.16213,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.00031907,0.14164,0.15045,1,1
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0081133,0.14145,0.12774,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0012886,0.14129,0.13558,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.004964,0.14116,0.13113,1,1
4,GO CELL REDOX HOMEOSTASIS,0.00019541,0.14114,0.17572,1,1
4,GO RESPONSE TO TESTOSTERONE,0.00046165,0.14089,0.17756,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0012177,0.14084,0.18953,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,2.2015e-05,0.1408,0.14666,1,1
4,GO RESPONSE TO MONOSACCHARIDE,5.9056e-05,0.14072,0.14596,1,1
4,GO REGULATION OF APPETITE,0.02128,0.14071,0.087115,1,1
4,GO LYSOSOMAL TRANSPORT,0.00062378,0.1407,0.15657,1,1
4,GO CELLULAR RESPONSE TO IRON ION,0.02174,0.14061,0.12886,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,5.6085e-05,0.14059,0.1383,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.023919,0.14034,0.11738,1,1
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0030436,0.14024,0.17221,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00035024,0.14022,0.16513,1,1
4,GO REGULATION OF TRANSPORT,3.5022e-05,0.14012,0.12156,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,3.0395e-05,0.13994,0.12968,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.000286,0.13976,0.13011,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.001955,0.13966,0.16409,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00020178,0.13966,0.14866,1,1
4,GO IRON ION TRANSPORT,4.1456e-06,0.13963,0.18058,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.00033955,0.13957,0.12779,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0022095,0.13954,0.15003,1,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0018006,0.1393,0.12432,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0046604,0.13926,0.15099,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,3.5461e-06,0.13892,0.15765,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0018508,0.13873,0.13528,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0021505,0.13873,0.15536,1,1
4,GO RESPONSE TO DRUG,4.6359e-05,0.1387,0.15701,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.0025961,0.13858,0.12963,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,4.1552e-07,0.13857,0.15896,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00084997,0.13842,0.13486,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.057179,0.13834,0.12853,1,1
4,GO RESPONSE TO RETINOIC ACID,0.022928,0.13823,0.11044,1,1
4,GO KERATINOCYTE PROLIFERATION,0.0063654,0.13819,0.1617,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00063314,0.1381,0.18067,1,1
4,GO VIRION ASSEMBLY,0.00084997,0.13806,0.1157,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.00045468,0.13802,0.12741,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0034243,0.13795,0.14486,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,9.9803e-06,0.13791,0.13855,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00098255,0.1379,0.13714,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00068191,0.13778,0.12857,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0044298,0.13776,0.14679,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,2.9859e-05,0.13772,0.14681,1,1
4,GO SPERM EGG RECOGNITION,0.00046165,0.13756,0.12232,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.018898,0.13753,0.12906,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,3.094e-05,0.13738,0.14219,1,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00062378,0.13736,0.13627,1,1
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0030839,0.13735,0.15396,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.03429,0.1373,0.14169,1,1
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0054872,0.13727,0.12487,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.001568,0.1371,0.13036,1,1
4,GO ATP TRANSPORT,0.034984,0.13695,0.087462,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.014823,0.13691,0.13124,1,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0047798,0.13659,0.1302,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0084096,0.13654,0.1209,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,5.0323e-06,0.13653,0.17059,1,1
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.00069207,0.13647,0.2088,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,1.155e-06,0.13644,0.16526,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,4.3997e-05,0.13636,0.13934,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0092477,0.13624,0.16399,1,1
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0022701,0.13624,0.13918,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.034636,0.13622,0.089443,1,1
4,GO CATION TRANSPORT,1.1806e-05,0.13616,0.13688,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0053519,0.13613,0.13668,1,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.00087508,0.13609,0.17358,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,2.2416e-05,0.13604,0.17646,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0022095,0.13594,0.13694,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,7.1274e-05,0.13594,0.14032,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.010895,0.13591,0.14673,1,1
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00029976,0.1358,0.18663,1,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.031311,0.13576,0.14035,1,1
4,GO LIPID IMPORT INTO CELL,0.0062108,0.13571,0.16784,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.00073415,0.13556,0.13445,1,1
4,GO POSITIVE T CELL SELECTION,0.0027747,0.13553,0.13053,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00031414,0.13553,0.1599,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.7172e-05,0.1355,0.14144,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.00076726,0.13547,0.15121,1,1
4,GO MEMBRANE ORGANIZATION,5.7059e-05,0.13529,0.12743,1,1
4,GO CARDIAC MUSCLE CONTRACTION,0.00044103,0.13528,0.14696,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0090315,0.13526,0.15237,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0005618,0.13518,0.16778,1,1
4,GO MUSCLE CELL PROLIFERATION,0.007921,0.13514,0.11771,1,1
4,GO OSSIFICATION,0.0018764,0.1351,0.15159,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0001862,0.13509,0.14996,1,1
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.012087,0.13497,0.15163,1,1
4,GO REGULATION OF PROTEIN MATURATION,0.014494,0.13493,0.11462,1,1
4,GO ANION HOMEOSTASIS,0.0047798,0.13488,0.14189,1,1
4,GO RESPONSE TO PEPTIDE,8.1623e-05,0.13454,0.13456,1,1
4,GO T CELL SELECTION,0.00036686,0.13452,0.13744,1,1
4,GO ENDOSOME ORGANIZATION,7.5001e-05,0.13439,0.16298,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0055559,0.13439,0.15653,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.015329,0.1343,0.14271,1,1
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.010895,0.13426,0.18302,1,1
4,GO REGULATION OF BONE MINERALIZATION,0.019523,0.13419,0.14244,1,1
4,GO RELAXATION OF MUSCLE,0.0022701,0.13407,0.16712,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00049802,0.13407,0.1492,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.015501,0.13398,0.14831,1,1
4,GO CALCIUM ION IMPORT,0.001118,0.13397,0.12271,1,1
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0020646,0.13393,0.12902,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.00013451,0.13386,0.15276,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,7.6657e-06,0.13383,0.18428,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.0033361,0.13378,0.15197,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.059331,0.1337,0.22262,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.012087,0.13366,0.14428,1,1
4,GO TISSUE REGENERATION,0.0067673,0.13365,0.14088,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.015501,0.13362,0.17508,1,1
4,GO ACTIN NUCLEATION,0.0012005,0.13354,0.15163,1,1
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.031953,0.1335,0.096498,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00099681,0.13348,0.15681,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.022928,0.1334,0.12156,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,9.6562e-05,0.13334,0.13157,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0014624,0.13334,0.16355,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00049802,0.13318,0.14625,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.031631,0.13314,0.12765,1,1
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.051595,0.13305,0.11499,1,1
4,GO EXOCYTIC PROCESS,0.00026438,0.13293,0.18172,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.0070192,0.1329,0.13401,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00030928,0.13283,0.19876,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.012087,0.13275,0.11414,1,1
4,GO TRANSMEMBRANE TRANSPORT,1.996e-06,0.13274,0.14167,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0056958,0.13246,0.10951,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0028492,0.13244,0.14472,1,1
4,GO OXIDATION REDUCTION PROCESS,9.6129e-06,0.1324,0.1562,1,1
4,GO REGULATION OF RESPONSE TO STRESS,5.9056e-05,0.13235,0.13317,1,1
4,GO RUFFLE ORGANIZATION,0.00020178,0.13213,0.16517,1,1
4,GO MOLTING CYCLE,0.01128,0.13195,0.10429,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.0018764,0.13184,0.11676,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,9.819e-05,0.13152,0.12845,1,1
4,GO CHOLESTEROL EFFLUX,0.0039481,0.13152,0.13624,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.4091e-05,0.13151,0.14245,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00013016,0.13148,0.12715,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00025215,0.13146,0.12103,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00058763,0.13142,0.11776,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.00018323,0.13124,0.15263,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,7.6283e-05,0.13121,0.11611,1,1
4,GO REGULATION OF ION TRANSPORT,0.00010497,0.13121,0.13242,1,1
4,GO COPPER ION HOMEOSTASIS,0.0047198,0.1312,0.15039,1,1
4,GO AUTOPHAGOSOME MATURATION,0.00076726,0.13119,0.16407,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,6.6578e-05,0.13102,0.12937,1,1
4,GO SIGNAL RELEASE,1.7706e-05,0.13074,0.15338,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00020178,0.1306,0.1522,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0043737,0.13051,0.11319,1,1
4,GO IMPORT INTO CELL,0.0046604,0.1305,0.1152,1,1
4,GO CELLULAR HOMEOSTASIS,1.7385e-05,0.13042,0.12324,1,1
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0025961,0.13026,0.15319,1,1
4,GO REGULATION OF CELL MATURATION,0.0005789,0.13016,0.14052,1,1
4,GO CELL MATURATION,2.0478e-05,0.1301,0.14509,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.00065224,0.13005,0.12885,1,1
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00094089,0.13,0.14135,1,1
4,GO AGING,1.2482e-05,0.12986,0.15058,1,1
4,GO FEAR RESPONSE,0.0068504,0.12974,0.11053,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00012388,0.12971,0.12926,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,5.7582e-06,0.12969,0.16002,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0052854,0.1296,0.12472,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0032078,0.12946,0.11097,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,2.2416e-05,0.12931,0.13399,1,1
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0011668,0.12917,0.14322,1,1
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0024941,0.1289,0.1435,1,1
4,GO METAL ION TRANSPORT,3.0395e-05,0.12889,0.13246,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.00042128,0.12886,0.11872,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,9.4959e-05,0.12871,0.13054,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0022095,0.12871,0.14084,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.014172,0.12856,0.12808,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.013394,0.12843,0.11125,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.001568,0.12837,0.13586,1,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.012798,0.12828,0.12186,1,1
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0012177,0.12827,0.12715,1,1
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00043435,0.12826,0.16517,1,1
4,GO MUSCLE SYSTEM PROCESS,0.00042777,0.12821,0.12374,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,3.094e-05,0.12808,0.19191,1,1
4,GO SODIUM ION TRANSPORT,7.105e-06,0.12804,0.17221,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,8.8796e-05,0.12799,0.13029,1,1
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0081133,0.1279,0.11291,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.001704,0.12775,0.12,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0007901,0.12758,0.16106,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0017277,0.12736,0.11891,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00159,0.12731,0.13831,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00016901,0.12719,0.14041,1,1
4,GO NEGATIVE REGULATION OF SECRETION,6.2175e-05,0.12703,0.12822,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0042095,0.12695,0.11605,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0021215,0.12692,0.11792,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00014839,0.12689,0.13462,1,1
4,GO SINGLE FERTILIZATION,0.00029052,0.12682,0.10944,1,1
4,GO EPITHELIAL CELL MATURATION,0.040981,0.12679,0.14404,1,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.0054192,0.12678,0.11399,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,8.4805e-07,0.12676,0.14918,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.00028155,0.1267,0.12541,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0005618,0.1265,0.1566,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0012886,0.12634,0.13126,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.023173,0.12632,0.11474,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0059852,0.12623,0.12877,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,2.3239e-05,0.12588,0.14507,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0025617,0.12583,0.10948,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00059648,0.12582,0.11787,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.00016901,0.12579,0.14067,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,1.6457e-05,0.12576,0.13691,1,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.011022,0.12557,0.1007,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.00014599,0.12553,0.1541,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.024947,0.12552,0.13667,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.0013633,0.12546,0.17034,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00042128,0.12535,0.15593,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00031907,0.12521,0.12774,1,1
4,GO PROTEIN PALMITOYLATION,0.017125,0.12518,0.12935,1,1
4,GO CALCIUM MEDIATED SIGNALING,1.4207e-05,0.12504,0.12306,1,1
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0019285,0.12492,0.13848,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.026838,0.12486,0.15339,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.00049802,0.12479,0.11531,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00011986,0.12478,0.16113,1,1
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00023294,0.12473,0.17851,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.0047198,0.12442,0.13058,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0052197,0.12429,0.14351,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0021505,0.12428,0.19977,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0017517,0.12414,0.12674,1,1
4,GO REGULATION OF TOR SIGNALING,6.1119e-05,0.12414,0.13332,1,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.00029511,0.12406,0.12342,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.00092737,0.12404,0.11936,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.001483,0.12401,0.15136,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,8.4424e-05,0.124,0.12818,1,1
4,GO TUBE MORPHOGENESIS,0.0072795,0.12399,0.11825,1,1
4,GO MUSCLE CELL DIFFERENTIATION,0.00068191,0.1236,0.13065,1,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.058247,0.12351,0.12946,1,1
4,GO ASTROCYTE DIFFERENTIATION,0.01829,0.12342,0.1435,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9694e-05,0.12331,0.14377,1,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0029645,0.12324,0.1238,1,1
4,GO REGULATION OF CHROMATIN BINDING,0.052083,0.12318,0.094747,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00054518,0.12303,0.15563,1,1
4,GO ORGANIC ACID TRANSPORT,8.2686e-06,0.12297,0.16097,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0032078,0.12284,0.12938,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,1.9749e-05,0.12278,0.13368,1,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0050269,0.12277,0.1917,1,1
4,GO FEEDING BEHAVIOR,0.001955,0.1227,0.1222,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0005133,0.12268,0.12315,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0053519,0.12263,0.13278,1,1
4,GO NEGATIVE REGULATION OF GROWTH,0.0015463,0.12231,0.13041,1,1
4,GO CARDIAC CONDUCTION,0.00049053,0.12225,0.1652,1,1
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.028264,0.1222,0.19214,1,1
4,GO NIK NF KAPPAB SIGNALING,0.00042128,0.12211,0.13006,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00032408,0.1221,0.15575,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.00025617,0.12205,0.13615,1,1
4,GO TUBE DEVELOPMENT,0.0029645,0.12204,0.12349,1,1
4,GO RESPONSE TO ETHER,0.010041,0.12177,0.11286,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00065224,0.12171,0.1201,1,1
4,GO ACTIN FILAMENT ORGANIZATION,0.02174,0.12158,0.096069,1,1
4,GO THYROID HORMONE METABOLIC PROCESS,0.014823,0.12132,0.15764,1,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.029754,0.12129,0.1028,1,1
4,GO MALE SEX DIFFERENTIATION,0.0024281,0.12123,0.12488,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.016938,0.12093,0.117,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.00013232,0.1207,0.12135,1,1
4,GO TRANSITION METAL ION TRANSPORT,5.0323e-06,0.12053,0.17011,1,1
4,GO SELECTIVE AUTOPHAGY,0.00029511,0.12048,0.15148,1,1
4,GO VIRAL RNA GENOME REPLICATION,0.015159,0.12036,0.11543,1,1
4,GO CELLULAR OXIDANT DETOXIFICATION,0.042609,0.12031,0.10993,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00010852,0.12022,0.14616,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,6.6578e-05,0.1202,0.14333,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00080175,0.12018,0.16288,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00070238,0.12014,0.12729,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,3.6924e-05,0.11998,0.12667,1,1
4,GO FIBROBLAST MIGRATION,0.066192,0.1199,0.10229,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00036686,0.11981,0.11473,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.0051547,0.11963,0.16143,1,1
4,GO VITAMIN METABOLIC PROCESS,0.0022701,0.1196,0.14832,1,1
4,GO BLOOD VESSEL MORPHOGENESIS,0.010645,0.11951,0.12291,1,1
4,GO CIRCADIAN RHYTHM,5.1446e-05,0.11948,0.13405,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.012945,0.11943,0.12468,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.02945,0.11935,0.12477,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00033955,0.11911,0.13985,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0085105,0.11891,0.10424,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.00031907,0.11861,0.12136,1,1
4,GO RESPONSE TO ACTIVITY,0.00091404,0.11861,0.14614,1,1
4,GO RESPONSE TO BMP,0.014494,0.11855,0.12722,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.024173,0.11849,0.11462,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00013673,0.11843,0.11889,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00080175,0.11842,0.11705,1,1
4,GO ANIMAL ORGAN REGENERATION,0.0034243,0.11824,0.12177,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00016098,0.11813,0.11673,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,1.9749e-05,0.11792,0.13845,1,1
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0035146,0.11785,0.11585,1,1
4,GO CELL SUBSTRATE ADHESION,0.021053,0.11784,0.12756,1,1
4,GO CARNITINE SHUTTLE,0.01585,0.11768,0.14919,1,1
4,GO REGULATION OF AUTOPHAGY,2.1234e-05,0.11761,0.13257,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0023009,0.11756,0.1328,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00014129,0.11755,0.15564,1,1
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.0087156,0.11752,0.15825,1,1
4,GO POSITIVE REGULATION OF MYELINATION,0.00062378,0.11747,0.14794,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.0052854,0.11745,0.1571,1,1
4,GO JNK CASCADE,0.00086244,0.11735,0.12261,1,1
4,GO REGULATION OF PROTEIN BINDING,0.00069207,0.11727,0.12995,1,1
4,GO CELLULAR IRON ION HOMEOSTASIS,0.012798,0.11726,0.11185,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,8.4424e-05,0.11723,0.14564,1,1
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.00084997,0.11703,0.13021,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.03068,0.117,0.096613,1,1
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.024687,0.11693,0.11971,1,1
4,GO ENDOCYTOSIS,0.0039481,0.11692,0.10749,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0074579,0.11676,0.13914,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0003557,0.11668,0.11317,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,9.6562e-05,0.11659,0.1233,1,1
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.01251,0.11659,0.10053,1,1
4,GO STRESS FIBER ASSEMBLY,0.015674,0.11659,0.12708,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,2.9332e-05,0.11654,0.1218,1,1
4,GO GOLGI ORGANIZATION,7.8124e-06,0.11653,0.16331,1,1
4,GO REGULATION OF CELL DEATH,0.00031414,0.11652,0.11569,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00069207,0.11641,0.11638,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00036686,0.11614,0.13584,1,1
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.016938,0.11612,0.08605,1,1
4,GO CELL JUNCTION ORGANIZATION,0.048285,0.1161,0.085829,1,1
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.033608,0.11604,0.10381,1,1
4,GO EAR DEVELOPMENT,0.01499,0.11588,0.10007,1,1
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.023173,0.11575,0.075246,1,1
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.046921,0.11564,0.092311,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001568,0.11563,0.11893,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0011668,0.11546,0.17094,1,1
4,GO RUFFLE ASSEMBLY,0.0043184,0.11544,0.13085,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.020828,0.11525,0.11118,1,1
4,GO RESPONSE TO ATP,0.011151,0.11521,0.10797,1,1
4,GO RESPONSE TO ETHANOL,0.00024819,0.11515,0.12418,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0048405,0.11513,0.12587,1,1
4,GO REGULATION OF MACROPHAGE MIGRATION,0.00049802,0.11511,0.15998,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.003607,0.11483,0.098341,1,1
4,GO RESPONSE TO GROWTH FACTOR,0.0060595,0.1148,0.11326,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00020504,0.1148,0.1254,1,1
4,GO DEVELOPMENTAL MATURATION,0.0020646,0.11475,0.11922,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.001483,0.11471,0.10836,1,1
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.061549,0.11449,0.11501,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.046474,0.11434,0.095184,1,1
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.006444,0.11401,0.10481,1,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.0021505,0.11383,0.10222,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001071,0.11378,0.10931,1,1
4,GO MACROPHAGE CHEMOTAXIS,0.0062877,0.11372,0.1408,1,1
4,GO SKIN EPIDERMIS DEVELOPMENT,0.02945,0.11363,0.1033,1,1
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.033271,0.11357,0.082226,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00040857,0.11333,0.12747,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.03006,0.11317,0.139,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.032938,0.11311,0.1307,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.048285,0.11299,0.088125,1,1
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.052575,0.11287,0.075112,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0062877,0.11273,0.14669,1,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.011022,0.11268,0.16313,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0016806,0.11261,0.12591,1,1
4,GO OSTEOBLAST DIFFERENTIATION,0.054582,0.1126,0.10746,1,1
4,GO FORMATION OF PRIMARY GERM LAYER,0.027401,0.11259,0.12604,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,5.9056e-05,0.11239,0.15285,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.00015083,0.1123,0.14849,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,3.0395e-05,0.11228,0.12767,1,1
4,GO TRANSLESION SYNTHESIS,0.00030449,0.11226,0.11922,1,1
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.0037016,0.11226,0.15808,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00014362,0.11202,0.14103,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.012945,0.11197,0.098397,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.00019541,0.11195,0.12531,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0045438,0.11182,0.11965,1,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.020605,0.11154,0.11302,1,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00032916,0.11149,0.11511,1,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.021509,0.11128,0.10245,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.010522,0.11106,0.092434,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.003607,0.11105,0.11316,1,1
4,GO NADPH REGENERATION,0.03902,0.111,0.12196,1,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00095459,0.11098,0.2076,1,1
4,GO LOCOMOTORY BEHAVIOR,0.059331,0.11092,0.09907,1,1
4,GO ACID SECRETION,0.0005789,0.11091,0.13607,1,1
4,GO GOLGI RIBBON FORMATION,0.010041,0.11085,0.15413,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00057029,0.11075,0.14395,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.0035605,0.1107,0.13223,1,1
4,GO POLYOL METABOLIC PROCESS,0.0011668,0.11051,0.11238,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00039622,0.11017,0.13476,1,1
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.010645,0.10987,0.13945,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0028872,0.1097,0.11986,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00062378,0.10952,0.10845,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.020828,0.10926,0.10951,1,1
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.016752,0.10925,0.097666,1,1
4,GO REGULATION OF MEMBRANE POTENTIAL,0.015674,0.10915,0.11031,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.0096941,0.10909,0.10798,1,1
4,GO T CELL DIFFERENTIATION IN THYMUS,0.010645,0.10872,0.11016,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,4.7999e-05,0.10869,0.15728,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.0012177,0.10849,0.11553,1,1
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.035691,0.10832,0.074831,1,1
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.056652,0.1081,0.092292,1,1
4,GO SENSORY PERCEPTION OF PAIN,0.0035605,0.1081,0.12022,1,1
4,GO AUTOPHAGIC CELL DEATH,0.029754,0.10791,0.11679,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00014599,0.1079,0.14016,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00039018,0.10768,0.10922,1,1
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0010865,0.10733,0.12717,1,1
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0043184,0.10729,0.11749,1,1
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.012653,0.10721,0.10883,1,1
4,GO ACTIN FILAMENT BASED MOVEMENT,0.0067673,0.10659,0.11828,1,1
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.0030038,0.10654,0.16211,1,1
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.024173,0.10634,0.0966,1,1
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0022095,0.10628,0.13804,1,1
4,GO ACTIN FILAMENT BASED PROCESS,0.032607,0.10625,0.087586,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0088198,0.10599,0.13575,1,1
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00090088,0.1059,0.1321,1,1
4,GO APOPTOTIC PROCESS,0.00013451,0.1059,0.1191,1,1
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.019312,0.10589,0.10259,1,1
4,GO POTASSIUM ION TRANSPORT,0.0034243,0.10589,0.12842,1,1
4,GO ANIMAL ORGAN MATURATION,0.0066851,0.10587,0.15687,1,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00038422,0.10586,0.13546,1,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.041789,0.10579,0.10615,1,1
4,GO RECEPTOR RECYCLING,0.0034243,0.10577,0.14352,1,1
4,GO SENSORY PERCEPTION,0.00011406,0.10571,0.11351,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.0043184,0.10561,0.10215,1,1
4,GO SOMITOGENESIS,0.002631,0.10558,0.11937,1,1
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.01849,0.10553,0.12574,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0104,0.10543,0.10935,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0001803,0.10487,0.11992,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.0007901,0.10486,0.10986,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00042777,0.10473,0.13488,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0035605,0.10463,0.10367,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.001422,0.10458,0.10544,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01829,0.10452,0.1225,1,1
4,GO MEMBRANE INVAGINATION,0.019312,0.10449,0.11803,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.0012886,0.10445,0.12522,1,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0066851,0.1044,0.19277,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.014823,0.10427,0.1072,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0023637,0.1042,0.1328,1,1
4,GO MAINTENANCE OF LOCATION,0.00081356,0.10415,0.11732,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0018764,0.10415,0.1046,1,1
4,GO CELLULAR EXTRAVASATION,0.019312,0.10409,0.11454,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.001118,0.10406,0.10746,1,1
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.032938,0.10393,0.11961,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00087508,0.10381,0.12045,1,1
4,GO DE NOVO PROTEIN FOLDING,0.017699,0.10377,0.11118,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0032928,0.10372,0.1153,1,1
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.019523,0.10363,0.10472,1,1
4,GO REGULATION OF VASOCONSTRICTION,0.001118,0.10312,0.15273,1,1
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.019312,0.10292,0.10158,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.00044781,0.10288,0.15276,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.052575,0.10281,0.09292,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.049681,0.10271,0.1324,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.011813,0.10264,0.13125,1,1
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.046031,0.1026,0.067326,1,1
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.046031,0.10256,0.10752,1,1
4,GO SYMBIOTIC PROCESS,0.0030436,0.10224,0.090737,1,1
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.019104,0.10206,0.10441,1,1
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.058787,0.10184,0.14488,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.00010152,0.10174,0.11431,1,1
4,GO REGULATION OF GROWTH,0.0030436,0.10158,0.10136,1,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.027973,0.1015,0.08999,1,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.004964,0.10143,0.099173,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0018764,0.10138,0.10947,1,1
4,GO AMINO SUGAR METABOLIC PROCESS,0.0047198,0.10133,0.15036,1,1
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.022928,0.10084,0.091467,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,1.0958e-05,0.10061,0.12816,1,1
4,GO RETINA HOMEOSTASIS,0.0032928,0.10026,0.080062,1,1
4,GO ACTIN MEDIATED CELL CONTRACTION,0.0066851,0.10024,0.12737,1,1
4,GO RESPONSE TO ALKALOID,0.001776,0.10022,0.11849,1,1
4,GO MUSCLE CONTRACTION,0.001235,0.10018,0.1171,1,1
4,GO ENSHEATHMENT OF NEURONS,0.0033361,0.10005,0.12919,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00024045,0.099987,0.11081,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0043184,0.099769,0.10653,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.020166,0.099684,0.11102,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.01016,0.099617,0.094341,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.012367,0.09937,0.098652,1,1
4,GO REPRODUCTION,0.0013069,0.099319,0.095989,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0030038,0.099298,0.096411,1,1
4,GO ORGANELLE DISASSEMBLY,0.00011218,0.099139,0.12842,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00019541,0.098845,0.11859,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0047798,0.09858,0.1061,1,1
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0015038,0.098375,0.10724,1,1
4,GO RESPONSE TO ESTRADIOL,0.0090315,0.097732,0.10184,1,1
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.051595,0.097671,0.12354,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0012005,0.097617,0.12351,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0030038,0.097567,0.1407,1,1
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.039795,0.097433,0.12305,1,1
4,GO DENDRITE EXTENSION,0.0086125,0.097094,0.18387,1,1
4,GO TOR SIGNALING,0.00016361,0.09703,0.10769,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.00071283,0.096801,0.11537,1,1
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.020166,0.096535,0.12012,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.039795,0.096498,0.082394,1,1
4,GO IRON ION HOMEOSTASIS,0.0017517,0.096436,0.13865,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.0089251,0.096353,0.12345,1,1
4,GO TISSUE MORPHOGENESIS,0.0093576,0.096321,0.10106,1,1
4,GO GLIOGENESIS,0.011813,0.09624,0.11584,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.013093,0.095985,0.12031,1,1
4,GO DEPHOSPHORYLATION,0.0026663,0.095596,0.088982,1,1
4,GO SKELETAL MUSCLE CONTRACTION,0.059331,0.095468,0.091397,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00010323,0.095192,0.14202,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0018006,0.094834,0.096271,1,1
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0088198,0.094828,0.13017,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0019285,0.094666,0.10252,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.02174,0.094449,0.082876,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.041383,0.09441,0.071493,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00016901,0.09435,0.12843,1,1
4,GO PHOSPHATE ION TRANSPORT,0.036048,0.094245,0.090079,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.060988,0.094229,0.079672,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0073682,0.094178,0.10817,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0081133,0.094175,0.092664,1,1
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.044292,0.094037,0.094587,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.00038422,0.093965,0.10175,1,1
4,GO RESPONSE TO CHEMOKINE,0.0010865,0.093825,0.10429,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0053519,0.093702,0.10427,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.0089251,0.093666,0.076008,1,1
4,GO GASTRULATION,0.03006,0.093573,0.10977,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.023419,0.093421,0.12687,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.0050904,0.093164,0.11064,1,1
4,GO ASSOCIATIVE LEARNING,0.060432,0.093107,0.082088,1,1
4,GO REGULATION OF EXOCYTOSIS,0.00071283,0.09306,0.14016,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0030839,0.09272,0.10903,1,1
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0018006,0.092706,0.11617,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.016027,0.092645,0.14526,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0024941,0.09258,0.12229,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0048405,0.092494,0.096509,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0025617,0.092287,0.11462,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0032501,0.092276,0.099296,1,1
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.010895,0.091884,0.10894,1,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0066039,0.091807,0.16798,1,1
4,GO PEPTIDYL SERINE MODIFICATION,0.0050269,0.091797,0.088964,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.026286,0.09162,0.073273,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.051595,0.09141,0.081148,1,1
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.01128,0.091312,0.10217,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0016575,0.091189,0.1104,1,1
4,GO REGULATION OF METAL ION TRANSPORT,0.0066851,0.091109,0.092644,1,1
4,GO T CELL HOMEOSTASIS,0.052575,0.091036,0.078988,1,1
4,GO APOPTOTIC CELL CLEARANCE,0.046474,0.091035,0.15383,1,1
4,GO DNA CATABOLIC PROCESS,0.00076726,0.090986,0.10553,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0028492,0.090736,0.10363,1,1
4,GO EXCRETION,0.0012177,0.090589,0.14355,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0056255,0.090487,0.13942,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0085105,0.090141,0.085799,1,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0094686,0.090043,0.10197,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0047198,0.089951,0.13161,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.041383,0.089794,0.093766,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.062684,0.089742,0.07815,1,1
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0056958,0.089619,0.090328,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.037882,0.089575,0.11975,1,1
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.003607,0.089444,0.088683,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.021053,0.089408,0.12134,1,1
4,GO GLIAL CELL DIFFERENTIATION,0.015329,0.089324,0.11841,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0029645,0.089263,0.1072,1,1
4,GO PEPTIDE CATABOLIC PROCESS,0.016386,0.089198,0.14658,1,1
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.013394,0.08914,0.093778,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.014013,0.089119,0.093299,1,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0068504,0.089086,0.098285,1,1
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.019104,0.088814,0.09478,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.011022,0.088786,0.09155,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.0021505,0.088543,0.12531,1,1
4,GO THIOESTER METABOLIC PROCESS,0.00038422,0.087917,0.15136,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.014494,0.087817,0.097311,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0020367,0.087603,0.11458,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.017506,0.087603,0.076135,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0090315,0.08749,0.095507,1,1
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0073682,0.08713,0.10319,1,1
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043444,0.086438,0.12855,1,1
4,GO POSTREPLICATION REPAIR,0.0088198,0.085867,0.075385,1,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.022209,0.085558,0.081982,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.013093,0.08528,0.12297,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.028264,0.085128,0.1033,1,1
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0092477,0.084979,0.11534,1,1
4,GO KIDNEY MORPHOGENESIS,0.02174,0.084947,0.11191,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023173,0.084417,0.083672,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.032938,0.08427,0.081697,1,1
4,GO GROWTH,0.03068,0.084137,0.078532,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.0016806,0.08382,0.094128,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0089251,0.083614,0.082723,1,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0077327,0.083576,0.14347,1,1
4,GO CELLULAR RESPONSE TO CAMP,0.019735,0.083571,0.10125,1,1
4,GO REGENERATION,0.024428,0.083314,0.096919,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.017894,0.083274,0.10443,1,1
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0066039,0.083265,0.12262,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.066192,0.083219,0.094447,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0056255,0.08262,0.1058,1,1
4,GO REGULATION OF CELL DIFFERENTIATION,0.038258,0.082482,0.077952,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.041383,0.08246,0.12676,1,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.061549,0.082342,0.079832,1,1
4,GO ATP METABOLIC PROCESS,0.0027747,0.082115,0.091069,1,1
4,GO REGULATION OF HAIR CYCLE,0.024173,0.08211,0.11217,1,1
4,GO RHYTHMIC PROCESS,0.0035146,0.081985,0.090873,1,1
4,GO FERTILIZATION,0.0013443,0.081887,0.08887,1,1
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.061549,0.081499,0.10423,1,1
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.015501,0.081379,0.088681,1,1
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.025743,0.081283,0.11891,1,1
4,GO SULFATE TRANSPORT,0.036048,0.081282,0.10774,1,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.048285,0.081182,0.081547,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0071918,0.081129,0.086417,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.030368,0.080893,0.08327,1,1
4,GO RENAL SODIUM EXCRETION,0.012087,0.080726,0.14105,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0037016,0.080421,0.11285,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.041789,0.080079,0.08382,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0061347,0.079728,0.081438,1,1
4,GO MULTI ORGANISM PROCESS,0.0043184,0.079688,0.078375,1,1
4,GO NEURON DEATH,0.0053519,0.07953,0.093004,1,1
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.062684,0.079448,0.076657,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.017315,0.079385,0.082714,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0012886,0.079311,0.11567,1,1
4,GO ENDOSOMAL TRANSPORT,0.0053519,0.078753,0.085834,1,1
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.065596,0.078688,0.068472,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0018764,0.07837,0.11893,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.026286,0.078221,0.063908,1,1
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.053071,0.078115,0.077071,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0048405,0.078112,0.096583,1,1
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011411,0.078105,0.082329,1,1
4,GO CELL CELL SIGNALING,0.020828,0.077578,0.078541,1,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.025475,0.077531,0.095312,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.015329,0.077139,0.11396,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.03006,0.076702,0.10667,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02915,0.076633,0.099488,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.00029052,0.076126,0.10546,1,1
4,GO BODY FLUID SECRETION,0.046474,0.075342,0.084664,1,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.012367,0.075324,0.096322,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0023957,0.07529,0.10534,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0010113,0.074942,0.13763,1,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.017699,0.074896,0.11495,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.024173,0.074346,0.083574,1,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.020605,0.074262,0.073341,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.009139,0.074231,0.10767,1,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.0087156,0.073912,0.074653,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.028556,0.073867,0.08105,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.020605,0.073738,0.10309,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0071918,0.0736,0.085881,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.0058389,0.073443,0.095958,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.00020504,0.073442,0.1135,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.013243,0.073312,0.083087,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.047827,0.073271,0.081832,1,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.023919,0.072827,0.070159,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0072795,0.072144,0.093481,1,1
4,GO RECEPTOR METABOLIC PROCESS,0.026561,0.072092,0.091416,1,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.055093,0.072066,0.092832,1,1
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.051111,0.07182,0.09483,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039992,0.071415,0.090614,1,1
4,GO NERVOUS SYSTEM PROCESS,0.021973,0.069791,0.079401,1,1
4,GO MATING,0.016205,0.069399,0.099969,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.03902,0.069396,0.074573,1,1
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.037509,0.06934,0.072401,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.03006,0.069199,0.081935,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.015674,0.068983,0.076115,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.0043184,0.068731,0.083348,1,1
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.05357,0.068674,0.121,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0016575,0.068505,0.08772,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00054518,0.068276,0.096064,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0023957,0.067682,0.11496,1,1
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.066192,0.067436,0.064128,1,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.031953,0.067384,0.067808,1,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.0071918,0.067067,0.076191,1,1
4,GO CELL GROWTH,0.018898,0.066972,0.090321,1,1
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.044722,0.066056,0.097084,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.016205,0.06548,0.074482,1,1
4,GO MITOPHAGY,0.040981,0.064353,0.10058,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.048746,0.064018,0.080806,1,1
4,GO SEXUAL REPRODUCTION,0.012227,0.062597,0.063512,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0099244,0.062541,0.14864,1,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.015159,0.062397,0.064622,1,1
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.037139,0.061987,0.065552,1,1
4,GO BLASTOCYST DEVELOPMENT,0.001704,0.061727,0.092257,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.026838,0.060212,0.06579,1,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.051111,0.059498,0.07565,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.017315,0.058867,0.11781,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0050269,0.057547,0.091425,1,1
4,GO PROTEIN STABILIZATION,0.0075485,0.057496,0.088156,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0044298,0.057279,0.084053,1,1
4,GO RESPONSE TO CAMP,0.027401,0.056891,0.094078,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.021509,0.056807,0.072003,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.019104,0.056704,0.066985,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.048285,0.054781,0.070141,1,1
4,GO CYTOSOLIC TRANSPORT,0.0065235,0.053791,0.096445,1,1
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.055093,0.052783,0.101,1,1
4,GO MACROAUTOPHAGY,0.00063314,0.051806,0.11117,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.055093,0.049988,0.080678,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.036048,0.049548,0.079551,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.01829,0.049455,0.057385,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.016938,0.048701,0.057678,1,1
4,GO MALE GAMETE GENERATION,0.040582,0.048392,0.052147,1,1
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.036409,0.046985,0.089429,1,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.058787,0.045789,0.057242,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.010895,0.044528,0.068822,1,1
4,GO MITOCHONDRION ORGANIZATION,0.020166,0.04349,0.06683,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0092477,0.042754,0.074596,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.0089251,0.040704,0.090835,1,1
4,GO MACROMOLECULE CATABOLIC PROCESS,0.032278,0.04016,0.058931,1,1
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.016386,0.2418,0.22186,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0080166,0.23956,0.14345,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0084096,0.22877,0.13867,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.013243,0.21549,0.13949,1,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.027118,0.21322,0.16894,1,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0083098,0.2123,0.16044,1,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00055343,0.20767,0.21462,1,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.044722,0.1957,0.14951,1,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.035691,0.19031,0.13278,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.003607,0.18904,0.20999,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0099244,0.18695,0.17598,1,0
4,GO PROTEIN OXIDATION,0.035336,0.17888,0.18112,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.008211,0.17441,0.293,1,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0051547,0.17415,0.21448,1,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.020605,0.1714,0.14136,1,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0094686,0.16946,0.17565,1,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00072342,0.16906,0.16209,1,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.040981,0.16817,0.099373,1,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.036772,0.16752,0.18529,1,0
4,GO METANEPHROS MORPHOGENESIS,0.020605,0.16739,0.14617,1,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00073415,0.16726,0.34252,1,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.060432,0.16621,0.1542,1,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,5.2344e-05,0.16613,0.17643,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0016806,0.15995,0.19674,1,0
4,GO AMINE CATABOLIC PROCESS,0.00043435,0.15373,0.20402,1,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.054582,0.15352,0.17188,1,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.045591,0.152,0.2153,1,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.041789,0.14813,0.1667,1,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.024173,0.14736,0.115,1,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0054872,0.14563,0.16829,1,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.058787,0.1431,0.11304,1,0
4,GO REPLICATIVE SENESCENCE,0.0089251,0.14197,0.18835,1,0
4,GO BLEB ASSEMBLY,0.060988,0.14193,0.22924,1,0
4,GO ORGANIC CATION TRANSPORT,0.00067188,0.13618,0.17675,1,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0035605,0.13592,0.13239,1,0
4,GO P38MAPK CASCADE,0.023173,0.13585,0.13249,1,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.029754,0.13352,0.16821,1,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.041789,0.13297,0.11775,1,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011813,0.13286,0.15411,1,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.031631,0.13267,0.17851,1,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.027686,0.13183,0.16558,1,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.011813,0.13148,0.19434,1,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.018898,0.12979,0.17143,1,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.057711,0.12915,0.10552,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.013093,0.12816,0.14508,1,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.059879,0.128,0.14002,1,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.053071,0.12798,0.13483,1,0
4,GO CERAMIDE TRANSPORT,0.040981,0.12701,0.12812,1,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.00094089,0.12603,0.12526,1,0
4,GO PIGMENT GRANULE ORGANIZATION,0.012798,0.12603,0.11253,1,0
4,GO COLLAGEN CATABOLIC PROCESS,0.02174,0.12501,0.14533,1,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.0062877,0.12493,0.15432,1,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.019104,0.12414,0.12138,1,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0070192,0.12346,0.13007,1,0
4,GO RESPONSE TO NICOTINE,0.034636,0.12282,0.10492,1,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.044722,0.12107,0.14782,1,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.030994,0.12076,0.11906,1,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0044298,0.11948,0.15182,1,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.010041,0.11947,0.12755,1,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.016938,0.11941,0.24413,1,0
4,GO MEMBRANE HYPERPOLARIZATION,0.031953,0.11827,0.11028,1,0
4,GO RESPONSE TO UV C,0.03068,0.11783,0.10078,1,0
4,GO GLIAL CELL MIGRATION,0.048285,0.11614,0.10469,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.032938,0.11612,0.11255,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0042095,0.11313,0.16003,1,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.020166,0.11266,0.10236,1,0
4,GO MALE GENITALIA DEVELOPMENT,0.017315,0.11217,0.14998,1,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.036048,0.11197,0.14588,1,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.027686,0.10887,0.13827,1,0
4,GO ESTROGEN METABOLIC PROCESS,0.0033799,0.10543,0.16056,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.061549,0.10543,0.061662,1,0
4,GO VASCULATURE DEVELOPMENT,0.02915,0.10497,0.10529,1,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.028264,0.10485,0.14365,1,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.018693,0.10402,0.092503,1,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.024173,0.1039,0.11399,1,0
4,GO PIGMENT CELL DIFFERENTIATION,0.014172,0.10383,0.11954,1,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.047827,0.1038,0.20324,1,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.011151,0.10237,0.10999,1,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.046474,0.10141,0.093099,1,0
4,GO VIRAL RELEASE FROM HOST CELL,0.0040509,0.10131,0.12144,1,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.009139,0.10112,0.17975,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.017699,0.09893,0.14039,1,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.042197,0.098777,0.15142,1,0
4,GO REGULATION OF PHAGOCYTOSIS,0.016205,0.097443,0.13405,1,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0055559,0.095734,0.12554,1,0
4,GO EPIBOLY,0.066792,0.094099,0.13351,1,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.027686,0.092016,0.1051,1,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.034984,0.090908,0.091296,1,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.0084096,0.090431,0.095249,1,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.044722,0.089722,0.13354,1,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.056128,0.089289,0.07595,1,0
4,GO CYTOKINETIC PROCESS,0.0027747,0.088772,0.11993,1,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.010769,0.088188,0.09509,1,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.01128,0.088183,0.12766,1,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.057179,0.088099,0.12709,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024687,0.088029,0.10076,1,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.015674,0.087923,0.096766,1,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.039795,0.086753,0.16119,1,0
4,GO SECRETORY GRANULE ORGANIZATION,0.039795,0.085375,0.10613,1,0
4,GO RESPONSE TO INTERLEUKIN 7,0.058787,0.085236,0.10004,1,0
4,GO ASTROCYTE DEVELOPMENT,0.024947,0.085007,0.15109,1,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.01829,0.084453,0.097172,1,0
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.057711,0.08441,0.085907,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.062684,0.084327,0.10536,1,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.066792,0.083228,0.09385,1,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.019104,0.08298,0.096211,1,0
4,GO REGULATION OF CELL SHAPE,0.050154,0.08289,0.095974,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.063836,0.080778,0.1072,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.023419,0.079713,0.11847,1,0
4,GO EMBRYONIC MORPHOGENESIS,0.05063,0.079567,0.077937,1,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.031631,0.079178,0.10925,1,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0094686,0.078719,0.12725,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0056255,0.07815,0.11007,1,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.043025,0.076803,0.08736,1,0
4,GO CHEMOSENSORY BEHAVIOR,0.064418,0.075264,0.090202,1,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.033271,0.07417,0.097532,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.036048,0.073802,0.15429,1,0
4,GO SMOOTH MUSCLE CONTRACTION,0.038258,0.073646,0.08648,1,0
4,GO REGULATION OF GLIOGENESIS,0.026013,0.072823,0.098538,1,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.030994,0.072117,0.12742,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.016752,0.071123,0.091105,1,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.047372,0.070666,0.091558,1,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.033948,0.069438,0.10505,1,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0068504,0.067653,0.10074,1,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.014658,0.067219,0.084128,1,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.054582,0.067109,0.11481,1,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.034984,0.065469,0.11684,1,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0086125,0.064537,0.078964,1,0
4,GO HISTONE H2B UBIQUITINATION,0.03902,0.064235,0.089037,1,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.05357,0.062933,0.098285,1,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.035336,0.062228,0.086342,1,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.043444,0.058396,0.12613,1,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.064418,0.058345,0.098338,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.063836,0.055372,0.065024,1,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.023419,0.054311,0.060173,1,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.028556,0.054208,0.10846,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.020385,0.054177,0.068124,1,0
4,GO GENITALIA DEVELOPMENT,0.062684,0.054065,0.082489,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.066792,0.053255,0.086093,1,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0039992,0.053108,0.10155,1,0
4,GO GAMETE GENERATION,0.045591,0.052405,0.051375,1,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.060432,0.050626,0.069293,1,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.021053,0.05044,0.062745,1,0
4,GO MESODERM MORPHOGENESIS,0.060988,0.049711,0.091084,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.055093,0.049603,0.080743,1,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.043866,0.049238,0.053217,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.033271,0.049196,0.067593,1,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.058247,0.048818,0.079469,1,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.063258,0.044667,0.063623,1,0
4,GO TRNA CATABOLIC PROCESS,0.066192,0.039333,0.16306,1,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.046031,0.03809,0.09529,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.05357,0.035948,0.048201,1,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.061549,-0.02695,-0.093277,1,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.055609,-0.028163,-0.06366,1,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.040582,-0.040643,-0.082012,1,0
4,GO TRANSPORT ALONG MICROTUBULE,0.045591,-0.043359,-0.053782,1,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.065005,-0.043645,-0.038974,1,0
4,GO AXO DENDRITIC TRANSPORT,0.043025,-0.047753,-0.065368,1,0
4,GO MIRNA METABOLIC PROCESS,0.048746,-0.049332,-0.06846,1,0
4,GO REGULATION OF RNA SPLICING,0.01016,-0.050609,-0.065824,1,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.062684,-0.050899,-0.10636,1,0
4,GO DNA REPAIR,0.02521,-0.051254,-0.040284,1,0
4,GO RNA POLYADENYLATION,0.040582,-0.051408,-0.064772,1,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.05357,-0.051707,-0.046624,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.058247,-0.053352,-0.036452,1,0
4,GO NUCLEAR EXPORT,0.024428,-0.055388,-0.059061,1,0
4,GO AXONAL TRANSPORT,0.041383,-0.056869,-0.073263,1,0
4,GO NCRNA METABOLIC PROCESS,0.030368,-0.057685,-0.083337,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.024428,-0.058246,-0.037486,1,0
4,GO MRNA METABOLIC PROCESS,0.0015038,-0.059716,-0.087826,1,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.0137,-0.060168,-0.11461,1,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.039406,-0.061286,-0.064383,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.020385,-0.061455,-0.052634,1,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.024173,-0.061874,-0.060758,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.049212,-0.063181,-0.068591,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.057179,-0.063907,-0.062563,1,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.050154,-0.064114,-0.11907,1,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.061549,-0.065114,-0.06541,1,0
4,GO PROTEIN NEDDYLATION,0.018091,-0.065522,-0.087763,1,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.036772,-0.066334,-0.099715,1,0
4,GO RRNA METABOLIC PROCESS,0.0050269,-0.066832,-0.12463,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.059331,-0.067745,-0.094876,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.062684,-0.067912,-0.048825,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.036409,-0.068447,-0.052084,1,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.0099244,-0.068452,-0.055397,1,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.053071,-0.069153,-0.078023,1,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.063836,-0.070314,-0.05721,1,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.016568,-0.070542,-0.095005,1,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.045155,-0.070686,-0.067518,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.031631,-0.07071,-0.046652,1,0
4,GO CHROMATIN SILENCING,0.017125,-0.072389,-0.084652,1,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.017125,-0.074121,-0.064113,1,0
4,GO NCRNA TRANSCRIPTION,0.0038977,-0.075602,-0.074139,1,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.012367,-0.07617,-0.066112,1,0
4,GO TRNA MODIFICATION,0.028264,-0.07627,-0.096875,1,0
4,GO BASE EXCISION REPAIR,0.0020929,-0.076677,-0.083996,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.025743,-0.077243,-0.14768,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0056255,-0.077581,-0.073817,1,0
4,GO TELOMERE ORGANIZATION,0.0035146,-0.07762,-0.072716,1,0
4,GO VIRAL GENE EXPRESSION,0.003166,-0.077931,-0.15341,1,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.022686,-0.078154,-0.074216,1,0
4,GO DNA GEOMETRIC CHANGE,0.0063654,-0.079123,-0.078296,1,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0033361,-0.079629,-0.094818,1,0
4,GO HISTONE H3 K27 METHYLATION,0.022686,-0.080171,-0.095993,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.043025,-0.080184,-0.095288,1,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0096941,-0.08147,-0.083658,1,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.05063,-0.082139,-0.086735,1,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0043184,-0.082882,-0.11193,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.010895,-0.082931,-0.070934,1,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0069343,-0.082944,-0.06563,1,0
4,GO NCRNA PROCESSING,0.0054872,-0.083995,-0.11356,1,0
4,GO LYMPHANGIOGENESIS,0.022446,-0.084215,-0.12781,1,0
4,GO RNA PROCESSING,0.0016575,-0.08522,-0.089247,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.019104,-0.085377,-0.070334,1,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.014332,-0.08703,-0.1554,1,0
4,GO REGULATION OF MRNA BINDING,0.038637,-0.087979,-0.1118,1,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.057711,-0.089624,-0.077745,1,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.010041,-0.090403,-0.071214,1,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.01016,-0.091123,-0.073295,1,0
4,GO RESPIRATORY SYSTEM PROCESS,0.019312,-0.092586,-0.10907,1,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.027686,-0.092645,-0.099053,1,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.066192,-0.09277,-0.072869,1,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.012653,-0.093942,-0.081679,1,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.022928,-0.094258,-0.098772,1,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.026838,-0.095052,-0.099711,1,0
4,GO MRNA 3 END PROCESSING,0.0027747,-0.095869,-0.086808,1,0
4,GO RNA 3 END PROCESSING,0.0032078,-0.095989,-0.082304,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00060545,-0.09649,-0.12669,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0015038,-0.096897,-0.091706,1,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0043184,-0.097033,-0.068866,1,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.023919,-0.098124,-0.14122,1,0
4,GO RNA LOCALIZATION,0.0013633,-0.098322,-0.093215,1,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.055609,-0.098537,-0.098188,1,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.035336,-0.098961,-0.102,1,0
4,GO MITOCHONDRION DISTRIBUTION,0.042197,-0.099756,-0.077732,1,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.03068,-0.10054,-0.10679,1,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.066192,-0.1008,-0.12881,1,0
4,GO ERYTHROCYTE MATURATION,0.056652,-0.10137,-0.097218,1,0
4,GO RNA SURVEILLANCE,0.0027747,-0.10138,-0.13132,1,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.012653,-0.10144,-0.10865,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.001442,-0.10185,-0.15337,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0023009,-0.10199,-0.12495,1,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.054582,-0.10208,-0.0924,1,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.0029256,-0.10298,-0.096882,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.012227,-0.10322,-0.060581,1,0
4,GO DENDRITE SELF AVOIDANCE,0.043866,-0.10415,-0.13851,1,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.054582,-0.10424,-0.079434,1,0
4,GO REGULATION OF DNA REPAIR,0.00074504,-0.10435,-0.082747,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.0099244,-0.10469,-0.12483,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.034984,-0.10476,-0.063336,1,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.031311,-0.10512,-0.12644,1,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.022209,-0.10539,-0.14362,1,0
4,GO HIPPO SIGNALING,0.054074,-0.1058,-0.12179,1,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.0011836,-0.10603,-0.13366,1,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.01995,-0.10714,-0.099991,1,0
4,GO TRANSLATIONAL INITIATION,0.0015463,-0.10717,-0.18242,1,0
4,GO RIBOSOME BIOGENESIS,0.0033361,-0.10756,-0.14678,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0057669,-0.10777,-0.14333,1,0
4,GO MRNA TRANSPORT,0.0025617,-0.11078,-0.085122,1,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.017506,-0.11185,-0.099094,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.048746,-0.11216,-0.091059,1,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0046018,-0.11222,-0.11731,1,0
4,GO GTP METABOLIC PROCESS,0.064418,-0.11434,-0.10412,1,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.055609,-0.11513,-0.093759,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.023668,-0.11515,-0.097866,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.00044781,-0.11575,-0.10592,1,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0016806,-0.11581,-0.080722,1,0
4,GO TRNA TRANSPORT,0.016752,-0.11583,-0.090014,1,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.055609,-0.11598,-0.12131,1,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.024173,-0.11613,-0.13507,1,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.026561,-0.11662,-0.096979,1,0
4,GO PROTEIN DEMETHYLATION,0.020385,-0.11707,-0.10292,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,4.9694e-05,-0.11762,-0.1139,1,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.044292,-0.11778,-0.072621,1,0
4,GO MATURATION OF 5 8S RRNA,0.0056255,-0.11791,-0.13967,1,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00092737,-0.11809,-0.10559,1,0
4,GO REGULATION OF RNA BINDING,0.0067673,-0.11845,-0.11888,1,0
4,GO REGULATION OF NEURON MIGRATION,0.013394,-0.11908,-0.15156,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.019104,-0.11933,-0.1279,1,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0069343,-0.11958,-0.11524,1,0
4,GO STRESS GRANULE ASSEMBLY,0.0033361,-0.1199,-0.12129,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00043435,-0.12018,-0.15391,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00014839,-0.1203,-0.10462,1,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.014332,-0.12076,-0.090772,1,0
4,GO CYTOPLASMIC TRANSLATION,0.00033955,-0.12179,-0.21404,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.024687,-0.12186,-0.084206,1,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0088198,-0.12193,-0.13193,1,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.02521,-0.12218,-0.093893,1,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.027401,-0.12247,-0.16188,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.031631,-0.1225,-0.1385,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.010769,-0.12283,-0.10384,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00012388,-0.12285,-0.10909,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0075485,-0.12307,-0.09023,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0087156,-0.12333,-0.18984,1,0
4,GO RNA EXPORT FROM NUCLEUS,0.0013255,-0.12364,-0.10341,1,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.0005211,-0.12382,-0.12821,1,0
4,GO RRNA MODIFICATION,0.046031,-0.1244,-0.088301,1,0
4,GO BLASTOCYST GROWTH,0.066792,-0.125,-0.067733,1,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.001704,-0.12546,-0.090944,1,0
4,GO MYOBLAST PROLIFERATION,0.026561,-0.12576,-0.13428,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.036048,-0.12632,-0.11616,1,0
4,GO MEMBRANE DISASSEMBLY,0.052575,-0.12865,-0.10102,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,5.6085e-05,-0.13008,-0.12279,1,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.010522,-0.13013,-0.12197,1,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0059852,-0.13088,-0.16348,1,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.028264,-0.13122,-0.089695,1,0
4,GO SNORNA METABOLIC PROCESS,0.0071918,-0.13164,-0.15051,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.00012594,-0.13364,-0.1129,1,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.040582,-0.13458,-0.089833,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0094686,-0.13556,-0.12799,1,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.0098086,-0.13562,-0.15302,1,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.002631,-0.13707,-0.13341,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.024947,-0.13716,-0.1062,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00020178,-0.1373,-0.14051,1,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00042128,-0.13854,-0.12765,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.014013,-0.13905,-0.1021,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.033271,-0.13953,-0.11969,1,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.016752,-0.14019,-0.13553,1,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0042636,-0.14117,-0.20124,1,0
4,GO RRNA TRANSCRIPTION,0.00096848,-0.14159,-0.14337,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.00022565,-0.142,-0.11131,1,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.015159,-0.14292,-0.11893,1,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00026438,-0.143,-0.20156,1,0
4,GO REGULATION OF HIPPO SIGNALING,0.027401,-0.14481,-0.13411,1,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.017125,-0.14529,-0.13374,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00039622,-0.1454,-0.12452,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0025961,-0.14549,-0.16241,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.019104,-0.14626,-0.16677,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0075485,-0.14629,-0.13693,1,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.033608,-0.1463,-0.1862,1,0
4,GO RRNA 3 END PROCESSING,0.057711,-0.149,-0.076641,1,0
4,GO DIVALENT METAL ION EXPORT,0.040582,-0.149,-0.16135,1,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0056958,-0.14933,-0.16169,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0010259,-0.15071,-0.19879,1,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00094089,-0.15148,-0.12444,1,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0012005,-0.15161,-0.1935,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.0072e-05,-0.15268,-0.13278,1,0
4,GO HISTONE DEUBIQUITINATION,0.0033799,-0.15439,-0.099156,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0094686,-0.15462,-0.20019,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0017517,-0.15578,-0.12732,1,0
4,GO CARDIOBLAST DIFFERENTIATION,0.031631,-0.1558,-0.13255,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.018693,-0.15592,-0.10675,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0012005,-0.15674,-0.13861,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,5.2303e-06,-0.15693,-0.17249,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.016752,-0.15879,-0.1799,1,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.024947,-0.15899,-0.12671,1,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.013856,-0.15953,-0.10637,1,0
4,GO RESPONSE TO L GLUTAMATE,0.028852,-0.16016,-0.15982,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.01128,-0.1602,-0.16212,1,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.05063,-0.16101,-0.14436,1,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0022095,-0.16162,-0.17776,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0005056,-0.16257,-0.13455,1,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.0021215,-0.16271,-0.1407,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00072342,-0.16382,-0.22478,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.0017517,-0.16423,-0.15273,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00159,-0.16469,-0.18867,1,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0027747,-0.16484,-0.21437,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0005789,-0.16524,-0.13712,1,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0054872,-0.16777,-0.12641,1,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0055559,-0.17096,-0.24308,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0059116,-0.17642,-0.13028,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,2.2824e-05,-0.17806,-0.15536,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.2414e-06,-0.1784,-0.184,1,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.022209,-0.17986,-0.14242,1,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0068504,-0.17995,-0.16643,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.026286,-0.1823,-0.1227,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00052901,-0.18365,-0.21046,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.016752,-0.18801,-0.17391,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00049802,-0.19158,-0.26892,1,0
4,GO MATURATION OF SSU RRNA,0.00094089,-0.19207,-0.19333,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.011678,-0.19261,-0.1404,1,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.047827,-0.19343,-0.16914,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00071283,-0.19375,-0.25211,1,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0029645,-0.19428,-0.25719,1,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0018508,-0.19457,-0.17167,1,0
4,GO MATURATION OF LSU RRNA,0.00055343,-0.19512,-0.22482,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.011544,-0.19727,-0.15907,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0055559,-0.19753,-0.19711,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.011813,-0.19922,-0.22931,1,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.0028118,-0.20055,-0.21477,1,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00067188,-0.20077,-0.21945,1,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0011836,-0.20081,-0.16065,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0072795,-0.20104,-0.14851,1,0
4,GO DNA LIGATION,0.0034692,-0.20233,-0.14026,1,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.0010865,-0.20521,-0.1679,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.027973,-0.20824,-0.14333,1,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0025277,-0.20844,-0.18618,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,8.2543e-08,-0.20912,-0.20598,1,0
4,GO DENDRITIC TRANSPORT,0.0024941,-0.21003,-0.18159,1,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0038977,-0.21081,-0.22014,1,0
4,GO MRNA SPLICE SITE SELECTION,0.0001179,-0.21101,-0.19201,1,0
4,GO LATERAL MESODERM DEVELOPMENT,0.0028872,-0.21255,-0.22658,1,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0031247,-0.21288,-0.15683,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.000662,-0.21567,-0.24207,1,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0083098,-0.21771,-0.16822,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,7.4873e-07,-0.21868,-0.25502,1,0
4,GO VIRAL TRANSLATION,0.00033432,-0.21974,-0.22274,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.03006,-0.22028,-0.14616,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.023173,-0.22216,-0.16349,1,0
4,GO NUCLEAR PORE ORGANIZATION,0.0069343,-0.22222,-0.15132,1,0
4,GO TELOMERASE RNA LOCALIZATION,0.00018923,-0.22365,-0.21194,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,2.2824e-05,-0.22514,-0.20918,1,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00021857,-0.22815,-0.21901,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.00017457,-0.22882,-0.21465,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0016806,-0.22893,-0.23744,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,2.5868e-06,-0.23197,-0.19306,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,7.6283e-05,-0.23447,-0.23346,1,0
4,GO POSTSYNAPSE ASSEMBLY,0.028852,-0.2357,-0.22842,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.024428,-0.23995,-0.19968,1,0
4,GO TELENCEPHALON REGIONALIZATION,0.0081133,-0.24215,-0.22183,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0010558,-0.24357,-0.22236,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,3.5461e-06,-0.24479,-0.23449,1,0
4,GO LIMB BUD FORMATION,0.014332,-0.24494,-0.22503,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00083767,-0.24521,-0.26648,1,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.014013,-0.24921,-0.18863,1,0
4,GO ADULT HEART DEVELOPMENT,0.0015463,-0.25036,-0.21919,1,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.00032408,-0.25564,-0.23378,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.0049019,-0.26173,-0.17298,1,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.0098086,-0.26313,-0.26864,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0068504,-0.26537,-0.19875,1,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00055343,-0.26785,-0.29302,1,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0046604,-0.27101,-0.3009,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00012388,-0.27171,-0.2282,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0014022,-0.27966,-0.2443,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0070192,-0.28638,-0.28781,1,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.016938,-0.28691,-0.20934,1,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0052854,-0.30807,-0.23715,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,2.3891e-06,-0.30823,-0.28985,1,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,2.011e-05,-0.32157,-0.41753,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0005056,-0.32524,-0.32724,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00043435,-0.38046,-0.28964,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00016901,-0.39217,-0.33724,1,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.00053704,-0.4053,-0.31075,1,0
4,GO CARDIAC CHAMBER FORMATION,2.5884e-05,-0.43388,-0.40148,1,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00021511,-0.43419,-0.34483,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00039018,-0.44353,-0.45228,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,2.5424e-05,-0.48476,-0.43081,1,0
4,GO CARDIAC VENTRICLE FORMATION,3.8924e-05,-0.49775,-0.42451,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00064263,-0.52087,-0.42615,1,0
4,GO HEMIDESMOSOME ASSEMBLY,0.21437,0.24684,0.091155,0,1
4,GO NEPHRIC DUCT MORPHOGENESIS,0.075674,0.24366,0.13182,0,1
4,GO SKIN MORPHOGENESIS,0.21437,0.2259,0.089179,0,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.1146,0.19373,0.18864,0,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.16407,0.18539,0.10747,0,1
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.1533,0.17443,0.10948,0,1
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.068619,0.16779,0.13505,0,1
4,GO FEMALE GENITALIA DEVELOPMENT,0.092339,0.16597,0.077874,0,1
4,GO SEGMENT SPECIFICATION,0.15447,0.15897,0.11327,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.075674,0.15865,0.14541,0,1
4,GO ENDODERM DEVELOPMENT,0.068619,0.15503,0.11422,0,1
4,GO STORE OPERATED CALCIUM ENTRY,0.081168,0.15034,0.097341,0,1
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.072397,0.14763,0.13424,0,1
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.12721,0.14704,0.081871,0,1
4,GO PARENTAL BEHAVIOR,0.068006,0.14663,0.12661,0,1
4,GO ENDODERMAL CELL DIFFERENTIATION,0.20265,0.1461,0.096011,0,1
4,GO RESPONSE TO LEUCINE,0.075674,0.1445,0.12533,0,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.075009,0.1443,0.11129,0,1
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.070488,0.1434,0.1317,0,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.20699,0.14179,0.10827,0,1
4,GO REGULATION OF GTP BINDING,0.096327,0.14159,0.10796,0,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.20265,0.14084,0.12319,0,1
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11092,0.14025,0.10329,0,1
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.39606,0.13782,0.050318,0,1
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.084034,0.13738,0.1527,0,1
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.11367,0.13715,0.088212,0,1
4,GO STARTLE RESPONSE,0.095518,0.13675,0.096885,0,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.086981,0.13215,0.09046,0,1
4,GO REGULATION OF GLUTAMATE SECRETION,0.084034,0.13029,0.11411,0,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.18866,0.13008,0.11018,0,1
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.079071,0.1292,0.10765,0,1
4,GO PROTEIN LOCALIZATION TO AXON,0.09714,0.12854,0.19095,0,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.1313,0.12847,0.11644,0,1
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.093918,0.12751,0.10395,0,1
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.27495,0.12637,0.067471,0,1
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.40973,0.12608,0.04579,0,1
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.27853,0.1243,0.07872,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.34627,0.12321,0.050039,0,1
4,GO MYELOID CELL DEVELOPMENT,0.075009,0.1226,0.09117,0,1
4,GO NEURAL NUCLEUS DEVELOPMENT,0.070488,0.12226,0.11506,0,1
4,GO SEX DETERMINATION,0.070488,0.12197,0.08275,0,1
4,GO CRANIAL NERVE MORPHOGENESIS,0.096327,0.12073,0.10919,0,1
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.14642,0.12039,0.15694,0,1
4,GO REGULATION OF CALCIUM ION IMPORT,0.095518,0.1203,0.084785,0,1
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.1252,0.11868,0.093044,0,1
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.3871,0.11819,0.063387,0,1
4,GO PROTEIN TRIMERIZATION,0.095518,0.11711,0.090884,0,1
4,GO MULTI ORGANISM CELLULAR PROCESS,0.077698,0.11671,0.090487,0,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.08331,0.1155,0.10934,0,1
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.1387,0.11498,0.07601,0,1
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.13027,0.11354,0.08162,0,1
4,GO VAGINA DEVELOPMENT,0.16654,0.1119,0.068108,0,1
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.071756,0.1107,0.10676,0,1
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.093126,0.1103,0.088079,0,1
4,GO PIRNA METABOLIC PROCESS,0.28578,0.10672,0.10936,0,1
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.178,0.10391,0.084646,0,1
4,GO COCHLEA DEVELOPMENT,0.46218,0.10054,0.017014,0,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.26789,0.10043,0.06139,0,1
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.10471,0.10031,0.084528,0,1
4,GO MAGNESIUM ION HOMEOSTASIS,0.51819,0.10012,0.028096,0,1
4,GO PODOSOME ASSEMBLY,0.33396,0.099716,0.065029,0,1
4,GO REGULATION OF EXCRETION,0.13027,0.099046,0.080891,0,1
4,GO REGULATION OF TUBULIN DEACETYLATION,0.12421,0.098806,0.10902,0,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.09796,0.098648,0.089041,0,1
4,GO RESPONSE TO ESTROGEN,0.11092,0.096311,0.077014,0,1
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.10823,0.095931,0.073809,0,1
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.10558,0.095122,0.11202,0,1
4,GO EAR MORPHOGENESIS,0.071756,0.095054,0.067623,0,1
4,GO CELL MIGRATION IN HINDBRAIN,0.37827,0.09473,0.084738,0,1
4,GO RESPONSE TO PROSTAGLANDIN,0.087731,0.093502,0.10929,0,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.068619,0.093163,0.0782,0,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.082591,0.0928,0.073457,0,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.13027,0.092396,0.064045,0,1
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.099614,0.09148,0.091962,0,1
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.18062,0.091471,0.086707,0,1
4,GO EMBRYO IMPLANTATION,0.17411,0.091394,0.090015,0,1
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.14869,0.091146,0.065592,0,1
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.16285,0.090033,0.07629,0,1
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.31021,0.089835,0.04371,0,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.22195,0.089324,0.045355,0,1
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.21587,0.088186,0.073566,0,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.13338,0.087738,0.077657,0,1
4,GO MULTICELLULAR ORGANISM GROWTH,0.13656,0.086151,0.062493,0,1
4,GO COLLATERAL SPROUTING,0.44994,0.086061,0.05224,0,1
4,GO LAMELLIPODIUM ORGANIZATION,0.22658,0.085557,0.064979,0,1
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.15802,0.08553,0.067794,0,1
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.24911,0.085342,0.067248,0,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.086981,0.085251,0.088271,0,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.10912,0.085112,0.094309,0,1
4,GO ENDODERM FORMATION,0.15214,0.084455,0.095654,0,1
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.077018,0.083605,0.05443,0,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.11367,0.082831,0.10064,0,1
4,GO GROOMING BEHAVIOR,0.1653,0.082658,0.085848,0,1
4,GO CARBOHYDRATE PHOSPHORYLATION,0.1653,0.082459,0.085901,0,1
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.12224,0.081853,0.098364,0,1
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.52082,0.081817,0.036082,0,1
4,GO HEAD MORPHOGENESIS,0.28578,0.081673,0.065116,0,1
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.14419,0.080859,0.071871,0,1
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.33396,0.080256,0.032753,0,1
4,GO INNER EAR MORPHOGENESIS,0.070488,0.078004,0.079491,0,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.077018,0.077564,0.062685,0,1
4,GO SENSORY ORGAN MORPHOGENESIS,0.16163,0.077518,0.052613,0,1
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.11367,0.077344,0.079351,0,1
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.16904,0.076853,0.060031,0,1
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.1252,0.076559,0.097807,0,1
4,GO TAXIS,0.093918,0.076448,0.069286,0,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.073694,0.076097,0.055495,0,1
4,GO POSITIVE REGULATION OF BINDING,0.086237,0.075927,0.062671,0,1
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.079765,0.075496,0.074099,0,1
4,GO ACETYL COA METABOLIC PROCESS,0.14419,0.075272,0.067327,0,1
4,GO HYPOTONIC RESPONSE,0.29502,0.074919,0.045883,0,1
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.11837,0.074893,0.073664,0,1
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.090782,0.074504,0.086681,0,1
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.22503,0.074463,0.040924,0,1
4,GO REGULATION OF MITOPHAGY,0.075009,0.073461,0.09248,0,1
4,GO ACTIVATION OF MAPKK ACTIVITY,0.093126,0.0727,0.095639,0,1
4,GO MITOCHONDRIAL FUSION,0.30829,0.072258,0.053427,0,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.090782,0.072191,0.084718,0,1
4,GO CELL CELL SIGNALING BY WNT,0.098784,0.072043,0.065203,0,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.17029,0.071969,0.081998,0,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.10214,0.07179,0.086547,0,1
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.10385,0.071558,0.16385,0,1
4,GO CELLULAR RESPONSE TO ATP,0.071119,0.071258,0.081187,0,1
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.18866,0.070942,0.060232,0,1
4,GO MUSCLE FIBER DEVELOPMENT,0.25583,0.070934,0.057249,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.26095,0.070854,0.060865,0,1
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.080464,0.070469,0.10158,0,1
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.14755,0.070117,0.064383,0,1
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.1262,0.069011,0.12485,0,1
4,GO CALCINEURIN MEDIATED SIGNALING,0.14642,0.06849,0.06605,0,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.32195,0.067392,0.051796,0,1
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.30829,0.066705,0.042597,0,1
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.42838,0.066273,0.040509,0,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.11183,0.065537,0.095502,0,1
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12924,0.065119,0.070282,0,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.54746,0.064598,0.027391,0,1
4,GO CELL RECOGNITION,0.48722,0.064587,0.027064,0,1
4,GO HEART GROWTH,0.38488,0.062414,0.043008,0,1
4,GO NUCLEOSIDE SALVAGE,0.12421,0.062372,0.056655,0,1
4,GO RESPONSE TO GAMMA RADIATION,0.18062,0.061522,0.051003,0,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.084034,0.060914,0.055768,0,1
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.082591,0.060276,0.11118,0,1
4,GO BEHAVIOR,0.12322,0.060103,0.065161,0,1
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.099614,0.059658,0.05655,0,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.086237,0.058784,0.068064,0,1
4,GO DEVELOPMENTAL GROWTH,0.27673,0.058531,0.044529,0,1
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.2644,0.058432,0.045146,0,1
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.079765,0.058056,0.069703,0,1
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.17669,0.056094,0.051894,0,1
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.33396,0.054785,0.027606,0,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.42133,0.054755,0.050527,0,1
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.1387,0.054592,0.048661,0,1
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.14197,0.054502,0.063505,0,1
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.36311,0.054086,0.046269,0,1
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.15565,0.053656,0.059912,0,1
4,GO NEURON APOPTOTIC PROCESS,0.073043,0.053557,0.060757,0,1
4,GO COENZYME A METABOLIC PROCESS,0.10646,0.052646,0.087009,0,1
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.28945,0.052428,0.042893,0,1
4,GO DEVELOPMENTAL CELL GROWTH,0.56103,0.052372,0.026356,0,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.51557,0.051707,0.039367,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.16407,0.050583,0.058718,0,1
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.075674,0.049519,0.058995,0,1
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20122,0.049255,0.053353,0,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.14197,0.049251,0.056195,0,1
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.27673,0.048547,0.03741,0,1
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.16163,0.048346,0.09361,0,1
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.19697,0.048146,0.065998,0,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.26614,0.047787,0.033523,0,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.12224,0.046848,0.065664,0,1
4,GO RESPONSE TO PROSTAGLANDIN E,0.22814,0.046451,0.061918,0,1
4,GO PHOTOPERIODISM,0.1262,0.045778,0.081399,0,1
4,GO REGULATION OF DEPHOSPHORYLATION,0.15565,0.045225,0.053751,0,1
4,GO RESPONSE TO IONIZING RADIATION,0.14983,0.045202,0.046285,0,1
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.079765,0.044659,0.063994,0,1
4,GO PROTEIN KINASE A SIGNALING,0.6515,0.044633,0.020569,0,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.088486,0.044348,0.056579,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.10823,0.043985,0.065442,0,1
4,GO REGULATION OF PROTEIN TARGETING,0.10385,0.043947,0.05972,0,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.84741,0.043175,0.020113,0,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.23286,0.042425,0.078951,0,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.15683,0.042037,0.065115,0,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.06986,0.041524,0.061197,0,1
4,GO NEUROMUSCULAR PROCESS,0.48215,0.041103,0.037324,0,1
4,GO RESPONSE TO SALT,0.14869,0.040855,0.062919,0,1
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.13027,0.040221,0.060021,0,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.15447,0.039744,0.042421,0,1
4,GO NADH METABOLIC PROCESS,0.39156,0.036198,0.057819,0,1
4,GO PHOTOTRANSDUCTION,0.10646,0.034676,0.032403,0,1
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.16163,0.034575,0.040987,0,1
4,GO CELL CYCLE ARREST,0.16904,0.032205,0.048033,0,1
4,GO MAINTENANCE OF PROTEIN LOCATION,0.27853,0.032168,0.046455,0,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.38933,0.031969,0.038196,0,1
4,GO REGULATION OF CELL CYCLE,0.38047,0.023812,0.026986,0,1
4,GO INTESTINAL LIPID ABSORPTION,2.913e-06,0.4489,0.57197,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0010113,0.37395,0.30563,0,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,6.8885e-07,0.37263,0.36912,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,3.2784e-06,0.31098,0.43858,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0077327,0.30913,0.27689,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.029754,0.26863,0.11193,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.079765,0.25522,0.2058,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.032607,0.25177,0.32274,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.21437,0.25006,0.1393,0,0
4,GO RESPONSE TO INSECTICIDE,0.000662,0.24599,0.27463,0,0
4,GO REGULATION OF RESPIRATORY BURST,2.342e-06,0.2423,0.30873,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.22195,0.22847,0.1148,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.40973,0.22482,0.085078,0,0
4,GO DIET INDUCED THERMOGENESIS,1.2253e-05,0.22222,0.23052,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.13763,0.22022,0.13758,0,0
4,GO RESPIRATORY BURST,0.00026438,0.21348,0.22179,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.016568,0.212,0.21145,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0051547,0.21091,0.19921,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.027686,0.21003,0.13121,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,2.1624e-06,0.20749,0.26799,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.019104,0.20077,0.13191,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0042636,0.19721,0.14623,0,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0022396,0.19621,0.18719,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.066192,0.19527,0.25638,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0022095,0.19321,0.27343,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,2.0478e-05,0.19299,0.19737,0,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00076726,0.19294,0.21681,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.00087508,0.19003,0.14325,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0021505,0.18954,0.24729,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.0039481,0.18917,0.27181,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0048405,0.18741,0.23102,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.29315,0.18692,0.073554,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.19278,0.1842,0.075468,0,0
4,GO ETHANOL OXIDATION,0.14869,0.18171,0.1638,0,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00054518,0.17825,0.26278,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.023919,0.17586,0.17923,0,0
4,GO MALE SEX DETERMINATION,0.03068,0.17522,0.13798,0,0
4,GO FLUID TRANSPORT,0.00015838,0.1739,0.19462,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.099614,0.17292,0.1373,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.022446,0.17164,0.30997,0,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.024687,0.1707,0.24598,0,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.0089251,0.16865,0.19119,0,0
4,GO RESPONSE TO LEPTIN,0.00037835,0.16791,0.19087,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.19417,0.16696,0.044244,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.59986,0.16685,0.026531,0,0
4,GO NEURON CELL CELL ADHESION,0.15802,0.16683,0.16294,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.090011,0.16629,0.14215,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0044864,0.16509,0.11411,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,3.4409e-05,0.16318,0.18498,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.5,0.16261,0.070022,0,0
4,GO GDP METABOLIC PROCESS,0.023419,0.16117,0.15378,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.010645,0.16046,0.23489,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.096327,0.15868,0.13588,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.062684,0.15796,0.25118,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.095518,0.15741,0.13681,0,0
4,GO DEVELOPMENTAL PIGMENTATION,0.0018764,0.15716,0.1319,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.0099244,0.15699,0.20975,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.03068,0.1563,0.1585,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.12924,0.15551,0.36914,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.086981,0.15545,0.16144,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.018898,0.1547,0.18505,0,0
4,GO MIDBODY ABSCISSION,4.1751e-05,0.15109,0.19582,0,0
4,GO HEART INDUCTION,0.061549,0.1506,0.19365,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.019104,0.14934,0.16728,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.0061347,0.14915,0.213,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.21288,0.14751,0.13654,0,0
4,GO ESTROUS CYCLE,0.060988,0.14667,0.14442,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.47461,0.14586,0.037464,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.004156,0.14554,0.18852,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.10299,0.14484,0.095639,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.018693,0.14477,0.14367,0,0
4,GO SYNAPSE MATURATION,0.34008,0.14417,0.094272,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.01829,0.1431,0.15578,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.00011218,0.14272,0.15427,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.079765,0.14256,0.1507,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0041031,0.14101,0.15378,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.17411,0.14015,0.077802,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.026838,0.14007,0.16921,0,0
4,GO REGULATION OF ODONTOGENESIS,0.05357,0.13975,0.16129,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.16042,0.13882,0.1095,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.071756,0.13876,0.11398,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.031311,0.13859,0.17308,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.1313,0.13774,0.094784,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.068006,0.13717,0.20477,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.34213,0.13528,0.06643,0,0
4,GO PLATELET MORPHOGENESIS,0.0072795,0.13495,0.1627,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.20554,0.13476,0.17555,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.000286,0.13401,0.19971,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0011668,0.13349,0.15934,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.31409,0.13286,0.077844,0,0
4,GO VIRAL BUDDING,0.00044781,0.13173,0.14058,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.14869,0.13097,0.141,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.018091,0.13012,0.20424,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.17156,0.12949,0.093316,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.063258,0.1294,0.11695,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.12224,0.12857,0.1003,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.34008,0.12811,0.19497,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.087731,0.1262,0.12352,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.36311,0.12558,0.012933,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.13656,0.1253,0.13332,0,0
4,GO RESPONSE TO UV B,0.18595,0.12504,0.083239,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.19697,0.12496,0.084373,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.084763,0.12408,0.10897,0,0
4,GO CELL AGGREGATION,0.34008,0.12367,0.051615,0,0
4,GO ZINC ION HOMEOSTASIS,0.014823,0.12355,0.19539,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.12924,0.1229,0.098318,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.000286,0.12233,0.13911,0,0
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0054872,0.12219,0.14459,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.46962,0.12211,0.030391,0,0
4,GO BLASTODERM SEGMENTATION,0.57476,0.12202,0.03826,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.178,0.12196,0.079969,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.23128,0.12164,0.11929,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.043866,0.12115,0.12449,0,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.05063,0.1211,0.13512,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.10214,0.12016,0.074116,0,0
4,GO LACTATE METABOLIC PROCESS,0.042197,0.11991,0.12533,0,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.077698,0.11969,0.1005,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.075009,0.11955,0.11359,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.022686,0.11955,0.13139,0,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00036686,0.11946,0.14043,0,0
4,GO PANCREAS DEVELOPMENT,0.016386,0.11936,0.12899,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.031311,0.11799,0.1754,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.01849,0.11754,0.14627,0,0
4,GO COPULATION,0.010041,0.11751,0.1515,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.015329,0.11718,0.16006,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.15098,0.11697,0.16593,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.36098,0.11669,0.067983,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.08331,0.11618,0.11049,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.021973,0.11548,0.14382,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.027401,0.11535,0.12461,0,0
4,GO REGULATION OF VESICLE FUSION,0.086237,0.11529,0.14422,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.040981,0.11517,0.12857,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.1793,0.11382,0.078253,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.08331,0.1136,0.14393,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.35463,0.11358,0.038705,0,0
4,GO SARCOMERE ORGANIZATION,0.022928,0.11354,0.11708,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.02128,0.11353,0.16952,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.15447,0.11332,0.08592,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.25246,0.11246,0.096887,0,0
4,GO POLYOL BIOSYNTHETIC PROCESS,6.3249e-05,0.11246,0.17431,0,0
4,GO OOCYTE DIFFERENTIATION,0.010769,0.11157,0.10299,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.47712,0.1112,0.042076,0,0
4,GO METANEPHROS DEVELOPMENT,0.049681,0.10997,0.10741,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.099614,0.1098,0.13543,0,0
4,GO ETHANOL METABOLIC PROCESS,0.37608,0.10958,0.051529,0,0
4,GO PREPULSE INHIBITION,0.70185,0.10953,0.018119,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.13979,0.10932,0.076973,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.035336,0.10911,0.14629,0,0
4,GO RENAL FILTRATION,0.13656,0.10909,0.16289,0,0
4,GO MAST CELL MIGRATION,0.62832,0.1088,0.039664,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.068619,0.10844,0.17264,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.12126,0.10823,0.067017,0,0
4,GO NOSE DEVELOPMENT,0.39832,0.10744,0.1506,0,0
4,GO CGMP MEDIATED SIGNALING,0.30066,0.10714,0.057175,0,0
4,GO ORGAN INDUCTION,0.012227,0.10714,0.12486,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.026013,0.10698,0.19808,0,0
4,GO ARTERY MORPHOGENESIS,0.10299,0.10678,0.07924,0,0
4,GO GANGLION DEVELOPMENT,0.24416,0.10623,0.15253,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.37608,0.10611,0.02496,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.084034,0.1059,0.082595,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.10734,0.10589,0.07982,0,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.022686,0.10581,0.096969,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.016938,0.10567,0.11294,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.45972,0.10559,0.031769,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.068619,0.10529,0.14176,0,0
4,GO PARTURITION,0.0086125,0.1045,0.17393,0,0
4,GO OXYGEN TRANSPORT,0.42838,0.10346,0.032416,0,0
4,GO PERICARDIUM DEVELOPMENT,0.44269,0.10333,0.044352,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.33803,0.1031,0.048796,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.094715,0.10309,0.1102,0,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0086125,0.10293,0.11368,0,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0037498,0.10287,0.12892,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.1754,0.10255,0.11486,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.14755,0.10249,0.082657,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.022686,0.10249,0.12508,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.17283,0.10233,0.13432,0,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.016205,0.10193,0.11658,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.45482,0.10191,0.033478,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0086125,0.10191,0.14008,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.086981,0.10143,0.10974,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.063836,0.1013,0.10615,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.41434,0.10112,0.051554,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00015838,0.10104,0.1584,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.086981,0.10069,0.1075,0,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.015674,0.10066,0.12532,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.035691,0.10011,0.13362,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0027747,0.10007,0.14359,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.11553,0.099933,0.088114,0,0
4,GO MYOBLAST DIFFERENTIATION,0.12029,0.099919,0.080071,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.024428,0.097847,0.15033,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.09714,0.097755,0.078231,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.61402,0.097398,-0.018939,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.088486,0.097262,0.090276,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.034984,0.097195,0.10056,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.21437,0.096947,0.057394,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.063258,0.09622,0.091503,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.19417,0.096055,0.074579,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.01585,0.095593,0.12493,0,0
4,GO FACE DEVELOPMENT,0.18327,0.095441,0.084869,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.02915,0.095152,0.11172,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.15098,0.094954,0.087527,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.42602,0.094867,0.08528,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.24416,0.094781,0.068823,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.22971,0.094346,0.10797,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.01829,0.094066,0.13923,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.011544,0.093937,0.15389,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.54208,0.093915,0.060855,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.54746,0.093356,0.045826,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.12029,0.093119,0.085259,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.019523,0.092945,0.12389,0,0
4,GO TRABECULA FORMATION,0.35043,0.092708,0.064123,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.31215,0.092105,0.074992,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.24745,0.092084,0.094945,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.14983,0.091942,0.10694,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.11367,0.091754,0.1135,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0093576,0.091202,0.14771,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.39156,0.090498,0.050002,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.011813,0.090336,0.11289,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.086237,0.090157,0.067569,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.572,0.090048,0.075203,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.24911,0.090044,0.16987,0,0
4,GO NOTOCHORD DEVELOPMENT,0.40514,0.090038,0.043236,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.12126,0.089614,0.085767,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.72299,0.089482,0.026582,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.08331,0.089257,0.094704,0,0
4,GO SEQUESTERING OF METAL ION,0.80012,0.089118,-0.033032,0,0
4,GO NEPHRON MORPHOGENESIS,0.037509,0.089115,0.1001,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.11367,0.089057,0.093056,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.178,0.088883,0.068486,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.065005,0.088469,0.10966,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.50516,0.08827,0.050378,0,0
4,GO BODY MORPHOGENESIS,0.13234,0.088018,0.10006,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.59144,0.087816,0.051391,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.057179,0.087641,0.11302,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.060432,0.087599,0.11313,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.33396,0.087094,0.054437,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.44994,0.086807,0.12111,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.30066,0.086794,0.066487,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.13656,0.086602,0.057841,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.014823,0.08651,0.12074,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.077698,0.086483,0.091966,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.017894,0.086171,0.15802,0,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.015674,0.086096,0.11147,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.040187,0.085992,0.16929,0,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0083098,0.085816,0.11399,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.075674,0.085744,0.092574,0,0
4,GO DNA DEALKYLATION,0.15214,0.085517,0.070342,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.46962,0.085337,0.075371,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.1146,0.085288,0.1108,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.070488,0.085214,0.094802,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.43312,0.084828,0.10099,0,0
4,GO ARGININE METABOLIC PROCESS,0.10471,0.08464,0.15884,0,0
4,GO RENAL WATER HOMEOSTASIS,0.16778,0.084351,0.072162,0,0
4,GO VESICLE DOCKING,0.038258,0.084146,0.099123,0,0
4,GO RESPONSE TO POTASSIUM ION,0.71391,0.084131,0.028422,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.11647,0.08391,0.075687,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.35463,0.083848,0.076716,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.088486,0.083828,0.079993,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.091558,0.08375,0.1043,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.41666,0.083555,0.036205,0,0
4,GO VASCULOGENESIS,0.31409,0.083485,0.059782,0,0
4,GO MEMBRANE BIOGENESIS,0.36526,0.083396,0.061503,0,0
4,GO RESPONSE TO AXON INJURY,0.099614,0.083352,0.10194,0,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.069238,0.083347,0.068512,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.29502,0.083177,0.077645,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.034636,0.082997,0.085525,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.3871,0.082716,0.057273,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.17411,0.082662,0.085744,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.12029,0.08256,0.061868,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.46466,0.082117,0.034533,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.63986,0.081975,0.011645,0,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.13979,0.081964,0.073089,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.027401,0.08176,0.088446,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.20992,0.081485,0.085083,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.039406,0.081392,0.13087,0,0
4,GO CGMP METABOLIC PROCESS,0.85059,0.081119,0.0077824,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.41203,0.081106,0.093308,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.38488,0.080483,0.035486,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.36526,0.08046,0.048489,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.17283,0.080383,0.10212,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.25583,0.08036,0.036936,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.15802,0.079807,0.053944,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.075009,0.07971,0.068734,0,0
4,GO REGULATION OF PINOCYTOSIS,0.51035,0.079589,0.022714,0,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.064418,0.079435,0.081839,0,0
4,GO AXIS ELONGATION,0.318,0.079295,0.051847,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.049212,0.079278,0.10482,0,0
4,GO NOREPINEPHRINE SECRETION,0.09714,0.079198,0.11906,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.1146,0.079064,0.080844,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.18461,0.078949,0.097507,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.37827,0.078928,0.058593,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.50258,0.078683,0.028506,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.012367,0.078266,0.090242,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.18327,0.078228,0.096293,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.11933,0.077839,0.081177,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.12421,0.077825,0.10993,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.15214,0.077682,0.080915,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.051111,0.077276,0.097015,0,0
4,GO FIBROBLAST ACTIVATION,0.12322,0.077264,0.09572,0,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.35886,0.077122,0.11004,0,0
4,GO ECTODERM DEVELOPMENT,0.085497,0.076864,0.072515,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.042609,0.076346,0.078098,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.18595,0.076277,0.091791,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.178,0.076205,0.14647,0,0
4,GO AXONEME ASSEMBLY,0.079071,0.07572,0.099917,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.7814,0.075603,-0.020429,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.572,0.075474,0.034592,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.30255,0.074899,0.087958,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.21288,0.074896,0.06357,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.20409,0.074847,0.038626,0,0
4,GO TRABECULA MORPHOGENESIS,0.23605,0.074817,0.066513,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21288,0.074752,0.078136,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.29689,0.074679,0.091605,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.27853,0.074359,0.067537,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.33194,0.074232,0.058887,0,0
4,GO RHYTHMIC BEHAVIOR,0.10299,0.074211,0.088913,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.042197,0.07416,0.088587,0,0
4,GO GONADOTROPIN SECRETION,0.10823,0.074157,0.11177,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.14197,0.07386,0.075609,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.2644,0.073311,0.060227,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.18461,0.073242,0.057626,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.5314,0.07317,0.046053,0,0
4,GO SEX DIFFERENTIATION,0.017315,0.072962,0.083589,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.10214,0.072923,0.065545,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.32993,0.072914,0.078819,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.35886,0.072913,0.043545,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.25078,0.072851,0.037122,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.26614,0.072704,0.054958,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.76281,0.072326,0.024678,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.15098,0.072265,0.17537,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.25753,0.071677,0.03723,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.30255,0.071676,0.041364,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.079765,0.071652,0.059602,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.024947,0.071629,0.14784,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.9113,0.071442,0.017049,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.58029,0.071406,0.040875,0,0
4,GO PINOCYTOSIS,0.29502,0.071128,0.050454,0,0
4,GO WATER TRANSPORT,0.089246,0.070908,0.090988,0,0
4,GO REGULATION OF BINDING,0.017894,0.070782,0.083015,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.14308,0.070593,0.07087,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.14755,0.07035,0.072541,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.5,0.070258,0.059054,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.27853,0.070105,0.15308,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.22814,0.070084,0.069693,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.69885,0.070083,0.022871,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.18595,0.069942,0.046439,0,0
4,GO EMBRYO DEVELOPMENT,0.093918,0.06993,0.057944,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.16163,0.069743,0.063823,0,0
4,GO REGIONALIZATION,0.12421,0.069671,0.066943,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.18866,0.069418,0.079862,0,0
4,GO AMP METABOLIC PROCESS,0.57752,0.069241,0.0071498,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.10214,0.069175,0.064426,0,0
4,GO SPROUTING ANGIOGENESIS,0.20122,0.06914,0.070268,0,0
4,GO EPITHELIAL TUBE FORMATION,0.10299,0.069098,0.062879,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.32592,0.069009,0.088382,0,0
4,GO MYOFIBRIL ASSEMBLY,0.028852,0.068994,0.10788,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.21437,0.068935,0.060798,0,0
4,GO ALDITOL METABOLIC PROCESS,0.29315,0.068616,0.043569,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.36956,0.068426,0.047549,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.19697,0.06838,0.070745,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.3871,0.068002,0.048492,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.062114,0.067983,0.078571,0,0
4,GO RNA INTERFERENCE,0.61687,0.067894,0.013981,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.70185,0.067872,0.013126,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.11275,0.067868,0.095099,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.2458,0.067775,0.083096,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.67501,0.067717,0.032344,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.46218,0.067697,0.015436,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.26267,0.067634,0.064956,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.052083,0.067482,0.10212,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.50258,0.067467,0.026838,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.18327,0.067262,0.063875,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.22814,0.067247,0.070991,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.318,0.067063,0.067298,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.12924,0.066892,0.071111,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22503,0.066342,0.068278,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.10214,0.066088,0.046195,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.43789,0.065493,0.035927,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15802,0.065064,0.097884,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.30066,0.06489,0.053491,0,0
4,GO MITOTIC DNA REPLICATION,0.33599,0.064651,0.054098,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.2714,0.064578,0.07009,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.21738,0.064527,0.14262,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.35886,0.064452,0.070923,0,0
4,GO NEURON REMODELING,0.23766,0.064202,0.073784,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.10471,0.064188,0.11103,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.10385,0.064186,0.10663,0,0
4,GO AORTA MORPHOGENESIS,0.1453,0.064111,0.090185,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.24252,0.063715,0.079235,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.30829,0.063712,0.079528,0,0
4,GO PIGMENT METABOLIC PROCESS,0.099614,0.063674,0.083037,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.09714,0.063603,0.073889,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.30637,0.063586,0.044301,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.28578,0.063422,0.078847,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.19003,0.063368,0.087073,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.31215,0.063306,0.057508,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.14088,0.063157,0.065702,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.13234,0.063117,0.06707,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.16654,0.063002,0.096041,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.0046018,0.062982,0.12112,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.3739,0.062483,0.038718,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.24252,0.062427,0.084899,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.11553,0.062364,0.077645,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.31997,0.062359,0.031518,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.28213,0.062207,0.04146,0,0
4,GO RETINA LAYER FORMATION,0.18461,0.061667,0.11828,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.50776,0.061605,0.081892,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.091558,0.061554,0.08933,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.11092,0.061348,0.088268,0,0
4,GO GROWTH HORMONE SECRETION,0.25414,0.061243,0.11973,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.15802,0.06114,0.065625,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.02174,0.061106,0.082541,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.66616,0.061074,0.044673,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.39156,0.061051,0.064174,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.32792,0.060955,0.09295,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.14642,0.060851,0.067819,0,0
4,GO OXIDATIVE PHOSPHORYLATION,0.043866,0.060668,0.074397,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.086237,0.060585,0.074112,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.14419,0.060538,0.063563,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.15565,0.060273,0.058481,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.13338,0.060181,0.065787,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.49743,0.060076,0.053244,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.027401,0.059984,0.072534,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.63986,0.059952,0.032164,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.55016,0.059843,0.03145,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.3739,0.059628,0.068721,0,0
4,GO OVULATION,0.21738,0.059555,0.060438,0,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.058787,0.059552,0.080186,0,0
4,GO LYMPH NODE DEVELOPMENT,0.016568,0.05946,0.12839,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.45238,0.059434,0.04205,0,0
4,GO L AMINO ACID TRANSPORT,0.065005,0.059303,0.08814,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.22195,0.05913,0.066301,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.43075,0.059013,0.048219,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.033608,0.058982,0.091879,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.11367,0.058778,0.10055,0,0
4,GO MEMORY,0.085497,0.058271,0.078897,0,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.25583,0.05822,0.062801,0,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.16654,0.05812,0.055144,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.040187,0.057825,0.080908,0,0
4,GO SEROTONIN SECRETION,0.46962,0.057736,0.055927,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.94026,0.057619,-0.0073782,0,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.022686,0.057515,0.10375,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.63697,0.057275,0.037508,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.08331,0.057084,0.065916,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.14869,0.057006,0.079988,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.09796,0.056322,0.11367,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.071756,0.05632,0.085291,0,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.15565,0.056173,0.064234,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.34835,0.056172,0.038443,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.29689,0.056093,0.08373,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.87926,0.055912,0.0072421,0,0
4,GO SPERM AXONEME ASSEMBLY,0.24089,0.055841,0.082828,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.40743,0.055579,0.067593,0,0
4,GO SEGMENTATION,0.13656,0.055552,0.068271,0,0
4,GO RESPONSE TO FOOD,0.43789,0.055513,0.023713,0,0
4,GO AXIS SPECIFICATION,0.15098,0.05542,0.065209,0,0
4,GO TONGUE MORPHOGENESIS,0.93382,0.055386,-0.023067,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.038637,0.05529,0.10215,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.077018,0.055202,0.064221,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.27495,0.055189,0.080317,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.66616,0.05511,0.024203,0,0
4,GO PROTEIN TETRAMERIZATION,0.35674,0.055003,0.034679,0,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.33194,0.054985,0.070418,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.22658,0.054919,0.10555,0,0
4,GO SOMITE DEVELOPMENT,0.077698,0.054594,0.072184,0,0
4,GO HEART DEVELOPMENT,0.24252,0.054557,0.053353,0,0
4,GO VESICLE LOCALIZATION,0.010522,0.054476,0.088292,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.99192,0.054299,0.0017468,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.23766,0.054297,0.086295,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.34008,0.054249,0.043572,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.12721,0.054247,0.097661,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.40514,0.054141,0.039967,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.18595,0.053978,0.11111,0,0
4,GO TUBE FORMATION,0.1533,0.053901,0.052809,0,0
4,GO URETER DEVELOPMENT,0.24089,0.053867,0.066595,0,0
4,GO AMINO ACID TRANSPORT,0.015159,0.05375,0.10857,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.42602,0.053446,0.052457,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.31215,0.053416,-0.10999,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.06986,0.053383,0.0991,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.25078,0.053196,0.050338,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.24745,0.052993,0.066423,0,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.19557,0.052984,0.058391,0,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.22348,0.052885,0.051166,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.20122,0.052829,0.099075,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.086981,0.052583,0.062942,0,0
4,GO CELLULAR RESPIRATION,0.086981,0.052558,0.071392,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.41203,0.052534,0.049281,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12822,0.052407,0.11565,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.87287,0.052023,0.019697,0,0
4,GO HINDBRAIN DEVELOPMENT,0.2114,0.051772,0.066602,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.46962,0.051482,0.059142,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.20992,0.051476,0.079534,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.082591,0.051469,0.057397,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12822,0.051449,0.06534,0,0
4,GO ADULT BEHAVIOR,0.2714,0.051205,0.074702,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.92416,0.050966,-0.033387,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.20265,0.05096,0.091076,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.37608,0.050911,0.085632,0,0
4,GO SYNAPSE ASSEMBLY,0.46466,0.050628,0.043396,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.62258,0.050509,0.023159,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.11742,0.050229,0.1139,0,0
4,GO GERM CELL DEVELOPMENT,0.12322,0.050121,0.041599,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.57752,0.05009,0.052429,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.17669,0.050039,0.058999,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.63986,0.049943,0.038952,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.34835,0.049908,0.078838,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.068006,0.049861,0.079249,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.67501,0.049767,0.0074626,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.71693,0.049648,0.025847,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.31997,0.049376,0.064884,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.39606,0.049325,0.060708,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.35674,0.049316,0.069718,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.2644,0.049274,0.064837,0,0
4,GO RRNA CATABOLIC PROCESS,0.4451,0.049156,0.047207,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.10045,0.049051,0.097111,0,0
4,GO RESPONSE TO VITAMIN A,0.29315,0.048861,0.043192,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.71996,0.048778,0.040908,0,0
4,GO OOGENESIS,0.5314,0.048731,0.026737,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.14197,0.04871,0.059148,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.35043,0.048654,0.062096,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.42133,0.048602,0.053004,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.26095,0.048522,0.054095,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.15802,0.048508,0.081119,0,0
4,GO OVULATION CYCLE,0.17669,0.048398,0.064073,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.77829,0.048396,0.017353,0,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.11275,0.04802,0.033403,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.50258,0.048006,0.025106,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.10299,0.047961,0.082727,0,0
4,GO ORGANELLE INHERITANCE,0.11367,0.047929,0.082881,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.29689,0.047752,0.055795,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.10823,0.047738,0.078756,0,0
4,GO MESENCHYME DEVELOPMENT,0.318,0.047694,0.0467,0,0
4,GO RESPONSE TO ZINC ION,0.044722,0.047584,0.14539,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.060432,0.047571,0.061442,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.15447,0.047551,0.065959,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.57752,0.047448,0.035183,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.32993,0.047443,0.099709,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.16042,0.047242,0.099897,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.22195,0.047238,0.065632,0,0
4,GO ODONTOGENESIS,0.44269,0.047168,0.051741,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.22503,0.047165,0.067946,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.20992,0.047064,0.073998,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.80639,0.047053,0.0058367,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.18062,0.046833,0.068268,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.12721,0.0468,0.082386,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.32592,0.046721,0.060852,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.26789,0.046685,0.09308,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.068619,0.04668,0.10779,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.19417,0.046674,0.049405,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.33194,0.046413,0.038827,0,0
4,GO RESPONSE TO COCAINE,0.11367,0.046411,0.07795,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.23128,0.046308,0.076463,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.52345,0.046292,0.046594,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.9693,0.046242,-0.0046473,0,0
4,GO TUBULIN DEACETYLATION,0.35674,0.046231,0.066503,0,0
4,GO EYE MORPHOGENESIS,0.40514,0.046187,0.040869,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.075674,0.046088,0.058611,0,0
4,GO BRONCHUS DEVELOPMENT,0.20699,0.046039,0.14379,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.31215,0.045895,0.068942,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.11647,0.04575,0.10315,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.24745,0.045745,0.049687,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.077698,0.045724,0.07294,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.31021,0.045658,0.06149,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.28033,0.045652,0.050456,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.1453,0.045625,0.074702,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.34835,0.045417,0.04585,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.28761,0.045362,0.054436,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.1146,0.045359,0.071221,0,0
4,GO STEM CELL DIVISION,0.54477,0.04519,0.035276,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.099614,0.044844,0.10497,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.28395,0.044785,0.042935,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.45482,0.044758,0.058509,0,0
4,GO PROTEIN REFOLDING,0.21889,0.044735,0.070817,0,0
4,GO TOXIN TRANSPORT,0.11553,0.044718,0.093434,0,0
4,GO VISUAL BEHAVIOR,0.11002,0.044629,0.079476,0,0
4,GO CELL FATE DETERMINATION,0.1533,0.044486,0.094091,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.09796,0.044462,0.14255,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.80012,0.044426,0.0461,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.19557,0.044283,0.064692,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.57752,0.04428,0.031329,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.17156,0.044107,0.071005,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.33599,0.043919,0.064102,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.44994,0.043755,0.027526,0,0
4,GO SPERMATID DIFFERENTIATION,0.21587,0.043748,0.035395,0,0
4,GO SYNAPSE ORGANIZATION,0.80953,0.043574,-0.0049698,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.58307,0.043567,0.032295,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.88245,0.043553,0.01502,0,0
4,GO NEUROGENESIS,0.73517,0.043504,0.018073,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.83474,0.043413,0.026514,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.41203,0.043358,0.097462,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.013856,0.043326,0.077483,0,0
4,GO RESPONSE TO GLUCAGON,0.28213,0.043196,0.050166,0,0
4,GO GASTRIC ACID SECRETION,0.090011,0.043154,0.087161,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.70486,0.043015,0.025036,0,0
4,GO MITOCHONDRIAL TRANSPORT,0.11553,0.042983,0.047441,0,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.2458,0.042957,0.042731,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.5665,0.042801,0.056825,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.23286,0.042728,0.05175,0,0
4,GO SYNAPTIC SIGNALING,0.80012,0.042129,0.019029,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.69286,0.041828,0.028843,0,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.24252,0.041811,0.060437,0,0
4,GO THYMUS DEVELOPMENT,0.22971,0.041736,0.051816,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.24416,0.041717,0.032103,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.25414,0.041696,0.07621,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.44994,0.041665,0.045537,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.35886,0.041507,0.044422,0,0
4,GO RESPONSE TO DOPAMINE,0.44752,0.041298,0.045113,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.27495,0.041177,0.034587,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.15802,0.040997,0.039425,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.042197,0.040941,0.13404,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.8379,0.040743,-0.0012129,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.40514,0.040702,0.045642,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.34213,0.040416,0.11741,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.10299,0.040413,0.081159,0,0
4,GO TOOTH MINERALIZATION,0.21437,0.040294,0.10249,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.42838,0.040261,0.085851,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.19417,0.040255,0.063136,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.42838,0.040252,0.070975,0,0
4,GO CYSTEINE METABOLIC PROCESS,0.88565,0.040223,0.0057687,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.23766,0.040063,0.045557,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.85694,0.039938,0.021901,0,0
4,GO CILIUM MOVEMENT,0.094715,0.039873,0.060407,0,0
4,GO EXPLORATION BEHAVIOR,0.93704,0.039706,-0.025827,0,0
4,GO SLEEP,0.20409,0.03961,0.065316,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.45727,0.039453,0.043437,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.31021,0.039451,0.060316,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.60834,0.039392,0.015272,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.13027,0.039244,0.039313,0,0
4,GO NEURON DEVELOPMENT,0.96607,0.039162,0.008948,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.076344,0.039155,0.099175,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.089246,0.039032,0.076229,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.2114,0.038991,0.052626,0,0
4,GO LYSINE METABOLIC PROCESS,0.45727,0.03881,0.040294,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.41899,0.03876,0.054366,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.83474,0.038732,0.024643,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.46713,0.038694,0.037443,0,0
4,GO HEAD DEVELOPMENT,0.57752,0.038692,0.02776,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.14197,0.038633,0.11578,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.43075,0.038497,0.04097,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.78451,0.038435,-0.018824,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.25078,0.038267,0.045559,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.31215,0.038178,0.046282,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.14983,0.038144,0.088871,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.16042,0.038125,0.21295,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.36956,0.038117,0.06003,0,0
4,GO ASYMMETRIC CELL DIVISION,0.1533,0.037887,0.10012,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.22814,0.037654,0.036807,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.55016,0.037617,0.043556,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.92738,0.037576,0.0015458,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.3739,0.037544,0.044085,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.1873,0.037467,0.12551,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.64858,0.037452,-0.0024195,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.38933,0.037448,0.061209,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.18595,0.037438,0.058463,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.28578,0.037386,0.055191,0,0
4,GO CELLULAR SENESCENCE,0.18062,0.037251,0.050699,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.98222,0.037132,-0.011917,0,0
4,GO MACROMOLECULE DEACYLATION,0.098784,0.037119,0.057375,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.11933,0.037003,0.073197,0,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.28395,0.036993,0.053097,0,0
4,GO T CELL CHEMOTAXIS,0.178,0.036871,0.053909,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.58029,0.036856,0.033939,0,0
4,GO DEMETHYLATION,0.21738,0.03685,0.047317,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.61972,0.03681,0.042952,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.67798,0.036792,0.040696,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.6312,0.03658,0.029442,0,0
4,GO NEURAL TUBE FORMATION,0.21288,0.036556,0.059327,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.40514,0.036319,0.076289,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.29315,0.036283,0.048764,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.23128,0.03618,0.059524,0,0
4,GO REGULATION OF HEAT GENERATION,0.82842,0.036117,0.02586,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.42367,0.035994,0.043584,0,0
4,GO ACTIN CROSSLINK FORMATION,0.63408,0.035932,0.028288,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.42133,0.03588,0.044846,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.24252,0.035843,0.051582,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.91451,0.035817,0.0093708,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.081877,0.035731,0.14489,0,0
4,GO CELL PROJECTION ORGANIZATION,0.56103,0.035675,0.025745,0,0
4,GO FEMALE GAMETE GENERATION,0.40058,0.035544,0.029875,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.54208,0.035525,0.029998,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.4451,0.035456,0.049673,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.86649,0.035433,-0.022659,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.51296,0.035421,0.03584,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.16042,0.035401,0.084576,0,0
4,GO NAD METABOLIC PROCESS,0.35886,0.035279,0.064752,0,0
4,GO NEURON PROJECTION REGENERATION,0.80326,0.034902,0.031277,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.32393,0.034836,0.048455,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.36098,0.03481,0.049167,0,0
4,GO HEME METABOLIC PROCESS,0.12029,0.034774,0.10997,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.10912,0.034631,0.087984,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.13763,0.034488,0.077281,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.89526,0.034482,0.011554,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.47211,0.034298,0.03879,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.75664,0.034279,0.01674,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.19979,0.034171,0.045115,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.19278,0.034164,0.08159,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.67206,0.034134,0.0015859,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.38488,0.034126,0.048358,0,0
4,GO RECEPTOR INTERNALIZATION,0.60268,0.0341,0.031922,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.47461,0.034037,0.11586,0,0
4,GO BONE MATURATION,0.92416,0.033919,0.010358,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.33194,0.033845,0.069884,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.55016,0.033835,0.017316,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.42602,0.03365,0.072206,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.64276,0.033644,0.032566,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.18062,0.033591,0.06613,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.14088,0.033547,0.088281,0,0
4,GO GOLGI LOCALIZATION,0.14642,0.033521,0.071973,0,0
4,GO SPERM MOTILITY,0.22658,0.033486,0.048795,0,0
4,GO ORGAN GROWTH,0.64858,0.033476,0.026907,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.6515,0.033395,0.022857,0,0
4,GO MITOCHONDRIAL FISSION,0.14983,0.033174,0.089436,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.92416,0.033133,-6.4125e-05,0,0
4,GO SEROTONIN TRANSPORT,0.7659,0.033015,0.037778,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.42367,0.033012,0.040905,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.98546,0.032966,0.0099857,0,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.38488,0.032755,0.048202,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.54477,0.032434,0.048519,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.94993,0.032396,0.0099102,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.10646,0.03227,0.049144,0,0
4,GO PRESYNAPTIC ENDOCYTOSIS,0.22503,0.032231,0.087518,0,0
4,GO INTERACTION WITH SYMBIONT,0.50516,0.032099,0.021959,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.87606,0.032057,0.015721,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.47211,0.031936,0.056394,0,0
4,GO METENCEPHALON DEVELOPMENT,0.70185,0.031553,0.030089,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.40743,0.031542,0.044412,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.21437,0.031383,0.077381,0,0
4,GO PROTEASOME ASSEMBLY,0.75972,0.031349,0.017454,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.31409,0.031302,0.029293,0,0
4,GO REGULATION OF CELL SIZE,0.86331,0.031237,0.014451,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29877,0.031174,0.041948,0,0
4,GO NEURON DIFFERENTIATION,0.95316,0.031149,0.004982,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.30829,0.031091,0.055476,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.89526,0.031062,-0.0050216,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.35253,0.030778,0.039693,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.22503,0.030602,0.099665,0,0
4,GO PROTEIN FOLDING,0.03429,0.0306,0.085395,0,0
4,GO CELL FATE SPECIFICATION,0.91451,0.030471,0.00052529,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.67798,0.0304,0.021171,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.27853,0.030369,0.077177,0,0
4,GO CYTOSKELETON ORGANIZATION,0.40743,0.030058,0.035258,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.54208,0.030008,0.030085,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.12322,0.030006,0.065731,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.73822,0.029838,0.017019,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.29877,0.029781,0.040003,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.55287,0.029749,-0.058555,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.62545,0.02973,0.02852,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.61117,0.029623,0.034579,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.67206,0.029418,-0.0099719,0,0
4,GO FAT CELL PROLIFERATION,0.80953,0.029331,0.026996,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.068006,0.029323,0.076333,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.64276,0.0293,0.010095,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.64567,0.02927,0.032316,0,0
4,GO CELL PROJECTION ASSEMBLY,0.30255,0.029171,0.037915,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.42367,0.029164,0.070791,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.19838,0.029135,0.063164,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.32993,0.029122,0.071467,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.82842,0.029119,0.0088053,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.26267,0.02907,0.050418,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.72603,0.029042,0.0094027,0,0
4,GO HEAT GENERATION,0.62545,0.028836,0.029819,0,0
4,GO HEART MORPHOGENESIS,0.69885,0.028619,0.021971,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.38488,0.02855,0.053136,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.34008,0.028433,0.026472,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.42133,0.028391,0.040284,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.51035,0.028309,-0.028593,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.21587,0.028177,0.056727,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.10912,0.028177,0.068374,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.26789,0.028109,0.072302,0,0
4,GO CELL AGING,0.094715,0.028108,0.061533,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.38488,0.028091,0.070618,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.50776,0.027995,0.028072,0,0
4,GO MIDBRAIN DEVELOPMENT,0.36311,0.027988,0.037426,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.20554,0.027965,0.11179,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.34627,0.027957,0.029111,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.59705,0.027939,0.047854,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.30637,0.027827,0.046444,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.78763,0.027757,0.013749,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.55016,0.027683,0.036194,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.68094,0.027645,-0.046354,0,0
4,GO RNA DESTABILIZATION,0.90167,0.027626,0.010336,0,0
4,GO MESENCHYME MORPHOGENESIS,0.59705,0.027554,0.041219,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.9113,0.027414,0.010741,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.30446,0.027386,0.032587,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.1653,0.027301,0.080958,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.6312,0.027208,0.023328,0,0
4,GO EXTRACELLULAR TRANSPORT,0.18461,0.027088,0.070783,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.6691,0.027046,0.030961,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.60834,0.026988,0.026891,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.48722,0.026974,0.043297,0,0
4,GO RESPONSE TO RADIATION,0.19003,0.026946,0.037245,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.98869,0.026914,0.016734,0,0
4,GO CELL FATE COMMITMENT,0.50258,0.026877,0.034941,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.85694,0.026863,-0.022958,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.95639,0.026828,0.0044526,0,0
4,GO SPINAL CORD PATTERNING,0.62832,0.026808,0.05435,0,0
4,GO COGNITION,0.81896,0.026805,0.016249,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.66028,0.026803,0.0075003,0,0
4,GO LIPID PHOSPHORYLATION,0.18595,0.026688,0.070794,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.22503,0.026632,0.060074,0,0
4,GO APPENDAGE DEVELOPMENT,0.91772,0.026615,0.01433,0,0
4,GO MESODERM DEVELOPMENT,0.56925,0.02648,0.027567,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.42838,0.026472,0.073981,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.44994,0.02636,0.022355,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.80953,0.026313,0.013635,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.27495,0.026234,0.035171,0,0
4,GO INTRACELLULAR TRANSPORT,0.037882,0.026128,0.05563,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.10558,0.025911,0.041076,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.41899,0.0259,0.025683,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.32393,0.025718,0.044709,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.64567,0.025709,0.026714,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.91772,0.025681,0.0057236,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.34213,0.025583,0.072592,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.48215,0.025433,0.032399,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.572,0.02533,0.028736,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.52345,0.025317,-0.049475,0,0
4,GO PEPTIDE CROSS LINKING,0.16778,0.02504,0.07589,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.31409,0.024905,0.034452,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.32792,0.024818,0.074848,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.39381,0.024809,0.027606,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.42367,0.024681,0.022527,0,0
4,GO TRNA 5 LEADER REMOVAL,0.6055,0.024625,0.024152,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.43789,0.02457,0.03648,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.20122,0.024516,0.083399,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.45238,0.024376,0.036134,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.50776,0.024351,0.0051298,0,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.38267,0.024188,0.03609,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.19979,0.024186,0.047,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.58307,0.024138,-0.031512,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.29315,0.024019,0.063032,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.6312,0.023863,0.02706,0,0
4,GO MEIOTIC CELL CYCLE,0.29502,0.023862,0.035557,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.31409,0.023852,0.041023,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.4355,0.023843,0.050068,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.71089,0.023823,0.017193,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.2644,0.023798,0.046882,0,0
4,GO RESPONSE TO MANGANESE ION,0.20845,0.02363,0.072531,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.82526,0.023522,0.016664,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.43789,0.023433,0.062411,0,0
4,GO DNA MODIFICATION,0.41434,0.023306,0.030273,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.24911,0.023094,0.047108,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.38488,0.023072,0.037462,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.46218,0.023056,0.028991,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.38267,0.022832,0.042244,0,0
4,GO RESPONSE TO HEAT,0.38267,0.022718,0.046795,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.99515,0.022649,0.0091696,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.56376,0.022613,0.026308,0,0
4,GO ORGANELLE LOCALIZATION,0.10045,0.022374,0.044525,0,0
4,GO CARTILAGE DEVELOPMENT,0.31604,0.02216,0.066207,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.29689,0.022111,0.093765,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.35674,0.021985,0.032432,0,0
4,GO NEGATIVE CHEMOTAXIS,0.96284,0.021743,-0.00041851,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.6055,0.021711,0.04218,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.80326,0.02139,0.013575,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.39606,0.02133,0.041578,0,0
4,GO DECIDUALIZATION,0.41434,0.021282,0.073788,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.31604,0.021258,0.093046,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.43312,0.021228,-0.023257,0,0
4,GO RESPONSE TO SALT STRESS,0.74128,0.021009,-0.019991,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.46466,0.020945,0.031237,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.92416,0.020918,0.0084523,0,0
4,GO LACTATION,0.61972,0.020852,0.039211,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.95961,0.020815,-0.0021007,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.37608,0.020783,0.036181,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.6691,0.02068,0.012071,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.64858,0.020575,0.032517,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.17029,0.020544,0.045732,0,0
4,GO PRESYNAPSE ORGANIZATION,0.83474,0.020521,0.0099587,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.40973,0.020331,0.039166,0,0
4,GO HEART FIELD SPECIFICATION,0.85376,0.02014,0.0041093,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.73212,0.020052,-0.0066211,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.31215,0.019946,0.054774,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.90488,0.019909,0.019767,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.71391,0.0198,0.057946,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.48215,0.019409,0.054168,0,0
4,GO ARTERY DEVELOPMENT,0.90809,0.019397,0.0014951,0,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.12322,0.019359,0.04177,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.24745,0.019324,0.10788,0,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.5394,0.019287,-0.027654,0,0
4,GO STEM CELL PROLIFERATION,0.64276,0.019067,0.031436,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.8379,0.019036,-0.0031575,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.73517,0.018932,-0.0089675,0,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10299,0.018874,0.13775,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.63697,0.018735,0.023955,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.87606,0.018735,0.02333,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.68094,0.018523,-0.0071664,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.27673,0.018523,0.042561,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.68988,0.018471,-0.073412,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.88565,0.018436,-0.03997,0,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.10471,0.01837,0.094446,0,0
4,GO NEURON PROJECTION EXTENSION,0.74435,0.018338,-0.010784,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.20265,0.018217,0.086998,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.85376,0.018068,0.0045463,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.36741,0.017934,0.07135,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.80326,0.017842,0.0037826,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.33599,0.017802,0.033343,0,0
4,GO CELL MORPHOGENESIS,0.90167,0.017772,0.017247,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.62545,0.017677,0.032014,0,0
4,GO STRIATUM DEVELOPMENT,0.75972,0.017642,0.021751,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.62832,0.017632,-0.031109,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72603,0.017572,0.032476,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.97899,0.017558,0.045515,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.85694,0.017238,-0.015523,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.47963,0.01711,0.057107,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.86012,0.016915,0.022368,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.74128,0.016879,0.010483,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.58029,0.016867,0.07814,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.67798,0.016855,0.028381,0,0
4,GO PROTEIN POLYMERIZATION,0.79075,0.016668,0.022236,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.49231,0.016508,0.052554,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.59986,0.016446,-0.0075329,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.98546,0.016294,0.0040452,0,0
4,GO MATING BEHAVIOR,0.23927,0.016288,0.056928,0,0
4,GO ANIMAL ORGAN FORMATION,0.99515,0.016106,-0.00011057,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.86649,0.015896,0.0037413,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.70787,0.015813,0.014442,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.37173,0.015767,0.031332,0,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.28761,0.015758,0.033017,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.48468,0.01565,0.02422,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.2714,0.015628,0.040759,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.97576,0.015548,-0.00089746,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.66616,0.015536,0.031954,0,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.57476,0.015492,-0.026087,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.97899,0.015307,0.0019814,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.47461,0.015277,0.042629,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.89846,0.015217,-0.0024973,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.37827,0.015173,0.056733,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.83158,0.015169,0.024397,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.95639,0.015166,0.0041159,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.63408,0.015027,-0.030693,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.58585,0.014976,-0.0064839,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.8379,0.014965,-0.0047678,0,0
4,GO REGULATION OF CELL AGING,0.96284,0.01489,0.005583,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.83158,0.014672,-0.00997,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.65442,0.014579,-0.015261,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.53672,0.014561,0.033891,0,0
4,GO BIOLOGICAL PHASE,0.42367,0.014354,0.074886,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.75664,0.014265,0.013475,0,0
4,GO GAS TRANSPORT,0.7814,0.013964,0.0017439,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.66028,0.013959,0.034298,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.80326,0.013885,0.0028366,0,0
4,GO NCRNA CATABOLIC PROCESS,0.3871,0.013873,0.044607,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.43075,0.013711,0.063134,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.99515,0.013625,0.007499,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.74435,0.01355,0.039674,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4355,0.013447,0.027487,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.68689,0.013315,0.021163,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.85694,0.013278,0.0099041,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.92738,0.013269,0.0095998,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.5394,0.013165,0.050982,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.70787,0.01306,-0.020587,0,0
4,GO METHYLATION,0.56103,0.012968,-0.018386,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.17669,0.012941,0.070211,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.6312,0.012774,0.028335,0,0
4,GO THALAMUS DEVELOPMENT,0.44028,0.01265,0.076457,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.77519,0.012601,0.020713,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.5394,0.012565,0.042005,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.88565,0.012552,0.0098192,0,0
4,GO APPENDAGE MORPHOGENESIS,0.72603,0.012498,-0.0089544,0,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.39606,0.012425,-0.083836,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.80012,0.012403,0.033794,0,0
4,GO EXIT FROM MITOSIS,0.46466,0.012281,0.037624,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.25246,0.012096,0.056033,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.58029,0.012047,0.018677,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.52082,0.011918,-0.019431,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87926,0.011888,0.032775,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.82842,0.011884,-0.01981,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.62832,0.011805,0.03101,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.46713,0.011783,0.063555,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.71996,0.011753,-0.026905,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.65442,0.011728,0.048525,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.66321,0.011508,0.040088,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.58029,0.011327,0.035259,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.82842,0.011248,-0.00017365,0,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.38267,0.011117,-0.046045,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.79075,0.011107,-0.040739,0,0
4,GO AORTA DEVELOPMENT,0.69885,0.011067,-0.016747,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.45727,0.011017,0.0030408,0,0
4,GO HISTONE MONOUBIQUITINATION,0.68094,0.011016,0.021151,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.73212,0.011004,0.027566,0,0
4,GO THYROID GLAND DEVELOPMENT,0.77829,0.010926,-0.024761,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.67501,0.010864,0.044176,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.76899,0.010783,0.02062,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.51296,0.010408,-0.017013,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.94993,0.010323,0.0053636,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.66616,0.0099642,0.033879,0,0
4,GO HEART VALVE DEVELOPMENT,0.6312,0.0099179,0.038642,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.98546,0.0099099,0.0084401,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.51557,0.0098285,0.028785,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.36311,0.0098053,0.029365,0,0
4,GO PROTEIN IMPORT,0.41203,0.0096825,0.037399,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.70787,0.0095743,0.047777,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.22195,0.0094965,0.06686,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.35463,0.0094828,0.042467,0,0
4,GO DOSAGE COMPENSATION,0.95639,0.0094525,0.011314,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.49231,0.0092805,0.084749,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.55558,0.0088933,-0.015971,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.67798,0.0088901,0.025228,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.51557,0.0088776,0.038035,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.51819,0.008877,0.069088,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.29315,0.0087761,0.04724,0,0
4,GO RNA MODIFICATION,0.48722,0.0087518,-0.021396,0,0
4,GO MITOTIC CYTOKINESIS,0.98546,0.0086874,0.010683,0,0
4,GO BONE DEVELOPMENT,0.91772,0.0085873,0.0098032,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.82842,0.0085465,0.013003,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.68392,0.0085133,0.030985,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.94348,0.0084249,0.020539,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.9693,0.0083926,0.010109,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.74741,0.0083164,0.011277,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.63697,0.0083026,-0.062373,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.95639,0.008048,-0.0035218,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.73822,0.0080084,0.028698,0,0
4,GO ORGANELLE FISSION,0.90809,0.0079455,0.010916,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.77519,0.0078607,0.0084898,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.71996,0.0077139,0.022334,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96284,0.0076671,0.0060202,0,0
4,GO MEMBRANE DOCKING,0.82211,0.0075529,0.019956,0,0
4,GO FOREBRAIN DEVELOPMENT,0.6691,0.007506,-0.0029673,0,0
4,GO REGULATION OF CELL DIVISION,0.37173,0.0073531,0.038327,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.25924,0.0071373,0.068677,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.9693,0.0071273,0.019304,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.75356,0.0070023,-0.018236,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.82526,0.0069714,0.0038056,0,0
4,GO TORC1 SIGNALING,0.48722,0.006659,0.036145,0,0
4,GO CELL CYCLE,0.99838,0.0065694,0.013205,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.41434,0.006441,0.074294,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.94671,0.0063781,0.0026662,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.46218,0.0063483,0.10005,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.78451,0.0063165,0.014821,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.80326,0.0062926,0.004293,0,0
4,GO NEUROBLAST DIVISION,0.82526,0.0062743,0.024682,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.6312,0.0062249,-0.015786,0,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.72907,0.0061864,0.020214,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.7659,0.0059652,0.021648,0,0
4,GO HISTONE DEACETYLATION,0.38488,0.0058506,0.040956,0,0
4,GO STEM CELL DIFFERENTIATION,0.64858,0.0057778,0.026677,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.20554,0.0055893,0.085028,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.72907,0.005546,0.030707,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.67501,0.005513,0.033165,0,0
4,GO OVULATION CYCLE PROCESS,0.38488,0.0053053,0.049747,0,0
4,GO HISTONE H4 ACETYLATION,0.9306,0.0049689,0.010214,0,0
4,GO REGULATION OF ERAD PATHWAY,0.48722,0.0049058,0.038819,0,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.60268,0.0048799,-0.015051,0,0
4,GO ORGANELLE ASSEMBLY,0.92416,0.0048173,0.010182,0,0
4,GO SPECIFICATION OF SYMMETRY,0.70787,0.0047791,-0.0075194,0,0
4,GO CYTOKINESIS,0.61972,0.0047697,-0.0007482,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.59705,0.0046355,0.020742,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.95961,0.0045202,0.026173,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.9113,0.0045116,0.0068525,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.74741,0.0045046,0.033005,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.5314,0.004459,-0.020047,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.56925,0.0042509,0.064897,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.40743,0.0041729,0.045173,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.77209,0.0041677,0.020546,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.50258,0.0041351,0.05707,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.34627,0.004132,-0.040385,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.39156,0.0039802,0.05816,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.9693,0.0038129,0.090039,0,0
4,GO REGULATION OF DNA METHYLATION,0.99515,0.0037807,0.01958,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.82211,0.003598,0.0020023,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.41899,0.0035602,0.047339,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.3739,0.0034376,-0.038407,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.77829,0.0033208,0.04509,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.81267,0.0033029,0.027293,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.79075,0.0032915,0.03791,0,0
4,GO RESPONSE TO VITAMIN D,0.89526,0.0032323,0.015391,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.9693,0.0032127,0.0048434,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.92416,0.0030969,0.0074067,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.85376,0.0030767,0.023384,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.90167,0.0030496,-0.0017228,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.70787,0.0029518,-0.01896,0,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.66028,0.0028718,-0.009736,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.93382,0.0025685,0.0055855,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.86331,0.0025029,0.010695,0,0
4,GO PROTEIN ACYLATION,0.97253,0.00243,0.0097233,0,0
4,GO MALE MEIOSIS I,0.48976,0.0024263,0.10358,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.98222,0.0023541,0.0048559,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.76899,0.0022897,-0.011295,0,0
4,GO PENILE ERECTION,0.84424,0.0022569,0.0016966,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.46466,0.0021511,-0.035444,0,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.88245,0.0018265,0.011029,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.46962,0.0017162,0.10726,0,0
4,GO BLASTOCYST FORMATION,0.25246,0.0016262,0.070721,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.72603,0.0014507,0.028243,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.55287,0.0014079,-0.0076967,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.93704,0.0012608,0.00024869,0,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.38488,0.0012011,0.066823,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.79075,0.0011717,0.0076201,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.6055,0.0010968,-0.016196,0,0
4,GO CRISTAE FORMATION,0.73517,0.0010472,0.034246,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.9306,0.00090402,0.029431,0,0
4,GO FEVER GENERATION,0.61402,0.00088014,-0.030085,0,0
4,GO AXONAL FASCICULATION,0.79387,0.00086958,-0.039538,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.94026,0.0007692,0.0057211,0,0
4,GO REGULATION OF DNA BINDING,0.98869,0.00072055,0.01316,0,0
4,GO PROTEIN NITROSYLATION,0.58029,0.00067034,-0.068542,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.46466,0.00058591,-0.015526,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.48722,0.00021305,0.087182,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.32792,0.00020278,0.048206,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.58585,0.00020062,0.036935,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.90167,0.00012814,0.0093668,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.59144,6.6957e-05,0.030308,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.97253,2.3244e-05,0.010774,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.60268,1.5644e-05,-0.015977,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.68988,-0.00015075,-0.021438,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.62832,-0.00022203,-0.023761,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.3871,-0.00022846,-0.043407,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.62258,-0.00028272,-0.0052562,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.57476,-0.00033943,-0.035486,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.81581,-0.0005587,-0.00048248,0,0
4,GO CONVERGENT EXTENSION,0.93704,-0.00059649,0.012113,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.54477,-0.00079893,-0.0045602,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.19003,-0.0010557,-0.08594,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.65442,-0.0012111,0.04331,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.86649,-0.0013633,0.0055794,0,0
4,GO AEROBIC RESPIRATION,0.11553,-0.0015915,0.079423,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.74128,-0.0015978,0.021319,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.59986,-0.0016073,-0.06949,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.40058,-0.0016243,0.094163,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.41203,-0.0016296,0.036019,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.46713,-0.0016483,-0.019351,0,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.94671,-0.0017518,0.014987,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.97576,-0.0018042,0.0082761,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.35674,-0.0018418,-0.047461,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.74128,-0.0019118,0.024465,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.55287,-0.0019437,0.06487,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.82526,-0.0020998,-0.0024163,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.48976,-0.0022615,-0.019543,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.82211,-0.0022679,0.01668,0,0
4,GO HYPEROSMOTIC RESPONSE,0.94993,-0.0022732,0.016596,0,0
4,GO PROTEIN TARGETING,0.96284,-0.0024082,0.0018904,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.59986,-0.0026756,-0.0085351,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.34213,-0.0027449,-0.046285,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.70185,-0.002745,-0.003789,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.48468,-0.0027663,0.035049,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.73517,-0.002908,0.024406,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.23445,-0.0030725,-0.045701,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.35253,-0.0030947,0.051124,0,0
4,GO HISTONE H2A UBIQUITINATION,0.95961,-0.0031106,-0.0015142,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.41899,-0.003321,0.03153,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.98546,-0.0033605,0.014133,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98869,-0.0036344,0.0067511,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.71089,-0.0036372,-0.0091668,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.90167,-0.0036795,0.0089895,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.82211,-0.0042977,0.014842,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.33803,-0.0043359,-0.022313,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.90167,-0.0044222,0.0031915,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.88245,-0.0045164,0.018625,0,0
4,GO IMPORT INTO NUCLEUS,0.81581,-0.004624,0.016647,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.73212,-0.0046838,-0.0066356,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.34008,-0.0047189,0.071757,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.89205,-0.005112,0.026061,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,1,-0.00517,0.017442,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.94026,-0.0054656,0.0096401,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.91451,-0.0055618,0.025269,0,0
4,GO CENTROSOME SEPARATION,0.6515,-0.0055778,0.048009,0,0
4,GO PORE COMPLEX ASSEMBLY,0.94026,-0.0056004,0.0080665,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.68988,-0.0056644,0.04292,0,0
4,GO RESPONSE TO X RAY,0.45972,-0.0056807,-0.045245,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.54477,-0.0057107,0.066603,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.77209,-0.0059148,0.011413,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.82526,-0.0059928,0.028788,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.37827,-0.0061761,-0.014327,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.61687,-0.0062574,-0.01118,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.29877,-0.0064931,-0.025614,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.86331,-0.0067243,0.020757,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.8379,-0.0068128,0.0068798,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.72907,-0.0068874,-0.023517,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.61117,-0.0069485,0.028005,0,0
4,GO LEARNING,0.53672,-0.0070792,-0.024695,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.7659,-0.0071318,-0.0049128,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.99838,-0.0071805,0.008598,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.69586,-0.0072351,-0.012509,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.86649,-0.007426,0.006214,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.7814,-0.0076584,0.03857,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.26789,-0.007672,-0.042011,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.8379,-0.0078214,0.035614,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.84107,-0.0079085,0.0032427,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.48468,-0.0081018,0.048492,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.87606,-0.008332,0.0051435,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.55016,-0.0083496,0.050678,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.50258,-0.0084143,-0.003632,0,0
4,GO NEUROBLAST PROLIFERATION,0.47461,-0.0084839,-0.028518,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.93704,-0.008516,0.014072,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.58307,-0.0085762,-0.016746,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.95639,-0.0085898,0.012021,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.84424,-0.0086304,0.012479,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.4355,-0.0089053,0.053667,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.15098,-0.0089324,-0.043583,0,0
4,GO CILIUM ORGANIZATION,0.88565,-0.0089483,0.0029819,0,0
4,GO GMP METABOLIC PROCESS,0.94671,-0.0090732,0.017729,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.55558,-0.0091032,0.032746,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.68094,-0.0091221,0.0017035,0,0
4,GO FOREGUT MORPHOGENESIS,0.92738,-0.0096038,-0.013412,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.90167,-0.0097263,0.0073835,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.83474,-0.0097503,0.051414,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.95961,-0.0098984,0.0052653,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.54477,-0.010047,0.085425,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.9306,-0.010103,0.023773,0,0
4,GO CELL PART MORPHOGENESIS,0.30446,-0.01026,-0.03671,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.8379,-0.010329,0.0020859,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.82211,-0.0104,0.0070687,0,0
4,GO NUCLEUS ORGANIZATION,0.71996,-0.010605,0.0267,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.98546,-0.010655,0.014378,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.52609,-0.01067,-0.0013481,0,0
4,GO VESICLE CARGO LOADING,0.71693,-0.010719,0.043337,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.89205,-0.010739,0.0086569,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.96607,-0.010789,0.024508,0,0
4,GO MISMATCH REPAIR,0.89526,-0.010791,-0.00077315,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.52874,-0.010797,-0.020305,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.94348,-0.010808,0.013366,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.32393,-0.011013,-0.09533,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.39156,-0.011146,-0.024846,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.59986,-0.011161,0.021325,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.52874,-0.01156,-0.034261,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.81896,-0.011565,0.012589,0,0
4,GO MICROTUBULE ANCHORING,0.40514,-0.011569,-0.026129,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.71391,-0.011787,-0.012945,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.91451,-0.012003,-0.0021845,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.54208,-0.012038,-0.010632,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.86968,-0.01217,0.0021129,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.88565,-0.012198,0.0046218,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.26614,-0.012249,-0.035338,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.26964,-0.012406,0.095394,0,0
4,GO CELL CYCLE CHECKPOINT,0.52609,-0.012517,-0.0039483,0,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.22042,-0.012634,-0.052349,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.85059,-0.012685,0.0041328,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.86331,-0.013019,0.0038152,0,0
4,GO GENE SILENCING,0.41434,-0.013031,-0.016937,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.48976,-0.013159,-0.029829,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.34008,-0.013172,-0.03211,0,0
4,GO ACROSOME ASSEMBLY,0.24745,-0.013328,-0.064422,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.47211,-0.013336,-0.012614,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.70486,-0.013344,0.0013907,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.41203,-0.013372,-0.020362,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.92094,-0.013487,-0.0035018,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.65734,-0.013628,-0.027683,0,0
4,GO L GLUTAMATE IMPORT,0.65734,-0.013672,-0.024046,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.70486,-0.013719,0.0016996,0,0
4,GO AXON DEVELOPMENT,0.22195,-0.013763,-0.053434,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.80326,-0.014074,0.013565,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.2458,-0.01412,-0.063493,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.77829,-0.014213,-0.0051642,0,0
4,GO HEART FORMATION,0.68094,-0.014261,-0.0087591,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.46962,-0.01428,-0.0062912,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.43312,-0.014412,-0.048606,0,0
4,GO P BODY ASSEMBLY,0.80012,-0.014759,0.0013517,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.5,-0.014836,-0.024351,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.87287,-0.014947,0.032896,0,0
4,GO RECEPTOR CLUSTERING,0.54477,-0.015184,-0.030145,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.9306,-0.015221,0.0089739,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.48468,-0.015293,-0.025426,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.39832,-0.015333,-0.030292,0,0
4,GO FORELIMB MORPHOGENESIS,0.42367,-0.015398,-0.054034,0,0
4,GO GLUTAMATE SECRETION,0.81581,-0.015551,0.023776,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,1,-0.015595,0.0028775,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.75664,-0.015907,0.017951,0,0
4,GO TRNA METABOLIC PROCESS,0.18595,-0.015924,-0.047092,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.76281,-0.016068,-0.0081256,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.67501,-0.01618,-0.041993,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.97576,-0.016278,0.01976,0,0
4,GO MRNA TRANSCRIPTION,0.87606,-0.016421,0.02968,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.6691,-0.016509,0.033064,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.62545,-0.016535,-0.012347,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.86012,-0.016586,0.028943,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.97253,-0.016586,-0.0065545,0,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.28578,-0.016587,-0.011042,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.79075,-0.016665,-0.0092215,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.48468,-0.016886,-0.024685,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.3442,-0.016897,-0.048033,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.93382,-0.016909,0.011225,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.59144,-0.016995,-0.0044785,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.29315,-0.017498,-0.031555,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.44994,-0.017895,-0.029125,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.19697,-0.017899,-0.058766,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.46713,-0.017951,-0.03526,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.83158,-0.01798,-0.0045023,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.49743,-0.018031,-0.041695,0,0
4,GO PRIMARY MIRNA PROCESSING,0.90809,-0.018347,-0.00053881,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.51296,-0.018505,-0.015005,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.70787,-0.01864,0.039178,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.71996,-0.018673,-0.01729,0,0
4,GO SIALYLATION,0.60834,-0.018723,0.054497,0,0
4,GO SOMATIC STEM CELL DIVISION,0.39381,-0.018782,-0.059249,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.95639,-0.018828,0.019919,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.63697,-0.018941,0.044518,0,0
4,GO CELL CYCLE PROCESS,0.52345,-0.018965,-0.0013411,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.85694,-0.01897,0.034977,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.36526,-0.019354,-0.0045829,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.63697,-0.019383,-0.0050391,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.82526,-0.019551,-0.010836,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.73517,-0.020007,0.0044907,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.35253,-0.02001,-0.028573,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.99192,-0.020021,0.0020013,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.75972,-0.020056,-0.0035744,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.32195,-0.020712,-0.050307,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.76281,-0.020834,0.090917,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.85694,-0.020862,0.0042549,0,0
4,GO PROTEIN ACETYLATION,0.28945,-0.020913,-0.0099825,0,0
4,GO REPLACEMENT OSSIFICATION,0.38933,-0.021215,-0.039572,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.66616,-0.021231,0.025393,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.82842,-0.021239,0.022309,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.60268,-0.021288,-0.023833,0,0
4,GO CHROMATIN ORGANIZATION,0.23128,-0.021294,-0.018666,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.63697,-0.021338,-0.02231,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.58307,-0.021461,-0.0066664,0,0
4,GO AMINO ACID ACTIVATION,0.98222,-0.021588,0.0088544,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.33194,-0.021648,-0.012038,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.98546,-0.021707,-0.00030669,0,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.65442,-0.021738,-0.027935,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.45727,-0.021823,-0.0082826,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.34213,-0.022005,-0.01306,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.68988,-0.022181,0.084694,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.51296,-0.022226,-0.0051111,0,0
4,GO GENITALIA MORPHOGENESIS,0.87606,-0.022329,0.0039224,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.34627,-0.022395,0.062044,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.92416,-0.022516,-0.004942,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.80639,-0.022583,-0.012129,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.76899,-0.022612,0.025547,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.5394,-0.02264,-0.0094354,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.74435,-0.022643,-0.0083498,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.5583,-0.022696,-0.034049,0,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.37608,-0.023029,-0.012838,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.4451,-0.023145,-0.033009,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.51557,-0.023222,-0.04299,0,0
4,GO DNA METABOLIC PROCESS,0.16654,-0.023246,-0.02014,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.057711,-0.023308,-0.077338,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.83474,-0.023331,0.031553,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.97253,-0.023365,-0.0085305,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.47712,-0.023443,-0.040381,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.58307,-0.023508,0.055732,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.88885,-0.023658,-0.0017117,0,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.32792,-0.023669,-0.042223,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.66028,-0.023895,0.028086,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.6055,-0.023991,-0.013399,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.15447,-0.024054,-0.032268,0,0
4,GO HISTONE PHOSPHORYLATION,0.94671,-0.024338,0.0021029,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.67206,-0.024374,-0.01544,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.88565,-0.024813,0.0027326,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.92094,-0.025002,0.026052,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.14869,-0.025265,-0.01508,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.91772,-0.025305,0.022308,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.44028,-0.025323,-0.022497,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.68392,-0.025446,-0.019456,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.40058,-0.025553,-0.036789,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.91772,-0.025698,-0.0033023,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.49487,-0.025906,-0.026573,0,0
4,GO METAPHASE PLATE CONGRESSION,0.51296,-0.025919,-0.0033819,0,0
4,GO CELL DIVISION,0.28761,-0.025919,-0.01224,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.72907,-0.025992,0.0015626,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.74741,-0.026354,-0.013431,0,0
4,GO GENETIC IMPRINTING,0.98546,-0.026686,0.0082412,0,0
4,GO HISTONE H3 DEACETYLATION,0.81581,-0.026805,-0.00082283,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.63408,-0.026836,-0.038052,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.66616,-0.026904,0.03146,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.83474,-0.026926,-0.0029089,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.37608,-0.026947,-0.043157,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.2114,-0.026948,-0.022795,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.14197,-0.027096,-0.058201,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.95639,-0.027222,-0.0052444,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.50516,-0.027261,-0.0021146,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.88245,-0.027463,0.011791,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.58029,-0.027465,-0.014636,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.58029,-0.027769,-0.0060895,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.95961,-0.027924,-0.029173,0,0
4,GO RNA CATABOLIC PROCESS,0.06986,-0.028155,-0.067934,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.68392,-0.028193,0.004902,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.11837,-0.028275,-0.049519,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.25583,-0.028463,-0.068047,0,0
4,GO RNA DECAPPING,0.572,-0.028634,-0.0044375,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.40058,-0.028675,-0.060613,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.92416,-0.028938,0.028782,0,0
4,GO REGULATION OF ORGAN GROWTH,0.49231,-0.028983,-0.015348,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59144,-0.029264,-0.0075258,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.77209,-0.029373,-0.034195,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.50776,-0.029384,-0.020412,0,0
4,GO NUCLEUS LOCALIZATION,0.45727,-0.029407,-0.022164,0,0
4,GO REGULATION OF URINE VOLUME,0.81267,-0.029551,-0.0027692,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.91451,-0.029559,0.027948,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.99192,-0.029633,0.0011155,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.40743,-0.029723,-0.052802,0,0
4,GO CENTROSOME DUPLICATION,0.73822,-0.029756,0.0020327,0,0
4,GO NEPHRON TUBULE FORMATION,0.45727,-0.030249,-0.064541,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.4355,-0.030296,-0.030795,0,0
4,GO RESPONSE TO UV,0.38488,-0.030353,-0.012816,0,0
4,GO NEUROTRANSMITTER SECRETION,0.79387,-0.030512,0.035278,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.87606,-0.030515,-0.006062,0,0
4,GO REGULATION OF AXONOGENESIS,0.28761,-0.030574,-0.053814,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.59424,-0.030708,-0.013538,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.61972,-0.030743,-0.023799,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.60268,-0.03083,0.07837,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.18866,-0.03093,-0.022422,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.25924,-0.031027,-0.084983,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.9113,-0.031099,0.067175,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.51035,-0.031393,-0.022021,0,0
4,GO REGULATION OF MYELINATION,0.29877,-0.031598,-0.023879,0,0
4,GO MITOTIC CELL CYCLE,0.51296,-0.031655,2.7317e-05,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.70787,-0.031688,0.00016752,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.44752,-0.031787,-0.010435,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.53672,-0.032295,-0.017849,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.63986,-0.032314,0.04289,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.31409,-0.032568,-0.052043,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.55287,-0.032689,-0.035275,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.090011,-0.032702,-0.054894,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.99838,-0.033057,0.011956,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.38267,-0.033065,-0.034494,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.81581,-0.033543,0.0059493,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.27853,-0.033578,-0.031743,0,0
4,GO REGULATION OF GASTRULATION,0.96607,-0.03365,0.015727,0,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.23286,-0.033689,-0.042053,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.33194,-0.033755,-0.017781,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.50516,-0.03376,-0.03236,0,0
4,GO PROTEIN METHYLATION,0.46466,-0.03377,-0.020934,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.96284,-0.033968,0.049933,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.18866,-0.034047,-0.041017,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.16042,-0.034064,-0.064075,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.24252,-0.034159,-0.030191,0,0
4,GO DNA REPLICATION,0.099614,-0.034208,-0.037618,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.82211,-0.034319,0.019367,0,0
4,GO SNRNA TRANSCRIPTION,0.079071,-0.034621,-0.045133,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.30446,-0.034668,-0.031912,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.55287,-0.034965,-0.044702,0,0
4,GO HISTONE H4 DEACETYLATION,0.18866,-0.03502,-0.068791,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.84107,-0.035128,0.036318,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.32393,-0.035209,-0.081957,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.91451,-0.035227,0.0093857,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.5665,-0.0353,-0.023977,0,0
4,GO PROTEIN SUMOYLATION,0.40286,-0.035439,-0.01181,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.5394,-0.03556,-0.029652,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.10823,-0.035576,-0.079753,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.98546,-0.035597,-2.552e-05,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.10646,-0.035899,-0.082899,0,0
4,GO PROSTATIC BUD FORMATION,0.63697,-0.035936,-0.055061,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.49231,-0.035994,-0.0082877,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.96607,-0.036309,0.034158,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.49487,-0.036496,-0.046162,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.70185,-0.036524,-0.014652,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.086981,-0.036537,-0.094798,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.22658,-0.036538,-0.10174,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.38933,-0.036677,-0.032491,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.32195,-0.037181,-0.03946,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.25924,-0.037272,-0.046046,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.56103,-0.037435,-0.012882,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.09796,-0.037595,-0.039725,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.74128,-0.037725,0.025644,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.48215,-0.03777,-0.0019599,0,0
4,GO TRACHEA MORPHOGENESIS,0.98546,-0.037906,0.023507,0,0
4,GO LONG TERM MEMORY,0.68094,-0.038309,-0.017883,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.5314,-0.03831,-0.056772,0,0
4,GO HISTONE H3 K36 METHYLATION,0.31997,-0.038381,-0.056972,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.32195,-0.038454,-0.041349,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.26267,-0.038572,-0.017622,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.92416,-0.038684,0.014483,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.35463,-0.038815,-0.03791,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.6515,-0.038864,-0.0037269,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.99515,-0.039254,0.028521,0,0
4,GO REGULATION OF BEHAVIOR,0.61972,-0.039295,-0.010565,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.076344,-0.039297,-0.066432,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.21288,-0.039331,-0.047188,0,0
4,GO HISTONE METHYLATION,0.14088,-0.039373,-0.042127,0,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.32792,-0.0394,-0.012959,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.16407,-0.039585,-0.064183,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.13656,-0.039745,-0.058239,0,0
4,GO CELLULAR RESPONSE TO PH,0.86649,-0.039845,0.016579,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.75972,-0.039866,-0.016518,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.87287,-0.039921,0.03195,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.66616,-0.040096,-0.006812,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.22503,-0.040277,-0.042719,0,0
4,GO VIRAL LATENCY,0.10045,-0.040533,-0.066761,0,0
4,GO REGULATION OF DNA REPLICATION,0.59424,-0.04065,-0.0044948,0,0
4,GO REGULATION OF GENE SILENCING,0.084763,-0.040728,-0.043313,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.71089,-0.040781,0.029225,0,0
4,GO RESPONSE TO LEAD ION,0.27495,-0.040924,-0.029834,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.085497,-0.041018,-0.10363,0,0
4,GO NUCLEAR TRANSPORT,0.1387,-0.041065,-0.028318,0,0
4,GO MUSCLE CELL FATE COMMITMENT,0.64567,-0.041066,-0.041082,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.54746,-0.041083,-0.024018,0,0
4,GO CHROMOSOME LOCALIZATION,0.25583,-0.041102,-0.018358,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.11647,-0.041121,-0.061485,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.087731,-0.041136,-0.065255,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.12322,-0.04114,-0.032748,0,0
4,GO HISTONE H3 ACETYLATION,0.1873,-0.041184,-0.026175,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.32195,-0.041361,-0.034762,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.1873,-0.041464,-0.044403,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.26095,-0.041473,-0.057004,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.30446,-0.041526,-0.017111,0,0
4,GO MICROTUBULE BASED PROCESS,0.10734,-0.041558,-0.0304,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.64858,-0.041708,-0.0044861,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.95316,-0.041713,0.0099553,0,0
4,GO TRANSLATIONAL ELONGATION,0.12126,-0.041768,-0.057203,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.35043,-0.041982,-0.017106,0,0
4,GO SUCKLING BEHAVIOR,0.35253,-0.042014,-0.058848,0,0
4,GO HISTONE H3 K9 METHYLATION,0.21738,-0.042211,-0.043606,0,0
4,GO SNRNA PROCESSING,0.14869,-0.042346,-0.063294,0,0
4,GO SNRNA METABOLIC PROCESS,0.28213,-0.042346,-0.042803,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.52609,-0.042522,-0.0077843,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.75048,-0.042677,0.025426,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.45238,-0.043069,-0.047669,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.090011,-0.043611,-0.03649,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.2644,-0.043659,-0.0513,0,0
4,GO DNA RECOMBINATION,0.068619,-0.043801,-0.038781,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.45972,-0.04401,-0.05527,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.23766,-0.04405,-0.036944,0,0
4,GO CHROMOSOME ORGANIZATION,0.077018,-0.044106,-0.027642,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.60268,-0.044338,0.042631,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.32195,-0.044481,-0.070858,0,0
4,GO NCRNA 3 END PROCESSING,0.1914,-0.044732,-0.057547,0,0
4,GO DENDRITE MORPHOGENESIS,0.10385,-0.044764,-0.069893,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.74435,-0.04484,0.037097,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.17411,-0.044908,-0.023192,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.13234,-0.04493,-0.027888,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.12924,-0.045022,-0.05334,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.72603,-0.045033,0.038226,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.29502,-0.045053,-0.029498,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.081168,-0.045092,-0.039812,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.17029,-0.045108,-0.053118,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.23445,-0.045118,-0.032833,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.49487,-0.045206,-0.052665,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.15447,-0.045313,-0.04543,0,0
4,GO TONGUE DEVELOPMENT,0.58029,-0.045321,-0.041994,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.14755,-0.045827,-0.020041,0,0
4,GO LIVER REGENERATION,0.33803,-0.046168,-0.041735,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.52345,-0.046172,-0.036765,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.45482,-0.046299,-0.02525,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.11933,-0.046392,-0.052691,0,0
4,GO REGULATION OF CYTOKINESIS,0.26614,-0.046435,-0.015695,0,0
4,GO TRNA PROCESSING,0.02945,-0.046457,-0.086663,0,0
4,GO TRNA 5 END PROCESSING,0.46713,-0.04652,-0.030708,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.64276,-0.046757,0.025517,0,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.19557,-0.046783,-0.054304,0,0
4,GO SHORT TERM MEMORY,0.88885,-0.046991,-0.0099995,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.40973,-0.047217,-0.034818,0,0
4,GO AXON EXTENSION,0.09796,-0.047305,-0.068533,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.031953,-0.04741,-0.070098,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.26789,-0.047412,-0.043293,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.18194,-0.047713,-0.05932,0,0
4,GO TRANSLATIONAL TERMINATION,0.34627,-0.04776,-0.036486,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.22658,-0.047918,-0.026828,0,0
4,GO DNA METHYLATION,0.34008,-0.047947,-0.027253,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.91451,-0.047962,0.0063156,0,0
4,GO SULFATION,0.15921,-0.048093,-0.0792,0,0
4,GO PEPTIDYL LYSINE METHYLATION,0.16407,-0.048261,-0.040537,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.26964,-0.048285,-0.049485,0,0
4,GO FOREBRAIN CELL MIGRATION,0.29315,-0.048327,-0.048275,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.73822,-0.048485,-0.023596,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.38267,-0.048544,-0.027893,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.94671,-0.04859,0.033034,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.10299,-0.048632,-0.047656,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.30066,-0.048751,-0.051351,0,0
4,GO HISTONE UBIQUITINATION,0.2458,-0.049023,-0.023545,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.41666,-0.049307,-0.044575,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.21437,-0.04936,-0.098084,0,0
4,GO NEURON RECOGNITION,0.21738,-0.049705,-0.084205,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.88565,-0.049874,0.021252,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.29315,-0.050253,-0.02691,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.14419,-0.050343,-0.06693,0,0
4,GO PENTOSE METABOLIC PROCESS,0.96607,-0.050347,0.0055371,0,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.17411,-0.050417,-0.074348,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.078382,-0.050578,-0.03243,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.10045,-0.050578,-0.061141,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.572,-0.050786,0.050364,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.12822,-0.050848,-0.05795,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.13549,-0.050879,-0.039176,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.44028,-0.050902,-0.050377,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.43075,-0.051072,-0.034531,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.99515,-0.051605,-0.011003,0,0
4,GO UTERUS DEVELOPMENT,0.51035,-0.051645,-0.038344,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.52874,-0.05175,-0.029294,0,0
4,GO DENDRITE DEVELOPMENT,0.23927,-0.05187,-0.042335,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.13338,-0.051995,-0.1031,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.99192,-0.052021,0.0089041,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.42367,-0.052055,-0.043082,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.40058,-0.052651,-0.033914,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.97253,-0.052681,0.00039776,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.35043,-0.052972,-0.032537,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.13549,-0.053205,-0.043856,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.17411,-0.053308,-0.049411,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.26789,-0.05339,-0.043661,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.14197,-0.053672,-0.056564,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.30446,-0.053892,-0.028539,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.32393,-0.053915,-0.018179,0,0
4,GO BONE MORPHOGENESIS,0.25924,-0.054015,-0.045218,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.75972,-0.05415,0.0078006,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.092339,-0.054171,-0.060661,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.42367,-0.05431,-0.040745,0,0
4,GO WALKING BEHAVIOR,0.23128,-0.054534,-0.046366,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.16163,-0.054556,-0.056307,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.27495,-0.054564,-0.044444,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.69885,-0.054653,0.0011701,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.19278,-0.054674,-0.089028,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.6055,-0.055105,-0.009686,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.17669,-0.055303,-0.094553,0,0
4,GO HISTONE H3 K4 METHYLATION,0.1313,-0.055513,-0.054355,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.41203,-0.055525,-0.035783,0,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.44752,-0.055734,-0.053571,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.38047,-0.05584,-0.05805,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.22042,-0.055872,-0.045616,0,0
4,GO OOCYTE MATURATION,0.80639,-0.055963,-0.0070113,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.086981,-0.055992,-0.040594,0,0
4,GO NEURAL TUBE PATTERNING,0.15683,-0.056097,-0.078752,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.26095,-0.056174,-0.03747,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.25246,-0.056186,-0.055229,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.23927,-0.056388,-0.040672,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.80012,-0.056481,0.071285,0,0
4,GO CELLULAR RESPONSE TO X RAY,0.068006,-0.056555,-0.10293,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.4355,-0.057354,-0.02839,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.58585,-0.057356,-0.044032,0,0
4,GO REGULATION OF OOGENESIS,0.41203,-0.057845,-0.019531,0,0
4,GO CELLULAR RESPONSE TO UV,0.11367,-0.057928,-0.040849,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.42602,-0.058022,0.009512,0,0
4,GO BRAIN MORPHOGENESIS,0.19697,-0.058486,-0.060783,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.093918,-0.058875,-0.044521,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.33803,-0.059232,-0.029627,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.91772,-0.059388,0.02732,0,0
4,GO HISTONE H2A ACETYLATION,0.29877,-0.059733,-0.039752,0,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.13979,-0.05975,-0.046818,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.97576,-0.059846,0.013684,0,0
4,GO MRNA CLEAVAGE,0.039406,-0.060091,-0.053388,0,0
4,GO MUSCLE FILAMENT SLIDING,0.22971,-0.060093,-0.067975,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.33599,-0.060684,-0.020286,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.65442,-0.060823,-0.019772,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.32195,-0.060858,-0.033863,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.26267,-0.060903,-0.027469,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.25583,-0.061189,-0.061774,0,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.065005,-0.06125,-0.065465,0,0
4,GO SISTER CHROMATID SEGREGATION,0.032938,-0.06127,-0.046741,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.025743,-0.061401,-0.078487,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.58864,-0.061777,0.02263,0,0
4,GO NEURAL CREST FORMATION,0.39156,-0.061828,-0.067665,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.6055,-0.061872,-0.01151,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.88565,-0.061877,0.0010441,0,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.14419,-0.061903,-0.062876,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.31604,-0.062043,-0.018539,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.14088,-0.062195,-0.081709,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.44752,-0.062244,-0.024041,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.12721,-0.062276,-0.084079,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.51296,-0.062277,-0.066743,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.21889,-0.06236,-0.05948,0,0
4,GO HAIR FOLLICLE MATURATION,0.88885,-0.062464,0.0033002,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.012367,-0.062532,-0.088114,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.073043,-0.062604,-0.050214,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.9306,-0.062637,0.022772,0,0
4,GO COCHLEA MORPHOGENESIS,0.90488,-0.062818,0.012421,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.2913,-0.063053,-0.068234,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.58029,-0.063119,-0.030696,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.037509,-0.063274,-0.044899,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.044292,-0.063566,-0.060937,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.17156,-0.06364,-0.039607,0,0
4,GO INTRACILIARY TRANSPORT,0.2114,-0.064515,-0.061227,0,0
4,GO TRACHEA DEVELOPMENT,0.72603,-0.064832,-0.009246,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.13234,-0.06528,-0.047941,0,0
4,GO MITOTIC RECOMBINATION,0.086237,-0.06553,-0.079203,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.40058,-0.065914,-0.01523,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.89205,-0.065981,0.037755,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.68988,-0.066305,0.0090234,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.15098,-0.066525,-0.034871,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.19557,-0.067291,-0.046121,0,0
4,GO MITOCHONDRION LOCALIZATION,0.071756,-0.06742,-0.052366,0,0
4,GO NUCLEAR MIGRATION,0.22195,-0.067803,-0.051758,0,0
4,GO REGULATION OF LYASE ACTIVITY,0.067397,-0.068066,-0.081966,0,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.12126,-0.068837,-0.062627,0,0
4,GO PALLIUM DEVELOPMENT,0.16654,-0.068906,-0.034894,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.2913,-0.068997,-0.074935,0,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.13338,-0.069183,-0.089461,0,0
4,GO OXIDATIVE DEMETHYLATION,0.058787,-0.06928,-0.05768,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0059852,-0.069572,-0.085801,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.12924,-0.06967,-0.067607,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.10646,-0.069983,-0.0728,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.21288,-0.069995,-0.078806,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.1754,-0.070034,-0.12876,0,0
4,GO HISTONE EXCHANGE,0.093126,-0.070155,-0.058492,0,0
4,GO CHROMOSOME SEGREGATION,0.034984,-0.070206,-0.043663,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.039795,-0.070241,-0.0613,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.20409,-0.070305,-0.058759,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.66028,-0.070407,-0.0087113,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.12721,-0.070451,-0.035165,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.05357,-0.070549,-0.083449,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.18866,-0.070645,-0.059445,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.33803,-0.071259,-0.067512,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.68392,-0.07139,0.0013197,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.19278,-0.071579,-0.051618,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.073043,-0.071591,-0.038022,0,0
4,GO CHROMATIN REMODELING,0.009139,-0.071608,-0.061378,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.18327,-0.071701,-0.042335,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.34008,-0.071941,-0.040129,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.15565,-0.071962,-0.064253,0,0
4,GO NEURON PROJECTION GUIDANCE,0.076344,-0.072065,-0.078852,0,0
4,GO SPINDLE LOCALIZATION,0.11183,-0.072162,-0.040572,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.23128,-0.07222,-0.031954,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.22658,-0.072802,-0.011892,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.02174,-0.072882,-0.057515,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.62258,-0.073162,-0.021143,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.11367,-0.07323,-0.093518,0,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.025475,-0.07328,-0.081006,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.77519,-0.073293,0.0043659,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.072397,-0.073875,-0.091683,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.3442,-0.074033,-0.082825,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.1914,-0.074374,-0.099233,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.99515,-0.07442,0.042195,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.13549,-0.074449,-0.060175,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.093126,-0.07481,-0.059928,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.40743,-0.075168,-0.0061753,0,0
4,GO CELL JUNCTION MAINTENANCE,0.35253,-0.075202,-0.039824,0,0
4,GO RNA METHYLATION,0.14642,-0.075301,-0.050302,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.087731,-0.075376,-0.056133,0,0
4,GO CELL CYCLE DNA REPLICATION,0.013856,-0.075377,-0.077106,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.27495,-0.075456,-0.052706,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.18062,-0.075586,-0.12633,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.13549,-0.075604,-0.099352,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.1252,-0.07568,-0.068545,0,0
4,GO SPINDLE ASSEMBLY,0.024428,-0.075684,-0.045764,0,0
4,GO REGULATION OF AXON GUIDANCE,0.1914,-0.075817,-0.050033,0,0
4,GO MICROTUBULE POLYMERIZATION,0.03068,-0.075838,-0.078587,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.09714,-0.076087,-0.078724,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.24911,-0.076319,-0.044509,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.23766,-0.076552,-0.086011,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.42602,-0.07697,-0.043024,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.19003,-0.077082,-0.057969,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.098784,-0.077289,-0.052245,0,0
4,GO NUCLEOSOME ASSEMBLY,0.044722,-0.077817,-0.072598,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0056255,-0.077856,-0.062479,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.068619,-0.078105,-0.045825,0,0
4,GO PROSTATE GLAND GROWTH,0.13763,-0.078285,-0.12939,0,0
4,GO RRNA METHYLATION,0.34008,-0.078291,-0.035594,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.15921,-0.078292,-0.036585,0,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.21738,-0.078735,-0.040568,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.30829,-0.078804,-0.037727,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.18194,-0.079075,-0.094945,0,0
4,GO MRNA PROCESSING,0.000662,-0.079177,-0.090529,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.042197,-0.07925,-0.10935,0,0
4,GO FILOPODIUM ASSEMBLY,0.31997,-0.07949,-0.027003,0,0
4,GO RNA CAPPING,0.008211,-0.080008,-0.071818,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.038258,-0.080054,-0.08887,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.65734,-0.080219,0.0054589,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.089246,-0.080362,-0.095524,0,0
4,GO HISTONE H4 K16 ACETYLATION,0.066792,-0.08059,-0.062511,0,0
4,GO NEURON FATE SPECIFICATION,0.62258,-0.080634,0.0040963,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.042609,-0.080778,-0.094833,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.24416,-0.080795,-0.073776,0,0
4,GO SISTER CHROMATID COHESION,0.14088,-0.081676,-0.044115,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.091558,-0.082365,-0.11706,0,0
4,GO RNA 5 END PROCESSING,0.21437,-0.082758,-0.044218,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.72299,-0.082781,0.02259,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.1313,-0.083,-0.075139,0,0
4,GO HISTONE H3 K9 ACETYLATION,0.0072795,-0.083087,-0.10952,0,0
4,GO CENTRIOLE ASSEMBLY,0.057179,-0.083352,-0.059423,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.086237,-0.083493,-0.041485,0,0
4,GO DNA CONFORMATION CHANGE,0.006444,-0.083625,-0.063416,0,0
4,GO NEURON PROJECTION ORGANIZATION,0.084034,-0.084091,-0.085196,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.25414,-0.084474,-0.017999,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.12126,-0.085141,-0.068329,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.36526,-0.085168,-0.066204,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.017315,-0.085222,-0.11369,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.32792,-0.085413,-0.06519,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.71089,-0.085741,-0.0067121,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.3442,-0.085847,-0.036703,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.58864,-0.086226,-0.057292,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.13444,-0.08673,-0.063241,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.094715,-0.087043,-0.055245,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.070488,-0.087135,-0.086071,0,0
4,GO PROTEIN DENEDDYLATION,0.077018,-0.087469,-0.07254,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.032938,-0.08758,-0.088006,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.1387,-0.088375,-0.065127,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.36526,-0.088618,-0.04791,0,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.091558,-0.08887,-0.10722,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.30829,-0.089306,-0.09317,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.33194,-0.090017,-0.039506,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.046031,-0.090118,-0.055276,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.090011,-0.090341,-0.063178,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.81581,-0.090376,0.0036755,0,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0047198,-0.090735,-0.096863,0,0
4,GO TRNA METHYLATION,0.10471,-0.09126,-0.073057,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.021973,-0.092112,-0.085272,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.44269,-0.09247,-0.061902,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.026013,-0.092592,-0.088226,0,0
4,GO RECOMBINATIONAL REPAIR,0.0022396,-0.092651,-0.086936,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.47461,-0.093301,-0.028678,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.21288,-0.093514,-0.054569,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.13549,-0.093879,-0.048518,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.22814,-0.094057,-0.11699,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.16407,-0.094115,-0.077653,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.11002,-0.094389,-0.084073,0,0
4,GO SPINDLE ORGANIZATION,0.0052854,-0.094628,-0.061705,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.085497,-0.094664,-0.10156,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0029645,-0.094706,-0.13412,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.17283,-0.094935,-0.084642,0,0
4,GO G0 TO G1 TRANSITION,0.014172,-0.095049,-0.079446,0,0
4,GO RNA SPLICING,0.0002117,-0.09558,-0.10233,0,0
4,GO FOREBRAIN REGIONALIZATION,0.090011,-0.095592,-0.099854,0,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0068504,-0.095889,-0.072461,0,0
4,GO RIBOSOME ASSEMBLY,0.0060595,-0.096058,-0.18464,0,0
4,GO NEURON MIGRATION,0.10385,-0.096637,-0.073446,0,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.0083098,-0.097317,-0.11985,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.97253,-0.097476,0.031165,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.1754,-0.097565,-0.071515,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.73822,-0.097784,0.0028963,0,0
4,GO TELOMERE CAPPING,0.037882,-0.099144,-0.046438,0,0
4,GO MYOBLAST MIGRATION,0.068006,-0.099279,-0.18409,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.080464,-0.099299,-0.078522,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0025277,-0.099319,-0.10841,0,0
4,GO NODAL SIGNALING PATHWAY,0.29502,-0.099747,-0.048082,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.34008,-0.10026,-0.062994,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.30829,-0.10036,-0.092902,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.10823,-0.101,-0.11857,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00082553,-0.10114,-0.095393,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.077018,-0.10115,-0.0603,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.045155,-0.10144,-0.071062,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.318,-0.10145,-0.066708,0,0
4,GO SPINAL CORD DEVELOPMENT,0.11742,-0.10273,-0.070582,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.00095459,-0.10277,-0.092757,0,0
4,GO DNA PACKAGING,0.0104,-0.1028,-0.063456,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.077698,-0.10298,-0.052687,0,0
4,GO MICROTUBULE NUCLEATION,0.041383,-0.10306,-0.050243,0,0
4,GO UV PROTECTION,0.10912,-0.10311,-0.10304,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.087731,-0.10358,-0.08033,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.18595,-0.10398,-0.089972,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.032607,-0.1041,-0.099995,0,0
4,GO REGULATION OF HEART GROWTH,0.23766,-0.1042,-0.041479,0,0
4,GO MICROTUBULE SEVERING,0.10823,-0.10446,-0.083876,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.058787,-0.10485,-0.089783,0,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0089251,-0.10535,-0.087093,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.074349,-0.10549,-0.059291,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.0096941,-0.10596,-0.064501,0,0
4,GO NEURAL CREST CELL MIGRATION,0.11553,-0.1065,-0.07578,0,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.14869,-0.10663,-0.053895,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.20122,-0.10704,-0.11168,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0018764,-0.10705,-0.12375,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.25924,-0.10734,-0.061558,0,0
4,GO CHROMOSOME SEPARATION,0.01251,-0.10745,-0.076689,0,0
4,GO CARTILAGE MORPHOGENESIS,0.081168,-0.10821,-0.14454,0,0
4,GO REPLICATION FORK PROCESSING,0.0012005,-0.10824,-0.15161,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.091558,-0.10842,-0.070742,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.071119,-0.10849,-0.10278,0,0
4,GO GLYCINE METABOLIC PROCESS,0.086237,-0.10857,-0.084487,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.0021215,-0.10912,-0.089944,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.1146,-0.10953,-0.05217,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0032928,-0.10953,-0.093527,0,0
4,GO NUCLEOSOME ORGANIZATION,0.0023957,-0.10953,-0.092276,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.26964,-0.11009,-0.040513,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0060595,-0.11029,-0.21759,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.074349,-0.11057,-0.1319,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.055093,-0.11121,-0.14037,0,0
4,GO RNA STABILIZATION,0.0035146,-0.11253,-0.087693,0,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0024281,-0.11268,-0.086151,0,0
4,GO NEURON FATE COMMITMENT,0.18194,-0.11325,-0.053059,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.26267,-0.11327,-0.087108,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.30829,-0.11418,-0.041293,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00032408,-0.11438,-0.21228,0,0
4,GO DNA REPLICATION CHECKPOINT,0.0089251,-0.11443,-0.12083,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.02945,-0.1145,-0.084108,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.058247,-0.11528,-0.094129,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.1873,-0.11542,-0.10486,0,0
4,GO REGULATION OF MRNA PROCESSING,0.0005211,-0.11601,-0.10117,0,0
4,GO SYNAPTIC VESICLE MATURATION,0.23445,-0.11806,-0.074525,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.2114,-0.1192,-0.063107,0,0
4,GO DNA STRAND ELONGATION,0.0025617,-0.11956,-0.10621,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.11002,-0.11965,-0.074078,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.12126,-0.11978,-0.087246,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00072342,-0.11981,-0.096439,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.077698,-0.12026,-0.099334,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.1252,-0.12044,-0.07731,0,0
4,GO IMP METABOLIC PROCESS,0.056652,-0.12078,-0.13663,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.01251,-0.12239,-0.090434,0,0
4,GO MRNA METHYLATION,0.012227,-0.12241,-0.11229,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.15921,-0.12251,-0.09295,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.1453,-0.12279,-0.1499,0,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.47963,-0.12435,-0.075565,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.06986,-0.12451,-0.10988,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.15802,-0.12457,-0.083601,0,0
4,GO CHONDROCYTE PROLIFERATION,0.17669,-0.12524,-0.084445,0,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,2.5424e-05,-0.12555,-0.12667,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.10646,-0.12579,-0.084566,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0049019,-0.12606,-0.12395,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0038977,-0.12643,-0.13947,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.50516,-0.12834,-0.029044,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.024428,-0.12925,-0.08969,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.52345,-0.13087,-0.042469,0,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00040235,-0.13137,-0.096344,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.027401,-0.13205,-0.10506,0,0
4,GO CHROMOSOME CONDENSATION,0.012653,-0.13294,-0.084042,0,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.009139,-0.13305,-0.095032,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.015674,-0.13336,-0.12763,0,0
4,GO RETROGRADE AXONAL TRANSPORT,0.0015463,-0.13355,-0.17381,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.22195,-0.13434,-0.095504,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.070488,-0.13493,-0.11524,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.11367,-0.135,-0.13957,0,0
4,GO KINETOCHORE ORGANIZATION,0.073694,-0.13656,-0.078829,0,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.023919,-0.13814,-0.091553,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.0053519,-0.13893,-0.11722,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.019735,-0.13912,-0.15326,0,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00058763,-0.13949,-0.10122,0,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.02521,-0.1401,-0.096529,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.10385,-0.14032,-0.1413,0,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.31409,-0.14109,-0.032835,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.019523,-0.14175,-0.12365,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.093918,-0.14185,-0.11563,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.068619,-0.14208,-0.13489,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.055609,-0.14277,-0.11333,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0007786,-0.14277,-0.098531,0,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,4.8839e-05,-0.14344,-0.13701,0,0
4,GO VOCALIZATION BEHAVIOR,0.093918,-0.14375,-0.18626,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.046031,-0.14414,-0.11857,0,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00032916,-0.14691,-0.20109,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00096848,-0.14726,-0.15075,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0045438,-0.14851,-0.12898,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.011678,-0.15093,-0.092423,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00060545,-0.15178,-0.14031,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.026838,-0.15202,-0.13345,0,0
4,GO HINDLIMB MORPHOGENESIS,0.074349,-0.15245,-0.095738,0,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00040235,-0.15291,-0.15571,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,2.3661e-05,-0.15305,-0.17121,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.12126,-0.1533,-0.12231,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.15921,-0.15399,-0.10316,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.09796,-0.15424,-0.07876,0,0
4,GO V D J RECOMBINATION,0.079071,-0.15607,-0.10699,0,0
4,GO DNA REPLICATION INITIATION,1.1806e-05,-0.15634,-0.17223,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.015674,-0.15659,-0.1431,0,0
4,GO MRNA MODIFICATION,0.0086125,-0.15831,-0.12982,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.12822,-0.16071,-0.094899,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.19838,-0.16224,-0.14391,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.10646,-0.16581,-0.10321,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.082591,-0.16748,-0.10136,0,0
4,GO HEART VALVE FORMATION,0.1533,-0.16762,-0.12357,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0049019,-0.16827,-0.16147,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.054582,-0.16861,-0.11104,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,8.3013e-05,-0.16876,-0.14393,0,0
4,GO SNORNA 3 END PROCESSING,0.0018764,-0.16941,-0.17548,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00049053,-0.17286,-0.20745,0,0
4,GO KINETOCHORE ASSEMBLY,0.085497,-0.17506,-0.083434,0,0
4,GO LEUKOCYTE AGGREGATION,0.18062,-0.17548,-0.14191,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.093126,-0.17594,-0.13651,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.50516,-0.1767,-0.041589,0,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0019819,-0.17744,-0.13164,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.5576e-05,-0.17886,-0.14886,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.098784,-0.17913,-0.11364,0,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.00028155,-0.17932,-0.16855,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.006444,-0.17939,-0.1345,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0046604,-0.18057,-0.14087,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0010408,-0.18295,-0.19272,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.046031,-0.18331,-0.14415,0,0
4,GO BONE GROWTH,0.080464,-0.18371,-0.097972,0,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,2.011e-05,-0.18602,-0.17736,0,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0018508,-0.18678,-0.12735,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.10385,-0.18804,-0.10446,0,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.082591,-0.19011,-0.1385,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.23766,-0.19057,-0.12419,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.015501,-0.19776,-0.13608,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.1806e-05,-0.20659,-0.22053,0,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.5865e-05,-0.20719,-0.18335,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.077018,-0.21971,-0.19017,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.35043,-0.22349,-0.078568,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0053519,-0.23498,-0.17407,0,0
4,GO L SERINE METABOLIC PROCESS,0.15447,-0.23553,-0.12596,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,1.5293e-05,-0.24448,-0.25323,0,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,1.8053e-06,-0.25538,-0.22285,0,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0032078,-0.25915,-0.2327,0,0
4,GO CHROMATIN DISASSEMBLY,1.2482e-05,-0.26435,-0.21794,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.021509,-0.26614,-0.1544,0,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00013016,-0.28211,-0.29636,0,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0015463,-0.28738,-0.22164,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.075674,-0.29789,-0.20121,0,0
